data_2l2b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l2b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.28 145.48 39.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.778 -1.201 . . . . 0.0 111.472 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.69 34.68 62.7 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.942 0.782 . . . . 0.0 114.363 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -146.14 -174.17 4.37 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.284 1.042 . . . . 0.0 111.843 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 143.49 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.682 1.593 . . . . 0.0 111.772 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.36 167.17 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.035 1.734 . . . . 0.0 112.253 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 116.43 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.964 1.306 . . . . 0.0 113.057 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.19 65.49 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.024 1.297 . . . . 0.0 113.141 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.77 -20.64 61.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.26 1.424 . . . . 0.0 113.448 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -110.35 -0.99 17.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.57 1.548 . . . . 0.0 112.834 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 tp -80.41 115.34 19.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.14 1.376 . . . . 0.0 112.013 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -142.2 169.18 18.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.232 1.413 . . . . 0.0 110.941 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.3 -40.96 50.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.865 1.666 . . . . 0.0 113.889 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.373 1.069 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.05 -45.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.019 1.728 . . . . 0.0 109.938 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -54.6 -47.06 73.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.385 0.674 . . . . 0.0 110.635 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.88 -52.6 63.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.636 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -48.26 -47.89 35.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.673 1.189 . . . . 0.0 112.658 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.83 -58.77 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.728 1.211 . . . . 0.0 111.853 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -32.55 73.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.09 1.356 . . . . 0.0 113.076 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.47 -55.96 13.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.224 1.01 . . . . 0.0 111.229 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -24.71 61.39 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.52 -48.29 69.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.741 1.616 . . . . 0.0 110.887 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 60.39 0.27 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.634 1.588 . . . . 0.0 111.662 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -53.53 119.64 5.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.282 1.433 . . . . 0.0 112.301 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -169.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.014 1.726 . . . . 0.0 110.074 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m -41.07 -42.96 2.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.708 2.403 . . . . 0.0 112.874 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 mtm105 -143.0 144.52 32.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.377 1.871 . . . . 0.0 109.575 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.99 165.08 4.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.71 2.804 . . . . 0.0 110.743 -170.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.8 pt -139.95 173.04 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.536 1.534 . . . . 0.0 110.652 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.01 107.15 6.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.991 1.316 . . . . 0.0 110.752 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.69 137.67 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.983 1.313 . . . . 0.0 111.451 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.7 116.98 0.8 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.746 0.689 . . . . 0.0 113.216 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.27 105.55 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.318 1.059 . . . . 0.0 109.694 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -84.6 108.87 17.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.293 1.437 . . . . 0.0 112.92 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -75.49 97.96 3.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.342 1.457 . . . . 0.0 111.393 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 8.94 12.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.469 1.908 . . . . 0.0 113.041 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.2 m -64.44 -44.94 89.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.09 -0.9 5.75 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.163 1.363 . . . . 0.0 116.329 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.76 28.07 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.745 1.773 . . . . 0.0 114.316 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -74.88 139.14 42.93 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.492 1.117 . . . . 0.0 113.112 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -111.8 163.31 14.32 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.696 1.199 . . . . 0.0 112.249 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.2 m -131.07 108.04 9.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.085 1.354 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 110.79 3.54 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.023 0.929 . . . . 0.0 108.987 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.36 -63.9 1.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.699 1.6 . . . . 0.0 111.097 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.23 170.39 2.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.299 2.24 . . . . 0.0 111.152 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.7 139.3 53.66 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 127.308 2.243 . . . . 0.0 110.489 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -131.61 114.87 15.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.183 1.793 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.68 101.3 5.7 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.563 1.545 . . . . 0.0 111.808 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -68.01 -42.96 79.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.219 1.408 . . . . 0.0 112.944 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -146.48 154.1 41.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.99 1.716 . . . . 0.0 111.381 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.55 -163.96 54.51 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.818 -0.551 . . . . 0.0 112.7 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.49 161.26 41.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.904 0.882 . . . . 0.0 110.546 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -145.43 137.7 25.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 110.131 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.21 4.71 44.72 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.749 1.219 . . . . 0.0 113.353 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -120.53 175.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.33 1.852 . . . . 0.0 113.564 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.03 132.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 109.843 -172.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 142.82 81.56 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 121.663 -0.648 . . . . 0.0 110.332 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.73 175.22 5.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 125.091 3.861 . . . . 0.0 111.533 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.15 -26.27 8.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.079 -1.013 . . . . 0.0 112.69 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -124.02 130.56 52.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 0.0 111.001 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -133.38 88.15 35.88 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.288 1.435 . . . . 0.0 109.425 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.32 163.39 23.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.306 2.004 . . . . 0.0 112.277 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.61 158.05 19.19 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.393 -0.817 . . . . 0.0 111.703 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 66.03 4.14 2.92 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.51 2.324 . . . . 0.0 114.208 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -126.9 147.9 50.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.325 1.85 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.96 158.0 27.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.349 1.459 . . . . 0.0 110.993 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.91 167.61 10.98 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.29 132.16 47.11 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.934 1.694 . . . . 0.0 108.763 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.67 163.57 35.48 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.374 1.07 . . . . 0.0 111.925 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.7 m -143.08 177.17 8.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.185 1.394 . . . . 0.0 111.298 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.74 97.66 0.14 Allowed Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.729 -1.04 . . . . 0.0 113.307 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.95 166.21 10.58 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.982 1.391 . . . . 0.0 113.595 -173.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -86.38 101.35 13.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.71 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t0 39.65 -146.14 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 126.683 1.993 . . . . 0.0 112.405 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -61.76 -35.44 78.13 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 119.706 -1.871 . . . . 0.0 112.151 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.74 -58.86 0.53 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.299 1.428 . . . . 0.0 113.565 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.62 4.38 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.947 3.765 . . . . 0.0 115.382 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.05 126.04 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.124 2.169 . . . . 0.0 110.485 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.33 62.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.429 1.491 . . . . 0.0 112.556 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -66.31 0.91 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.691 1.596 . . . . 0.0 111.777 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 175.09 39.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.529 2.014 . . . . 0.0 110.334 -173.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.09 102.41 3.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.892 1.277 . . . . 0.0 107.937 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.97 134.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.036 1.734 . . . . 0.0 108.188 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.67 159.52 38.48 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 124.382 1.073 . . . . 0.0 110.068 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.8 146.46 33.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 110.858 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.05 169.15 21.9 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.2 1.8 . . . . 0.0 110.236 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.78 146.84 34.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.122 0.569 . . . . 0.0 111.703 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.83 118.83 23.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.824 0.85 . . . . 0.0 110.871 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 114.09 17.93 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.846 1.658 . . . . 0.0 110.274 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.7 mtt -70.72 162.47 29.0 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.491 0.662 . . . . 0.0 112.182 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t -60.18 -23.45 63.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.82 1.248 . . . . 0.0 113.722 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -10.69 56.21 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.535 1.534 . . . . 0.0 113.39 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.56 9.86 56.14 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.772 1.177 . . . . 0.0 115.179 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -87.06 171.72 10.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.372 1.086 . . . . 0.0 110.263 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.5 m -129.99 147.53 51.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.439 0.696 . . . . 0.0 110.961 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.08 111.75 16.32 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.26 139.54 28.21 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.5 t -143.31 131.54 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.066 0.947 . . . . 0.0 109.84 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -143.77 160.51 40.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.93 -0.481 . . . . 0.0 111.77 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 153.05 46.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.894 1.278 . . . . 0.0 110.187 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -145.89 113.36 6.3 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.976 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.0 110.55 43.69 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 126.634 1.974 . . . . 0.0 108.224 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -79.33 175.27 10.95 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.486 2.791 . . . . 0.0 111.399 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -81.63 -40.94 22.19 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.814 -0.554 . . . . 0.0 111.269 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 112.51 24.33 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.476 -0.765 . . . . 0.0 112.789 -161.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.14 -54.85 41.02 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.17 17.16 24.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.14 1.376 . . . . 0.0 113.829 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.62 -3.57 2.62 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.286 1.834 . . . . 0.0 112.748 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -173.61 4.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.34 2.656 . . . . 0.0 109.692 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -152.58 160.65 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.492 1.517 . . . . 0.0 110.596 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.48 158.0 31.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.316 1.046 . . . . 0.0 110.214 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -143.68 151.88 40.64 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.283 -0.886 . . . . 0.0 111.932 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -164.38 154.55 14.47 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.952 1.701 . . . . 0.0 109.675 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -143.78 140.27 29.82 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.894 1.677 . . . . 0.0 108.8 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.21 124.37 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 128.952 2.901 . . . . 0.0 109.6 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -144.9 148.32 33.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.498 1.919 . . . . 0.0 109.894 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.92 113.53 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.827 1.651 . . . . 0.0 108.868 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -126.23 142.95 51.32 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.558 1.543 . . . . 0.0 112.939 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.0 p -75.34 92.67 2.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.14 . . . . 0.0 112.537 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.64 -167.88 39.83 Favored Glycine 0 N--CA 1.471 0.993 0 O-C-N 121.531 -0.731 . . . . 0.0 114.397 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 119.19 24.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.489 1.915 . . . . 0.0 111.398 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.22 156.11 40.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 111.133 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -137.93 161.87 35.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.34 1.456 . . . . 0.0 111.056 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 90.72 2.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.411 0.684 . . . . 0.0 111.15 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -110.23 -66.57 1.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.136 1.374 . . . . 0.0 109.135 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -70.92 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.58 1.552 . . . . 0.0 109.35 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.56 81.33 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.333 0.968 . . . . 0.0 114.333 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -69.6 -53.08 20.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.293 1.046 . . . . 0.0 110.78 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.25 -43.76 79.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.792 0.837 . . . . 0.0 110.428 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -62.6 -46.37 88.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -56.86 -19.94 20.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.722 1.146 . . . . 0.0 113.377 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.66 -59.13 2.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.227 1.411 . . . . 0.0 110.438 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.99 -56.55 19.82 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.299 1.04 . . . . 0.0 111.383 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -80.93 -16.66 52.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.198 1.399 . . . . 0.0 112.064 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.28 -77.17 0.25 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 0.0 113.271 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -162.41 90.75 1.33 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.935 1.694 . . . . 0.0 109.966 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.28 158.15 45.16 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.016 1.144 . . . . 0.0 110.492 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.74 5.84 50.39 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.74 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 130.145 3.378 . . . . 0.0 117.808 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.07 5.39 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.043 -1.035 . . . . 0.0 112.245 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -63.55 7.18 0.11 Allowed 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.347 11.3 p30 55.84 25.55 8.63 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.193 2.597 . . . . 0.0 116.424 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -139.58 165.44 25.82 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.456 1.979 . . . . 0.0 111.499 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -70.42 114.53 8.64 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.16 -1.2 . . . . 0.0 109.689 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 127.77 53.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.043 1.337 . . . . 0.0 109.975 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.08 139.34 21.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.185 1.394 . . . . 0.0 110.352 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -144.65 126.46 15.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.241 1.416 . . . . 0.0 109.921 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -62.1 117.6 6.22 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.805 0.442 . . . . 0.0 111.414 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -142.98 -26.62 0.59 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.486 1.114 . . . . 0.0 113.93 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.18 15.82 20.35 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.821 1.201 . . . . 0.0 114.469 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.45 10.62 1.92 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.829 2.452 . . . . 0.0 115.403 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.9 -47.6 0.05 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.274 1.416 . . . . 0.0 112.773 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.52 161.49 17.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 111.324 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 170.99 19.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 113.074 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.73 138.53 31.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.28 1.432 . . . . 0.0 109.487 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -130.5 109.07 10.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.761 1.624 . . . . 0.0 108.656 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.62 169.87 27.04 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.3 143.24 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 109.702 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.7 ttt -150.79 150.91 31.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.673 1.989 . . . . 0.0 107.352 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.0 p -101.13 165.47 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.599 0.76 . . . . 0.0 111.929 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.0 t -90.84 46.28 1.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.685 1.594 . . . . 0.0 110.051 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.57 158.16 42.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.33 1.452 . . . . 0.0 112.656 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.1 -45.55 93.79 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 121.439 -0.788 . . . . 0.0 113.089 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 64.02 2.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.737 1.615 . . . . 0.0 113.741 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -94.61 147.29 23.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -91.49 150.11 21.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.687 1.195 . . . . 0.0 107.963 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 36.2 ttp -143.72 91.84 2.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.389 0.995 . . . . 0.0 112.16 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -107.04 146.41 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.406 -0.809 . . . . 0.0 111.164 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.69 104.27 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.886 1.675 . . . . 0.0 109.426 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -99.2 90.42 4.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.81 2.044 . . . . 0.0 110.51 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.63 118.22 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.378 0.671 . . . . 0.0 110.137 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.5 p -146.41 166.17 27.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.994 1.318 . . . . 0.0 113.029 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.691 2.397 . . . . 0.0 111.7 176.218 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.13 143.0 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.324 0.965 . . . . 0.0 112.442 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.86 43.46 8.94 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.051 0.834 . . . . 0.0 115.027 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.9 p -147.65 -166.77 2.61 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 119.064 1.432 . . . . 0.0 111.977 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 pt -117.26 139.46 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.295 2.238 . . . . 0.0 109.947 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.3 pt -145.55 159.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.006 1.322 . . . . 0.0 111.732 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.68 128.96 39.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.048 1.339 . . . . 0.0 112.477 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.59 -24.35 76.25 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.588 0.613 . . . . 0.0 113.413 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.2 73.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.419 1.088 . . . . 0.0 111.395 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -74.11 -28.45 61.36 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.259 1.024 . . . . 0.0 112.896 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.26 114.57 6.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.274 1.429 . . . . 0.0 112.54 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 m -145.11 172.85 12.5 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.159 1.784 . . . . 0.0 110.157 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -42.17 37.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.38 1.472 . . . . 0.0 113.952 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.88 -35.91 79.73 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.13 -42.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.517 0.727 . . . . 0.0 110.29 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.52 -50.48 69.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.832 0.742 . . . . 0.0 112.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -39.99 90.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.153 0.581 . . . . 0.0 112.113 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -57.21 -43.44 82.79 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.009 1.324 . . . . 0.0 112.717 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.22 -48.01 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.394 1.078 . . . . 0.0 111.325 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -61.96 -42.82 99.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.171 0.988 . . . . 0.0 112.267 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.87 -31.79 71.84 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -77.0 -42.19 39.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.826 1.65 . . . . 0.0 113.82 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.64 -56.85 16.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.775 1.63 . . . . 0.0 111.59 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 64.61 0.09 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.029 1.3 . . . . 0.0 112.149 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -51.16 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.353 2.261 . . . . 0.0 112.421 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -90.42 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.096 1.758 . . . . 0.0 109.942 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -44.2 -49.55 9.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.552 1.141 . . . . 0.0 112.083 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -139.45 146.57 40.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 112.727 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.4 150.93 11.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.046 2.538 . . . . 0.0 108.931 -169.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -139.72 153.95 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.822 1.249 . . . . 0.0 109.507 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.63 110.81 20.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.364 1.066 . . . . 0.0 109.878 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -105.31 128.74 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.892 0.877 . . . . 0.0 111.265 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.7 114.47 0.79 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.357 1.456 . . . . 0.0 112.094 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.86 104.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.515 1.126 . . . . 0.0 109.082 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.2 111.16 21.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.149 1.379 . . . . 0.0 111.15 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -84.54 96.42 9.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.41 1.084 . . . . 0.0 111.615 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.0 18.97 20.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.601 1.161 . . . . 0.0 113.167 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.0 p -63.87 -40.22 96.03 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.46 3.98 5.01 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.886 1.707 . . . . 0.0 115.854 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.06 30.47 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.767 1.783 . . . . 0.0 114.491 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -74.8 130.63 39.8 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 122.007 -0.701 . . . . 0.0 112.165 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.37 164.39 11.8 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.901 1.28 . . . . 0.0 111.277 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 m -133.82 110.32 9.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.458 1.503 . . . . 0.0 109.467 -176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.1 133.3 55.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.75 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mt -75.23 -68.56 0.54 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.864 0.466 . . . . 0.0 109.866 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -179.44 173.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.502 2.321 . . . . 0.0 110.592 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.82 145.74 51.23 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.353 2.261 . . . . 0.0 109.515 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 115.65 15.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.971 0.908 . . . . 0.0 111.015 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -70.31 106.65 3.43 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 111.221 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -68.95 -47.53 65.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.434 1.494 . . . . 0.0 110.603 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -141.7 154.4 45.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.917 2.087 . . . . 0.0 110.703 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -163.52 54.62 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.834 -0.541 . . . . 0.0 113.353 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -151.66 177.91 9.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 111.998 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.0 p -144.48 178.65 7.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.376 1.47 . . . . 0.0 111.563 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.25 20.15 8.15 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.771 1.228 . . . . 0.0 112.008 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.86 172.21 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 126.721 2.008 . . . . 0.0 113.244 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 mt -143.38 135.59 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.027 1.731 . . . . 0.0 109.812 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 149.68 60.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 119.547 1.067 . . . . 0.0 112.1 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.21 155.51 56.29 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 124.249 3.299 . . . . 0.0 111.579 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -93.27 -23.64 18.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.977 -1.077 . . . . 0.0 113.424 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.95 141.13 49.93 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.931 -1.106 . . . . 0.0 110.648 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.0 102.77 5.73 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.643 1.177 . . . . 0.0 109.234 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.3 164.67 24.79 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.903 1.735 . . . . 0.0 111.637 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -62.78 163.67 9.02 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.957 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 66.27 -0.91 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 126.542 1.937 . . . . 0.0 114.151 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.96 -174.38 2.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.188 2.995 . . . . 0.0 110.81 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.31 172.85 17.23 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.651 2.38 . . . . 0.0 111.049 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.99 178.47 4.55 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.713 0.805 . . . . 0.0 109.737 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -134.88 131.9 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.886 2.074 . . . . 0.0 109.118 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -148.05 166.27 28.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.274 1.03 . . . . 0.0 110.486 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -149.44 174.85 12.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.152 0.981 . . . . 0.0 111.068 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.95 119.22 0.88 Allowed Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.39 1.471 . . . . 0.0 111.369 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.04 150.06 42.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.909 1.355 . . . . 0.0 112.393 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.462 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -69.7 107.6 3.54 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 40.06 -150.49 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 126.113 1.765 . . . . 0.0 113.122 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -77.83 -38.74 45.58 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.82 -1.8 . . . . 0.0 111.347 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.82 -56.23 0.51 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.628 -1.096 . . . . 0.0 114.78 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.54 -6.27 18.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.529 3.486 . . . . 0.0 114.825 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.7 m -122.8 139.96 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.268 1.827 . . . . 0.0 109.126 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.03 78.08 1.52 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.326 . . . . 0.0 110.77 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 80.6 m -102.73 -65.16 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.848 0.859 . . . . 0.0 111.318 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.18 172.07 29.13 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.752 1.644 . . . . 0.0 111.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.33 108.69 8.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.409 1.105 . . . . 0.0 110.541 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -137.81 131.32 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.44 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.179 0.592 . . . . 0.0 110.651 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.96 149.97 35.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.935 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.84 172.47 12.98 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.858 1.663 . . . . 0.0 110.651 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 150.44 45.9 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.249 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.37 114.37 16.76 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.66 1.184 . . . . 0.0 111.352 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -75.02 115.13 14.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.559 1.544 . . . . 0.0 110.801 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.99 157.9 34.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.195 0.998 . . . . 0.0 111.733 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 87.4 p -59.65 -20.22 54.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -81.56 -11.7 59.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.615 1.966 . . . . 0.0 113.44 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.58 60.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.089 1.328 . . . . 0.0 115.244 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.27 175.11 8.64 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.811 1.245 . . . . 0.0 110.863 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -141.73 147.75 37.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.725 0.774 . . . . 0.0 110.288 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.11 118.94 34.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.19 0.996 . . . . 0.0 108.34 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.33 142.3 22.88 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.6 m -140.89 137.97 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.547 1.139 . . . . 0.0 110.762 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.41 152.52 44.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.155 0.582 . . . . 0.0 110.879 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -125.88 142.22 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.684 1.193 . . . . 0.0 109.768 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.0 m -125.87 97.95 5.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.947 1.699 . . . . 0.0 110.309 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.2 112.31 58.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.674 1.59 . . . . 0.0 109.616 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -76.83 -173.08 1.61 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.336 3.357 . . . . 0.0 111.996 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' CD1' ' HE3' ' A' ' 75' ' ' LYS . 16.8 t80 -106.5 -13.04 15.44 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.37 1.068 . . . . 0.0 112.895 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -110.73 131.13 55.32 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 119.741 -1.849 . . . . 0.0 111.138 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -66.4 0.7 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.02 -1.05 . . . . 0.0 110.837 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -82.19 -3.98 56.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.51 -1.48 9.58 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.093 1.757 . . . . 0.0 112.699 -164.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -150.24 179.93 7.71 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 129.536 3.134 . . . . 0.0 108.887 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.9 t -142.48 163.57 32.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.938 1.695 . . . . 0.0 109.037 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -92.37 136.98 32.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.351 0.66 . . . . 0.0 109.227 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 151.1 46.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.096 0.959 . . . . 0.0 110.357 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -157.1 157.48 34.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.612 1.565 . . . . 0.0 110.632 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.13 155.23 43.19 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.624 -0.673 . . . . 0.0 109.909 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.87 122.02 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.947 1.299 . . . . 0.0 109.751 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -124.86 145.3 49.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.66 1.584 . . . . 0.0 109.737 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.4 mt -115.5 120.39 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.755 2.022 . . . . 0.0 108.659 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -132.42 144.72 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.126 1.371 . . . . 0.0 112.13 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.8 p -80.39 77.97 7.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.635 1.174 . . . . 0.0 112.59 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.67 36.88 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.413 1.006 . . . . 0.0 113.818 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 116.78 26.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.754 1.622 . . . . 0.0 111.858 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -142.43 155.26 45.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.105 1.362 . . . . 0.0 109.445 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -133.05 161.91 33.12 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.78 1.232 . . . . 0.0 111.141 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.8 78.98 0.45 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.602 1.161 . . . . 0.0 111.337 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -101.86 -65.59 0.97 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.444 1.498 . . . . 0.0 110.244 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.55 -71.77 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.088 1.755 . . . . 0.0 109.233 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.4 -19.33 68.53 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.541 1.067 . . . . 0.0 114.603 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.34 -52.71 5.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.117 0.958 . . . . 0.0 111.574 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.44 -45.9 76.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.335 0.654 . . . . 0.0 111.775 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -35.37 72.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -22.85 66.98 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.283 -0.886 . . . . 0.0 113.244 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -93.71 -35.91 12.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.427 1.091 . . . . 0.0 110.89 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -76.26 -45.14 34.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.309 -1.494 . . . . 0.0 113.197 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -92.06 -14.87 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.929 1.292 . . . . 0.0 113.143 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.08 63.14 3.59 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.992 0.806 . . . . 0.0 113.706 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 31.97 73.75 0.5 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 127.598 2.359 . . . . 0.0 112.528 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.06 133.09 29.83 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.355 1.37 . . . . 0.0 110.895 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 124.8 23.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.31 31.98 0.34 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.385 1.874 . . . . 0.0 114.046 -176.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.39 62.96 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.51 1.529 . . . . 0.0 114.073 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.59 24.97 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.338 1.855 . . . . 0.0 114.703 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.9 p30 47.76 30.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.164 2.586 . . . . 0.0 116.852 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.93 139.19 7.57 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.997 1.76 . . . . 0.0 111.156 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -49.58 124.05 8.82 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.839 1.256 . . . . 0.0 113.129 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -110.41 120.83 43.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.105 2.162 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.79 138.76 17.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.729 1.212 . . . . 0.0 111.168 174.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -154.78 134.79 13.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 111.266 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -54.23 132.67 43.92 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.6 tp -156.32 -41.06 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.758 1.223 . . . . 0.0 112.51 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.93 31.66 2.79 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 114.082 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.47 11.99 1.36 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.355 2.262 . . . . 0.0 115.743 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 170.85 -43.21 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.349 1.452 . . . . 0.0 113.097 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.37 151.5 26.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.519 1.127 . . . . 0.0 110.657 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.88 170.19 16.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.539 1.136 . . . . 0.0 113.06 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -82.51 126.5 32.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.671 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -121.24 102.78 8.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.438 1.095 . . . . 0.0 108.36 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.91 171.45 25.47 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 143.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.074 0.95 . . . . 0.0 110.045 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.03 148.8 33.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.407 1.883 . . . . 0.0 108.216 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.3 p -107.74 162.37 14.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.463 1.905 . . . . 0.0 111.025 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.7 p -92.11 19.82 6.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.533 1.533 . . . . 0.0 113.542 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.73 175.06 5.62 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.28 2.232 . . . . 0.0 113.456 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.57 9.8 Favored Glycine 0 N--CA 1.475 1.249 0 C-N-CA 125.362 1.458 . . . . 0.0 112.401 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.39 73.51 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.037 1.335 . . . . 0.0 109.639 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.23 91.69 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.688 0.795 . . . . 0.0 111.298 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -56.76 149.89 17.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.072 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.4 tpp -151.08 96.26 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.871 0.843 . . . . 0.0 110.649 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -124.96 134.93 52.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.602 -1.311 . . . . 0.0 109.636 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.66 101.1 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.571 1.548 . . . . 0.0 109.664 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -99.32 99.89 10.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.288 1.835 . . . . 0.0 109.845 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -85.92 118.08 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.449 -0.782 . . . . 0.0 111.16 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.05 165.78 26.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.87 1.668 . . . . 0.0 113.038 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.039 2.136 . . . . 0.0 111.648 174.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.59 143.03 53.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.023 0.929 . . . . 0.0 111.085 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.85 38.1 65.61 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -149.15 -169.73 3.45 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.425 1.113 . . . . 0.0 111.774 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 pt -126.47 153.27 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.974 1.71 . . . . 0.0 111.059 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 pt -148.94 170.0 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.824 1.65 . . . . 0.0 111.792 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.35 129.26 39.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.099 0.959 . . . . 0.0 109.601 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.34 42.05 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.947 1.26 . . . . 0.0 113.932 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.66 81.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.224 1.41 . . . . 0.0 112.267 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -32.58 32.34 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.94 1.296 . . . . 0.0 112.605 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.41 107.93 0.74 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.349 . . . . 0.0 111.896 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 m -149.37 168.17 24.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.755 1.222 . . . . 0.0 110.149 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -39.02 21.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.766 1.626 . . . . 0.0 114.222 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -59.38 -35.0 73.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.72 -44.02 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 110.474 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.52 -43.87 72.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.886 0.766 . . . . 0.0 112.226 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.16 -47.31 80.37 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.982 -0.449 . . . . 0.0 110.881 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -39.15 76.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.578 1.551 . . . . 0.0 114.0 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.19 -56.34 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.152 1.781 . . . . 0.0 109.598 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.41 -40.82 89.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.149 1.38 . . . . 0.0 112.646 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -56.52 -54.58 44.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 112.933 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.11 -42.0 89.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 tp -53.21 -55.54 23.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.03 1.732 . . . . 0.0 112.722 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.99 49.24 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.927 0.775 . . . . 0.0 114.12 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.91 123.71 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.561 1.944 . . . . 0.0 114.342 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.73 -161.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 127.086 2.154 . . . . 0.0 111.442 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 m -51.91 -34.07 39.86 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.807 1.643 . . . . 0.0 114.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -144.21 139.66 28.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.827 2.051 . . . . 0.0 108.932 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.73 148.32 12.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.574 1.949 . . . . 0.0 110.988 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.35 151.79 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.14 0.976 . . . . 0.0 108.803 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.57 113.1 25.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.596 1.159 . . . . 0.0 109.866 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.75 130.4 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.693 0.797 . . . . 0.0 111.436 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.96 0.85 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.654 1.121 . . . . 0.0 112.759 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.11 101.54 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.846 1.258 . . . . 0.0 108.745 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -85.44 104.25 15.07 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.599 1.56 . . . . 0.0 111.696 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -82.79 104.35 12.96 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.572 1.149 . . . . 0.0 112.052 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.66 29.44 8.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.096 1.358 . . . . 0.0 112.331 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -84.02 -3.74 58.24 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.075 1.75 . . . . 0.0 114.747 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.21 14.64 80.12 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.505 -1.372 . . . . 0.0 114.287 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.65 20.23 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.445 1.498 . . . . 0.0 113.611 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.4 p -81.79 131.7 35.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.241 1.417 . . . . 0.0 112.527 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -108.35 164.43 12.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.741 1.216 . . . . 0.0 111.955 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -129.33 107.72 9.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.211 1.405 . . . . 0.0 110.082 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.27 117.82 10.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.309 -0.869 . . . . 0.0 109.985 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.03 -69.87 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.363 1.465 . . . . 0.0 111.223 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -170.95 164.41 7.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.531 1.932 . . . . 0.0 111.015 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.71 52.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.91 2.084 . . . . 0.0 110.068 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -108.21 109.75 21.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.546 1.138 . . . . 0.0 111.504 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -78.29 96.53 5.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.341 1.456 . . . . 0.0 112.053 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -66.07 -51.94 53.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.759 1.224 . . . . 0.0 112.003 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -138.63 141.48 39.11 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.822 2.049 . . . . 0.0 110.552 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.89 -171.46 42.91 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.32 0.486 . . . . 0.0 112.771 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.97 176.43 9.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.808 0.843 . . . . 0.0 111.984 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -142.65 -179.17 6.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.214 1.406 . . . . 0.0 111.355 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -137.52 22.89 2.94 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.915 1.286 . . . . 0.0 112.021 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.73 171.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.726 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.01 138.82 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 108.733 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.95 151.2 46.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.107 0.867 . . . . 0.0 111.426 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.67 165.73 26.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.741 2.96 . . . . 0.0 110.136 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -29.89 9.44 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.91 -1.119 . . . . 0.0 111.474 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.04 132.8 55.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.168 1.387 . . . . 0.0 111.044 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.45 81.94 47.47 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.051 1.74 . . . . 0.0 108.207 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.06 157.69 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 121.959 1.773 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -56.09 151.1 12.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.414 -0.803 . . . . 0.0 111.563 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 66.24 3.99 2.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.21 2.204 . . . . 0.0 115.257 -171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -130.95 99.13 4.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.146 1.779 . . . . 0.0 113.163 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.59 161.77 28.31 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.744 1.218 . . . . 0.0 112.628 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.91 170.89 7.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.911 0.885 . . . . 0.0 110.642 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.27 130.29 40.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.099 2.159 . . . . 0.0 107.877 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -149.12 161.48 41.88 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.307 1.443 . . . . 0.0 110.334 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -140.12 157.9 44.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.325 0.65 . . . . 0.0 111.512 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.07 118.69 1.4 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.579 1.561 . . . . 0.0 111.937 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.85 169.47 13.21 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.175 1.39 . . . . 0.0 112.011 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -99.89 111.61 23.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.891 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 t70 36.89 -145.72 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 128.637 2.775 . . . . 0.0 114.061 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 m -58.06 -57.56 12.31 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.942 -1.724 . . . . 0.0 111.941 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.8 -75.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.621 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.21 73.02 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 125.216 3.944 . . . . 0.0 113.042 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.6 159.64 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.091 1.756 . . . . 0.0 111.662 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.05 65.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.065 1.346 . . . . 0.0 111.766 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -127.1 -88.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.637 1.575 . . . . 0.0 110.389 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.6 172.99 32.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.526 1.536 . . . . 0.0 111.322 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.58 116.9 22.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.719 1.207 . . . . 0.0 109.385 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -142.5 128.29 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.599 1.16 . . . . 0.0 108.351 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.54 165.78 33.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.605 0.717 . . . . 0.0 110.67 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.62 139.56 20.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.298 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.42 175.85 9.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 -171.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.17 37.51 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.607 -0.683 . . . . 0.0 112.261 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.93 119.45 23.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.688 1.195 . . . . 0.0 110.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.59 112.07 17.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.461 1.904 . . . . 0.0 110.126 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -67.43 162.49 22.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.944 0.898 . . . . 0.0 111.749 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.9 p -59.59 -21.7 60.73 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 m -84.8 -14.95 46.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.511 1.925 . . . . 0.0 113.453 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.42 55.54 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.038 1.304 . . . . 0.0 115.447 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -82.01 165.36 20.74 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.482 1.141 . . . . 0.0 109.662 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.0 m -123.49 143.72 49.99 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 109.147 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -117.36 109.18 16.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.134 0.974 . . . . 0.0 109.354 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.65 114.24 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.26 140.22 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.171 0.988 . . . . 0.0 110.991 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.25 45.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.338 0.655 . . . . 0.0 111.312 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.84 153.68 51.07 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.216 1.006 . . . . 0.0 111.516 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.3 t -137.39 115.03 11.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.403 1.081 . . . . 0.0 110.604 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.05 92.48 48.29 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 126.154 1.782 . . . . 0.0 108.579 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.76 171.6 17.89 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.081 2.521 . . . . 0.0 112.729 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -73.25 -55.95 5.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.514 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.75 122.0 22.6 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.36 1.464 . . . . 0.0 113.325 -161.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -67.22 -58.47 4.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -100.51 15.24 28.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.967 1.307 . . . . 0.0 114.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 0.31 4.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.856 2.063 . . . . 0.0 112.192 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.44 -179.02 7.37 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.419 2.288 . . . . 0.0 110.679 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -154.07 173.03 16.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.172 1.389 . . . . 0.0 112.076 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -95.8 147.54 23.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -134.86 142.48 46.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 110.545 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.442 ' CZ2' ' CD2' ' A' ' 147' ' ' HIS . 30.0 p-90 -145.51 152.82 40.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.39 1.476 . . . . 0.0 109.411 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -153.63 145.8 23.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.739 1.216 . . . . 0.0 110.22 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -143.28 112.88 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.261 1.825 . . . . 0.0 110.5 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.55 129.29 56.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.129 0.971 . . . . 0.0 109.518 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.52 112.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.223 1.809 . . . . 0.0 108.755 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -124.19 141.45 52.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.473 1.509 . . . . 0.0 112.354 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.3 p -77.1 78.66 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.96 1.304 . . . . 0.0 112.858 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.13 165.18 20.91 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.44 1.019 . . . . 0.0 113.245 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 140.16 57.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.761 1.624 . . . . 0.0 111.856 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -156.04 168.32 27.62 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.516 1.527 . . . . 0.0 110.444 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -142.08 -175.42 4.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.097 1.759 . . . . 0.0 109.714 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.2 111.36 16.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.34 -67.22 0.99 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.287 1.035 . . . . 0.0 109.238 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.33 -71.53 0.21 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.153 0.981 . . . . 0.0 110.594 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.34 -22.91 74.94 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.935 0.778 . . . . 0.0 114.61 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.2 tpp -74.22 -54.18 8.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -40.72 85.33 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.565 1.146 . . . . 0.0 111.666 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.63 -36.24 66.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.352 1.461 . . . . 0.0 111.812 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -21.58 66.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.324 1.05 . . . . 0.0 113.113 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.67 -43.25 10.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 108.558 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.67 -49.74 65.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.866 -1.147 . . . . 0.0 113.669 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.56 -12.74 31.02 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.22 -66.91 2.5 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 124.191 0.9 . . . . 0.0 112.869 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.49 77.96 0.27 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.374 2.67 . . . . 0.0 108.928 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.4 143.44 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.509 1.473 . . . . 0.0 108.315 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -79.44 -11.78 59.9 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.7 129.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.054 3.342 . . . . 0.0 112.529 -173.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.36 62.09 0.6 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.05 2.262 . . . . 0.0 114.377 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -78.51 29.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.067 1.747 . . . . 0.0 114.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.253 10.9 p30 50.13 30.46 4.25 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 174.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.27 152.17 20.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.027 1.775 . . . . 0.0 111.017 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -64.37 112.67 3.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.442 ' CD2' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -110.03 123.51 49.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.053 1.741 . . . . 0.0 111.062 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -149.1 154.17 38.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.703 2.001 . . . . 0.0 111.836 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.39 135.85 10.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.308 1.043 . . . . 0.0 111.15 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.49 127.47 31.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.002 0.521 . . . . 0.0 111.447 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.1 tp -149.67 -27.99 0.26 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -84.29 18.76 21.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.998 1.285 . . . . 0.0 114.553 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.47 10.04 1.72 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.477 2.311 . . . . 0.0 115.438 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.85 -61.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.118 1.818 . . . . 0.0 110.579 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.1 159.78 15.52 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.796 0.838 . . . . 0.0 112.476 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 169.3 25.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.847 1.659 . . . . 0.0 112.82 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -88.54 133.79 34.05 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.004 0.922 . . . . 0.0 112.011 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.16 107.24 9.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.329 1.452 . . . . 0.0 107.68 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -136.24 175.31 21.0 Favored Glycine 0 C--N 1.325 -0.077 0 CA-C-O 121.941 0.745 . . . . 0.0 113.441 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.65 141.49 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.82 1.648 . . . . 0.0 108.074 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.7 ttt -144.23 130.59 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 161.54 25.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.346 1.058 . . . . 0.0 110.095 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.55 24.91 6.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.403 1.481 . . . . 0.0 113.278 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.76 171.7 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.235 1.814 . . . . 0.0 112.269 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.44 -54.54 36.34 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.621 -0.674 . . . . 0.0 113.192 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.91 47.55 1.51 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.04 1.736 . . . . 0.0 113.777 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.18 141.49 57.33 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.895 0.855 . . . . 0.0 113.103 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -96.0 136.93 35.8 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 108.757 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.6 ttp -134.62 95.37 3.35 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.775 1.23 . . . . 0.0 111.733 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -108.72 145.38 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.915 -0.491 . . . . 0.0 110.465 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.26 112.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 125.764 1.626 . . . . 0.0 108.138 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -99.39 108.15 20.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.14 1.776 . . . . 0.0 108.765 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -92.44 109.66 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.691 . . . . 0.0 110.266 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.39 171.32 14.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 111.996 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 127.637 2.375 . . . . 0.0 110.385 175.028 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.18 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.02 40.66 9.15 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.933 1.254 . . . . 0.0 114.81 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -145.51 -166.29 2.4 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.309 1.555 . . . . 0.0 112.639 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.11 140.14 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.319 2.248 . . . . 0.0 110.1 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -145.1 170.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.177 1.391 . . . . 0.0 111.987 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.76 111.39 5.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.759 -1.213 . . . . 0.0 110.898 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.91 -25.23 67.57 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.981 0.8 . . . . 0.0 113.302 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.42 -23.68 64.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.956 1.303 . . . . 0.0 114.08 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.02 1.16 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.111 1.364 . . . . 0.0 113.319 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.51 117.16 12.71 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.097 1.759 . . . . 0.0 111.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -145.84 169.0 19.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.577 1.551 . . . . 0.0 110.157 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.64 -41.33 42.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.128 1.371 . . . . 0.0 114.141 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -58.39 -42.59 87.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.644 0.777 . . . . 0.0 112.109 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.37 -46.75 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.447 1.099 . . . . 0.0 111.382 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.92 -49.85 70.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.736 0.814 . . . . 0.0 111.474 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -41.26 96.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -53.45 -45.35 69.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.091 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.84 -56.89 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.99 -33.87 71.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.258 1.423 . . . . 0.0 113.953 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -55.77 30.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.816 1.246 . . . . 0.0 110.277 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -15.36 60.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -30.6 56.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.448 1.099 . . . . 0.0 111.9 174.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 44.51 47.84 8.75 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.452 1.977 . . . . 0.0 113.959 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.73 175.84 1.03 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.356 1.462 . . . . 0.0 114.48 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -172.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 126.146 1.778 . . . . 0.0 110.922 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 m -48.92 -27.92 3.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.133 1.373 . . . . 0.0 114.591 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -127.36 149.86 49.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.753 1.221 . . . . 0.0 111.277 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.27 154.38 8.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.319 2.248 . . . . 0.0 109.899 -175.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.6 147.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.993 1.717 . . . . 0.0 109.083 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.23 105.59 13.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.67 1.188 . . . . 0.0 110.008 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.14 135.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.73 1.612 . . . . 0.0 111.569 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.06 115.4 0.69 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.979 1.276 . . . . 0.0 112.62 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.4 mt -106.63 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.337 1.455 . . . . 0.0 109.16 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.38 122.49 24.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.729 1.612 . . . . 0.0 113.845 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -77.34 90.52 3.78 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.195 1.798 . . . . 0.0 111.458 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.46 17.8 14.47 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.401 1.48 . . . . 0.0 112.635 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -76.48 -38.64 55.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 9.79 13.63 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.931 1.253 . . . . 0.0 115.568 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.06 166.19 29.39 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 119.466 1.633 . . . . 0.0 114.946 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -81.66 130.89 35.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.35 1.46 . . . . 0.0 112.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 m0 -106.58 161.35 14.7 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.683 1.193 . . . . 0.0 111.04 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.8 m -129.58 110.35 11.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.252 1.421 . . . . 0.0 109.051 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.41 130.19 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.053 -1.029 . . . . 0.0 109.792 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.23 -70.3 0.37 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 109.942 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -174.06 175.86 2.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.045 2.138 . . . . 0.0 110.549 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.03 154.87 42.37 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.728 2.011 . . . . 0.0 110.277 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.52 108.05 5.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.06 1.344 . . . . 0.0 111.022 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 55' ' ' THR . 77.9 m-85 -74.33 105.91 5.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.101 1.361 . . . . 0.0 111.12 175.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -45.74 54.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.183 0.993 . . . . 0.0 111.503 175.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.0 m -140.19 156.76 46.38 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.892 2.077 . . . . 0.0 110.932 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.17 -168.32 45.13 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.68 0.6 . . . . 0.0 112.611 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -138.42 169.32 18.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.534 1.134 . . . . 0.0 110.142 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.4 ' HB ' ' CZ ' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -147.23 137.11 23.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.91 0.862 . . . . 0.0 109.791 175.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.13 5.75 50.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.197 1.799 . . . . 0.0 112.754 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.1 169.58 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.19 141.77 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.486 1.114 . . . . 0.0 109.495 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.67 151.48 61.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 0.0 111.619 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 164.41 35.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.124 3.216 . . . . 0.0 110.524 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 -34.34 10.17 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.704 -0.622 . . . . 0.0 112.001 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.6 136.14 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.862 1.21 . . . . 0.0 110.82 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.03 89.24 7.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.78 1.232 . . . . 0.0 109.754 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.46 166.43 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.668 2.245 . . . . 0.0 113.49 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -58.81 153.5 16.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.6 p 69.89 -9.15 0.73 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -115.69 123.87 49.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.251 1.82 . . . . 0.0 111.914 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.32 176.69 6.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.872 1.269 . . . . 0.0 110.128 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.14 173.08 6.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.656 0.782 . . . . 0.0 109.247 174.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.51 131.79 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.385 1.474 . . . . 0.0 110.042 175.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -148.67 163.81 36.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 111.334 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.1 m -151.39 173.88 14.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 110.903 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.27 132.57 3.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.885 1.707 . . . . 0.0 110.323 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 178.57 6.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.3 1.04 . . . . 0.0 110.17 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -64.12 -174.95 0.13 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.027 0.931 . . . . 0.0 109.881 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.34 -167.88 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 121.137 -0.977 . . . . 0.0 109.989 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -34.28 -42.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.794 2.037 . . . . 0.0 114.85 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -51.75 0.48 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.51 1.528 . . . . 0.0 113.781 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.02 6.07 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.426 3.418 . . . . 0.0 115.073 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 109.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.447 2.299 . . . . 0.0 111.496 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.09 70.06 3.86 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.079 1.752 . . . . 0.0 112.895 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -97.51 -81.12 0.43 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.315 1.046 . . . . 0.0 111.996 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.06 176.3 43.21 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.115 1.817 . . . . 0.0 110.319 -172.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.13 86.55 1.5 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.542 1.163 . . . . 0.0 109.08 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.8 t -132.58 118.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.266 1.426 . . . . 0.0 107.639 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.06 166.29 25.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.055 0.931 . . . . 0.0 110.971 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.73 155.98 40.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.1 177.09 10.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 110.32 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.35 40.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.579 1.151 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.66 118.72 27.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.713 1.205 . . . . 0.0 110.594 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.89 107.72 9.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.042 1.737 . . . . 0.0 109.229 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mtt -64.54 166.64 8.2 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.498 -0.751 . . . . 0.0 112.212 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 t -62.98 -19.13 64.02 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -82.35 -18.83 40.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 113.203 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.19 -0.72 54.33 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.165 1.364 . . . . 0.0 114.906 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -79.93 166.23 21.83 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.597 1.198 . . . . 0.0 109.948 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 m -123.03 149.82 43.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.938 0.875 . . . . 0.0 110.318 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.37 112.43 18.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 108.257 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.18 127.8 8.2 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 m -134.57 131.99 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.106 0.953 . . . . 0.0 110.157 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.48 156.65 45.18 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.156 0.582 . . . . 0.0 112.192 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -126.72 158.81 35.5 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.739 1.215 . . . . 0.0 111.191 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 t -138.67 108.25 6.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.486 1.115 . . . . 0.0 111.166 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.5 t -109.74 98.1 31.7 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.633 1.973 . . . . 0.0 108.612 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.97 169.37 22.34 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.342 2.695 . . . . 0.0 112.844 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.65 -17.48 41.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.13 110.72 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.149 0.98 . . . . 0.0 110.741 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.4 -58.4 5.37 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.09 -1.006 . . . . 0.0 113.269 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.81 10.76 27.21 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.688 1.195 . . . . 0.0 114.129 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.15 0.56 5.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.189 1.796 . . . . 0.0 112.609 -175.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -153.84 173.16 16.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.237 2.215 . . . . 0.0 110.01 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.2 m -138.57 170.02 16.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.587 1.155 . . . . 0.0 112.155 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -90.84 142.64 27.55 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.396 -0.815 . . . . 0.0 110.143 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -135.69 139.92 44.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 108.755 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -158.14 150.77 22.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.788 1.635 . . . . 0.0 109.322 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -151.36 154.65 37.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.79 1.236 . . . . 0.0 109.912 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.05 121.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.514 1.525 . . . . 0.0 111.4 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -123.31 136.17 54.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.513 1.525 . . . . 0.0 110.627 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.71 116.38 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.919 2.088 . . . . 0.0 108.363 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -129.77 136.41 49.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.235 1.814 . . . . 0.0 112.54 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.5 p -79.99 79.36 6.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.09 1.356 . . . . 0.0 112.465 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.53 176.12 43.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.446 1.498 . . . . 0.0 112.355 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 104.11 16.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.584 1.954 . . . . 0.0 111.135 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -134.41 158.85 42.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.631 1.172 . . . . 0.0 111.371 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -136.75 164.77 27.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.092 1.757 . . . . 0.0 110.57 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.3 87.89 6.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.631 0.772 . . . . 0.0 111.2 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -102.27 -66.9 0.9 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 110.375 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -147.67 -75.0 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.677 1.991 . . . . 0.0 108.554 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.54 -37.17 88.07 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.357 0.979 . . . . 0.0 113.943 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -70.44 -52.97 18.42 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.145 0.972 . . . . 0.0 111.821 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.09 91.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.302 0.641 . . . . 0.0 111.381 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.92 -34.33 77.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.815 -0.612 . . . . 0.0 112.247 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -23.06 64.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.669 1.122 . . . . 0.0 112.177 175.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.54 -58.09 2.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 108.898 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.24 -56.96 15.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.899 -1.126 . . . . 0.0 111.803 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.33 -18.66 44.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 0.0 112.049 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.7 -68.9 1.45 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.346 0.974 . . . . 0.0 113.077 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.31 88.98 0.27 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 127.732 2.413 . . . . 0.0 108.599 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.17 142.06 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.609 1.539 . . . . 0.0 109.429 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -77.5 -9.68 59.05 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.13 107.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 128.931 2.892 . . . . 0.0 112.221 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.19 85.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.344 1.926 . . . . 0.0 114.214 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -89.25 22.99 2.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.504 2.321 . . . . 0.0 113.865 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.286 11.9 p30 50.47 33.6 8.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.871 2.068 . . . . 0.0 114.927 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.91 156.84 23.08 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.24 1.876 . . . . 0.0 111.965 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -69.16 114.07 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.801 -0.823 . . . . 0.0 111.282 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.29 121.65 43.53 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.026 1.73 . . . . 0.0 111.114 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.27 144.53 38.43 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.826 2.05 . . . . 0.0 110.126 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 133.7 13.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.29 1.036 . . . . 0.0 111.477 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.56 115.24 2.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.172 0.989 . . . . 0.0 111.192 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -29.87 1.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.71 1.204 . . . . 0.0 113.279 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.5 18.05 35.79 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.357 1.456 . . . . 0.0 114.427 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 59.09 13.31 2.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.923 2.089 . . . . 0.0 114.709 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -175.42 -69.16 0.05 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 126.658 2.075 . . . . 0.0 109.664 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -87.19 150.15 24.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.324 1.059 . . . . 0.0 111.95 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 172.33 13.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.46 1.904 . . . . 0.0 110.896 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.9 ptm -101.57 150.05 23.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.626 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -130.71 107.55 9.24 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.255 1.822 . . . . 0.0 107.473 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.48 176.98 19.13 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-O 121.748 0.638 . . . . 0.0 113.119 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.79 144.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 107.501 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -145.4 140.87 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.445 1.498 . . . . 0.0 108.439 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.34 162.26 13.42 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.89 1.676 . . . . 0.0 110.623 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.56 16.54 23.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.215 1.006 . . . . 0.0 113.405 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -107.6 172.74 6.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.861 2.064 . . . . 0.0 112.439 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.8 -46.54 94.31 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.431 1.015 . . . . 0.0 114.097 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.99 60.01 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.369 1.468 . . . . 0.0 113.026 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.12 144.86 40.4 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -89.01 147.95 24.01 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.909 0.884 . . . . 0.0 109.254 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.2 mtt -135.5 105.68 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.869 1.667 . . . . 0.0 110.068 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.86 143.17 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.871 -1.143 . . . . 0.0 109.515 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.24 106.04 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.88 1.272 . . . . 0.0 108.503 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -100.22 103.87 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.093 1.757 . . . . 0.0 108.713 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.0 136.94 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.132 0.573 . . . . 0.0 110.042 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 p -158.4 159.87 36.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 128.695 2.798 . . . . 0.0 113.455 176.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.6 161.31 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.887 2.475 . . . . 0.0 113.364 -166.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.4 46.71 93.82 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.036 -1.04 . . . . 0.0 115.091 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 p -155.11 -170.99 3.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.977 0.911 . . . . 0.0 111.75 -170.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 pt -118.82 144.01 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.786 2.034 . . . . 0.0 110.336 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.72 169.79 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.659 1.584 . . . . 0.0 112.065 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 125.35 25.05 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.728 1.211 . . . . 0.0 112.143 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.12 -28.75 73.92 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.389 0.995 . . . . 0.0 114.382 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.62 74.98 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.669 -0.901 . . . . 0.0 112.567 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -82.62 -22.8 34.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.466 1.106 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.48 120.23 10.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.984 1.714 . . . . 0.0 110.029 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -152.43 171.96 17.24 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.109 1.764 . . . . 0.0 110.009 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -50.94 -36.33 38.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 113.997 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.73 -35.5 76.52 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.741 -1.224 . . . . 0.0 112.988 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.04 -42.59 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.734 0.814 . . . . 0.0 110.248 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -51.34 -49.59 61.12 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.109 0.963 . . . . 0.0 111.755 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.47 -48.6 77.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.43 0.692 . . . . 0.0 111.986 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -56.87 -35.02 68.43 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.47 -56.84 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.073 1.349 . . . . 0.0 110.059 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.35 -41.75 94.28 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.201 1.4 . . . . 0.0 112.369 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -54.75 -49.36 71.04 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.949 0.9 . . . . 0.0 112.318 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -85.86 -32.42 21.72 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -54.23 35.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.392 1.477 . . . . 0.0 111.239 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.82 58.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.383 0.992 . . . . 0.0 112.462 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 139.6 7.34 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.925 1.29 . . . . 0.0 111.913 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.05 -163.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.036 1.334 . . . . 0.0 110.709 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.83 -44.9 1.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.19 1.796 . . . . 0.0 114.138 175.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -148.98 138.88 22.04 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.132 1.373 . . . . 0.0 110.93 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.02 151.63 16.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.869 1.668 . . . . 0.0 111.165 -172.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.5 pt -134.95 152.3 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.108 1.363 . . . . 0.0 109.4 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.52 117.92 33.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.341 1.457 . . . . 0.0 109.38 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.85 126.97 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.81 109.44 0.66 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.38 1.466 . . . . 0.0 112.455 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 mt -107.54 101.9 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.763 1.225 . . . . 0.0 108.246 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.63 120.77 26.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.568 1.547 . . . . 0.0 112.62 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -84.99 102.49 13.23 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.1 1.36 . . . . 0.0 112.054 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.67 25.68 7.42 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 111.615 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -77.99 -19.94 53.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.784 1.634 . . . . 0.0 114.387 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.75 26.85 25.88 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 114.743 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.08 150.38 18.2 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.77 1.176 . . . . 0.0 113.959 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -71.14 140.27 50.53 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.439 -1.036 . . . . 0.0 112.918 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -114.35 164.41 13.98 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.47 1.108 . . . . 0.0 112.237 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 m -132.91 108.75 9.13 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.038 1.335 . . . . 0.0 109.714 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.87 131.49 46.4 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.22 -69.32 0.48 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.735 -0.603 . . . . 0.0 110.539 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.7 163.02 2.8 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.059 2.143 . . . . 0.0 111.076 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.86 122.88 48.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.225 1.81 . . . . 0.0 109.224 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -110.1 105.75 14.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.434 1.094 . . . . 0.0 111.629 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -73.92 115.02 12.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.817 1.247 . . . . 0.0 112.034 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -46.62 11.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.604 1.561 . . . . 0.0 111.495 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.8 m -139.15 157.0 46.72 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.932 2.093 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.0 -158.5 53.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.48 0.562 . . . . 0.0 112.631 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -148.52 -168.8 3.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.068 -0.666 . . . . 0.0 112.323 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.2 p -142.26 178.67 7.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.105 2.162 . . . . 0.0 111.155 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.21 10.61 6.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.348 1.459 . . . . 0.0 111.971 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.8 m -139.2 169.18 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.184 2.593 . . . . 0.0 113.88 -168.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.43 132.57 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.788 2.035 . . . . 0.0 109.804 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.61 153.97 65.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 119.672 1.123 . . . . 0.0 111.842 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.5 165.45 30.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.824 3.016 . . . . 0.0 109.947 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.13 -33.67 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.414 -0.804 . . . . 0.0 112.153 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -115.11 133.72 55.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.509 1.524 . . . . 0.0 109.917 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.96 106.36 5.77 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.373 1.069 . . . . 0.0 110.121 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.71 163.35 35.59 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.776 1.651 . . . . 0.0 112.051 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.87 150.94 27.01 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.636 -0.665 . . . . 0.0 111.075 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 0.5 OUTLIER 76.96 -3.19 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.838 2.855 . . . . 0.0 114.17 -176.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -112.54 149.53 32.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.499 1.52 . . . . 0.0 109.372 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.23 157.72 29.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 109.916 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -94.38 176.81 6.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.883 0.849 . . . . 0.0 109.72 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.48 129.7 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.925 2.09 . . . . 0.0 109.16 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -149.12 168.94 21.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.624 0.77 . . . . 0.0 111.204 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -148.66 174.43 12.17 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.157 0.983 . . . . 0.0 111.255 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.3 118.7 0.85 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.1 1.333 . . . . 0.0 111.839 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -118.7 150.15 40.24 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.002 1.401 . . . . 0.0 112.379 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.16 116.08 10.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 42.85 -151.2 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.745 1.618 . . . . 0.0 113.533 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -75.05 -39.95 60.61 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.268 -1.52 . . . . 0.0 112.034 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.41 -62.08 0.37 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.21 1.386 . . . . 0.0 113.646 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.68 3.86 2.95 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 125.279 3.986 . . . . 0.0 115.601 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.56 132.31 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 127.646 2.379 . . . . 0.0 109.404 -174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 69.85 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.303 1.441 . . . . 0.0 111.274 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -108.42 -71.21 0.77 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.364 1.065 . . . . 0.0 110.859 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.95 35.86 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.988 0.804 . . . . 0.0 112.164 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.38 112.18 10.14 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.765 1.226 . . . . 0.0 108.466 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 135.31 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.63 167.16 23.64 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.43 141.66 22.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 110.968 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.96 172.65 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.381 1.472 . . . . 0.0 109.151 -176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.54 148.31 44.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.8 120.2 27.35 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.755 1.222 . . . . 0.0 110.779 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -82.69 125.11 30.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.614 . . . . 0.0 110.687 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 mtm -88.2 164.36 15.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.934 0.894 . . . . 0.0 112.953 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -60.52 -22.7 63.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.688 1.195 . . . . 0.0 113.634 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -81.98 -8.19 59.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.672 1.589 . . . . 0.0 113.272 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.23 65.56 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.928 1.251 . . . . 0.0 115.252 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.06 171.93 9.48 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.127 0.971 . . . . 0.0 110.979 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.6 m -133.74 146.43 50.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.059 0.944 . . . . 0.0 111.611 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.45 130.61 56.58 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.432 1.093 . . . . 0.0 108.31 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.6 145.34 17.9 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.93 115.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.729 1.212 . . . . 0.0 109.005 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.494 ' HG3' ' H ' ' A' ' 116' ' ' ASP . 1.9 ptm -113.49 160.89 18.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.958 0.503 . . . . 0.0 112.086 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.46 141.62 39.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.554 1.142 . . . . 0.0 109.678 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 m -128.5 106.62 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.411 1.884 . . . . 0.0 108.801 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.2 101.59 53.67 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 126.487 1.915 . . . . 0.0 108.813 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.6 171.36 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.317 2.678 . . . . 0.0 111.977 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.02 -24.31 28.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.5 0.72 . . . . 0.0 112.023 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.49 116.32 32.15 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.267 1.427 . . . . 0.0 111.889 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -71.12 -59.3 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.32 10.54 29.33 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.103 -0.998 . . . . 0.0 113.612 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.76 -4.86 5.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.01 2.124 . . . . 0.0 112.615 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 160.49 39.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.837 2.455 . . . . 0.0 109.249 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.6 m -125.02 164.7 19.61 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.07 -1.019 . . . . 0.0 110.834 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -85.12 140.9 30.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.516 0.727 . . . . 0.0 109.884 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 156.94 47.63 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -161.93 140.73 9.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.501 1.52 . . . . 0.0 111.156 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.494 ' H ' ' HG3' ' A' ' 101' ' ' MET . 10.8 t70 -125.57 142.42 51.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.384 1.474 . . . . 0.0 109.214 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -138.36 113.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.345 1.458 . . . . 0.0 109.834 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.65 143.1 50.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.795 1.638 . . . . 0.0 108.845 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.28 118.59 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.661 1.984 . . . . 0.0 108.514 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -129.89 136.0 49.01 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.454 1.501 . . . . 0.0 112.426 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.1 p -70.32 84.77 0.57 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.483 1.913 . . . . 0.0 112.242 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.51 -174.12 44.44 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.451 1.024 . . . . 0.0 113.655 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -115.82 114.37 24.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.598 1.959 . . . . 0.0 110.151 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 159.65 40.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.984 0.913 . . . . 0.0 111.877 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 163.15 33.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.254 1.422 . . . . 0.0 111.27 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.33 89.09 0.2 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.255 1.422 . . . . 0.0 110.923 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.52 -61.33 1.61 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 109.88 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -71.89 0.19 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.245 1.418 . . . . 0.0 109.046 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.1 -32.54 72.96 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.981 0.8 . . . . 0.0 114.416 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -66.07 -53.2 41.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.082 0.941 . . . . 0.0 110.549 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -57.76 -39.83 78.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.455 0.702 . . . . 0.0 110.592 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -48.38 79.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -27.52 67.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.915 0.886 . . . . 0.0 112.923 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -82.7 -50.15 9.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.21 1.004 . . . . 0.0 110.127 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.15 -47.71 67.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.095 1.358 . . . . 0.0 113.7 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -88.81 -13.82 38.48 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.84 -83.15 0.05 OUTLIER Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.824 1.202 . . . . 0.0 112.197 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -168.12 72.75 0.88 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.013 1.725 . . . . 0.0 110.139 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.4 133.04 29.01 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.625 0.883 . . . . 0.0 110.336 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -61.42 158.34 14.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.046 1.338 . . . . 0.0 110.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -95.16 3.71 54.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -164.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 54.69 49.45 61.44 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.481 1.039 . . . . 0.0 112.946 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.91 20.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.41 2.284 . . . . 0.0 115.058 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.265 9.7 p30 48.79 38.45 11.88 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.362 2.265 . . . . 0.0 114.674 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.86 160.35 26.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.596 1.57 . . . . 0.0 112.731 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -68.75 127.12 31.94 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.137 0.975 . . . . 0.0 111.423 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -120.84 106.38 11.61 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.602 1.961 . . . . 0.0 109.464 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.74 150.12 43.01 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.893 1.277 . . . . 0.0 110.989 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 142.28 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.2 1.8 . . . . 0.0 110.241 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -61.53 132.41 53.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.111 0.564 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 tp -147.4 -37.24 0.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.52 25.66 4.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.04 1.305 . . . . 0.0 114.47 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.86 9.75 1.3 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.338 2.255 . . . . 0.0 115.492 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.96 -49.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.239 1.399 . . . . 0.0 112.18 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.88 156.63 18.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.854 0.835 . . . . 0.0 111.597 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 169.09 22.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.974 1.709 . . . . 0.0 112.06 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -94.77 138.8 32.11 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.214 1.006 . . . . 0.0 111.473 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -126.69 106.42 9.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.039 1.736 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.29 169.13 24.64 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 114.779 0.671 . . . . 0.0 114.779 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.92 143.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 125.951 1.7 . . . . 0.0 109.317 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.84 147.6 33.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.537 1.535 . . . . 0.0 108.06 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -96.08 171.58 8.53 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.241 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m -104.28 21.83 15.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.317 1.447 . . . . 0.0 112.458 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 -178.32 3.54 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 112.591 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.57 -36.52 78.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.99 0.805 . . . . 0.0 114.424 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.89 75.21 4.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.666 1.587 . . . . 0.0 111.023 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.91 73.06 1.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 112.251 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -43.99 141.14 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.585 1.954 . . . . 0.0 110.465 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 ttm -142.13 106.25 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.132 0.967 . . . . 0.0 110.566 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -124.2 139.67 53.7 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.39 101.33 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.633 1.573 . . . . 0.0 108.964 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.71 104.78 16.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.363 1.865 . . . . 0.0 109.432 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -87.63 124.28 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 121.819 -0.551 . . . . 0.0 110.989 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.1 m -141.21 167.88 21.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 112.959 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 128.153 2.581 . . . . 0.0 112.686 175.126 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.647 0.261 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.35 158.05 0.06 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.699 2.8 . . . . 0.0 113.335 -166.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.84 44.59 96.92 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.296 -0.878 . . . . 0.0 114.1 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -144.74 -176.59 5.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.433 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.69 135.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.288 1.835 . . . . 0.0 110.616 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -141.06 167.0 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.382 1.473 . . . . 0.0 111.225 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.0 125.73 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.925 -1.109 . . . . 0.0 110.423 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.36 -21.14 59.53 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.897 0.761 . . . . 0.0 113.447 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.32 72.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.226 1.41 . . . . 0.0 112.049 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.63 -30.33 41.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.707 1.203 . . . . 0.0 112.762 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 tp -55.53 106.41 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.053 1.741 . . . . 0.0 111.151 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 m -149.88 166.98 27.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.543 1.537 . . . . 0.0 109.762 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -44.62 -39.28 4.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.968 1.707 . . . . 0.0 114.618 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.31 -36.02 76.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.12 -35.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.874 1.669 . . . . 0.0 110.618 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -56.44 -52.22 65.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.902 0.774 . . . . 0.0 111.127 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -53.53 -39.82 64.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.973 0.806 . . . . 0.0 112.148 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -59.84 -32.44 70.69 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.547 1.139 . . . . 0.0 113.274 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.0 t -63.97 -52.31 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 108.968 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.04 -41.16 74.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.021 0.528 . . . . 0.0 111.757 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.8 -56.7 18.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.485 1.114 . . . . 0.0 112.617 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.81 -38.6 46.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -21.79 66.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.262 1.025 . . . . 0.0 111.07 175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.46 73.09 0.96 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.037 1.303 . . . . 0.0 110.153 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -45.2 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.637 1.575 . . . . 0.0 112.449 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.07 -163.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.51 1.524 . . . . 0.0 110.22 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -44.28 -33.95 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.606 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.05 134.36 13.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.179 1.791 . . . . 0.0 110.78 175.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.2 165.01 34.58 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.75 155.0 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.013 0.824 . . . . 0.0 111.731 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.23 115.58 30.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.005 0.922 . . . . 0.0 110.58 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.16 144.03 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.006 1.322 . . . . 0.0 110.948 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.36 0.77 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.92 0.771 . . . . 0.0 112.789 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.89 103.93 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.817 1.247 . . . . 0.0 110.438 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.32 124.31 27.96 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.699 1.6 . . . . 0.0 113.741 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.43 103.81 9.61 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.328 1.851 . . . . 0.0 113.954 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.25 36.49 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.803 2.041 . . . . 0.0 112.323 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.549 1.54 . . . . 0.0 113.662 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.59 11.63 49.29 Favored Glycine 0 CA--C 1.541 1.687 0 O-C-N 120.983 -1.073 . . . . 0.0 115.182 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.97 162.31 28.33 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.001 1.762 . . . . 0.0 113.051 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -76.57 137.67 39.68 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.601 1.16 . . . . 0.0 112.517 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.419 ' CD1' ' HA ' ' A' ' 92' ' ' MET . 49.0 m0 -107.61 164.32 12.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.91 1.684 . . . . 0.0 111.574 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -131.01 111.75 12.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.767 1.227 . . . . 0.0 109.28 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.64 127.19 30.12 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.71 -68.14 0.41 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 176.99 172.47 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.903 2.481 . . . . 0.0 110.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.26 47.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.638 2.375 . . . . 0.0 109.514 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -123.96 109.93 14.16 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.282 1.033 . . . . 0.0 111.177 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -70.19 112.26 6.42 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 111.347 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -94.15 -32.94 13.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.714 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -142.58 148.99 38.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 109.646 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -175.46 47.76 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.549 1.071 . . . . 0.0 115.141 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.95 144.73 35.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.964 1.306 . . . . 0.0 111.93 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -102.26 167.25 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.944 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.72 -0.76 21.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.482 1.113 . . . . 0.0 112.587 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.91 -178.56 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.873 2.069 . . . . 0.0 112.568 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.38 139.54 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 110.696 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.71 146.33 79.82 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 118.856 0.753 . . . . 0.0 112.957 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.12 150.99 54.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.014 3.809 . . . . 0.0 111.608 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.45 -22.21 19.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -123.54 126.85 47.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.575 1.55 . . . . 0.0 110.646 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.14 96.22 12.89 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 109.672 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.0 167.6 21.2 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.848 2.366 . . . . 0.0 113.444 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.87 158.0 8.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.194 -0.941 . . . . 0.0 109.925 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.271 7.3 t 59.45 6.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.154 2.181 . . . . 0.0 114.474 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -127.38 121.47 31.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.82 2.048 . . . . 0.0 110.102 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.4 171.63 8.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.248 1.019 . . . . 0.0 110.15 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.41 171.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.53 130.35 52.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.909 1.284 . . . . 0.0 109.872 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.55 171.16 17.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.885 0.85 . . . . 0.0 110.857 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.3 m -156.71 170.44 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.88 1.272 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.27 121.85 2.17 Favored Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.52 156.97 38.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.573 1.687 . . . . 0.0 109.564 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -61.44 179.5 0.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.95 0.5 . . . . 0.0 111.176 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.7 -160.08 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 121.061 -1.024 . . . . 0.0 110.738 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.5 m -30.67 -51.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.429 1.892 . . . . 0.0 115.922 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.54 -60.64 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.769 1.176 . . . . 0.0 113.269 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.82 -7.7 21.74 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.398 3.399 . . . . 0.0 114.957 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -74.34 123.55 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.441 1.896 . . . . 0.0 112.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.47 71.8 4.37 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.893 -1.13 . . . . 0.0 111.646 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.6 m -119.21 -85.32 0.65 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.419 1.088 . . . . 0.0 111.689 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.16 -178.59 33.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.874 1.226 . . . . 0.0 111.251 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.96 111.43 6.24 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.597 0.759 . . . . 0.0 112.728 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.84 122.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.43 41.28 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.969 0.908 . . . . 0.0 111.111 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.64 143.97 51.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 111.115 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.64 175.17 10.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.522 1.929 . . . . 0.0 111.721 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.1 153.18 41.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.109 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -133.8 117.37 16.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.604 1.562 . . . . 0.0 111.03 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -75.19 117.24 16.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 110.3 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.419 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 17.3 mtm -74.25 161.96 29.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 112.156 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 t -60.87 -23.62 65.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.532 1.133 . . . . 0.0 113.519 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 m -78.63 -20.49 50.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 114.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.63 39.69 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.671 1.129 . . . . 0.0 115.777 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -87.42 171.34 10.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.564 1.145 . . . . 0.0 110.666 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.9 m -140.07 136.99 34.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.748 175.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.19 126.99 53.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.538 -0.755 . . . . 0.0 108.984 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.58 128.76 8.71 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.54 140.24 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.593 1.157 . . . . 0.0 110.345 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.6 ptm -144.54 170.11 16.69 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.94 156.46 41.47 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.436 1.095 . . . . 0.0 111.142 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.7 t -140.07 123.72 17.25 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.406 1.482 . . . . 0.0 109.754 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.81 91.37 47.4 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 126.895 2.078 . . . . 0.0 107.686 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.24 143.39 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.399 2.733 . . . . 0.0 110.705 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.45 -41.08 85.29 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.103 0.561 . . . . 0.0 111.633 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.43 138.26 36.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 111.042 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.04 -72.01 0.37 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.458 -0.776 . . . . 0.0 111.457 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -1.91 23.88 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.774 1.23 . . . . 0.0 113.639 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -5.84 6.22 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.811 2.044 . . . . 0.0 112.731 -164.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.38 149.47 28.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.822 2.449 . . . . 0.0 109.48 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -111.07 163.73 13.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.661 0.784 . . . . 0.0 110.14 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.96 137.86 32.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.419 1.088 . . . . 0.0 109.234 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -126.81 138.49 53.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.717 1.207 . . . . 0.0 111.571 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -150.02 146.21 26.85 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.28 -1.512 . . . . 0.0 111.335 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.91 154.89 45.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.975 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.38 115.44 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.397 1.479 . . . . 0.0 111.384 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -114.97 117.7 31.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 108.738 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mt -103.24 111.79 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.872 1.669 . . . . 0.0 107.587 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.14 162.83 34.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.475 0.71 . . . . 0.0 112.58 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -80.05 79.94 6.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.662 1.185 . . . . 0.0 112.275 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 -149.45 8.55 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.25 0.929 . . . . 0.0 113.509 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -131.26 84.51 2.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 128.322 2.649 . . . . 0.0 111.665 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.85 77.7 7.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.066 1.347 . . . . 0.0 111.827 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -65.11 164.43 13.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.608 0.763 . . . . 0.0 112.399 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.84 112.71 12.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.857 2.063 . . . . 0.0 110.211 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -111.35 -75.17 0.62 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -152.06 -74.94 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.953 1.701 . . . . 0.0 108.087 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.66 -11.15 62.13 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.072 1.32 . . . . 0.0 115.027 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -63.98 1.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 1.316 . . . . 0.0 107.612 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -16.46 60.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -33.03 61.9 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.849 0.749 . . . . 0.0 110.731 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.24 -28.97 64.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.397 1.079 . . . . 0.0 112.908 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.79 -33.85 22.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.338 1.055 . . . . 0.0 110.003 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -75.83 -45.45 35.76 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.206 -0.934 . . . . 0.0 113.21 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -96.2 -16.9 21.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.877 0.871 . . . . 0.0 113.336 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -70.09 1.06 Allowed Glycine 0 N--CA 1.475 1.242 0 C-N-CA 124.104 0.859 . . . . 0.0 112.556 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 179.99 73.32 0.17 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 128.215 2.606 . . . . 0.0 111.072 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 158.19 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.769 1.646 . . . . 0.0 110.965 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.56 121.64 30.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 158.43 35.76 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.328 -0.857 . . . . 0.0 112.163 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.21 70.79 1.02 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.514 1.531 . . . . 0.0 112.633 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.26 24.48 0.34 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.388 1.875 . . . . 0.0 113.853 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.2 p30 48.19 35.3 5.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.923 2.089 . . . . 0.0 114.901 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.96 156.46 23.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.057 1.313 . . . . 0.0 113.049 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -65.19 126.75 29.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.203 1.001 . . . . 0.0 110.538 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.57 105.58 9.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.804 1.642 . . . . 0.0 108.919 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.09 140.5 36.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.609 1.563 . . . . 0.0 111.419 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -160.7 137.82 9.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.006 . . . . 0.0 111.391 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -57.71 107.17 0.42 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.789 1.235 . . . . 0.0 112.309 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 tp -128.67 -30.23 2.32 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.046 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.93 22.16 7.08 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.656 1.122 . . . . 0.0 114.092 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.37 13.19 3.87 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.297 2.239 . . . . 0.0 115.091 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.38 -57.59 0.11 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.126 1.822 . . . . 0.0 111.65 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.2 mp -91.3 148.49 22.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.726 0.774 . . . . 0.0 110.606 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 169.5 17.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.512 1.525 . . . . 0.0 111.731 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 144.66 29.52 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.757 1.223 . . . . 0.0 110.37 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.88 102.06 6.61 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.742 2.017 . . . . 0.0 108.464 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.29 167.55 21.86 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.0 0.778 . . . . 0.0 112.93 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.1 tt -151.81 139.36 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.548 1.939 . . . . 0.0 108.527 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.7 ttm -142.29 139.63 31.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 78.2 p -88.14 169.68 11.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 110.977 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -87.15 11.36 14.15 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.098 -1.001 . . . . 0.0 113.615 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.92 170.44 10.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.147 2.179 . . . . 0.0 113.226 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.6 -73.6 0.72 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.937 1.256 . . . . 0.0 111.525 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.72 38.66 0.05 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.984 2.113 . . . . 0.0 114.808 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 176.13 4.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 0.0 113.301 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -129.8 145.53 51.57 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.008 1.323 . . . . 0.0 110.403 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.3 ttm -136.95 88.89 2.4 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.424 1.89 . . . . 0.0 110.672 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -83.42 157.46 22.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 111.044 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.91 116.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.101 1.76 . . . . 0.0 107.572 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.39 109.52 20.85 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.922 1.689 . . . . 0.0 108.4 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.24 147.16 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -127.93 170.99 12.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.214 1.805 . . . . 0.0 111.239 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.534 1.934 . . . . 0.0 113.381 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.2 169.79 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.916 2.086 . . . . 0.0 113.847 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.2 40.27 91.4 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 p -141.0 -170.94 3.15 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.561 1.144 . . . . 0.0 111.869 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.9 141.1 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.661 1.984 . . . . 0.0 111.024 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -142.09 167.05 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.232 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.53 124.27 18.41 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.751 1.22 . . . . 0.0 112.033 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.67 -24.19 39.17 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.558 1.552 . . . . 0.0 114.055 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.95 70.31 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.474 1.11 . . . . 0.0 111.898 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.61 -19.9 44.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.714 1.605 . . . . 0.0 113.237 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tp -66.97 105.99 1.8 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.241 1.416 . . . . 0.0 111.206 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 m -144.36 167.87 21.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.249 1.42 . . . . 0.0 109.676 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -46.81 -33.65 4.63 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.623 1.569 . . . . 0.0 113.251 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -58.91 -53.73 55.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.192 0.997 . . . . 0.0 111.128 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -40.5 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.945 0.898 . . . . 0.0 111.894 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 mt -59.65 -54.01 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.176 0.991 . . . . 0.0 111.759 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.55 -38.73 92.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -57.91 -48.45 79.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.256 1.022 . . . . 0.0 112.156 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -55.91 -47.58 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.367 1.067 . . . . 0.0 111.253 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.3 -42.47 95.58 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.45 1.1 . . . . 0.0 113.608 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.25 -47.77 84.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.768 0.427 . . . . 0.0 111.529 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.17 -39.18 72.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 tp -52.81 -57.27 10.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.91 2.084 . . . . 0.0 111.387 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.56 51.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.661 1.124 . . . . 0.0 112.896 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -37.65 127.69 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.514 1.926 . . . . 0.0 113.639 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.83 -169.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.102 1.761 . . . . 0.0 110.623 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 m -43.63 -32.11 0.9 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.675 1.99 . . . . 0.0 115.06 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -141.69 145.91 35.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.422 1.889 . . . . 0.0 107.604 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -165.22 147.64 7.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.822 1.249 . . . . 0.0 110.432 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.52 144.42 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.562 0.619 . . . . 0.0 111.16 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.2 116.27 30.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.243 1.017 . . . . 0.0 110.772 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 t -107.45 138.68 32.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 110.3 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.84 114.81 0.67 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.419 1.009 . . . . 0.0 112.196 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.73 104.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.436 1.094 . . . . 0.0 109.622 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -82.77 107.49 15.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.916 1.286 . . . . 0.0 112.258 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -84.12 71.38 10.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.984 1.314 . . . . 0.0 114.225 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.23 21.45 0.18 Allowed 'General case' 0 CA--C 1.558 1.286 0 O-C-N 119.778 -1.826 . . . . 0.0 115.118 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 p -57.85 -48.47 79.71 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.0 -17.36 6.0 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.565 2.031 . . . . 0.0 116.107 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.2 -104.04 1.89 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.931 1.866 . . . . 0.0 116.282 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.0 t -162.58 135.95 6.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.875 1.67 . . . . 0.0 111.671 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -115.04 167.43 10.82 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.793 1.637 . . . . 0.0 111.276 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.9 m -141.36 111.35 6.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.158 0.983 . . . . 0.0 110.292 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.33 133.8 55.6 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.895 -1.128 . . . . 0.0 108.429 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -70.88 -69.26 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -172.41 171.29 4.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 110.453 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.59 142.46 51.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.816 2.046 . . . . 0.0 109.301 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.55 121.0 18.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.532 1.133 . . . . 0.0 111.43 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -74.5 128.25 35.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.829 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -45.12 6.24 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.929 1.692 . . . . 0.0 111.66 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -141.58 153.97 45.15 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.186 1.794 . . . . 0.0 110.324 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.88 -170.05 53.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 121.493 0.496 . . . . 0.0 113.054 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 t -140.86 164.04 31.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 110.651 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.6 p -149.71 178.98 8.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.774 1.23 . . . . 0.0 111.18 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 25.99 4.12 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.456 1.102 . . . . 0.0 112.446 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.33 172.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.71 2.004 . . . . 0.0 113.535 -174.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 mt -137.02 151.59 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.246 2.219 . . . . 0.0 109.199 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 141.16 22.22 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 120.212 1.369 . . . . 0.0 110.935 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.05 160.45 47.24 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.94 3.094 . . . . 0.0 111.028 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -104.22 -46.23 4.48 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.328 -0.857 . . . . 0.0 112.073 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.59 132.38 46.01 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.082 1.31 . . . . 0.0 111.938 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.91 92.15 11.25 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.868 1.667 . . . . 0.0 110.2 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.31 160.66 37.83 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.118 1.879 . . . . 0.0 112.042 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -58.14 159.9 5.45 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.124 -0.985 . . . . 0.0 110.706 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p 68.67 8.7 6.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.583 1.953 . . . . 0.0 113.543 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -136.66 110.12 7.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.368 1.867 . . . . 0.0 111.99 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.1 164.75 19.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.606 0.762 . . . . 0.0 112.164 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 173.54 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.214 0.606 . . . . 0.0 110.947 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.7 127.66 40.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.478 1.911 . . . . 0.0 107.82 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.49 154.98 41.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.882 0.873 . . . . 0.0 110.65 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -148.52 162.93 38.65 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 111.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.76 138.71 6.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.308 0.956 . . . . 0.0 111.953 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 167.57 19.91 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.823 0.849 . . . . 0.0 110.293 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -65.29 -179.62 0.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.044 0.538 . . . . 0.0 110.467 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.85 -179.95 0.23 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.63 -0.669 . . . . 0.0 110.642 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.4 m -24.65 -54.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 128.053 2.541 . . . . 0.0 116.166 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.79 -58.98 0.32 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.404 1.478 . . . . 0.0 112.797 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.91 0.09 7.66 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.779 3.653 . . . . 0.0 115.736 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.06 104.5 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.242 2.217 . . . . 0.0 112.008 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.94 77.87 1.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.632 1.573 . . . . 0.0 112.927 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.8 m -110.74 -82.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.004 1.321 . . . . 0.0 111.304 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 161.95 179.42 36.6 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.099 1.333 . . . . 0.0 111.886 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.82 114.88 10.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 110.026 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.48 130.35 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.21 167.84 25.73 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.731 0.777 . . . . 0.0 110.743 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.46 154.72 36.09 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.017 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.39 169.39 21.53 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.038 1.735 . . . . 0.0 110.838 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.15 140.53 47.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.697 1.199 . . . . 0.0 110.964 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.67 112.56 17.53 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.032 1.333 . . . . 0.0 111.763 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -76.66 115.68 16.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 110.738 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.5 mtm -78.98 162.68 25.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.95 0.9 . . . . 0.0 112.284 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -60.23 -19.84 56.27 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -79.71 -11.37 59.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.405 1.482 . . . . 0.0 113.007 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.27 2.49 65.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.887 1.232 . . . . 0.0 114.435 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.71 169.99 11.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.778 1.231 . . . . 0.0 110.608 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.5 m -135.98 154.69 51.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.441 1.096 . . . . 0.0 110.19 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 127.95 48.34 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.267 1.027 . . . . 0.0 109.726 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.22 114.47 4.13 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.24 126.07 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.233 1.013 . . . . 0.0 108.716 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -140.8 164.32 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.73 0.776 . . . . 0.0 112.285 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -140.63 151.4 44.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.767 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -130.5 116.31 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.948 1.699 . . . . 0.0 110.066 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.67 99.19 47.63 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.834 1.654 . . . . 0.0 108.77 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.76 169.08 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.31 2.674 . . . . 0.0 112.432 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -76.51 -18.61 58.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.452 0.701 . . . . 0.0 112.783 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.23 109.5 18.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.685 1.594 . . . . 0.0 110.81 -167.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -64.98 -65.41 0.68 Allowed 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.276 -0.89 . . . . 0.0 113.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -86.57 9.3 18.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.66 -6.15 6.92 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.715 2.006 . . . . 0.0 112.661 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 139.06 14.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.728 2.011 . . . . 0.0 110.141 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 t -95.94 164.51 12.69 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.625 -1.297 . . . . 0.0 112.375 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.63 159.02 25.48 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.604 0.762 . . . . 0.0 109.092 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -141.27 141.18 33.98 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.27 -0.894 . . . . 0.0 111.531 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.2 p-90 -156.14 148.62 23.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.247 1.419 . . . . 0.0 110.502 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -145.3 155.21 43.07 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.309 1.843 . . . . 0.0 109.39 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.14 116.35 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.38 1.872 . . . . 0.0 109.414 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -120.41 137.33 54.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.488 1.915 . . . . 0.0 109.298 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.7 mt -102.41 120.19 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.971 1.708 . . . . 0.0 108.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.93 147.9 51.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.493 1.517 . . . . 0.0 112.062 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 p -77.02 78.98 3.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.41 1.084 . . . . 0.0 112.574 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.28 158.48 8.47 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.076 0.846 . . . . 0.0 114.883 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 121.87 16.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.522 1.529 . . . . 0.0 112.793 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -136.63 85.54 2.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.143 1.777 . . . . 0.0 109.289 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -60.21 170.97 1.12 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.007 0.923 . . . . 0.0 111.407 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.26 92.79 4.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.627 0.771 . . . . 0.0 111.067 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -98.39 -68.75 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.548 0.739 . . . . 0.0 110.404 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.28 -70.08 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.557 1.143 . . . . 0.0 110.408 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.12 -25.05 76.38 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.059 0.838 . . . . 0.0 114.661 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -48.08 27.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.261 1.024 . . . . 0.0 110.48 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -37.34 81.79 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.099 0.959 . . . . 0.0 110.927 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -54.75 -33.35 61.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.15 -33.35 73.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.434 1.016 . . . . 0.0 112.706 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.49 -41.19 61.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.024 0.829 . . . . 0.0 110.313 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -65.36 -59.31 4.17 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.756 -1.215 . . . . 0.0 111.741 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -79.44 -19.55 49.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.189 1.396 . . . . 0.0 112.698 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -76.66 0.22 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.365 0.983 . . . . 0.0 112.598 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.37 84.15 1.59 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.67 1.188 . . . . 0.0 110.433 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.49 157.21 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.539 1.493 . . . . 0.0 111.262 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.71 4.98 49.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.684 1.194 . . . . 0.0 113.412 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.25 66.81 0.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 128.194 2.597 . . . . 0.0 113.438 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -33.48 90.77 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.398 2.904 . . . . 0.0 114.869 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -110.07 43.89 1.3 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.957 1.703 . . . . 0.0 110.349 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 58.18 42.57 21.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.548 1.539 . . . . 0.0 112.84 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.84 146.99 18.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 112.813 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -68.58 131.15 44.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.091 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -127.68 108.08 10.45 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.885 1.674 . . . . 0.0 109.293 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.31 153.09 35.49 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.285 1.434 . . . . 0.0 111.947 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -167.86 146.02 4.52 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.318 1.447 . . . . 0.0 111.004 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.67 125.5 25.99 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.443 0.565 . . . . 0.0 109.806 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.2 tp -141.01 -36.19 0.46 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.35 1.06 . . . . 0.0 112.834 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.72 20.02 5.68 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.685 1.136 . . . . 0.0 114.486 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.5 12.35 2.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.311 2.245 . . . . 0.0 115.286 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.91 -67.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.379 1.942 . . . . 0.0 110.605 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.06 147.78 27.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.925 0.89 . . . . 0.0 110.604 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.83 168.1 24.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.376 1.47 . . . . 0.0 111.924 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -96.15 139.14 32.75 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.717 0.807 . . . . 0.0 111.655 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -128.67 108.33 10.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.72 1.608 . . . . 0.0 108.427 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.46 167.67 25.74 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 121.951 0.75 . . . . 0.0 114.154 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.3 tt -149.09 142.94 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.847 2.059 . . . . 0.0 108.823 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.2 ttm -134.82 137.36 43.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.427 1.091 . . . . 0.0 108.801 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.53 156.19 33.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.6 1.16 . . . . 0.0 111.7 175.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.93 9.15 31.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.42 177.67 4.8 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.132 2.173 . . . . 0.0 112.293 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.16 55.68 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.835 0.731 . . . . 0.0 113.053 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -86.5 51.45 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.476 1.51 . . . . 0.0 113.694 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.95 17.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.777 1.231 . . . . 0.0 113.828 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.69 53.77 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 0.0 112.432 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.42 90.29 3.27 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.392 2.277 . . . . 0.0 110.954 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -84.55 143.14 29.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.86 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.42 122.49 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.458 1.903 . . . . 0.0 107.506 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -118.71 111.01 17.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.879 1.272 . . . . 0.0 109.759 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.3 mm -83.13 117.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.183 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m -89.29 174.8 7.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 0.0 111.75 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.313 1.845 . . . . 0.0 113.196 -177.417 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.22 168.08 0.57 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.36 36.11 63.28 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.563 -0.711 . . . . 0.0 113.825 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -150.82 -169.19 3.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.121 0.968 . . . . 0.0 111.152 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.71 137.63 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.538 1.935 . . . . 0.0 111.861 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pp -145.5 165.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.223 1.809 . . . . 0.0 111.472 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.22 126.7 19.64 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.155 0.982 . . . . 0.0 112.803 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.15 -21.09 30.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.087 1.327 . . . . 0.0 114.047 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.02 72.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.465 1.506 . . . . 0.0 112.324 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -34.71 66.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.386 1.074 . . . . 0.0 112.113 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.63 100.02 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.784 1.634 . . . . 0.0 112.25 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -143.08 172.01 13.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.629 1.572 . . . . 0.0 110.463 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.41 -39.74 33.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.594 1.558 . . . . 0.0 113.697 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.66 -41.97 91.77 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.598 -0.689 . . . . 0.0 112.521 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.38 -46.81 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.626 0.77 . . . . 0.0 110.044 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -53.35 -60.18 3.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.596 0.759 . . . . 0.0 111.036 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.45 -43.28 67.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.071 0.948 . . . . 0.0 112.371 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -59.43 -29.17 67.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.686 1.195 . . . . 0.0 113.533 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.3 -48.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.226 -1.546 . . . . 0.0 110.009 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.3 -34.81 66.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.959 0.504 . . . . 0.0 111.526 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.1 -57.69 6.31 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.86 -40.38 47.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.853 1.206 . . . . 0.0 114.06 -172.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.43 -23.38 66.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.346 1.058 . . . . 0.0 111.532 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 68.2 1.44 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.368 1.461 . . . . 0.0 111.214 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.35 127.83 4.67 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 110.774 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 -161.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.118 2.167 . . . . 0.0 110.049 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -41.21 -49.3 3.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.12 1.368 . . . . 0.0 113.508 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -146.31 137.16 24.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.333 1.453 . . . . 0.0 111.377 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -157.6 171.15 20.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.511 1.524 . . . . 0.0 113.952 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.83 163.21 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.456 1.102 . . . . 0.0 112.122 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.68 111.91 17.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.302 1.441 . . . . 0.0 110.471 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -97.11 145.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.649 1.58 . . . . 0.0 111.904 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.53 122.38 1.14 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.022 1.296 . . . . 0.0 111.33 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.78 112.74 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.185 1.492 . . . . 0.0 110.226 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.0 134.97 35.02 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.35 79.22 7.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.056 1.742 . . . . 0.0 113.243 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.86 2.6 53.79 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.3 t -65.55 -17.52 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.521 2.328 . . . . 0.0 114.72 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.71 4.3 89.32 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 114.74 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.58 161.31 23.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.551 1.548 . . . . 0.0 114.026 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 t -78.25 134.86 37.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.491 1.516 . . . . 0.0 112.037 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -112.12 168.08 9.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.864 2.066 . . . . 0.0 111.469 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -136.93 108.06 6.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 110.737 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.54 117.76 6.65 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.873 -1.142 . . . . 0.0 108.539 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.49 -64.46 0.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.774 0.829 . . . . 0.0 109.88 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -177.98 171.05 1.8 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.517 2.327 . . . . 0.0 110.874 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.72 138.82 54.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 109.096 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -128.43 110.22 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.234 1.414 . . . . 0.0 111.133 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -72.5 121.32 19.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.724 1.209 . . . . 0.0 111.477 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.77 -33.6 14.93 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.446 1.498 . . . . 0.0 112.926 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 t -145.04 162.32 37.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.598 1.559 . . . . 0.0 111.115 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.9 -160.68 29.68 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.727 0.651 . . . . 0.0 114.727 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -144.83 -178.73 6.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.444 1.498 . . . . 0.0 111.972 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -147.25 166.19 27.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.846 1.658 . . . . 0.0 110.617 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.64 6.97 20.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.591 1.156 . . . . 0.0 111.608 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.72 153.41 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 128.305 2.642 . . . . 0.0 111.038 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -122.04 140.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.502 1.521 . . . . 0.0 108.764 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 140.1 75.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.369 -0.832 . . . . 0.0 109.618 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.5 176.64 3.26 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.459 3.439 . . . . 0.0 110.956 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -119.19 -21.89 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.656 -1.278 . . . . 0.0 113.036 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -128.83 137.28 51.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.414 1.886 . . . . 0.0 109.792 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.413 HG23 ' HH ' ' A' ' 90' ' ' TYR . 27.1 t -139.86 96.91 8.18 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.843 1.257 . . . . 0.0 109.715 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.88 168.57 18.36 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 112.557 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.27 159.83 5.69 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.578 -0.701 . . . . 0.0 110.148 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.273 5.6 t 57.66 15.62 2.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.638 1.975 . . . . 0.0 113.792 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -133.09 120.12 20.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.927 2.491 . . . . 0.0 110.371 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.87 163.54 13.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.674 1.19 . . . . 0.0 110.45 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.96 169.0 9.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.19 132.93 46.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.871 2.068 . . . . 0.0 108.893 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -153.13 164.04 38.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.799 1.24 . . . . 0.0 110.44 175.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 m -145.31 175.29 10.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.462 1.105 . . . . 0.0 111.207 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.58 103.66 0.24 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 125.176 1.37 . . . . 0.0 110.742 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 176.98 4.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.428 1.114 . . . . 0.0 111.572 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HZ1' ' HA ' ' A' ' 106' ' ' PHE . 16.7 mmtt -66.59 -176.98 0.52 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.44 -177.02 0.27 Allowed 'General case' 0 CA--C 1.559 1.298 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -10.33 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 127.944 2.497 . . . . 0.0 116.521 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.43 -72.07 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.212 0.91 . . . . 0.0 113.038 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.99 84.07 1.72 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.757 3.638 . . . . 0.0 112.368 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.08 140.8 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.151 1.381 . . . . 0.0 112.256 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 64.59 0.84 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.015 1.326 . . . . 0.0 111.635 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 t -122.53 -97.22 0.45 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 110.855 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.74 -177.46 43.87 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.967 2.698 . . . . 0.0 110.883 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.29 99.46 3.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.111 1.364 . . . . 0.0 108.742 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 131.12 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.107 . . . . 0.0 108.584 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.1 166.9 31.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.57 0.748 . . . . 0.0 111.22 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.05 158.14 43.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.711 0.767 . . . . 0.0 112.42 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.46 171.18 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.648 1.979 . . . . 0.0 110.478 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.51 142.37 43.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.155 0.982 . . . . 0.0 111.174 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.413 ' HH ' HG23 ' A' ' 63' ' ' VAL . 1.1 m-85 -125.84 111.73 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.047 1.339 . . . . 0.0 111.33 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -73.61 114.35 11.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.004 1.321 . . . . 0.0 110.805 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.1 mtt -76.6 160.7 29.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.435 0.636 . . . . 0.0 111.364 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 t -61.66 -17.76 56.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.0 m -79.51 -13.33 59.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.014 1.726 . . . . 0.0 113.548 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.21 55.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.605 1.098 . . . . 0.0 114.835 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.88 173.43 11.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.242 1.017 . . . . 0.0 111.687 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 m -133.77 142.94 48.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.94 0.896 . . . . 0.0 108.587 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.92 125.72 54.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 108.932 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.62 148.46 24.95 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.8 130.55 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.312 1.045 . . . . 0.0 109.255 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.65 45.88 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' CZ ' ' HA3' ' A' ' 73' ' ' GLY . 22.8 p90 -127.01 153.27 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.147 1.379 . . . . 0.0 110.696 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.9 t -136.9 111.45 8.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.497 1.119 . . . . 0.0 111.49 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.1 t -115.02 102.18 54.75 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.51 1.924 . . . . 0.0 109.344 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.01 171.25 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.841 2.361 . . . . 0.0 112.542 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.459 ' HA ' ' HZ1' ' A' ' 75' ' ' LYS . 42.6 t80 -72.39 -53.83 11.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.326 . . . . 0.0 110.632 174.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.01 107.48 7.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.227 3.411 . . . . 0.0 112.398 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.19 -60.16 3.79 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.274 1.03 . . . . 0.0 113.539 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.59 9.45 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -4.15 6.85 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.566 1.947 . . . . 0.0 112.456 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.2 146.04 26.61 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.395 2.278 . . . . 0.0 109.496 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.92 165.31 11.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.365 1.066 . . . . 0.0 111.869 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.44 156.93 18.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.666 -0.646 . . . . 0.0 110.112 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -140.5 146.14 37.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.35 0.66 . . . . 0.0 109.92 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -147.97 155.6 41.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.991 1.316 . . . . 0.0 110.021 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.56 138.23 20.93 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.846 -0.534 . . . . 0.0 111.62 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.7 t -147.74 103.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.334 1.854 . . . . 0.0 110.102 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -120.6 143.37 48.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.036 1.335 . . . . 0.0 110.065 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.51 111.6 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.249 1.819 . . . . 0.0 108.756 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -116.33 141.47 48.11 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.711 1.604 . . . . 0.0 111.853 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.7 p -72.48 80.55 1.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.288 1.435 . . . . 0.0 113.104 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.06 159.56 8.64 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.221 1.391 . . . . 0.0 113.321 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -73.79 133.94 43.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.466 0.707 . . . . 0.0 112.383 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -141.9 143.15 33.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.515 1.926 . . . . 0.0 111.215 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -99.32 -179.35 4.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.662 1.585 . . . . 0.0 110.942 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.9 95.9 4.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.206 1.803 . . . . 0.0 110.177 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.79 -71.08 0.78 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.903 1.281 . . . . 0.0 110.559 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.48 -69.79 0.24 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.323 1.849 . . . . 0.0 109.637 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.54 73.27 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.638 1.113 . . . . 0.0 115.241 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -84.2 -45.82 12.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.182 0.991 . . . . 0.0 110.872 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.15 -44.01 96.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.995 0.918 . . . . 0.0 112.393 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.77 -29.23 69.29 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.025 -1.047 . . . . 0.0 112.441 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -16.06 60.42 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.192 -0.943 . . . . 0.0 112.499 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.66 -55.58 2.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 108.44 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -69.03 -48.14 63.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -87.62 -15.21 37.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.746 0.819 . . . . 0.0 112.743 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.78 60.18 4.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.575 1.083 . . . . 0.0 114.208 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 42.75 76.97 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 127.046 2.138 . . . . 0.0 111.754 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.64 149.04 73.37 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.783 1.655 . . . . 0.0 110.827 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.89 156.7 36.12 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.951 0.881 . . . . 0.0 110.489 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 115.42 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 109.207 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.61 67.01 0.78 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.323 1.439 . . . . 0.0 113.511 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.75 25.36 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.786 2.034 . . . . 0.0 114.386 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 54.72 41.71 31.73 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.994 1.717 . . . . 0.0 113.063 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.4 167.51 24.15 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.656 2.074 . . . . 0.0 112.232 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -75.34 128.56 35.68 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.593 -0.945 . . . . 0.0 111.592 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -120.1 112.86 19.65 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG2' HH21 ' A' ' 156' ' ' ARG . 1.3 pm0 -153.88 148.59 26.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 111.507 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -161.88 147.08 13.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.038 1.335 . . . . 0.0 111.4 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -62.97 123.05 17.54 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.926 -0.484 . . . . 0.0 110.972 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -142.84 -31.6 0.5 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.263 1.025 . . . . 0.0 113.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.85 17.26 16.82 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.963 1.268 . . . . 0.0 114.541 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.2 t80 59.87 10.31 2.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.416 2.287 . . . . 0.0 114.697 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.9 -67.32 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.647 1.594 . . . . 0.0 110.606 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.35 156.54 16.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.577 0.703 . . . . 0.0 111.626 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.468 HH21 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -143.94 165.88 26.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.067 1.747 . . . . 0.0 112.719 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -92.44 133.59 35.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.85 1.26 . . . . 0.0 110.143 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -123.11 106.79 11.09 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.718 1.207 . . . . 0.0 109.339 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-O 122.38 0.989 . . . . 0.0 114.65 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.64 145.29 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.974 2.11 . . . . 0.0 108.186 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.8 131.3 33.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.234 1.814 . . . . 0.0 106.687 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 166.83 19.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.108 0.963 . . . . 0.0 112.079 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 m -95.13 11.6 31.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.661 1.584 . . . . 0.0 113.793 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.13 167.95 10.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 112.368 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.05 26.4 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 121.348 -0.845 . . . . 0.0 112.992 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.16 47.51 0.46 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.503 1.521 . . . . 0.0 113.715 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.46 161.39 27.82 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.716 -1.24 . . . . 0.0 113.44 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.08 133.99 55.47 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 108.913 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.1 ttp -128.53 110.46 12.3 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.494 1.518 . . . . 0.0 111.081 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -122.65 140.98 52.23 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.626 -0.671 . . . . 0.0 109.654 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.7 111.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.754 1.622 . . . . 0.0 109.729 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -100.44 105.37 16.84 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.409 1.484 . . . . 0.0 108.368 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.6 mm -74.06 136.23 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.0 t -151.09 167.18 28.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.956 . . . . 0.0 112.108 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.263 2.225 . . . . 0.0 110.344 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.21 150.33 39.22 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.111 -0.993 . . . . 0.0 111.381 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.94 34.18 87.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 p -142.52 -165.08 1.96 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.596 1.198 . . . . 0.0 111.539 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.36 144.1 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.891 1.676 . . . . 0.0 110.991 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.0 168.88 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.079 1.352 . . . . 0.0 112.18 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 120.67 7.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.105 1.362 . . . . 0.0 111.555 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.14 -25.36 64.37 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.156 0.884 . . . . 0.0 113.11 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.05 68.62 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.174 1.389 . . . . 0.0 113.078 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -96.29 -16.41 21.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.147 1.379 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tp -68.64 107.22 2.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.15 1.38 . . . . 0.0 110.233 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -145.5 169.92 17.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.275 1.03 . . . . 0.0 109.883 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -50.85 -31.53 17.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.878 1.271 . . . . 0.0 113.703 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -61.74 -36.24 80.43 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.358 0.663 . . . . 0.0 112.567 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -39.97 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.782 1.233 . . . . 0.0 111.104 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.28 -47.84 77.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.031 0.932 . . . . 0.0 112.03 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.02 -49.32 76.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.061 0.544 . . . . 0.0 111.69 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -58.53 -36.79 74.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 t -63.79 -59.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.211 1.404 . . . . 0.0 111.237 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.43 -38.09 73.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.815 1.246 . . . . 0.0 112.141 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -41.33 67.52 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.008 0.822 . . . . 0.0 111.953 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.68 -37.07 65.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -48.39 -52.77 20.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.496 1.518 . . . . 0.0 111.638 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.15 58.67 0.15 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.699 1.143 . . . . 0.0 111.002 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 142.33 6.06 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.253 1.421 . . . . 0.0 112.444 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.78 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 109.711 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.3 m -45.0 -31.23 1.22 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.311 1.844 . . . . 0.0 115.525 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.93 134.89 17.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.487 1.515 . . . . 0.0 109.222 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.43 161.04 30.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.371 2.268 . . . . 0.0 110.628 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -139.21 166.22 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.732 1.613 . . . . 0.0 110.326 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.54 110.55 14.6 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.751 1.22 . . . . 0.0 110.866 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.91 138.6 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.8 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 112.18 0.54 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.535 1.064 . . . . 0.0 112.911 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.2 109.87 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.456 1.128 . . . . 0.0 109.214 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -87.81 110.76 20.73 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 112.41 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -71.45 98.1 1.76 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.271 1.428 . . . . 0.0 111.31 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.93 12.75 15.82 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.942 1.697 . . . . 0.0 113.34 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 t -62.68 -54.51 38.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.559 1.144 . . . . 0.0 114.001 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.3 2.36 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.949 1.261 . . . . 0.0 116.166 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.48 163.36 29.9 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.625 1.712 . . . . 0.0 114.03 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.4 p -74.09 138.85 44.22 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.108 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -112.76 167.73 10.25 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.304 1.442 . . . . 0.0 112.236 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -140.14 106.25 5.22 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.016 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.89 125.55 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.88 -1.138 . . . . 0.0 108.667 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.56 -62.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.636 1.174 . . . . 0.0 110.384 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -176.87 174.9 1.7 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.825 2.45 . . . . 0.0 110.644 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.8 146.6 50.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.223 2.209 . . . . 0.0 109.492 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.15 113.33 13.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.146 1.378 . . . . 0.0 111.406 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -73.49 122.92 22.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.78 1.232 . . . . 0.0 110.188 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.95 -38.6 7.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.825 1.65 . . . . 0.0 112.633 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 m -136.92 152.14 49.86 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.653 1.581 . . . . 0.0 109.929 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.13 50.05 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 123.925 0.774 . . . . 0.0 114.88 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -135.81 145.65 46.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 111.54 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -133.26 125.52 29.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.348 1.059 . . . . 0.0 108.747 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.4 -1.04 31.54 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.327 1.051 . . . . 0.0 112.943 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 m -110.89 174.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.812 1.645 . . . . 0.0 113.045 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.11 139.88 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.917 1.687 . . . . 0.0 108.801 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 146.01 86.63 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-N 119.578 1.081 . . . . 0.0 110.86 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.35 167.17 25.99 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.575 3.516 . . . . 0.0 111.277 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -107.64 -24.27 11.81 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.416 -1.427 . . . . 0.0 113.487 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -125.81 133.3 52.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.433 1.493 . . . . 0.0 111.061 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 HG22 ' HH ' ' A' ' 90' ' ' TYR . 25.8 t -133.84 94.63 18.43 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.589 1.556 . . . . 0.0 109.891 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.26 161.36 34.52 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.595 1.53 . . . . 0.0 111.868 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -63.31 160.12 16.58 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.726 -0.609 . . . . 0.0 110.724 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 68.0 -0.85 1.92 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.045 2.138 . . . . 0.0 114.418 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.284 1.833 . . . . 0.0 111.738 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.5 160.79 31.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.971 1.308 . . . . 0.0 111.68 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.85 174.94 6.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.4 133.0 41.84 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.464 1.906 . . . . 0.0 108.394 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -153.99 164.19 38.84 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.112 0.965 . . . . 0.0 112.589 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -150.48 164.25 36.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.914 1.286 . . . . 0.0 111.014 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.97 118.1 1.08 Allowed Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.275 1.417 . . . . 0.0 111.067 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.33 161.56 29.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.714 1.257 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -174.25 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.859 0.464 . . . . 0.0 110.102 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.96 -143.02 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 O-C-N 121.277 -0.89 . . . . 0.0 113.015 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -40.89 -38.33 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 119.044 -2.285 . . . . 0.0 114.796 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.26 -60.94 0.47 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.566 1.555 . . . . 0.0 112.774 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.22 -3.68 11.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.99 3.794 . . . . 0.0 116.156 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.8 160.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.438 1.095 . . . . 0.0 111.717 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.87 66.43 1.03 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.244 1.017 . . . . 0.0 111.24 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.6 m -126.72 -85.32 0.61 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.83 1.252 . . . . 0.0 112.049 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.59 -177.21 32.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.116 1.341 . . . . 0.0 112.33 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.58 26.77 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.76 121.24 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.44 152.59 49.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.441 0.696 . . . . 0.0 110.737 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.7 47.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.82 0.848 . . . . 0.0 111.469 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 171.06 15.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.508 1.523 . . . . 0.0 110.307 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.52 138.09 50.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.159 0.983 . . . . 0.0 110.203 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.405 ' HH ' HG22 ' A' ' 63' ' ' VAL . 1.3 m-85 -119.31 118.61 31.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.709 1.204 . . . . 0.0 111.081 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -83.12 113.36 20.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.162 1.385 . . . . 0.0 110.787 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.5 mtt -70.15 162.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.057 0.943 . . . . 0.0 111.315 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.9 p -61.27 -22.63 65.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 114.102 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t -82.98 -14.57 53.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.46 1.904 . . . . 0.0 113.007 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.14 56.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.284 1.421 . . . . 0.0 115.069 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -80.18 164.34 23.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.618 1.167 . . . . 0.0 109.518 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.0 m -122.95 143.24 50.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.817 0.847 . . . . 0.0 110.193 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.55 115.7 23.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 128.34 8.43 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 m -130.63 128.93 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.679 0.792 . . . . 0.0 109.539 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.11 154.8 49.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 175.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -134.05 153.9 51.5 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.701 1.201 . . . . 0.0 110.639 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.2 t -137.31 114.55 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.078 2.151 . . . . 0.0 108.931 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.76 95.2 27.16 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 128.683 2.793 . . . . 0.0 106.95 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.97 -168.66 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.509 2.14 . . . . 0.0 111.454 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -108.69 -43.46 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.995 0.918 . . . . 0.0 112.154 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.68 127.19 32.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.105 1.762 . . . . 0.0 112.36 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -58.22 3.44 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -100.25 11.55 39.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.255 1.422 . . . . 0.0 113.917 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.23 0.87 7.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.108 2.163 . . . . 0.0 111.917 -175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.43 178.36 10.24 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.753 2.421 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 t -154.8 164.78 38.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.223 1.409 . . . . 0.0 110.932 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 112.72 24.77 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.01 -1.056 . . . . 0.0 111.181 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.58 136.32 38.85 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -142.92 145.23 32.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.658 1.183 . . . . 0.0 111.214 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -137.0 139.37 41.37 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.391 1.077 . . . . 0.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.06 110.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.121 1.768 . . . . 0.0 109.981 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -126.84 133.51 50.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.763 1.625 . . . . 0.0 110.189 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 mt -97.83 129.79 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.756 1.622 . . . . 0.0 108.592 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -133.63 144.18 49.07 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.822 . . . . 0.0 112.902 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 p -75.02 92.21 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.167 1.787 . . . . 0.0 113.102 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.7 -179.15 21.32 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.314 1.435 . . . . 0.0 112.483 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 145.21 25.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.626 1.17 . . . . 0.0 111.713 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -163.48 164.57 24.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.778 1.631 . . . . 0.0 111.002 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -140.55 156.16 46.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.243 1.417 . . . . 0.0 110.862 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 92.26 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.655 0.782 . . . . 0.0 111.019 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.67 -72.05 0.71 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.145 1.378 . . . . 0.0 110.583 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 -71.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 108.091 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.43 -42.93 57.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.379 0.99 . . . . 0.0 113.999 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.4 tpt -74.22 -50.08 20.67 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.498 1.149 . . . . 0.0 112.628 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -48.22 80.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.906 0.483 . . . . 0.0 110.061 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.16 -33.6 76.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.77 -28.68 70.15 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.508 1.504 . . . . 0.0 112.051 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.79 -40.21 12.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.562 0.745 . . . . 0.0 111.453 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -78.49 -42.32 29.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.427 -1.421 . . . . 0.0 114.104 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -96.29 -12.97 23.71 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.043 -1.036 . . . . 0.0 112.798 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.51 -77.22 0.16 Allowed Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.577 1.084 . . . . 0.0 112.083 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -175.06 69.05 0.27 Allowed Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 127.531 2.333 . . . . 0.0 110.608 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.76 130.38 18.02 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.789 0.993 . . . . 0.0 111.106 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.22 124.36 22.89 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 15.51 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.013 2.125 . . . . 0.0 114.425 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 52.97 59.1 9.84 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.3 1.429 . . . . 0.0 112.319 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.16 16.91 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 67.57 29.75 6.98 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.748 2.019 . . . . 0.0 112.97 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.1 158.16 23.79 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.809 1.671 . . . . 0.0 113.832 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -72.74 131.1 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.783 1.233 . . . . 0.0 112.034 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -122.88 108.48 13.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.747 2.019 . . . . 0.0 111.016 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.75 153.59 45.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.184 1.793 . . . . 0.0 110.782 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.99 138.99 1.35 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.63 1.172 . . . . 0.0 110.268 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -60.54 134.77 57.4 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.276 0.489 . . . . 0.0 111.403 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.54 -30.53 0.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.79 24.41 5.18 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.001 1.286 . . . . 0.0 114.623 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 t80 58.67 15.15 3.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.44 2.296 . . . . 0.0 114.708 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 176.42 -77.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.833 1.683 . . . . 0.0 110.976 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.35 145.8 37.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.401 1.081 . . . . 0.0 110.459 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.99 168.41 20.05 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.5 1.52 . . . . 0.0 112.162 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.48 142.54 32.82 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.912 1.285 . . . . 0.0 111.239 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -140.08 107.06 5.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.589 1.956 . . . . 0.0 108.523 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.6 168.02 26.02 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-O 121.503 0.502 . . . . 0.0 114.206 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.0 tt -143.49 142.82 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.322 1.849 . . . . 0.0 109.011 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.0 ttt -145.59 151.09 37.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.945 1.698 . . . . 0.0 108.479 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.8 p -88.26 165.07 15.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.425 0.69 . . . . 0.0 111.548 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.8 m -80.71 9.56 6.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 112.819 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.08 157.22 17.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.843 2.057 . . . . 0.0 111.382 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.01 3.16 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 119.311 0.959 . . . . 0.0 111.868 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.58 87.97 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.894 0.878 . . . . 0.0 109.507 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.92 146.86 50.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.0 1.32 . . . . 0.0 112.31 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -91.67 129.89 37.56 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.3 ttm -127.06 83.46 2.17 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.672 1.989 . . . . 0.0 109.503 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -89.07 144.48 26.11 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.677 -0.639 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 59.1 mt -127.23 124.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.954 1.702 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -114.09 107.23 15.36 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.173 1.789 . . . . 0.0 109.182 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 35.8 mm -88.95 103.94 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.633 0.73 . . . . 0.0 110.794 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.7 p -153.27 173.78 15.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.639 1.575 . . . . 0.0 112.571 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.347 1.859 . . . . 0.0 111.429 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.73 146.11 0.27 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.051 1.74 . . . . 0.0 115.286 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.07 38.75 34.28 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.583 1.087 . . . . 0.0 113.985 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.0 p -145.25 -170.6 3.47 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 118.732 1.266 . . . . 0.0 111.895 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.4 pt -118.51 142.51 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.776 2.03 . . . . 0.0 110.479 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 pt -145.63 162.48 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.26 1.424 . . . . 0.0 111.813 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.36 126.5 27.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.725 0.81 . . . . 0.0 110.863 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.93 -23.08 60.98 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.299 0.952 . . . . 0.0 113.059 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.57 91.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.98 1.312 . . . . 0.0 112.085 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 m -79.92 -24.02 41.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.763 1.225 . . . . 0.0 113.541 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.32 97.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.062 1.345 . . . . 0.0 112.2 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -145.52 172.46 13.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.926 1.69 . . . . 0.0 110.17 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -46.56 -39.83 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.155 1.382 . . . . 0.0 114.6 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -56.62 -43.68 80.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.563 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.15 -45.2 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.274 1.03 . . . . 0.0 111.072 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 mt -56.05 -50.01 72.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.547 0.612 . . . . 0.0 111.492 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.33 -42.47 92.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -52.83 60.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 111.809 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.71 -49.21 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.728 1.211 . . . . 0.0 110.404 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -43.11 62.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.727 0.811 . . . . 0.0 112.399 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.4 -53.25 14.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.892 1.277 . . . . 0.0 112.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -72.41 -29.26 63.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.536 1.534 . . . . 0.0 114.254 -171.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.61 -53.93 43.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.591 1.557 . . . . 0.0 110.589 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.45 75.24 0.2 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.268 1.413 . . . . 0.0 111.926 -169.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 139.95 2.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.496 1.518 . . . . 0.0 111.887 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.05 -177.85 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 126.754 2.021 . . . . 0.0 109.725 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -45.78 -42.86 12.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.287 1.835 . . . . 0.0 115.151 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -148.79 141.37 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.31 1.444 . . . . 0.0 111.371 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.5 168.94 7.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.584 1.953 . . . . 0.0 112.32 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.13 161.15 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.613 1.165 . . . . 0.0 110.637 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.18 106.95 13.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.406 1.482 . . . . 0.0 109.882 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.48 140.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.333 1.453 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.58 120.56 1.0 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.706 1.146 . . . . 0.0 111.992 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -112.28 97.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 109.373 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.89 114.12 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.205 1.402 . . . . 0.0 113.513 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.09 96.75 9.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.267 1.427 . . . . 0.0 111.227 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -124.17 34.33 5.07 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.239 1.816 . . . . 0.0 110.186 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 t -80.34 -51.0 9.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.948 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.14 15.02 1.93 Allowed Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.83 160.6 32.57 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.53 1.665 . . . . 0.0 114.085 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.5 p -73.41 138.32 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.983 -0.716 . . . . 0.0 111.919 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.38 165.72 11.55 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.495 1.118 . . . . 0.0 111.457 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 m -133.78 115.58 14.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.084 1.354 . . . . 0.0 108.739 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.89 136.87 57.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.199 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -70.08 0.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -179.19 175.19 0.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.403 2.281 . . . . 0.0 110.285 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.1 147.16 51.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.377 2.271 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.17 109.79 9.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.912 1.285 . . . . 0.0 110.638 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -71.43 116.57 11.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.726 1.21 . . . . 0.0 110.779 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -45.86 9.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.655 1.182 . . . . 0.0 112.123 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.1 m -137.37 146.94 45.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.087 1.755 . . . . 0.0 110.457 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 -163.98 41.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.682 0.658 . . . . 0.0 113.191 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.45 174.64 14.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.265 1.026 . . . . 0.0 111.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -143.94 173.23 11.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.195 0.998 . . . . 0.0 112.009 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.84 11.65 11.91 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.618 1.567 . . . . 0.0 112.061 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.57 166.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.226 2.21 . . . . 0.0 111.351 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.97 133.36 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.971 1.308 . . . . 0.0 109.943 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.94 152.67 90.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 119.533 1.06 . . . . 0.0 112.326 176.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.53 171.61 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.414 3.41 . . . . 0.0 110.313 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -111.05 -18.87 12.93 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -124.62 131.18 53.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.85 1.66 . . . . 0.0 110.26 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.98 98.14 6.91 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.675 1.19 . . . . 0.0 109.639 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.67 164.82 25.15 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.728 1.619 . . . . 0.0 112.573 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -62.28 157.72 18.92 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.493 -0.754 . . . . 0.0 110.393 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p 68.67 -0.02 2.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.568 1.947 . . . . 0.0 114.248 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -125.45 145.81 49.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 110.723 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.46 169.16 10.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.922 1.689 . . . . 0.0 110.826 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.22 177.52 4.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.876 0.846 . . . . 0.0 110.187 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.23 128.78 40.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.371 1.868 . . . . 0.0 108.747 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -149.22 163.8 36.6 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.512 0.725 . . . . 0.0 111.951 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -149.8 172.51 15.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.559 1.144 . . . . 0.0 111.199 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.67 106.19 0.29 Allowed Glycine 0 N--CA 1.47 0.922 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.735 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 162.97 14.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.07 1.348 . . . . 0.0 112.75 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.66 105.28 17.25 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.333 -0.855 . . . . 0.0 110.944 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t0 33.26 -134.58 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.918 2.487 . . . . 0.0 112.928 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -39.58 80.94 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.164 -1.585 . . . . 0.0 112.138 174.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.39 -62.28 0.53 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.566 1.555 . . . . 0.0 112.993 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.94 -3.71 7.52 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 125.001 3.801 . . . . 0.0 116.494 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.96 168.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.778 1.231 . . . . 0.0 112.267 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.22 68.61 1.41 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.652 1.181 . . . . 0.0 111.644 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -120.7 -89.35 0.61 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.258 1.423 . . . . 0.0 110.839 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.51 174.55 35.21 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.285 1.422 . . . . 0.0 111.315 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.19 111.77 11.16 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 110.122 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -139.34 120.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 168.21 20.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.841 0.857 . . . . 0.0 110.851 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.21 155.95 42.53 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.83 173.72 12.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.964 2.106 . . . . 0.0 110.716 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.96 149.7 45.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.275 1.03 . . . . 0.0 111.398 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.39 117.13 18.46 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.016 1.327 . . . . 0.0 111.624 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -79.39 108.85 13.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.502 1.521 . . . . 0.0 110.213 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mtt -71.06 162.7 28.99 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.575 0.703 . . . . 0.0 111.612 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -59.69 -21.32 60.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.924 1.69 . . . . 0.0 113.956 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.5 m -79.93 -12.4 59.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.631 1.972 . . . . 0.0 113.208 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 6.2 65.73 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.94 1.257 . . . . 0.0 115.072 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -90.74 170.45 10.11 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.517 1.127 . . . . 0.0 110.496 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.6 m -131.68 149.38 52.5 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.136 0.969 . . . . 0.0 110.94 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 122.74 42.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.195 1.398 . . . . 0.0 109.037 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 139.4 24.4 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.15 122.16 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.781 1.291 . . . . 0.0 109.03 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.4 ptm -127.81 158.76 36.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.606 0.762 . . . . 0.0 112.109 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.78 150.74 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.213 1.405 . . . . 0.0 110.244 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.73 100.7 4.26 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.895 1.278 . . . . 0.0 110.524 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.69 104.27 13.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 127.332 2.253 . . . . 0.0 109.854 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.08 169.69 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.147 2.565 . . . . 0.0 112.718 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -89.87 -37.0 14.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.68 111.65 23.96 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.895 1.678 . . . . 0.0 111.273 -163.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -66.8 -56.86 8.54 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.754 -1.216 . . . . 0.0 113.8 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -94.31 12.83 25.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.644 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.91 -14.76 3.08 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.328 1.851 . . . . 0.0 113.068 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.95 -179.32 6.28 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.832 3.253 . . . . 0.0 109.446 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.56 167.73 23.78 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.931 1.292 . . . . 0.0 111.016 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.57 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.586 -0.697 . . . . 0.0 111.188 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -139.67 147.73 41.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.741 1.216 . . . . 0.0 111.205 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.41 148.82 20.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -141.86 149.01 39.7 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.085 1.312 . . . . 0.0 111.603 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -143.97 86.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.559 1.543 . . . . 0.0 113.584 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -88.4 138.91 31.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.225 1.01 . . . . 0.0 108.504 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mt -108.23 114.65 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.547 1.539 . . . . 0.0 108.68 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -127.53 136.44 51.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.326 1.451 . . . . 0.0 112.464 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 p -78.08 84.28 4.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.284 1.434 . . . . 0.0 112.294 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.24 -175.45 37.86 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.3 0.952 . . . . 0.0 113.418 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -112.91 107.02 15.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.427 1.891 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -140.55 167.97 20.9 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.518 1.927 . . . . 0.0 111.344 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.92 166.97 26.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.973 1.709 . . . . 0.0 112.486 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.32 84.96 4.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.294 1.438 . . . . 0.0 111.232 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.28 -64.61 1.03 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.786 0.834 . . . . 0.0 110.843 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -152.2 -77.0 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.144 2.178 . . . . 0.0 108.501 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.6 -24.87 71.33 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.338 0.97 . . . . 0.0 115.022 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -56.49 4.66 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.667 1.234 . . . . 0.0 110.506 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.33 -38.89 78.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.485 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -58.42 -38.72 77.98 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.341 0.973 . . . . 0.0 112.668 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.01 -38.67 89.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.646 0.657 . . . . 0.0 111.904 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -34.34 64.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.456 0.702 . . . . 0.0 111.166 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.49 -47.87 37.78 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.52 -1.363 . . . . 0.0 112.823 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -94.6 -15.99 23.59 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.946 0.898 . . . . 0.0 113.285 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -70.64 0.9 Allowed Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.309 0.957 . . . . 0.0 112.664 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -178.17 77.47 0.23 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.807 2.443 . . . . 0.0 109.658 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.04 128.18 18.2 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.56 -1.361 . . . . 0.0 108.56 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.48 150.55 26.48 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.574 1.178 . . . . 0.0 110.311 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 120.61 28.02 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.462 1.105 . . . . 0.0 108.687 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.8 55.95 1.34 Allowed Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.197 1.379 . . . . 0.0 113.976 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.4 25.71 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.229 1.812 . . . . 0.0 115.462 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.267 12.0 p30 52.84 31.72 11.16 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.154 2.182 . . . . 0.0 114.57 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.77 175.9 18.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.721 2.105 . . . . 0.0 113.092 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -79.63 122.88 27.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.04 0.936 . . . . 0.0 111.759 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -114.34 116.2 28.58 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.431 1.892 . . . . 0.0 109.452 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -142.93 146.12 33.69 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.6 1.16 . . . . 0.0 110.777 175.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -147.19 121.53 9.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.874 1.27 . . . . 0.0 111.747 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.12 93.92 1.47 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.153 1.381 . . . . 0.0 112.269 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.24 8.82 0.94 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -94.68 21.6 42.35 Favored Glycine 0 N--CA 1.476 1.334 0 O-C-N 120.623 -1.298 . . . . 0.0 115.341 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 65.35 9.32 5.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.388 1.875 . . . . 0.0 115.022 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.65 -40.84 0.21 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.546 1.546 . . . . 0.0 113.997 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.42 150.53 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 110.388 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 167.16 21.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.815 0.846 . . . . 0.0 112.904 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.36 139.77 30.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 109.898 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -130.37 115.26 16.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.02 172.14 25.29 Favored Glycine 0 C--O 1.23 -0.12 0 CA-C-O 121.901 0.723 . . . . 0.0 113.494 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 tt -138.54 131.88 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 109.318 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 8.7 ttt -129.1 143.07 50.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.183 1.793 . . . . 0.0 107.021 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.29 154.16 19.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.071 1.749 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.6 m -92.59 27.26 2.36 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.108 1.363 . . . . 0.0 112.715 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.39 170.71 8.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.518 1.927 . . . . 0.0 111.58 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.41 -62.09 5.14 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.289 -0.882 . . . . 0.0 112.823 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.52 51.11 1.4 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.406 1.882 . . . . 0.0 111.73 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.63 175.85 3.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.69 1.596 . . . . 0.0 112.443 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -134.67 154.11 51.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.285 1.434 . . . . 0.0 109.161 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.6 ttp -142.69 85.31 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.164 0.986 . . . . 0.0 111.969 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.36 142.04 28.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.263 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 58.7 mt -125.18 123.52 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.605 1.962 . . . . 0.0 107.697 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.37 117.28 33.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.31 130.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.953 0.501 . . . . 0.0 110.452 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.3 m -144.5 167.82 21.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 112.89 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.645 2.378 . . . . 0.0 113.594 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 141.88 58.12 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.963 0.905 . . . . 0.0 112.576 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.68 40.29 85.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.304 0.954 . . . . 0.0 114.825 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.7 p -144.92 -171.48 3.64 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.163 0.982 . . . . 0.0 112.573 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 pt -127.0 138.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.214 2.205 . . . . 0.0 111.662 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 pt -148.1 170.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.109 1.764 . . . . 0.0 111.904 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.97 116.91 2.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.611 1.564 . . . . 0.0 112.335 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.78 -23.86 67.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.553 0.597 . . . . 0.0 113.266 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.49 81.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.521 1.128 . . . . 0.0 113.076 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -86.49 -13.16 46.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.798 1.239 . . . . 0.0 114.091 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.5 tp -68.95 113.65 6.54 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.23 1.012 . . . . 0.0 111.102 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -144.35 166.63 24.55 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 110.578 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.21 -37.29 22.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 114.64 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -60.75 -45.02 95.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.225 0.61 . . . . 0.0 111.79 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.07 -46.3 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.906 1.283 . . . . 0.0 110.492 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.8 -48.45 63.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.205 1.002 . . . . 0.0 112.594 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.35 -43.81 76.65 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.425 -0.797 . . . . 0.0 111.864 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.12 -40.76 74.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.201 1.4 . . . . 0.0 113.081 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.9 -59.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.506 1.922 . . . . 0.0 109.984 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.39 -43.47 98.81 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.558 1.943 . . . . 0.0 112.757 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -51.15 -53.58 33.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.28 1.032 . . . . 0.0 112.086 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -78.4 -35.02 47.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -42.09 62.66 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.12 1.368 . . . . 0.0 111.074 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.09 58.69 0.87 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -59.32 171.65 0.75 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.737 1.215 . . . . 0.0 111.775 175.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -162.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.808 1.243 . . . . 0.0 110.324 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -46.65 -41.28 14.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.614 1.566 . . . . 0.0 112.96 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 137.16 49.1 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.637 1.575 . . . . 0.0 111.136 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 162.24 36.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 112.44 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.48 151.95 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.885 1.674 . . . . 0.0 109.592 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.87 126.69 50.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.917 1.687 . . . . 0.0 107.452 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.43 132.61 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.354 1.462 . . . . 0.0 110.217 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.62 119.98 1.34 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.071 1.319 . . . . 0.0 111.249 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.2 mt -111.8 100.76 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.96 102.85 4.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.909 1.283 . . . . 0.0 111.502 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -70.98 96.47 1.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.916 0.887 . . . . 0.0 112.039 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.77 16.47 9.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.131 1.772 . . . . 0.0 112.592 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.1 p -67.84 -41.21 83.34 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.858 -1.151 . . . . 0.0 113.808 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 12.82 3.94 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.27 162.63 30.7 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.765 1.783 . . . . 0.0 114.347 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -71.29 132.69 45.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 0.0 112.87 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -106.61 163.6 12.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 111.6 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.7 m -129.72 114.05 15.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.683 1.193 . . . . 0.0 109.699 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 129.07 38.98 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.507 -0.746 . . . . 0.0 109.315 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -68.32 0.44 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.943 0.497 . . . . 0.0 109.868 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 179.41 173.56 0.83 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.63 2.372 . . . . 0.0 110.483 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 146.83 50.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.764 2.026 . . . . 0.0 109.308 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.89 115.92 15.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.292 1.437 . . . . 0.0 110.626 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -78.52 115.78 18.46 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.054 1.342 . . . . 0.0 111.037 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -92.93 -39.28 11.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.107 0.963 . . . . 0.0 112.795 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.3 m -141.63 151.79 43.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.84 2.056 . . . . 0.0 110.372 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.04 -171.57 54.43 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.749 0.69 . . . . 0.0 113.87 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -136.39 173.77 11.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.933 1.293 . . . . 0.0 112.275 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -143.34 171.01 14.7 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.752 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.67 10.2 8.39 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.697 1.199 . . . . 0.0 112.396 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.06 170.35 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.488 2.315 . . . . 0.0 113.362 -171.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.75 140.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 127.196 2.199 . . . . 0.0 109.731 -172.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.99 156.22 77.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.119 0.872 . . . . 0.0 111.858 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.52 176.01 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.332 3.355 . . . . 0.0 110.457 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -118.04 -22.84 7.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.198 -0.939 . . . . 0.0 113.077 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.9 123.18 41.88 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.7 1.6 . . . . 0.0 110.416 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.1 93.32 26.83 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.859 1.264 . . . . 0.0 110.298 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.9 165.32 21.65 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.328 2.019 . . . . 0.0 112.51 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.87 160.18 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.212 0.605 . . . . 0.0 110.19 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 t 56.41 13.74 1.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 128.365 2.666 . . . . 0.0 113.857 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.61 136.65 46.66 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 127.006 2.123 . . . . 0.0 109.653 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.84 161.07 20.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.381 1.072 . . . . 0.0 111.407 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.34 169.11 9.1 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.608 0.718 . . . . 0.0 109.709 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.2 130.72 51.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.45 1.9 . . . . 0.0 107.951 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -147.51 162.44 39.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.523 1.129 . . . . 0.0 110.506 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 m -150.75 163.47 38.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.452 0.701 . . . . 0.0 110.798 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.95 115.69 0.7 Allowed Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.536 1.065 . . . . 0.0 110.896 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 174.18 5.98 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.709 1.254 . . . . 0.0 111.134 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -64.07 -172.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.685 0.794 . . . . 0.0 109.561 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.97 -174.13 0.07 Allowed 'General case' 0 CA--C 1.555 1.15 0 O-C-N 120.084 -1.635 . . . . 0.0 111.216 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -37.22 -41.6 0.4 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.421 1.888 . . . . 0.0 115.698 -172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.5 -57.52 0.42 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.235 1.398 . . . . 0.0 112.955 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.45 1.77 5.2 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.763 3.642 . . . . 0.0 115.154 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.31 109.47 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.345 2.258 . . . . 0.0 111.141 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.01 78.76 5.91 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.489 1.516 . . . . 0.0 112.372 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.0 m -100.96 -70.99 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.516 1.126 . . . . 0.0 111.321 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.45 41.86 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.073 1.32 . . . . 0.0 112.043 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.22 106.97 5.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.927 0.891 . . . . 0.0 109.797 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.35 123.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.805 -1.185 . . . . 0.0 108.668 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.38 169.94 18.4 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.642 0.734 . . . . 0.0 110.989 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.61 158.21 43.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.902 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.0 170.54 16.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.432 1.893 . . . . 0.0 110.311 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.87 155.79 49.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.911 0.885 . . . . 0.0 111.382 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -136.13 121.95 19.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.019 1.328 . . . . 0.0 110.969 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.18 115.94 19.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.665 1.586 . . . . 0.0 110.483 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.83 161.98 30.14 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.647 0.779 . . . . 0.0 112.362 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -62.28 -23.39 66.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 113.403 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.9 m -78.33 -13.85 59.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.899 1.68 . . . . 0.0 113.581 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.15 60.27 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.796 1.188 . . . . 0.0 115.086 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -84.9 172.54 11.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.286 1.043 . . . . 0.0 109.896 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.1 m -131.92 152.71 50.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.735 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.82 135.37 53.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.441 1.097 . . . . 0.0 109.697 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 142.38 17.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.19 112.94 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 118.642 1.221 . . . . 0.0 109.518 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.87 150.44 46.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.144 0.578 . . . . 0.0 110.659 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -126.9 146.61 50.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.473 1.109 . . . . 0.0 109.672 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 t -131.16 110.89 11.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.54 1.136 . . . . 0.0 110.893 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.0 102.1 54.74 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.363 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.78 163.86 34.8 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.897 2.398 . . . . 0.0 112.492 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.01 -26.77 59.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.34 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 112.96 24.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.351 -1.468 . . . . 0.0 111.255 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.25 -71.4 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.931 -1.105 . . . . 0.0 112.172 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.91 10.67 3.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.31 -3.42 4.95 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.896 . . . . 0.0 112.927 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.82 133.09 11.79 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.348 1.459 . . . . 0.0 110.926 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -84.62 171.93 12.01 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.285 -0.884 . . . . 0.0 111.805 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -100.78 151.34 21.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.123 1.369 . . . . 0.0 111.097 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.63 139.48 40.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.548 -0.72 . . . . 0.0 110.632 -172.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -151.71 150.78 30.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.965 1.706 . . . . 0.0 110.043 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -148.54 147.49 29.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.644 1.578 . . . . 0.0 109.189 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -143.98 109.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.146 1.778 . . . . 0.0 109.77 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -113.6 144.76 42.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 109.288 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.6 mt -109.75 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.537 1.935 . . . . 0.0 108.466 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.69 143.4 51.25 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.658 1.583 . . . . 0.0 112.239 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.2 m -79.06 85.69 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.009 1.324 . . . . 0.0 111.817 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.64 176.38 22.76 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.422 1.487 . . . . 0.0 112.328 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 149.14 37.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.176 0.991 . . . . 0.0 111.979 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -154.37 135.69 14.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.997 1.319 . . . . 0.0 111.134 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -98.4 -176.66 3.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.369 1.468 . . . . 0.0 111.534 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -139.21 100.83 4.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.946 1.698 . . . . 0.0 109.114 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -120.55 -72.24 0.7 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.692 1.197 . . . . 0.0 110.161 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -145.57 -64.22 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.907 1.283 . . . . 0.0 110.215 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.25 70.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.408 1.004 . . . . 0.0 114.557 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 tpp -90.67 -37.58 13.65 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.623 1.169 . . . . 0.0 112.988 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -41.09 93.24 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 111.135 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -59.74 -25.18 64.64 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -18.4 65.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.81 -37.72 9.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.997 1.319 . . . . 0.0 108.662 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -68.23 -47.45 67.78 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.786 -1.196 . . . . 0.0 113.628 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -99.22 -13.55 19.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 113.447 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.69 -63.65 4.55 Favored Glycine 0 N--CA 1.475 1.246 0 C-N-CA 124.074 0.845 . . . . 0.0 112.639 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.64 80.29 0.24 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 128.089 2.556 . . . . 0.0 109.104 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.8 135.49 32.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 108.706 -1.305 . . . . 0.0 108.706 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -71.28 -12.59 61.53 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.21 118.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.337 3.055 . . . . 0.0 112.688 -170.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.77 58.96 2.14 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.046 1.784 . . . . 0.0 113.925 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.09 22.35 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.435 2.294 . . . . 0.0 113.628 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.18 27.89 12.23 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.879 1.672 . . . . 0.0 113.328 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.27 135.96 9.31 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.787 1.661 . . . . 0.0 112.207 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -59.71 139.14 57.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 111.883 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -130.01 121.25 26.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.735 1.614 . . . . 0.0 110.528 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.74 154.82 40.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.97 1.708 . . . . 0.0 110.614 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -165.37 131.53 2.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.862 1.265 . . . . 0.0 110.874 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -62.85 112.15 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.308 1.043 . . . . 0.0 111.235 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.2 -24.94 1.39 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.397 1.079 . . . . 0.0 113.732 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.15 17.84 9.06 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.122 1.344 . . . . 0.0 114.96 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.14 16.81 4.1 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.97 2.108 . . . . 0.0 114.15 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.69 -65.18 0.06 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.93 1.252 . . . . 0.0 111.293 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.36 164.37 13.24 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.153 1.381 . . . . 0.0 112.454 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.47 30.58 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.544 1.938 . . . . 0.0 112.627 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.71 143.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.843 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -128.46 103.71 7.28 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.295 1.838 . . . . 0.0 107.874 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.41 169.48 21.26 Favored Glycine 0 N--CA 1.455 -0.067 0 CA-C-O 121.796 0.664 . . . . 0.0 113.218 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 146.63 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 123.893 0.877 . . . . 0.0 109.872 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.83 132.19 41.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.657 1.583 . . . . 0.0 107.861 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.6 p -85.95 164.09 17.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.612 0.765 . . . . 0.0 109.905 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.36 19.69 19.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.922 0.889 . . . . 0.0 112.967 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -106.05 -175.52 2.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 0.0 112.999 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.54 74.98 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.444 1.497 . . . . 0.0 114.413 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.46 92.45 5.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.446 1.498 . . . . 0.0 107.627 175.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.73 69.02 1.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.232 1.013 . . . . 0.0 111.733 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -53.11 129.95 32.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.728 -1.232 . . . . 0.0 110.954 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.7 ttm -134.61 123.83 24.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.131 1.772 . . . . 0.0 110.015 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -139.34 141.26 37.66 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.941 -1.099 . . . . 0.0 109.599 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.67 93.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.936 1.694 . . . . 0.0 109.167 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -86.0 109.26 18.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.043 0.937 . . . . 0.0 110.419 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.4 mm -91.57 116.42 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.751 0.82 . . . . 0.0 111.215 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -148.11 161.36 41.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.859 2.063 . . . . 0.0 110.581 174.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.6 tp . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 146.31 51.16 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.19 -1.569 . . . . 0.0 111.379 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.68 39.6 40.02 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.666 0.65 . . . . 0.0 114.488 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.26 -169.35 3.03 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.555 1.177 . . . . 0.0 111.822 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.02 141.75 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.765 2.026 . . . . 0.0 109.844 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.28 173.93 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.569 1.548 . . . . 0.0 111.409 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.29 115.4 6.21 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.42 -30.78 65.35 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.448 -0.783 . . . . 0.0 112.808 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.29 69.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.246 -1.15 . . . . 0.0 113.345 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -90.48 -13.62 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.113 1.365 . . . . 0.0 113.39 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -68.14 113.01 5.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.968 0.907 . . . . 0.0 111.733 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -145.12 165.84 27.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.595 1.558 . . . . 0.0 109.737 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -45.91 -41.69 11.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.618 1.567 . . . . 0.0 114.487 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.54 -36.77 76.78 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.74 -44.48 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.818 0.847 . . . . 0.0 110.247 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.15 -42.64 86.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.782 0.833 . . . . 0.0 111.145 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.01 -40.13 71.98 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.133 -0.979 . . . . 0.0 113.21 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.36 -43.19 88.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.911 0.884 . . . . 0.0 111.924 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.04 -51.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.716 -0.615 . . . . 0.0 111.215 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -53.2 -43.83 67.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.689 0.796 . . . . 0.0 112.628 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.48 -46.19 70.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 117.986 0.357 . . . . 0.0 111.857 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.4 -38.96 59.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.554 1.542 . . . . 0.0 113.863 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.02 -40.14 66.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.421 1.089 . . . . 0.0 111.381 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.37 62.82 0.55 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.977 1.275 . . . . 0.0 111.737 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 133.53 3.13 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.034 1.333 . . . . 0.0 113.298 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.95 -163.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.388 1.875 . . . . 0.0 109.603 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 m -39.39 -46.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.491 1.516 . . . . 0.0 114.938 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -147.97 126.31 12.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.95 2.1 . . . . 0.0 110.319 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.35 158.39 41.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.676 1.591 . . . . 0.0 111.832 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.18 173.72 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.725 1.21 . . . . 0.0 112.441 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.51 115.14 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.503 1.121 . . . . 0.0 110.525 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.26 143.74 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 111.213 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.39 125.61 1.8 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.407 1.004 . . . . 0.0 111.687 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 mt -130.39 112.28 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.532 1.666 . . . . 0.0 111.362 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.93 109.0 20.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.118 1.767 . . . . 0.0 111.796 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -87.14 109.27 19.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.789 1.28 . . . . 0.0 112.179 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -122.61 27.55 7.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.482 1.913 . . . . 0.0 111.176 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -81.71 -1.79 48.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.734 2.014 . . . . 0.0 114.553 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 12.62 83.97 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.934 -1.103 . . . . 0.0 114.492 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.54 145.36 12.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.422 1.487 . . . . 0.0 113.501 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -69.83 141.48 53.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.59 1.156 . . . . 0.0 112.811 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -112.07 162.59 15.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.54 1.936 . . . . 0.0 111.431 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 m -128.97 114.92 17.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.754 1.222 . . . . 0.0 109.328 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 122.72 18.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.704 -0.622 . . . . 0.0 110.146 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -66.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.785 1.234 . . . . 0.0 109.855 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 176.43 173.76 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.884 2.874 . . . . 0.0 109.657 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 143.87 48.0 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.456 2.302 . . . . 0.0 109.217 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -136.25 112.32 9.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.04 0.936 . . . . 0.0 111.444 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -72.92 115.48 12.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.514 1.526 . . . . 0.0 111.487 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -89.87 -37.69 14.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.629 1.572 . . . . 0.0 112.756 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -146.46 159.46 43.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.382 2.273 . . . . 0.0 110.606 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.47 49.63 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 121.612 0.562 . . . . 0.0 113.386 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 t -140.42 148.03 40.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.526 1.13 . . . . 0.0 109.726 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -138.58 138.79 38.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.418 1.087 . . . . 0.0 110.205 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.06 11.15 40.09 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.906 1.682 . . . . 0.0 112.854 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.48 169.63 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.74 2.016 . . . . 0.0 112.364 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.11 135.78 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.577 1.551 . . . . 0.0 109.758 -169.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -77.27 152.95 81.96 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.291 0.951 . . . . 0.0 112.379 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.41 174.17 8.65 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.555 3.504 . . . . 0.0 110.759 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -116.3 -17.56 10.72 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.13 -0.981 . . . . 0.0 113.173 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -124.59 130.38 52.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.285 1.834 . . . . 0.0 110.343 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.59 82.67 44.6 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.324 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.6 153.66 77.2 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.162 1.908 . . . . 0.0 111.427 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -53.31 148.42 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.545 0.738 . . . . 0.0 111.176 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 72.86 -0.95 3.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.953 2.501 . . . . 0.0 114.805 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -124.47 106.24 10.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.065 1.746 . . . . 0.0 112.391 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.59 160.0 25.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.55 170.05 8.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.129 0.572 . . . . 0.0 109.769 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.39 134.77 50.94 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 109.636 174.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.21 169.86 20.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.601 0.76 . . . . 0.0 111.642 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.4 m -151.21 171.58 17.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.509 1.524 . . . . 0.0 110.474 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.97 115.99 0.71 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.71 163.14 15.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.161 1.481 . . . . 0.0 111.18 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -65.41 -177.23 0.39 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 110.404 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.79 178.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.353 -0.842 . . . . 0.0 110.322 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -24.59 -53.34 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.175 2.59 . . . . 0.0 116.308 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.36 -62.75 0.26 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.604 1.573 . . . . 0.0 112.325 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.15 -1.27 8.52 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.711 3.607 . . . . 0.0 115.439 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.72 123.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.484 2.314 . . . . 0.0 110.453 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.51 81.5 2.97 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.351 1.46 . . . . 0.0 111.241 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 m -114.1 -80.89 0.6 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.985 1.314 . . . . 0.0 110.523 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.43 -177.34 41.95 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.238 1.399 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -139.14 110.61 7.03 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.054 1.342 . . . . 0.0 109.159 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.22 130.65 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.649 -0.657 . . . . 0.0 109.755 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 158.32 44.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 110.293 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.97 155.43 45.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.936 0.874 . . . . 0.0 111.636 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.71 168.03 25.59 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.416 1.886 . . . . 0.0 109.689 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.48 157.23 45.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.584 0.753 . . . . 0.0 110.868 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -138.95 118.5 12.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.702 0.801 . . . . 0.0 112.125 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -75.59 121.83 23.01 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.649 0.78 . . . . 0.0 111.226 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -87.44 159.3 18.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.47 1.108 . . . . 0.0 110.123 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.7 p -63.83 -13.89 48.46 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -88.38 0.49 56.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.852 1.661 . . . . 0.0 113.05 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.12 82.96 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.695 1.141 . . . . 0.0 114.126 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.46 167.22 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.837 2.055 . . . . 0.0 110.644 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.0 m -130.99 153.62 49.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.027 1.331 . . . . 0.0 109.629 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.21 138.66 53.66 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.396 1.079 . . . . 0.0 109.587 175.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.25 139.08 15.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.94 125.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.229 1.015 . . . . 0.0 109.476 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.01 155.94 46.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.405 0.682 . . . . 0.0 112.016 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.97 144.22 49.0 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.691 1.197 . . . . 0.0 110.086 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.03 110.64 11.8 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 110.11 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.78 100.6 46.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 125.705 1.602 . . . . 0.0 109.655 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.03 163.93 34.3 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.277 1.985 . . . . 0.0 110.844 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.61 -47.25 76.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.726 0.811 . . . . 0.0 111.08 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.08 117.41 22.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.478 2.311 . . . . 0.0 111.958 -172.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.2 -70.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.113 -0.992 . . . . 0.0 112.646 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -82.5 11.19 5.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.48 5.42 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.134 2.174 . . . . 0.0 112.433 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -160.13 129.07 4.97 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.175 1.79 . . . . 0.0 110.718 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.9 m -90.94 168.13 11.91 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.567 -1.333 . . . . 0.0 113.214 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -89.67 155.74 19.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.149 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -142.14 140.53 32.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.582 1.153 . . . . 0.0 109.284 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -156.63 146.69 21.12 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.318 1.447 . . . . 0.0 110.399 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -140.98 147.49 38.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.675 1.19 . . . . 0.0 110.072 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.3 t -146.01 90.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.032 1.333 . . . . 0.0 112.051 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.09 144.81 32.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.237 1.415 . . . . 0.0 110.526 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -108.33 123.34 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.293 2.237 . . . . 0.0 108.587 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -127.71 148.3 50.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.288 1.435 . . . . 0.0 112.955 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.2 p -74.08 87.82 1.9 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.578 1.951 . . . . 0.0 112.679 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.78 179.35 21.1 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.878 1.704 . . . . 0.0 112.387 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 140.83 29.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.441 1.497 . . . . 0.0 112.266 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.35 152.28 30.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.145 2.178 . . . . 0.0 110.411 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -131.53 153.37 49.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.457 1.903 . . . . 0.0 110.75 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.71 93.15 0.7 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.328 1.051 . . . . 0.0 111.762 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.3 -76.81 0.58 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 110.279 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -142.85 -67.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.393 2.277 . . . . 0.0 107.758 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.19 -30.97 75.25 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.618 1.104 . . . . 0.0 115.257 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -75.45 -57.89 3.61 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.437 1.619 . . . . 0.0 110.864 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -49.98 -49.6 49.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.58 1.152 . . . . 0.0 111.504 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -37.61 80.14 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.79 -27.34 67.93 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.649 1.113 . . . . 0.0 112.627 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.1 -46.83 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.743 0.817 . . . . 0.0 110.563 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -72.41 -49.02 36.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.835 -1.166 . . . . 0.0 113.773 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -91.83 -17.09 25.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.377 1.071 . . . . 0.0 113.046 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.99 -70.18 0.99 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.224 0.916 . . . . 0.0 112.8 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -179.66 75.48 0.19 Allowed Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 127.962 2.505 . . . . 0.0 110.618 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 131.71 19.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.812 1.674 . . . . 0.0 110.981 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 118.49 13.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.58 123.48 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.898 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.75 69.84 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.733 1.635 . . . . 0.0 113.114 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.82 38.81 0.46 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.29 1.836 . . . . 0.0 111.841 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 54.44 41.79 31.76 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.83 1.652 . . . . 0.0 113.168 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.36 156.2 26.88 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.061 1.315 . . . . 0.0 113.418 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.15 134.38 51.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.156 0.983 . . . . 0.0 111.523 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.53 111.7 11.99 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.965 2.106 . . . . 0.0 108.902 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -147.91 146.78 29.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.017 1.727 . . . . 0.0 111.184 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 144.6 9.97 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.422 1.089 . . . . 0.0 111.208 175.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 137.09 58.24 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.841 0.457 . . . . 0.0 112.008 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.44 -30.37 0.06 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 113.646 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.9 16.3 55.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.078 1.323 . . . . 0.0 114.169 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.38 14.06 4.47 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.091 2.157 . . . . 0.0 114.965 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.25 -65.45 0.06 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.254 1.883 . . . . 0.0 110.816 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.28 156.34 16.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.905 0.882 . . . . 0.0 110.845 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -149.55 170.33 18.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.433 1.493 . . . . 0.0 112.397 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -89.23 145.49 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.964 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -137.95 106.13 5.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.528 1.931 . . . . 0.0 108.684 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.85 170.65 25.72 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-O 121.765 0.647 . . . . 0.0 113.972 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.14 148.29 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.847 2.059 . . . . 0.0 108.531 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.5 ttt -142.11 131.99 24.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.379 1.072 . . . . 0.0 108.607 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.06 160.81 31.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.052 1.341 . . . . 0.0 111.608 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.6 t -93.4 5.0 53.06 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.993 1.317 . . . . 0.0 113.362 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.74 174.52 5.84 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.712 2.005 . . . . 0.0 112.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.17 -56.77 21.93 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.011 0.815 . . . . 0.0 113.552 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.04 36.52 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.545 1.938 . . . . 0.0 113.685 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.38 32.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.599 1.159 . . . . 0.0 114.045 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -106.49 131.2 53.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.905 1.682 . . . . 0.0 109.504 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 34.2 ttp -128.01 95.27 4.14 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.843 1.257 . . . . 0.0 111.361 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -109.34 143.57 38.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.73 -0.606 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.45 107.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.759 2.023 . . . . 0.0 109.668 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 101.12 10.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.232 1.413 . . . . 0.0 109.795 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.66 129.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.872 -0.517 . . . . 0.0 110.654 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.99 171.97 18.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.002 0.921 . . . . 0.0 113.16 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 128.973 2.909 . . . . 0.0 112.837 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.24 147.05 38.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.553 -1.342 . . . . 0.0 111.88 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.94 34.33 81.81 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.605 0.622 . . . . 0.0 113.777 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -148.49 178.3 8.73 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.987 0.893 . . . . 0.0 111.501 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.35 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.489 1.516 . . . . 0.0 111.949 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 pt -144.84 167.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.804 1.642 . . . . 0.0 111.708 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.57 124.34 16.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.633 1.173 . . . . 0.0 112.173 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.95 -19.67 30.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 114.1 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.3 95.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.02 1.328 . . . . 0.0 111.692 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -35.28 25.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.321 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -52.44 100.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.081 1.752 . . . . 0.0 112.602 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -145.72 170.3 16.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.019 1.328 . . . . 0.0 109.793 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.88 -36.9 28.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.115 1.366 . . . . 0.0 113.702 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 -35.21 76.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.026 0.93 . . . . 0.0 113.305 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.74 -46.71 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.644 1.178 . . . . 0.0 109.519 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.74 -44.84 73.93 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 112.412 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.5 -42.08 95.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.838 -0.539 . . . . 0.0 111.361 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -42.04 97.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.318 1.047 . . . . 0.0 111.407 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.5 t -61.2 -54.47 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.599 1.159 . . . . 0.0 111.247 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.27 -49.48 61.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 0.0 111.569 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.99 -42.83 72.55 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.2 -38.06 44.14 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.71 -45.14 73.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.487 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.33 66.48 0.48 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.229 1.395 . . . . 0.0 111.564 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 124.21 1.11 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.542 1.537 . . . . 0.0 112.946 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.09 -159.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.688 1.595 . . . . 0.0 109.556 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.06 -30.59 6.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 114.117 176.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.27 135.11 11.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.143 1.777 . . . . 0.0 111.439 176.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.77 165.25 35.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.755 1.222 . . . . 0.0 113.343 174.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.39 161.27 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.181 1.392 . . . . 0.0 109.099 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.49 125.73 51.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.068 1.347 . . . . 0.0 108.07 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.55 142.21 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.171 1.788 . . . . 0.0 110.388 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.46 122.51 1.32 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.948 0.785 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.53 111.69 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 118.336 1.068 . . . . 0.0 110.208 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.61 120.58 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.972 1.709 . . . . 0.0 113.798 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.39 90.39 1.29 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.089 1.756 . . . . 0.0 110.171 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -107.53 12.39 27.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 112.595 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -82.33 -34.63 28.47 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -171.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.63 17.35 10.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.241 0.928 . . . . 0.0 114.997 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.3 160.93 31.3 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 118.988 1.394 . . . . 0.0 114.844 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -74.08 134.42 42.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.805 1.242 . . . . 0.0 111.874 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.46 166.47 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.96 1.704 . . . . 0.0 111.26 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 m -133.93 113.24 11.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.986 1.315 . . . . 0.0 110.064 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 113.02 4.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.72 -64.46 0.93 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.674 1.19 . . . . 0.0 110.142 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -175.22 169.11 3.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.892 2.077 . . . . 0.0 111.459 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.12 139.03 54.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.977 2.111 . . . . 0.0 109.103 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.9 110.93 11.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.55 101.49 3.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.174 1.39 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -68.03 -42.33 80.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.46 1.504 . . . . 0.0 111.942 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.11 157.79 43.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.692 2.397 . . . . 0.0 111.144 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 -169.69 39.86 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 123.729 0.681 . . . . 0.0 114.574 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -136.77 173.3 11.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.056 1.342 . . . . 0.0 112.363 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.7 p -143.04 176.57 8.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 110.66 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -123.35 17.59 9.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.434 1.094 . . . . 0.0 112.193 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.07 175.51 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.985 2.114 . . . . 0.0 111.904 -168.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mt -139.04 133.72 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.014 1.326 . . . . 0.0 109.76 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 142.24 75.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.93 172.01 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.607 3.538 . . . . 0.0 110.811 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -115.39 -20.26 10.35 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.204 -1.56 . . . . 0.0 112.556 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -129.88 141.35 50.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.353 1.461 . . . . 0.0 110.297 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.03 95.5 5.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.92 161.53 32.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.556 1.504 . . . . 0.0 111.303 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.7 153.53 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.568 -0.707 . . . . 0.0 111.517 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -25.79 0.18 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.038 1.735 . . . . 0.0 113.384 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -89.03 121.15 31.09 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.133 1.333 . . . . 0.0 110.659 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.11 160.5 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 111.402 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.68 164.46 11.73 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.65 134.74 48.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.96 2.104 . . . . 0.0 109.01 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -147.42 171.18 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.962 1.305 . . . . 0.0 111.786 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -148.08 168.82 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.834 1.253 . . . . 0.0 110.831 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -146.43 116.38 0.87 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-O 118.036 -1.425 . . . . 0.0 110.602 175.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.09 163.81 15.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.704 1.252 . . . . 0.0 110.737 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -177.81 0.66 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.1 -175.25 0.2 Allowed 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.143 -0.973 . . . . 0.0 111.036 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 m -19.7 -56.58 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.187 2.995 . . . . 0.0 115.589 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.94 -63.08 0.3 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.424 1.488 . . . . 0.0 112.226 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 0.14 6.78 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.925 3.75 . . . . 0.0 115.972 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.38 122.87 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.888 1.675 . . . . 0.0 111.783 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.91 80.17 4.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.367 1.467 . . . . 0.0 111.713 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -104.91 -86.51 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.494 1.518 . . . . 0.0 110.789 177.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 82' ' ' THR . . . 174.24 179.94 45.18 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 127.41 2.433 . . . . 0.0 110.581 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.35 101.18 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.176 1.391 . . . . 0.0 109.966 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -140.77 126.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.95 164.94 34.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.351 -0.843 . . . . 0.0 110.8 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.6 155.93 40.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.961 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.23 168.02 27.39 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.968 1.307 . . . . 0.0 109.881 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 148.91 43.05 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.727 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -134.62 115.77 14.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.279 1.032 . . . . 0.0 111.165 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -69.62 118.5 12.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.404 1.482 . . . . 0.0 109.36 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -82.47 151.68 26.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.604 1.562 . . . . 0.0 110.404 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -58.33 -19.18 33.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 63.2 m -82.3 -12.28 58.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.484 1.914 . . . . 0.0 113.848 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.51 -10.6 42.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.298 1.428 . . . . 0.0 115.127 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.55 173.32 12.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.514 1.525 . . . . 0.0 110.737 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -137.63 142.76 41.2 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.698 1.199 . . . . 0.0 108.39 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.23 140.75 38.7 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.25 145.57 16.27 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.87 130.15 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 109.725 175.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.53 50.1 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.04 . . . . 0.0 110.296 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.499 ' CZ ' ' HA3' ' A' ' 73' ' ' GLY . 10.4 p90 -123.21 152.99 40.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.037 1.335 . . . . 0.0 109.453 174.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.3 p -140.37 122.5 15.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.024 0.929 . . . . 0.0 110.626 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.7 t -119.75 108.15 39.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 126.407 1.883 . . . . 0.0 108.33 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.16 155.56 37.67 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.297 1.998 . . . . 0.0 111.493 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.68 -36.09 83.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.646 0.778 . . . . 0.0 110.76 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.99 114.68 27.31 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.785 2.434 . . . . 0.0 111.612 -171.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.0 -63.77 1.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.047 -1.033 . . . . 0.0 113.445 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -88.86 10.86 19.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -6.0 6.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.83 2.052 . . . . 0.0 112.743 -174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.35 179.35 8.62 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.835 2.454 . . . . 0.0 110.284 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -136.75 159.96 40.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.161 1.385 . . . . 0.0 110.955 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -79.63 155.33 28.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -136.83 151.61 49.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.75 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -161.6 157.73 25.15 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.675 1.19 . . . . 0.0 110.16 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 12.5 t70 -154.47 161.32 41.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.602 1.161 . . . . 0.0 110.245 174.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.5 t -146.23 138.0 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.346 1.858 . . . . 0.0 109.921 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.87 46.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.055 1.742 . . . . 0.0 110.007 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.8 119.24 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.097 1.759 . . . . 0.0 108.71 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -127.92 139.4 52.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.465 1.906 . . . . 0.0 112.385 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.6 p -77.34 79.4 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.919 1.688 . . . . 0.0 112.525 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.75 174.78 32.05 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.979 . . . . 0.0 112.606 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 99.65 10.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.855 2.062 . . . . 0.0 110.593 -173.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.82 161.43 34.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.781 2.032 . . . . 0.0 111.464 -176.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.44 30.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.527 1.531 . . . . 0.0 111.301 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.41 87.96 0.64 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.128 0.971 . . . . 0.0 111.293 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.63 -64.16 1.12 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.999 1.32 . . . . 0.0 109.292 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -75.02 0.17 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.989 1.716 . . . . 0.0 108.543 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.41 93.98 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.804 1.192 . . . . 0.0 113.93 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.31 -46.42 76.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.299 1.049 . . . . 0.0 111.398 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.35 -43.66 93.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.575 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -62.35 -42.66 99.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.514 1.126 . . . . 0.0 112.338 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -16.71 35.11 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 113.153 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.43 -52.4 4.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.55 -43.09 97.63 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 112.794 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -98.46 -14.65 19.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.786 1.234 . . . . 0.0 113.591 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.48 4.16 Favored Glycine 0 N--CA 1.475 1.286 0 O-C-N 121.541 -0.724 . . . . 0.0 114.655 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 44.3 77.21 0.46 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.222 1.809 . . . . 0.0 111.78 -165.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.67 157.58 50.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.04 1.826 . . . . 0.0 111.01 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 116' ' ' ASP . 23.8 m-85 -90.28 2.9 54.99 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER 46.61 16.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 129.426 3.09 . . . . 0.0 116.848 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 45.69 62.98 3.01 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.176 0.893 . . . . 0.0 112.611 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.74 16.65 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.281 10.7 p30 49.17 33.69 5.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.409 2.283 . . . . 0.0 115.15 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.24 147.89 19.36 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.965 1.745 . . . . 0.0 111.06 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -64.98 116.06 6.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.362 0.665 . . . . 0.0 110.382 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 138.09 49.26 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.42 128.57 4.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.91 1.284 . . . . 0.0 111.333 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -137.86 119.57 15.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.299 1.04 . . . . 0.0 113.372 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.77 123.94 5.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.3 -24.48 0.08 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.77 22.34 14.5 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.958 1.266 . . . . 0.0 114.085 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.0 t80 58.43 14.8 3.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.566 2.346 . . . . 0.0 115.024 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.98 -64.03 0.05 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 125.456 1.503 . . . . 0.0 110.913 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.13 161.07 15.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.183 0.993 . . . . 0.0 111.149 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 174.44 10.51 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.886 2.074 . . . . 0.0 111.407 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -78.2 131.13 37.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.91 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -122.23 104.67 9.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.717 1.207 . . . . 0.0 108.696 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.38 165.41 27.48 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-O 122.401 1.0 . . . . 0.0 114.643 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.3 tt -146.9 141.54 20.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 127.573 2.349 . . . . 0.0 108.469 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.1 ttt -141.7 140.6 33.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.07 1.748 . . . . 0.0 106.371 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.99 163.14 19.07 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.436 0.694 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 9.77 13.54 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.03 1.332 . . . . 0.0 113.776 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.28 170.58 9.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.234 2.214 . . . . 0.0 112.663 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.34 -71.79 0.88 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.46 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.665 2.386 . . . . 0.0 115.995 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 158.49 8.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.168 2.187 . . . . 0.0 113.627 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.22 140.44 36.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.271 1.428 . . . . 0.0 110.685 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.2 ttm -133.48 135.4 44.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.999 1.719 . . . . 0.0 110.087 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -144.46 152.6 40.86 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.927 0.891 . . . . 0.0 109.225 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.1 mt -133.18 117.4 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.494 1.518 . . . . 0.0 108.453 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -106.59 113.78 27.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.795 1.638 . . . . 0.0 109.561 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.35 101.07 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 60.3 p -161.73 -179.56 7.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.426 1.891 . . . . 0.0 114.914 -174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 127.997 2.519 . . . . 0.0 115.408 -164.715 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.84 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.169 2.588 . . . . 0.0 113.082 -167.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.36 47.46 90.77 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 114.817 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.9 p -147.51 -174.65 4.59 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.33 1.052 . . . . 0.0 112.574 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -124.47 136.82 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.673 1.989 . . . . 0.0 111.041 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.53 174.21 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.476 1.51 . . . . 0.0 111.905 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.14 1.69 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.984 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' H ' ' HA ' ' A' ' 67' ' ' LYS . . . -64.14 -25.26 69.46 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.241 -0.912 . . . . 0.0 113.096 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.0 71.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.418 1.087 . . . . 0.0 112.549 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 m -83.63 -19.41 35.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.79 1.236 . . . . 0.0 113.374 175.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.2 tp -66.7 97.7 0.47 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.927 1.291 . . . . 0.0 111.688 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 m -144.44 174.44 10.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.562 1.545 . . . . 0.0 109.508 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.05 -33.63 11.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.95 1.3 . . . . 0.0 114.149 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -64.23 -32.9 74.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -77.5 -30.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.224 1.41 . . . . 0.0 111.422 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.6 mt -59.03 -52.84 64.02 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.92 -38.41 72.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.547 1.139 . . . . 0.0 111.666 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -58.88 -36.94 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.12 -46.49 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.332 0.969 . . . . 0.0 110.78 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -40.17 85.03 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.213 1.405 . . . . 0.0 110.418 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.35 -53.36 37.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.385 0.674 . . . . 0.0 112.813 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -48.72 41.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.496 -0.753 . . . . 0.0 112.766 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.32 -39.45 94.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.77 0.828 . . . . 0.0 111.7 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.74 69.53 0.8 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.137 1.351 . . . . 0.0 112.758 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.277 1.831 . . . . 0.0 112.376 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.03 -160.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.123 1.769 . . . . 0.0 110.421 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.5 m -44.02 -35.01 1.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.987 1.715 . . . . 0.0 114.754 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -149.71 137.48 20.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.616 1.966 . . . . 0.0 110.221 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -165.85 143.17 5.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.556 1.542 . . . . 0.0 112.017 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.22 143.46 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.371 0.987 . . . . 0.0 111.443 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.99 118.57 36.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 108.867 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.64 139.67 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.984 0.913 . . . . 0.0 111.227 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.77 133.73 4.42 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.925 1.25 . . . . 0.0 111.596 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.26 99.3 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.028 0.931 . . . . 0.0 108.699 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.02 105.61 12.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.814 0.846 . . . . 0.0 111.142 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -73.61 96.15 2.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 111.283 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.74 10.81 15.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 113.442 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.3 t -64.06 -55.06 24.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.911 1.284 . . . . 0.0 114.006 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.02 0.9 3.03 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.38 157.21 27.12 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 119.489 1.645 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -69.63 138.06 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.554 1.142 . . . . 0.0 113.129 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -115.26 166.05 12.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.551 1.54 . . . . 0.0 112.112 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -134.62 114.02 12.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.995 1.318 . . . . 0.0 110.295 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.49 124.29 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.959 -1.088 . . . . 0.0 108.994 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.41 -66.78 0.5 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 110.622 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.23 159.78 7.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.125 2.17 . . . . 0.0 110.558 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.08 122.92 47.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.478 1.911 . . . . 0.0 109.7 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.59 116.81 26.09 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.177 0.991 . . . . 0.0 111.829 -176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -71.49 114.2 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.177 1.391 . . . . 0.0 112.727 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -44.83 44.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.044 1.738 . . . . 0.0 110.591 174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 m -147.38 162.22 39.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.496 2.318 . . . . 0.0 111.574 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.67 -166.18 54.02 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.358 0.98 . . . . 0.0 113.934 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -147.32 173.32 12.7 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.889 -0.771 . . . . 0.0 111.954 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.1 p -143.82 -174.69 4.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.182 1.393 . . . . 0.0 111.479 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.07 13.46 6.22 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.286 1.034 . . . . 0.0 112.918 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 m -136.45 170.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.898 2.079 . . . . 0.0 114.043 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.33 133.35 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.915 1.686 . . . . 0.0 110.785 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 143.48 52.06 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.196 0.907 . . . . 0.0 111.713 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.79 146.36 59.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.655 3.57 . . . . 0.0 112.051 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -85.6 -26.74 25.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -113.63 128.03 56.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.216 1.371 . . . . 0.0 111.897 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.52 86.63 28.68 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.609 1.564 . . . . 0.0 110.137 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.73 162.12 36.01 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.303 2.002 . . . . 0.0 112.124 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -63.64 159.48 18.89 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.758 -0.589 . . . . 0.0 111.063 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p 68.45 -5.42 0.94 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.68 2.392 . . . . 0.0 114.444 -172.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HA ' ' H ' ' A' ' 9' ' ' GLY . 73.9 mttt -116.31 165.44 13.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.581 1.952 . . . . 0.0 112.026 174.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.66 32.2 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.321 1.448 . . . . 0.0 111.272 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 167.02 10.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.292 0.567 . . . . 0.0 109.857 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.51 136.08 52.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.506 1.922 . . . . 0.0 108.764 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -150.17 166.29 30.3 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.185 0.994 . . . . 0.0 110.662 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -155.29 170.12 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.591 0.757 . . . . 0.0 112.447 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.15 145.0 10.6 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.748 1.166 . . . . 0.0 112.582 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -127.17 148.92 50.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.652 1.981 . . . . 0.0 110.981 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -67.36 121.11 15.02 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 38.24 -149.77 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 126.034 1.733 . . . . 0.0 114.381 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.7 m -88.17 -42.65 12.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.634 -1.291 . . . . 0.0 111.598 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.9 -61.16 0.37 Allowed Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.696 -1.058 . . . . 0.0 114.252 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.16 0.81 5.4 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.929 3.753 . . . . 0.0 115.27 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.76 135.72 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 127.677 2.391 . . . . 0.0 108.995 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.14 80.95 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.627 1.571 . . . . 0.0 110.226 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.8 m -110.42 -66.7 1.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.726 1.211 . . . . 0.0 110.75 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.02 -179.64 33.58 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.731 0.681 . . . . 0.0 112.793 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.1 115.46 9.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 110.427 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.8 t -138.63 139.51 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.71 158.82 40.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.31 0.644 . . . . 0.0 109.863 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.67 139.81 22.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 111.919 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.73 176.43 8.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.573 1.949 . . . . 0.0 109.682 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.73 37.07 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.336 0.655 . . . . 0.0 112.125 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.44 113.02 15.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.686 1.194 . . . . 0.0 111.112 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -73.04 111.77 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.215 1.806 . . . . 0.0 110.747 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 mtt -71.68 161.42 31.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.724 0.81 . . . . 0.0 112.106 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.3 t -60.98 -26.08 67.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.118 0.967 . . . . 0.0 113.245 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -74.96 -12.1 60.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.622 1.569 . . . . 0.0 112.957 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.34 -2.86 59.48 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.665 1.602 . . . . 0.0 114.489 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.79 176.38 9.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.533 1.533 . . . . 0.0 109.664 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.9 m -136.56 148.71 47.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 0.0 110.241 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.33 134.89 54.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 108.637 175.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 144.04 19.03 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.26 121.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 118.445 1.122 . . . . 0.0 109.481 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -128.64 162.22 27.83 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.359 0.664 . . . . 0.0 112.668 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -131.4 150.89 51.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.875 1.27 . . . . 0.0 109.603 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 t -139.08 110.37 6.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.52 0.728 . . . . 0.0 110.383 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.59 100.01 9.91 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 127.897 2.479 . . . . 0.0 109.112 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.4 145.72 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.34 2.027 . . . . 0.0 111.372 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -72.89 -31.55 64.76 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.41 0.624 . . . . 0.0 110.167 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.73 114.85 28.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.522 2.329 . . . . 0.0 111.714 -165.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.01 -54.74 8.97 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -95.01 14.43 21.85 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -16.92 2.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.373 1.869 . . . . 0.0 113.06 -175.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.07 175.1 10.11 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.062 2.945 . . . . 0.0 109.497 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.8 m -136.01 171.0 15.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.438 1.495 . . . . 0.0 110.768 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -87.24 151.97 22.71 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.069 0.947 . . . . 0.0 109.964 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -138.78 142.02 38.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.231 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -159.6 163.2 35.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 111.154 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -163.71 147.19 10.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.395 1.478 . . . . 0.0 110.421 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.21 108.25 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.009 1.723 . . . . 0.0 109.529 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -111.76 149.11 32.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.041 1.736 . . . . 0.0 109.734 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.1 117.76 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.687 1.595 . . . . 0.0 108.898 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -125.21 135.88 53.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.145 1.778 . . . . 0.0 112.092 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -75.66 80.63 2.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.379 1.472 . . . . 0.0 112.792 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.14 167.63 14.5 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 115.207 0.843 . . . . 0.0 115.207 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -72.86 102.66 3.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.432 1.493 . . . . 0.0 111.665 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.51 132.45 31.22 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.318 1.847 . . . . 0.0 109.436 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 167.13 17.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.048 1.339 . . . . 0.0 111.837 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.64 88.54 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.598 1.559 . . . . 0.0 111.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -111.53 -64.38 1.29 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.776 1.23 . . . . 0.0 109.712 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -68.52 0.23 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.597 1.159 . . . . 0.0 109.139 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.77 90.62 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.682 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -52.77 33.27 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.086 1.443 . . . . 0.0 111.02 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.89 -44.43 78.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.253 1.021 . . . . 0.0 110.801 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.85 -39.38 94.08 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -22.32 61.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.453 1.101 . . . . 0.0 112.216 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.19 -58.86 2.47 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.431 1.492 . . . . 0.0 109.557 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -63.36 -57.63 9.73 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.295 -0.878 . . . . 0.0 111.248 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -82.26 -17.95 44.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.347 1.059 . . . . 0.0 112.247 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.21 56.51 4.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.935 0.778 . . . . 0.0 114.676 -172.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.49 83.28 0.23 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 126.444 1.898 . . . . 0.0 111.818 -166.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.48 151.27 83.41 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.132 1.888 . . . . 0.0 109.256 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.42 -2.9 57.93 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.1 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 129.179 2.992 . . . . 0.0 112.819 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -38.67 75.32 0.0 OUTLIER Glycine 0 CA--C 1.542 1.781 0 C-N-CA 128.319 2.866 . . . . 0.0 117.239 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -81.97 25.55 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.629 1.972 . . . . 0.0 114.668 -170.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.275 11.6 p30 52.44 24.79 3.15 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.178 2.191 . . . . 0.0 114.842 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.35 172.25 18.07 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 126.888 2.185 . . . . 0.0 113.189 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -79.69 117.89 21.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.727 1.211 . . . . 0.0 111.919 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -104.84 117.33 33.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.053 1.741 . . . . 0.0 109.526 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.9 134.55 17.59 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 111.293 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -148.09 127.77 13.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.608 1.163 . . . . 0.0 112.146 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.84 113.54 1.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.136 1.374 . . . . 0.0 113.016 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tt -137.1 -28.36 0.94 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.944 1.298 . . . . 0.0 113.385 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.11 18.24 33.0 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.883 1.23 . . . . 0.0 114.498 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.66 11.25 2.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.385 2.274 . . . . 0.0 114.785 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.69 -72.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 C-N-CA 126.101 1.81 . . . . 0.0 110.319 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.43 156.75 22.77 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.813 0.816 . . . . 0.0 111.632 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.62 170.87 18.64 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.599 1.56 . . . . 0.0 112.43 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.9 130.87 35.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.303 1.041 . . . . 0.0 109.401 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -125.71 101.32 6.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -134.45 168.76 23.35 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 121.963 0.757 . . . . 0.0 113.843 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.7 tt -143.74 141.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.343 1.857 . . . . 0.0 109.049 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.5 ttt -146.28 143.07 28.93 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.78 1.632 . . . . 0.0 107.501 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.7 p -97.53 173.22 7.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.22 1.008 . . . . 0.0 111.539 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.0 m -109.43 33.72 4.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.555 1.542 . . . . 0.0 112.392 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.8 175.08 5.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.248 1.419 . . . . 0.0 112.376 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.65 -47.47 91.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.177 0.894 . . . . 0.0 113.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -108.87 72.01 0.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.784 1.278 . . . . 0.0 111.633 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.5 175.01 7.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.918 1.287 . . . . 0.0 111.211 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.81 151.16 47.83 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 109.312 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.9 tpp -140.68 87.77 2.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.147 0.979 . . . . 0.0 111.736 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.38 148.78 23.34 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.984 0.514 . . . . 0.0 111.05 174.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.87 99.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.25 1.42 . . . . 0.0 111.19 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -83.76 108.16 16.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.798 1.639 . . . . 0.0 109.844 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 110.07 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.132 0.573 . . . . 0.0 110.86 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 55.4 m -147.29 161.33 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.921 1.289 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 128.211 2.604 . . . . 0.0 111.686 177.834 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.01 139.58 50.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.46 -1.4 . . . . 0.0 111.084 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.02 31.83 61.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -142.76 177.22 8.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 118.639 1.22 . . . . 0.0 112.398 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.51 144.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.448 1.499 . . . . 0.0 112.734 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.38 174.09 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.748 1.619 . . . . 0.0 112.236 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.52 121.01 8.68 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.023 1.329 . . . . 0.0 111.587 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.7 -21.74 44.31 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.111 1.339 . . . . 0.0 113.863 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.81 76.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.059 1.344 . . . . 0.0 111.931 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.9 m -88.51 -32.8 18.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.42 1.488 . . . . 0.0 112.361 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.42 106.54 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.761 1.224 . . . . 0.0 111.623 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -146.29 168.98 19.73 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.825 1.25 . . . . 0.0 109.747 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.85 -37.87 14.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 114.05 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.85 -34.27 71.38 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.51 -48.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.191 1.397 . . . . 0.0 110.198 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.31 -44.84 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 112.629 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.87 -45.5 77.89 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.963 0.505 . . . . 0.0 111.624 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -56.34 -41.54 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.821 1.649 . . . . 0.0 113.044 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -50.07 -55.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.197 1.399 . . . . 0.0 111.193 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.17 -38.65 88.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 112.479 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -49.63 75.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.12 1.368 . . . . 0.0 110.741 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.01 -36.07 61.96 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.08 -50.94 69.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.66 1.584 . . . . 0.0 112.23 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 62.83 0.36 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.893 1.235 . . . . 0.0 112.328 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -45.94 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.617 2.367 . . . . 0.0 114.04 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.5 -166.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.591 1.956 . . . . 0.0 111.211 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -43.78 -41.34 4.89 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.819 2.047 . . . . 0.0 113.99 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -144.38 138.91 28.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.551 1.94 . . . . 0.0 108.84 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -167.34 146.39 5.04 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.234 2.214 . . . . 0.0 109.591 -172.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.401 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -137.92 160.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.608 1.163 . . . . 0.0 110.916 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.49 118.04 31.57 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.995 1.318 . . . . 0.0 109.034 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.4 139.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.87 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.65 118.14 0.88 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.921 0.772 . . . . 0.0 111.711 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.79 97.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.128 0.971 . . . . 0.0 108.461 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -76.96 117.51 18.63 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 0.0 111.403 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -92.77 101.7 14.09 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.976 0.894 . . . . 0.0 112.215 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -111.38 12.46 21.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.451 1.1 . . . . 0.0 113.489 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -56.42 -51.97 66.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.1 1.76 . . . . 0.0 114.36 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.42 4.83 0.74 Allowed Glycine 0 CA--C 1.538 1.526 0 N-CA-C 116.505 1.362 . . . . 0.0 116.505 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 166.85 32.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.642 1.721 . . . . 0.0 114.348 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 t -69.94 126.93 31.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.125 1.37 . . . . 0.0 112.401 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -98.99 165.33 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.63 1.572 . . . . 0.0 111.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 m -135.41 106.97 6.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.104 1.362 . . . . 0.0 109.574 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.23 132.33 52.38 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.66 -72.63 0.3 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.587 0.755 . . . . 0.0 110.291 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.51 165.33 8.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.499 1.92 . . . . 0.0 111.048 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.21 124.18 51.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.885 1.674 . . . . 0.0 109.772 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.21 108.77 19.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.549 1.14 . . . . 0.0 111.37 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -73.31 118.54 16.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.481 1.112 . . . . 0.0 110.896 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.62 12.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.769 1.228 . . . . 0.0 111.942 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -143.42 150.98 39.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.78 2.032 . . . . 0.0 111.397 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.29 51.7 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.183 0.897 . . . . 0.0 113.648 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -149.13 163.23 38.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.875 -0.779 . . . . 0.0 111.094 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -142.43 130.17 21.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.892 1.277 . . . . 0.0 110.095 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.01 2.9 54.63 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.546 1.538 . . . . 0.0 113.521 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.71 169.76 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.697 1.199 . . . . 0.0 111.134 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.07 131.53 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.203 1.001 . . . . 0.0 110.037 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.44 154.27 83.91 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 118.289 0.495 . . . . 0.0 111.169 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 167.76 25.02 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.365 3.377 . . . . 0.0 109.957 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.14 -16.75 12.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.061 -1.025 . . . . 0.0 112.952 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -128.99 144.0 51.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.483 1.513 . . . . 0.0 109.958 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.5 t -143.52 99.48 5.28 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.674 1.19 . . . . 0.0 109.634 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.61 155.02 71.82 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.884 1.723 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -55.86 150.2 13.58 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.953 -0.467 . . . . 0.0 111.597 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 0.9 OUTLIER 68.83 -7.3 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.185 2.194 . . . . 0.0 115.417 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -101.58 141.71 34.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.402 1.455 . . . . 0.0 108.07 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.73 154.48 26.1 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.213 -0.929 . . . . 0.0 111.784 175.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 171.01 9.59 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.44 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -135.45 134.11 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.577 2.351 . . . . 0.0 107.364 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -150.19 162.35 40.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.766 1.626 . . . . 0.0 111.206 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.6 m -154.21 155.32 35.04 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.367 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.401 ' H ' HD13 ' A' ' 31' ' ' ILE . . . -150.42 143.65 10.93 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 121.2 -0.937 . . . . 0.0 113.411 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.06 163.63 29.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.779 1.232 . . . . 0.0 113.48 -172.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 99.32 7.86 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.699 1.237 . . . . 0.0 110.411 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 36.28 -131.0 0.1 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.87 2.468 . . . . 0.0 113.191 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -57.54 -53.67 55.57 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.806 -1.184 . . . . 0.0 112.73 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.22 -61.93 0.41 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.47 -8.72 23.91 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 124.433 3.422 . . . . 0.0 115.554 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.91 163.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.347 1.459 . . . . 0.0 112.836 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.64 74.51 1.01 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.056 1.342 . . . . 0.0 112.599 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 t -106.99 -107.91 0.32 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.723 1.609 . . . . 0.0 109.76 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.57 174.88 45.14 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.628 2.537 . . . . 0.0 111.163 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.82 93.13 2.81 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.067 1.347 . . . . 0.0 109.584 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.84 124.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.55 157.82 42.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.33 130.53 17.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.95 0.9 . . . . 0.0 110.916 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.58 176.44 8.32 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.734 1.613 . . . . 0.0 110.241 -172.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 150.35 44.79 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.466 0.651 . . . . 0.0 112.686 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.88 114.11 13.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 111.02 -175.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -79.54 123.54 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.219 1.408 . . . . 0.0 111.239 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 mtp -81.63 157.28 24.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.179 1.391 . . . . 0.0 112.257 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 p -62.2 -19.52 63.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.233 1.413 . . . . 0.0 114.757 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -84.06 -11.39 56.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.005 1.722 . . . . 0.0 113.755 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.85 -5.06 46.46 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.936 1.255 . . . . 0.0 115.11 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -76.12 171.82 13.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.654 1.182 . . . . 0.0 110.213 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 m -136.69 140.7 42.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.979 0.912 . . . . 0.0 110.158 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 123.51 50.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.51 139.08 18.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.14 122.18 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.711 1.205 . . . . 0.0 110.242 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.0 159.61 40.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -134.03 153.7 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.47 1.508 . . . . 0.0 110.913 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 t -137.1 104.79 5.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.574 1.55 . . . . 0.0 110.009 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.65 97.05 13.48 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 127.032 2.133 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.57 167.05 28.23 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.773 2.316 . . . . 0.0 111.617 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -69.69 -45.27 68.66 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.614 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 114.59 26.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.573 1.549 . . . . 0.0 111.569 -165.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -65.76 -62.07 1.72 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.07 12.35 22.28 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -7.72 5.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.606 1.963 . . . . 0.0 112.568 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.68 139.92 19.42 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.458 2.303 . . . . 0.0 109.116 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 t -98.55 159.23 15.09 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -84.22 157.78 21.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.792 -0.567 . . . . 0.0 109.805 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -138.98 145.67 40.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.986 0.915 . . . . 0.0 110.819 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -155.32 148.21 24.46 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.864 1.265 . . . . 0.0 110.792 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.59 151.36 37.16 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.46 107.45 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.825 1.65 . . . . 0.0 109.77 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -115.86 148.03 40.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.221 1.408 . . . . 0.0 109.724 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.51 111.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.863 2.065 . . . . 0.0 109.241 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -118.33 145.13 45.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 0.0 112.349 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.6 t -73.35 90.11 1.64 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.385 1.074 . . . . 0.0 110.79 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.63 -174.23 42.04 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.476 0.56 . . . . 0.0 113.768 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 111.68 23.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.047 2.139 . . . . 0.0 110.908 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -147.84 156.56 42.84 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.312 -0.868 . . . . 0.0 111.655 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -140.38 167.4 22.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.522 1.529 . . . . 0.0 111.299 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.73 86.79 0.94 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.537 1.135 . . . . 0.0 111.555 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -111.18 -67.0 1.03 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 108.911 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.18 -67.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.849 1.26 . . . . 0.0 109.779 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.23 -36.62 90.12 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.961 0.791 . . . . 0.0 114.325 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.5 ttp -65.71 -48.26 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.791 1.295 . . . . 0.0 111.642 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.19 -49.42 75.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.674 0.79 . . . . 0.0 111.068 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -64.82 -37.33 87.26 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.37 -20.86 61.08 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.163 -1.585 . . . . 0.0 113.286 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.71 -50.41 5.39 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.484 1.513 . . . . 0.0 112.132 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -75.32 -57.16 4.06 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.587 1.085 . . . . 0.0 112.76 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.73 -19.35 49.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.337 1.455 . . . . 0.0 111.858 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.51 -90.14 0.05 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.003 1.287 . . . . 0.0 112.467 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.02 79.17 1.99 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.073 1.349 . . . . 0.0 110.598 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 150.1 52.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.689 1.593 . . . . 0.0 111.546 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 164.51 26.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.864 0.866 . . . . 0.0 109.171 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.76 118.61 36.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.143 1.377 . . . . 0.0 108.856 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.32 65.5 1.63 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.878 0.763 . . . . 0.0 112.627 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -82.52 18.69 1.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.437 1.895 . . . . 0.0 113.647 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 64.52 43.35 4.5 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.526 1.93 . . . . 0.0 112.63 -173.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.64 153.57 21.72 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.604 1.573 . . . . 0.0 113.652 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -70.15 133.57 47.24 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.613 1.165 . . . . 0.0 111.893 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.91 113.73 14.38 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.294 1.837 . . . . 0.0 110.158 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.58 153.7 41.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.684 1.594 . . . . 0.0 110.578 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -166.48 150.65 7.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.237 1.815 . . . . 0.0 110.23 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.09 127.48 32.28 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.164 0.893 . . . . 0.0 110.143 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 tt -135.48 -39.74 0.73 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.522 1.129 . . . . 0.0 112.09 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.85 20.98 10.25 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.008 1.29 . . . . 0.0 114.475 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.73 14.46 4.1 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.991 2.116 . . . . 0.0 114.668 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 177.3 -56.85 0.1 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.065 1.793 . . . . 0.0 110.955 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.43 153.69 21.71 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.904 0.859 . . . . 0.0 110.128 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.6 169.51 24.51 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.043 1.337 . . . . 0.0 112.331 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -100.89 140.85 34.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.661 1.184 . . . . 0.0 111.606 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -126.38 113.91 17.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -146.36 172.19 27.01 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-O 121.661 0.589 . . . . 0.0 113.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.8 tt -153.63 145.91 14.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 126.466 1.907 . . . . 0.0 108.316 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.3 ttm -140.96 137.91 33.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.223 1.009 . . . . 0.0 109.24 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.89 161.02 30.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.428 1.891 . . . . 0.0 112.187 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -33.95 23.15 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.335 -0.853 . . . . 0.0 113.269 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.13 172.62 6.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 112.536 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.22 -42.07 99.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.352 -0.843 . . . . 0.0 113.27 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' CB ' ' HE3' ' A' ' 30' ' ' LYS . 10.9 pt-20 -81.52 57.91 3.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.858 1.663 . . . . 0.0 113.908 178.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.74 170.61 9.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 124.02 15.73 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.025 -1.047 . . . . 0.0 112.559 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.02 91.17 3.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.699 2.0 . . . . 0.0 111.899 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.45 139.02 30.97 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.874 -0.516 . . . . 0.0 110.373 165.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.5 114.27 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.618 1.967 . . . . 0.0 108.37 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -110.01 108.52 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 110.177 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.8 mm -89.13 120.22 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.658 1.183 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 49.9 m -117.32 170.02 9.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.597 1.559 . . . . 0.0 112.789 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.895 2.078 . . . . 0.0 113.667 -179.4 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.58 54.56 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.205 -0.935 . . . . 0.0 111.578 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 41.34 11.99 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.301 0.953 . . . . 0.0 114.732 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.8 p -142.88 -169.67 3.06 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 119.194 1.497 . . . . 0.0 112.902 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 pt -122.99 127.25 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.615 2.366 . . . . 0.0 110.757 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.59 166.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.767 1.227 . . . . 0.0 111.787 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 110.91 1.96 Allowed 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.658 -1.277 . . . . 0.0 113.044 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -29.08 61.51 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.164 0.888 . . . . 0.0 113.752 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.97 74.49 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.267 -1.137 . . . . 0.0 112.834 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -89.59 -18.39 26.67 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.945 1.298 . . . . 0.0 113.291 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.41 115.34 5.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.126 1.371 . . . . 0.0 110.481 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -142.94 166.3 25.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.553 1.141 . . . . 0.0 110.043 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -40.26 26.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.706 1.602 . . . . 0.0 113.927 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.35 -34.95 74.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.314 1.446 . . . . 0.0 113.267 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.01 -45.68 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 109.82 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.63 -45.9 66.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.029 0.931 . . . . 0.0 112.435 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.31 -47.8 78.07 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.93 -0.481 . . . . 0.0 112.253 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -53.54 -42.17 67.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.783 1.233 . . . . 0.0 112.683 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -54.22 -57.08 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.829 0.852 . . . . 0.0 111.216 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.49 -40.9 96.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.028 1.331 . . . . 0.0 112.671 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.98 -45.89 82.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.528 0.731 . . . . 0.0 112.164 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.98 -21.02 29.69 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.26 -45.65 87.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.713 2.005 . . . . 0.0 113.605 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 32.78 7.17 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 114.747 0.659 . . . . 0.0 114.747 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 174.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.831 2.052 . . . . 0.0 114.293 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.33 -162.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.177 1.791 . . . . 0.0 111.478 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -54.5 -24.63 21.37 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -123.75 141.69 51.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.191 1.796 . . . . 0.0 110.293 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 149.32 15.84 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.342 1.857 . . . . 0.0 111.555 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -143.41 145.93 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.795 1.638 . . . . 0.0 109.917 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.23 121.64 41.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.403 1.481 . . . . 0.0 108.029 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.96 136.46 50.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.108 1.763 . . . . 0.0 110.589 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.5 120.74 1.23 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.014 1.292 . . . . 0.0 111.829 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.56 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.262 1.425 . . . . 0.0 108.451 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 104.94 8.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.071 0.948 . . . . 0.0 112.095 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -73.61 96.89 2.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.484 0.714 . . . . 0.0 110.684 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -122.25 21.62 10.34 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.106 1.762 . . . . 0.0 112.08 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.6 t -71.53 -43.23 66.82 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.294 1.438 . . . . 0.0 113.687 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.03 16.83 3.17 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.925 1.726 . . . . 0.0 115.667 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.83 155.44 26.81 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 119.597 1.698 . . . . 0.0 115.057 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -68.45 132.02 46.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -105.12 165.25 11.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.504 1.522 . . . . 0.0 111.849 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 m -134.45 113.76 12.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.105 1.362 . . . . 0.0 108.921 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 136.6 57.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.155 -0.966 . . . . 0.0 109.557 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.29 -70.76 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -177.48 175.78 1.38 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.617 2.367 . . . . 0.0 110.082 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.26 150.02 50.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.171 2.188 . . . . 0.0 109.306 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 112.3 8.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.232 . . . . 0.0 110.256 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -71.69 121.39 18.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.487 1.115 . . . . 0.0 110.846 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -95.5 -43.54 7.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.106 0.963 . . . . 0.0 112.032 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.4 m -141.22 156.89 45.85 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.935 2.094 . . . . 0.0 110.299 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.1 -176.74 53.86 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.468 0.556 . . . . 0.0 113.508 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -137.67 164.44 28.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.602 1.161 . . . . 0.0 111.027 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -144.38 175.47 10.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.451 1.1 . . . . 0.0 111.76 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -134.23 17.05 3.75 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.367 1.067 . . . . 0.0 112.279 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.95 166.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.818 2.047 . . . . 0.0 112.565 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.96 134.14 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.833 1.653 . . . . 0.0 109.632 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 154.47 86.42 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.993 0.815 . . . . 0.0 112.339 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.42 172.47 13.23 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.452 3.435 . . . . 0.0 110.525 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -113.38 -21.41 10.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -125.62 125.81 43.72 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 110.675 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.97 95.0 19.45 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.034 1.333 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.04 160.33 34.53 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.876 1.717 . . . . 0.0 111.23 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.61 156.86 10.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.801 -0.562 . . . . 0.0 111.586 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m 75.13 -22.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.182 2.193 . . . . 0.0 112.892 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -100.68 141.66 33.24 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.547 1.939 . . . . 0.0 109.576 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.05 178.0 4.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.775 2.03 . . . . 0.0 109.558 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.28 175.92 5.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 109.796 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.28 124.37 34.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.633 1.573 . . . . 0.0 107.363 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -146.0 150.17 35.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.592 0.357 . . . . 0.0 110.723 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.4 m -147.35 158.93 44.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.35 0.595 . . . . 0.0 111.129 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.01 10.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.515 1.531 . . . . 0.0 111.183 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -131.72 168.91 16.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.524 1.53 . . . . 0.0 110.467 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.52 179.34 0.47 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.029 0.932 . . . . 0.0 110.098 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.94 -179.98 0.24 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 121.114 -0.991 . . . . 0.0 111.264 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -28.58 -49.64 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.375 2.67 . . . . 0.0 115.939 -172.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.58 -59.61 0.33 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.016 1.293 . . . . 0.0 112.677 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.77 -2.66 11.77 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.25 3.3 . . . . 0.0 115.067 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.71 124.2 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.462 1.505 . . . . 0.0 111.297 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.24 75.71 1.66 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.19 1.796 . . . . 0.0 111.786 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.8 m -100.58 -75.44 0.58 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.623 1.169 . . . . 0.0 111.244 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.57 -176.52 45.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.74 1.162 . . . . 0.0 112.253 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.54 105.29 5.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.695 1.198 . . . . 0.0 110.671 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.18 120.41 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.311 1.044 . . . . 0.0 108.585 -171.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.94 168.59 19.89 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.89 0.852 . . . . 0.0 111.526 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.57 156.25 43.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.077 0.951 . . . . 0.0 111.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.73 175.52 11.9 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.777 2.031 . . . . 0.0 110.66 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.35 43.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.897 0.879 . . . . 0.0 111.504 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.73 118.66 26.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 110.957 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.52 117.43 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.992 1.717 . . . . 0.0 110.309 176.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.9 mtm -75.58 162.6 28.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.487 0.66 . . . . 0.0 112.492 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -60.41 -21.55 62.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.928 1.291 . . . . 0.0 114.078 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -83.23 -12.19 57.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.05 2.14 . . . . 0.0 113.56 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.03 -1.56 57.78 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.475 1.512 . . . . 0.0 115.252 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.35 171.22 15.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.066 1.347 . . . . 0.0 110.143 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.0 m -131.59 148.34 52.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.746 0.818 . . . . 0.0 110.473 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.42 112.81 18.52 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.761 1.224 . . . . 0.0 108.237 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.44 141.9 29.43 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.25 127.69 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 109.191 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -140.72 162.97 34.15 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.43 159.93 41.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.84 1.256 . . . . 0.0 111.46 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -140.71 112.8 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.939 1.696 . . . . 0.0 109.351 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.33 101.06 54.3 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.265 1.826 . . . . 0.0 108.48 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 163.88 34.49 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.554 2.169 . . . . 0.0 111.756 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.59 -26.72 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.06 114.48 27.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.04 1.336 . . . . 0.0 111.506 -172.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.33 -57.17 4.02 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.325 1.05 . . . . 0.0 113.66 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.13 13.65 12.65 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.908 -1.12 . . . . 0.0 113.807 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.72 -19.26 2.36 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.241 1.816 . . . . 0.0 113.438 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -141.83 169.6 17.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.934 2.893 . . . . 0.0 108.753 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 t -132.95 161.21 34.89 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.017 -1.052 . . . . 0.0 109.867 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -88.53 161.32 17.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.793 0.806 . . . . 0.0 111.415 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -141.58 151.46 43.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.116 0.966 . . . . 0.0 110.688 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.5 p-90 -154.17 157.83 39.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.124 1.37 . . . . 0.0 110.492 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -150.83 146.92 26.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.922 2.089 . . . . 0.0 109.509 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.02 117.88 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.534 1.534 . . . . 0.0 108.797 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -122.42 140.13 53.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.818 1.247 . . . . 0.0 110.471 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -109.38 117.33 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.777 2.031 . . . . 0.0 108.525 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.79 145.43 50.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.164 1.386 . . . . 0.0 112.836 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 p -75.61 79.51 2.6 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.139 1.775 . . . . 0.0 112.661 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.03 173.54 23.92 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.147 1.356 . . . . 0.0 112.82 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 148.99 48.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.876 1.27 . . . . 0.0 111.683 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.8 112.69 2.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.433 1.093 . . . . 0.0 111.622 174.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.38 175.93 9.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.127 0.971 . . . . 0.0 110.564 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.56 99.08 4.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.825 1.65 . . . . 0.0 108.452 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.05 -70.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.108 0.963 . . . . 0.0 110.226 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -67.47 0.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.56 1.144 . . . . 0.0 110.84 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.66 -9.08 84.83 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.429 1.014 . . . . 0.0 115.252 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -43.65 9.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.518 1.127 . . . . 0.0 111.083 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -36.91 83.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.65 1.18 . . . . 0.0 111.299 175.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.74 -29.72 66.94 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.067 -1.02 . . . . 0.0 113.092 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -20.09 63.31 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.717 1.207 . . . . 0.0 112.816 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.08 -50.89 5.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.108 1.363 . . . . 0.0 109.196 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.06 -47.4 84.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -94.44 -13.87 25.78 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.045 0.938 . . . . 0.0 113.103 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.53 -62.85 5.43 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.547 1.07 . . . . 0.0 113.049 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -177.17 78.41 0.25 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 128.392 2.677 . . . . 0.0 108.694 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.3 157.62 60.6 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.493 1.462 . . . . 0.0 110.833 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.97 6.35 41.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.11 65.09 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.732 2.813 . . . . 0.0 113.617 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -44.02 101.56 0.03 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.399 1.952 . . . . 0.0 115.177 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.58 28.29 1.53 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.16 2.184 . . . . 0.0 113.314 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.55 52.75 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.251 1.821 . . . . 0.0 112.849 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -151.59 154.38 25.52 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.276 1.417 . . . . 0.0 113.178 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -62.95 117.05 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.642 1.177 . . . . 0.0 113.31 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -108.09 119.18 38.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.152 2.181 . . . . 0.0 110.966 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.94 133.01 15.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.151 0.98 . . . . 0.0 111.236 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -146.3 130.12 17.16 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.688 1.195 . . . . 0.0 111.981 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.85 107.98 0.79 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.048 1.339 . . . . 0.0 112.277 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.65 -32.34 3.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.009 1.324 . . . . 0.0 112.872 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.28 22.16 6.46 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.049 1.309 . . . . 0.0 114.821 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 56.84 8.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 115.631 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.64 -57.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.328 1.442 . . . . 0.0 111.413 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.64 156.53 17.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.832 0.825 . . . . 0.0 112.18 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.82 168.35 27.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.871 1.668 . . . . 0.0 112.21 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.5 141.46 28.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.878 0.871 . . . . 0.0 110.871 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.16 104.13 7.13 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.33 169.66 24.18 Favored Glycine 0 N--CA 1.454 -0.13 0 CA-C-O 121.888 0.716 . . . . 0.0 114.526 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.78 144.43 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.691 1.196 . . . . 0.0 109.312 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 ttt -141.94 130.16 22.21 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.777 1.231 . . . . 0.0 108.556 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.1 p -88.31 163.05 16.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 110.952 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -96.12 -22.47 17.3 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.45 172.95 4.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.492 1.517 . . . . 0.0 113.165 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.59 -41.8 42.92 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.344 1.45 . . . . 0.0 114.158 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.87 78.34 8.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 111.105 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.41 79.85 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.804 0.841 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.23 149.16 24.85 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 120.868 -1.145 . . . . 0.0 110.549 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.1 ttm -144.58 124.53 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.766 1.227 . . . . 0.0 109.975 -174.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -141.14 139.02 33.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.96 92.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.776 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.24 107.02 17.74 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.319 1.448 . . . . 0.0 108.553 174.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.79 131.37 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 0.0 110.73 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 p -154.51 165.4 36.55 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 128.468 2.707 . . . . 0.0 111.903 175.867 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.27 148.52 50.68 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.806 -1.184 . . . . 0.0 112.287 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.81 36.85 91.32 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.84 0.733 . . . . 0.0 114.2 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -142.28 175.79 9.49 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.908 0.854 . . . . 0.0 112.34 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 pt -118.17 138.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.789 1.636 . . . . 0.0 111.38 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -146.76 174.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.12 1.768 . . . . 0.0 111.587 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 103.53 0.11 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 112.364 175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.42 -25.66 67.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.252 0.93 . . . . 0.0 113.9 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.88 14.79 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -117.43 7.31 12.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.804 1.641 . . . . 0.0 113.218 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 114.48 11.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.513 1.125 . . . . 0.0 112.199 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 m -146.25 172.55 13.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.261 1.425 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -48.41 -37.64 17.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.935 1.694 . . . . 0.0 114.188 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -56.41 -35.9 68.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.652 1.181 . . . . 0.0 113.302 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.79 -47.48 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.082 1.753 . . . . 0.0 109.643 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.59 -46.18 80.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.393 1.077 . . . . 0.0 113.237 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.16 -42.75 99.49 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.654 -0.654 . . . . 0.0 111.103 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -39.23 72.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.758 1.223 . . . . 0.0 113.516 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.5 -59.55 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.294 1.038 . . . . 0.0 110.601 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.72 -42.24 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.49 1.516 . . . . 0.0 112.406 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.17 -53.34 54.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.176 0.99 . . . . 0.0 112.167 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.35 -42.59 62.06 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.402 HD22 ' CZ ' ' A' ' 74' ' ' ARG . 15.5 tp -48.52 -52.38 22.84 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.379 1.872 . . . . 0.0 112.349 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.01 59.79 0.23 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.607 1.098 . . . . 0.0 112.552 -172.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 141.74 6.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.588 1.155 . . . . 0.0 112.516 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -160.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.771 1.628 . . . . 0.0 110.825 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -50.69 -31.91 17.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.238 1.415 . . . . 0.0 113.058 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -146.39 143.78 29.29 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.591 2.357 . . . . 0.0 110.237 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.69 153.54 12.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 128.078 2.551 . . . . 0.0 110.185 -173.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -146.08 150.3 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.822 1.649 . . . . 0.0 109.953 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.51 123.85 51.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.614 1.166 . . . . 0.0 110.777 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -116.48 123.85 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.602 1.561 . . . . 0.0 110.778 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.67 112.05 0.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.854 1.216 . . . . 0.0 112.3 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 mt -109.18 111.09 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.635 1.174 . . . . 0.0 109.427 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.93 131.15 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.947 0.899 . . . . 0.0 113.228 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.51 93.16 7.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.552 0.741 . . . . 0.0 110.572 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.94 20.37 11.58 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.411 1.485 . . . . 0.0 112.278 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -85.56 -40.94 15.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.815 1.646 . . . . 0.0 114.748 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 12.48 10.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 -173.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.99 161.14 29.46 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.336 1.568 . . . . 0.0 115.05 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -76.99 127.4 32.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.211 1.404 . . . . 0.0 112.122 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -102.86 162.12 13.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.322 1.449 . . . . 0.0 111.62 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -133.46 115.89 15.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.844 1.257 . . . . 0.0 109.439 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.16 57.44 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.005 -1.059 . . . . 0.0 110.355 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.27 -71.02 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -174.72 176.54 2.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.992 2.117 . . . . 0.0 110.563 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.95 154.69 40.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.953 2.101 . . . . 0.0 109.841 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.73 106.04 6.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.035 1.334 . . . . 0.0 110.564 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.85 105.02 5.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.791 1.237 . . . . 0.0 111.18 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -78.37 -51.94 9.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.937 1.295 . . . . 0.0 111.692 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -137.27 155.88 48.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.901 2.081 . . . . 0.0 110.361 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 -173.64 52.06 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.722 -0.611 . . . . 0.0 113.329 -174.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -134.88 176.32 8.76 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.641 1.176 . . . . 0.0 110.316 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -150.5 178.12 9.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.525 1.53 . . . . 0.0 110.479 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -139.3 18.15 2.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.179 1.391 . . . . 0.0 112.025 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -134.6 171.76 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.892 2.077 . . . . 0.0 110.809 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mt -143.87 132.3 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.377 1.071 . . . . 0.0 109.463 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 150.17 84.33 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.587 0.63 . . . . 0.0 111.572 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.68 166.3 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.73 2.954 . . . . 0.0 109.928 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -105.81 -30.01 9.67 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.312 -0.868 . . . . 0.0 111.572 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -117.26 127.81 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.547 1.139 . . . . 0.0 111.029 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.06 91.31 24.17 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.89 1.276 . . . . 0.0 108.911 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -63.19 162.79 25.24 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.34 2.027 . . . . 0.0 111.483 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -57.61 158.72 5.73 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 72.5 -35.42 0.33 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.941 2.097 . . . . 0.0 114.211 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -86.91 124.71 33.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.08 171.63 8.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.431 1.092 . . . . 0.0 109.493 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.84 163.26 13.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.53 133.27 48.38 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.248 1.819 . . . . 0.0 107.824 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.8 167.22 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 110.438 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -156.52 160.41 39.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.57 0.7 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 127.41 3.24 Favored Glycine 0 N--CA 1.462 0.415 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -126.32 167.16 15.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.223 1.012 . . . . 0.0 110.082 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 179.98 1.49 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 109.886 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -172.67 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.824 1.649 . . . . 0.0 111.357 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.1 m -25.94 -56.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 127.312 2.245 . . . . 0.0 115.238 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.43 -57.07 0.41 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.596 1.093 . . . . 0.0 113.831 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.79 -2.34 11.76 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.621 3.548 . . . . 0.0 115.574 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.66 130.84 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.96 1.704 . . . . 0.0 110.792 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.68 88.6 5.44 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.567 -1.333 . . . . 0.0 111.959 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.4 m -122.83 -86.51 0.65 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 111.522 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.41 -177.97 42.74 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.781 1.173 . . . . 0.0 112.938 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.52 108.65 6.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.063 0.945 . . . . 0.0 111.012 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.93 119.63 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.987 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.42 171.45 14.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.995 0.902 . . . . 0.0 111.587 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.09 40.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.312 1.045 . . . . 0.0 111.716 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.38 175.76 11.54 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.711 1.605 . . . . 0.0 110.415 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.95 140.87 47.04 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.833 1.253 . . . . 0.0 110.602 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 113.53 18.62 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.58 1.152 . . . . 0.0 111.356 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.39 118.71 15.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.765 1.626 . . . . 0.0 110.691 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.7 mtt -73.06 163.53 28.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 112.181 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -62.52 -21.03 65.22 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.76 1.224 . . . . 0.0 113.884 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.71 -16.22 39.71 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.76 1.624 . . . . 0.0 113.515 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.38 2.12 47.51 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.192 1.377 . . . . 0.0 115.647 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -86.23 173.53 9.71 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.738 1.215 . . . . 0.0 110.421 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 m -136.04 143.22 44.58 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.144 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.15 115.76 30.71 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 135.12 15.13 Favored Glycine 0 N--CA 1.463 0.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.2 126.85 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 118.049 0.925 . . . . 0.0 109.704 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.3 153.65 51.1 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.717 0.807 . . . . 0.0 110.673 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.01 154.55 51.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.749 . . . . 0.0 111.991 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -137.08 109.55 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 110.773 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.7 106.17 57.58 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 124.527 1.131 . . . . 0.0 110.257 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.18 161.81 39.99 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.944 2.429 . . . . 0.0 112.007 174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.0 -28.23 64.27 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.783 0.833 . . . . 0.0 112.807 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.36 120.86 41.21 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.471 1.508 . . . . 0.0 110.955 -170.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -73.93 -63.91 1.12 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.81 9.23 19.71 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.884 -1.135 . . . . 0.0 114.031 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -5.62 6.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.259 2.224 . . . . 0.0 112.225 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 138.75 10.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.678 1.991 . . . . 0.0 109.583 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -103.27 159.56 15.45 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.07 -1.019 . . . . 0.0 110.031 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -80.23 161.69 25.03 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.866 -0.521 . . . . 0.0 109.738 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -139.51 143.53 37.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.708 0.803 . . . . 0.0 110.804 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -155.06 149.77 26.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.658 1.583 . . . . 0.0 110.239 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -149.01 154.72 39.75 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.993 1.717 . . . . 0.0 107.675 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 66.7 t -147.37 116.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 126.87 2.068 . . . . 0.0 109.416 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -123.39 148.15 46.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.542 1.537 . . . . 0.0 110.096 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 mt -110.97 112.57 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 108.821 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -127.39 136.39 51.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 112.2 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.1 p -76.67 81.68 3.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.324 1.45 . . . . 0.0 112.58 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.35 178.6 45.31 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.27 0.938 . . . . 0.0 113.645 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -111.78 104.99 13.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.497 1.919 . . . . 0.0 110.885 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -145.81 158.14 43.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.918 1.287 . . . . 0.0 111.228 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.25 163.97 29.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.125 1.37 . . . . 0.0 112.527 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.57 79.07 1.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.633 1.173 . . . . 0.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.21 -67.37 0.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.057 1.343 . . . . 0.0 109.576 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -149.3 -72.56 0.18 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.368 1.867 . . . . 0.0 108.801 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.9 64.59 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.94 1.257 . . . . 0.0 114.732 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.3 ttp -83.85 -57.83 3.05 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.288 1.044 . . . . 0.0 110.409 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -48.85 -49.83 37.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.083 1.353 . . . . 0.0 111.638 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -62.36 -32.25 73.01 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.01 -13.55 62.28 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.155 -0.965 . . . . 0.0 113.12 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.01 -47.96 5.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.445 1.498 . . . . 0.0 109.456 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.06 -61.51 2.0 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.637 -1.29 . . . . 0.0 112.35 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.58 -19.89 48.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 111.658 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.39 -80.91 0.07 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.334 1.445 . . . . 0.0 112.828 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.36 86.29 0.89 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.318 1.447 . . . . 0.0 110.529 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.62 160.2 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.696 1.597 . . . . 0.0 111.709 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.94 1.01 39.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.52 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 33.87 60.03 0.54 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.796 2.438 . . . . 0.0 114.25 176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -20.23 82.4 0.0 OUTLIER Glycine 0 N--CA 1.472 1.083 0 C-N-CA 129.409 3.385 . . . . 0.0 116.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.0 35.41 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.424 1.49 . . . . 0.0 112.052 -172.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 68.25 26.36 6.96 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.59 1.556 . . . . 0.0 112.245 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.89 146.01 18.0 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.552 1.549 . . . . 0.0 113.3 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -65.97 138.15 57.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.858 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.67 118.04 18.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.041 1.736 . . . . 0.0 110.641 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.97 145.64 32.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.296 1.438 . . . . 0.0 110.903 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -146.31 121.83 10.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.248 1.419 . . . . 0.0 110.549 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.09 91.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.682 1.593 . . . . 0.0 113.358 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.96 4.5 1.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.32 22.57 31.83 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.578 -1.326 . . . . 0.0 115.881 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.52 7.69 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.597 1.959 . . . . 0.0 115.39 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.38 -36.71 0.19 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.764 -1.21 . . . . 0.0 114.365 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.0 mp -129.48 147.64 51.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.02 1.328 . . . . 0.0 110.681 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 173.94 9.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.122 1.369 . . . . 0.0 111.956 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.17 139.96 38.48 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.69 1.596 . . . . 0.0 109.56 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -131.76 107.75 8.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.567 1.547 . . . . 0.0 108.086 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.9 171.57 19.17 Favored Glycine 0 CA--C 1.517 0.217 0 CA-C-O 121.382 0.434 . . . . 0.0 113.477 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.7 143.83 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 124.506 1.122 . . . . 0.0 109.215 176.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.9 ttm -144.17 140.16 29.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.882 1.673 . . . . 0.0 109.014 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.19 157.72 27.8 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.505 2.322 . . . . 0.0 111.562 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.83 5.91 26.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.309 -1.494 . . . . 0.0 114.801 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.43 177.53 4.82 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.703 2.001 . . . . 0.0 112.77 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.67 -67.87 1.99 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.368 0.985 . . . . 0.0 112.269 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -74.85 39.52 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.536 1.934 . . . . 0.0 115.223 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.03 138.94 58.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.378 1.071 . . . . 0.0 112.861 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.28 124.35 35.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 109.2 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 17.7 mtp -117.87 107.15 13.76 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.863 1.665 . . . . 0.0 109.971 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -114.96 151.4 34.17 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.521 -0.737 . . . . 0.0 111.358 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.8 96.62 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.733 1.613 . . . . 0.0 110.912 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -84.81 107.86 17.19 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.864 1.666 . . . . 0.0 109.919 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.3 mm -84.51 117.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.401 -0.812 . . . . 0.0 110.089 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 m -141.9 169.95 16.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.471 1.509 . . . . 0.0 113.195 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.355 1.862 . . . . 0.0 111.526 -178.047 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.45 156.38 39.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.696 -1.252 . . . . 0.0 111.484 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.06 36.87 90.41 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.33 -168.52 3.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 111.923 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.39 149.14 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.671 1.588 . . . . 0.0 111.29 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pt -151.25 169.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.343 1.857 . . . . 0.0 112.577 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.44 124.81 17.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.892 1.677 . . . . 0.0 111.755 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.9 48.38 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.284 0.945 . . . . 0.0 113.976 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.99 82.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.916 1.286 . . . . 0.0 112.49 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 -30.92 35.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.832 0.853 . . . . 0.0 112.385 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.8 tp -59.66 90.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.625 1.97 . . . . 0.0 113.635 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -146.73 169.29 19.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 0.0 109.368 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -43.98 -37.46 2.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.018 1.727 . . . . 0.0 114.735 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.2 -39.24 78.48 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.38 -42.05 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.665 . . . . 0.0 110.74 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.79 -47.73 70.5 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.304 1.041 . . . . 0.0 111.386 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.16 -42.55 96.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.437 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -58.79 -39.28 80.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.177 1.391 . . . . 0.0 113.668 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -55.37 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.548 1.539 . . . . 0.0 109.867 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mp -55.68 -45.9 77.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 0.0 112.49 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.15 -38.04 81.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.05 -43.9 41.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 113.058 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.71 -53.87 41.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.502 1.521 . . . . 0.0 111.173 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.13 63.02 0.11 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.356 0.979 . . . . 0.0 112.516 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -42.89 127.95 4.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 110.653 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.79 -165.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.353 1.861 . . . . 0.0 110.212 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -48.99 -45.46 42.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.647 1.579 . . . . 0.0 114.358 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -139.3 129.7 25.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.469 1.907 . . . . 0.0 109.569 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.43 155.54 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.112 2.165 . . . . 0.0 110.049 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.17 162.49 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.173 0.989 . . . . 0.0 111.46 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.93 116.22 30.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.835 1.254 . . . . 0.0 109.529 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.63 142.95 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.709 1.203 . . . . 0.0 110.86 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.28 122.55 1.13 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.314 0.959 . . . . 0.0 111.953 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.0 mt -113.04 102.7 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.151 1.38 . . . . 0.0 108.654 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.61 111.81 19.45 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.72 0.808 . . . . 0.0 112.231 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -71.69 99.76 2.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.793 1.237 . . . . 0.0 111.117 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.68 14.31 15.34 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.26 1.824 . . . . 0.0 113.281 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.4 t -70.09 -45.59 66.67 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.93 8.08 5.29 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.234 1.397 . . . . 0.0 116.058 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.67 160.47 29.02 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 119.578 1.689 . . . . 0.0 113.634 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.9 p -73.96 138.87 44.47 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.722 -0.869 . . . . 0.0 112.185 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -112.84 167.05 10.81 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.777 1.231 . . . . 0.0 112.006 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -131.92 105.78 7.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.128 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.5 122.68 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.21 -66.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.34 163.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.211 2.604 . . . . 0.0 110.155 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -108.77 123.91 49.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.349 1.86 . . . . 0.0 110.4 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.95 111.71 19.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.301 1.041 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.26 124.34 26.91 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.993 1.317 . . . . 0.0 111.993 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -47.63 7.26 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.093 1.357 . . . . 0.0 112.241 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -135.37 149.17 49.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.537 1.935 . . . . 0.0 109.951 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.06 -157.5 50.18 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.891 -0.506 . . . . 0.0 113.09 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -152.86 -176.71 5.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.521 0.676 . . . . 0.0 112.2 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -141.97 173.95 11.04 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.183 1.793 . . . . 0.0 111.367 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -121.51 12.79 10.85 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.927 1.291 . . . . 0.0 112.229 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.31 176.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.047 2.139 . . . . 0.0 113.628 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.95 135.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.53 1.932 . . . . 0.0 109.776 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.01 142.48 41.66 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 118.765 0.711 . . . . 0.0 110.606 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.81 164.86 22.85 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.95 3.1 . . . . 0.0 111.117 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -107.55 -17.61 14.06 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.502 -0.749 . . . . 0.0 112.716 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.64 133.97 53.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.956 1.702 . . . . 0.0 111.097 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.88 88.04 23.69 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.896 1.678 . . . . 0.0 108.868 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.42 161.13 32.38 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.919 1.746 . . . . 0.0 112.06 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.44 153.66 34.63 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.407 -0.808 . . . . 0.0 111.448 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 p 66.23 5.04 3.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.692 1.997 . . . . 0.0 114.267 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -123.39 147.81 46.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.621 2.368 . . . . 0.0 110.108 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 160.44 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.647 1.179 . . . . 0.0 111.354 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.16 170.75 8.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.408 0.623 . . . . 0.0 110.335 175.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -126.44 133.89 51.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.334 1.854 . . . . 0.0 108.877 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -152.82 162.44 41.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.191 1.397 . . . . 0.0 111.536 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -142.37 166.6 24.24 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.769 1.228 . . . . 0.0 110.972 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.75 115.24 0.77 Allowed Glycine 0 N--CA 1.472 1.092 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.769 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 156.22 20.92 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.18 1.49 . . . . 0.0 114.378 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.88 110.64 7.34 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 40.78 -151.19 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.69 1.596 . . . . 0.0 113.664 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -74.14 -49.57 23.17 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.958 -1.714 . . . . 0.0 111.286 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.91 -59.27 0.37 Allowed Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.665 1.126 . . . . 0.0 114.394 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.33 0.15 7.22 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.699 3.599 . . . . 0.0 114.984 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.32 132.48 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 127.599 2.36 . . . . 0.0 109.364 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.82 71.84 0.81 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.034 1.333 . . . . 0.0 110.516 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 m -97.27 -65.03 0.99 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.01 0.924 . . . . 0.0 110.895 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.61 176.41 35.52 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.988 1.28 . . . . 0.0 111.712 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.34 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.065 0.946 . . . . 0.0 110.479 175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.36 138.9 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.96 0.904 . . . . 0.0 109.585 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.11 161.98 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.967 0.907 . . . . 0.0 110.779 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.43 20.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.786 0.803 . . . . 0.0 112.976 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.57 169.0 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.795 1.638 . . . . 0.0 109.446 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.98 148.96 47.23 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.42 104.57 6.18 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 111.796 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -73.54 111.82 9.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.084 1.354 . . . . 0.0 111.639 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 160.41 30.72 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 112.317 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 p -60.99 -20.08 62.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 m -84.78 -16.09 42.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.524 1.93 . . . . 0.0 113.84 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.52 4.95 46.13 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.39 0.995 . . . . 0.0 115.565 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.51 165.31 13.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.449 1.5 . . . . 0.0 108.757 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -136.32 151.11 49.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 109.566 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.38 130.55 56.57 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.278 0.631 . . . . 0.0 110.354 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.21 138.74 18.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.5 t -136.02 118.0 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.354 1.062 . . . . 0.0 108.816 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptm -121.46 156.89 31.8 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 141.03 52.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.104 1.362 . . . . 0.0 108.852 174.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -130.63 104.37 7.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.907 0.883 . . . . 0.0 110.75 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 t -115.61 101.57 54.21 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.007 2.123 . . . . 0.0 109.119 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.39 168.07 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.273 1.982 . . . . 0.0 110.454 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -75.37 -41.33 56.69 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.707 -0.621 . . . . 0.0 110.32 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.35 121.86 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.637 1.175 . . . . 0.0 111.954 -166.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -72.83 -59.83 2.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -91.29 9.44 31.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -4.37 5.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.023 2.129 . . . . 0.0 112.538 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.71 158.34 36.76 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.791 2.436 . . . . 0.0 109.111 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 169.36 10.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.826 -1.171 . . . . 0.0 111.602 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.26 148.36 25.14 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.752 -0.592 . . . . 0.0 110.445 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.51 157.63 44.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.035 0.534 . . . . 0.0 112.351 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -161.67 136.83 7.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.411 1.484 . . . . 0.0 110.396 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.76 147.51 48.62 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.28 118.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.099 1.36 . . . . 0.0 110.623 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.23 138.23 53.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.1 1.76 . . . . 0.0 109.452 174.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.4 mt -109.37 119.66 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.178 1.791 . . . . 0.0 108.543 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 147.61 52.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 0.0 112.555 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 p -74.0 80.97 1.7 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.652 1.981 . . . . 0.0 112.27 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.29 -166.8 37.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.705 -0.622 . . . . 0.0 114.393 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -113.18 115.87 28.93 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.384 1.874 . . . . 0.0 111.361 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -134.09 83.76 2.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.043 2.537 . . . . 0.0 108.46 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 168.36 5.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.657 1.183 . . . . 0.0 110.95 177.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.19 99.04 8.5 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 111.15 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -106.67 -70.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.112 0.965 . . . . 0.0 110.706 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -150.0 -68.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.167 1.787 . . . . 0.0 109.811 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.39 -24.26 77.11 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.386 0.993 . . . . 0.0 114.893 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -76.33 -56.63 4.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.266 1.033 . . . . 0.0 109.82 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -35.51 63.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.859 0.864 . . . . 0.0 111.429 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.06 -34.0 54.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -61.43 -41.26 96.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.903 0.881 . . . . 0.0 111.093 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.79 -38.0 73.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.858 -1.152 . . . . 0.0 111.715 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -74.06 -51.73 14.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -88.0 -17.89 30.22 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 113.079 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.87 -80.24 0.08 OUTLIER Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.711 1.148 . . . . 0.0 112.066 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -170.15 74.78 0.63 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.74 1.616 . . . . 0.0 110.968 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.19 135.37 31.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 119.918 1.006 . . . . 0.0 109.788 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -60.19 156.86 14.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.743 1.217 . . . . 0.0 110.439 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -93.36 5.01 53.01 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -165.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 53.95 55.61 24.98 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.559 1.076 . . . . 0.0 112.654 -172.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.33 24.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.571 1.548 . . . . 0.0 114.901 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.252 10.1 p30 48.31 34.45 4.6 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.665 2.386 . . . . 0.0 115.021 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.38 159.62 26.75 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.912 1.72 . . . . 0.0 112.058 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -61.78 127.37 31.12 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 110.934 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -122.91 105.67 10.2 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.144 1.778 . . . . 0.0 109.637 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -138.38 137.12 36.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.579 1.952 . . . . 0.0 110.89 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -147.8 133.44 18.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.264 1.426 . . . . 0.0 110.964 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -58.9 123.96 18.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.995 0.518 . . . . 0.0 111.347 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 tt -147.6 -34.29 0.25 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.182 0.993 . . . . 0.0 112.342 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.71 19.7 5.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.182 1.372 . . . . 0.0 114.748 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 t80 60.06 9.27 1.75 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.799 2.44 . . . . 0.0 114.966 -175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.74 -71.38 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.403 1.478 . . . . 0.0 110.74 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.53 151.43 21.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.949 0.88 . . . . 0.0 111.419 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.55 171.32 14.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.72 1.608 . . . . 0.0 111.527 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -87.15 147.09 25.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.512 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -137.07 103.39 5.12 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.894 2.078 . . . . 0.0 108.506 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -133.02 169.43 22.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-O 121.593 0.552 . . . . 0.0 112.884 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.61 141.06 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.905 1.682 . . . . 0.0 108.769 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.4 ttt -144.35 140.48 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 171.94 14.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.098 0.959 . . . . 0.0 111.553 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.0 p -93.67 7.71 43.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.52 1.528 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.22 165.22 12.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.635 1.974 . . . . 0.0 112.063 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.87 -55.29 29.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.209 0.909 . . . . 0.0 113.784 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.09 59.39 2.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 113.251 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.06 171.81 7.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.905 1.282 . . . . 0.0 112.859 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.71 141.61 50.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 108.421 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.8 ttp -133.88 83.7 2.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.076 1.35 . . . . 0.0 111.014 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.39 158.17 20.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.452 0.644 . . . . 0.0 111.524 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.94 122.02 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.866 2.067 . . . . 0.0 108.419 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -113.39 103.81 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.571 2.348 . . . . 0.0 108.941 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.36 119.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.437 -0.79 . . . . 0.0 110.802 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 p -152.13 169.27 22.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.376 1.07 . . . . 0.0 112.956 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.729 2.411 . . . . 0.0 112.934 176.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.0 150.93 19.57 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.82 -1.175 . . . . 0.0 111.683 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.28 49.13 34.32 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.425 0.535 . . . . 0.0 113.687 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.5 p -146.78 -166.38 2.48 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.193 0.997 . . . . 0.0 112.115 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.02 132.26 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.68 2.392 . . . . 0.0 110.74 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 pt -142.46 170.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.461 1.504 . . . . 0.0 111.777 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 111.19 1.02 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.484 1.114 . . . . 0.0 112.185 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.25 -24.33 67.23 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.424 1.011 . . . . 0.0 113.363 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.61 78.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.786 1.234 . . . . 0.0 111.983 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.5 -24.83 22.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.82 1.248 . . . . 0.0 113.196 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.6 tp -59.23 110.36 1.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.266 1.426 . . . . 0.0 111.534 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 m -146.78 168.16 22.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.654 1.582 . . . . 0.0 109.669 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.23 1.812 . . . . 0.0 113.814 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -58.01 -35.8 71.77 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -73.63 -46.05 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.494 1.518 . . . . 0.0 109.859 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.5 mt -54.48 -44.88 73.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 0.0 113.008 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.17 -39.09 88.81 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.714 0.406 . . . . 0.0 111.927 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -50.21 74.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.013 1.325 . . . . 0.0 111.622 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -53.51 -50.04 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.766 1.226 . . . . 0.0 111.994 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.7 mp -60.11 -41.87 93.53 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.212 1.005 . . . . 0.0 112.359 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -43.68 90.78 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 110.781 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.38 -31.01 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.163 1.785 . . . . 0.0 114.271 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.3 tp -66.81 -51.48 55.23 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.697 1.199 . . . . 0.0 110.014 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.25 54.62 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.103 1.335 . . . . 0.0 111.991 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -43.54 129.1 5.26 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.713 1.605 . . . . 0.0 112.817 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -164.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.183 1.393 . . . . 0.0 112.144 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.0 t -42.43 -33.02 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.993 2.517 . . . . 0.0 113.958 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -153.31 137.89 16.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.599 1.96 . . . . 0.0 109.804 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 155.69 20.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.688 2.395 . . . . 0.0 110.416 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -135.49 152.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.531 1.132 . . . . 0.0 109.509 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.06 122.75 48.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.171 0.988 . . . . 0.0 108.365 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.0 135.47 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.593 1.157 . . . . 0.0 110.803 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.33 129.55 3.39 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.177 0.894 . . . . 0.0 111.82 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mm -117.87 103.33 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.046 0.938 . . . . 0.0 109.742 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.96 122.45 27.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.899 1.28 . . . . 0.0 113.304 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.88 96.21 3.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.437 1.895 . . . . 0.0 112.02 175.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -123.83 30.81 6.05 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 112.137 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.7 t -91.96 -48.12 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.916 1.687 . . . . 0.0 114.142 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.07 17.73 4.02 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.288 0.947 . . . . 0.0 115.453 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.22 159.92 31.62 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.039 1.42 . . . . 0.0 114.125 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -70.51 135.83 48.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.079 0.952 . . . . 0.0 111.858 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -109.95 168.43 9.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.449 1.5 . . . . 0.0 111.382 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.3 m -134.61 107.14 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 109.108 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.64 124.96 24.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.911 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.89 -64.87 0.78 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.307 0.643 . . . . 0.0 109.966 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.63 172.24 0.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.825 2.45 . . . . 0.0 110.736 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.95 135.84 48.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.446 2.298 . . . . 0.0 110.105 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -124.3 114.83 20.08 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 111.361 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -72.0 106.95 4.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.485 1.514 . . . . 0.0 112.357 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -50.02 44.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.131 1.773 . . . . 0.0 110.71 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -136.0 155.95 49.48 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.518 1.527 . . . . 0.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.75 -156.51 39.85 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 123.042 0.353 . . . . 0.0 113.395 -172.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -154.21 -176.17 5.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 110.534 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -139.37 -179.31 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.49 1.516 . . . . 0.0 111.384 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.63 12.87 13.24 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.639 1.176 . . . . 0.0 111.586 174.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.13 175.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.154 1.781 . . . . 0.0 113.151 -170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 134.86 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.392 1.477 . . . . 0.0 110.091 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.44 141.12 56.51 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.256 -0.902 . . . . 0.0 110.601 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.84 163.68 32.51 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.045 3.163 . . . . 0.0 111.091 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -104.83 -21.22 13.37 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.816 -1.178 . . . . 0.0 112.945 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -126.51 137.14 53.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.127 1.371 . . . . 0.0 110.155 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.54 97.99 7.31 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 110.257 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -64.57 162.12 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.682 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.88 154.3 9.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.615 -0.678 . . . . 0.0 111.584 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m 72.03 -23.55 0.19 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.978 1.711 . . . . 0.0 113.83 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -95.89 126.87 41.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.707 1.603 . . . . 0.0 110.714 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.41 171.94 8.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.009 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -110.24 169.07 8.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.47 133.47 52.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.516 1.527 . . . . 0.0 110.505 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.96 166.73 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.129 0.971 . . . . 0.0 111.09 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 p -160.46 170.22 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.53 1.132 . . . . 0.0 110.635 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.71 137.27 5.89 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.664 175.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.55 161.42 30.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.123 1.462 . . . . 0.0 112.529 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -70.7 113.03 7.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t0 32.31 -136.8 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.565 2.346 . . . . 0.0 114.138 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -61.64 -46.18 90.89 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.5 -1.375 . . . . 0.0 111.053 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.57 -58.58 0.45 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.025 -0.875 . . . . 0.0 115.079 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -71.77 8.08 1.41 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 125.207 3.938 . . . . 0.0 115.44 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.84 132.92 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.001 2.52 . . . . 0.0 110.561 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.63 88.45 3.07 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.544 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -114.77 -84.69 0.61 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.164 1.786 . . . . 0.0 110.866 178.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 82' ' ' THR . . . 172.61 173.68 39.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 127.262 2.363 . . . . 0.0 110.802 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.63 109.41 7.1 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.584 1.154 . . . . 0.0 109.442 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.49 126.71 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 120.789 -1.194 . . . . 0.0 108.259 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.35 169.01 24.71 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.78 157.78 43.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.17 0.988 . . . . 0.0 111.603 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.17 169.9 20.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.895 1.678 . . . . 0.0 110.657 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.98 146.67 41.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.048 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -127.78 115.82 19.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.906 1.283 . . . . 0.0 111.525 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -81.08 112.61 18.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.194 1.398 . . . . 0.0 111.0 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.8 mtp -74.01 158.06 35.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.963 0.905 . . . . 0.0 111.414 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -62.35 -18.85 62.53 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.7 m -80.23 -15.34 57.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 113.739 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.26 55.2 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.668 1.128 . . . . 0.0 115.194 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -85.62 166.7 16.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.194 0.998 . . . . 0.0 110.384 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -137.08 153.53 50.54 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 110.73 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.62 134.14 53.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 108.991 174.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.63 8.48 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.76 137.29 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 117.537 0.668 . . . . 0.0 110.488 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.31 161.31 35.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.648 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.04 142.54 47.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.983 1.313 . . . . 0.0 109.516 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -127.16 114.25 17.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.757 1.623 . . . . 0.0 109.086 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.85 92.61 48.35 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.478 1.511 . . . . 0.0 108.931 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.29 167.97 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.165 2.576 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.42 -23.69 37.38 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.626 -0.671 . . . . 0.0 112.437 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.54 111.93 24.81 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.327 -1.483 . . . . 0.0 112.392 -165.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.21 -51.81 22.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.39 12.34 29.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.51 1.124 . . . . 0.0 113.575 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.14 -11.0 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.491 1.917 . . . . 0.0 112.716 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.32 175.92 11.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.722 2.809 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m -145.86 164.86 30.63 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.492 -1.38 . . . . 0.0 111.167 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.04 138.16 34.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 110.276 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 152.61 49.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.315 0.507 . . . . 0.0 112.063 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -159.32 146.76 17.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.423 1.889 . . . . 0.0 110.634 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.32 149.47 49.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.148 1.379 . . . . 0.0 110.154 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -145.77 105.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.315 1.046 . . . . 0.0 111.481 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -117.42 134.03 55.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.111 1.364 . . . . 0.0 110.365 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -97.75 112.39 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.296 1.438 . . . . 0.0 109.355 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -115.17 147.83 39.79 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.873 1.669 . . . . 0.0 112.826 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 p -75.74 82.59 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.739 1.615 . . . . 0.0 112.881 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.81 -173.91 36.57 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.529 1.061 . . . . 0.0 113.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -112.4 130.82 55.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.471 1.509 . . . . 0.0 111.59 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -153.24 163.97 38.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.594 1.157 . . . . 0.0 112.2 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -139.36 148.87 43.47 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.603 1.561 . . . . 0.0 111.621 -171.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.99 90.69 0.64 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.245 1.018 . . . . 0.0 111.957 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.15 -68.57 0.92 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.517 1.527 . . . . 0.0 110.812 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -144.37 -76.19 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.533 1.933 . . . . 0.0 108.959 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.8 -28.54 73.51 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.381 0.991 . . . . 0.0 114.701 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -57.46 5.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.086 0.943 . . . . 0.0 109.576 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -52.25 -40.87 62.27 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.921 1.289 . . . . 0.0 111.107 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -55.48 -43.28 75.42 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.641 -0.662 . . . . 0.0 112.734 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 -19.43 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.977 -1.077 . . . . 0.0 112.346 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.4 mt -91.37 -55.57 3.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.557 1.543 . . . . 0.0 111.435 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -74.82 -46.32 37.47 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.341 -0.85 . . . . 0.0 113.029 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.17 -17.47 30.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.232 -0.917 . . . . 0.0 111.121 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.76 52.5 4.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.357 0.979 . . . . 0.0 114.132 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 36.05 72.44 0.77 Allowed Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.623 2.369 . . . . 0.0 114.133 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 140.14 57.76 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.936 1.757 . . . . 0.0 109.027 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 143.77 55.73 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.81 0.844 . . . . 0.0 109.528 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 12.88 21.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.831 1.252 . . . . 0.0 113.818 -166.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 58.32 57.68 18.54 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.204 0.907 . . . . 0.0 112.145 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -72.57 33.96 0.07 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.802 1.241 . . . . 0.0 114.217 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.0 p30 45.97 34.24 1.91 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.833 2.853 . . . . 0.0 115.791 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -145.66 167.41 27.61 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.031 1.776 . . . . 0.0 112.262 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.96 123.48 21.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.417 0.687 . . . . 0.0 110.53 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -119.71 116.75 26.59 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.082 1.753 . . . . 0.0 108.684 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.09 131.69 15.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.989 1.316 . . . . 0.0 110.735 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -141.84 122.58 14.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.717 1.207 . . . . 0.0 110.72 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.19 115.57 3.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.445 0.698 . . . . 0.0 111.486 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.48 -36.42 0.98 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -77.73 22.49 2.78 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.118 1.342 . . . . 0.0 114.672 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 t80 58.01 10.74 1.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.245 2.618 . . . . 0.0 115.177 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.86 -60.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.929 1.728 . . . . 0.0 110.178 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.83 150.29 21.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 122.062 0.935 . . . . 0.0 112.479 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 163.1 35.18 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.413 1.885 . . . . 0.0 111.402 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.12 151.39 29.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.436 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -143.44 110.98 5.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.502 1.921 . . . . 0.0 108.262 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.7 32.47 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-O 121.642 0.579 . . . . 0.0 114.071 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.79 141.04 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.081 1.752 . . . . 0.0 109.311 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.7 ttt -144.84 142.41 29.91 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.25 1.82 . . . . 0.0 107.887 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.22 165.71 22.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.955 0.902 . . . . 0.0 111.042 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.93 14.97 12.35 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.609 1.164 . . . . 0.0 112.875 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.26 167.52 11.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 111.661 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.92 -59.94 8.83 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.943 0.783 . . . . 0.0 114.492 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -76.4 40.85 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.443 1.497 . . . . 0.0 114.254 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.04 157.3 35.06 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.847 1.259 . . . . 0.0 112.702 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -103.11 140.49 37.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 108.43 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.9 ttp -132.04 116.53 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.582 1.553 . . . . 0.0 109.461 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 138.8 43.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.7 106.76 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.208 1.403 . . . . 0.0 108.556 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -94.81 105.34 17.26 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.966 2.106 . . . . 0.0 109.204 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.27 124.97 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.4 m -128.28 177.1 7.18 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.571 1.148 . . . . 0.0 111.771 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 128.261 2.625 . . . . 0.0 113.342 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.31 139.62 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.907 1.283 . . . . 0.0 111.985 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.79 40.85 8.54 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.099 0.857 . . . . 0.0 114.278 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 p -146.38 -165.69 2.28 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.571 1.185 . . . . 0.0 111.945 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.98 143.86 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.365 1.866 . . . . 0.0 110.487 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.19 165.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.297 . . . . 0.0 112.248 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 119.37 6.72 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.799 1.24 . . . . 0.0 111.066 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.07 -18.73 42.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.195 0.902 . . . . 0.0 113.897 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.92 -38.05 76.13 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.953 1.301 . . . . 0.0 111.735 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -31.33 27.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.843 1.257 . . . . 0.0 112.444 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.5 tp -50.02 100.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.61 1.964 . . . . 0.0 112.422 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -145.79 164.78 30.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.216 1.406 . . . . 0.0 109.843 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -46.95 -40.24 13.93 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.443 1.497 . . . . 0.0 114.125 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.54 -47.31 86.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.166 0.586 . . . . 0.0 112.197 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.0 -48.66 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.804 0.841 . . . . 0.0 109.547 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.32 -47.04 76.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.629 0.771 . . . . 0.0 112.669 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.05 -42.97 88.8 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.686 -0.633 . . . . 0.0 112.366 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.15 -42.46 77.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.299 1.44 . . . . 0.0 112.917 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.1 t -51.77 -57.04 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.57 1.548 . . . . 0.0 109.721 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.11 -38.22 88.07 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.618 1.567 . . . . 0.0 113.108 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -49.5 76.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.634 -0.666 . . . . 0.0 111.599 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.47 -15.83 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.7 tp -65.39 -53.72 39.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.816 2.046 . . . . 0.0 112.841 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.55 29.57 7.74 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 174.82 0.14 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.928 2.091 . . . . 0.0 114.671 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.38 -168.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.487 1.915 . . . . 0.0 111.049 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -49.59 -28.01 5.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.94 53.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.762 1.625 . . . . 0.0 109.601 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.43 146.19 2.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 112.154 -167.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.454 HD12 ' CE2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -141.66 152.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.097 1.359 . . . . 0.0 110.167 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.61 114.4 24.04 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 109.661 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 t -102.08 137.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.845 1.258 . . . . 0.0 110.38 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.66 114.59 0.71 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.048 0.832 . . . . 0.0 113.384 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.72 106.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.47 1.108 . . . . 0.0 110.573 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -89.3 104.65 17.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.846 1.658 . . . . 0.0 112.306 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -72.98 105.46 4.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.125 1.77 . . . . 0.0 111.333 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.5 22.51 8.37 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.611 1.964 . . . . 0.0 112.606 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -84.8 -29.22 25.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.549 1.54 . . . . 0.0 114.679 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.64 20.4 8.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.047 1.784 . . . . 0.0 115.391 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.49 17.38 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 118.984 1.392 . . . . 0.0 114.408 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -66.36 141.12 58.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.169 0.988 . . . . 0.0 112.812 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -115.07 170.71 8.15 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.919 1.688 . . . . 0.0 111.499 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 m -135.39 110.2 8.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 108.912 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.37 50.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.52 -1.362 . . . . 0.0 109.969 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -71.11 -68.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.525 0.73 . . . . 0.0 109.791 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.92 174.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.677 2.391 . . . . 0.0 110.58 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.6 144.18 51.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.541 2.337 . . . . 0.0 108.797 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.19 110.97 11.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.546 1.139 . . . . 0.0 110.269 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.61 121.63 18.25 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.262 1.025 . . . . 0.0 111.165 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.27 -41.42 8.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.964 1.306 . . . . 0.0 112.372 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m -138.29 149.35 45.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.578 1.151 . . . . 0.0 110.685 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.07 54.2 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.158 0.408 . . . . 0.0 113.163 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -151.99 175.0 12.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.933 0.893 . . . . 0.0 111.196 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -140.45 177.11 8.24 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.236 1.414 . . . . 0.0 111.336 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -127.22 16.09 7.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.652 1.181 . . . . 0.0 112.684 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.55 176.85 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.711 2.004 . . . . 0.0 112.745 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.25 137.07 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.484 1.914 . . . . 0.0 109.467 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.3 154.76 82.11 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 119.902 1.228 . . . . 0.0 112.333 176.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.97 165.32 31.59 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 124.026 3.15 . . . . 0.0 109.58 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.87 -18.02 14.04 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.1 144.13 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.492 1.517 . . . . 0.0 110.161 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.51 92.66 5.49 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.88 1.272 . . . . 0.0 110.287 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.16 155.26 66.1 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.769 1.646 . . . . 0.0 111.362 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.3 155.16 12.09 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.094 -0.379 . . . . 0.0 111.095 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m 74.4 -22.42 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.236 1.814 . . . . 0.0 113.027 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -99.47 146.38 26.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.925 1.69 . . . . 0.0 109.016 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.53 162.3 17.38 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.769 1.228 . . . . 0.0 111.934 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 167.78 10.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.446 174.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.75 126.74 43.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.899 2.48 . . . . 0.0 108.652 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -144.37 151.22 38.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.823 0.849 . . . . 0.0 110.97 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -155.76 157.51 36.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.733 0.813 . . . . 0.0 110.883 -174.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.4 166.66 30.15 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.199 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.01 44.79 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.86 1.33 . . . . 0.0 113.064 -174.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -74.96 113.75 12.63 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 39.62 -147.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.646 1.578 . . . . 0.0 113.887 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.7 m -77.72 -47.73 18.38 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.496 -1.378 . . . . 0.0 111.334 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.85 -60.53 0.36 Allowed Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.819 -0.989 . . . . 0.0 114.455 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.29 -2.51 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.612 3.541 . . . . 0.0 114.974 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.42 142.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.007 1.723 . . . . 0.0 108.705 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.94 69.15 1.19 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 0.0 110.982 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.4 m -96.65 -61.62 1.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.144 0.978 . . . . 0.0 111.335 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.88 172.15 31.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.737 1.16 . . . . 0.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.96 111.45 9.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.744 1.218 . . . . 0.0 110.364 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.57 135.82 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.969 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.76 162.33 40.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.107 1.363 . . . . 0.0 110.594 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.51 40.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.406 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.12 171.66 13.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.247 1.819 . . . . 0.0 110.365 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.72 152.0 46.31 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.971 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -128.18 117.14 21.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 110.715 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -79.56 110.56 15.0 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.444 1.498 . . . . 0.0 110.872 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 73.8 mtm -78.77 160.07 27.59 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.8 p -60.75 -17.76 50.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -73.75 -14.53 61.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.956 . . . . 0.0 112.491 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.52 7.46 72.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.689 1.138 . . . . 0.0 113.982 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -92.85 163.61 13.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.019 1.328 . . . . 0.0 109.736 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -125.19 152.74 44.1 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.121 0.968 . . . . 0.0 109.802 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.94 131.95 53.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.765 0.826 . . . . 0.0 109.904 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.52 140.77 19.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.64 126.33 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.666 1.186 . . . . 0.0 109.283 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.86 157.21 45.61 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 112.058 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -126.79 139.42 53.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.143 1.377 . . . . 0.0 110.554 175.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 m -127.27 114.12 17.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.708 1.203 . . . . 0.0 109.76 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.7 t -119.05 99.77 50.8 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.322 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.81 172.23 16.69 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.235 1.957 . . . . 0.0 110.102 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.99 -59.51 2.69 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.297 -0.877 . . . . 0.0 111.418 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.32 122.22 17.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.757 2.023 . . . . 0.0 112.489 -167.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.54 -52.25 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.184 -0.948 . . . . 0.0 113.209 -175.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -87.89 -4.51 58.84 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.95 1.3 . . . . 0.0 113.465 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.8 -4.13 7.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 112.074 -164.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.43 167.58 29.55 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.741 2.816 . . . . 0.0 108.414 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.6 m -141.19 166.83 23.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -81.78 157.17 24.59 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.377 -0.827 . . . . 0.0 110.514 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -142.3 153.34 43.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.179 0.991 . . . . 0.0 110.587 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -152.16 159.8 43.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.564 1.546 . . . . 0.0 110.945 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.31 150.46 25.33 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -147.34 143.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 125.632 1.573 . . . . 0.0 110.354 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -149.04 146.55 27.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.168 1.787 . . . . 0.0 108.959 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.17 118.41 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.999 1.72 . . . . 0.0 108.89 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.81 148.3 44.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.768 1.627 . . . . 0.0 112.827 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.4 p -77.7 80.96 4.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.568 1.547 . . . . 0.0 112.912 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.84 179.98 27.94 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.081 1.324 . . . . 0.0 112.958 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 126.23 36.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.835 1.654 . . . . 0.0 111.367 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -135.29 147.38 49.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.116 2.166 . . . . 0.0 108.538 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -115.24 179.93 3.82 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.435 1.494 . . . . 0.0 110.063 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.47 94.02 4.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.163 0.985 . . . . 0.0 110.093 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.84 -69.95 0.79 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.931 0.893 . . . . 0.0 109.429 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -147.55 -69.4 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.984 1.314 . . . . 0.0 109.771 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.97 -28.8 73.94 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.457 1.027 . . . . 0.0 115.319 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -53.72 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.327 1.063 . . . . 0.0 110.249 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.48 -38.77 75.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.529 1.132 . . . . 0.0 111.148 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.98 -44.29 74.31 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.42 -0.8 . . . . 0.0 111.288 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -24.0 67.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.168 0.987 . . . . 0.0 113.128 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.09 -55.69 4.93 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.66 -48.25 81.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.998 1.319 . . . . 0.0 113.377 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -86.74 -11.72 50.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.7 0.8 . . . . 0.0 113.054 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.18 -71.69 0.69 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.104 0.859 . . . . 0.0 112.039 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.32 82.14 1.15 Allowed Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.604 1.561 . . . . 0.0 109.949 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.35 143.71 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.555 1.504 . . . . 0.0 110.885 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.404 ' HB3' ' CD2' ' A' ' 147' ' ' HIS . 38.8 m-85 -81.37 4.46 20.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.01 1.324 . . . . 0.0 113.563 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 57.72 10.95 1.18 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.74 2.816 . . . . 0.0 116.067 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 48.5 47.78 28.78 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.943 1.258 . . . . 0.0 112.611 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.92 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.25 12.2 p30 48.71 27.55 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.736 2.815 . . . . 0.0 115.711 178.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.16 151.44 20.76 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.718 1.628 . . . . 0.0 112.236 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -57.89 131.08 49.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 111.938 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 140' ' ' TYR . 32.5 m-70 -124.22 114.19 19.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.335 1.854 . . . . 0.0 110.132 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.57 131.05 12.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.984 1.314 . . . . 0.0 111.986 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -144.57 126.0 14.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.34 1.856 . . . . 0.0 110.645 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.95 101.28 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.261 1.025 . . . . 0.0 113.051 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -124.92 -26.39 3.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.829 1.251 . . . . 0.0 113.467 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.45 13.97 43.35 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.926 1.251 . . . . 0.0 114.679 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 t80 61.0 7.77 1.65 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.619 2.367 . . . . 0.0 114.964 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.1 -57.46 0.04 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.075 1.321 . . . . 0.0 112.066 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.05 155.74 19.1 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.9 166.37 26.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.485 1.914 . . . . 0.0 112.169 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.07 135.29 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.079 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -125.72 101.7 6.99 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.03 169.42 22.11 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-O 121.565 0.536 . . . . 0.0 112.955 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 147.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 109.264 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 31.0 ttp -152.8 144.7 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.483 1.513 . . . . 0.0 107.259 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.2 p -86.65 163.01 17.63 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.865 0.84 . . . . 0.0 111.381 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.2 p -81.47 13.67 2.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.417 1.887 . . . . 0.0 113.121 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.38 151.69 35.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.028 2.531 . . . . 0.0 111.612 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.46 -57.21 16.3 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.145 0.879 . . . . 0.0 114.146 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.67 59.59 2.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 113.832 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.2 176.89 6.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.236 1.414 . . . . 0.0 113.989 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 136.05 48.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.339 1.856 . . . . 0.0 109.052 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.4 ttp -124.96 88.49 2.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.069 1.348 . . . . 0.0 110.801 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -83.67 153.8 24.03 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.553 -0.717 . . . . 0.0 111.746 165.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 57.9 mt -136.08 115.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.184 2.194 . . . . 0.0 106.893 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -113.12 97.14 6.32 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.434 1.894 . . . . 0.0 108.872 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.21 106.91 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.206 0.527 . . . . 0.0 110.748 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 m -139.82 -179.62 6.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.852 1.661 . . . . 0.0 112.041 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.147 1.779 . . . . 0.0 111.992 178.859 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.3 18.18 3.7 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.118 1.367 . . . . 0.0 113.087 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.28 145.48 39.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.778 -1.201 . . . . 0.0 111.472 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.69 34.68 62.7 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.942 0.782 . . . . 0.0 114.363 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -146.14 -174.17 4.37 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.284 1.042 . . . . 0.0 111.843 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -126.72 143.49 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.682 1.593 . . . . 0.0 111.772 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.36 167.17 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.035 1.734 . . . . 0.0 112.253 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 116.43 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.964 1.306 . . . . 0.0 113.057 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.19 65.49 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.024 1.297 . . . . 0.0 113.141 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.77 -20.64 61.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.26 1.424 . . . . 0.0 113.448 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -110.35 -0.99 17.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.57 1.548 . . . . 0.0 112.834 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 tp -80.41 115.34 19.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.14 1.376 . . . . 0.0 112.013 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -142.2 169.18 18.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.232 1.413 . . . . 0.0 110.941 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.3 -40.96 50.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.865 1.666 . . . . 0.0 113.889 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.373 1.069 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.05 -45.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.019 1.728 . . . . 0.0 109.938 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 83.3 mt -54.6 -47.06 73.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.385 0.674 . . . . 0.0 110.635 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.88 -52.6 63.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.636 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -48.26 -47.89 35.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.673 1.189 . . . . 0.0 112.658 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.83 -58.77 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.728 1.211 . . . . 0.0 111.853 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -32.55 73.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.09 1.356 . . . . 0.0 113.076 177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.47 -55.96 13.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.224 1.01 . . . . 0.0 111.229 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -24.71 61.39 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.52 -48.29 69.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.741 1.616 . . . . 0.0 110.887 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 60.39 0.27 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.634 1.588 . . . . 0.0 111.662 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -53.53 119.64 5.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.282 1.433 . . . . 0.0 112.301 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -169.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.014 1.726 . . . . 0.0 110.074 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m -41.07 -42.96 2.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.708 2.403 . . . . 0.0 112.874 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 mtm105 -143.0 144.52 32.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.377 1.871 . . . . 0.0 109.575 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.99 165.08 4.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.71 2.804 . . . . 0.0 110.743 -170.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 32.8 pt -139.95 173.04 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.536 1.534 . . . . 0.0 110.652 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.01 107.15 6.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.991 1.316 . . . . 0.0 110.752 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.69 137.67 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.983 1.313 . . . . 0.0 111.451 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.7 116.98 0.8 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.746 0.689 . . . . 0.0 113.216 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.27 105.55 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.318 1.059 . . . . 0.0 109.694 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -84.6 108.87 17.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.293 1.437 . . . . 0.0 112.92 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -75.49 97.96 3.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.342 1.457 . . . . 0.0 111.393 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 8.94 12.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.469 1.908 . . . . 0.0 113.041 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.2 m -64.44 -44.94 89.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.09 -0.9 5.75 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.163 1.363 . . . . 0.0 116.329 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.76 28.07 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.745 1.773 . . . . 0.0 114.316 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -74.88 139.14 42.93 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.492 1.117 . . . . 0.0 113.112 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -111.8 163.31 14.32 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.696 1.199 . . . . 0.0 112.249 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.2 m -131.07 108.04 9.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.085 1.354 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 110.79 3.54 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.023 0.929 . . . . 0.0 108.987 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.36 -63.9 1.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.699 1.6 . . . . 0.0 111.097 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.23 170.39 2.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.299 2.24 . . . . 0.0 111.152 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.7 139.3 53.66 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 127.308 2.243 . . . . 0.0 110.489 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -131.61 114.87 15.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.183 1.793 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.68 101.3 5.7 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.563 1.545 . . . . 0.0 111.808 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -68.01 -42.96 79.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.219 1.408 . . . . 0.0 112.944 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -146.48 154.1 41.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.99 1.716 . . . . 0.0 111.381 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.55 -163.96 54.51 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.818 -0.551 . . . . 0.0 112.7 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.49 161.26 41.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.904 0.882 . . . . 0.0 110.546 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.9 m -145.43 137.7 25.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 110.131 -174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.21 4.71 44.72 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.749 1.219 . . . . 0.0 113.353 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -120.53 175.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.33 1.852 . . . . 0.0 113.564 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.03 132.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 109.843 -172.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 142.82 81.56 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 121.663 -0.648 . . . . 0.0 110.332 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.73 175.22 5.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 125.091 3.861 . . . . 0.0 111.533 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.15 -26.27 8.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.079 -1.013 . . . . 0.0 112.69 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -124.02 130.56 52.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 0.0 111.001 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -133.38 88.15 35.88 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.288 1.435 . . . . 0.0 109.425 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.32 163.39 23.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.306 2.004 . . . . 0.0 112.277 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.61 158.05 19.19 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.393 -0.817 . . . . 0.0 111.703 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 66.03 4.14 2.92 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.51 2.324 . . . . 0.0 114.208 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -126.9 147.9 50.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.325 1.85 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.96 158.0 27.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.349 1.459 . . . . 0.0 110.993 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.91 167.61 10.98 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.29 132.16 47.11 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.934 1.694 . . . . 0.0 108.763 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.67 163.57 35.48 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.374 1.07 . . . . 0.0 111.925 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.7 m -143.08 177.17 8.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.185 1.394 . . . . 0.0 111.298 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.74 97.66 0.14 Allowed Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.729 -1.04 . . . . 0.0 113.307 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.95 166.21 10.58 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.982 1.391 . . . . 0.0 113.595 -173.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -86.38 101.35 13.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.71 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t0 39.65 -146.14 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 126.683 1.993 . . . . 0.0 112.405 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -61.76 -35.44 78.13 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 119.706 -1.871 . . . . 0.0 112.151 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.74 -58.86 0.53 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.299 1.428 . . . . 0.0 113.565 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.62 4.38 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.947 3.765 . . . . 0.0 115.382 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.05 126.04 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.124 2.169 . . . . 0.0 110.485 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.33 62.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.429 1.491 . . . . 0.0 112.556 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -66.31 0.91 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.691 1.596 . . . . 0.0 111.777 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 175.09 39.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.529 2.014 . . . . 0.0 110.334 -173.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.09 102.41 3.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.892 1.277 . . . . 0.0 107.937 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.97 134.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.036 1.734 . . . . 0.0 108.188 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.67 159.52 38.48 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 124.382 1.073 . . . . 0.0 110.068 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.8 146.46 33.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 110.858 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.05 169.15 21.9 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.2 1.8 . . . . 0.0 110.236 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.78 146.84 34.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.122 0.569 . . . . 0.0 111.703 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.83 118.83 23.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.824 0.85 . . . . 0.0 110.871 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 114.09 17.93 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.846 1.658 . . . . 0.0 110.274 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.7 mtt -70.72 162.47 29.0 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.491 0.662 . . . . 0.0 112.182 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t -60.18 -23.45 63.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.82 1.248 . . . . 0.0 113.722 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -10.69 56.21 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.535 1.534 . . . . 0.0 113.39 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.56 9.86 56.14 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.772 1.177 . . . . 0.0 115.179 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -87.06 171.72 10.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.372 1.086 . . . . 0.0 110.263 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.5 m -129.99 147.53 51.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.439 0.696 . . . . 0.0 110.961 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.08 111.75 16.32 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.26 139.54 28.21 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 18.5 t -143.31 131.54 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.066 0.947 . . . . 0.0 109.84 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -143.77 160.51 40.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.93 -0.481 . . . . 0.0 111.77 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 153.05 46.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.894 1.278 . . . . 0.0 110.187 175.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -145.89 113.36 6.3 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.976 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.0 110.55 43.69 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 126.634 1.974 . . . . 0.0 108.224 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -79.33 175.27 10.95 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.486 2.791 . . . . 0.0 111.399 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -81.63 -40.94 22.19 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.814 -0.554 . . . . 0.0 111.269 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 112.51 24.33 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.476 -0.765 . . . . 0.0 112.789 -161.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.14 -54.85 41.02 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.17 17.16 24.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.14 1.376 . . . . 0.0 113.829 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.62 -3.57 2.62 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.286 1.834 . . . . 0.0 112.748 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -173.61 4.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.34 2.656 . . . . 0.0 109.692 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -152.58 160.65 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.492 1.517 . . . . 0.0 110.596 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.48 158.0 31.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.316 1.046 . . . . 0.0 110.214 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -143.68 151.88 40.64 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.283 -0.886 . . . . 0.0 111.932 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -164.38 154.55 14.47 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.952 1.701 . . . . 0.0 109.675 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -143.78 140.27 29.82 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.894 1.677 . . . . 0.0 108.8 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.21 124.37 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 128.952 2.901 . . . . 0.0 109.6 174.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -144.9 148.32 33.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.498 1.919 . . . . 0.0 109.894 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.92 113.53 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.827 1.651 . . . . 0.0 108.868 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -126.23 142.95 51.32 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.558 1.543 . . . . 0.0 112.939 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.0 p -75.34 92.67 2.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.14 . . . . 0.0 112.537 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.64 -167.88 39.83 Favored Glycine 0 N--CA 1.471 0.993 0 O-C-N 121.531 -0.731 . . . . 0.0 114.397 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 119.19 24.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.489 1.915 . . . . 0.0 111.398 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.22 156.11 40.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 111.133 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -137.93 161.87 35.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.34 1.456 . . . . 0.0 111.056 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 90.72 2.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.411 0.684 . . . . 0.0 111.15 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -110.23 -66.57 1.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.136 1.374 . . . . 0.0 109.135 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -70.92 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.58 1.552 . . . . 0.0 109.35 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.56 81.33 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.333 0.968 . . . . 0.0 114.333 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -69.6 -53.08 20.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.293 1.046 . . . . 0.0 110.78 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.25 -43.76 79.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.792 0.837 . . . . 0.0 110.428 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -62.6 -46.37 88.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -56.86 -19.94 20.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.722 1.146 . . . . 0.0 113.377 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.66 -59.13 2.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.227 1.411 . . . . 0.0 110.438 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.99 -56.55 19.82 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.299 1.04 . . . . 0.0 111.383 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -80.93 -16.66 52.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.198 1.399 . . . . 0.0 112.064 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.28 -77.17 0.25 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 0.0 113.271 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -162.41 90.75 1.33 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.935 1.694 . . . . 0.0 109.966 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.28 158.15 45.16 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.016 1.144 . . . . 0.0 110.492 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.74 5.84 50.39 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.74 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 130.145 3.378 . . . . 0.0 117.808 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.07 5.39 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.043 -1.035 . . . . 0.0 112.245 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -63.55 7.18 0.11 Allowed 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.347 11.3 p30 55.84 25.55 8.63 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.193 2.597 . . . . 0.0 116.424 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -139.58 165.44 25.82 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.456 1.979 . . . . 0.0 111.499 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -70.42 114.53 8.64 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.16 -1.2 . . . . 0.0 109.689 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 127.77 53.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.043 1.337 . . . . 0.0 109.975 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.08 139.34 21.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.185 1.394 . . . . 0.0 110.352 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -144.65 126.46 15.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.241 1.416 . . . . 0.0 109.921 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -62.1 117.6 6.22 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.805 0.442 . . . . 0.0 111.414 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -142.98 -26.62 0.59 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.486 1.114 . . . . 0.0 113.93 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.18 15.82 20.35 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.821 1.201 . . . . 0.0 114.469 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.45 10.62 1.92 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.829 2.452 . . . . 0.0 115.403 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.9 -47.6 0.05 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.274 1.416 . . . . 0.0 112.773 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.52 161.49 17.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 111.324 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 170.99 19.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 113.074 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.73 138.53 31.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.28 1.432 . . . . 0.0 109.487 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -130.5 109.07 10.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.761 1.624 . . . . 0.0 108.656 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.62 169.87 27.04 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.3 143.24 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 109.702 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.7 ttt -150.79 150.91 31.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.673 1.989 . . . . 0.0 107.352 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.0 p -101.13 165.47 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.599 0.76 . . . . 0.0 111.929 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.0 t -90.84 46.28 1.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.685 1.594 . . . . 0.0 110.051 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.57 158.16 42.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.33 1.452 . . . . 0.0 112.656 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.1 -45.55 93.79 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 121.439 -0.788 . . . . 0.0 113.089 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 64.02 2.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.737 1.615 . . . . 0.0 113.741 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -94.61 147.29 23.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -91.49 150.11 21.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.687 1.195 . . . . 0.0 107.963 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 36.2 ttp -143.72 91.84 2.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.389 0.995 . . . . 0.0 112.16 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -107.04 146.41 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.406 -0.809 . . . . 0.0 111.164 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.69 104.27 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.886 1.675 . . . . 0.0 109.426 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -99.2 90.42 4.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.81 2.044 . . . . 0.0 110.51 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.63 118.22 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.378 0.671 . . . . 0.0 110.137 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.5 p -146.41 166.17 27.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.994 1.318 . . . . 0.0 113.029 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.691 2.397 . . . . 0.0 111.7 176.218 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.88 -26.92 7.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.13 143.0 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.324 0.965 . . . . 0.0 112.442 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.86 43.46 8.94 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.051 0.834 . . . . 0.0 115.027 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.9 p -147.65 -166.77 2.61 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 119.064 1.432 . . . . 0.0 111.977 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 pt -117.26 139.46 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.295 2.238 . . . . 0.0 109.947 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.3 pt -145.55 159.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.006 1.322 . . . . 0.0 111.732 174.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.68 128.96 39.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.048 1.339 . . . . 0.0 112.477 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.59 -24.35 76.25 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.588 0.613 . . . . 0.0 113.413 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.2 73.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.419 1.088 . . . . 0.0 111.395 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -74.11 -28.45 61.36 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.259 1.024 . . . . 0.0 112.896 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.2 tt -67.26 114.57 6.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.274 1.429 . . . . 0.0 112.54 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 m -145.11 172.85 12.5 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.159 1.784 . . . . 0.0 110.157 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -42.17 37.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.38 1.472 . . . . 0.0 113.952 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.88 -35.91 79.73 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.13 -42.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.517 0.727 . . . . 0.0 110.29 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.1 mt -55.52 -50.48 69.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.832 0.742 . . . . 0.0 112.092 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -39.99 90.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.153 0.581 . . . . 0.0 112.113 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -57.21 -43.44 82.79 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.009 1.324 . . . . 0.0 112.717 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.22 -48.01 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.394 1.078 . . . . 0.0 111.325 176.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 mp -61.96 -42.82 99.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.171 0.988 . . . . 0.0 112.267 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.87 -31.79 71.84 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -77.0 -42.19 39.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.826 1.65 . . . . 0.0 113.82 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.64 -56.85 16.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.775 1.63 . . . . 0.0 111.59 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 64.61 0.09 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.029 1.3 . . . . 0.0 112.149 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -51.16 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.353 2.261 . . . . 0.0 112.421 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.8 p -90.42 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.096 1.758 . . . . 0.0 109.942 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.4 m -44.2 -49.55 9.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.552 1.141 . . . . 0.0 112.083 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -139.45 146.57 40.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 112.727 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.4 150.93 11.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.046 2.538 . . . . 0.0 108.931 -169.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.0 pt -139.72 153.95 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.822 1.249 . . . . 0.0 109.507 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.63 110.81 20.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.364 1.066 . . . . 0.0 109.878 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -105.31 128.74 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.892 0.877 . . . . 0.0 111.265 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.7 114.47 0.79 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.357 1.456 . . . . 0.0 112.094 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.86 104.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.515 1.126 . . . . 0.0 109.082 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.2 111.16 21.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.149 1.379 . . . . 0.0 111.15 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -84.54 96.42 9.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.41 1.084 . . . . 0.0 111.615 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.0 18.97 20.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.601 1.161 . . . . 0.0 113.167 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.0 p -63.87 -40.22 96.03 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.46 3.98 5.01 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.886 1.707 . . . . 0.0 115.854 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.06 30.47 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.767 1.783 . . . . 0.0 114.491 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -74.8 130.63 39.8 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 122.007 -0.701 . . . . 0.0 112.165 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.37 164.39 11.8 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.901 1.28 . . . . 0.0 111.277 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 m -133.82 110.32 9.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.458 1.503 . . . . 0.0 109.467 -176.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.1 133.3 55.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.75 174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mt -75.23 -68.56 0.54 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.864 0.466 . . . . 0.0 109.866 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -179.44 173.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.502 2.321 . . . . 0.0 110.592 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.82 145.74 51.23 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.353 2.261 . . . . 0.0 109.515 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 115.65 15.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.971 0.908 . . . . 0.0 111.015 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -70.31 106.65 3.43 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 111.221 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -68.95 -47.53 65.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.434 1.494 . . . . 0.0 110.603 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -141.7 154.4 45.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.917 2.087 . . . . 0.0 110.703 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -163.52 54.62 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.834 -0.541 . . . . 0.0 113.353 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -151.66 177.91 9.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 111.998 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.0 p -144.48 178.65 7.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.376 1.47 . . . . 0.0 111.563 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.25 20.15 8.15 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.771 1.228 . . . . 0.0 112.008 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.86 172.21 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 126.721 2.008 . . . . 0.0 113.244 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 mt -143.38 135.59 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.027 1.731 . . . . 0.0 109.812 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 149.68 60.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 119.547 1.067 . . . . 0.0 112.1 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.21 155.51 56.29 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 124.249 3.299 . . . . 0.0 111.579 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -93.27 -23.64 18.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.977 -1.077 . . . . 0.0 113.424 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.95 141.13 49.93 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.931 -1.106 . . . . 0.0 110.648 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.0 102.77 5.73 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.643 1.177 . . . . 0.0 109.234 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.3 164.67 24.79 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.903 1.735 . . . . 0.0 111.637 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -62.78 163.67 9.02 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.957 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 66.27 -0.91 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 126.542 1.937 . . . . 0.0 114.151 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.96 -174.38 2.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.188 2.995 . . . . 0.0 110.81 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.31 172.85 17.23 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.651 2.38 . . . . 0.0 111.049 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.99 178.47 4.55 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.713 0.805 . . . . 0.0 109.737 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 tp -134.88 131.9 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.886 2.074 . . . . 0.0 109.118 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -148.05 166.27 28.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.274 1.03 . . . . 0.0 110.486 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -149.44 174.85 12.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.152 0.981 . . . . 0.0 111.068 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.95 119.22 0.88 Allowed Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.39 1.471 . . . . 0.0 111.369 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.04 150.06 42.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.909 1.355 . . . . 0.0 112.393 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.462 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -69.7 107.6 3.54 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 40.06 -150.49 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 126.113 1.765 . . . . 0.0 113.122 174.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -77.83 -38.74 45.58 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.82 -1.8 . . . . 0.0 111.347 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.82 -56.23 0.51 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.628 -1.096 . . . . 0.0 114.78 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.54 -6.27 18.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.529 3.486 . . . . 0.0 114.825 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.7 m -122.8 139.96 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.268 1.827 . . . . 0.0 109.126 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.03 78.08 1.52 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.326 . . . . 0.0 110.77 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 80.6 m -102.73 -65.16 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.848 0.859 . . . . 0.0 111.318 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.18 172.07 29.13 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.752 1.644 . . . . 0.0 111.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.33 108.69 8.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.409 1.105 . . . . 0.0 110.541 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -137.81 131.32 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.44 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.179 0.592 . . . . 0.0 110.651 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.96 149.97 35.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.935 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.84 172.47 12.98 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.858 1.663 . . . . 0.0 110.651 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 150.44 45.9 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.249 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.37 114.37 16.76 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.66 1.184 . . . . 0.0 111.352 -178.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -75.02 115.13 14.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.559 1.544 . . . . 0.0 110.801 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.99 157.9 34.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.195 0.998 . . . . 0.0 111.733 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 87.4 p -59.65 -20.22 54.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -81.56 -11.7 59.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.615 1.966 . . . . 0.0 113.44 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.58 60.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.089 1.328 . . . . 0.0 115.244 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.27 175.11 8.64 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.811 1.245 . . . . 0.0 110.863 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.9 m -141.73 147.75 37.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.725 0.774 . . . . 0.0 110.288 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.11 118.94 34.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.19 0.996 . . . . 0.0 108.34 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.33 142.3 22.88 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 25.6 m -140.89 137.97 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.547 1.139 . . . . 0.0 110.762 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.41 152.52 44.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.155 0.582 . . . . 0.0 110.879 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -125.88 142.22 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.684 1.193 . . . . 0.0 109.768 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.0 m -125.87 97.95 5.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.947 1.699 . . . . 0.0 110.309 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.2 112.31 58.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.674 1.59 . . . . 0.0 109.616 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -76.83 -173.08 1.61 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.336 3.357 . . . . 0.0 111.996 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' CD1' ' HE3' ' A' ' 75' ' ' LYS . 16.8 t80 -106.5 -13.04 15.44 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.37 1.068 . . . . 0.0 112.895 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -110.73 131.13 55.32 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 119.741 -1.849 . . . . 0.0 111.138 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -66.4 0.7 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.02 -1.05 . . . . 0.0 110.837 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -82.19 -3.98 56.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.51 -1.48 9.58 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.093 1.757 . . . . 0.0 112.699 -164.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -150.24 179.93 7.71 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 129.536 3.134 . . . . 0.0 108.887 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.9 t -142.48 163.57 32.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.938 1.695 . . . . 0.0 109.037 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -92.37 136.98 32.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.351 0.66 . . . . 0.0 109.227 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 151.1 46.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.096 0.959 . . . . 0.0 110.357 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -157.1 157.48 34.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.612 1.565 . . . . 0.0 110.632 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.13 155.23 43.19 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.624 -0.673 . . . . 0.0 109.909 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.6 t -140.87 122.02 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.947 1.299 . . . . 0.0 109.751 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -124.86 145.3 49.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.66 1.584 . . . . 0.0 109.737 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.4 mt -115.5 120.39 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.755 2.022 . . . . 0.0 108.659 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -132.42 144.72 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.126 1.371 . . . . 0.0 112.13 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.8 p -80.39 77.97 7.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.635 1.174 . . . . 0.0 112.59 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.67 36.88 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.413 1.006 . . . . 0.0 113.818 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 116.78 26.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.754 1.622 . . . . 0.0 111.858 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -142.43 155.26 45.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.105 1.362 . . . . 0.0 109.445 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -133.05 161.91 33.12 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.78 1.232 . . . . 0.0 111.141 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.8 78.98 0.45 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.602 1.161 . . . . 0.0 111.337 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -101.86 -65.59 0.97 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.444 1.498 . . . . 0.0 110.244 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.55 -71.77 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.088 1.755 . . . . 0.0 109.233 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.4 -19.33 68.53 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.541 1.067 . . . . 0.0 114.603 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.34 -52.71 5.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.117 0.958 . . . . 0.0 111.574 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.44 -45.9 76.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.335 0.654 . . . . 0.0 111.775 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -35.37 72.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -22.85 66.98 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.283 -0.886 . . . . 0.0 113.244 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -93.71 -35.91 12.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.427 1.091 . . . . 0.0 110.89 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -76.26 -45.14 34.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.309 -1.494 . . . . 0.0 113.197 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -92.06 -14.87 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.929 1.292 . . . . 0.0 113.143 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.08 63.14 3.59 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.992 0.806 . . . . 0.0 113.706 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 31.97 73.75 0.5 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 127.598 2.359 . . . . 0.0 112.528 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.06 133.09 29.83 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.355 1.37 . . . . 0.0 110.895 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 124.8 23.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.31 31.98 0.34 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.385 1.874 . . . . 0.0 114.046 -176.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.39 62.96 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.51 1.529 . . . . 0.0 114.073 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.59 24.97 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.338 1.855 . . . . 0.0 114.703 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.9 p30 47.76 30.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.164 2.586 . . . . 0.0 116.852 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.93 139.19 7.57 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.997 1.76 . . . . 0.0 111.156 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -49.58 124.05 8.82 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.839 1.256 . . . . 0.0 113.129 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -110.41 120.83 43.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.105 2.162 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.79 138.76 17.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.729 1.212 . . . . 0.0 111.168 174.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -154.78 134.79 13.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 111.266 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -54.23 132.67 43.92 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.6 tp -156.32 -41.06 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.758 1.223 . . . . 0.0 112.51 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.93 31.66 2.79 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 114.082 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.47 11.99 1.36 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.355 2.262 . . . . 0.0 115.743 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 170.85 -43.21 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.349 1.452 . . . . 0.0 113.097 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.37 151.5 26.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.519 1.127 . . . . 0.0 110.657 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.88 170.19 16.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.539 1.136 . . . . 0.0 113.06 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -82.51 126.5 32.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.671 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -121.24 102.78 8.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.438 1.095 . . . . 0.0 108.36 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.91 171.45 25.47 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 143.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.074 0.95 . . . . 0.0 110.045 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.03 148.8 33.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.407 1.883 . . . . 0.0 108.216 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.3 p -107.74 162.37 14.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.463 1.905 . . . . 0.0 111.025 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.7 p -92.11 19.82 6.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.533 1.533 . . . . 0.0 113.542 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.73 175.06 5.62 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.28 2.232 . . . . 0.0 113.456 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.57 9.8 Favored Glycine 0 N--CA 1.475 1.249 0 C-N-CA 125.362 1.458 . . . . 0.0 112.401 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.39 73.51 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.037 1.335 . . . . 0.0 109.639 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.23 91.69 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.688 0.795 . . . . 0.0 111.298 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -56.76 149.89 17.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.072 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.4 tpp -151.08 96.26 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.871 0.843 . . . . 0.0 110.649 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -124.96 134.93 52.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.602 -1.311 . . . . 0.0 109.636 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.66 101.1 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.571 1.548 . . . . 0.0 109.664 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -99.32 99.89 10.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.288 1.835 . . . . 0.0 109.845 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -85.92 118.08 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.449 -0.782 . . . . 0.0 111.16 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.05 165.78 26.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.87 1.668 . . . . 0.0 113.038 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.039 2.136 . . . . 0.0 111.648 174.968 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.53 -0.77 42.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.59 143.03 53.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.023 0.929 . . . . 0.0 111.085 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.85 38.1 65.61 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -149.15 -169.73 3.45 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.425 1.113 . . . . 0.0 111.774 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 pt -126.47 153.27 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.974 1.71 . . . . 0.0 111.059 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 pt -148.94 170.0 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.824 1.65 . . . . 0.0 111.792 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.35 129.26 39.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.099 0.959 . . . . 0.0 109.601 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.34 42.05 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.947 1.26 . . . . 0.0 113.932 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.66 81.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.224 1.41 . . . . 0.0 112.267 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -32.58 32.34 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.94 1.296 . . . . 0.0 112.605 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.41 107.93 0.74 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.349 . . . . 0.0 111.896 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 m -149.37 168.17 24.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.755 1.222 . . . . 0.0 110.149 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -39.02 21.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.766 1.626 . . . . 0.0 114.222 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -59.38 -35.0 73.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.72 -44.02 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 110.474 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.52 -43.87 72.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.886 0.766 . . . . 0.0 112.226 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.16 -47.31 80.37 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.982 -0.449 . . . . 0.0 110.881 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -39.15 76.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.578 1.551 . . . . 0.0 114.0 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.19 -56.34 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.152 1.781 . . . . 0.0 109.598 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.41 -40.82 89.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.149 1.38 . . . . 0.0 112.646 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -56.52 -54.58 44.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 112.933 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.11 -42.0 89.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 tp -53.21 -55.54 23.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.03 1.732 . . . . 0.0 112.722 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.99 49.24 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.927 0.775 . . . . 0.0 114.12 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.91 123.71 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.561 1.944 . . . . 0.0 114.342 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.73 -161.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 127.086 2.154 . . . . 0.0 111.442 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 m -51.91 -34.07 39.86 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.807 1.643 . . . . 0.0 114.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -144.21 139.66 28.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.827 2.051 . . . . 0.0 108.932 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.73 148.32 12.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.574 1.949 . . . . 0.0 110.988 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -138.35 151.79 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.14 0.976 . . . . 0.0 108.803 175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.57 113.1 25.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.596 1.159 . . . . 0.0 109.866 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.75 130.4 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.693 0.797 . . . . 0.0 111.436 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.96 0.85 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.654 1.121 . . . . 0.0 112.759 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.11 101.54 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.846 1.258 . . . . 0.0 108.745 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -85.44 104.25 15.07 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.599 1.56 . . . . 0.0 111.696 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -82.79 104.35 12.96 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.572 1.149 . . . . 0.0 112.052 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.66 29.44 8.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.096 1.358 . . . . 0.0 112.331 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -84.02 -3.74 58.24 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.075 1.75 . . . . 0.0 114.747 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.21 14.64 80.12 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.505 -1.372 . . . . 0.0 114.287 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.65 20.23 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.445 1.498 . . . . 0.0 113.611 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.4 p -81.79 131.7 35.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.241 1.417 . . . . 0.0 112.527 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -108.35 164.43 12.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.741 1.216 . . . . 0.0 111.955 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -129.33 107.72 9.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.211 1.405 . . . . 0.0 110.082 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.27 117.82 10.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.309 -0.869 . . . . 0.0 109.985 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.03 -69.87 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.363 1.465 . . . . 0.0 111.223 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -170.95 164.41 7.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.531 1.932 . . . . 0.0 111.015 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.71 52.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.91 2.084 . . . . 0.0 110.068 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -108.21 109.75 21.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.546 1.138 . . . . 0.0 111.504 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -78.29 96.53 5.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.341 1.456 . . . . 0.0 112.053 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -66.07 -51.94 53.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.759 1.224 . . . . 0.0 112.003 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -138.63 141.48 39.11 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.822 2.049 . . . . 0.0 110.552 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.89 -171.46 42.91 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.32 0.486 . . . . 0.0 112.771 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.97 176.43 9.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.808 0.843 . . . . 0.0 111.984 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -142.65 -179.17 6.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.214 1.406 . . . . 0.0 111.355 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -137.52 22.89 2.94 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.915 1.286 . . . . 0.0 112.021 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.73 171.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.726 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.01 138.82 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 108.733 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.95 151.2 46.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.107 0.867 . . . . 0.0 111.426 177.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.67 165.73 26.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.741 2.96 . . . . 0.0 110.136 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -29.89 9.44 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.91 -1.119 . . . . 0.0 111.474 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.04 132.8 55.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.168 1.387 . . . . 0.0 111.044 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.45 81.94 47.47 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.051 1.74 . . . . 0.0 108.207 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.06 157.69 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 121.959 1.773 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -56.09 151.1 12.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.414 -0.803 . . . . 0.0 111.563 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 66.24 3.99 2.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.21 2.204 . . . . 0.0 115.257 -171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -130.95 99.13 4.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.146 1.779 . . . . 0.0 113.163 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.59 161.77 28.31 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.744 1.218 . . . . 0.0 112.628 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.91 170.89 7.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.911 0.885 . . . . 0.0 110.642 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.27 130.29 40.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.099 2.159 . . . . 0.0 107.877 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -149.12 161.48 41.88 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.307 1.443 . . . . 0.0 110.334 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -140.12 157.9 44.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.325 0.65 . . . . 0.0 111.512 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.07 118.69 1.4 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.579 1.561 . . . . 0.0 111.937 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.85 169.47 13.21 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.175 1.39 . . . . 0.0 112.011 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -99.89 111.61 23.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.891 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 t70 36.89 -145.72 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 128.637 2.775 . . . . 0.0 114.061 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 m -58.06 -57.56 12.31 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.942 -1.724 . . . . 0.0 111.941 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.8 -75.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.621 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.21 73.02 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 125.216 3.944 . . . . 0.0 113.042 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.6 159.64 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.091 1.756 . . . . 0.0 111.662 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.05 65.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.065 1.346 . . . . 0.0 111.766 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -127.1 -88.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.637 1.575 . . . . 0.0 110.389 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.6 172.99 32.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.526 1.536 . . . . 0.0 111.322 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.58 116.9 22.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.719 1.207 . . . . 0.0 109.385 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -142.5 128.29 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.599 1.16 . . . . 0.0 108.351 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.54 165.78 33.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.605 0.717 . . . . 0.0 110.67 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.62 139.56 20.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.298 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.42 175.85 9.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 -171.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.17 37.51 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.607 -0.683 . . . . 0.0 112.261 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.93 119.45 23.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.688 1.195 . . . . 0.0 110.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.59 112.07 17.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.461 1.904 . . . . 0.0 110.126 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -67.43 162.49 22.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.944 0.898 . . . . 0.0 111.749 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.9 p -59.59 -21.7 60.73 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 m -84.8 -14.95 46.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.511 1.925 . . . . 0.0 113.453 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.42 55.54 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.038 1.304 . . . . 0.0 115.447 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -82.01 165.36 20.74 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.482 1.141 . . . . 0.0 109.662 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.0 m -123.49 143.72 49.99 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 109.147 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -117.36 109.18 16.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.134 0.974 . . . . 0.0 109.354 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.65 114.24 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.26 140.22 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.171 0.988 . . . . 0.0 110.991 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.25 45.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.338 0.655 . . . . 0.0 111.312 174.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -132.84 153.68 51.07 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.216 1.006 . . . . 0.0 111.516 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.3 t -137.39 115.03 11.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.403 1.081 . . . . 0.0 110.604 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 53.2 t -124.05 92.48 48.29 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 126.154 1.782 . . . . 0.0 108.579 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.76 171.6 17.89 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.081 2.521 . . . . 0.0 112.729 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -73.25 -55.95 5.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.514 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.75 122.0 22.6 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.36 1.464 . . . . 0.0 113.325 -161.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -67.22 -58.47 4.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -100.51 15.24 28.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.967 1.307 . . . . 0.0 114.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 0.31 4.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.856 2.063 . . . . 0.0 112.192 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.44 -179.02 7.37 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.419 2.288 . . . . 0.0 110.679 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -154.07 173.03 16.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.172 1.389 . . . . 0.0 112.076 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -95.8 147.54 23.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -134.86 142.48 46.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 110.545 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.442 ' CZ2' ' CD2' ' A' ' 147' ' ' HIS . 30.0 p-90 -145.51 152.82 40.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.39 1.476 . . . . 0.0 109.411 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -153.63 145.8 23.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.739 1.216 . . . . 0.0 110.22 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.7 t -143.28 112.88 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.261 1.825 . . . . 0.0 110.5 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.55 129.29 56.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.129 0.971 . . . . 0.0 109.518 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.52 112.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.223 1.809 . . . . 0.0 108.755 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -124.19 141.45 52.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.473 1.509 . . . . 0.0 112.354 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.3 p -77.1 78.66 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.96 1.304 . . . . 0.0 112.858 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.13 165.18 20.91 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.44 1.019 . . . . 0.0 113.245 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 140.16 57.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.761 1.624 . . . . 0.0 111.856 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -156.04 168.32 27.62 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.516 1.527 . . . . 0.0 110.444 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -142.08 -175.42 4.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.097 1.759 . . . . 0.0 109.714 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.2 111.36 16.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.34 -67.22 0.99 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.287 1.035 . . . . 0.0 109.238 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.33 -71.53 0.21 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.153 0.981 . . . . 0.0 110.594 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.34 -22.91 74.94 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.935 0.778 . . . . 0.0 114.61 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.2 tpp -74.22 -54.18 8.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -40.72 85.33 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.565 1.146 . . . . 0.0 111.666 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.63 -36.24 66.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.352 1.461 . . . . 0.0 111.812 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -21.58 66.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.324 1.05 . . . . 0.0 113.113 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.67 -43.25 10.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 108.558 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -66.67 -49.74 65.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.866 -1.147 . . . . 0.0 113.669 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.56 -12.74 31.02 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.22 -66.91 2.5 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 124.191 0.9 . . . . 0.0 112.869 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.49 77.96 0.27 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.374 2.67 . . . . 0.0 108.928 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.4 143.44 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.509 1.473 . . . . 0.0 108.315 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -79.44 -11.78 59.9 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.7 129.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.054 3.342 . . . . 0.0 112.529 -173.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.36 62.09 0.6 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.05 2.262 . . . . 0.0 114.377 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -78.51 29.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.067 1.747 . . . . 0.0 114.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.253 10.9 p30 50.13 30.46 4.25 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 174.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.27 152.17 20.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.027 1.775 . . . . 0.0 111.017 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -64.37 112.67 3.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.442 ' CD2' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -110.03 123.51 49.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.053 1.741 . . . . 0.0 111.062 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -149.1 154.17 38.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.703 2.001 . . . . 0.0 111.836 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.39 135.85 10.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.308 1.043 . . . . 0.0 111.15 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.49 127.47 31.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.002 0.521 . . . . 0.0 111.447 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.1 tp -149.67 -27.99 0.26 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -84.29 18.76 21.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.998 1.285 . . . . 0.0 114.553 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.47 10.04 1.72 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.477 2.311 . . . . 0.0 115.438 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.85 -61.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.118 1.818 . . . . 0.0 110.579 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.1 159.78 15.52 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.796 0.838 . . . . 0.0 112.476 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 169.3 25.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.847 1.659 . . . . 0.0 112.82 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -88.54 133.79 34.05 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.004 0.922 . . . . 0.0 112.011 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.16 107.24 9.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.329 1.452 . . . . 0.0 107.68 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -136.24 175.31 21.0 Favored Glycine 0 C--N 1.325 -0.077 0 CA-C-O 121.941 0.745 . . . . 0.0 113.441 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.65 141.49 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.82 1.648 . . . . 0.0 108.074 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.7 ttt -144.23 130.59 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 161.54 25.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.346 1.058 . . . . 0.0 110.095 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.55 24.91 6.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.403 1.481 . . . . 0.0 113.278 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.76 171.7 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.235 1.814 . . . . 0.0 112.269 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.44 -54.54 36.34 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.621 -0.674 . . . . 0.0 113.192 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -88.91 47.55 1.51 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.04 1.736 . . . . 0.0 113.777 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.18 141.49 57.33 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.895 0.855 . . . . 0.0 113.103 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -96.0 136.93 35.8 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 108.757 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.6 ttp -134.62 95.37 3.35 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.775 1.23 . . . . 0.0 111.733 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -108.72 145.38 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.915 -0.491 . . . . 0.0 110.465 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.26 112.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 125.764 1.626 . . . . 0.0 108.138 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -99.39 108.15 20.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.14 1.776 . . . . 0.0 108.765 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -92.44 109.66 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.691 . . . . 0.0 110.266 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.39 171.32 14.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 111.996 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 127.637 2.375 . . . . 0.0 110.385 175.028 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 119.83 -0.128 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -32.28 24.05 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.746 -0.596 . . . . 0.0 112.084 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.18 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.02 40.66 9.15 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.933 1.254 . . . . 0.0 114.81 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -145.51 -166.29 2.4 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.309 1.555 . . . . 0.0 112.639 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.11 140.14 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.319 2.248 . . . . 0.0 110.1 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -145.1 170.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.177 1.391 . . . . 0.0 111.987 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.76 111.39 5.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.759 -1.213 . . . . 0.0 110.898 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.91 -25.23 67.57 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.981 0.8 . . . . 0.0 113.302 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.42 -23.68 64.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.956 1.303 . . . . 0.0 114.08 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.02 1.16 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.111 1.364 . . . . 0.0 113.319 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.51 117.16 12.71 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.097 1.759 . . . . 0.0 111.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -145.84 169.0 19.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.577 1.551 . . . . 0.0 110.157 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.64 -41.33 42.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.128 1.371 . . . . 0.0 114.141 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -58.39 -42.59 87.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.644 0.777 . . . . 0.0 112.109 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.37 -46.75 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.447 1.099 . . . . 0.0 111.382 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.92 -49.85 70.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.736 0.814 . . . . 0.0 111.474 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -41.26 96.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -53.45 -45.35 69.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.091 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.3 t -56.84 -56.89 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 mp -58.99 -33.87 71.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.258 1.423 . . . . 0.0 113.953 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -55.77 30.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.816 1.246 . . . . 0.0 110.277 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -15.36 60.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -30.6 56.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.448 1.099 . . . . 0.0 111.9 174.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 44.51 47.84 8.75 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.452 1.977 . . . . 0.0 113.959 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.73 175.84 1.03 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.356 1.462 . . . . 0.0 114.48 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -172.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 126.146 1.778 . . . . 0.0 110.922 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 m -48.92 -27.92 3.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.133 1.373 . . . . 0.0 114.591 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -127.36 149.86 49.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.753 1.221 . . . . 0.0 111.277 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.27 154.38 8.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.319 2.248 . . . . 0.0 109.899 -175.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 13.9 pt -144.6 147.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.993 1.717 . . . . 0.0 109.083 174.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.23 105.59 13.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.67 1.188 . . . . 0.0 110.008 176.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.14 135.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.73 1.612 . . . . 0.0 111.569 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.06 115.4 0.69 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.979 1.276 . . . . 0.0 112.62 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.4 mt -106.63 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.337 1.455 . . . . 0.0 109.16 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.38 122.49 24.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.729 1.612 . . . . 0.0 113.845 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -77.34 90.52 3.78 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.195 1.798 . . . . 0.0 111.458 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.46 17.8 14.47 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.401 1.48 . . . . 0.0 112.635 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -76.48 -38.64 55.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 9.79 13.63 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.931 1.253 . . . . 0.0 115.568 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.06 166.19 29.39 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 119.466 1.633 . . . . 0.0 114.946 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -81.66 130.89 35.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.35 1.46 . . . . 0.0 112.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 m0 -106.58 161.35 14.7 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.683 1.193 . . . . 0.0 111.04 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.8 m -129.58 110.35 11.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.252 1.421 . . . . 0.0 109.051 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.41 130.19 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.053 -1.029 . . . . 0.0 109.792 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.23 -70.3 0.37 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 109.942 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -174.06 175.86 2.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.045 2.138 . . . . 0.0 110.549 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.03 154.87 42.37 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.728 2.011 . . . . 0.0 110.277 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.52 108.05 5.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.06 1.344 . . . . 0.0 111.022 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.4 ' CZ ' ' HB ' ' A' ' 55' ' ' THR . 77.9 m-85 -74.33 105.91 5.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.101 1.361 . . . . 0.0 111.12 175.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -45.74 54.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.183 0.993 . . . . 0.0 111.503 175.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.0 m -140.19 156.76 46.38 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.892 2.077 . . . . 0.0 110.932 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.17 -168.32 45.13 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.68 0.6 . . . . 0.0 112.611 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -138.42 169.32 18.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.534 1.134 . . . . 0.0 110.142 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.4 ' HB ' ' CZ ' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -147.23 137.11 23.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.91 0.862 . . . . 0.0 109.791 175.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.13 5.75 50.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.197 1.799 . . . . 0.0 112.754 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.5 m -116.1 169.58 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.19 141.77 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.486 1.114 . . . . 0.0 109.495 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.67 151.48 61.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 0.0 111.619 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 164.41 35.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.124 3.216 . . . . 0.0 110.524 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 -34.34 10.17 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.704 -0.622 . . . . 0.0 112.001 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.6 136.14 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.862 1.21 . . . . 0.0 110.82 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.03 89.24 7.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.78 1.232 . . . . 0.0 109.754 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.46 166.43 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.668 2.245 . . . . 0.0 113.49 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -58.81 153.5 16.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.6 p 69.89 -9.15 0.73 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -115.69 123.87 49.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.251 1.82 . . . . 0.0 111.914 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.32 176.69 6.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.872 1.269 . . . . 0.0 110.128 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.14 173.08 6.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.656 0.782 . . . . 0.0 109.247 174.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.51 131.79 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.385 1.474 . . . . 0.0 110.042 175.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -148.67 163.81 36.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 111.334 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.1 m -151.39 173.88 14.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 110.903 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.27 132.57 3.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.885 1.707 . . . . 0.0 110.323 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 178.57 6.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.3 1.04 . . . . 0.0 110.17 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -64.12 -174.95 0.13 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.027 0.931 . . . . 0.0 109.881 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.34 -167.88 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 121.137 -0.977 . . . . 0.0 109.989 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -34.28 -42.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.794 2.037 . . . . 0.0 114.85 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -51.75 0.48 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.51 1.528 . . . . 0.0 113.781 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.02 6.07 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.426 3.418 . . . . 0.0 115.073 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 109.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.447 2.299 . . . . 0.0 111.496 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.09 70.06 3.86 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.079 1.752 . . . . 0.0 112.895 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -97.51 -81.12 0.43 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.315 1.046 . . . . 0.0 111.996 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.06 176.3 43.21 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.115 1.817 . . . . 0.0 110.319 -172.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.13 86.55 1.5 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.542 1.163 . . . . 0.0 109.08 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.8 t -132.58 118.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.266 1.426 . . . . 0.0 107.639 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -141.06 166.29 25.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.055 0.931 . . . . 0.0 110.971 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.73 155.98 40.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.1 177.09 10.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 110.32 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.35 40.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.579 1.151 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.66 118.72 27.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.713 1.205 . . . . 0.0 110.594 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.89 107.72 9.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.042 1.737 . . . . 0.0 109.229 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mtt -64.54 166.64 8.2 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.498 -0.751 . . . . 0.0 112.212 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 t -62.98 -19.13 64.02 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -82.35 -18.83 40.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 113.203 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.19 -0.72 54.33 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.165 1.364 . . . . 0.0 114.906 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -79.93 166.23 21.83 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.597 1.198 . . . . 0.0 109.948 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 m -123.03 149.82 43.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.938 0.875 . . . . 0.0 110.318 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.37 112.43 18.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 108.257 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.18 127.8 8.2 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 m -134.57 131.99 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.106 0.953 . . . . 0.0 110.157 -176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.48 156.65 45.18 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.156 0.582 . . . . 0.0 112.192 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -126.72 158.81 35.5 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.739 1.215 . . . . 0.0 111.191 175.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 t -138.67 108.25 6.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.486 1.115 . . . . 0.0 111.166 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 38.5 t -109.74 98.1 31.7 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.633 1.973 . . . . 0.0 108.612 177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.97 169.37 22.34 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.342 2.695 . . . . 0.0 112.844 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.65 -17.48 41.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.13 110.72 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.149 0.98 . . . . 0.0 110.741 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.4 -58.4 5.37 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.09 -1.006 . . . . 0.0 113.269 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.81 10.76 27.21 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.688 1.195 . . . . 0.0 114.129 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.15 0.56 5.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.189 1.796 . . . . 0.0 112.609 -175.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -153.84 173.16 16.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.237 2.215 . . . . 0.0 110.01 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.2 m -138.57 170.02 16.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.587 1.155 . . . . 0.0 112.155 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -90.84 142.64 27.55 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.396 -0.815 . . . . 0.0 110.143 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -135.69 139.92 44.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 108.755 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -158.14 150.77 22.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.788 1.635 . . . . 0.0 109.322 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -151.36 154.65 37.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.79 1.236 . . . . 0.0 109.912 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.05 121.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.514 1.525 . . . . 0.0 111.4 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -123.31 136.17 54.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.513 1.525 . . . . 0.0 110.627 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.71 116.38 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.919 2.088 . . . . 0.0 108.363 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -129.77 136.41 49.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.235 1.814 . . . . 0.0 112.54 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.5 p -79.99 79.36 6.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.09 1.356 . . . . 0.0 112.465 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.53 176.12 43.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.446 1.498 . . . . 0.0 112.355 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 104.11 16.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.584 1.954 . . . . 0.0 111.135 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -134.41 158.85 42.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.631 1.172 . . . . 0.0 111.371 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -136.75 164.77 27.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.092 1.757 . . . . 0.0 110.57 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.3 87.89 6.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.631 0.772 . . . . 0.0 111.2 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -102.27 -66.9 0.9 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 110.375 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -147.67 -75.0 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.677 1.991 . . . . 0.0 108.554 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.54 -37.17 88.07 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.357 0.979 . . . . 0.0 113.943 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -70.44 -52.97 18.42 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.145 0.972 . . . . 0.0 111.821 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.09 91.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.302 0.641 . . . . 0.0 111.381 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.92 -34.33 77.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.815 -0.612 . . . . 0.0 112.247 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -23.06 64.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.669 1.122 . . . . 0.0 112.177 175.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.54 -58.09 2.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 108.898 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.24 -56.96 15.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.899 -1.126 . . . . 0.0 111.803 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.33 -18.66 44.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 0.0 112.049 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.7 -68.9 1.45 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.346 0.974 . . . . 0.0 113.077 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.31 88.98 0.27 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 127.732 2.413 . . . . 0.0 108.599 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.17 142.06 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.609 1.539 . . . . 0.0 109.429 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -77.5 -9.68 59.05 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.13 107.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 128.931 2.892 . . . . 0.0 112.221 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.19 85.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.344 1.926 . . . . 0.0 114.214 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -89.25 22.99 2.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.504 2.321 . . . . 0.0 113.865 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.286 11.9 p30 50.47 33.6 8.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.871 2.068 . . . . 0.0 114.927 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.91 156.84 23.08 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.24 1.876 . . . . 0.0 111.965 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -69.16 114.07 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.801 -0.823 . . . . 0.0 111.282 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.29 121.65 43.53 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.026 1.73 . . . . 0.0 111.114 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.27 144.53 38.43 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.826 2.05 . . . . 0.0 110.126 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 133.7 13.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.29 1.036 . . . . 0.0 111.477 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.56 115.24 2.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.172 0.989 . . . . 0.0 111.192 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -29.87 1.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.71 1.204 . . . . 0.0 113.279 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.5 18.05 35.79 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.357 1.456 . . . . 0.0 114.427 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 59.09 13.31 2.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.923 2.089 . . . . 0.0 114.709 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -175.42 -69.16 0.05 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 126.658 2.075 . . . . 0.0 109.664 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -87.19 150.15 24.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.324 1.059 . . . . 0.0 111.95 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 172.33 13.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.46 1.904 . . . . 0.0 110.896 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.9 ptm -101.57 150.05 23.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.626 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -130.71 107.55 9.24 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.255 1.822 . . . . 0.0 107.473 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.48 176.98 19.13 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-O 121.748 0.638 . . . . 0.0 113.119 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.79 144.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 107.501 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -145.4 140.87 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.445 1.498 . . . . 0.0 108.439 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.34 162.26 13.42 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.89 1.676 . . . . 0.0 110.623 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.56 16.54 23.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.215 1.006 . . . . 0.0 113.405 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -107.6 172.74 6.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.861 2.064 . . . . 0.0 112.439 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.8 -46.54 94.31 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.431 1.015 . . . . 0.0 114.097 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.99 60.01 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.369 1.468 . . . . 0.0 113.026 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.12 144.86 40.4 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -89.01 147.95 24.01 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.909 0.884 . . . . 0.0 109.254 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.2 mtt -135.5 105.68 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.869 1.667 . . . . 0.0 110.068 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.86 143.17 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.871 -1.143 . . . . 0.0 109.515 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.24 106.04 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.88 1.272 . . . . 0.0 108.503 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -100.22 103.87 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.093 1.757 . . . . 0.0 108.713 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.0 136.94 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.132 0.573 . . . . 0.0 110.042 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 p -158.4 159.87 36.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 128.695 2.798 . . . . 0.0 113.455 176.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.43 -46.77 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.54 -1.35 . . . . 0.0 111.847 -175.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.6 161.31 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.887 2.475 . . . . 0.0 113.364 -166.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.4 46.71 93.82 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.036 -1.04 . . . . 0.0 115.091 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 p -155.11 -170.99 3.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.977 0.911 . . . . 0.0 111.75 -170.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 pt -118.82 144.01 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.786 2.034 . . . . 0.0 110.336 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.72 169.79 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.659 1.584 . . . . 0.0 112.065 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 125.35 25.05 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.728 1.211 . . . . 0.0 112.143 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.12 -28.75 73.92 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.389 0.995 . . . . 0.0 114.382 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.62 74.98 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.669 -0.901 . . . . 0.0 112.567 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -82.62 -22.8 34.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.466 1.106 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.48 120.23 10.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.984 1.714 . . . . 0.0 110.029 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -152.43 171.96 17.24 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.109 1.764 . . . . 0.0 110.009 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -50.94 -36.33 38.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 113.997 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.73 -35.5 76.52 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.741 -1.224 . . . . 0.0 112.988 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.04 -42.59 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.734 0.814 . . . . 0.0 110.248 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -51.34 -49.59 61.12 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.109 0.963 . . . . 0.0 111.755 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.47 -48.6 77.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.43 0.692 . . . . 0.0 111.986 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -56.87 -35.02 68.43 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.47 -56.84 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.073 1.349 . . . . 0.0 110.059 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.35 -41.75 94.28 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.201 1.4 . . . . 0.0 112.369 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -54.75 -49.36 71.04 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.949 0.9 . . . . 0.0 112.318 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -85.86 -32.42 21.72 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -54.23 35.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.392 1.477 . . . . 0.0 111.239 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.82 58.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.383 0.992 . . . . 0.0 112.462 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 139.6 7.34 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.925 1.29 . . . . 0.0 111.913 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.05 -163.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.036 1.334 . . . . 0.0 110.709 -173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -38.83 -44.9 1.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.19 1.796 . . . . 0.0 114.138 175.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -148.98 138.88 22.04 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.132 1.373 . . . . 0.0 110.93 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.02 151.63 16.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.869 1.668 . . . . 0.0 111.165 -172.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.5 pt -134.95 152.3 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.108 1.363 . . . . 0.0 109.4 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.52 117.92 33.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.341 1.457 . . . . 0.0 109.38 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.85 126.97 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.81 109.44 0.66 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.38 1.466 . . . . 0.0 112.455 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.8 mt -107.54 101.9 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.763 1.225 . . . . 0.0 108.246 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.63 120.77 26.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.568 1.547 . . . . 0.0 112.62 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -84.99 102.49 13.23 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.1 1.36 . . . . 0.0 112.054 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.67 25.68 7.42 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 111.615 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -77.99 -19.94 53.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.784 1.634 . . . . 0.0 114.387 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.75 26.85 25.88 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 114.743 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.08 150.38 18.2 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.77 1.176 . . . . 0.0 113.959 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -71.14 140.27 50.53 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.439 -1.036 . . . . 0.0 112.918 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -114.35 164.41 13.98 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.47 1.108 . . . . 0.0 112.237 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 m -132.91 108.75 9.13 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.038 1.335 . . . . 0.0 109.714 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.87 131.49 46.4 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.22 -69.32 0.48 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.735 -0.603 . . . . 0.0 110.539 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.7 163.02 2.8 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.059 2.143 . . . . 0.0 111.076 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -110.86 122.88 48.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.225 1.81 . . . . 0.0 109.224 175.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -110.1 105.75 14.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.434 1.094 . . . . 0.0 111.629 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -73.92 115.02 12.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.817 1.247 . . . . 0.0 112.034 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -46.62 11.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.604 1.561 . . . . 0.0 111.495 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.8 m -139.15 157.0 46.72 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.932 2.093 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.0 -158.5 53.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.48 0.562 . . . . 0.0 112.631 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -148.52 -168.8 3.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.068 -0.666 . . . . 0.0 112.323 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.2 p -142.26 178.67 7.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.105 2.162 . . . . 0.0 111.155 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.21 10.61 6.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.348 1.459 . . . . 0.0 111.971 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.8 m -139.2 169.18 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.184 2.593 . . . . 0.0 113.88 -168.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.43 132.57 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.788 2.035 . . . . 0.0 109.804 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.61 153.97 65.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 119.672 1.123 . . . . 0.0 111.842 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.5 165.45 30.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.824 3.016 . . . . 0.0 109.947 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.13 -33.67 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.414 -0.804 . . . . 0.0 112.153 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -115.11 133.72 55.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.509 1.524 . . . . 0.0 109.917 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.96 106.36 5.77 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.373 1.069 . . . . 0.0 110.121 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.71 163.35 35.59 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.776 1.651 . . . . 0.0 112.051 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.87 150.94 27.01 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.636 -0.665 . . . . 0.0 111.075 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 0.5 OUTLIER 76.96 -3.19 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.838 2.855 . . . . 0.0 114.17 -176.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -112.54 149.53 32.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.499 1.52 . . . . 0.0 109.372 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.23 157.72 29.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 109.916 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -94.38 176.81 6.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.883 0.849 . . . . 0.0 109.72 175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.48 129.7 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.925 2.09 . . . . 0.0 109.16 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -149.12 168.94 21.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.624 0.77 . . . . 0.0 111.204 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -148.66 174.43 12.17 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.157 0.983 . . . . 0.0 111.255 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.3 118.7 0.85 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.1 1.333 . . . . 0.0 111.839 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -118.7 150.15 40.24 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.002 1.401 . . . . 0.0 112.379 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.16 116.08 10.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 42.85 -151.2 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.745 1.618 . . . . 0.0 113.533 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -75.05 -39.95 60.61 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.268 -1.52 . . . . 0.0 112.034 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.41 -62.08 0.37 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.21 1.386 . . . . 0.0 113.646 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.68 3.86 2.95 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 125.279 3.986 . . . . 0.0 115.601 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.56 132.31 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 127.646 2.379 . . . . 0.0 109.404 -174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 69.85 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.303 1.441 . . . . 0.0 111.274 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -108.42 -71.21 0.77 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.364 1.065 . . . . 0.0 110.859 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.95 35.86 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.988 0.804 . . . . 0.0 112.164 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.38 112.18 10.14 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.765 1.226 . . . . 0.0 108.466 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 135.31 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.63 167.16 23.64 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.43 141.66 22.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 110.968 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.96 172.65 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.381 1.472 . . . . 0.0 109.151 -176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.54 148.31 44.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.8 120.2 27.35 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.755 1.222 . . . . 0.0 110.779 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -82.69 125.11 30.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.614 . . . . 0.0 110.687 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.4 mtm -88.2 164.36 15.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.934 0.894 . . . . 0.0 112.953 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -60.52 -22.7 63.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.688 1.195 . . . . 0.0 113.634 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -81.98 -8.19 59.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.672 1.589 . . . . 0.0 113.272 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.23 65.56 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.928 1.251 . . . . 0.0 115.252 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.06 171.93 9.48 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.127 0.971 . . . . 0.0 110.979 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.6 m -133.74 146.43 50.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.059 0.944 . . . . 0.0 111.611 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.45 130.61 56.58 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.432 1.093 . . . . 0.0 108.31 175.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.6 145.34 17.9 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.93 115.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.729 1.212 . . . . 0.0 109.005 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.494 ' HG3' ' H ' ' A' ' 116' ' ' ASP . 1.9 ptm -113.49 160.89 18.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.958 0.503 . . . . 0.0 112.086 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.46 141.62 39.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.554 1.142 . . . . 0.0 109.678 175.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 m -128.5 106.62 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.411 1.884 . . . . 0.0 108.801 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.2 101.59 53.67 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 126.487 1.915 . . . . 0.0 108.813 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.6 171.36 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.317 2.678 . . . . 0.0 111.977 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.02 -24.31 28.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.5 0.72 . . . . 0.0 112.023 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.49 116.32 32.15 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.267 1.427 . . . . 0.0 111.889 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -71.12 -59.3 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.32 10.54 29.33 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.103 -0.998 . . . . 0.0 113.612 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.76 -4.86 5.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.01 2.124 . . . . 0.0 112.615 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 160.49 39.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.837 2.455 . . . . 0.0 109.249 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.6 m -125.02 164.7 19.61 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.07 -1.019 . . . . 0.0 110.834 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -85.12 140.9 30.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.516 0.727 . . . . 0.0 109.884 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 156.94 47.63 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -161.93 140.73 9.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.501 1.52 . . . . 0.0 111.156 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.494 ' H ' ' HG3' ' A' ' 101' ' ' MET . 10.8 t70 -125.57 142.42 51.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.384 1.474 . . . . 0.0 109.214 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -138.36 113.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.345 1.458 . . . . 0.0 109.834 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.65 143.1 50.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.795 1.638 . . . . 0.0 108.845 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.28 118.59 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.661 1.984 . . . . 0.0 108.514 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -129.89 136.0 49.01 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.454 1.501 . . . . 0.0 112.426 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.1 p -70.32 84.77 0.57 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.483 1.913 . . . . 0.0 112.242 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.51 -174.12 44.44 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.451 1.024 . . . . 0.0 113.655 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -115.82 114.37 24.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.598 1.959 . . . . 0.0 110.151 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 159.65 40.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.984 0.913 . . . . 0.0 111.877 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 163.15 33.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.254 1.422 . . . . 0.0 111.27 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.33 89.09 0.2 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.255 1.422 . . . . 0.0 110.923 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.52 -61.33 1.61 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 109.88 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -71.89 0.19 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.245 1.418 . . . . 0.0 109.046 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.1 -32.54 72.96 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.981 0.8 . . . . 0.0 114.416 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -66.07 -53.2 41.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.082 0.941 . . . . 0.0 110.549 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -57.76 -39.83 78.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.455 0.702 . . . . 0.0 110.592 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -48.38 79.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -27.52 67.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.915 0.886 . . . . 0.0 112.923 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -82.7 -50.15 9.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.21 1.004 . . . . 0.0 110.127 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.15 -47.71 67.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.095 1.358 . . . . 0.0 113.7 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -88.81 -13.82 38.48 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.84 -83.15 0.05 OUTLIER Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.824 1.202 . . . . 0.0 112.197 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -168.12 72.75 0.88 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.013 1.725 . . . . 0.0 110.139 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.4 133.04 29.01 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.625 0.883 . . . . 0.0 110.336 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -61.42 158.34 14.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.046 1.338 . . . . 0.0 110.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -95.16 3.71 54.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -164.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 54.69 49.45 61.44 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.481 1.039 . . . . 0.0 112.946 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.91 20.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.41 2.284 . . . . 0.0 115.058 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.265 9.7 p30 48.79 38.45 11.88 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.362 2.265 . . . . 0.0 114.674 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.86 160.35 26.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.596 1.57 . . . . 0.0 112.731 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -68.75 127.12 31.94 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.137 0.975 . . . . 0.0 111.423 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -120.84 106.38 11.61 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.602 1.961 . . . . 0.0 109.464 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.74 150.12 43.01 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.893 1.277 . . . . 0.0 110.989 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 142.28 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.2 1.8 . . . . 0.0 110.241 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -61.53 132.41 53.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.111 0.564 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 tp -147.4 -37.24 0.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.52 25.66 4.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.04 1.305 . . . . 0.0 114.47 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.86 9.75 1.3 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.338 2.255 . . . . 0.0 115.492 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.96 -49.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.239 1.399 . . . . 0.0 112.18 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.88 156.63 18.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.854 0.835 . . . . 0.0 111.597 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 169.09 22.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.974 1.709 . . . . 0.0 112.06 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -94.77 138.8 32.11 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.214 1.006 . . . . 0.0 111.473 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -126.69 106.42 9.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.039 1.736 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.29 169.13 24.64 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 114.779 0.671 . . . . 0.0 114.779 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.92 143.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 125.951 1.7 . . . . 0.0 109.317 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.84 147.6 33.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.537 1.535 . . . . 0.0 108.06 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -96.08 171.58 8.53 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.241 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m -104.28 21.83 15.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.317 1.447 . . . . 0.0 112.458 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 -178.32 3.54 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 112.591 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.57 -36.52 78.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.99 0.805 . . . . 0.0 114.424 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.89 75.21 4.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.666 1.587 . . . . 0.0 111.023 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.91 73.06 1.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 112.251 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -43.99 141.14 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.585 1.954 . . . . 0.0 110.465 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 ttm -142.13 106.25 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.132 0.967 . . . . 0.0 110.566 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -124.2 139.67 53.7 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.39 101.33 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.633 1.573 . . . . 0.0 108.964 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.71 104.78 16.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.363 1.865 . . . . 0.0 109.432 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -87.63 124.28 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 121.819 -0.551 . . . . 0.0 110.989 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.1 m -141.21 167.88 21.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 112.959 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 128.153 2.581 . . . . 0.0 112.686 175.126 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.1 -51.77 0.07 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.579 -1.326 . . . . 0.0 110.783 -171.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.35 158.05 0.06 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.699 2.8 . . . . 0.0 113.335 -166.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.84 44.59 96.92 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.296 -0.878 . . . . 0.0 114.1 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -144.74 -176.59 5.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.433 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.69 135.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.288 1.835 . . . . 0.0 110.616 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -141.06 167.0 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.382 1.473 . . . . 0.0 111.225 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.0 125.73 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.925 -1.109 . . . . 0.0 110.423 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.36 -21.14 59.53 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.897 0.761 . . . . 0.0 113.447 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.32 72.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.226 1.41 . . . . 0.0 112.049 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.63 -30.33 41.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.707 1.203 . . . . 0.0 112.762 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 tp -55.53 106.41 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.053 1.741 . . . . 0.0 111.151 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 m -149.88 166.98 27.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.543 1.537 . . . . 0.0 109.762 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -44.62 -39.28 4.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.968 1.707 . . . . 0.0 114.618 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.31 -36.02 76.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.12 -35.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.874 1.669 . . . . 0.0 110.618 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.9 mt -56.44 -52.22 65.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.902 0.774 . . . . 0.0 111.127 175.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -53.53 -39.82 64.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.973 0.806 . . . . 0.0 112.148 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -59.84 -32.44 70.69 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.547 1.139 . . . . 0.0 113.274 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.0 t -63.97 -52.31 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 108.968 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.04 -41.16 74.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.021 0.528 . . . . 0.0 111.757 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.8 -56.7 18.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.485 1.114 . . . . 0.0 112.617 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.81 -38.6 46.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -21.79 66.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.262 1.025 . . . . 0.0 111.07 175.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.46 73.09 0.96 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.037 1.303 . . . . 0.0 110.153 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -45.2 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.637 1.575 . . . . 0.0 112.449 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.07 -163.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.51 1.524 . . . . 0.0 110.22 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.0 t -44.28 -33.95 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.606 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.05 134.36 13.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.179 1.791 . . . . 0.0 110.78 175.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.2 165.01 34.58 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.75 155.0 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.013 0.824 . . . . 0.0 111.731 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.23 115.58 30.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.005 0.922 . . . . 0.0 110.58 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.16 144.03 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.006 1.322 . . . . 0.0 110.948 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.36 0.77 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.92 0.771 . . . . 0.0 112.789 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.89 103.93 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.817 1.247 . . . . 0.0 110.438 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.32 124.31 27.96 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.699 1.6 . . . . 0.0 113.741 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.43 103.81 9.61 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.328 1.851 . . . . 0.0 113.954 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.25 36.49 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.803 2.041 . . . . 0.0 112.323 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.549 1.54 . . . . 0.0 113.662 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.59 11.63 49.29 Favored Glycine 0 CA--C 1.541 1.687 0 O-C-N 120.983 -1.073 . . . . 0.0 115.182 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.97 162.31 28.33 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.001 1.762 . . . . 0.0 113.051 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -76.57 137.67 39.68 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.601 1.16 . . . . 0.0 112.517 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.419 ' CD1' ' HA ' ' A' ' 92' ' ' MET . 49.0 m0 -107.61 164.32 12.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.91 1.684 . . . . 0.0 111.574 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -131.01 111.75 12.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.767 1.227 . . . . 0.0 109.28 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.64 127.19 30.12 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.71 -68.14 0.41 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 176.99 172.47 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.903 2.481 . . . . 0.0 110.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.26 47.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.638 2.375 . . . . 0.0 109.514 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -123.96 109.93 14.16 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.282 1.033 . . . . 0.0 111.177 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -70.19 112.26 6.42 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 111.347 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -94.15 -32.94 13.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.714 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -142.58 148.99 38.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 109.646 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -175.46 47.76 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.549 1.071 . . . . 0.0 115.141 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.95 144.73 35.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.964 1.306 . . . . 0.0 111.93 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -102.26 167.25 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.944 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.72 -0.76 21.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.482 1.113 . . . . 0.0 112.587 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.91 -178.56 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.873 2.069 . . . . 0.0 112.568 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.38 139.54 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 110.696 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.71 146.33 79.82 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 118.856 0.753 . . . . 0.0 112.957 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.12 150.99 54.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.014 3.809 . . . . 0.0 111.608 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -92.45 -22.21 19.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -123.54 126.85 47.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.575 1.55 . . . . 0.0 110.646 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.14 96.22 12.89 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 109.672 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.0 167.6 21.2 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.848 2.366 . . . . 0.0 113.444 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.87 158.0 8.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.194 -0.941 . . . . 0.0 109.925 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.271 7.3 t 59.45 6.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.154 2.181 . . . . 0.0 114.474 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -127.38 121.47 31.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.82 2.048 . . . . 0.0 110.102 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.4 171.63 8.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.248 1.019 . . . . 0.0 110.15 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.41 171.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.53 130.35 52.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.909 1.284 . . . . 0.0 109.872 174.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.55 171.16 17.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.885 0.85 . . . . 0.0 110.857 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.3 m -156.71 170.44 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.88 1.272 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.27 121.85 2.17 Favored Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.52 156.97 38.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.573 1.687 . . . . 0.0 109.564 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -61.44 179.5 0.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.95 0.5 . . . . 0.0 111.176 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.7 -160.08 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 121.061 -1.024 . . . . 0.0 110.738 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.5 m -30.67 -51.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.429 1.892 . . . . 0.0 115.922 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.54 -60.64 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.769 1.176 . . . . 0.0 113.269 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.82 -7.7 21.74 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.398 3.399 . . . . 0.0 114.957 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 m -74.34 123.55 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.441 1.896 . . . . 0.0 112.443 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.47 71.8 4.37 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.893 -1.13 . . . . 0.0 111.646 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.6 m -119.21 -85.32 0.65 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.419 1.088 . . . . 0.0 111.689 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.16 -178.59 33.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.874 1.226 . . . . 0.0 111.251 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.96 111.43 6.24 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.597 0.759 . . . . 0.0 112.728 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.84 122.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -142.03 150.43 41.28 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.969 0.908 . . . . 0.0 111.111 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.64 143.97 51.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 111.115 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.64 175.17 10.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.522 1.929 . . . . 0.0 111.721 -174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.1 153.18 41.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.109 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -133.8 117.37 16.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.604 1.562 . . . . 0.0 111.03 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -75.19 117.24 16.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 110.3 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.419 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 17.3 mtm -74.25 161.96 29.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 112.156 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 t -60.87 -23.62 65.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.532 1.133 . . . . 0.0 113.519 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 m -78.63 -20.49 50.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 114.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.63 39.69 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.671 1.129 . . . . 0.0 115.777 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -87.42 171.34 10.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.564 1.145 . . . . 0.0 110.666 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.9 m -140.07 136.99 34.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.748 175.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.19 126.99 53.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.538 -0.755 . . . . 0.0 108.984 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.58 128.76 8.71 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.54 140.24 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.593 1.157 . . . . 0.0 110.345 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.6 ptm -144.54 170.11 16.69 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -126.94 156.46 41.47 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.436 1.095 . . . . 0.0 111.142 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.7 t -140.07 123.72 17.25 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.406 1.482 . . . . 0.0 109.754 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.81 91.37 47.4 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 126.895 2.078 . . . . 0.0 107.686 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.24 143.39 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.399 2.733 . . . . 0.0 110.705 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.45 -41.08 85.29 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.103 0.561 . . . . 0.0 111.633 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.43 138.26 36.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 111.042 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.04 -72.01 0.37 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.458 -0.776 . . . . 0.0 111.457 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -1.91 23.88 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.774 1.23 . . . . 0.0 113.639 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -5.84 6.22 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.811 2.044 . . . . 0.0 112.731 -164.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.38 149.47 28.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.822 2.449 . . . . 0.0 109.48 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -111.07 163.73 13.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.661 0.784 . . . . 0.0 110.14 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.96 137.86 32.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.419 1.088 . . . . 0.0 109.234 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -126.81 138.49 53.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.717 1.207 . . . . 0.0 111.571 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -150.02 146.21 26.85 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.28 -1.512 . . . . 0.0 111.335 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.91 154.89 45.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.975 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.38 115.44 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.397 1.479 . . . . 0.0 111.384 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -114.97 117.7 31.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 108.738 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mt -103.24 111.79 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.872 1.669 . . . . 0.0 107.587 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.14 162.83 34.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.475 0.71 . . . . 0.0 112.58 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -80.05 79.94 6.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.662 1.185 . . . . 0.0 112.275 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 -149.45 8.55 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.25 0.929 . . . . 0.0 113.509 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -131.26 84.51 2.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 128.322 2.649 . . . . 0.0 111.665 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.85 77.7 7.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.066 1.347 . . . . 0.0 111.827 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -65.11 164.43 13.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.608 0.763 . . . . 0.0 112.399 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.84 112.71 12.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.857 2.063 . . . . 0.0 110.211 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -111.35 -75.17 0.62 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -152.06 -74.94 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.953 1.701 . . . . 0.0 108.087 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.66 -11.15 62.13 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.072 1.32 . . . . 0.0 115.027 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -63.98 1.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 1.316 . . . . 0.0 107.612 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -16.46 60.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -33.03 61.9 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.849 0.749 . . . . 0.0 110.731 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.24 -28.97 64.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.397 1.079 . . . . 0.0 112.908 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.79 -33.85 22.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.338 1.055 . . . . 0.0 110.003 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -75.83 -45.45 35.76 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.206 -0.934 . . . . 0.0 113.21 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -96.2 -16.9 21.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.877 0.871 . . . . 0.0 113.336 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -70.09 1.06 Allowed Glycine 0 N--CA 1.475 1.242 0 C-N-CA 124.104 0.859 . . . . 0.0 112.556 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 179.99 73.32 0.17 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 128.215 2.606 . . . . 0.0 111.072 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 158.19 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.769 1.646 . . . . 0.0 110.965 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.56 121.64 30.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.45 158.43 35.76 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.328 -0.857 . . . . 0.0 112.163 175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.21 70.79 1.02 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.514 1.531 . . . . 0.0 112.633 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.26 24.48 0.34 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.388 1.875 . . . . 0.0 113.853 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.2 p30 48.19 35.3 5.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.923 2.089 . . . . 0.0 114.901 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.96 156.46 23.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.057 1.313 . . . . 0.0 113.049 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -65.19 126.75 29.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.203 1.001 . . . . 0.0 110.538 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.57 105.58 9.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.804 1.642 . . . . 0.0 108.919 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.09 140.5 36.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.609 1.563 . . . . 0.0 111.419 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -160.7 137.82 9.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.006 . . . . 0.0 111.391 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -57.71 107.17 0.42 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.789 1.235 . . . . 0.0 112.309 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 tp -128.67 -30.23 2.32 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.046 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.93 22.16 7.08 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.656 1.122 . . . . 0.0 114.092 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.37 13.19 3.87 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.297 2.239 . . . . 0.0 115.091 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.38 -57.59 0.11 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.126 1.822 . . . . 0.0 111.65 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.2 mp -91.3 148.49 22.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.726 0.774 . . . . 0.0 110.606 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 169.5 17.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.512 1.525 . . . . 0.0 111.731 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 144.66 29.52 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.757 1.223 . . . . 0.0 110.37 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.88 102.06 6.61 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.742 2.017 . . . . 0.0 108.464 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.29 167.55 21.86 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.0 0.778 . . . . 0.0 112.93 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.1 tt -151.81 139.36 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.548 1.939 . . . . 0.0 108.527 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.7 ttm -142.29 139.63 31.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 78.2 p -88.14 169.68 11.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 110.977 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -87.15 11.36 14.15 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.098 -1.001 . . . . 0.0 113.615 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.92 170.44 10.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.147 2.179 . . . . 0.0 113.226 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.6 -73.6 0.72 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.937 1.256 . . . . 0.0 111.525 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.72 38.66 0.05 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.984 2.113 . . . . 0.0 114.808 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 176.13 4.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 0.0 113.301 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -129.8 145.53 51.57 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.008 1.323 . . . . 0.0 110.403 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.3 ttm -136.95 88.89 2.4 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.424 1.89 . . . . 0.0 110.672 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -83.42 157.46 22.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 111.044 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.91 116.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.101 1.76 . . . . 0.0 107.572 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.39 109.52 20.85 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.922 1.689 . . . . 0.0 108.4 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.24 147.16 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -127.93 170.99 12.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.214 1.805 . . . . 0.0 111.239 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.534 1.934 . . . . 0.0 113.381 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 tp -92.85 -103.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 48.2 169.79 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.916 2.086 . . . . 0.0 113.847 -166.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.2 40.27 91.4 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 p -141.0 -170.94 3.15 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.561 1.144 . . . . 0.0 111.869 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.9 141.1 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.661 1.984 . . . . 0.0 111.024 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -142.09 167.05 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.232 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.53 124.27 18.41 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.751 1.22 . . . . 0.0 112.033 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.67 -24.19 39.17 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.558 1.552 . . . . 0.0 114.055 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.95 70.31 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.474 1.11 . . . . 0.0 111.898 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.61 -19.9 44.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.714 1.605 . . . . 0.0 113.237 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.3 tp -66.97 105.99 1.8 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.241 1.416 . . . . 0.0 111.206 174.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 m -144.36 167.87 21.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.249 1.42 . . . . 0.0 109.676 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -46.81 -33.65 4.63 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.623 1.569 . . . . 0.0 113.251 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -58.91 -53.73 55.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.192 0.997 . . . . 0.0 111.128 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -40.5 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.945 0.898 . . . . 0.0 111.894 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 mt -59.65 -54.01 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.176 0.991 . . . . 0.0 111.759 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.55 -38.73 92.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -57.91 -48.45 79.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.256 1.022 . . . . 0.0 112.156 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -55.91 -47.58 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.367 1.067 . . . . 0.0 111.253 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.3 -42.47 95.58 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.45 1.1 . . . . 0.0 113.608 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.25 -47.77 84.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.768 0.427 . . . . 0.0 111.529 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.17 -39.18 72.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 tp -52.81 -57.27 10.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.91 2.084 . . . . 0.0 111.387 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.56 51.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.661 1.124 . . . . 0.0 112.896 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -37.65 127.69 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.514 1.926 . . . . 0.0 113.639 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.83 -169.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.102 1.761 . . . . 0.0 110.623 -175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.1 m -43.63 -32.11 0.9 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.675 1.99 . . . . 0.0 115.06 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -141.69 145.91 35.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.422 1.889 . . . . 0.0 107.604 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -165.22 147.64 7.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.822 1.249 . . . . 0.0 110.432 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 pt -141.52 144.42 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.562 0.619 . . . . 0.0 111.16 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.2 116.27 30.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.243 1.017 . . . . 0.0 110.772 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 t -107.45 138.68 32.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 110.3 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.84 114.81 0.67 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.419 1.009 . . . . 0.0 112.196 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.73 104.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.436 1.094 . . . . 0.0 109.622 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -82.77 107.49 15.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.916 1.286 . . . . 0.0 112.258 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -84.12 71.38 10.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.984 1.314 . . . . 0.0 114.225 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.23 21.45 0.18 Allowed 'General case' 0 CA--C 1.558 1.286 0 O-C-N 119.778 -1.826 . . . . 0.0 115.118 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 p -57.85 -48.47 79.71 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.0 -17.36 6.0 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.565 2.031 . . . . 0.0 116.107 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.2 -104.04 1.89 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.931 1.866 . . . . 0.0 116.282 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.0 t -162.58 135.95 6.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.875 1.67 . . . . 0.0 111.671 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -115.04 167.43 10.82 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.793 1.637 . . . . 0.0 111.276 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.9 m -141.36 111.35 6.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.158 0.983 . . . . 0.0 110.292 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.33 133.8 55.6 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.895 -1.128 . . . . 0.0 108.429 174.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -70.88 -69.26 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -172.41 171.29 4.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 110.453 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -123.59 142.46 51.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.816 2.046 . . . . 0.0 109.301 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.55 121.0 18.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.532 1.133 . . . . 0.0 111.43 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -74.5 128.25 35.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.829 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -45.12 6.24 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.929 1.692 . . . . 0.0 111.66 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -141.58 153.97 45.15 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.186 1.794 . . . . 0.0 110.324 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.88 -170.05 53.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 121.493 0.496 . . . . 0.0 113.054 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 t -140.86 164.04 31.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 110.651 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.6 p -149.71 178.98 8.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.774 1.23 . . . . 0.0 111.18 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 25.99 4.12 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.456 1.102 . . . . 0.0 112.446 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.33 172.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.71 2.004 . . . . 0.0 113.535 -174.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 mt -137.02 151.59 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.246 2.219 . . . . 0.0 109.199 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.14 141.16 22.22 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 120.212 1.369 . . . . 0.0 110.935 176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.05 160.45 47.24 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.94 3.094 . . . . 0.0 111.028 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -104.22 -46.23 4.48 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.328 -0.857 . . . . 0.0 112.073 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.59 132.38 46.01 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.082 1.31 . . . . 0.0 111.938 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.91 92.15 11.25 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.868 1.667 . . . . 0.0 110.2 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.31 160.66 37.83 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.118 1.879 . . . . 0.0 112.042 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -58.14 159.9 5.45 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.124 -0.985 . . . . 0.0 110.706 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p 68.67 8.7 6.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.583 1.953 . . . . 0.0 113.543 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -136.66 110.12 7.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.368 1.867 . . . . 0.0 111.99 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.1 164.75 19.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.606 0.762 . . . . 0.0 112.164 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 173.54 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.214 0.606 . . . . 0.0 110.947 174.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -129.7 127.66 40.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.478 1.911 . . . . 0.0 107.82 175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.49 154.98 41.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.882 0.873 . . . . 0.0 110.65 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -148.52 162.93 38.65 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 111.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.76 138.71 6.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.308 0.956 . . . . 0.0 111.953 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 167.57 19.91 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.823 0.849 . . . . 0.0 110.293 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -65.29 -179.62 0.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.044 0.538 . . . . 0.0 110.467 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.85 -179.95 0.23 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.63 -0.669 . . . . 0.0 110.642 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.4 m -24.65 -54.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 128.053 2.541 . . . . 0.0 116.166 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.79 -58.98 0.32 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.404 1.478 . . . . 0.0 112.797 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.91 0.09 7.66 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.779 3.653 . . . . 0.0 115.736 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.06 104.5 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.242 2.217 . . . . 0.0 112.008 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.94 77.87 1.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.632 1.573 . . . . 0.0 112.927 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.8 m -110.74 -82.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.004 1.321 . . . . 0.0 111.304 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 161.95 179.42 36.6 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.099 1.333 . . . . 0.0 111.886 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.82 114.88 10.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 110.026 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.48 130.35 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.21 167.84 25.73 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.731 0.777 . . . . 0.0 110.743 174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.46 154.72 36.09 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.017 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.39 169.39 21.53 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.038 1.735 . . . . 0.0 110.838 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.15 140.53 47.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.697 1.199 . . . . 0.0 110.964 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -123.67 112.56 17.53 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.032 1.333 . . . . 0.0 111.763 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -76.66 115.68 16.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 110.738 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.5 mtm -78.98 162.68 25.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.95 0.9 . . . . 0.0 112.284 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -60.23 -19.84 56.27 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -79.71 -11.37 59.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.405 1.482 . . . . 0.0 113.007 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.27 2.49 65.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.887 1.232 . . . . 0.0 114.435 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.71 169.99 11.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.778 1.231 . . . . 0.0 110.608 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.5 m -135.98 154.69 51.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.441 1.096 . . . . 0.0 110.19 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 127.95 48.34 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.267 1.027 . . . . 0.0 109.726 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.22 114.47 4.13 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.24 126.07 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.233 1.013 . . . . 0.0 108.716 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -140.8 164.32 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.73 0.776 . . . . 0.0 112.285 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -140.63 151.4 44.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.767 175.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -130.5 116.31 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.948 1.699 . . . . 0.0 110.066 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.67 99.19 47.63 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.834 1.654 . . . . 0.0 108.77 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.76 169.08 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.31 2.674 . . . . 0.0 112.432 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -76.51 -18.61 58.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.452 0.701 . . . . 0.0 112.783 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.23 109.5 18.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.685 1.594 . . . . 0.0 110.81 -167.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -64.98 -65.41 0.68 Allowed 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.276 -0.89 . . . . 0.0 113.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -86.57 9.3 18.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.66 -6.15 6.92 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.715 2.006 . . . . 0.0 112.661 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 139.06 14.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.728 2.011 . . . . 0.0 110.141 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 t -95.94 164.51 12.69 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.625 -1.297 . . . . 0.0 112.375 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.63 159.02 25.48 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.604 0.762 . . . . 0.0 109.092 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -141.27 141.18 33.98 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.27 -0.894 . . . . 0.0 111.531 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.2 p-90 -156.14 148.62 23.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.247 1.419 . . . . 0.0 110.502 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -145.3 155.21 43.07 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.309 1.843 . . . . 0.0 109.39 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.14 116.35 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.38 1.872 . . . . 0.0 109.414 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -120.41 137.33 54.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.488 1.915 . . . . 0.0 109.298 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.7 mt -102.41 120.19 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.971 1.708 . . . . 0.0 108.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.93 147.9 51.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.493 1.517 . . . . 0.0 112.062 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 p -77.02 78.98 3.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.41 1.084 . . . . 0.0 112.574 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.28 158.48 8.47 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.076 0.846 . . . . 0.0 114.883 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 121.87 16.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.522 1.529 . . . . 0.0 112.793 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -136.63 85.54 2.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.143 1.777 . . . . 0.0 109.289 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -60.21 170.97 1.12 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.007 0.923 . . . . 0.0 111.407 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.26 92.79 4.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.627 0.771 . . . . 0.0 111.067 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -98.39 -68.75 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.548 0.739 . . . . 0.0 110.404 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.28 -70.08 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.557 1.143 . . . . 0.0 110.408 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.12 -25.05 76.38 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.059 0.838 . . . . 0.0 114.661 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -48.08 27.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.261 1.024 . . . . 0.0 110.48 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -37.34 81.79 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.099 0.959 . . . . 0.0 110.927 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -54.75 -33.35 61.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.15 -33.35 73.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.434 1.016 . . . . 0.0 112.706 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.49 -41.19 61.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.024 0.829 . . . . 0.0 110.313 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -65.36 -59.31 4.17 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.756 -1.215 . . . . 0.0 111.741 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -79.44 -19.55 49.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.189 1.396 . . . . 0.0 112.698 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -76.66 0.22 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.365 0.983 . . . . 0.0 112.598 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.37 84.15 1.59 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.67 1.188 . . . . 0.0 110.433 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.49 157.21 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.539 1.493 . . . . 0.0 111.262 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.71 4.98 49.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.684 1.194 . . . . 0.0 113.412 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.25 66.81 0.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 128.194 2.597 . . . . 0.0 113.438 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -33.48 90.77 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.398 2.904 . . . . 0.0 114.869 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -110.07 43.89 1.3 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.957 1.703 . . . . 0.0 110.349 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 58.18 42.57 21.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.548 1.539 . . . . 0.0 112.84 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.84 146.99 18.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 112.813 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -68.58 131.15 44.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.091 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -127.68 108.08 10.45 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.885 1.674 . . . . 0.0 109.293 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.31 153.09 35.49 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.285 1.434 . . . . 0.0 111.947 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -167.86 146.02 4.52 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.318 1.447 . . . . 0.0 111.004 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.67 125.5 25.99 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.443 0.565 . . . . 0.0 109.806 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.2 tp -141.01 -36.19 0.46 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.35 1.06 . . . . 0.0 112.834 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.72 20.02 5.68 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.685 1.136 . . . . 0.0 114.486 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.5 12.35 2.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.311 2.245 . . . . 0.0 115.286 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.91 -67.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.379 1.942 . . . . 0.0 110.605 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.06 147.78 27.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.925 0.89 . . . . 0.0 110.604 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.83 168.1 24.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.376 1.47 . . . . 0.0 111.924 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -96.15 139.14 32.75 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.717 0.807 . . . . 0.0 111.655 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -128.67 108.33 10.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.72 1.608 . . . . 0.0 108.427 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.46 167.67 25.74 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 121.951 0.75 . . . . 0.0 114.154 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.3 tt -149.09 142.94 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.847 2.059 . . . . 0.0 108.823 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.2 ttm -134.82 137.36 43.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.427 1.091 . . . . 0.0 108.801 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.53 156.19 33.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.6 1.16 . . . . 0.0 111.7 175.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.93 9.15 31.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.42 177.67 4.8 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.132 2.173 . . . . 0.0 112.293 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.16 55.68 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.835 0.731 . . . . 0.0 113.053 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -86.5 51.45 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.476 1.51 . . . . 0.0 113.694 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.95 17.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.777 1.231 . . . . 0.0 113.828 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.69 53.77 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 0.0 112.432 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.42 90.29 3.27 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.392 2.277 . . . . 0.0 110.954 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -84.55 143.14 29.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.86 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.42 122.49 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.458 1.903 . . . . 0.0 107.506 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -118.71 111.01 17.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.879 1.272 . . . . 0.0 109.759 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.3 mm -83.13 117.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.183 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m -89.29 174.8 7.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 0.0 111.75 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.313 1.845 . . . . 0.0 113.196 -177.417 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 68.17 19.63 9.11 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.22 168.08 0.57 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.36 36.11 63.28 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.563 -0.711 . . . . 0.0 113.825 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -150.82 -169.19 3.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.121 0.968 . . . . 0.0 111.152 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.71 137.63 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.538 1.935 . . . . 0.0 111.861 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pp -145.5 165.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.223 1.809 . . . . 0.0 111.472 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.22 126.7 19.64 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.155 0.982 . . . . 0.0 112.803 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.15 -21.09 30.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.087 1.327 . . . . 0.0 114.047 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.02 72.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.465 1.506 . . . . 0.0 112.324 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -34.71 66.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.386 1.074 . . . . 0.0 112.113 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.63 100.02 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.784 1.634 . . . . 0.0 112.25 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -143.08 172.01 13.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.629 1.572 . . . . 0.0 110.463 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -49.41 -39.74 33.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.594 1.558 . . . . 0.0 113.697 178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.66 -41.97 91.77 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.598 -0.689 . . . . 0.0 112.521 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.38 -46.81 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.626 0.77 . . . . 0.0 110.044 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -53.35 -60.18 3.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.596 0.759 . . . . 0.0 111.036 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.45 -43.28 67.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.071 0.948 . . . . 0.0 112.371 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -59.43 -29.17 67.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.686 1.195 . . . . 0.0 113.533 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.3 -48.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.226 -1.546 . . . . 0.0 110.009 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.3 -34.81 66.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.959 0.504 . . . . 0.0 111.526 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.1 -57.69 6.31 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.86 -40.38 47.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.853 1.206 . . . . 0.0 114.06 -172.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.43 -23.38 66.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.346 1.058 . . . . 0.0 111.532 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 68.2 1.44 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.368 1.461 . . . . 0.0 111.214 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.35 127.83 4.67 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 110.774 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 -161.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.118 2.167 . . . . 0.0 110.049 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -41.21 -49.3 3.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.12 1.368 . . . . 0.0 113.508 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -146.31 137.16 24.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.333 1.453 . . . . 0.0 111.377 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -157.6 171.15 20.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.511 1.524 . . . . 0.0 113.952 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.83 163.21 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.456 1.102 . . . . 0.0 112.122 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.68 111.91 17.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.302 1.441 . . . . 0.0 110.471 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -97.11 145.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.649 1.58 . . . . 0.0 111.904 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.53 122.38 1.14 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.022 1.296 . . . . 0.0 111.33 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.78 112.74 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.185 1.492 . . . . 0.0 110.226 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.0 134.97 35.02 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.35 79.22 7.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.056 1.742 . . . . 0.0 113.243 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.86 2.6 53.79 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.3 t -65.55 -17.52 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.521 2.328 . . . . 0.0 114.72 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.71 4.3 89.32 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 114.74 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.58 161.31 23.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.551 1.548 . . . . 0.0 114.026 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 t -78.25 134.86 37.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.491 1.516 . . . . 0.0 112.037 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -112.12 168.08 9.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.864 2.066 . . . . 0.0 111.469 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -136.93 108.06 6.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 110.737 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.54 117.76 6.65 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.873 -1.142 . . . . 0.0 108.539 175.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.49 -64.46 0.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.774 0.829 . . . . 0.0 109.88 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -177.98 171.05 1.8 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.517 2.327 . . . . 0.0 110.874 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.72 138.82 54.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 109.096 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -128.43 110.22 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.234 1.414 . . . . 0.0 111.133 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -72.5 121.32 19.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.724 1.209 . . . . 0.0 111.477 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.77 -33.6 14.93 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.446 1.498 . . . . 0.0 112.926 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 t -145.04 162.32 37.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.598 1.559 . . . . 0.0 111.115 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.9 -160.68 29.68 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.727 0.651 . . . . 0.0 114.727 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -144.83 -178.73 6.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.444 1.498 . . . . 0.0 111.972 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -147.25 166.19 27.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.846 1.658 . . . . 0.0 110.617 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.64 6.97 20.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.591 1.156 . . . . 0.0 111.608 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.72 153.41 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 128.305 2.642 . . . . 0.0 111.038 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -122.04 140.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.502 1.521 . . . . 0.0 108.764 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.31 140.1 75.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.369 -0.832 . . . . 0.0 109.618 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.5 176.64 3.26 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.459 3.439 . . . . 0.0 110.956 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -119.19 -21.89 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.656 -1.278 . . . . 0.0 113.036 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -128.83 137.28 51.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.414 1.886 . . . . 0.0 109.792 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.413 HG23 ' HH ' ' A' ' 90' ' ' TYR . 27.1 t -139.86 96.91 8.18 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.843 1.257 . . . . 0.0 109.715 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.88 168.57 18.36 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 112.557 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.27 159.83 5.69 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.578 -0.701 . . . . 0.0 110.148 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.273 5.6 t 57.66 15.62 2.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.638 1.975 . . . . 0.0 113.792 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -133.09 120.12 20.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.927 2.491 . . . . 0.0 110.371 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.87 163.54 13.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.674 1.19 . . . . 0.0 110.45 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.96 169.0 9.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.19 132.93 46.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.871 2.068 . . . . 0.0 108.893 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -153.13 164.04 38.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.799 1.24 . . . . 0.0 110.44 175.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 m -145.31 175.29 10.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.462 1.105 . . . . 0.0 111.207 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.472 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.58 103.66 0.24 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 125.176 1.37 . . . . 0.0 110.742 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 176.98 4.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.428 1.114 . . . . 0.0 111.572 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' HZ1' ' HA ' ' A' ' 106' ' ' PHE . 16.7 mmtt -66.59 -176.98 0.52 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.44 -177.02 0.27 Allowed 'General case' 0 CA--C 1.559 1.298 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -10.33 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 127.944 2.497 . . . . 0.0 116.521 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.43 -72.07 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.212 0.91 . . . . 0.0 113.038 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.99 84.07 1.72 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.757 3.638 . . . . 0.0 112.368 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.08 140.8 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.151 1.381 . . . . 0.0 112.256 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 64.59 0.84 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.015 1.326 . . . . 0.0 111.635 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.8 t -122.53 -97.22 0.45 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 110.855 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -174.74 -177.46 43.87 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.967 2.698 . . . . 0.0 110.883 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.29 99.46 3.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.111 1.364 . . . . 0.0 108.742 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 131.12 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.107 . . . . 0.0 108.584 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.1 166.9 31.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.57 0.748 . . . . 0.0 111.22 175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.05 158.14 43.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.711 0.767 . . . . 0.0 112.42 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.46 171.18 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.648 1.979 . . . . 0.0 110.478 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.51 142.37 43.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.155 0.982 . . . . 0.0 111.174 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.413 ' HH ' HG23 ' A' ' 63' ' ' VAL . 1.1 m-85 -125.84 111.73 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.047 1.339 . . . . 0.0 111.33 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -73.61 114.35 11.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.004 1.321 . . . . 0.0 110.805 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.1 mtt -76.6 160.7 29.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.435 0.636 . . . . 0.0 111.364 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 t -61.66 -17.76 56.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.0 m -79.51 -13.33 59.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.014 1.726 . . . . 0.0 113.548 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.21 55.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.605 1.098 . . . . 0.0 114.835 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.88 173.43 11.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.242 1.017 . . . . 0.0 111.687 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 m -133.77 142.94 48.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.94 0.896 . . . . 0.0 108.587 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.92 125.72 54.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 108.932 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.62 148.46 24.95 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.8 130.55 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.312 1.045 . . . . 0.0 109.255 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.65 45.88 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' CZ ' ' HA3' ' A' ' 73' ' ' GLY . 22.8 p90 -127.01 153.27 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.147 1.379 . . . . 0.0 110.696 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.9 t -136.9 111.45 8.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.497 1.119 . . . . 0.0 111.49 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 32.1 t -115.02 102.18 54.75 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.51 1.924 . . . . 0.0 109.344 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.01 171.25 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.841 2.361 . . . . 0.0 112.542 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.459 ' HA ' ' HZ1' ' A' ' 75' ' ' LYS . 42.6 t80 -72.39 -53.83 11.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.326 . . . . 0.0 110.632 174.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.01 107.48 7.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.227 3.411 . . . . 0.0 112.398 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.19 -60.16 3.79 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.274 1.03 . . . . 0.0 113.539 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.59 9.45 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -4.15 6.85 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.566 1.947 . . . . 0.0 112.456 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.2 146.04 26.61 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.395 2.278 . . . . 0.0 109.496 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.92 165.31 11.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.365 1.066 . . . . 0.0 111.869 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.44 156.93 18.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.666 -0.646 . . . . 0.0 110.112 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -140.5 146.14 37.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.35 0.66 . . . . 0.0 109.92 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -147.97 155.6 41.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.991 1.316 . . . . 0.0 110.021 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.56 138.23 20.93 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.846 -0.534 . . . . 0.0 111.62 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.7 t -147.74 103.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.334 1.854 . . . . 0.0 110.102 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -120.6 143.37 48.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.036 1.335 . . . . 0.0 110.065 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.51 111.6 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.249 1.819 . . . . 0.0 108.756 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -116.33 141.47 48.11 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.711 1.604 . . . . 0.0 111.853 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.7 p -72.48 80.55 1.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.288 1.435 . . . . 0.0 113.104 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.06 159.56 8.64 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.221 1.391 . . . . 0.0 113.321 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -73.79 133.94 43.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.466 0.707 . . . . 0.0 112.383 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -141.9 143.15 33.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.515 1.926 . . . . 0.0 111.215 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -99.32 -179.35 4.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.662 1.585 . . . . 0.0 110.942 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.9 95.9 4.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.206 1.803 . . . . 0.0 110.177 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.79 -71.08 0.78 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.903 1.281 . . . . 0.0 110.559 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.48 -69.79 0.24 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.323 1.849 . . . . 0.0 109.637 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.54 73.27 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.638 1.113 . . . . 0.0 115.241 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -84.2 -45.82 12.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.182 0.991 . . . . 0.0 110.872 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.15 -44.01 96.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.995 0.918 . . . . 0.0 112.393 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.77 -29.23 69.29 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.025 -1.047 . . . . 0.0 112.441 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -16.06 60.42 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.192 -0.943 . . . . 0.0 112.499 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.66 -55.58 2.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 108.44 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -69.03 -48.14 63.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -87.62 -15.21 37.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.746 0.819 . . . . 0.0 112.743 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.78 60.18 4.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.575 1.083 . . . . 0.0 114.208 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 42.75 76.97 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 127.046 2.138 . . . . 0.0 111.754 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.64 149.04 73.37 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.783 1.655 . . . . 0.0 110.827 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.89 156.7 36.12 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.951 0.881 . . . . 0.0 110.489 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 115.42 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 109.207 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.61 67.01 0.78 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.323 1.439 . . . . 0.0 113.511 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.75 25.36 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.786 2.034 . . . . 0.0 114.386 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 54.72 41.71 31.73 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.994 1.717 . . . . 0.0 113.063 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.4 167.51 24.15 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.656 2.074 . . . . 0.0 112.232 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -75.34 128.56 35.68 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.593 -0.945 . . . . 0.0 111.592 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -120.1 112.86 19.65 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' HG2' HH21 ' A' ' 156' ' ' ARG . 1.3 pm0 -153.88 148.59 26.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 111.507 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -161.88 147.08 13.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.038 1.335 . . . . 0.0 111.4 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -62.97 123.05 17.54 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.926 -0.484 . . . . 0.0 110.972 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -142.84 -31.6 0.5 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.263 1.025 . . . . 0.0 113.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.85 17.26 16.82 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.963 1.268 . . . . 0.0 114.541 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.2 t80 59.87 10.31 2.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.416 2.287 . . . . 0.0 114.697 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.9 -67.32 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.647 1.594 . . . . 0.0 110.606 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.35 156.54 16.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.577 0.703 . . . . 0.0 111.626 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.468 HH21 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -143.94 165.88 26.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.067 1.747 . . . . 0.0 112.719 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -92.44 133.59 35.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.85 1.26 . . . . 0.0 110.143 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -123.11 106.79 11.09 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.718 1.207 . . . . 0.0 109.339 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-O 122.38 0.989 . . . . 0.0 114.65 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.64 145.29 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.974 2.11 . . . . 0.0 108.186 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.8 131.3 33.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.234 1.814 . . . . 0.0 106.687 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 166.83 19.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.108 0.963 . . . . 0.0 112.079 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 m -95.13 11.6 31.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.661 1.584 . . . . 0.0 113.793 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.13 167.95 10.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 112.368 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.05 26.4 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 121.348 -0.845 . . . . 0.0 112.992 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.16 47.51 0.46 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.503 1.521 . . . . 0.0 113.715 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.46 161.39 27.82 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.716 -1.24 . . . . 0.0 113.44 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.08 133.99 55.47 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 108.913 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.1 ttp -128.53 110.46 12.3 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.494 1.518 . . . . 0.0 111.081 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -122.65 140.98 52.23 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.626 -0.671 . . . . 0.0 109.654 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.7 111.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.754 1.622 . . . . 0.0 109.729 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -100.44 105.37 16.84 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.409 1.484 . . . . 0.0 108.368 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.6 mm -74.06 136.23 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.0 t -151.09 167.18 28.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.956 . . . . 0.0 112.108 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.263 2.225 . . . . 0.0 110.344 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.66 2.92 18.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.654 1.182 . . . . 0.0 113.424 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.21 150.33 39.22 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.111 -0.993 . . . . 0.0 111.381 174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.94 34.18 87.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 p -142.52 -165.08 1.96 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.596 1.198 . . . . 0.0 111.539 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.36 144.1 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.891 1.676 . . . . 0.0 110.991 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.0 168.88 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.079 1.352 . . . . 0.0 112.18 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 120.67 7.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.105 1.362 . . . . 0.0 111.555 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.14 -25.36 64.37 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.156 0.884 . . . . 0.0 113.11 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.05 68.62 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.174 1.389 . . . . 0.0 113.078 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -96.29 -16.41 21.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.147 1.379 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tp -68.64 107.22 2.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.15 1.38 . . . . 0.0 110.233 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -145.5 169.92 17.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.275 1.03 . . . . 0.0 109.883 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -50.85 -31.53 17.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.878 1.271 . . . . 0.0 113.703 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -61.74 -36.24 80.43 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.358 0.663 . . . . 0.0 112.567 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -39.97 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.782 1.233 . . . . 0.0 111.104 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.28 -47.84 77.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.031 0.932 . . . . 0.0 112.03 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.02 -49.32 76.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.061 0.544 . . . . 0.0 111.69 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -58.53 -36.79 74.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 t -63.79 -59.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.211 1.404 . . . . 0.0 111.237 175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.43 -38.09 73.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.815 1.246 . . . . 0.0 112.141 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -41.33 67.52 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.008 0.822 . . . . 0.0 111.953 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.68 -37.07 65.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -48.39 -52.77 20.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.496 1.518 . . . . 0.0 111.638 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.15 58.67 0.15 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.699 1.143 . . . . 0.0 111.002 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 142.33 6.06 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.253 1.421 . . . . 0.0 112.444 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.78 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 109.711 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.3 m -45.0 -31.23 1.22 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.311 1.844 . . . . 0.0 115.525 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.93 134.89 17.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.487 1.515 . . . . 0.0 109.222 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.43 161.04 30.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.371 2.268 . . . . 0.0 110.628 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -139.21 166.22 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.732 1.613 . . . . 0.0 110.326 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.54 110.55 14.6 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.751 1.22 . . . . 0.0 110.866 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.91 138.6 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.8 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 112.18 0.54 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.535 1.064 . . . . 0.0 112.911 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.2 109.87 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.456 1.128 . . . . 0.0 109.214 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -87.81 110.76 20.73 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 112.41 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -71.45 98.1 1.76 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.271 1.428 . . . . 0.0 111.31 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.93 12.75 15.82 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.942 1.697 . . . . 0.0 113.34 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 t -62.68 -54.51 38.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.559 1.144 . . . . 0.0 114.001 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.3 2.36 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.949 1.261 . . . . 0.0 116.166 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.48 163.36 29.9 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.625 1.712 . . . . 0.0 114.03 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.4 p -74.09 138.85 44.22 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.108 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -112.76 167.73 10.25 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.304 1.442 . . . . 0.0 112.236 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -140.14 106.25 5.22 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.016 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.89 125.55 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.88 -1.138 . . . . 0.0 108.667 175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.56 -62.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.636 1.174 . . . . 0.0 110.384 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -176.87 174.9 1.7 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.825 2.45 . . . . 0.0 110.644 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.8 146.6 50.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.223 2.209 . . . . 0.0 109.492 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.15 113.33 13.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.146 1.378 . . . . 0.0 111.406 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -73.49 122.92 22.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.78 1.232 . . . . 0.0 110.188 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.95 -38.6 7.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.825 1.65 . . . . 0.0 112.633 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 m -136.92 152.14 49.86 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.653 1.581 . . . . 0.0 109.929 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.13 50.05 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 123.925 0.774 . . . . 0.0 114.88 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -135.81 145.65 46.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 111.54 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -133.26 125.52 29.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.348 1.059 . . . . 0.0 108.747 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.4 -1.04 31.54 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.327 1.051 . . . . 0.0 112.943 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.4 m -110.89 174.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.812 1.645 . . . . 0.0 113.045 178.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.11 139.88 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.917 1.687 . . . . 0.0 108.801 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 146.01 86.63 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-N 119.578 1.081 . . . . 0.0 110.86 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.35 167.17 25.99 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.575 3.516 . . . . 0.0 111.277 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -107.64 -24.27 11.81 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.416 -1.427 . . . . 0.0 113.487 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -125.81 133.3 52.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.433 1.493 . . . . 0.0 111.061 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 HG22 ' HH ' ' A' ' 90' ' ' TYR . 25.8 t -133.84 94.63 18.43 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.589 1.556 . . . . 0.0 109.891 178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.26 161.36 34.52 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.595 1.53 . . . . 0.0 111.868 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -63.31 160.12 16.58 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.726 -0.609 . . . . 0.0 110.724 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 68.0 -0.85 1.92 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.045 2.138 . . . . 0.0 114.418 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.284 1.833 . . . . 0.0 111.738 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.5 160.79 31.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.971 1.308 . . . . 0.0 111.68 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.85 174.94 6.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 174.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.4 133.0 41.84 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.464 1.906 . . . . 0.0 108.394 174.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -153.99 164.19 38.84 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.112 0.965 . . . . 0.0 112.589 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -150.48 164.25 36.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.914 1.286 . . . . 0.0 111.014 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.97 118.1 1.08 Allowed Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.275 1.417 . . . . 0.0 111.067 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -129.33 161.56 29.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.714 1.257 . . . . 0.0 110.696 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -174.25 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.859 0.464 . . . . 0.0 110.102 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.96 -143.02 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 O-C-N 121.277 -0.89 . . . . 0.0 113.015 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -40.89 -38.33 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 119.044 -2.285 . . . . 0.0 114.796 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.26 -60.94 0.47 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.566 1.555 . . . . 0.0 112.774 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.22 -3.68 11.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.99 3.794 . . . . 0.0 116.156 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.8 160.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.438 1.095 . . . . 0.0 111.717 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.87 66.43 1.03 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.244 1.017 . . . . 0.0 111.24 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.6 m -126.72 -85.32 0.61 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.83 1.252 . . . . 0.0 112.049 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.59 -177.21 32.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.116 1.341 . . . . 0.0 112.33 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.05 125.58 26.77 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.76 121.24 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.44 152.59 49.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.441 0.696 . . . . 0.0 110.737 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.7 47.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.82 0.848 . . . . 0.0 111.469 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 171.06 15.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.508 1.523 . . . . 0.0 110.307 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.52 138.09 50.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.159 0.983 . . . . 0.0 110.203 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.405 ' HH ' HG22 ' A' ' 63' ' ' VAL . 1.3 m-85 -119.31 118.61 31.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.709 1.204 . . . . 0.0 111.081 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -83.12 113.36 20.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.162 1.385 . . . . 0.0 110.787 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.5 mtt -70.15 162.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.057 0.943 . . . . 0.0 111.315 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.9 p -61.27 -22.63 65.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 114.102 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t -82.98 -14.57 53.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.46 1.904 . . . . 0.0 113.007 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.14 56.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.284 1.421 . . . . 0.0 115.069 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -80.18 164.34 23.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.618 1.167 . . . . 0.0 109.518 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.0 m -122.95 143.24 50.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.817 0.847 . . . . 0.0 110.193 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.55 115.7 23.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 128.34 8.43 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 m -130.63 128.93 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.679 0.792 . . . . 0.0 109.539 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.11 154.8 49.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 175.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -134.05 153.9 51.5 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.701 1.201 . . . . 0.0 110.639 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.2 t -137.31 114.55 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.078 2.151 . . . . 0.0 108.931 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.76 95.2 27.16 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 128.683 2.793 . . . . 0.0 106.95 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.97 -168.66 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.509 2.14 . . . . 0.0 111.454 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -108.69 -43.46 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.995 0.918 . . . . 0.0 112.154 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.68 127.19 32.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.105 1.762 . . . . 0.0 112.36 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -58.22 3.44 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -100.25 11.55 39.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.255 1.422 . . . . 0.0 113.917 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.23 0.87 7.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.108 2.163 . . . . 0.0 111.917 -175.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.43 178.36 10.24 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.753 2.421 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 t -154.8 164.78 38.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.223 1.409 . . . . 0.0 110.932 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 112.72 24.77 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.01 -1.056 . . . . 0.0 111.181 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.58 136.32 38.85 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -142.92 145.23 32.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.658 1.183 . . . . 0.0 111.214 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -137.0 139.37 41.37 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.391 1.077 . . . . 0.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.8 t -136.06 110.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.121 1.768 . . . . 0.0 109.981 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -126.84 133.51 50.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.763 1.625 . . . . 0.0 110.189 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 mt -97.83 129.79 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.756 1.622 . . . . 0.0 108.592 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -133.63 144.18 49.07 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.822 . . . . 0.0 112.902 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 p -75.02 92.21 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.167 1.787 . . . . 0.0 113.102 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.7 -179.15 21.32 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.314 1.435 . . . . 0.0 112.483 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 145.21 25.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.626 1.17 . . . . 0.0 111.713 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -163.48 164.57 24.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.778 1.631 . . . . 0.0 111.002 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -140.55 156.16 46.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.243 1.417 . . . . 0.0 110.862 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 92.26 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.655 0.782 . . . . 0.0 111.019 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.67 -72.05 0.71 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.145 1.378 . . . . 0.0 110.583 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 -71.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 108.091 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.43 -42.93 57.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.379 0.99 . . . . 0.0 113.999 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.4 tpt -74.22 -50.08 20.67 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.498 1.149 . . . . 0.0 112.628 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -48.22 80.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.906 0.483 . . . . 0.0 110.061 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.16 -33.6 76.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.77 -28.68 70.15 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.508 1.504 . . . . 0.0 112.051 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.79 -40.21 12.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.562 0.745 . . . . 0.0 111.453 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -78.49 -42.32 29.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.427 -1.421 . . . . 0.0 114.104 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -96.29 -12.97 23.71 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.043 -1.036 . . . . 0.0 112.798 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.51 -77.22 0.16 Allowed Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.577 1.084 . . . . 0.0 112.083 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -175.06 69.05 0.27 Allowed Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 127.531 2.333 . . . . 0.0 110.608 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.76 130.38 18.02 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.789 0.993 . . . . 0.0 111.106 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.22 124.36 22.89 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 15.51 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.013 2.125 . . . . 0.0 114.425 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 52.97 59.1 9.84 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.3 1.429 . . . . 0.0 112.319 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.16 16.91 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 67.57 29.75 6.98 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.748 2.019 . . . . 0.0 112.97 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.1 158.16 23.79 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.809 1.671 . . . . 0.0 113.832 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -72.74 131.1 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.783 1.233 . . . . 0.0 112.034 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -122.88 108.48 13.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.747 2.019 . . . . 0.0 111.016 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.75 153.59 45.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.184 1.793 . . . . 0.0 110.782 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.99 138.99 1.35 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.63 1.172 . . . . 0.0 110.268 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -60.54 134.77 57.4 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.276 0.489 . . . . 0.0 111.403 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.54 -30.53 0.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.79 24.41 5.18 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.001 1.286 . . . . 0.0 114.623 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 t80 58.67 15.15 3.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.44 2.296 . . . . 0.0 114.708 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 176.42 -77.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.833 1.683 . . . . 0.0 110.976 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.35 145.8 37.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.401 1.081 . . . . 0.0 110.459 176.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.99 168.41 20.05 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.5 1.52 . . . . 0.0 112.162 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.48 142.54 32.82 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.912 1.285 . . . . 0.0 111.239 174.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -140.08 107.06 5.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.589 1.956 . . . . 0.0 108.523 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.6 168.02 26.02 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-O 121.503 0.502 . . . . 0.0 114.206 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.0 tt -143.49 142.82 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.322 1.849 . . . . 0.0 109.011 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.0 ttt -145.59 151.09 37.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.945 1.698 . . . . 0.0 108.479 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.8 p -88.26 165.07 15.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.425 0.69 . . . . 0.0 111.548 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.8 m -80.71 9.56 6.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 112.819 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.08 157.22 17.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.843 2.057 . . . . 0.0 111.382 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.01 3.16 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 119.311 0.959 . . . . 0.0 111.868 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.58 87.97 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.894 0.878 . . . . 0.0 109.507 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.92 146.86 50.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.0 1.32 . . . . 0.0 112.31 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -91.67 129.89 37.56 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.3 ttm -127.06 83.46 2.17 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.672 1.989 . . . . 0.0 109.503 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -89.07 144.48 26.11 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.677 -0.639 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 59.1 mt -127.23 124.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.954 1.702 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -114.09 107.23 15.36 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.173 1.789 . . . . 0.0 109.182 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 35.8 mm -88.95 103.94 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.633 0.73 . . . . 0.0 110.794 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.7 p -153.27 173.78 15.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.639 1.575 . . . . 0.0 112.571 -175.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.347 1.859 . . . . 0.0 111.429 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.877 -0.106 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -36.19 11.52 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.81 0.844 . . . . 0.0 113.119 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -41.73 146.11 0.27 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.051 1.74 . . . . 0.0 115.286 175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.07 38.75 34.28 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.583 1.087 . . . . 0.0 113.985 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.0 p -145.25 -170.6 3.47 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 118.732 1.266 . . . . 0.0 111.895 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.4 pt -118.51 142.51 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.776 2.03 . . . . 0.0 110.479 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 pt -145.63 162.48 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.26 1.424 . . . . 0.0 111.813 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.36 126.5 27.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.725 0.81 . . . . 0.0 110.863 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.93 -23.08 60.98 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.299 0.952 . . . . 0.0 113.059 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.57 91.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.98 1.312 . . . . 0.0 112.085 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 m -79.92 -24.02 41.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.763 1.225 . . . . 0.0 113.541 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.32 97.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.062 1.345 . . . . 0.0 112.2 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -145.52 172.46 13.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.926 1.69 . . . . 0.0 110.17 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -46.56 -39.83 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.155 1.382 . . . . 0.0 114.6 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -56.62 -43.68 80.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.563 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.15 -45.2 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.274 1.03 . . . . 0.0 111.072 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 mt -56.05 -50.01 72.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.547 0.612 . . . . 0.0 111.492 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.33 -42.47 92.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -52.83 60.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 111.809 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.7 t -56.71 -49.21 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.728 1.211 . . . . 0.0 110.404 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -43.11 62.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.727 0.811 . . . . 0.0 112.399 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.4 -53.25 14.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.892 1.277 . . . . 0.0 112.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -72.41 -29.26 63.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.536 1.534 . . . . 0.0 114.254 -171.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.61 -53.93 43.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.591 1.557 . . . . 0.0 110.589 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.45 75.24 0.2 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.268 1.413 . . . . 0.0 111.926 -169.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 139.95 2.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.496 1.518 . . . . 0.0 111.887 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.05 -177.85 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 126.754 2.021 . . . . 0.0 109.725 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -45.78 -42.86 12.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.287 1.835 . . . . 0.0 115.151 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -148.79 141.37 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.31 1.444 . . . . 0.0 111.371 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -170.5 168.94 7.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.584 1.953 . . . . 0.0 112.32 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.13 161.15 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.613 1.165 . . . . 0.0 110.637 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.18 106.95 13.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.406 1.482 . . . . 0.0 109.882 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.48 140.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.333 1.453 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.58 120.56 1.0 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.706 1.146 . . . . 0.0 111.992 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -112.28 97.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 109.373 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -75.89 114.12 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.205 1.402 . . . . 0.0 113.513 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.09 96.75 9.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.267 1.427 . . . . 0.0 111.227 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -124.17 34.33 5.07 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.239 1.816 . . . . 0.0 110.186 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 t -80.34 -51.0 9.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.948 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.14 15.02 1.93 Allowed Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.83 160.6 32.57 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.53 1.665 . . . . 0.0 114.085 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.5 p -73.41 138.32 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.983 -0.716 . . . . 0.0 111.919 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.38 165.72 11.55 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.495 1.118 . . . . 0.0 111.457 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 m -133.78 115.58 14.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.084 1.354 . . . . 0.0 108.739 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.89 136.87 57.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.199 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -70.08 0.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -179.19 175.19 0.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.403 2.281 . . . . 0.0 110.285 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.1 147.16 51.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.377 2.271 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.17 109.79 9.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.912 1.285 . . . . 0.0 110.638 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -71.43 116.57 11.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.726 1.21 . . . . 0.0 110.779 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -45.86 9.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.655 1.182 . . . . 0.0 112.123 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.1 m -137.37 146.94 45.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.087 1.755 . . . . 0.0 110.457 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.2 -163.98 41.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.682 0.658 . . . . 0.0 113.191 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.45 174.64 14.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.265 1.026 . . . . 0.0 111.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -143.94 173.23 11.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.195 0.998 . . . . 0.0 112.009 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.84 11.65 11.91 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.618 1.567 . . . . 0.0 112.061 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.57 166.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.226 2.21 . . . . 0.0 111.351 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.97 133.36 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.971 1.308 . . . . 0.0 109.943 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.94 152.67 90.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 119.533 1.06 . . . . 0.0 112.326 176.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.53 171.61 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.414 3.41 . . . . 0.0 110.313 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -111.05 -18.87 12.93 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -124.62 131.18 53.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.85 1.66 . . . . 0.0 110.26 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.98 98.14 6.91 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.675 1.19 . . . . 0.0 109.639 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.67 164.82 25.15 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.728 1.619 . . . . 0.0 112.573 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -62.28 157.72 18.92 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.493 -0.754 . . . . 0.0 110.393 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p 68.67 -0.02 2.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.568 1.947 . . . . 0.0 114.248 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -125.45 145.81 49.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 110.723 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.46 169.16 10.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.922 1.689 . . . . 0.0 110.826 176.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.22 177.52 4.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.876 0.846 . . . . 0.0 110.187 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.23 128.78 40.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.371 1.868 . . . . 0.0 108.747 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -149.22 163.8 36.6 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.512 0.725 . . . . 0.0 111.951 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -149.8 172.51 15.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.559 1.144 . . . . 0.0 111.199 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.67 106.19 0.29 Allowed Glycine 0 N--CA 1.47 0.922 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.735 -176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 162.97 14.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.07 1.348 . . . . 0.0 112.75 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.66 105.28 17.25 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.333 -0.855 . . . . 0.0 110.944 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t0 33.26 -134.58 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.918 2.487 . . . . 0.0 112.928 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -39.58 80.94 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.164 -1.585 . . . . 0.0 112.138 174.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.39 -62.28 0.53 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.566 1.555 . . . . 0.0 112.993 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.94 -3.71 7.52 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 125.001 3.801 . . . . 0.0 116.494 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.96 168.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.778 1.231 . . . . 0.0 112.267 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.22 68.61 1.41 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.652 1.181 . . . . 0.0 111.644 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -120.7 -89.35 0.61 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.258 1.423 . . . . 0.0 110.839 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.51 174.55 35.21 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.285 1.422 . . . . 0.0 111.315 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.19 111.77 11.16 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 110.122 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -139.34 120.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.83 168.21 20.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.841 0.857 . . . . 0.0 110.851 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.21 155.95 42.53 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.83 173.72 12.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.964 2.106 . . . . 0.0 110.716 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.96 149.7 45.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.275 1.03 . . . . 0.0 111.398 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.39 117.13 18.46 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.016 1.327 . . . . 0.0 111.624 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -79.39 108.85 13.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.502 1.521 . . . . 0.0 110.213 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mtt -71.06 162.7 28.99 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.575 0.703 . . . . 0.0 111.612 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -59.69 -21.32 60.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.924 1.69 . . . . 0.0 113.956 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.5 m -79.93 -12.4 59.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.631 1.972 . . . . 0.0 113.208 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 6.2 65.73 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.94 1.257 . . . . 0.0 115.072 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -90.74 170.45 10.11 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.517 1.127 . . . . 0.0 110.496 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.6 m -131.68 149.38 52.5 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.136 0.969 . . . . 0.0 110.94 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 122.74 42.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.195 1.398 . . . . 0.0 109.037 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 139.4 24.4 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.15 122.16 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.781 1.291 . . . . 0.0 109.03 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.4 ptm -127.81 158.76 36.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.606 0.762 . . . . 0.0 112.109 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -131.78 150.74 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.213 1.405 . . . . 0.0 110.244 175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.73 100.7 4.26 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.895 1.278 . . . . 0.0 110.524 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.2 t -94.69 104.27 13.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 127.332 2.253 . . . . 0.0 109.854 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.08 169.69 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.147 2.565 . . . . 0.0 112.718 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -89.87 -37.0 14.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.68 111.65 23.96 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.895 1.678 . . . . 0.0 111.273 -163.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -66.8 -56.86 8.54 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.754 -1.216 . . . . 0.0 113.8 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -94.31 12.83 25.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.644 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.91 -14.76 3.08 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.328 1.851 . . . . 0.0 113.068 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.95 -179.32 6.28 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.832 3.253 . . . . 0.0 109.446 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.56 167.73 23.78 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.931 1.292 . . . . 0.0 111.016 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.57 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.586 -0.697 . . . . 0.0 111.188 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -139.67 147.73 41.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.741 1.216 . . . . 0.0 111.205 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.41 148.82 20.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -141.86 149.01 39.7 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.085 1.312 . . . . 0.0 111.603 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -143.97 86.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.559 1.543 . . . . 0.0 113.584 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -88.4 138.91 31.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.225 1.01 . . . . 0.0 108.504 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mt -108.23 114.65 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.547 1.539 . . . . 0.0 108.68 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -127.53 136.44 51.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.326 1.451 . . . . 0.0 112.464 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 p -78.08 84.28 4.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.284 1.434 . . . . 0.0 112.294 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.24 -175.45 37.86 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.3 0.952 . . . . 0.0 113.418 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -112.91 107.02 15.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.427 1.891 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -140.55 167.97 20.9 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.518 1.927 . . . . 0.0 111.344 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.92 166.97 26.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.973 1.709 . . . . 0.0 112.486 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.32 84.96 4.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.294 1.438 . . . . 0.0 111.232 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.28 -64.61 1.03 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.786 0.834 . . . . 0.0 110.843 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -152.2 -77.0 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.144 2.178 . . . . 0.0 108.501 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.6 -24.87 71.33 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.338 0.97 . . . . 0.0 115.022 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -56.49 4.66 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.667 1.234 . . . . 0.0 110.506 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.33 -38.89 78.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.485 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -58.42 -38.72 77.98 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.341 0.973 . . . . 0.0 112.668 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.01 -38.67 89.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.646 0.657 . . . . 0.0 111.904 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -34.34 64.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.456 0.702 . . . . 0.0 111.166 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.49 -47.87 37.78 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.52 -1.363 . . . . 0.0 112.823 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -94.6 -15.99 23.59 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.946 0.898 . . . . 0.0 113.285 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -70.64 0.9 Allowed Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.309 0.957 . . . . 0.0 112.664 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -178.17 77.47 0.23 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.807 2.443 . . . . 0.0 109.658 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.04 128.18 18.2 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.56 -1.361 . . . . 0.0 108.56 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.48 150.55 26.48 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.574 1.178 . . . . 0.0 110.311 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 120.61 28.02 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.462 1.105 . . . . 0.0 108.687 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.8 55.95 1.34 Allowed Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.197 1.379 . . . . 0.0 113.976 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.4 25.71 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.229 1.812 . . . . 0.0 115.462 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.267 12.0 p30 52.84 31.72 11.16 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.154 2.182 . . . . 0.0 114.57 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.77 175.9 18.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.721 2.105 . . . . 0.0 113.092 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -79.63 122.88 27.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.04 0.936 . . . . 0.0 111.759 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -114.34 116.2 28.58 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.431 1.892 . . . . 0.0 109.452 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -142.93 146.12 33.69 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.6 1.16 . . . . 0.0 110.777 175.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -147.19 121.53 9.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.874 1.27 . . . . 0.0 111.747 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.12 93.92 1.47 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.153 1.381 . . . . 0.0 112.269 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.24 8.82 0.94 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -94.68 21.6 42.35 Favored Glycine 0 N--CA 1.476 1.334 0 O-C-N 120.623 -1.298 . . . . 0.0 115.341 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 65.35 9.32 5.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.388 1.875 . . . . 0.0 115.022 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.65 -40.84 0.21 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.546 1.546 . . . . 0.0 113.997 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.42 150.53 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 110.388 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 167.16 21.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.815 0.846 . . . . 0.0 112.904 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.36 139.77 30.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 109.898 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -130.37 115.26 16.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.02 172.14 25.29 Favored Glycine 0 C--O 1.23 -0.12 0 CA-C-O 121.901 0.723 . . . . 0.0 113.494 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 tt -138.54 131.88 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 109.318 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 8.7 ttt -129.1 143.07 50.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.183 1.793 . . . . 0.0 107.021 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.29 154.16 19.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.071 1.749 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.6 m -92.59 27.26 2.36 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.108 1.363 . . . . 0.0 112.715 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.39 170.71 8.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.518 1.927 . . . . 0.0 111.58 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.41 -62.09 5.14 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.289 -0.882 . . . . 0.0 112.823 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.52 51.11 1.4 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.406 1.882 . . . . 0.0 111.73 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.63 175.85 3.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.69 1.596 . . . . 0.0 112.443 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -134.67 154.11 51.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.285 1.434 . . . . 0.0 109.161 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.6 ttp -142.69 85.31 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.164 0.986 . . . . 0.0 111.969 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.36 142.04 28.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.263 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 58.7 mt -125.18 123.52 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.605 1.962 . . . . 0.0 107.697 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.37 117.28 33.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.31 130.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.953 0.501 . . . . 0.0 110.452 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.3 m -144.5 167.82 21.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 112.89 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.645 2.378 . . . . 0.0 113.594 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.06 -4.01 33.41 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 141.88 58.12 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.963 0.905 . . . . 0.0 112.576 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.68 40.29 85.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.304 0.954 . . . . 0.0 114.825 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.7 p -144.92 -171.48 3.64 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.163 0.982 . . . . 0.0 112.573 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 pt -127.0 138.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.214 2.205 . . . . 0.0 111.662 174.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 pt -148.1 170.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.109 1.764 . . . . 0.0 111.904 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.97 116.91 2.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.611 1.564 . . . . 0.0 112.335 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.78 -23.86 67.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.553 0.597 . . . . 0.0 113.266 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.49 81.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.521 1.128 . . . . 0.0 113.076 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -86.49 -13.16 46.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.798 1.239 . . . . 0.0 114.091 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.5 tp -68.95 113.65 6.54 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.23 1.012 . . . . 0.0 111.102 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -144.35 166.63 24.55 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 110.578 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.21 -37.29 22.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 114.64 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -60.75 -45.02 95.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.225 0.61 . . . . 0.0 111.79 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.07 -46.3 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.906 1.283 . . . . 0.0 110.492 175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.8 -48.45 63.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.205 1.002 . . . . 0.0 112.594 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.35 -43.81 76.65 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.425 -0.797 . . . . 0.0 111.864 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.12 -40.76 74.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.201 1.4 . . . . 0.0 113.081 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.1 t -52.9 -59.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.506 1.922 . . . . 0.0 109.984 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.39 -43.47 98.81 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.558 1.943 . . . . 0.0 112.757 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -51.15 -53.58 33.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.28 1.032 . . . . 0.0 112.086 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -78.4 -35.02 47.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -42.09 62.66 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.12 1.368 . . . . 0.0 111.074 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.09 58.69 0.87 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -59.32 171.65 0.75 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.737 1.215 . . . . 0.0 111.775 175.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -162.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.808 1.243 . . . . 0.0 110.324 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -46.65 -41.28 14.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.614 1.566 . . . . 0.0 112.96 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 137.16 49.1 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.637 1.575 . . . . 0.0 111.136 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 162.24 36.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 112.44 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.48 151.95 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.885 1.674 . . . . 0.0 109.592 174.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.87 126.69 50.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.917 1.687 . . . . 0.0 107.452 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.43 132.61 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.354 1.462 . . . . 0.0 110.217 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.62 119.98 1.34 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.071 1.319 . . . . 0.0 111.249 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.2 mt -111.8 100.76 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.96 102.85 4.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.909 1.283 . . . . 0.0 111.502 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -70.98 96.47 1.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.916 0.887 . . . . 0.0 112.039 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.77 16.47 9.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.131 1.772 . . . . 0.0 112.592 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.1 p -67.84 -41.21 83.34 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.858 -1.151 . . . . 0.0 113.808 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 12.82 3.94 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.27 162.63 30.7 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.765 1.783 . . . . 0.0 114.347 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -71.29 132.69 45.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 0.0 112.87 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -106.61 163.6 12.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 111.6 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.7 m -129.72 114.05 15.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.683 1.193 . . . . 0.0 109.699 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.46 129.07 38.98 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.507 -0.746 . . . . 0.0 109.315 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -68.32 0.44 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.943 0.497 . . . . 0.0 109.868 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 179.41 173.56 0.83 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.63 2.372 . . . . 0.0 110.483 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.13 146.83 50.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.764 2.026 . . . . 0.0 109.308 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.89 115.92 15.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.292 1.437 . . . . 0.0 110.626 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -78.52 115.78 18.46 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.054 1.342 . . . . 0.0 111.037 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -92.93 -39.28 11.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.107 0.963 . . . . 0.0 112.795 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.3 m -141.63 151.79 43.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.84 2.056 . . . . 0.0 110.372 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.04 -171.57 54.43 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.749 0.69 . . . . 0.0 113.87 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -136.39 173.77 11.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.933 1.293 . . . . 0.0 112.275 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -143.34 171.01 14.7 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.752 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.67 10.2 8.39 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.697 1.199 . . . . 0.0 112.396 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.06 170.35 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.488 2.315 . . . . 0.0 113.362 -171.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.75 140.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 127.196 2.199 . . . . 0.0 109.731 -172.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.99 156.22 77.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.119 0.872 . . . . 0.0 111.858 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.52 176.01 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.332 3.355 . . . . 0.0 110.457 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -118.04 -22.84 7.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.198 -0.939 . . . . 0.0 113.077 175.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.9 123.18 41.88 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.7 1.6 . . . . 0.0 110.416 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.1 93.32 26.83 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.859 1.264 . . . . 0.0 110.298 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.9 165.32 21.65 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.328 2.019 . . . . 0.0 112.51 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.87 160.18 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.212 0.605 . . . . 0.0 110.19 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 t 56.41 13.74 1.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 128.365 2.666 . . . . 0.0 113.857 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.61 136.65 46.66 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 127.006 2.123 . . . . 0.0 109.653 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.84 161.07 20.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.381 1.072 . . . . 0.0 111.407 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.34 169.11 9.1 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.608 0.718 . . . . 0.0 109.709 174.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.2 130.72 51.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.45 1.9 . . . . 0.0 107.951 174.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -147.51 162.44 39.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.523 1.129 . . . . 0.0 110.506 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 m -150.75 163.47 38.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.452 0.701 . . . . 0.0 110.798 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.95 115.69 0.7 Allowed Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.536 1.065 . . . . 0.0 110.896 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 174.18 5.98 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.709 1.254 . . . . 0.0 111.134 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -64.07 -172.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.685 0.794 . . . . 0.0 109.561 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.97 -174.13 0.07 Allowed 'General case' 0 CA--C 1.555 1.15 0 O-C-N 120.084 -1.635 . . . . 0.0 111.216 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -37.22 -41.6 0.4 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.421 1.888 . . . . 0.0 115.698 -172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.5 -57.52 0.42 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.235 1.398 . . . . 0.0 112.955 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.45 1.77 5.2 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.763 3.642 . . . . 0.0 115.154 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.31 109.47 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.345 2.258 . . . . 0.0 111.141 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.01 78.76 5.91 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.489 1.516 . . . . 0.0 112.372 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.0 m -100.96 -70.99 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.516 1.126 . . . . 0.0 111.321 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.45 41.86 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.073 1.32 . . . . 0.0 112.043 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.22 106.97 5.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.927 0.891 . . . . 0.0 109.797 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.35 123.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.805 -1.185 . . . . 0.0 108.668 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.38 169.94 18.4 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.642 0.734 . . . . 0.0 110.989 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.61 158.21 43.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.902 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.0 170.54 16.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.432 1.893 . . . . 0.0 110.311 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.87 155.79 49.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.911 0.885 . . . . 0.0 111.382 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -136.13 121.95 19.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.019 1.328 . . . . 0.0 110.969 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.18 115.94 19.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.665 1.586 . . . . 0.0 110.483 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.83 161.98 30.14 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.647 0.779 . . . . 0.0 112.362 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -62.28 -23.39 66.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 113.403 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.9 m -78.33 -13.85 59.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.899 1.68 . . . . 0.0 113.581 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.15 60.27 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.796 1.188 . . . . 0.0 115.086 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -84.9 172.54 11.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.286 1.043 . . . . 0.0 109.896 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.1 m -131.92 152.71 50.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.735 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.82 135.37 53.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.441 1.097 . . . . 0.0 109.697 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 142.38 17.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.19 112.94 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 118.642 1.221 . . . . 0.0 109.518 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.87 150.44 46.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.144 0.578 . . . . 0.0 110.659 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -126.9 146.61 50.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.473 1.109 . . . . 0.0 109.672 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 t -131.16 110.89 11.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.54 1.136 . . . . 0.0 110.893 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.0 102.1 54.74 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.363 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.78 163.86 34.8 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.897 2.398 . . . . 0.0 112.492 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.01 -26.77 59.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.34 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 112.96 24.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.351 -1.468 . . . . 0.0 111.255 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.25 -71.4 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.931 -1.105 . . . . 0.0 112.172 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.91 10.67 3.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.31 -3.42 4.95 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.896 . . . . 0.0 112.927 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.82 133.09 11.79 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.348 1.459 . . . . 0.0 110.926 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -84.62 171.93 12.01 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.285 -0.884 . . . . 0.0 111.805 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -100.78 151.34 21.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.123 1.369 . . . . 0.0 111.097 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.63 139.48 40.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.548 -0.72 . . . . 0.0 110.632 -172.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -151.71 150.78 30.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.965 1.706 . . . . 0.0 110.043 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -148.54 147.49 29.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.644 1.578 . . . . 0.0 109.189 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -143.98 109.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.146 1.778 . . . . 0.0 109.77 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -113.6 144.76 42.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 109.288 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.6 mt -109.75 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.537 1.935 . . . . 0.0 108.466 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.69 143.4 51.25 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.658 1.583 . . . . 0.0 112.239 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.2 m -79.06 85.69 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.009 1.324 . . . . 0.0 111.817 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.64 176.38 22.76 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.422 1.487 . . . . 0.0 112.328 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 149.14 37.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.176 0.991 . . . . 0.0 111.979 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -154.37 135.69 14.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.997 1.319 . . . . 0.0 111.134 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -98.4 -176.66 3.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.369 1.468 . . . . 0.0 111.534 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -139.21 100.83 4.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.946 1.698 . . . . 0.0 109.114 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -120.55 -72.24 0.7 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.692 1.197 . . . . 0.0 110.161 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -145.57 -64.22 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.907 1.283 . . . . 0.0 110.215 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.25 70.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.408 1.004 . . . . 0.0 114.557 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 tpp -90.67 -37.58 13.65 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.623 1.169 . . . . 0.0 112.988 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -41.09 93.24 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 111.135 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -59.74 -25.18 64.64 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -18.4 65.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.81 -37.72 9.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.997 1.319 . . . . 0.0 108.662 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -68.23 -47.45 67.78 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.786 -1.196 . . . . 0.0 113.628 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -99.22 -13.55 19.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 113.447 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.69 -63.65 4.55 Favored Glycine 0 N--CA 1.475 1.246 0 C-N-CA 124.074 0.845 . . . . 0.0 112.639 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.64 80.29 0.24 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 128.089 2.556 . . . . 0.0 109.104 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.8 135.49 32.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 108.706 -1.305 . . . . 0.0 108.706 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -71.28 -12.59 61.53 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.21 118.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.337 3.055 . . . . 0.0 112.688 -170.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.77 58.96 2.14 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.046 1.784 . . . . 0.0 113.925 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.09 22.35 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.435 2.294 . . . . 0.0 113.628 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.18 27.89 12.23 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.879 1.672 . . . . 0.0 113.328 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.27 135.96 9.31 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.787 1.661 . . . . 0.0 112.207 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -59.71 139.14 57.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 111.883 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -130.01 121.25 26.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.735 1.614 . . . . 0.0 110.528 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.74 154.82 40.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.97 1.708 . . . . 0.0 110.614 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -165.37 131.53 2.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.862 1.265 . . . . 0.0 110.874 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -62.85 112.15 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.308 1.043 . . . . 0.0 111.235 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.2 -24.94 1.39 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.397 1.079 . . . . 0.0 113.732 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.15 17.84 9.06 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.122 1.344 . . . . 0.0 114.96 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.14 16.81 4.1 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.97 2.108 . . . . 0.0 114.15 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.69 -65.18 0.06 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.93 1.252 . . . . 0.0 111.293 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.36 164.37 13.24 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.153 1.381 . . . . 0.0 112.454 176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.47 30.58 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.544 1.938 . . . . 0.0 112.627 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.71 143.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.843 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -128.46 103.71 7.28 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.295 1.838 . . . . 0.0 107.874 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.41 169.48 21.26 Favored Glycine 0 N--CA 1.455 -0.067 0 CA-C-O 121.796 0.664 . . . . 0.0 113.218 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 146.63 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 123.893 0.877 . . . . 0.0 109.872 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.83 132.19 41.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.657 1.583 . . . . 0.0 107.861 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.6 p -85.95 164.09 17.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.612 0.765 . . . . 0.0 109.905 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.36 19.69 19.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.922 0.889 . . . . 0.0 112.967 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -106.05 -175.52 2.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 0.0 112.999 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.54 74.98 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.444 1.497 . . . . 0.0 114.413 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.46 92.45 5.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.446 1.498 . . . . 0.0 107.627 175.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.73 69.02 1.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.232 1.013 . . . . 0.0 111.733 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -53.11 129.95 32.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.728 -1.232 . . . . 0.0 110.954 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.7 ttm -134.61 123.83 24.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.131 1.772 . . . . 0.0 110.015 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -139.34 141.26 37.66 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.941 -1.099 . . . . 0.0 109.599 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.67 93.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.936 1.694 . . . . 0.0 109.167 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -86.0 109.26 18.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.043 0.937 . . . . 0.0 110.419 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.4 mm -91.57 116.42 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.751 0.82 . . . . 0.0 111.215 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -148.11 161.36 41.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.859 2.063 . . . . 0.0 110.581 174.976 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.887 -0.102 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 23.6 tp -97.15 -6.33 35.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.495 1.118 . . . . 0.0 113.271 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.22 146.31 51.16 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.19 -1.569 . . . . 0.0 111.379 174.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.68 39.6 40.02 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.666 0.65 . . . . 0.0 114.488 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.26 -169.35 3.03 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.555 1.177 . . . . 0.0 111.822 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.02 141.75 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.765 2.026 . . . . 0.0 109.844 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.28 173.93 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.569 1.548 . . . . 0.0 111.409 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.29 115.4 6.21 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.42 -30.78 65.35 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.448 -0.783 . . . . 0.0 112.808 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.29 69.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.246 -1.15 . . . . 0.0 113.345 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -90.48 -13.62 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.113 1.365 . . . . 0.0 113.39 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -68.14 113.01 5.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.968 0.907 . . . . 0.0 111.733 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -145.12 165.84 27.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.595 1.558 . . . . 0.0 109.737 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -45.91 -41.69 11.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.618 1.567 . . . . 0.0 114.487 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.54 -36.77 76.78 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.74 -44.48 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.818 0.847 . . . . 0.0 110.247 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.15 -42.64 86.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.782 0.833 . . . . 0.0 111.145 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.01 -40.13 71.98 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.133 -0.979 . . . . 0.0 113.21 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.36 -43.19 88.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.911 0.884 . . . . 0.0 111.924 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.04 -51.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.716 -0.615 . . . . 0.0 111.215 175.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -53.2 -43.83 67.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.689 0.796 . . . . 0.0 112.628 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.48 -46.19 70.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 117.986 0.357 . . . . 0.0 111.857 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.4 -38.96 59.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.554 1.542 . . . . 0.0 113.863 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.02 -40.14 66.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.421 1.089 . . . . 0.0 111.381 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.37 62.82 0.55 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.977 1.275 . . . . 0.0 111.737 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 133.53 3.13 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.034 1.333 . . . . 0.0 113.298 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.95 -163.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.388 1.875 . . . . 0.0 109.603 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 m -39.39 -46.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.491 1.516 . . . . 0.0 114.938 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -147.97 126.31 12.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.95 2.1 . . . . 0.0 110.319 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.35 158.39 41.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.676 1.591 . . . . 0.0 111.832 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.18 173.72 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.725 1.21 . . . . 0.0 112.441 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.51 115.14 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.503 1.121 . . . . 0.0 110.525 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.26 143.74 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 111.213 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.39 125.61 1.8 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.407 1.004 . . . . 0.0 111.687 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 mt -130.39 112.28 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.532 1.666 . . . . 0.0 111.362 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.93 109.0 20.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.118 1.767 . . . . 0.0 111.796 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -87.14 109.27 19.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.789 1.28 . . . . 0.0 112.179 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -122.61 27.55 7.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.482 1.913 . . . . 0.0 111.176 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -81.71 -1.79 48.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.734 2.014 . . . . 0.0 114.553 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 12.62 83.97 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.934 -1.103 . . . . 0.0 114.492 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.54 145.36 12.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.422 1.487 . . . . 0.0 113.501 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -69.83 141.48 53.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.59 1.156 . . . . 0.0 112.811 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -112.07 162.59 15.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.54 1.936 . . . . 0.0 111.431 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 m -128.97 114.92 17.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.754 1.222 . . . . 0.0 109.328 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 122.72 18.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.704 -0.622 . . . . 0.0 110.146 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.67 -66.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.785 1.234 . . . . 0.0 109.855 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 176.43 173.76 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.884 2.874 . . . . 0.0 109.657 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 143.87 48.0 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.456 2.302 . . . . 0.0 109.217 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -136.25 112.32 9.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.04 0.936 . . . . 0.0 111.444 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -72.92 115.48 12.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.514 1.526 . . . . 0.0 111.487 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -89.87 -37.69 14.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.629 1.572 . . . . 0.0 112.756 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -146.46 159.46 43.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.382 2.273 . . . . 0.0 110.606 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.47 49.63 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 121.612 0.562 . . . . 0.0 113.386 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 t -140.42 148.03 40.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.526 1.13 . . . . 0.0 109.726 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 m -138.58 138.79 38.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.418 1.087 . . . . 0.0 110.205 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.06 11.15 40.09 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.906 1.682 . . . . 0.0 112.854 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.48 169.63 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.74 2.016 . . . . 0.0 112.364 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.11 135.78 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.577 1.551 . . . . 0.0 109.758 -169.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -77.27 152.95 81.96 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.291 0.951 . . . . 0.0 112.379 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.41 174.17 8.65 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.555 3.504 . . . . 0.0 110.759 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -116.3 -17.56 10.72 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.13 -0.981 . . . . 0.0 113.173 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -124.59 130.38 52.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.285 1.834 . . . . 0.0 110.343 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.59 82.67 44.6 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.324 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.6 153.66 77.2 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.162 1.908 . . . . 0.0 111.427 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -53.31 148.42 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.545 0.738 . . . . 0.0 111.176 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 72.86 -0.95 3.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.953 2.501 . . . . 0.0 114.805 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -124.47 106.24 10.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.065 1.746 . . . . 0.0 112.391 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.59 160.0 25.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.55 170.05 8.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.129 0.572 . . . . 0.0 109.769 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.39 134.77 50.94 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 109.636 174.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.21 169.86 20.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.601 0.76 . . . . 0.0 111.642 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.4 m -151.21 171.58 17.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.509 1.524 . . . . 0.0 110.474 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.97 115.99 0.71 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.71 163.14 15.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.161 1.481 . . . . 0.0 111.18 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -65.41 -177.23 0.39 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 110.404 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.79 178.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.353 -0.842 . . . . 0.0 110.322 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -24.59 -53.34 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.175 2.59 . . . . 0.0 116.308 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.36 -62.75 0.26 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.604 1.573 . . . . 0.0 112.325 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.15 -1.27 8.52 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.711 3.607 . . . . 0.0 115.439 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.72 123.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.484 2.314 . . . . 0.0 110.453 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.51 81.5 2.97 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.351 1.46 . . . . 0.0 111.241 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 m -114.1 -80.89 0.6 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.985 1.314 . . . . 0.0 110.523 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.43 -177.34 41.95 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.238 1.399 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -139.14 110.61 7.03 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.054 1.342 . . . . 0.0 109.159 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.22 130.65 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.649 -0.657 . . . . 0.0 109.755 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 158.32 44.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 110.293 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.97 155.43 45.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.936 0.874 . . . . 0.0 111.636 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.71 168.03 25.59 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.416 1.886 . . . . 0.0 109.689 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.48 157.23 45.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.584 0.753 . . . . 0.0 110.868 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -138.95 118.5 12.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.702 0.801 . . . . 0.0 112.125 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -75.59 121.83 23.01 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.649 0.78 . . . . 0.0 111.226 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -87.44 159.3 18.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.47 1.108 . . . . 0.0 110.123 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.7 p -63.83 -13.89 48.46 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -88.38 0.49 56.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.852 1.661 . . . . 0.0 113.05 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.12 82.96 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.695 1.141 . . . . 0.0 114.126 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.46 167.22 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.837 2.055 . . . . 0.0 110.644 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.0 m -130.99 153.62 49.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.027 1.331 . . . . 0.0 109.629 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.21 138.66 53.66 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.396 1.079 . . . . 0.0 109.587 175.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.25 139.08 15.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.94 125.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.229 1.015 . . . . 0.0 109.476 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.01 155.94 46.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.405 0.682 . . . . 0.0 112.016 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.97 144.22 49.0 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.691 1.197 . . . . 0.0 110.086 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.03 110.64 11.8 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 110.11 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.78 100.6 46.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 125.705 1.602 . . . . 0.0 109.655 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.03 163.93 34.3 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.277 1.985 . . . . 0.0 110.844 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.61 -47.25 76.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.726 0.811 . . . . 0.0 111.08 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.08 117.41 22.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.478 2.311 . . . . 0.0 111.958 -172.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.2 -70.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.113 -0.992 . . . . 0.0 112.646 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -82.5 11.19 5.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.48 5.42 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.134 2.174 . . . . 0.0 112.433 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -160.13 129.07 4.97 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.175 1.79 . . . . 0.0 110.718 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.9 m -90.94 168.13 11.91 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.567 -1.333 . . . . 0.0 113.214 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -89.67 155.74 19.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.149 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -142.14 140.53 32.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.582 1.153 . . . . 0.0 109.284 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -156.63 146.69 21.12 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.318 1.447 . . . . 0.0 110.399 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -140.98 147.49 38.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.675 1.19 . . . . 0.0 110.072 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.3 t -146.01 90.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.032 1.333 . . . . 0.0 112.051 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.09 144.81 32.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.237 1.415 . . . . 0.0 110.526 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -108.33 123.34 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.293 2.237 . . . . 0.0 108.587 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -127.71 148.3 50.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.288 1.435 . . . . 0.0 112.955 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.2 p -74.08 87.82 1.9 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.578 1.951 . . . . 0.0 112.679 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.78 179.35 21.1 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.878 1.704 . . . . 0.0 112.387 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 140.83 29.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.441 1.497 . . . . 0.0 112.266 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.35 152.28 30.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.145 2.178 . . . . 0.0 110.411 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -131.53 153.37 49.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.457 1.903 . . . . 0.0 110.75 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.71 93.15 0.7 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.328 1.051 . . . . 0.0 111.762 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.3 -76.81 0.58 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 110.279 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -142.85 -67.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.393 2.277 . . . . 0.0 107.758 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.19 -30.97 75.25 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.618 1.104 . . . . 0.0 115.257 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -75.45 -57.89 3.61 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.437 1.619 . . . . 0.0 110.864 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -49.98 -49.6 49.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.58 1.152 . . . . 0.0 111.504 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -37.61 80.14 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.79 -27.34 67.93 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.649 1.113 . . . . 0.0 112.627 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.1 -46.83 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.743 0.817 . . . . 0.0 110.563 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -72.41 -49.02 36.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.835 -1.166 . . . . 0.0 113.773 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -91.83 -17.09 25.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.377 1.071 . . . . 0.0 113.046 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.99 -70.18 0.99 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.224 0.916 . . . . 0.0 112.8 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -179.66 75.48 0.19 Allowed Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 127.962 2.505 . . . . 0.0 110.618 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 131.71 19.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.812 1.674 . . . . 0.0 110.981 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 118.49 13.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.58 123.48 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.898 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.75 69.84 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.733 1.635 . . . . 0.0 113.114 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.82 38.81 0.46 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.29 1.836 . . . . 0.0 111.841 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 54.44 41.79 31.76 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.83 1.652 . . . . 0.0 113.168 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.36 156.2 26.88 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.061 1.315 . . . . 0.0 113.418 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.15 134.38 51.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.156 0.983 . . . . 0.0 111.523 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.53 111.7 11.99 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.965 2.106 . . . . 0.0 108.902 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -147.91 146.78 29.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.017 1.727 . . . . 0.0 111.184 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 144.6 9.97 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.422 1.089 . . . . 0.0 111.208 175.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 137.09 58.24 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.841 0.457 . . . . 0.0 112.008 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.44 -30.37 0.06 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 113.646 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.9 16.3 55.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.078 1.323 . . . . 0.0 114.169 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.38 14.06 4.47 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.091 2.157 . . . . 0.0 114.965 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.25 -65.45 0.06 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.254 1.883 . . . . 0.0 110.816 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.28 156.34 16.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.905 0.882 . . . . 0.0 110.845 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -149.55 170.33 18.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.433 1.493 . . . . 0.0 112.397 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -89.23 145.49 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.964 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -137.95 106.13 5.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.528 1.931 . . . . 0.0 108.684 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.85 170.65 25.72 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-O 121.765 0.647 . . . . 0.0 113.972 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.14 148.29 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.847 2.059 . . . . 0.0 108.531 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.5 ttt -142.11 131.99 24.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.379 1.072 . . . . 0.0 108.607 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.06 160.81 31.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.052 1.341 . . . . 0.0 111.608 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.6 t -93.4 5.0 53.06 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.993 1.317 . . . . 0.0 113.362 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.74 174.52 5.84 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.712 2.005 . . . . 0.0 112.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.17 -56.77 21.93 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.011 0.815 . . . . 0.0 113.552 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.04 36.52 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.545 1.938 . . . . 0.0 113.685 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.38 32.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.599 1.159 . . . . 0.0 114.045 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -106.49 131.2 53.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.905 1.682 . . . . 0.0 109.504 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 34.2 ttp -128.01 95.27 4.14 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.843 1.257 . . . . 0.0 111.361 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -109.34 143.57 38.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.73 -0.606 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.45 107.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.759 2.023 . . . . 0.0 109.668 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 101.12 10.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.232 1.413 . . . . 0.0 109.795 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.66 129.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.872 -0.517 . . . . 0.0 110.654 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.99 171.97 18.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.002 0.921 . . . . 0.0 113.16 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 128.973 2.909 . . . . 0.0 112.837 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.68 6.17 34.07 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.836 1.254 . . . . 0.0 113.175 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.24 147.05 38.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.553 -1.342 . . . . 0.0 111.88 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.94 34.33 81.81 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.605 0.622 . . . . 0.0 113.777 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -148.49 178.3 8.73 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.987 0.893 . . . . 0.0 111.501 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 pt -128.35 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.489 1.516 . . . . 0.0 111.949 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 pt -144.84 167.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.804 1.642 . . . . 0.0 111.708 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.57 124.34 16.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.633 1.173 . . . . 0.0 112.173 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.95 -19.67 30.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 114.1 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.3 95.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.02 1.328 . . . . 0.0 111.692 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -35.28 25.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.321 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.5 tp -52.44 100.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.081 1.752 . . . . 0.0 112.602 177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -145.72 170.3 16.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.019 1.328 . . . . 0.0 109.793 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.88 -36.9 28.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.115 1.366 . . . . 0.0 113.702 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 -35.21 76.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.026 0.93 . . . . 0.0 113.305 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.74 -46.71 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.644 1.178 . . . . 0.0 109.519 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.74 -44.84 73.93 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 112.412 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.5 -42.08 95.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.838 -0.539 . . . . 0.0 111.361 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -42.04 97.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.318 1.047 . . . . 0.0 111.407 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.5 t -61.2 -54.47 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.599 1.159 . . . . 0.0 111.247 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.27 -49.48 61.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 0.0 111.569 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.99 -42.83 72.55 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.2 -38.06 44.14 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tt -54.71 -45.14 73.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.487 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.33 66.48 0.48 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.229 1.395 . . . . 0.0 111.564 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 124.21 1.11 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.542 1.537 . . . . 0.0 112.946 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 p -104.09 -159.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.688 1.595 . . . . 0.0 109.556 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.06 -30.59 6.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 114.117 176.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.27 135.11 11.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.143 1.777 . . . . 0.0 111.439 176.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.77 165.25 35.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.755 1.222 . . . . 0.0 113.343 174.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.39 161.27 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.181 1.392 . . . . 0.0 109.099 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.49 125.73 51.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.068 1.347 . . . . 0.0 108.07 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.55 142.21 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.171 1.788 . . . . 0.0 110.388 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.46 122.51 1.32 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.948 0.785 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.53 111.69 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 118.336 1.068 . . . . 0.0 110.208 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.61 120.58 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.972 1.709 . . . . 0.0 113.798 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.39 90.39 1.29 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.089 1.756 . . . . 0.0 110.171 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -107.53 12.39 27.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 112.595 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -82.33 -34.63 28.47 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -171.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.63 17.35 10.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.241 0.928 . . . . 0.0 114.997 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.3 160.93 31.3 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 118.988 1.394 . . . . 0.0 114.844 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -74.08 134.42 42.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.805 1.242 . . . . 0.0 111.874 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.46 166.47 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.96 1.704 . . . . 0.0 111.26 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 m -133.93 113.24 11.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.986 1.315 . . . . 0.0 110.064 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 113.02 4.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.72 -64.46 0.93 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.674 1.19 . . . . 0.0 110.142 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -175.22 169.11 3.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.892 2.077 . . . . 0.0 111.459 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.12 139.03 54.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.977 2.111 . . . . 0.0 109.103 175.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.9 110.93 11.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.55 101.49 3.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.174 1.39 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -68.03 -42.33 80.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.46 1.504 . . . . 0.0 111.942 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.11 157.79 43.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.692 2.397 . . . . 0.0 111.144 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 -169.69 39.86 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 123.729 0.681 . . . . 0.0 114.574 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -136.77 173.3 11.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.056 1.342 . . . . 0.0 112.363 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.7 p -143.04 176.57 8.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 110.66 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -123.35 17.59 9.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.434 1.094 . . . . 0.0 112.193 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.07 175.51 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.985 2.114 . . . . 0.0 111.904 -168.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mt -139.04 133.72 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.014 1.326 . . . . 0.0 109.76 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.0 142.24 75.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.93 172.01 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.607 3.538 . . . . 0.0 110.811 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -115.39 -20.26 10.35 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.204 -1.56 . . . . 0.0 112.556 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -129.88 141.35 50.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.353 1.461 . . . . 0.0 110.297 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.03 95.5 5.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.92 161.53 32.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.556 1.504 . . . . 0.0 111.303 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.7 153.53 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.568 -0.707 . . . . 0.0 111.517 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -25.79 0.18 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.038 1.735 . . . . 0.0 113.384 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -89.03 121.15 31.09 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.133 1.333 . . . . 0.0 110.659 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -91.11 160.5 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 111.402 174.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.68 164.46 11.73 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.65 134.74 48.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.96 2.104 . . . . 0.0 109.01 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -147.42 171.18 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.962 1.305 . . . . 0.0 111.786 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -148.08 168.82 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.834 1.253 . . . . 0.0 110.831 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -146.43 116.38 0.87 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-O 118.036 -1.425 . . . . 0.0 110.602 175.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.09 163.81 15.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.704 1.252 . . . . 0.0 110.737 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -177.81 0.66 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.1 -175.25 0.2 Allowed 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.143 -0.973 . . . . 0.0 111.036 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 m -19.7 -56.58 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.187 2.995 . . . . 0.0 115.589 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.94 -63.08 0.3 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.424 1.488 . . . . 0.0 112.226 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 0.14 6.78 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.925 3.75 . . . . 0.0 115.972 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.38 122.87 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.888 1.675 . . . . 0.0 111.783 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.91 80.17 4.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.367 1.467 . . . . 0.0 111.713 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -104.91 -86.51 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.494 1.518 . . . . 0.0 110.789 177.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 82' ' ' THR . . . 174.24 179.94 45.18 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 127.41 2.433 . . . . 0.0 110.581 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.35 101.18 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.176 1.391 . . . . 0.0 109.966 177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -140.77 126.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -149.95 164.94 34.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.351 -0.843 . . . . 0.0 110.8 174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.6 155.93 40.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.961 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.23 168.02 27.39 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.968 1.307 . . . . 0.0 109.881 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 148.91 43.05 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.727 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -134.62 115.77 14.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.279 1.032 . . . . 0.0 111.165 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -69.62 118.5 12.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.404 1.482 . . . . 0.0 109.36 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -82.47 151.68 26.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.604 1.562 . . . . 0.0 110.404 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -58.33 -19.18 33.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 63.2 m -82.3 -12.28 58.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.484 1.914 . . . . 0.0 113.848 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.51 -10.6 42.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.298 1.428 . . . . 0.0 115.127 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.55 173.32 12.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.514 1.525 . . . . 0.0 110.737 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -137.63 142.76 41.2 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.698 1.199 . . . . 0.0 108.39 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.23 140.75 38.7 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.25 145.57 16.27 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.87 130.15 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 109.725 175.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.53 50.1 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.04 . . . . 0.0 110.296 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.499 ' CZ ' ' HA3' ' A' ' 73' ' ' GLY . 10.4 p90 -123.21 152.99 40.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.037 1.335 . . . . 0.0 109.453 174.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.3 p -140.37 122.5 15.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.024 0.929 . . . . 0.0 110.626 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 23.7 t -119.75 108.15 39.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 126.407 1.883 . . . . 0.0 108.33 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.16 155.56 37.67 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.297 1.998 . . . . 0.0 111.493 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.68 -36.09 83.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.646 0.778 . . . . 0.0 110.76 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.99 114.68 27.31 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.785 2.434 . . . . 0.0 111.612 -171.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.0 -63.77 1.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.047 -1.033 . . . . 0.0 113.445 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -88.86 10.86 19.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -6.0 6.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.83 2.052 . . . . 0.0 112.743 -174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.35 179.35 8.62 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.835 2.454 . . . . 0.0 110.284 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -136.75 159.96 40.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.161 1.385 . . . . 0.0 110.955 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -79.63 155.33 28.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -136.83 151.61 49.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.75 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -161.6 157.73 25.15 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.675 1.19 . . . . 0.0 110.16 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 12.5 t70 -154.47 161.32 41.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.602 1.161 . . . . 0.0 110.245 174.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 67.5 t -146.23 138.0 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.346 1.858 . . . . 0.0 109.921 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.87 46.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.055 1.742 . . . . 0.0 110.007 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.8 119.24 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.097 1.759 . . . . 0.0 108.71 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -127.92 139.4 52.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.465 1.906 . . . . 0.0 112.385 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.6 p -77.34 79.4 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.919 1.688 . . . . 0.0 112.525 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.75 174.78 32.05 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.979 . . . . 0.0 112.606 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 99.65 10.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.855 2.062 . . . . 0.0 110.593 -173.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.82 161.43 34.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.781 2.032 . . . . 0.0 111.464 -176.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.44 30.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.527 1.531 . . . . 0.0 111.301 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.41 87.96 0.64 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.128 0.971 . . . . 0.0 111.293 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.63 -64.16 1.12 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.999 1.32 . . . . 0.0 109.292 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -75.02 0.17 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.989 1.716 . . . . 0.0 108.543 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.41 93.98 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.804 1.192 . . . . 0.0 113.93 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.31 -46.42 76.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.299 1.049 . . . . 0.0 111.398 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.35 -43.66 93.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.575 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -62.35 -42.66 99.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.514 1.126 . . . . 0.0 112.338 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -16.71 35.11 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 113.153 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.43 -52.4 4.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.55 -43.09 97.63 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 112.794 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -98.46 -14.65 19.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.786 1.234 . . . . 0.0 113.591 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.48 4.16 Favored Glycine 0 N--CA 1.475 1.286 0 O-C-N 121.541 -0.724 . . . . 0.0 114.655 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 44.3 77.21 0.46 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.222 1.809 . . . . 0.0 111.78 -165.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.67 157.58 50.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.04 1.826 . . . . 0.0 111.01 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' CE2' ' HA ' ' A' ' 116' ' ' ASP . 23.8 m-85 -90.28 2.9 54.99 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER 46.61 16.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 129.426 3.09 . . . . 0.0 116.848 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 45.69 62.98 3.01 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.176 0.893 . . . . 0.0 112.611 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.74 16.65 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.281 10.7 p30 49.17 33.69 5.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.409 2.283 . . . . 0.0 115.15 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.24 147.89 19.36 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.965 1.745 . . . . 0.0 111.06 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -64.98 116.06 6.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.362 0.665 . . . . 0.0 110.382 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 138.09 49.26 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.42 128.57 4.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.91 1.284 . . . . 0.0 111.333 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -137.86 119.57 15.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.299 1.04 . . . . 0.0 113.372 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.77 123.94 5.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.3 -24.48 0.08 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.77 22.34 14.5 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.958 1.266 . . . . 0.0 114.085 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.0 t80 58.43 14.8 3.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.566 2.346 . . . . 0.0 115.024 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.98 -64.03 0.05 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 125.456 1.503 . . . . 0.0 110.913 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.13 161.07 15.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.183 0.993 . . . . 0.0 111.149 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 174.44 10.51 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.886 2.074 . . . . 0.0 111.407 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -78.2 131.13 37.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.91 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -122.23 104.67 9.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.717 1.207 . . . . 0.0 108.696 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.38 165.41 27.48 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-O 122.401 1.0 . . . . 0.0 114.643 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.3 tt -146.9 141.54 20.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 127.573 2.349 . . . . 0.0 108.469 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.1 ttt -141.7 140.6 33.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.07 1.748 . . . . 0.0 106.371 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.99 163.14 19.07 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.436 0.694 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 9.77 13.54 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.03 1.332 . . . . 0.0 113.776 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.28 170.58 9.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.234 2.214 . . . . 0.0 112.663 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.34 -71.79 0.88 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.46 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.665 2.386 . . . . 0.0 115.995 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 158.49 8.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.168 2.187 . . . . 0.0 113.627 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.22 140.44 36.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.271 1.428 . . . . 0.0 110.685 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.2 ttm -133.48 135.4 44.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.999 1.719 . . . . 0.0 110.087 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -144.46 152.6 40.86 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.927 0.891 . . . . 0.0 109.225 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.1 mt -133.18 117.4 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.494 1.518 . . . . 0.0 108.453 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -106.59 113.78 27.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.795 1.638 . . . . 0.0 109.561 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.35 101.07 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 60.3 p -161.73 -179.56 7.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.426 1.891 . . . . 0.0 114.914 -174.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 127.997 2.519 . . . . 0.0 115.408 -164.715 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.149 0.5 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.33 -55.42 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.69 1.596 . . . . 0.0 110.1 -176.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.84 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.169 2.588 . . . . 0.0 113.082 -167.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.36 47.46 90.77 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 114.817 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.9 p -147.51 -174.65 4.59 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.33 1.052 . . . . 0.0 112.574 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -124.47 136.82 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.673 1.989 . . . . 0.0 111.041 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.53 174.21 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.476 1.51 . . . . 0.0 111.905 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.14 1.69 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.984 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' H ' ' HA ' ' A' ' 67' ' ' LYS . . . -64.14 -25.26 69.46 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.241 -0.912 . . . . 0.0 113.096 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.0 71.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.418 1.087 . . . . 0.0 112.549 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 m -83.63 -19.41 35.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.79 1.236 . . . . 0.0 113.374 175.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 16.2 tp -66.7 97.7 0.47 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.927 1.291 . . . . 0.0 111.688 -178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.4 m -144.44 174.44 10.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.562 1.545 . . . . 0.0 109.508 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.05 -33.63 11.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.95 1.3 . . . . 0.0 114.149 178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -64.23 -32.9 74.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -77.5 -30.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.224 1.41 . . . . 0.0 111.422 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.6 mt -59.03 -52.84 64.02 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.92 -38.41 72.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.547 1.139 . . . . 0.0 111.666 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -58.88 -36.94 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.12 -46.49 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.332 0.969 . . . . 0.0 110.78 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -40.17 85.03 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.213 1.405 . . . . 0.0 110.418 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.35 -53.36 37.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.385 0.674 . . . . 0.0 112.813 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -48.72 41.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.496 -0.753 . . . . 0.0 112.766 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.32 -39.45 94.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.77 0.828 . . . . 0.0 111.7 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.74 69.53 0.8 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.137 1.351 . . . . 0.0 112.758 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.277 1.831 . . . . 0.0 112.376 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.0 p -84.03 -160.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.123 1.769 . . . . 0.0 110.421 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.5 m -44.02 -35.01 1.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.987 1.715 . . . . 0.0 114.754 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -149.71 137.48 20.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.616 1.966 . . . . 0.0 110.221 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -165.85 143.17 5.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.556 1.542 . . . . 0.0 112.017 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.22 143.46 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.371 0.987 . . . . 0.0 111.443 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.99 118.57 36.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 108.867 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.64 139.67 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.984 0.913 . . . . 0.0 111.227 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.77 133.73 4.42 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.925 1.25 . . . . 0.0 111.596 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.26 99.3 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.028 0.931 . . . . 0.0 108.699 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.02 105.61 12.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.814 0.846 . . . . 0.0 111.142 -174.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -73.61 96.15 2.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 111.283 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.74 10.81 15.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 113.442 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.3 t -64.06 -55.06 24.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.911 1.284 . . . . 0.0 114.006 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.02 0.9 3.03 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.38 157.21 27.12 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 119.489 1.645 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -69.63 138.06 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.554 1.142 . . . . 0.0 113.129 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -115.26 166.05 12.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.551 1.54 . . . . 0.0 112.112 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -134.62 114.02 12.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.995 1.318 . . . . 0.0 110.295 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.49 124.29 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.959 -1.088 . . . . 0.0 108.994 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.41 -66.78 0.5 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 110.622 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.23 159.78 7.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.125 2.17 . . . . 0.0 110.558 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.08 122.92 47.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.478 1.911 . . . . 0.0 109.7 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.59 116.81 26.09 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.177 0.991 . . . . 0.0 111.829 -176.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -71.49 114.2 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.177 1.391 . . . . 0.0 112.727 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -44.83 44.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.044 1.738 . . . . 0.0 110.591 174.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 m -147.38 162.22 39.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.496 2.318 . . . . 0.0 111.574 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.67 -166.18 54.02 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.358 0.98 . . . . 0.0 113.934 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -147.32 173.32 12.7 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.889 -0.771 . . . . 0.0 111.954 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.1 p -143.82 -174.69 4.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.182 1.393 . . . . 0.0 111.479 -178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.07 13.46 6.22 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.286 1.034 . . . . 0.0 112.918 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.9 m -136.45 170.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.898 2.079 . . . . 0.0 114.043 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.33 133.35 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.915 1.686 . . . . 0.0 110.785 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 143.48 52.06 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.196 0.907 . . . . 0.0 111.713 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.79 146.36 59.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.655 3.57 . . . . 0.0 112.051 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -85.6 -26.74 25.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -113.63 128.03 56.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.216 1.371 . . . . 0.0 111.897 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.52 86.63 28.68 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.609 1.564 . . . . 0.0 110.137 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.73 162.12 36.01 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.303 2.002 . . . . 0.0 112.124 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -63.64 159.48 18.89 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.758 -0.589 . . . . 0.0 111.063 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p 68.45 -5.42 0.94 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.68 2.392 . . . . 0.0 114.444 -172.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.404 ' HA ' ' H ' ' A' ' 9' ' ' GLY . 73.9 mttt -116.31 165.44 13.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.581 1.952 . . . . 0.0 112.026 174.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.89 162.66 32.2 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.321 1.448 . . . . 0.0 111.272 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 167.02 10.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.292 0.567 . . . . 0.0 109.857 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.51 136.08 52.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.506 1.922 . . . . 0.0 108.764 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -150.17 166.29 30.3 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.185 0.994 . . . . 0.0 110.662 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -155.29 170.12 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.591 0.757 . . . . 0.0 112.447 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.15 145.0 10.6 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.748 1.166 . . . . 0.0 112.582 175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -127.17 148.92 50.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.652 1.981 . . . . 0.0 110.981 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.4 pttp -67.36 121.11 15.02 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 38.24 -149.77 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 126.034 1.733 . . . . 0.0 114.381 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.7 m -88.17 -42.65 12.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.634 -1.291 . . . . 0.0 111.598 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.9 -61.16 0.37 Allowed Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.696 -1.058 . . . . 0.0 114.252 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.16 0.81 5.4 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.929 3.753 . . . . 0.0 115.27 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.76 135.72 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 127.677 2.391 . . . . 0.0 108.995 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.14 80.95 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.627 1.571 . . . . 0.0 110.226 -176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.8 m -110.42 -66.7 1.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.726 1.211 . . . . 0.0 110.75 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.02 -179.64 33.58 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.731 0.681 . . . . 0.0 112.793 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.1 115.46 9.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 110.427 175.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.8 t -138.63 139.51 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.71 158.82 40.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.31 0.644 . . . . 0.0 109.863 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.67 139.81 22.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 111.919 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.73 176.43 8.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.573 1.949 . . . . 0.0 109.682 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.73 37.07 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.336 0.655 . . . . 0.0 112.125 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.44 113.02 15.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.686 1.194 . . . . 0.0 111.112 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -73.04 111.77 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.215 1.806 . . . . 0.0 110.747 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 mtt -71.68 161.42 31.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.724 0.81 . . . . 0.0 112.106 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.3 t -60.98 -26.08 67.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.118 0.967 . . . . 0.0 113.245 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -74.96 -12.1 60.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.622 1.569 . . . . 0.0 112.957 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.34 -2.86 59.48 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.665 1.602 . . . . 0.0 114.489 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.79 176.38 9.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.533 1.533 . . . . 0.0 109.664 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.9 m -136.56 148.71 47.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 0.0 110.241 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.33 134.89 54.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 108.637 175.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 144.04 19.03 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.26 121.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 118.445 1.122 . . . . 0.0 109.481 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -128.64 162.22 27.83 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.359 0.664 . . . . 0.0 112.668 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -131.4 150.89 51.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.875 1.27 . . . . 0.0 109.603 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 t -139.08 110.37 6.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.52 0.728 . . . . 0.0 110.383 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -99.59 100.01 9.91 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 127.897 2.479 . . . . 0.0 109.112 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.4 145.72 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.34 2.027 . . . . 0.0 111.372 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -72.89 -31.55 64.76 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.41 0.624 . . . . 0.0 110.167 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.73 114.85 28.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.522 2.329 . . . . 0.0 111.714 -165.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.01 -54.74 8.97 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -95.01 14.43 21.85 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -16.92 2.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.373 1.869 . . . . 0.0 113.06 -175.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.07 175.1 10.11 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.062 2.945 . . . . 0.0 109.497 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.8 m -136.01 171.0 15.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.438 1.495 . . . . 0.0 110.768 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -87.24 151.97 22.71 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.069 0.947 . . . . 0.0 109.964 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -138.78 142.02 38.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.231 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -159.6 163.2 35.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 111.154 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -163.71 147.19 10.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.395 1.478 . . . . 0.0 110.421 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.21 108.25 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.009 1.723 . . . . 0.0 109.529 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -111.76 149.11 32.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.041 1.736 . . . . 0.0 109.734 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.1 117.76 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.687 1.595 . . . . 0.0 108.898 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -125.21 135.88 53.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.145 1.778 . . . . 0.0 112.092 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -75.66 80.63 2.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.379 1.472 . . . . 0.0 112.792 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.14 167.63 14.5 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 115.207 0.843 . . . . 0.0 115.207 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -72.86 102.66 3.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.432 1.493 . . . . 0.0 111.665 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.51 132.45 31.22 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.318 1.847 . . . . 0.0 109.436 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 167.13 17.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.048 1.339 . . . . 0.0 111.837 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.64 88.54 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.598 1.559 . . . . 0.0 111.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -111.53 -64.38 1.29 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.776 1.23 . . . . 0.0 109.712 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -68.52 0.23 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.597 1.159 . . . . 0.0 109.139 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.77 90.62 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.682 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -52.77 33.27 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.086 1.443 . . . . 0.0 111.02 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.89 -44.43 78.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.253 1.021 . . . . 0.0 110.801 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.85 -39.38 94.08 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -22.32 61.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.453 1.101 . . . . 0.0 112.216 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.19 -58.86 2.47 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.431 1.492 . . . . 0.0 109.557 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -63.36 -57.63 9.73 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.295 -0.878 . . . . 0.0 111.248 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -82.26 -17.95 44.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.347 1.059 . . . . 0.0 112.247 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.21 56.51 4.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.935 0.778 . . . . 0.0 114.676 -172.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.49 83.28 0.23 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 126.444 1.898 . . . . 0.0 111.818 -166.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.48 151.27 83.41 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.132 1.888 . . . . 0.0 109.256 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.42 -2.9 57.93 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.1 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 129.179 2.992 . . . . 0.0 112.819 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -38.67 75.32 0.0 OUTLIER Glycine 0 CA--C 1.542 1.781 0 C-N-CA 128.319 2.866 . . . . 0.0 117.239 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -81.97 25.55 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.629 1.972 . . . . 0.0 114.668 -170.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.275 11.6 p30 52.44 24.79 3.15 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.178 2.191 . . . . 0.0 114.842 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.35 172.25 18.07 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 126.888 2.185 . . . . 0.0 113.189 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -79.69 117.89 21.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.727 1.211 . . . . 0.0 111.919 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -104.84 117.33 33.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.053 1.741 . . . . 0.0 109.526 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.9 134.55 17.59 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 111.293 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -148.09 127.77 13.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.608 1.163 . . . . 0.0 112.146 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.84 113.54 1.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.136 1.374 . . . . 0.0 113.016 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tt -137.1 -28.36 0.94 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.944 1.298 . . . . 0.0 113.385 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.11 18.24 33.0 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.883 1.23 . . . . 0.0 114.498 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.66 11.25 2.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.385 2.274 . . . . 0.0 114.785 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.69 -72.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 C-N-CA 126.101 1.81 . . . . 0.0 110.319 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.43 156.75 22.77 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.813 0.816 . . . . 0.0 111.632 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.62 170.87 18.64 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.599 1.56 . . . . 0.0 112.43 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.9 130.87 35.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.303 1.041 . . . . 0.0 109.401 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -125.71 101.32 6.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -134.45 168.76 23.35 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 121.963 0.757 . . . . 0.0 113.843 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.7 tt -143.74 141.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.343 1.857 . . . . 0.0 109.049 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.5 ttt -146.28 143.07 28.93 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.78 1.632 . . . . 0.0 107.501 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.7 p -97.53 173.22 7.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.22 1.008 . . . . 0.0 111.539 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.0 m -109.43 33.72 4.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.555 1.542 . . . . 0.0 112.392 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.8 175.08 5.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.248 1.419 . . . . 0.0 112.376 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.65 -47.47 91.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.177 0.894 . . . . 0.0 113.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -108.87 72.01 0.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.784 1.278 . . . . 0.0 111.633 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.5 175.01 7.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.918 1.287 . . . . 0.0 111.211 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.81 151.16 47.83 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 109.312 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.9 tpp -140.68 87.77 2.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.147 0.979 . . . . 0.0 111.736 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.38 148.78 23.34 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.984 0.514 . . . . 0.0 111.05 174.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.87 99.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.25 1.42 . . . . 0.0 111.19 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -83.76 108.16 16.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.798 1.639 . . . . 0.0 109.844 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 110.07 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.132 0.573 . . . . 0.0 110.86 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 55.4 m -147.29 161.33 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.921 1.289 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 128.211 2.604 . . . . 0.0 111.686 177.834 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.79 11.07 22.56 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.504 1.122 . . . . 0.0 112.59 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.01 139.58 50.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.46 -1.4 . . . . 0.0 111.084 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.02 31.83 61.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -142.76 177.22 8.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 118.639 1.22 . . . . 0.0 112.398 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.5 pt -125.51 144.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.448 1.499 . . . . 0.0 112.734 175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.38 174.09 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.748 1.619 . . . . 0.0 112.236 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.52 121.01 8.68 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.023 1.329 . . . . 0.0 111.587 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.7 -21.74 44.31 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.111 1.339 . . . . 0.0 113.863 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.81 76.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.059 1.344 . . . . 0.0 111.931 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.9 m -88.51 -32.8 18.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.42 1.488 . . . . 0.0 112.361 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.6 tp -55.42 106.54 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.761 1.224 . . . . 0.0 111.623 175.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -146.29 168.98 19.73 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.825 1.25 . . . . 0.0 109.747 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.85 -37.87 14.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 114.05 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.85 -34.27 71.38 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -72.51 -48.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.191 1.397 . . . . 0.0 110.198 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.5 mt -54.31 -44.84 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 112.629 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.87 -45.5 77.89 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.963 0.505 . . . . 0.0 111.624 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -56.34 -41.54 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.821 1.649 . . . . 0.0 113.044 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 67.0 t -50.07 -55.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.197 1.399 . . . . 0.0 111.193 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.17 -38.65 88.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 112.479 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -49.63 75.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.12 1.368 . . . . 0.0 110.741 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.01 -36.07 61.96 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.08 -50.94 69.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.66 1.584 . . . . 0.0 112.23 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 62.83 0.36 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.893 1.235 . . . . 0.0 112.328 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -45.94 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.617 2.367 . . . . 0.0 114.04 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.5 -166.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.591 1.956 . . . . 0.0 111.211 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -43.78 -41.34 4.89 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.819 2.047 . . . . 0.0 113.99 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -144.38 138.91 28.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.551 1.94 . . . . 0.0 108.84 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -167.34 146.39 5.04 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.234 2.214 . . . . 0.0 109.591 -172.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.401 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -137.92 160.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.608 1.163 . . . . 0.0 110.916 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.49 118.04 31.57 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.995 1.318 . . . . 0.0 109.034 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.4 139.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.87 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.65 118.14 0.88 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.921 0.772 . . . . 0.0 111.711 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.79 97.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.128 0.971 . . . . 0.0 108.461 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -76.96 117.51 18.63 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 0.0 111.403 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -92.77 101.7 14.09 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.976 0.894 . . . . 0.0 112.215 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -111.38 12.46 21.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.451 1.1 . . . . 0.0 113.489 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -56.42 -51.97 66.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.1 1.76 . . . . 0.0 114.36 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.42 4.83 0.74 Allowed Glycine 0 CA--C 1.538 1.526 0 N-CA-C 116.505 1.362 . . . . 0.0 116.505 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 166.85 32.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.642 1.721 . . . . 0.0 114.348 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 t -69.94 126.93 31.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.125 1.37 . . . . 0.0 112.401 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -98.99 165.33 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.63 1.572 . . . . 0.0 111.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 m -135.41 106.97 6.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.104 1.362 . . . . 0.0 109.574 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.23 132.33 52.38 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.66 -72.63 0.3 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.587 0.755 . . . . 0.0 110.291 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.51 165.33 8.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.499 1.92 . . . . 0.0 111.048 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -114.21 124.18 51.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.885 1.674 . . . . 0.0 109.772 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.21 108.77 19.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.549 1.14 . . . . 0.0 111.37 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -73.31 118.54 16.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.481 1.112 . . . . 0.0 110.896 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.62 12.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.769 1.228 . . . . 0.0 111.942 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -143.42 150.98 39.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.78 2.032 . . . . 0.0 111.397 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.29 51.7 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.183 0.897 . . . . 0.0 113.648 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -149.13 163.23 38.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.875 -0.779 . . . . 0.0 111.094 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -142.43 130.17 21.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.892 1.277 . . . . 0.0 110.095 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.01 2.9 54.63 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.546 1.538 . . . . 0.0 113.521 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.71 169.76 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.697 1.199 . . . . 0.0 111.134 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.07 131.53 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.203 1.001 . . . . 0.0 110.037 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.44 154.27 83.91 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 118.289 0.495 . . . . 0.0 111.169 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.93 167.76 25.02 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.365 3.377 . . . . 0.0 109.957 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.14 -16.75 12.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.061 -1.025 . . . . 0.0 112.952 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -128.99 144.0 51.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.483 1.513 . . . . 0.0 109.958 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.5 t -143.52 99.48 5.28 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.674 1.19 . . . . 0.0 109.634 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.61 155.02 71.82 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.884 1.723 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -55.86 150.2 13.58 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.953 -0.467 . . . . 0.0 111.597 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 0.9 OUTLIER 68.83 -7.3 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.185 2.194 . . . . 0.0 115.417 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -101.58 141.71 34.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.402 1.455 . . . . 0.0 108.07 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.73 154.48 26.1 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.213 -0.929 . . . . 0.0 111.784 175.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 171.01 9.59 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.44 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -135.45 134.11 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.577 2.351 . . . . 0.0 107.364 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -150.19 162.35 40.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.766 1.626 . . . . 0.0 111.206 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.6 m -154.21 155.32 35.04 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.367 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' H ' HD13 ' A' ' 31' ' ' ILE . . . -150.42 143.65 10.93 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 121.2 -0.937 . . . . 0.0 113.411 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.06 163.63 29.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.779 1.232 . . . . 0.0 113.48 -172.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 99.32 7.86 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.699 1.237 . . . . 0.0 110.411 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 36.28 -131.0 0.1 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.87 2.468 . . . . 0.0 113.191 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -57.54 -53.67 55.57 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.806 -1.184 . . . . 0.0 112.73 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.22 -61.93 0.41 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.47 -8.72 23.91 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 124.433 3.422 . . . . 0.0 115.554 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.91 163.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.347 1.459 . . . . 0.0 112.836 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.64 74.51 1.01 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.056 1.342 . . . . 0.0 112.599 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.8 t -106.99 -107.91 0.32 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.723 1.609 . . . . 0.0 109.76 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -171.57 174.88 45.14 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.628 2.537 . . . . 0.0 111.163 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -136.82 93.13 2.81 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.067 1.347 . . . . 0.0 109.584 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.84 124.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.55 157.82 42.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.33 130.53 17.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.95 0.9 . . . . 0.0 110.916 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.58 176.44 8.32 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.734 1.613 . . . . 0.0 110.241 -172.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 150.35 44.79 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.466 0.651 . . . . 0.0 112.686 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.88 114.11 13.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 111.02 -175.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -79.54 123.54 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.219 1.408 . . . . 0.0 111.239 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 mtp -81.63 157.28 24.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.179 1.391 . . . . 0.0 112.257 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 p -62.2 -19.52 63.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.233 1.413 . . . . 0.0 114.757 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -84.06 -11.39 56.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.005 1.722 . . . . 0.0 113.755 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.85 -5.06 46.46 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.936 1.255 . . . . 0.0 115.11 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -76.12 171.82 13.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.654 1.182 . . . . 0.0 110.213 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 m -136.69 140.7 42.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.979 0.912 . . . . 0.0 110.158 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 123.51 50.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.51 139.08 18.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.14 122.18 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.711 1.205 . . . . 0.0 110.242 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.0 159.61 40.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -134.03 153.7 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.47 1.508 . . . . 0.0 110.913 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 t -137.1 104.79 5.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.574 1.55 . . . . 0.0 110.009 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.65 97.05 13.48 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 127.032 2.133 . . . . 0.0 108.475 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.57 167.05 28.23 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.773 2.316 . . . . 0.0 111.617 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -69.69 -45.27 68.66 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.614 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 114.59 26.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.573 1.549 . . . . 0.0 111.569 -165.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -65.76 -62.07 1.72 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.07 12.35 22.28 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -7.72 5.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.606 1.963 . . . . 0.0 112.568 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.68 139.92 19.42 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.458 2.303 . . . . 0.0 109.116 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 t -98.55 159.23 15.09 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -84.22 157.78 21.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.792 -0.567 . . . . 0.0 109.805 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -138.98 145.67 40.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.986 0.915 . . . . 0.0 110.819 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -155.32 148.21 24.46 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.864 1.265 . . . . 0.0 110.792 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.59 151.36 37.16 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.46 107.45 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.825 1.65 . . . . 0.0 109.77 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -115.86 148.03 40.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.221 1.408 . . . . 0.0 109.724 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.51 111.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.863 2.065 . . . . 0.0 109.241 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -118.33 145.13 45.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 0.0 112.349 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.6 t -73.35 90.11 1.64 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.385 1.074 . . . . 0.0 110.79 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.63 -174.23 42.04 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.476 0.56 . . . . 0.0 113.768 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 111.68 23.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.047 2.139 . . . . 0.0 110.908 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -147.84 156.56 42.84 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.312 -0.868 . . . . 0.0 111.655 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -140.38 167.4 22.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.522 1.529 . . . . 0.0 111.299 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.73 86.79 0.94 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.537 1.135 . . . . 0.0 111.555 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -111.18 -67.0 1.03 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 108.911 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.18 -67.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.849 1.26 . . . . 0.0 109.779 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.23 -36.62 90.12 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.961 0.791 . . . . 0.0 114.325 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.5 ttp -65.71 -48.26 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.791 1.295 . . . . 0.0 111.642 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.19 -49.42 75.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.674 0.79 . . . . 0.0 111.068 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -64.82 -37.33 87.26 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.37 -20.86 61.08 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.163 -1.585 . . . . 0.0 113.286 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.71 -50.41 5.39 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.484 1.513 . . . . 0.0 112.132 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -75.32 -57.16 4.06 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.587 1.085 . . . . 0.0 112.76 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.73 -19.35 49.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.337 1.455 . . . . 0.0 111.858 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.51 -90.14 0.05 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.003 1.287 . . . . 0.0 112.467 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.02 79.17 1.99 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.073 1.349 . . . . 0.0 110.598 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 150.1 52.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.689 1.593 . . . . 0.0 111.546 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 164.51 26.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.864 0.866 . . . . 0.0 109.171 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.76 118.61 36.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.143 1.377 . . . . 0.0 108.856 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.32 65.5 1.63 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.878 0.763 . . . . 0.0 112.627 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -82.52 18.69 1.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.437 1.895 . . . . 0.0 113.647 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 64.52 43.35 4.5 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.526 1.93 . . . . 0.0 112.63 -173.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.64 153.57 21.72 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.604 1.573 . . . . 0.0 113.652 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -70.15 133.57 47.24 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.613 1.165 . . . . 0.0 111.893 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.91 113.73 14.38 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.294 1.837 . . . . 0.0 110.158 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.58 153.7 41.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.684 1.594 . . . . 0.0 110.578 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -166.48 150.65 7.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.237 1.815 . . . . 0.0 110.23 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.09 127.48 32.28 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.164 0.893 . . . . 0.0 110.143 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 tt -135.48 -39.74 0.73 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.522 1.129 . . . . 0.0 112.09 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.85 20.98 10.25 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.008 1.29 . . . . 0.0 114.475 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.73 14.46 4.1 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.991 2.116 . . . . 0.0 114.668 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 177.3 -56.85 0.1 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.065 1.793 . . . . 0.0 110.955 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.43 153.69 21.71 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.904 0.859 . . . . 0.0 110.128 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.6 169.51 24.51 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.043 1.337 . . . . 0.0 112.331 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -100.89 140.85 34.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.661 1.184 . . . . 0.0 111.606 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -126.38 113.91 17.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -146.36 172.19 27.01 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-O 121.661 0.589 . . . . 0.0 113.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.8 tt -153.63 145.91 14.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 126.466 1.907 . . . . 0.0 108.316 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.3 ttm -140.96 137.91 33.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.223 1.009 . . . . 0.0 109.24 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.89 161.02 30.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.428 1.891 . . . . 0.0 112.187 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -33.95 23.15 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.335 -0.853 . . . . 0.0 113.269 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.13 172.62 6.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 112.536 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.22 -42.07 99.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.352 -0.843 . . . . 0.0 113.27 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' CB ' ' HE3' ' A' ' 30' ' ' LYS . 10.9 pt-20 -81.52 57.91 3.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.858 1.663 . . . . 0.0 113.908 178.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.74 170.61 9.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 124.02 15.73 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.025 -1.047 . . . . 0.0 112.559 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.02 91.17 3.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.699 2.0 . . . . 0.0 111.899 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -87.45 139.02 30.97 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.874 -0.516 . . . . 0.0 110.373 165.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.5 114.27 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.618 1.967 . . . . 0.0 108.37 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -110.01 108.52 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 110.177 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.8 mm -89.13 120.22 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.658 1.183 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 49.9 m -117.32 170.02 9.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.597 1.559 . . . . 0.0 112.789 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.895 2.078 . . . . 0.0 113.667 -179.4 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.33 -14.34 21.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.58 54.56 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.205 -0.935 . . . . 0.0 111.578 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 41.34 11.99 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.301 0.953 . . . . 0.0 114.732 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.8 p -142.88 -169.67 3.06 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 119.194 1.497 . . . . 0.0 112.902 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 pt -122.99 127.25 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.615 2.366 . . . . 0.0 110.757 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.59 166.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.767 1.227 . . . . 0.0 111.787 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 110.91 1.96 Allowed 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.658 -1.277 . . . . 0.0 113.044 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -29.08 61.51 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.164 0.888 . . . . 0.0 113.752 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.97 74.49 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.267 -1.137 . . . . 0.0 112.834 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -89.59 -18.39 26.67 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.945 1.298 . . . . 0.0 113.291 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.8 tp -65.41 115.34 5.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.126 1.371 . . . . 0.0 110.481 174.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -142.94 166.3 25.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.553 1.141 . . . . 0.0 110.043 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -40.26 26.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.706 1.602 . . . . 0.0 113.927 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.35 -34.95 74.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.314 1.446 . . . . 0.0 113.267 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.01 -45.68 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 109.82 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.63 -45.9 66.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.029 0.931 . . . . 0.0 112.435 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.31 -47.8 78.07 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.93 -0.481 . . . . 0.0 112.253 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -53.54 -42.17 67.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.783 1.233 . . . . 0.0 112.683 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -54.22 -57.08 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.829 0.852 . . . . 0.0 111.216 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.49 -40.9 96.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.028 1.331 . . . . 0.0 112.671 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.98 -45.89 82.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.528 0.731 . . . . 0.0 112.164 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.98 -21.02 29.69 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.26 -45.65 87.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.713 2.005 . . . . 0.0 113.605 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 32.78 7.17 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 114.747 0.659 . . . . 0.0 114.747 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 174.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.831 2.052 . . . . 0.0 114.293 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.33 -162.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.177 1.791 . . . . 0.0 111.478 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -54.5 -24.63 21.37 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -123.75 141.69 51.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.191 1.796 . . . . 0.0 110.293 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.1 149.32 15.84 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.342 1.857 . . . . 0.0 111.555 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -143.41 145.93 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.795 1.638 . . . . 0.0 109.917 175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.23 121.64 41.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.403 1.481 . . . . 0.0 108.029 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.96 136.46 50.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.108 1.763 . . . . 0.0 110.589 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.5 120.74 1.23 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.014 1.292 . . . . 0.0 111.829 174.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.56 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.262 1.425 . . . . 0.0 108.451 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 104.94 8.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.071 0.948 . . . . 0.0 112.095 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -73.61 96.89 2.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.484 0.714 . . . . 0.0 110.684 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -122.25 21.62 10.34 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.106 1.762 . . . . 0.0 112.08 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.6 t -71.53 -43.23 66.82 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.294 1.438 . . . . 0.0 113.687 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.03 16.83 3.17 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.925 1.726 . . . . 0.0 115.667 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.83 155.44 26.81 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 119.597 1.698 . . . . 0.0 115.057 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -68.45 132.02 46.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -105.12 165.25 11.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.504 1.522 . . . . 0.0 111.849 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 m -134.45 113.76 12.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.105 1.362 . . . . 0.0 108.921 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.5 136.6 57.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.155 -0.966 . . . . 0.0 109.557 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.29 -70.76 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -177.48 175.78 1.38 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.617 2.367 . . . . 0.0 110.082 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.26 150.02 50.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.171 2.188 . . . . 0.0 109.306 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 112.3 8.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.232 . . . . 0.0 110.256 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -71.69 121.39 18.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.487 1.115 . . . . 0.0 110.846 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -95.5 -43.54 7.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.106 0.963 . . . . 0.0 112.032 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.4 m -141.22 156.89 45.85 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.935 2.094 . . . . 0.0 110.299 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.1 -176.74 53.86 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.468 0.556 . . . . 0.0 113.508 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -137.67 164.44 28.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.602 1.161 . . . . 0.0 111.027 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -144.38 175.47 10.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.451 1.1 . . . . 0.0 111.76 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -134.23 17.05 3.75 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.367 1.067 . . . . 0.0 112.279 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.95 166.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.818 2.047 . . . . 0.0 112.565 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.96 134.14 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.833 1.653 . . . . 0.0 109.632 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 154.47 86.42 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.993 0.815 . . . . 0.0 112.339 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.42 172.47 13.23 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.452 3.435 . . . . 0.0 110.525 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -113.38 -21.41 10.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -125.62 125.81 43.72 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 110.675 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.97 95.0 19.45 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.034 1.333 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.04 160.33 34.53 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.876 1.717 . . . . 0.0 111.23 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.61 156.86 10.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.801 -0.562 . . . . 0.0 111.586 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m 75.13 -22.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.182 2.193 . . . . 0.0 112.892 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -100.68 141.66 33.24 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.547 1.939 . . . . 0.0 109.576 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.05 178.0 4.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.775 2.03 . . . . 0.0 109.558 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.28 175.92 5.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 109.796 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.28 124.37 34.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.633 1.573 . . . . 0.0 107.363 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -146.0 150.17 35.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.592 0.357 . . . . 0.0 110.723 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.4 m -147.35 158.93 44.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.35 0.595 . . . . 0.0 111.129 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.01 10.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.515 1.531 . . . . 0.0 111.183 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -131.72 168.91 16.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.524 1.53 . . . . 0.0 110.467 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.52 179.34 0.47 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.029 0.932 . . . . 0.0 110.098 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.94 -179.98 0.24 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 121.114 -0.991 . . . . 0.0 111.264 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -28.58 -49.64 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.375 2.67 . . . . 0.0 115.939 -172.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.58 -59.61 0.33 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.016 1.293 . . . . 0.0 112.677 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.77 -2.66 11.77 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.25 3.3 . . . . 0.0 115.067 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.71 124.2 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.462 1.505 . . . . 0.0 111.297 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.24 75.71 1.66 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.19 1.796 . . . . 0.0 111.786 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.8 m -100.58 -75.44 0.58 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.623 1.169 . . . . 0.0 111.244 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.57 -176.52 45.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.74 1.162 . . . . 0.0 112.253 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.54 105.29 5.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.695 1.198 . . . . 0.0 110.671 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.18 120.41 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.311 1.044 . . . . 0.0 108.585 -171.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.94 168.59 19.89 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.89 0.852 . . . . 0.0 111.526 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.57 156.25 43.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.077 0.951 . . . . 0.0 111.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.73 175.52 11.9 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.777 2.031 . . . . 0.0 110.66 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.35 43.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.897 0.879 . . . . 0.0 111.504 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.73 118.66 26.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 110.957 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.52 117.43 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.992 1.717 . . . . 0.0 110.309 176.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.9 mtm -75.58 162.6 28.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.487 0.66 . . . . 0.0 112.492 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -60.41 -21.55 62.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.928 1.291 . . . . 0.0 114.078 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -83.23 -12.19 57.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.05 2.14 . . . . 0.0 113.56 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.03 -1.56 57.78 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.475 1.512 . . . . 0.0 115.252 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.35 171.22 15.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.066 1.347 . . . . 0.0 110.143 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.0 m -131.59 148.34 52.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.746 0.818 . . . . 0.0 110.473 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.42 112.81 18.52 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.761 1.224 . . . . 0.0 108.237 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.44 141.9 29.43 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.25 127.69 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 109.191 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -140.72 162.97 34.15 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -140.43 159.93 41.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.84 1.256 . . . . 0.0 111.46 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -140.71 112.8 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.939 1.696 . . . . 0.0 109.351 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.33 101.06 54.3 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.265 1.826 . . . . 0.0 108.48 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 163.88 34.49 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.554 2.169 . . . . 0.0 111.756 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.59 -26.72 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.06 114.48 27.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.04 1.336 . . . . 0.0 111.506 -172.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.33 -57.17 4.02 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.325 1.05 . . . . 0.0 113.66 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.13 13.65 12.65 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.908 -1.12 . . . . 0.0 113.807 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.72 -19.26 2.36 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.241 1.816 . . . . 0.0 113.438 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -141.83 169.6 17.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.934 2.893 . . . . 0.0 108.753 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 t -132.95 161.21 34.89 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.017 -1.052 . . . . 0.0 109.867 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -88.53 161.32 17.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.793 0.806 . . . . 0.0 111.415 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -141.58 151.46 43.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.116 0.966 . . . . 0.0 110.688 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.5 p-90 -154.17 157.83 39.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.124 1.37 . . . . 0.0 110.492 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -150.83 146.92 26.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.922 2.089 . . . . 0.0 109.509 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.02 117.88 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.534 1.534 . . . . 0.0 108.797 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -122.42 140.13 53.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.818 1.247 . . . . 0.0 110.471 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -109.38 117.33 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.777 2.031 . . . . 0.0 108.525 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.79 145.43 50.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.164 1.386 . . . . 0.0 112.836 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 p -75.61 79.51 2.6 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.139 1.775 . . . . 0.0 112.661 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.03 173.54 23.92 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.147 1.356 . . . . 0.0 112.82 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 148.99 48.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.876 1.27 . . . . 0.0 111.683 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.8 112.69 2.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.433 1.093 . . . . 0.0 111.622 174.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.38 175.93 9.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.127 0.971 . . . . 0.0 110.564 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.56 99.08 4.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.825 1.65 . . . . 0.0 108.452 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.05 -70.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.108 0.963 . . . . 0.0 110.226 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -67.47 0.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.56 1.144 . . . . 0.0 110.84 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.66 -9.08 84.83 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.429 1.014 . . . . 0.0 115.252 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -43.65 9.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.518 1.127 . . . . 0.0 111.083 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -36.91 83.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.65 1.18 . . . . 0.0 111.299 175.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.74 -29.72 66.94 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.067 -1.02 . . . . 0.0 113.092 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -20.09 63.31 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.717 1.207 . . . . 0.0 112.816 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.08 -50.89 5.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.108 1.363 . . . . 0.0 109.196 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.06 -47.4 84.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -94.44 -13.87 25.78 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.045 0.938 . . . . 0.0 113.103 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.53 -62.85 5.43 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.547 1.07 . . . . 0.0 113.049 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -177.17 78.41 0.25 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 128.392 2.677 . . . . 0.0 108.694 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.3 157.62 60.6 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.493 1.462 . . . . 0.0 110.833 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.97 6.35 41.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.11 65.09 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.732 2.813 . . . . 0.0 113.617 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -44.02 101.56 0.03 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.399 1.952 . . . . 0.0 115.177 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.58 28.29 1.53 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.16 2.184 . . . . 0.0 113.314 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.55 52.75 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.251 1.821 . . . . 0.0 112.849 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -151.59 154.38 25.52 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.276 1.417 . . . . 0.0 113.178 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -62.95 117.05 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.642 1.177 . . . . 0.0 113.31 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -108.09 119.18 38.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.152 2.181 . . . . 0.0 110.966 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.94 133.01 15.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.151 0.98 . . . . 0.0 111.236 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -146.3 130.12 17.16 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.688 1.195 . . . . 0.0 111.981 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.85 107.98 0.79 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.048 1.339 . . . . 0.0 112.277 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.65 -32.34 3.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.009 1.324 . . . . 0.0 112.872 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.28 22.16 6.46 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.049 1.309 . . . . 0.0 114.821 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 56.84 8.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 115.631 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.64 -57.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.328 1.442 . . . . 0.0 111.413 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.64 156.53 17.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.832 0.825 . . . . 0.0 112.18 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.82 168.35 27.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.871 1.668 . . . . 0.0 112.21 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.5 141.46 28.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.878 0.871 . . . . 0.0 110.871 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.16 104.13 7.13 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.33 169.66 24.18 Favored Glycine 0 N--CA 1.454 -0.13 0 CA-C-O 121.888 0.716 . . . . 0.0 114.526 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.78 144.43 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.691 1.196 . . . . 0.0 109.312 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 ttt -141.94 130.16 22.21 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.777 1.231 . . . . 0.0 108.556 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.1 p -88.31 163.05 16.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 110.952 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -96.12 -22.47 17.3 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.45 172.95 4.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.492 1.517 . . . . 0.0 113.165 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.59 -41.8 42.92 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.344 1.45 . . . . 0.0 114.158 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.87 78.34 8.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 111.105 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.41 79.85 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.804 0.841 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.23 149.16 24.85 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 120.868 -1.145 . . . . 0.0 110.549 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.1 ttm -144.58 124.53 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.766 1.227 . . . . 0.0 109.975 -174.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -141.14 139.02 33.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.96 92.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.776 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.24 107.02 17.74 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.319 1.448 . . . . 0.0 108.553 174.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.79 131.37 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 0.0 110.73 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 p -154.51 165.4 36.55 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 128.468 2.707 . . . . 0.0 111.903 175.867 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.98 8.81 41.67 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 112.87 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.27 148.52 50.68 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.806 -1.184 . . . . 0.0 112.287 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.81 36.85 91.32 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.84 0.733 . . . . 0.0 114.2 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -142.28 175.79 9.49 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.908 0.854 . . . . 0.0 112.34 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 pt -118.17 138.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.789 1.636 . . . . 0.0 111.38 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -146.76 174.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.12 1.768 . . . . 0.0 111.587 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 103.53 0.11 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 112.364 175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.42 -25.66 67.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.252 0.93 . . . . 0.0 113.9 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.88 14.79 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -117.43 7.31 12.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.804 1.641 . . . . 0.0 113.218 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 114.48 11.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.513 1.125 . . . . 0.0 112.199 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 m -146.25 172.55 13.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.261 1.425 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -48.41 -37.64 17.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.935 1.694 . . . . 0.0 114.188 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -56.41 -35.9 68.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.652 1.181 . . . . 0.0 113.302 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.79 -47.48 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.082 1.753 . . . . 0.0 109.643 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.59 -46.18 80.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.393 1.077 . . . . 0.0 113.237 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.16 -42.75 99.49 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.654 -0.654 . . . . 0.0 111.103 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -39.23 72.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.758 1.223 . . . . 0.0 113.516 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.5 -59.55 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.294 1.038 . . . . 0.0 110.601 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.72 -42.24 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.49 1.516 . . . . 0.0 112.406 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.17 -53.34 54.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.176 0.99 . . . . 0.0 112.167 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.35 -42.59 62.06 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.402 HD22 ' CZ ' ' A' ' 74' ' ' ARG . 15.5 tp -48.52 -52.38 22.84 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.379 1.872 . . . . 0.0 112.349 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.01 59.79 0.23 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.607 1.098 . . . . 0.0 112.552 -172.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 141.74 6.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.588 1.155 . . . . 0.0 112.516 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -160.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.771 1.628 . . . . 0.0 110.825 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -50.69 -31.91 17.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.238 1.415 . . . . 0.0 113.058 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -146.39 143.78 29.29 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.591 2.357 . . . . 0.0 110.237 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.69 153.54 12.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 128.078 2.551 . . . . 0.0 110.185 -173.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -146.08 150.3 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.822 1.649 . . . . 0.0 109.953 175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.51 123.85 51.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.614 1.166 . . . . 0.0 110.777 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -116.48 123.85 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.602 1.561 . . . . 0.0 110.778 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.67 112.05 0.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.854 1.216 . . . . 0.0 112.3 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 mt -109.18 111.09 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.635 1.174 . . . . 0.0 109.427 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.93 131.15 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.947 0.899 . . . . 0.0 113.228 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.51 93.16 7.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.552 0.741 . . . . 0.0 110.572 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.94 20.37 11.58 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.411 1.485 . . . . 0.0 112.278 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -85.56 -40.94 15.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.815 1.646 . . . . 0.0 114.748 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 12.48 10.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 -173.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.99 161.14 29.46 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.336 1.568 . . . . 0.0 115.05 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -76.99 127.4 32.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.211 1.404 . . . . 0.0 112.122 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -102.86 162.12 13.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.322 1.449 . . . . 0.0 111.62 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -133.46 115.89 15.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.844 1.257 . . . . 0.0 109.439 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.18 137.16 57.44 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.005 -1.059 . . . . 0.0 110.355 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.27 -71.02 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -174.72 176.54 2.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.992 2.117 . . . . 0.0 110.563 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -124.95 154.69 40.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.953 2.101 . . . . 0.0 109.841 175.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.73 106.04 6.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.035 1.334 . . . . 0.0 110.564 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.85 105.02 5.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.791 1.237 . . . . 0.0 111.18 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -78.37 -51.94 9.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.937 1.295 . . . . 0.0 111.692 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -137.27 155.88 48.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.901 2.081 . . . . 0.0 110.361 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 -173.64 52.06 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.722 -0.611 . . . . 0.0 113.329 -174.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -134.88 176.32 8.76 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.641 1.176 . . . . 0.0 110.316 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -150.5 178.12 9.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.525 1.53 . . . . 0.0 110.479 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -139.3 18.15 2.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.179 1.391 . . . . 0.0 112.025 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.0 m -134.6 171.76 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.892 2.077 . . . . 0.0 110.809 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mt -143.87 132.3 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.377 1.071 . . . . 0.0 109.463 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.55 150.17 84.33 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.587 0.63 . . . . 0.0 111.572 178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.68 166.3 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.73 2.954 . . . . 0.0 109.928 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -105.81 -30.01 9.67 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.312 -0.868 . . . . 0.0 111.572 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -117.26 127.81 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.547 1.139 . . . . 0.0 111.029 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.06 91.31 24.17 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.89 1.276 . . . . 0.0 108.911 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -63.19 162.79 25.24 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.34 2.027 . . . . 0.0 111.483 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -57.61 158.72 5.73 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 72.5 -35.42 0.33 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.941 2.097 . . . . 0.0 114.211 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -86.91 124.71 33.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.08 171.63 8.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.431 1.092 . . . . 0.0 109.493 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.84 163.26 13.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.53 133.27 48.38 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.248 1.819 . . . . 0.0 107.824 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.8 167.22 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 110.438 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -156.52 160.41 39.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.57 0.7 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 127.41 3.24 Favored Glycine 0 N--CA 1.462 0.415 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.402 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -126.32 167.16 15.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.223 1.012 . . . . 0.0 110.082 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 179.98 1.49 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 109.886 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -172.67 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.824 1.649 . . . . 0.0 111.357 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.1 m -25.94 -56.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 127.312 2.245 . . . . 0.0 115.238 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.43 -57.07 0.41 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.596 1.093 . . . . 0.0 113.831 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.79 -2.34 11.76 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.621 3.548 . . . . 0.0 115.574 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.66 130.84 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.96 1.704 . . . . 0.0 110.792 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.68 88.6 5.44 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.567 -1.333 . . . . 0.0 111.959 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.4 m -122.83 -86.51 0.65 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 111.522 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.41 -177.97 42.74 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.781 1.173 . . . . 0.0 112.938 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.52 108.65 6.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.063 0.945 . . . . 0.0 111.012 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.93 119.63 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.987 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -144.42 171.45 14.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.995 0.902 . . . . 0.0 111.587 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.09 40.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.312 1.045 . . . . 0.0 111.716 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.38 175.76 11.54 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.711 1.605 . . . . 0.0 110.415 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.95 140.87 47.04 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.833 1.253 . . . . 0.0 110.602 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.89 113.53 18.62 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.58 1.152 . . . . 0.0 111.356 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.39 118.71 15.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.765 1.626 . . . . 0.0 110.691 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.7 mtt -73.06 163.53 28.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 112.181 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -62.52 -21.03 65.22 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.76 1.224 . . . . 0.0 113.884 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.71 -16.22 39.71 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.76 1.624 . . . . 0.0 113.515 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.38 2.12 47.51 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.192 1.377 . . . . 0.0 115.647 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -86.23 173.53 9.71 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.738 1.215 . . . . 0.0 110.421 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 m -136.04 143.22 44.58 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.144 175.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.15 115.76 30.71 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 135.12 15.13 Favored Glycine 0 N--CA 1.463 0.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.2 126.85 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 118.049 0.925 . . . . 0.0 109.704 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.3 153.65 51.1 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.717 0.807 . . . . 0.0 110.673 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -135.01 154.55 51.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.749 . . . . 0.0 111.991 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -137.08 109.55 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 110.773 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.7 106.17 57.58 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 124.527 1.131 . . . . 0.0 110.257 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.18 161.81 39.99 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.944 2.429 . . . . 0.0 112.007 174.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.0 -28.23 64.27 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.783 0.833 . . . . 0.0 112.807 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.36 120.86 41.21 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.471 1.508 . . . . 0.0 110.955 -170.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -73.93 -63.91 1.12 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.81 9.23 19.71 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.884 -1.135 . . . . 0.0 114.031 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -5.62 6.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.259 2.224 . . . . 0.0 112.225 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 138.75 10.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.678 1.991 . . . . 0.0 109.583 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -103.27 159.56 15.45 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.07 -1.019 . . . . 0.0 110.031 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -80.23 161.69 25.03 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.866 -0.521 . . . . 0.0 109.738 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -139.51 143.53 37.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.708 0.803 . . . . 0.0 110.804 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -155.06 149.77 26.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.658 1.583 . . . . 0.0 110.239 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -149.01 154.72 39.75 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.993 1.717 . . . . 0.0 107.675 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 66.7 t -147.37 116.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 126.87 2.068 . . . . 0.0 109.416 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -123.39 148.15 46.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.542 1.537 . . . . 0.0 110.096 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 mt -110.97 112.57 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 108.821 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -127.39 136.39 51.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 112.2 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.1 p -76.67 81.68 3.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.324 1.45 . . . . 0.0 112.58 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.35 178.6 45.31 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.27 0.938 . . . . 0.0 113.645 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -111.78 104.99 13.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.497 1.919 . . . . 0.0 110.885 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -145.81 158.14 43.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.918 1.287 . . . . 0.0 111.228 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.25 163.97 29.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.125 1.37 . . . . 0.0 112.527 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.57 79.07 1.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.633 1.173 . . . . 0.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.21 -67.37 0.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.057 1.343 . . . . 0.0 109.576 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -149.3 -72.56 0.18 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.368 1.867 . . . . 0.0 108.801 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.9 64.59 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.94 1.257 . . . . 0.0 114.732 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.3 ttp -83.85 -57.83 3.05 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.288 1.044 . . . . 0.0 110.409 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -48.85 -49.83 37.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.083 1.353 . . . . 0.0 111.638 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -62.36 -32.25 73.01 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.01 -13.55 62.28 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.155 -0.965 . . . . 0.0 113.12 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.01 -47.96 5.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.445 1.498 . . . . 0.0 109.456 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.06 -61.51 2.0 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.637 -1.29 . . . . 0.0 112.35 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.58 -19.89 48.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 111.658 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.39 -80.91 0.07 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.334 1.445 . . . . 0.0 112.828 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.36 86.29 0.89 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.318 1.447 . . . . 0.0 110.529 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.62 160.2 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.696 1.597 . . . . 0.0 111.709 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.94 1.01 39.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.52 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 33.87 60.03 0.54 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.796 2.438 . . . . 0.0 114.25 176.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -20.23 82.4 0.0 OUTLIER Glycine 0 N--CA 1.472 1.083 0 C-N-CA 129.409 3.385 . . . . 0.0 116.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.0 35.41 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.424 1.49 . . . . 0.0 112.052 -172.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 68.25 26.36 6.96 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.59 1.556 . . . . 0.0 112.245 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.89 146.01 18.0 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.552 1.549 . . . . 0.0 113.3 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -65.97 138.15 57.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.858 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.67 118.04 18.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.041 1.736 . . . . 0.0 110.641 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.97 145.64 32.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.296 1.438 . . . . 0.0 110.903 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -146.31 121.83 10.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.248 1.419 . . . . 0.0 110.549 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.09 91.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.682 1.593 . . . . 0.0 113.358 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.96 4.5 1.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.32 22.57 31.83 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.578 -1.326 . . . . 0.0 115.881 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.52 7.69 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.597 1.959 . . . . 0.0 115.39 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.38 -36.71 0.19 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.764 -1.21 . . . . 0.0 114.365 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.0 mp -129.48 147.64 51.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.02 1.328 . . . . 0.0 110.681 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 173.94 9.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.122 1.369 . . . . 0.0 111.956 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.17 139.96 38.48 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.69 1.596 . . . . 0.0 109.56 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -131.76 107.75 8.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.567 1.547 . . . . 0.0 108.086 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.9 171.57 19.17 Favored Glycine 0 CA--C 1.517 0.217 0 CA-C-O 121.382 0.434 . . . . 0.0 113.477 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.7 143.83 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 124.506 1.122 . . . . 0.0 109.215 176.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.9 ttm -144.17 140.16 29.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.882 1.673 . . . . 0.0 109.014 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.19 157.72 27.8 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.505 2.322 . . . . 0.0 111.562 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.83 5.91 26.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.309 -1.494 . . . . 0.0 114.801 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.43 177.53 4.82 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.703 2.001 . . . . 0.0 112.77 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.67 -67.87 1.99 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.368 0.985 . . . . 0.0 112.269 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -74.85 39.52 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.536 1.934 . . . . 0.0 115.223 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.03 138.94 58.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.378 1.071 . . . . 0.0 112.861 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.28 124.35 35.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 109.2 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 17.7 mtp -117.87 107.15 13.76 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.863 1.665 . . . . 0.0 109.971 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -114.96 151.4 34.17 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.521 -0.737 . . . . 0.0 111.358 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.8 96.62 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.733 1.613 . . . . 0.0 110.912 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -84.81 107.86 17.19 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.864 1.666 . . . . 0.0 109.919 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.3 mm -84.51 117.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.401 -0.812 . . . . 0.0 110.089 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 m -141.9 169.95 16.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.471 1.509 . . . . 0.0 113.195 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.355 1.862 . . . . 0.0 111.526 -178.047 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.36 -2.98 20.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.589 1.556 . . . . 0.0 112.704 177.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.45 156.38 39.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.696 -1.252 . . . . 0.0 111.484 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.06 36.87 90.41 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.33 -168.52 3.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 111.923 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.39 149.14 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.671 1.588 . . . . 0.0 111.29 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pt -151.25 169.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.343 1.857 . . . . 0.0 112.577 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.44 124.81 17.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.892 1.677 . . . . 0.0 111.755 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.9 48.38 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.284 0.945 . . . . 0.0 113.976 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.99 82.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.916 1.286 . . . . 0.0 112.49 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 -30.92 35.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.832 0.853 . . . . 0.0 112.385 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.8 tp -59.66 90.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.625 1.97 . . . . 0.0 113.635 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -146.73 169.29 19.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 0.0 109.368 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -43.98 -37.46 2.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.018 1.727 . . . . 0.0 114.735 177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.2 -39.24 78.48 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.38 -42.05 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.665 . . . . 0.0 110.74 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.79 -47.73 70.5 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.304 1.041 . . . . 0.0 111.386 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.16 -42.55 96.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.437 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -58.79 -39.28 80.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.177 1.391 . . . . 0.0 113.668 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.2 t -62.8 -55.37 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.548 1.539 . . . . 0.0 109.867 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 mp -55.68 -45.9 77.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 0.0 112.49 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.15 -38.04 81.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.05 -43.9 41.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 113.058 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.71 -53.87 41.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.502 1.521 . . . . 0.0 111.173 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.13 63.02 0.11 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.356 0.979 . . . . 0.0 112.516 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -42.89 127.95 4.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 110.653 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.79 -165.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.353 1.861 . . . . 0.0 110.212 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -48.99 -45.46 42.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.647 1.579 . . . . 0.0 114.358 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -139.3 129.7 25.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.469 1.907 . . . . 0.0 109.569 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.43 155.54 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.112 2.165 . . . . 0.0 110.049 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.17 162.49 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.173 0.989 . . . . 0.0 111.46 175.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.93 116.22 30.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.835 1.254 . . . . 0.0 109.529 174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.63 142.95 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.709 1.203 . . . . 0.0 110.86 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.28 122.55 1.13 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.314 0.959 . . . . 0.0 111.953 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.0 mt -113.04 102.7 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.151 1.38 . . . . 0.0 108.654 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.61 111.81 19.45 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.72 0.808 . . . . 0.0 112.231 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -71.69 99.76 2.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.793 1.237 . . . . 0.0 111.117 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.68 14.31 15.34 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.26 1.824 . . . . 0.0 113.281 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.4 t -70.09 -45.59 66.67 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.93 8.08 5.29 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.234 1.397 . . . . 0.0 116.058 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.67 160.47 29.02 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 119.578 1.689 . . . . 0.0 113.634 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.9 p -73.96 138.87 44.47 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.722 -0.869 . . . . 0.0 112.185 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -112.84 167.05 10.81 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.777 1.231 . . . . 0.0 112.006 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -131.92 105.78 7.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.128 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.5 122.68 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.21 -66.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.34 163.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.211 2.604 . . . . 0.0 110.155 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -108.77 123.91 49.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.349 1.86 . . . . 0.0 110.4 175.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.95 111.71 19.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.301 1.041 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.26 124.34 26.91 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.993 1.317 . . . . 0.0 111.993 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -47.63 7.26 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.093 1.357 . . . . 0.0 112.241 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -135.37 149.17 49.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.537 1.935 . . . . 0.0 109.951 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.06 -157.5 50.18 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.891 -0.506 . . . . 0.0 113.09 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -152.86 -176.71 5.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.521 0.676 . . . . 0.0 112.2 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -141.97 173.95 11.04 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.183 1.793 . . . . 0.0 111.367 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -121.51 12.79 10.85 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.927 1.291 . . . . 0.0 112.229 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.31 176.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.047 2.139 . . . . 0.0 113.628 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.95 135.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.53 1.932 . . . . 0.0 109.776 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.01 142.48 41.66 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 118.765 0.711 . . . . 0.0 110.606 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.81 164.86 22.85 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.95 3.1 . . . . 0.0 111.117 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -107.55 -17.61 14.06 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.502 -0.749 . . . . 0.0 112.716 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.64 133.97 53.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.956 1.702 . . . . 0.0 111.097 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.88 88.04 23.69 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.896 1.678 . . . . 0.0 108.868 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.42 161.13 32.38 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.919 1.746 . . . . 0.0 112.06 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.44 153.66 34.63 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.407 -0.808 . . . . 0.0 111.448 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 p 66.23 5.04 3.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.692 1.997 . . . . 0.0 114.267 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -123.39 147.81 46.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.621 2.368 . . . . 0.0 110.108 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.57 160.44 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.647 1.179 . . . . 0.0 111.354 177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.16 170.75 8.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.408 0.623 . . . . 0.0 110.335 175.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -126.44 133.89 51.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.334 1.854 . . . . 0.0 108.877 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -152.82 162.44 41.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.191 1.397 . . . . 0.0 111.536 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -142.37 166.6 24.24 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.769 1.228 . . . . 0.0 110.972 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.75 115.24 0.77 Allowed Glycine 0 N--CA 1.472 1.092 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.769 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 156.22 20.92 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.18 1.49 . . . . 0.0 114.378 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.88 110.64 7.34 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 40.78 -151.19 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.69 1.596 . . . . 0.0 113.664 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -74.14 -49.57 23.17 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.958 -1.714 . . . . 0.0 111.286 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.91 -59.27 0.37 Allowed Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.665 1.126 . . . . 0.0 114.394 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.33 0.15 7.22 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.699 3.599 . . . . 0.0 114.984 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.32 132.48 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 127.599 2.36 . . . . 0.0 109.364 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.82 71.84 0.81 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.034 1.333 . . . . 0.0 110.516 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 m -97.27 -65.03 0.99 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.01 0.924 . . . . 0.0 110.895 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.61 176.41 35.52 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.988 1.28 . . . . 0.0 111.712 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.69 108.34 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.065 0.946 . . . . 0.0 110.479 175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.36 138.9 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.96 0.904 . . . . 0.0 109.585 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.11 161.98 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.967 0.907 . . . . 0.0 110.779 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.43 20.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.786 0.803 . . . . 0.0 112.976 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.57 169.0 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.795 1.638 . . . . 0.0 109.446 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.98 148.96 47.23 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.42 104.57 6.18 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 111.796 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -73.54 111.82 9.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.084 1.354 . . . . 0.0 111.639 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 160.41 30.72 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 112.317 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 p -60.99 -20.08 62.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 m -84.78 -16.09 42.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.524 1.93 . . . . 0.0 113.84 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.52 4.95 46.13 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.39 0.995 . . . . 0.0 115.565 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.51 165.31 13.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.449 1.5 . . . . 0.0 108.757 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -136.32 151.11 49.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 109.566 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.38 130.55 56.57 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.278 0.631 . . . . 0.0 110.354 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.21 138.74 18.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.5 t -136.02 118.0 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.354 1.062 . . . . 0.0 108.816 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptm -121.46 156.89 31.8 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 174.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.39 141.03 52.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.104 1.362 . . . . 0.0 108.852 174.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -130.63 104.37 7.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.907 0.883 . . . . 0.0 110.75 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 t -115.61 101.57 54.21 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.007 2.123 . . . . 0.0 109.119 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.39 168.07 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.273 1.982 . . . . 0.0 110.454 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -75.37 -41.33 56.69 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.707 -0.621 . . . . 0.0 110.32 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.35 121.86 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.637 1.175 . . . . 0.0 111.954 -166.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -72.83 -59.83 2.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -91.29 9.44 31.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -4.37 5.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.023 2.129 . . . . 0.0 112.538 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.71 158.34 36.76 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.791 2.436 . . . . 0.0 109.111 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 169.36 10.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.826 -1.171 . . . . 0.0 111.602 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.26 148.36 25.14 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.752 -0.592 . . . . 0.0 110.445 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.51 157.63 44.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.035 0.534 . . . . 0.0 112.351 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -161.67 136.83 7.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.411 1.484 . . . . 0.0 110.396 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.76 147.51 48.62 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.28 118.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.099 1.36 . . . . 0.0 110.623 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.23 138.23 53.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.1 1.76 . . . . 0.0 109.452 174.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.4 mt -109.37 119.66 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.178 1.791 . . . . 0.0 108.543 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 147.61 52.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 0.0 112.555 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 p -74.0 80.97 1.7 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.652 1.981 . . . . 0.0 112.27 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.29 -166.8 37.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.705 -0.622 . . . . 0.0 114.393 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -113.18 115.87 28.93 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.384 1.874 . . . . 0.0 111.361 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -134.09 83.76 2.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.043 2.537 . . . . 0.0 108.46 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 168.36 5.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.657 1.183 . . . . 0.0 110.95 177.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.19 99.04 8.5 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 111.15 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -106.67 -70.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.112 0.965 . . . . 0.0 110.706 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -150.0 -68.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.167 1.787 . . . . 0.0 109.811 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.39 -24.26 77.11 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.386 0.993 . . . . 0.0 114.893 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -76.33 -56.63 4.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.266 1.033 . . . . 0.0 109.82 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -35.51 63.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.859 0.864 . . . . 0.0 111.429 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.06 -34.0 54.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -61.43 -41.26 96.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.903 0.881 . . . . 0.0 111.093 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.79 -38.0 73.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.858 -1.152 . . . . 0.0 111.715 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -74.06 -51.73 14.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -88.0 -17.89 30.22 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 113.079 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.87 -80.24 0.08 OUTLIER Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.711 1.148 . . . . 0.0 112.066 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -170.15 74.78 0.63 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.74 1.616 . . . . 0.0 110.968 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.19 135.37 31.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 119.918 1.006 . . . . 0.0 109.788 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -60.19 156.86 14.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.743 1.217 . . . . 0.0 110.439 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -93.36 5.01 53.01 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -165.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 53.95 55.61 24.98 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.559 1.076 . . . . 0.0 112.654 -172.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.33 24.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.571 1.548 . . . . 0.0 114.901 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.252 10.1 p30 48.31 34.45 4.6 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.665 2.386 . . . . 0.0 115.021 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.38 159.62 26.75 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.912 1.72 . . . . 0.0 112.058 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -61.78 127.37 31.12 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 110.934 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -122.91 105.67 10.2 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.144 1.778 . . . . 0.0 109.637 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -138.38 137.12 36.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.579 1.952 . . . . 0.0 110.89 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -147.8 133.44 18.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.264 1.426 . . . . 0.0 110.964 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -58.9 123.96 18.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.995 0.518 . . . . 0.0 111.347 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 tt -147.6 -34.29 0.25 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.182 0.993 . . . . 0.0 112.342 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.71 19.7 5.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.182 1.372 . . . . 0.0 114.748 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 t80 60.06 9.27 1.75 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.799 2.44 . . . . 0.0 114.966 -175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.74 -71.38 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.403 1.478 . . . . 0.0 110.74 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.53 151.43 21.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.949 0.88 . . . . 0.0 111.419 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.55 171.32 14.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.72 1.608 . . . . 0.0 111.527 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -87.15 147.09 25.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.512 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -137.07 103.39 5.12 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.894 2.078 . . . . 0.0 108.506 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -133.02 169.43 22.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-O 121.593 0.552 . . . . 0.0 112.884 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.61 141.06 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.905 1.682 . . . . 0.0 108.769 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.4 ttt -144.35 140.48 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 171.94 14.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.098 0.959 . . . . 0.0 111.553 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.0 p -93.67 7.71 43.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.52 1.528 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.22 165.22 12.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.635 1.974 . . . . 0.0 112.063 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.87 -55.29 29.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.209 0.909 . . . . 0.0 113.784 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.09 59.39 2.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 113.251 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.06 171.81 7.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.905 1.282 . . . . 0.0 112.859 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.71 141.61 50.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 108.421 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.8 ttp -133.88 83.7 2.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.076 1.35 . . . . 0.0 111.014 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.39 158.17 20.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.452 0.644 . . . . 0.0 111.524 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.94 122.02 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.866 2.067 . . . . 0.0 108.419 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -113.39 103.81 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.571 2.348 . . . . 0.0 108.941 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.36 119.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.437 -0.79 . . . . 0.0 110.802 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 p -152.13 169.27 22.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.376 1.07 . . . . 0.0 112.956 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.729 2.411 . . . . 0.0 112.934 176.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 119.979 -0.058 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 -23.23 7.56 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.11 1.364 . . . . 0.0 113.058 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.0 150.93 19.57 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.82 -1.175 . . . . 0.0 111.683 176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.28 49.13 34.32 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.425 0.535 . . . . 0.0 113.687 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.5 p -146.78 -166.38 2.48 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.193 0.997 . . . . 0.0 112.115 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.02 132.26 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.68 2.392 . . . . 0.0 110.74 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 pt -142.46 170.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.461 1.504 . . . . 0.0 111.777 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 111.19 1.02 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.484 1.114 . . . . 0.0 112.185 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.25 -24.33 67.23 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.424 1.011 . . . . 0.0 113.363 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.61 78.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.786 1.234 . . . . 0.0 111.983 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.5 -24.83 22.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.82 1.248 . . . . 0.0 113.196 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.6 tp -59.23 110.36 1.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.266 1.426 . . . . 0.0 111.534 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 m -146.78 168.16 22.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.654 1.582 . . . . 0.0 109.669 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.23 1.812 . . . . 0.0 113.814 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -58.01 -35.8 71.77 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -73.63 -46.05 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.494 1.518 . . . . 0.0 109.859 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.5 mt -54.48 -44.88 73.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 0.0 113.008 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.17 -39.09 88.81 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.714 0.406 . . . . 0.0 111.927 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -50.21 74.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.013 1.325 . . . . 0.0 111.622 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -53.51 -50.04 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.766 1.226 . . . . 0.0 111.994 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.7 mp -60.11 -41.87 93.53 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.212 1.005 . . . . 0.0 112.359 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -43.68 90.78 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 110.781 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.38 -31.01 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.163 1.785 . . . . 0.0 114.271 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.3 tp -66.81 -51.48 55.23 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.697 1.199 . . . . 0.0 110.014 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.25 54.62 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.103 1.335 . . . . 0.0 111.991 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -43.54 129.1 5.26 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.713 1.605 . . . . 0.0 112.817 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -164.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.183 1.393 . . . . 0.0 112.144 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.0 t -42.43 -33.02 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.993 2.517 . . . . 0.0 113.958 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -153.31 137.89 16.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.599 1.96 . . . . 0.0 109.804 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 155.69 20.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.688 2.395 . . . . 0.0 110.416 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -135.49 152.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.531 1.132 . . . . 0.0 109.509 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -111.06 122.75 48.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.171 0.988 . . . . 0.0 108.365 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.0 135.47 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.593 1.157 . . . . 0.0 110.803 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.33 129.55 3.39 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.177 0.894 . . . . 0.0 111.82 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mm -117.87 103.33 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.046 0.938 . . . . 0.0 109.742 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.96 122.45 27.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.899 1.28 . . . . 0.0 113.304 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.88 96.21 3.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.437 1.895 . . . . 0.0 112.02 175.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -123.83 30.81 6.05 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 112.137 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.7 t -91.96 -48.12 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.916 1.687 . . . . 0.0 114.142 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.07 17.73 4.02 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.288 0.947 . . . . 0.0 115.453 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.22 159.92 31.62 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.039 1.42 . . . . 0.0 114.125 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -70.51 135.83 48.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.079 0.952 . . . . 0.0 111.858 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -109.95 168.43 9.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.449 1.5 . . . . 0.0 111.382 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.3 m -134.61 107.14 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 109.108 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.64 124.96 24.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.911 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.89 -64.87 0.78 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.307 0.643 . . . . 0.0 109.966 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.63 172.24 0.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.825 2.45 . . . . 0.0 110.736 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.95 135.84 48.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.446 2.298 . . . . 0.0 110.105 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -124.3 114.83 20.08 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 111.361 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -72.0 106.95 4.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.485 1.514 . . . . 0.0 112.357 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -50.02 44.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.131 1.773 . . . . 0.0 110.71 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -136.0 155.95 49.48 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.518 1.527 . . . . 0.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.75 -156.51 39.85 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 123.042 0.353 . . . . 0.0 113.395 -172.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -154.21 -176.17 5.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 110.534 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -139.37 -179.31 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.49 1.516 . . . . 0.0 111.384 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.63 12.87 13.24 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.639 1.176 . . . . 0.0 111.586 174.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 m -132.13 175.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.154 1.781 . . . . 0.0 113.151 -170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 134.86 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.392 1.477 . . . . 0.0 110.091 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.44 141.12 56.51 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.256 -0.902 . . . . 0.0 110.601 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.84 163.68 32.51 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.045 3.163 . . . . 0.0 111.091 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -104.83 -21.22 13.37 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.816 -1.178 . . . . 0.0 112.945 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -126.51 137.14 53.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.127 1.371 . . . . 0.0 110.155 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.54 97.99 7.31 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 110.257 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -64.57 162.12 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.682 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.88 154.3 9.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.615 -0.678 . . . . 0.0 111.584 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m 72.03 -23.55 0.19 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.978 1.711 . . . . 0.0 113.83 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -95.89 126.87 41.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.707 1.603 . . . . 0.0 110.714 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.41 171.94 8.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.009 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -110.24 169.07 8.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.47 133.47 52.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.516 1.527 . . . . 0.0 110.505 175.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.96 166.73 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.129 0.971 . . . . 0.0 111.09 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 p -160.46 170.22 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.53 1.132 . . . . 0.0 110.635 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.71 137.27 5.89 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.664 175.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.55 161.42 30.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.123 1.462 . . . . 0.0 112.529 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -70.7 113.03 7.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t0 32.31 -136.8 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.565 2.346 . . . . 0.0 114.138 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -61.64 -46.18 90.89 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.5 -1.375 . . . . 0.0 111.053 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.57 -58.58 0.45 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.025 -0.875 . . . . 0.0 115.079 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -71.77 8.08 1.41 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 125.207 3.938 . . . . 0.0 115.44 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.84 132.92 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.001 2.52 . . . . 0.0 110.561 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.63 88.45 3.07 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.544 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -114.77 -84.69 0.61 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.164 1.786 . . . . 0.0 110.866 178.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' H ' HG23 ' A' ' 82' ' ' THR . . . 172.61 173.68 39.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 127.262 2.363 . . . . 0.0 110.802 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.63 109.41 7.1 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.584 1.154 . . . . 0.0 109.442 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.49 126.71 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 120.789 -1.194 . . . . 0.0 108.259 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.35 169.01 24.71 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.78 157.78 43.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.17 0.988 . . . . 0.0 111.603 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.17 169.9 20.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.895 1.678 . . . . 0.0 110.657 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.98 146.67 41.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.048 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -127.78 115.82 19.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.906 1.283 . . . . 0.0 111.525 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -81.08 112.61 18.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.194 1.398 . . . . 0.0 111.0 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.8 mtp -74.01 158.06 35.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.963 0.905 . . . . 0.0 111.414 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -62.35 -18.85 62.53 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.7 m -80.23 -15.34 57.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 113.739 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.26 55.2 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.668 1.128 . . . . 0.0 115.194 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -85.62 166.7 16.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.194 0.998 . . . . 0.0 110.384 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -137.08 153.53 50.54 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 110.73 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.62 134.14 53.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 108.991 174.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.63 8.48 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 m -126.76 137.29 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 117.537 0.668 . . . . 0.0 110.488 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.31 161.31 35.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.648 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.04 142.54 47.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.983 1.313 . . . . 0.0 109.516 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -127.16 114.25 17.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.757 1.623 . . . . 0.0 109.086 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.85 92.61 48.35 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.478 1.511 . . . . 0.0 108.931 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.29 167.97 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.165 2.576 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.42 -23.69 37.38 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.626 -0.671 . . . . 0.0 112.437 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.54 111.93 24.81 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.327 -1.483 . . . . 0.0 112.392 -165.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.21 -51.81 22.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.39 12.34 29.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.51 1.124 . . . . 0.0 113.575 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.14 -11.0 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.491 1.917 . . . . 0.0 112.716 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.32 175.92 11.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.722 2.809 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m -145.86 164.86 30.63 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.492 -1.38 . . . . 0.0 111.167 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.04 138.16 34.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 110.276 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 152.61 49.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.315 0.507 . . . . 0.0 112.063 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -159.32 146.76 17.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.423 1.889 . . . . 0.0 110.634 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.32 149.47 49.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.148 1.379 . . . . 0.0 110.154 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.5 t -145.77 105.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.315 1.046 . . . . 0.0 111.481 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -117.42 134.03 55.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.111 1.364 . . . . 0.0 110.365 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -97.75 112.39 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.296 1.438 . . . . 0.0 109.355 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -115.17 147.83 39.79 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.873 1.669 . . . . 0.0 112.826 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 p -75.74 82.59 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.739 1.615 . . . . 0.0 112.881 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.81 -173.91 36.57 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.529 1.061 . . . . 0.0 113.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -112.4 130.82 55.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.471 1.509 . . . . 0.0 111.59 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -153.24 163.97 38.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.594 1.157 . . . . 0.0 112.2 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -139.36 148.87 43.47 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.603 1.561 . . . . 0.0 111.621 -171.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.99 90.69 0.64 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.245 1.018 . . . . 0.0 111.957 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.15 -68.57 0.92 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.517 1.527 . . . . 0.0 110.812 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -144.37 -76.19 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.533 1.933 . . . . 0.0 108.959 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.8 -28.54 73.51 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.381 0.991 . . . . 0.0 114.701 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -57.46 5.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.086 0.943 . . . . 0.0 109.576 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -52.25 -40.87 62.27 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.921 1.289 . . . . 0.0 111.107 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -55.48 -43.28 75.42 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.641 -0.662 . . . . 0.0 112.734 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 -19.43 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.977 -1.077 . . . . 0.0 112.346 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.4 mt -91.37 -55.57 3.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.557 1.543 . . . . 0.0 111.435 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -74.82 -46.32 37.47 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.341 -0.85 . . . . 0.0 113.029 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.17 -17.47 30.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.232 -0.917 . . . . 0.0 111.121 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.76 52.5 4.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.357 0.979 . . . . 0.0 114.132 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 36.05 72.44 0.77 Allowed Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.623 2.369 . . . . 0.0 114.133 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 140.14 57.76 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.936 1.757 . . . . 0.0 109.027 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 143.77 55.73 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.81 0.844 . . . . 0.0 109.528 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 12.88 21.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.831 1.252 . . . . 0.0 113.818 -166.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 58.32 57.68 18.54 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.204 0.907 . . . . 0.0 112.145 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -72.57 33.96 0.07 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.802 1.241 . . . . 0.0 114.217 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.0 p30 45.97 34.24 1.91 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.833 2.853 . . . . 0.0 115.791 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -145.66 167.41 27.61 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.031 1.776 . . . . 0.0 112.262 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.96 123.48 21.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.417 0.687 . . . . 0.0 110.53 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -119.71 116.75 26.59 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.082 1.753 . . . . 0.0 108.684 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.09 131.69 15.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.989 1.316 . . . . 0.0 110.735 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -141.84 122.58 14.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.717 1.207 . . . . 0.0 110.72 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.19 115.57 3.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.445 0.698 . . . . 0.0 111.486 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.48 -36.42 0.98 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -77.73 22.49 2.78 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.118 1.342 . . . . 0.0 114.672 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 t80 58.01 10.74 1.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.245 2.618 . . . . 0.0 115.177 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.86 -60.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.929 1.728 . . . . 0.0 110.178 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.83 150.29 21.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 122.062 0.935 . . . . 0.0 112.479 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 163.1 35.18 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.413 1.885 . . . . 0.0 111.402 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.12 151.39 29.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.436 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -143.44 110.98 5.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.502 1.921 . . . . 0.0 108.262 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.7 32.47 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-O 121.642 0.579 . . . . 0.0 114.071 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.79 141.04 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.081 1.752 . . . . 0.0 109.311 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.7 ttt -144.84 142.41 29.91 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.25 1.82 . . . . 0.0 107.887 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.22 165.71 22.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.955 0.902 . . . . 0.0 111.042 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.93 14.97 12.35 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.609 1.164 . . . . 0.0 112.875 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.26 167.52 11.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 111.661 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.92 -59.94 8.83 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.943 0.783 . . . . 0.0 114.492 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -76.4 40.85 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.443 1.497 . . . . 0.0 114.254 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.04 157.3 35.06 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.847 1.259 . . . . 0.0 112.702 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -103.11 140.49 37.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 108.43 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.9 ttp -132.04 116.53 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.582 1.553 . . . . 0.0 109.461 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 138.8 43.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.7 106.76 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.208 1.403 . . . . 0.0 108.556 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -94.81 105.34 17.26 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.966 2.106 . . . . 0.0 109.204 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.27 124.97 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.4 m -128.28 177.1 7.18 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.571 1.148 . . . . 0.0 111.771 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 128.261 2.625 . . . . 0.0 113.342 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 119.946 -0.073 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.97 -17.18 16.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.389 1.076 . . . . 0.0 113.284 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -55.31 139.62 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.907 1.283 . . . . 0.0 111.985 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.79 40.85 8.54 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.099 0.857 . . . . 0.0 114.278 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 p -146.38 -165.69 2.28 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.571 1.185 . . . . 0.0 111.945 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.98 143.86 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.365 1.866 . . . . 0.0 110.487 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.19 165.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.297 . . . . 0.0 112.248 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 119.37 6.72 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.799 1.24 . . . . 0.0 111.066 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.07 -18.73 42.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.195 0.902 . . . . 0.0 113.897 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.92 -38.05 76.13 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.953 1.301 . . . . 0.0 111.735 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -31.33 27.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.843 1.257 . . . . 0.0 112.444 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.5 tp -50.02 100.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.61 1.964 . . . . 0.0 112.422 175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -145.79 164.78 30.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.216 1.406 . . . . 0.0 109.843 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -46.95 -40.24 13.93 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.443 1.497 . . . . 0.0 114.125 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.54 -47.31 86.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.166 0.586 . . . . 0.0 112.197 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.1 t -57.0 -48.66 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.804 0.841 . . . . 0.0 109.547 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.32 -47.04 76.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.629 0.771 . . . . 0.0 112.669 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.05 -42.97 88.8 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.686 -0.633 . . . . 0.0 112.366 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.15 -42.46 77.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.299 1.44 . . . . 0.0 112.917 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.1 t -51.77 -57.04 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.57 1.548 . . . . 0.0 109.721 176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 mp -62.11 -38.22 88.07 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.618 1.567 . . . . 0.0 113.108 178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -49.5 76.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.634 -0.666 . . . . 0.0 111.599 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.47 -15.83 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.7 tp -65.39 -53.72 39.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.816 2.046 . . . . 0.0 112.841 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.55 29.57 7.74 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 174.82 0.14 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.928 2.091 . . . . 0.0 114.671 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -103.38 -168.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.487 1.915 . . . . 0.0 111.049 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -49.59 -28.01 5.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.94 53.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.762 1.625 . . . . 0.0 109.601 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.43 146.19 2.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 112.154 -167.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.454 HD12 ' CE2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -141.66 152.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.097 1.359 . . . . 0.0 110.167 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.61 114.4 24.04 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 109.661 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 t -102.08 137.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.845 1.258 . . . . 0.0 110.38 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.66 114.59 0.71 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.048 0.832 . . . . 0.0 113.384 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.72 106.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.47 1.108 . . . . 0.0 110.573 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -89.3 104.65 17.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.846 1.658 . . . . 0.0 112.306 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -72.98 105.46 4.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.125 1.77 . . . . 0.0 111.333 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.5 22.51 8.37 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.611 1.964 . . . . 0.0 112.606 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -84.8 -29.22 25.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.549 1.54 . . . . 0.0 114.679 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.64 20.4 8.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.047 1.784 . . . . 0.0 115.391 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.49 17.38 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 118.984 1.392 . . . . 0.0 114.408 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -66.36 141.12 58.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.169 0.988 . . . . 0.0 112.812 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -115.07 170.71 8.15 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.919 1.688 . . . . 0.0 111.499 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 m -135.39 110.2 8.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 108.912 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.37 50.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.52 -1.362 . . . . 0.0 109.969 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -71.11 -68.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.525 0.73 . . . . 0.0 109.791 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.92 174.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.677 2.391 . . . . 0.0 110.58 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.6 144.18 51.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.541 2.337 . . . . 0.0 108.797 175.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.19 110.97 11.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.546 1.139 . . . . 0.0 110.269 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.61 121.63 18.25 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.262 1.025 . . . . 0.0 111.165 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.27 -41.42 8.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.964 1.306 . . . . 0.0 112.372 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m -138.29 149.35 45.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.578 1.151 . . . . 0.0 110.685 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.07 54.2 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.158 0.408 . . . . 0.0 113.163 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -151.99 175.0 12.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.933 0.893 . . . . 0.0 111.196 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.7 p -140.45 177.11 8.24 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.236 1.414 . . . . 0.0 111.336 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -127.22 16.09 7.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.652 1.181 . . . . 0.0 112.684 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.55 176.85 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.711 2.004 . . . . 0.0 112.745 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.25 137.07 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.484 1.914 . . . . 0.0 109.467 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.3 154.76 82.11 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 119.902 1.228 . . . . 0.0 112.333 176.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.97 165.32 31.59 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 124.026 3.15 . . . . 0.0 109.58 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.87 -18.02 14.04 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.1 144.13 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.492 1.517 . . . . 0.0 110.161 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.51 92.66 5.49 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.88 1.272 . . . . 0.0 110.287 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.16 155.26 66.1 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.769 1.646 . . . . 0.0 111.362 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.3 155.16 12.09 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.094 -0.379 . . . . 0.0 111.095 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m 74.4 -22.42 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.236 1.814 . . . . 0.0 113.027 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -99.47 146.38 26.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.925 1.69 . . . . 0.0 109.016 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.53 162.3 17.38 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.769 1.228 . . . . 0.0 111.934 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 167.78 10.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.446 174.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.75 126.74 43.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.899 2.48 . . . . 0.0 108.652 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -144.37 151.22 38.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.823 0.849 . . . . 0.0 110.97 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -155.76 157.51 36.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.733 0.813 . . . . 0.0 110.883 -174.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.4 166.66 30.15 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.199 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.85 158.01 44.79 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.86 1.33 . . . . 0.0 113.064 -174.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -74.96 113.75 12.63 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 39.62 -147.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.646 1.578 . . . . 0.0 113.887 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.7 m -77.72 -47.73 18.38 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.496 -1.378 . . . . 0.0 111.334 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.85 -60.53 0.36 Allowed Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.819 -0.989 . . . . 0.0 114.455 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.29 -2.51 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.612 3.541 . . . . 0.0 114.974 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.42 142.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.007 1.723 . . . . 0.0 108.705 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.94 69.15 1.19 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 0.0 110.982 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.4 m -96.65 -61.62 1.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.144 0.978 . . . . 0.0 111.335 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.88 172.15 31.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.737 1.16 . . . . 0.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -134.96 111.45 9.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.744 1.218 . . . . 0.0 110.364 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.57 135.82 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.969 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.76 162.33 40.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.107 1.363 . . . . 0.0 110.594 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.51 40.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.406 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.12 171.66 13.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.247 1.819 . . . . 0.0 110.365 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.72 152.0 46.31 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.971 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -128.18 117.14 21.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 110.715 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -79.56 110.56 15.0 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.444 1.498 . . . . 0.0 110.872 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 73.8 mtm -78.77 160.07 27.59 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.8 p -60.75 -17.76 50.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -73.75 -14.53 61.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.956 . . . . 0.0 112.491 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.52 7.46 72.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.689 1.138 . . . . 0.0 113.982 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -92.85 163.61 13.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.019 1.328 . . . . 0.0 109.736 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.1 m -125.19 152.74 44.1 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.121 0.968 . . . . 0.0 109.802 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.94 131.95 53.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.765 0.826 . . . . 0.0 109.904 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.52 140.77 19.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.64 126.33 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.666 1.186 . . . . 0.0 109.283 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.86 157.21 45.61 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 112.058 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.454 ' CE2' HD12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -126.79 139.42 53.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.143 1.377 . . . . 0.0 110.554 175.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 m -127.27 114.12 17.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.708 1.203 . . . . 0.0 109.76 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 98.7 t -119.05 99.77 50.8 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.322 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.81 172.23 16.69 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.235 1.957 . . . . 0.0 110.102 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.99 -59.51 2.69 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.297 -0.877 . . . . 0.0 111.418 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.32 122.22 17.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.757 2.023 . . . . 0.0 112.489 -167.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.54 -52.25 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.184 -0.948 . . . . 0.0 113.209 -175.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -87.89 -4.51 58.84 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.95 1.3 . . . . 0.0 113.465 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.8 -4.13 7.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 112.074 -164.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.43 167.58 29.55 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.741 2.816 . . . . 0.0 108.414 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.6 m -141.19 166.83 23.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -81.78 157.17 24.59 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.377 -0.827 . . . . 0.0 110.514 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -142.3 153.34 43.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.179 0.991 . . . . 0.0 110.587 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -152.16 159.8 43.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.564 1.546 . . . . 0.0 110.945 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.31 150.46 25.33 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -147.34 143.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 125.632 1.573 . . . . 0.0 110.354 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -149.04 146.55 27.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.168 1.787 . . . . 0.0 108.959 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.17 118.41 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.999 1.72 . . . . 0.0 108.89 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.81 148.3 44.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.768 1.627 . . . . 0.0 112.827 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.4 p -77.7 80.96 4.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.568 1.547 . . . . 0.0 112.912 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.84 179.98 27.94 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.081 1.324 . . . . 0.0 112.958 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 126.23 36.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.835 1.654 . . . . 0.0 111.367 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -135.29 147.38 49.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.116 2.166 . . . . 0.0 108.538 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -115.24 179.93 3.82 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.435 1.494 . . . . 0.0 110.063 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.47 94.02 4.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.163 0.985 . . . . 0.0 110.093 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.84 -69.95 0.79 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.931 0.893 . . . . 0.0 109.429 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -147.55 -69.4 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.984 1.314 . . . . 0.0 109.771 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.97 -28.8 73.94 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.457 1.027 . . . . 0.0 115.319 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -53.72 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.327 1.063 . . . . 0.0 110.249 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.48 -38.77 75.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.529 1.132 . . . . 0.0 111.148 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.98 -44.29 74.31 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.42 -0.8 . . . . 0.0 111.288 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -24.0 67.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.168 0.987 . . . . 0.0 113.128 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.09 -55.69 4.93 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.66 -48.25 81.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.998 1.319 . . . . 0.0 113.377 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -86.74 -11.72 50.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.7 0.8 . . . . 0.0 113.054 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.18 -71.69 0.69 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.104 0.859 . . . . 0.0 112.039 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.32 82.14 1.15 Allowed Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.604 1.561 . . . . 0.0 109.949 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.35 143.71 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.555 1.504 . . . . 0.0 110.885 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.404 ' HB3' ' CD2' ' A' ' 147' ' ' HIS . 38.8 m-85 -81.37 4.46 20.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.01 1.324 . . . . 0.0 113.563 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 57.72 10.95 1.18 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.74 2.816 . . . . 0.0 116.067 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 48.5 47.78 28.78 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.943 1.258 . . . . 0.0 112.611 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.92 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.25 12.2 p30 48.71 27.55 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.736 2.815 . . . . 0.0 115.711 178.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.16 151.44 20.76 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.718 1.628 . . . . 0.0 112.236 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -57.89 131.08 49.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 111.938 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.404 ' CD2' ' HB3' ' A' ' 140' ' ' TYR . 32.5 m-70 -124.22 114.19 19.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.335 1.854 . . . . 0.0 110.132 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.57 131.05 12.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.984 1.314 . . . . 0.0 111.986 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -144.57 126.0 14.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.34 1.856 . . . . 0.0 110.645 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.95 101.28 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.261 1.025 . . . . 0.0 113.051 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -124.92 -26.39 3.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.829 1.251 . . . . 0.0 113.467 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.45 13.97 43.35 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.926 1.251 . . . . 0.0 114.679 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 t80 61.0 7.77 1.65 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.619 2.367 . . . . 0.0 114.964 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.1 -57.46 0.04 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.075 1.321 . . . . 0.0 112.066 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.05 155.74 19.1 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.9 166.37 26.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.485 1.914 . . . . 0.0 112.169 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.07 135.29 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.079 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -125.72 101.7 6.99 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.03 169.42 22.11 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-O 121.565 0.536 . . . . 0.0 112.955 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 147.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 109.264 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 31.0 ttp -152.8 144.7 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.483 1.513 . . . . 0.0 107.259 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.2 p -86.65 163.01 17.63 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.865 0.84 . . . . 0.0 111.381 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.2 p -81.47 13.67 2.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.417 1.887 . . . . 0.0 113.121 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.38 151.69 35.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.028 2.531 . . . . 0.0 111.612 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.46 -57.21 16.3 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.145 0.879 . . . . 0.0 114.146 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.67 59.59 2.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 113.832 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.2 176.89 6.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.236 1.414 . . . . 0.0 113.989 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 136.05 48.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.339 1.856 . . . . 0.0 109.052 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.4 ttp -124.96 88.49 2.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.069 1.348 . . . . 0.0 110.801 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -83.67 153.8 24.03 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.553 -0.717 . . . . 0.0 111.746 165.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 57.9 mt -136.08 115.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.184 2.194 . . . . 0.0 106.893 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -113.12 97.14 6.32 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.434 1.894 . . . . 0.0 108.872 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.21 106.91 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.206 0.527 . . . . 0.0 110.748 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 m -139.82 -179.62 6.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.852 1.661 . . . . 0.0 112.041 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.147 1.779 . . . . 0.0 111.992 178.859 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.28 145.48 39.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.778 -1.201 . . . . 0.0 111.472 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.69 34.68 62.7 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.942 0.782 . . . . 0.0 114.363 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -146.14 -174.17 4.37 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.284 1.042 . . . . 0.0 111.843 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' A' ' 69' ' ' LEU . 3.7 pt -126.72 143.49 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.682 1.593 . . . . 0.0 111.772 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.36 167.17 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.035 1.734 . . . . 0.0 112.253 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 116.43 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.964 1.306 . . . . 0.0 113.057 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.19 65.49 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.024 1.297 . . . . 0.0 113.141 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.77 -20.64 61.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.26 1.424 . . . . 0.0 113.448 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -110.35 -0.99 17.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.57 1.548 . . . . 0.0 112.834 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 tp -80.41 115.34 19.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.14 1.376 . . . . 0.0 112.013 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -142.2 169.18 18.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.232 1.413 . . . . 0.0 110.941 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.3 -40.96 50.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.865 1.666 . . . . 0.0 113.889 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.373 1.069 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.05 -45.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.019 1.728 . . . . 0.0 109.938 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 170' ' ' GLN . 83.3 mt -54.6 -47.06 73.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.385 0.674 . . . . 0.0 110.635 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.88 -52.6 63.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.636 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -48.26 -47.89 35.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.673 1.189 . . . . 0.0 112.658 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.83 -58.77 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.728 1.211 . . . . 0.0 111.853 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.442 HD11 ' HD3' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -62.21 -32.55 73.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.09 1.356 . . . . 0.0 113.076 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.47 -55.96 13.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.224 1.01 . . . . 0.0 111.229 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -24.71 61.39 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.52 -48.29 69.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.741 1.616 . . . . 0.0 110.887 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 60.39 0.27 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.634 1.588 . . . . 0.0 111.662 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -53.53 119.64 5.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.282 1.433 . . . . 0.0 112.301 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -169.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.014 1.726 . . . . 0.0 110.074 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m -41.07 -42.96 2.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.708 2.403 . . . . 0.0 112.874 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 mtm105 -143.0 144.52 32.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.377 1.871 . . . . 0.0 109.575 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -173.99 165.08 4.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.71 2.804 . . . . 0.0 110.743 -170.035 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.8 HD13 ' CD2' ' A' ' 102' ' ' PHE . 32.8 pt -139.95 173.04 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.536 1.534 . . . . 0.0 110.652 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.01 107.15 6.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.991 1.316 . . . . 0.0 110.752 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.69 137.67 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.983 1.313 . . . . 0.0 111.451 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.7 116.98 0.8 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.746 0.689 . . . . 0.0 113.216 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.27 105.55 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.318 1.059 . . . . 0.0 109.694 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -84.6 108.87 17.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.293 1.437 . . . . 0.0 112.92 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -75.49 97.96 3.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.342 1.457 . . . . 0.0 111.393 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 8.94 12.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.469 1.908 . . . . 0.0 113.041 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.2 m -64.44 -44.94 89.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.09 -0.9 5.75 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.163 1.363 . . . . 0.0 116.329 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.76 28.07 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.745 1.773 . . . . 0.0 114.316 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -74.88 139.14 42.93 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.492 1.117 . . . . 0.0 113.112 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -111.8 163.31 14.32 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.696 1.199 . . . . 0.0 112.249 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.2 m -131.07 108.04 9.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.085 1.354 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 110.79 3.54 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.023 0.929 . . . . 0.0 108.987 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.36 -63.9 1.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.699 1.6 . . . . 0.0 111.097 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.23 170.39 2.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.299 2.24 . . . . 0.0 111.152 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.7 139.3 53.66 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 127.308 2.243 . . . . 0.0 110.489 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -131.61 114.87 15.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.183 1.793 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.68 101.3 5.7 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.563 1.545 . . . . 0.0 111.808 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -68.01 -42.96 79.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.219 1.408 . . . . 0.0 112.944 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -146.48 154.1 41.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.99 1.716 . . . . 0.0 111.381 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.55 -163.96 54.51 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.818 -0.551 . . . . 0.0 112.7 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.49 161.26 41.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.904 0.882 . . . . 0.0 110.546 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.9 m -145.43 137.7 25.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 110.131 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.21 4.71 44.72 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.749 1.219 . . . . 0.0 113.353 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 55' ' ' THR . 9.0 m -120.53 175.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.33 1.852 . . . . 0.0 113.564 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.03 132.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 109.843 -172.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 142.82 81.56 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 121.663 -0.648 . . . . 0.0 110.332 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HG3' HG23 ' A' ' 6' ' ' ILE . 66.4 Cg_endo -66.73 175.22 5.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 125.091 3.861 . . . . 0.0 111.533 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.15 -26.27 8.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.079 -1.013 . . . . 0.0 112.69 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -124.02 130.56 52.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 0.0 111.001 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -133.38 88.15 35.88 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.288 1.435 . . . . 0.0 109.425 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.32 163.39 23.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.306 2.004 . . . . 0.0 112.277 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.61 158.05 19.19 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.393 -0.817 . . . . 0.0 111.703 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 66.03 4.14 2.92 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.51 2.324 . . . . 0.0 114.208 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -126.9 147.9 50.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.325 1.85 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.96 158.0 27.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.349 1.459 . . . . 0.0 110.993 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -96.91 167.61 10.98 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.29 132.16 47.11 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.934 1.694 . . . . 0.0 108.763 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.67 163.57 35.48 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.374 1.07 . . . . 0.0 111.925 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.7 m -143.08 177.17 8.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.185 1.394 . . . . 0.0 111.298 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.74 97.66 0.14 Allowed Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.729 -1.04 . . . . 0.0 113.307 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.95 166.21 10.58 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.982 1.391 . . . . 0.0 113.595 -173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -86.38 101.35 13.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.71 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t0 39.65 -146.14 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 126.683 1.993 . . . . 0.0 112.405 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -61.76 -35.44 78.13 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 119.706 -1.871 . . . . 0.0 112.151 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.74 -58.86 0.53 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.299 1.428 . . . . 0.0 113.565 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.62 4.38 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.947 3.765 . . . . 0.0 115.382 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.05 126.04 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.124 2.169 . . . . 0.0 110.485 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.33 62.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.429 1.491 . . . . 0.0 112.556 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -66.31 0.91 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.691 1.596 . . . . 0.0 111.777 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 175.09 39.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.529 2.014 . . . . 0.0 110.334 -173.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.09 102.41 3.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.892 1.277 . . . . 0.0 107.937 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.97 134.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.036 1.734 . . . . 0.0 108.188 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.67 159.52 38.48 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 124.382 1.073 . . . . 0.0 110.068 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.8 146.46 33.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 110.858 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.05 169.15 21.9 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.2 1.8 . . . . 0.0 110.236 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.78 146.84 34.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.122 0.569 . . . . 0.0 111.703 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.83 118.83 23.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.824 0.85 . . . . 0.0 110.871 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 114.09 17.93 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.846 1.658 . . . . 0.0 110.274 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.7 mtt -70.72 162.47 29.0 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.491 0.662 . . . . 0.0 112.182 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t -60.18 -23.45 63.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.82 1.248 . . . . 0.0 113.722 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -10.69 56.21 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.535 1.534 . . . . 0.0 113.39 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.56 9.86 56.14 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.772 1.177 . . . . 0.0 115.179 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -87.06 171.72 10.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.372 1.086 . . . . 0.0 110.263 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.5 m -129.99 147.53 51.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.439 0.696 . . . . 0.0 110.961 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.08 111.75 16.32 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.26 139.54 28.21 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 117' ' ' VAL . 18.5 t -143.31 131.54 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.066 0.947 . . . . 0.0 109.84 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -143.77 160.51 40.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.93 -0.481 . . . . 0.0 111.77 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.8 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -127.18 153.05 46.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.894 1.278 . . . . 0.0 110.187 175.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -145.89 113.36 6.3 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.976 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.0 110.55 43.69 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 126.634 1.974 . . . . 0.0 108.224 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -79.33 175.27 10.95 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.486 2.791 . . . . 0.0 111.399 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -81.63 -40.94 22.19 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.814 -0.554 . . . . 0.0 111.269 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 112.51 24.33 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.476 -0.765 . . . . 0.0 112.789 -161.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.14 -54.85 41.02 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.17 17.16 24.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.14 1.376 . . . . 0.0 113.829 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.62 -3.57 2.62 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.286 1.834 . . . . 0.0 112.748 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -173.61 4.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.34 2.656 . . . . 0.0 109.692 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -152.58 160.65 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.492 1.517 . . . . 0.0 110.596 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.48 158.0 31.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.316 1.046 . . . . 0.0 110.214 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -143.68 151.88 40.64 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.283 -0.886 . . . . 0.0 111.932 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -164.38 154.55 14.47 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.952 1.701 . . . . 0.0 109.675 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -143.78 140.27 29.82 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.894 1.677 . . . . 0.0 108.8 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -139.21 124.37 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 128.952 2.901 . . . . 0.0 109.6 174.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -144.9 148.32 33.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.498 1.919 . . . . 0.0 109.894 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.92 113.53 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.827 1.651 . . . . 0.0 108.868 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -126.23 142.95 51.32 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.558 1.543 . . . . 0.0 112.939 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.0 p -75.34 92.67 2.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.14 . . . . 0.0 112.537 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.64 -167.88 39.83 Favored Glycine 0 N--CA 1.471 0.993 0 O-C-N 121.531 -0.731 . . . . 0.0 114.397 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 119.19 24.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.489 1.915 . . . . 0.0 111.398 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.22 156.11 40.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 111.133 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -137.93 161.87 35.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.34 1.456 . . . . 0.0 111.056 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 90.72 2.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.411 0.684 . . . . 0.0 111.15 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -110.23 -66.57 1.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.136 1.374 . . . . 0.0 109.135 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -70.92 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.58 1.552 . . . . 0.0 109.35 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.56 81.33 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.333 0.968 . . . . 0.0 114.333 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -69.6 -53.08 20.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.293 1.046 . . . . 0.0 110.78 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.25 -43.76 79.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.792 0.837 . . . . 0.0 110.428 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -62.6 -46.37 88.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -56.86 -19.94 20.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.722 1.146 . . . . 0.0 113.377 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.66 -59.13 2.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.227 1.411 . . . . 0.0 110.438 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.99 -56.55 19.82 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.299 1.04 . . . . 0.0 111.383 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -80.93 -16.66 52.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.198 1.399 . . . . 0.0 112.064 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.28 -77.17 0.25 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 0.0 113.271 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -162.41 90.75 1.33 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.935 1.694 . . . . 0.0 109.966 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.28 158.15 45.16 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.016 1.144 . . . . 0.0 110.492 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.74 5.84 50.39 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.74 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 130.145 3.378 . . . . 0.0 117.808 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.07 5.39 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.043 -1.035 . . . . 0.0 112.245 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -63.55 7.18 0.11 Allowed 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.347 11.3 p30 55.84 25.55 8.63 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.193 2.597 . . . . 0.0 116.424 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -139.58 165.44 25.82 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.456 1.979 . . . . 0.0 111.499 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -70.42 114.53 8.64 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.16 -1.2 . . . . 0.0 109.689 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 127.77 53.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.043 1.337 . . . . 0.0 109.975 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.08 139.34 21.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.185 1.394 . . . . 0.0 110.352 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -144.65 126.46 15.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.241 1.416 . . . . 0.0 109.921 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -62.1 117.6 6.22 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.805 0.442 . . . . 0.0 111.414 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -142.98 -26.62 0.59 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.486 1.114 . . . . 0.0 113.93 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.18 15.82 20.35 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.821 1.201 . . . . 0.0 114.469 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.45 10.62 1.92 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.829 2.452 . . . . 0.0 115.403 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.9 -47.6 0.05 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.274 1.416 . . . . 0.0 112.773 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.52 161.49 17.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 111.324 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 170.99 19.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 113.074 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.73 138.53 31.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.28 1.432 . . . . 0.0 109.487 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -130.5 109.07 10.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.761 1.624 . . . . 0.0 108.656 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.62 169.87 27.04 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.3 143.24 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 109.702 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.7 ttt -150.79 150.91 31.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.673 1.989 . . . . 0.0 107.352 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.0 p -101.13 165.47 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.599 0.76 . . . . 0.0 111.929 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.0 t -90.84 46.28 1.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.685 1.594 . . . . 0.0 110.051 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.57 158.16 42.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.33 1.452 . . . . 0.0 112.656 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.1 -45.55 93.79 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 121.439 -0.788 . . . . 0.0 113.089 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 64.02 2.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.737 1.615 . . . . 0.0 113.741 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -94.61 147.29 23.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -91.49 150.11 21.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.687 1.195 . . . . 0.0 107.963 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 36.2 ttp -143.72 91.84 2.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.389 0.995 . . . . 0.0 112.16 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 17' ' ' LEU . 35.0 tt0 -107.04 146.41 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.406 -0.809 . . . . 0.0 111.164 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.69 104.27 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.886 1.675 . . . . 0.0 109.426 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -99.2 90.42 4.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.81 2.044 . . . . 0.0 110.51 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.63 118.22 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.378 0.671 . . . . 0.0 110.137 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.5 p -146.41 166.17 27.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.994 1.318 . . . . 0.0 113.029 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.691 2.397 . . . . 0.0 111.7 176.218 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.13 143.0 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.324 0.965 . . . . 0.0 112.442 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.86 43.46 8.94 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.051 0.834 . . . . 0.0 115.027 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.9 p -147.65 -166.77 2.61 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 119.064 1.432 . . . . 0.0 111.977 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 pt -117.26 139.46 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.295 2.238 . . . . 0.0 109.947 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 12' ' ' LEU . 20.3 pt -145.55 159.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.006 1.322 . . . . 0.0 111.732 174.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.68 128.96 39.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.048 1.339 . . . . 0.0 112.477 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.59 -24.35 76.25 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.588 0.613 . . . . 0.0 113.413 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.2 73.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.419 1.088 . . . . 0.0 111.395 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -74.11 -28.45 61.36 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.259 1.024 . . . . 0.0 112.896 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 7' ' ' ILE . 9.2 tt -67.26 114.57 6.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.274 1.429 . . . . 0.0 112.54 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 m -145.11 172.85 12.5 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.159 1.784 . . . . 0.0 110.157 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -42.17 37.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.38 1.472 . . . . 0.0 113.952 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.88 -35.91 79.73 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.13 -42.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.517 0.727 . . . . 0.0 110.29 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 170' ' ' GLN . 11.1 mt -55.52 -50.48 69.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.832 0.742 . . . . 0.0 112.092 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -39.99 90.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.153 0.581 . . . . 0.0 112.113 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -57.21 -43.44 82.79 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.009 1.324 . . . . 0.0 112.717 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 70' ' ' LEU . 77.4 t -62.22 -48.01 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.394 1.078 . . . . 0.0 111.325 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.5 mp -61.96 -42.82 99.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.171 0.988 . . . . 0.0 112.267 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.87 -31.79 71.84 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -77.0 -42.19 39.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.826 1.65 . . . . 0.0 113.82 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.64 -56.85 16.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.775 1.63 . . . . 0.0 111.59 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 64.61 0.09 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.029 1.3 . . . . 0.0 112.149 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -51.16 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.353 2.261 . . . . 0.0 112.421 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 28' ' ' SER . 3.8 p -90.42 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.096 1.758 . . . . 0.0 109.942 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 27' ' ' VAL . 19.4 m -44.2 -49.55 9.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.552 1.141 . . . . 0.0 112.083 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -139.45 146.57 40.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 112.727 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.4 150.93 11.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.046 2.538 . . . . 0.0 108.931 -169.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 21' ' ' LEU . 7.0 pt -139.72 153.95 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.822 1.249 . . . . 0.0 109.507 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.63 110.81 20.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.364 1.066 . . . . 0.0 109.878 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -105.31 128.74 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.892 0.877 . . . . 0.0 111.265 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.7 114.47 0.79 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.357 1.456 . . . . 0.0 112.094 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.86 104.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.515 1.126 . . . . 0.0 109.082 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.2 111.16 21.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.149 1.379 . . . . 0.0 111.15 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -84.54 96.42 9.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.41 1.084 . . . . 0.0 111.615 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.0 18.97 20.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.601 1.161 . . . . 0.0 113.167 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.0 p -63.87 -40.22 96.03 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.46 3.98 5.01 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.886 1.707 . . . . 0.0 115.854 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.06 30.47 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.767 1.783 . . . . 0.0 114.491 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -74.8 130.63 39.8 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 122.007 -0.701 . . . . 0.0 112.165 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.37 164.39 11.8 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.901 1.28 . . . . 0.0 111.277 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 m -133.82 110.32 9.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.458 1.503 . . . . 0.0 109.467 -176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.1 133.3 55.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.75 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mt -75.23 -68.56 0.54 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.864 0.466 . . . . 0.0 109.866 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -179.44 173.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.502 2.321 . . . . 0.0 110.592 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.82 145.74 51.23 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.353 2.261 . . . . 0.0 109.515 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 115.65 15.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.971 0.908 . . . . 0.0 111.015 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -70.31 106.65 3.43 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 111.221 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -68.95 -47.53 65.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.434 1.494 . . . . 0.0 110.603 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -141.7 154.4 45.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.917 2.087 . . . . 0.0 110.703 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -163.52 54.62 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.834 -0.541 . . . . 0.0 113.353 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -151.66 177.91 9.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 111.998 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.0 p -144.48 178.65 7.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.376 1.47 . . . . 0.0 111.563 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.25 20.15 8.15 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.771 1.228 . . . . 0.0 112.008 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.86 172.21 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 126.721 2.008 . . . . 0.0 113.244 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 mt -143.38 135.59 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.027 1.731 . . . . 0.0 109.812 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 149.68 60.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 119.547 1.067 . . . . 0.0 112.1 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.21 155.51 56.29 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 124.249 3.299 . . . . 0.0 111.579 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -93.27 -23.64 18.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.977 -1.077 . . . . 0.0 113.424 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.95 141.13 49.93 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.931 -1.106 . . . . 0.0 110.648 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.0 102.77 5.73 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.643 1.177 . . . . 0.0 109.234 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.3 164.67 24.79 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.903 1.735 . . . . 0.0 111.637 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.78 163.67 9.02 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.957 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 66.27 -0.91 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 126.542 1.937 . . . . 0.0 114.151 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.96 -174.38 2.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.188 2.995 . . . . 0.0 110.81 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.31 172.85 17.23 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.651 2.38 . . . . 0.0 111.049 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.99 178.47 4.55 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.713 0.805 . . . . 0.0 109.737 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 20' ' ' VAL . 1.2 tp -134.88 131.9 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.886 2.074 . . . . 0.0 109.118 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -148.05 166.27 28.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.274 1.03 . . . . 0.0 110.486 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -149.44 174.85 12.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.152 0.981 . . . . 0.0 111.068 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.95 119.22 0.88 Allowed Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.39 1.471 . . . . 0.0 111.369 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.04 150.06 42.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.909 1.355 . . . . 0.0 112.393 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -69.7 107.6 3.54 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' CB ' HG23 ' A' ' 80' ' ' VAL . 7.3 m-20 40.06 -150.49 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 126.113 1.765 . . . . 0.0 113.122 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -77.83 -38.74 45.58 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.82 -1.8 . . . . 0.0 111.347 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.82 -56.23 0.51 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.628 -1.096 . . . . 0.0 114.78 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.54 -6.27 18.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.529 3.486 . . . . 0.0 114.825 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' CB ' ' A' ' 76' ' ' ASP . 9.7 m -122.8 139.96 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.268 1.827 . . . . 0.0 109.126 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.03 78.08 1.52 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.326 . . . . 0.0 110.77 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 80.6 m -102.73 -65.16 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.848 0.859 . . . . 0.0 111.318 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.18 172.07 29.13 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.752 1.644 . . . . 0.0 111.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.33 108.69 8.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.409 1.105 . . . . 0.0 110.541 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -137.81 131.32 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.44 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.179 0.592 . . . . 0.0 110.651 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.96 149.97 35.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.935 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.84 172.47 12.98 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.858 1.663 . . . . 0.0 110.651 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -138.95 150.44 45.9 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.249 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -128.37 114.37 16.76 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.66 1.184 . . . . 0.0 111.352 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -75.02 115.13 14.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.559 1.544 . . . . 0.0 110.801 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.99 157.9 34.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.195 0.998 . . . . 0.0 111.733 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 87.4 p -59.65 -20.22 54.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -81.56 -11.7 59.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.615 1.966 . . . . 0.0 113.44 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.58 60.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.089 1.328 . . . . 0.0 115.244 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.27 175.11 8.64 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.811 1.245 . . . . 0.0 110.863 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.515 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 18.9 m -141.73 147.75 37.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.725 0.774 . . . . 0.0 110.288 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.11 118.94 34.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.19 0.996 . . . . 0.0 108.34 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.33 142.3 22.88 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 117' ' ' VAL . 25.6 m -140.89 137.97 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.547 1.139 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.41 152.52 44.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.155 0.582 . . . . 0.0 110.879 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -125.88 142.22 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.684 1.193 . . . . 0.0 109.768 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.0 m -125.87 97.95 5.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.947 1.699 . . . . 0.0 110.309 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.2 112.31 58.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.674 1.59 . . . . 0.0 109.616 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -76.83 -173.08 1.61 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.336 3.357 . . . . 0.0 111.996 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.461 ' CD1' ' HE3' ' A' ' 75' ' ' LYS . 16.8 t80 -106.5 -13.04 15.44 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.37 1.068 . . . . 0.0 112.895 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -110.73 131.13 55.32 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 119.741 -1.849 . . . . 0.0 111.138 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -66.4 0.7 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.02 -1.05 . . . . 0.0 110.837 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -82.19 -3.98 56.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.51 -1.48 9.58 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.093 1.757 . . . . 0.0 112.699 -164.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -150.24 179.93 7.71 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 129.536 3.134 . . . . 0.0 108.887 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.9 t -142.48 163.57 32.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.938 1.695 . . . . 0.0 109.037 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -92.37 136.98 32.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.351 0.66 . . . . 0.0 109.227 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 151.1 46.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.096 0.959 . . . . 0.0 110.357 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -157.1 157.48 34.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.612 1.565 . . . . 0.0 110.632 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.13 155.23 43.19 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.624 -0.673 . . . . 0.0 109.909 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 100' ' ' VAL . 43.6 t -140.87 122.02 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.947 1.299 . . . . 0.0 109.751 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -124.86 145.3 49.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.66 1.584 . . . . 0.0 109.737 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.4 mt -115.5 120.39 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.755 2.022 . . . . 0.0 108.659 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -132.42 144.72 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.126 1.371 . . . . 0.0 112.13 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.8 p -80.39 77.97 7.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.635 1.174 . . . . 0.0 112.59 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.67 36.88 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.413 1.006 . . . . 0.0 113.818 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 116.78 26.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.754 1.622 . . . . 0.0 111.858 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -142.43 155.26 45.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.105 1.362 . . . . 0.0 109.445 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -133.05 161.91 33.12 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.78 1.232 . . . . 0.0 111.141 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.8 78.98 0.45 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.602 1.161 . . . . 0.0 111.337 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -101.86 -65.59 0.97 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.444 1.498 . . . . 0.0 110.244 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.55 -71.77 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.088 1.755 . . . . 0.0 109.233 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.4 -19.33 68.53 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.541 1.067 . . . . 0.0 114.603 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.34 -52.71 5.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.117 0.958 . . . . 0.0 111.574 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.44 -45.9 76.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.335 0.654 . . . . 0.0 111.775 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -35.37 72.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -22.85 66.98 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.283 -0.886 . . . . 0.0 113.244 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -93.71 -35.91 12.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.427 1.091 . . . . 0.0 110.89 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -76.26 -45.14 34.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.309 -1.494 . . . . 0.0 113.197 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -92.06 -14.87 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.929 1.292 . . . . 0.0 113.143 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.08 63.14 3.59 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.992 0.806 . . . . 0.0 113.706 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 31.97 73.75 0.5 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 127.598 2.359 . . . . 0.0 112.528 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.06 133.09 29.83 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.355 1.37 . . . . 0.0 110.895 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 124.8 23.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.31 31.98 0.34 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.385 1.874 . . . . 0.0 114.046 -176.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.39 62.96 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.51 1.529 . . . . 0.0 114.073 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.59 24.97 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.338 1.855 . . . . 0.0 114.703 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.9 p30 47.76 30.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.164 2.586 . . . . 0.0 116.852 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.93 139.19 7.57 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.997 1.76 . . . . 0.0 111.156 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -49.58 124.05 8.82 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.839 1.256 . . . . 0.0 113.129 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -110.41 120.83 43.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.105 2.162 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.79 138.76 17.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.729 1.212 . . . . 0.0 111.168 174.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -154.78 134.79 13.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 111.266 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -54.23 132.67 43.92 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.6 tp -156.32 -41.06 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.758 1.223 . . . . 0.0 112.51 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.93 31.66 2.79 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 114.082 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.47 11.99 1.36 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.355 2.262 . . . . 0.0 115.743 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 170.85 -43.21 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.349 1.452 . . . . 0.0 113.097 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.37 151.5 26.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.519 1.127 . . . . 0.0 110.657 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.88 170.19 16.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.539 1.136 . . . . 0.0 113.06 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -82.51 126.5 32.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.671 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -121.24 102.78 8.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.438 1.095 . . . . 0.0 108.36 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.91 171.45 25.47 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 143.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.074 0.95 . . . . 0.0 110.045 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.03 148.8 33.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.407 1.883 . . . . 0.0 108.216 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.3 p -107.74 162.37 14.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.463 1.905 . . . . 0.0 111.025 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.7 p -92.11 19.82 6.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.533 1.533 . . . . 0.0 113.542 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.73 175.06 5.62 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.28 2.232 . . . . 0.0 113.456 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.57 9.8 Favored Glycine 0 N--CA 1.475 1.249 0 C-N-CA 125.362 1.458 . . . . 0.0 112.401 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.39 73.51 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.037 1.335 . . . . 0.0 109.639 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.23 91.69 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.688 0.795 . . . . 0.0 111.298 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -56.76 149.89 17.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.072 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.4 tpp -151.08 96.26 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.871 0.843 . . . . 0.0 110.649 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 17' ' ' LEU . 54.6 tt0 -124.96 134.93 52.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.602 -1.311 . . . . 0.0 109.636 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.66 101.1 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.571 1.548 . . . . 0.0 109.664 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -99.32 99.89 10.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.288 1.835 . . . . 0.0 109.845 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -85.92 118.08 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.449 -0.782 . . . . 0.0 111.16 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.05 165.78 26.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.87 1.668 . . . . 0.0 113.038 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.039 2.136 . . . . 0.0 111.648 174.968 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.59 143.03 53.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.023 0.929 . . . . 0.0 111.085 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.85 38.1 65.61 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -149.15 -169.73 3.45 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.425 1.113 . . . . 0.0 111.774 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 pt -126.47 153.27 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.974 1.71 . . . . 0.0 111.059 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 pt -148.94 170.0 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.824 1.65 . . . . 0.0 111.792 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.35 129.26 39.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.099 0.959 . . . . 0.0 109.601 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.34 42.05 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.947 1.26 . . . . 0.0 113.932 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.66 81.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.224 1.41 . . . . 0.0 112.267 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -32.58 32.34 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.94 1.296 . . . . 0.0 112.605 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 68' ' ' ALA . 5.9 tp -60.41 107.93 0.74 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.349 . . . . 0.0 111.896 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 m -149.37 168.17 24.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.755 1.222 . . . . 0.0 110.149 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -39.02 21.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.766 1.626 . . . . 0.0 114.222 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -59.38 -35.0 73.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.72 -44.02 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 110.474 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.52 -43.87 72.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.886 0.766 . . . . 0.0 112.226 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.16 -47.31 80.37 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.982 -0.449 . . . . 0.0 110.881 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -39.15 76.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.578 1.551 . . . . 0.0 114.0 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.19 -56.34 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.152 1.781 . . . . 0.0 109.598 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.41 -40.82 89.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.149 1.38 . . . . 0.0 112.646 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -56.52 -54.58 44.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 112.933 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.11 -42.0 89.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 tp -53.21 -55.54 23.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.03 1.732 . . . . 0.0 112.722 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.99 49.24 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.927 0.775 . . . . 0.0 114.12 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.91 123.71 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.561 1.944 . . . . 0.0 114.342 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.73 -161.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 127.086 2.154 . . . . 0.0 111.442 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 m -51.91 -34.07 39.86 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.807 1.643 . . . . 0.0 114.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -144.21 139.66 28.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.827 2.051 . . . . 0.0 108.932 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -162.73 148.32 12.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.574 1.949 . . . . 0.0 110.988 -174.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 104' ' ' VAL . 3.1 pt -138.35 151.79 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.14 0.976 . . . . 0.0 108.803 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.57 113.1 25.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.596 1.159 . . . . 0.0 109.866 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.75 130.4 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.693 0.797 . . . . 0.0 111.436 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.96 0.85 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.654 1.121 . . . . 0.0 112.759 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.11 101.54 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.846 1.258 . . . . 0.0 108.745 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -85.44 104.25 15.07 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.599 1.56 . . . . 0.0 111.696 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -82.79 104.35 12.96 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.572 1.149 . . . . 0.0 112.052 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.66 29.44 8.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.096 1.358 . . . . 0.0 112.331 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -84.02 -3.74 58.24 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.075 1.75 . . . . 0.0 114.747 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.21 14.64 80.12 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.505 -1.372 . . . . 0.0 114.287 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.65 20.23 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.445 1.498 . . . . 0.0 113.611 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.4 p -81.79 131.7 35.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.241 1.417 . . . . 0.0 112.527 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -108.35 164.43 12.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.741 1.216 . . . . 0.0 111.955 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -129.33 107.72 9.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.211 1.405 . . . . 0.0 110.082 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.27 117.82 10.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.309 -0.869 . . . . 0.0 109.985 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.03 -69.87 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.363 1.465 . . . . 0.0 111.223 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -170.95 164.41 7.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.531 1.932 . . . . 0.0 111.015 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -113.73 124.71 52.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.91 2.084 . . . . 0.0 110.068 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -108.21 109.75 21.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.546 1.138 . . . . 0.0 111.504 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -78.29 96.53 5.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.341 1.456 . . . . 0.0 112.053 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -66.07 -51.94 53.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.759 1.224 . . . . 0.0 112.003 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -138.63 141.48 39.11 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.822 2.049 . . . . 0.0 110.552 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.89 -171.46 42.91 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.32 0.486 . . . . 0.0 112.771 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.97 176.43 9.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.808 0.843 . . . . 0.0 111.984 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -142.65 -179.17 6.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.214 1.406 . . . . 0.0 111.355 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -137.52 22.89 2.94 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.915 1.286 . . . . 0.0 112.021 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.73 171.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.726 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.01 138.82 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 108.733 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -88.95 151.2 46.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.107 0.867 . . . . 0.0 111.426 177.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.67 165.73 26.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.741 2.96 . . . . 0.0 110.136 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -29.89 9.44 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.91 -1.119 . . . . 0.0 111.474 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.04 132.8 55.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.168 1.387 . . . . 0.0 111.044 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.45 81.94 47.47 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.051 1.74 . . . . 0.0 108.207 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.06 157.69 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 121.959 1.773 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -56.09 151.1 12.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.414 -0.803 . . . . 0.0 111.563 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 66.24 3.99 2.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.21 2.204 . . . . 0.0 115.257 -171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -130.95 99.13 4.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.146 1.779 . . . . 0.0 113.163 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.551 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -76.59 161.77 28.31 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.744 1.218 . . . . 0.0 112.628 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.91 170.89 7.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.911 0.885 . . . . 0.0 110.642 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.27 130.29 40.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.099 2.159 . . . . 0.0 107.877 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -149.12 161.48 41.88 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.307 1.443 . . . . 0.0 110.334 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -140.12 157.9 44.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.325 0.65 . . . . 0.0 111.512 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.07 118.69 1.4 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.579 1.561 . . . . 0.0 111.937 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.85 169.47 13.21 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.175 1.39 . . . . 0.0 112.011 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -99.89 111.61 23.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.891 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 t70 36.89 -145.72 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 128.637 2.775 . . . . 0.0 114.061 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 m -58.06 -57.56 12.31 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.942 -1.724 . . . . 0.0 111.941 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.8 -75.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.621 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.21 73.02 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 125.216 3.944 . . . . 0.0 113.042 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.6 159.64 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.091 1.756 . . . . 0.0 111.662 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.05 65.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.065 1.346 . . . . 0.0 111.766 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -127.1 -88.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.637 1.575 . . . . 0.0 110.389 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.6 172.99 32.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.526 1.536 . . . . 0.0 111.322 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.58 116.9 22.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.719 1.207 . . . . 0.0 109.385 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -142.5 128.29 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.599 1.16 . . . . 0.0 108.351 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -151.54 165.78 33.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.605 0.717 . . . . 0.0 110.67 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.62 139.56 20.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.298 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -134.42 175.85 9.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 -171.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.17 37.51 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.607 -0.683 . . . . 0.0 112.261 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.93 119.45 23.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.688 1.195 . . . . 0.0 110.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.59 112.07 17.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.461 1.904 . . . . 0.0 110.126 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -67.43 162.49 22.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.944 0.898 . . . . 0.0 111.749 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.9 p -59.59 -21.7 60.73 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 m -84.8 -14.95 46.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.511 1.925 . . . . 0.0 113.453 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.42 55.54 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.038 1.304 . . . . 0.0 115.447 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -82.01 165.36 20.74 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.482 1.141 . . . . 0.0 109.662 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.0 m -123.49 143.72 49.99 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 109.147 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -117.36 109.18 16.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.134 0.974 . . . . 0.0 109.354 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.65 114.24 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 117' ' ' VAL . 19.8 m -108.26 140.22 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.171 0.988 . . . . 0.0 110.991 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 135' ' ' TYR . 0.0 OUTLIER -141.39 155.25 45.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.338 0.655 . . . . 0.0 111.312 174.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -132.84 153.68 51.07 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.216 1.006 . . . . 0.0 111.516 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.3 t -137.39 115.03 11.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.403 1.081 . . . . 0.0 110.604 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.592 HG21 HG21 ' A' ' 31' ' ' ILE . 53.2 t -124.05 92.48 48.29 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 126.154 1.782 . . . . 0.0 108.579 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.76 171.6 17.89 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.081 2.521 . . . . 0.0 112.729 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -73.25 -55.95 5.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.514 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.75 122.0 22.6 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.36 1.464 . . . . 0.0 113.325 -161.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -67.22 -58.47 4.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -100.51 15.24 28.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.967 1.307 . . . . 0.0 114.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 0.31 4.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.856 2.063 . . . . 0.0 112.192 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.44 -179.02 7.37 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.419 2.288 . . . . 0.0 110.679 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -154.07 173.03 16.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.172 1.389 . . . . 0.0 112.076 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -95.8 147.54 23.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -134.86 142.48 46.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 110.545 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.51 152.82 40.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.39 1.476 . . . . 0.0 109.411 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -153.63 145.8 23.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.739 1.216 . . . . 0.0 110.22 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 100' ' ' VAL . 71.7 t -143.28 112.88 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.261 1.825 . . . . 0.0 110.5 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.55 129.29 56.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.129 0.971 . . . . 0.0 109.518 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.52 112.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.223 1.809 . . . . 0.0 108.755 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -124.19 141.45 52.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.473 1.509 . . . . 0.0 112.354 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.3 p -77.1 78.66 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.96 1.304 . . . . 0.0 112.858 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.13 165.18 20.91 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.44 1.019 . . . . 0.0 113.245 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 140.16 57.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.761 1.624 . . . . 0.0 111.856 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -156.04 168.32 27.62 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.516 1.527 . . . . 0.0 110.444 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -142.08 -175.42 4.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.097 1.759 . . . . 0.0 109.714 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.2 111.36 16.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.34 -67.22 0.99 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.287 1.035 . . . . 0.0 109.238 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.33 -71.53 0.21 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.153 0.981 . . . . 0.0 110.594 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.34 -22.91 74.94 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.935 0.778 . . . . 0.0 114.61 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.2 tpp -74.22 -54.18 8.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -40.72 85.33 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.565 1.146 . . . . 0.0 111.666 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.63 -36.24 66.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.352 1.461 . . . . 0.0 111.812 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -21.58 66.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.324 1.05 . . . . 0.0 113.113 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.67 -43.25 10.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 108.558 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.458 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 8.3 t80 -66.67 -49.74 65.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.866 -1.147 . . . . 0.0 113.669 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.56 -12.74 31.02 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.22 -66.91 2.5 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 124.191 0.9 . . . . 0.0 112.869 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.49 77.96 0.27 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.374 2.67 . . . . 0.0 108.928 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.4 143.44 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.509 1.473 . . . . 0.0 108.315 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -79.44 -11.78 59.9 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.7 129.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.054 3.342 . . . . 0.0 112.529 -173.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.36 62.09 0.6 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.05 2.262 . . . . 0.0 114.377 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -78.51 29.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.067 1.747 . . . . 0.0 114.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.253 10.9 p30 50.13 30.46 4.25 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 174.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.27 152.17 20.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.027 1.775 . . . . 0.0 111.017 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -64.37 112.67 3.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.03 123.51 49.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.053 1.741 . . . . 0.0 111.062 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -149.1 154.17 38.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.703 2.001 . . . . 0.0 111.836 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.39 135.85 10.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.308 1.043 . . . . 0.0 111.15 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.49 127.47 31.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.002 0.521 . . . . 0.0 111.447 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.1 tp -149.67 -27.99 0.26 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -84.29 18.76 21.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.998 1.285 . . . . 0.0 114.553 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.47 10.04 1.72 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.477 2.311 . . . . 0.0 115.438 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.85 -61.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.118 1.818 . . . . 0.0 110.579 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.1 159.78 15.52 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.796 0.838 . . . . 0.0 112.476 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 169.3 25.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.847 1.659 . . . . 0.0 112.82 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.491 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.3 pmm? -88.54 133.79 34.05 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.004 0.922 . . . . 0.0 112.011 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.16 107.24 9.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.329 1.452 . . . . 0.0 107.68 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -136.24 175.31 21.0 Favored Glycine 0 C--N 1.325 -0.077 0 CA-C-O 121.941 0.745 . . . . 0.0 113.441 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.65 141.49 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.82 1.648 . . . . 0.0 108.074 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.7 ttt -144.23 130.59 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 161.54 25.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.346 1.058 . . . . 0.0 110.095 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.55 24.91 6.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.403 1.481 . . . . 0.0 113.278 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.76 171.7 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.235 1.814 . . . . 0.0 112.269 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.44 -54.54 36.34 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.621 -0.674 . . . . 0.0 113.192 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.7 pt-20 -88.91 47.55 1.51 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.04 1.736 . . . . 0.0 113.777 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.18 141.49 57.33 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.895 0.855 . . . . 0.0 113.103 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -96.0 136.93 35.8 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 108.757 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.6 ttp -134.62 95.37 3.35 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.775 1.23 . . . . 0.0 111.733 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -108.72 145.38 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.915 -0.491 . . . . 0.0 110.465 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.26 112.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 125.764 1.626 . . . . 0.0 108.138 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -99.39 108.15 20.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.14 1.776 . . . . 0.0 108.765 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 157' ' ' MET . 33.3 mm -92.44 109.66 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.691 . . . . 0.0 110.266 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.39 171.32 14.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 111.996 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 127.637 2.375 . . . . 0.0 110.385 175.028 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.18 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.02 40.66 9.15 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.933 1.254 . . . . 0.0 114.81 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -145.51 -166.29 2.4 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.309 1.555 . . . . 0.0 112.639 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.11 140.14 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.319 2.248 . . . . 0.0 110.1 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -145.1 170.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.177 1.391 . . . . 0.0 111.987 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.76 111.39 5.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.759 -1.213 . . . . 0.0 110.898 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.91 -25.23 67.57 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.981 0.8 . . . . 0.0 113.302 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.42 -23.68 64.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.956 1.303 . . . . 0.0 114.08 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.02 1.16 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.111 1.364 . . . . 0.0 113.319 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.51 117.16 12.71 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.097 1.759 . . . . 0.0 111.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -145.84 169.0 19.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.577 1.551 . . . . 0.0 110.157 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.64 -41.33 42.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.128 1.371 . . . . 0.0 114.141 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -58.39 -42.59 87.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.644 0.777 . . . . 0.0 112.109 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.37 -46.75 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.447 1.099 . . . . 0.0 111.382 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 170' ' ' GLN . 33.7 mt -54.92 -49.85 70.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.736 0.814 . . . . 0.0 111.474 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -41.26 96.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -53.45 -45.35 69.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.091 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 70' ' ' LEU . 85.3 t -56.84 -56.89 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.0 mp -58.99 -33.87 71.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.258 1.423 . . . . 0.0 113.953 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -55.77 30.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.816 1.246 . . . . 0.0 110.277 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -15.36 60.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -30.6 56.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.448 1.099 . . . . 0.0 111.9 174.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 44.51 47.84 8.75 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.452 1.977 . . . . 0.0 113.959 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.73 175.84 1.03 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.356 1.462 . . . . 0.0 114.48 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -172.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 126.146 1.778 . . . . 0.0 110.922 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 m -48.92 -27.92 3.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.133 1.373 . . . . 0.0 114.591 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -127.36 149.86 49.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.753 1.221 . . . . 0.0 111.277 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.27 154.38 8.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.319 2.248 . . . . 0.0 109.899 -175.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.654 HD12 ' SD ' ' A' ' 169' ' ' MET . 13.9 pt -144.6 147.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.993 1.717 . . . . 0.0 109.083 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.23 105.59 13.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.67 1.188 . . . . 0.0 110.008 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.14 135.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.73 1.612 . . . . 0.0 111.569 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.06 115.4 0.69 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.979 1.276 . . . . 0.0 112.62 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.4 mt -106.63 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.337 1.455 . . . . 0.0 109.16 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.38 122.49 24.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.729 1.612 . . . . 0.0 113.845 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -77.34 90.52 3.78 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.195 1.798 . . . . 0.0 111.458 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.46 17.8 14.47 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.401 1.48 . . . . 0.0 112.635 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -76.48 -38.64 55.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 9.79 13.63 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.931 1.253 . . . . 0.0 115.568 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.06 166.19 29.39 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 119.466 1.633 . . . . 0.0 114.946 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -81.66 130.89 35.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.35 1.46 . . . . 0.0 112.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 m0 -106.58 161.35 14.7 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.683 1.193 . . . . 0.0 111.04 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.8 m -129.58 110.35 11.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.252 1.421 . . . . 0.0 109.051 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.41 130.19 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.053 -1.029 . . . . 0.0 109.792 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.23 -70.3 0.37 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 109.942 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -174.06 175.86 2.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.045 2.138 . . . . 0.0 110.549 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.03 154.87 42.37 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.728 2.011 . . . . 0.0 110.277 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.52 108.05 5.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.06 1.344 . . . . 0.0 111.022 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -74.33 105.91 5.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.101 1.361 . . . . 0.0 111.12 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -45.74 54.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.183 0.993 . . . . 0.0 111.503 175.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.0 m -140.19 156.76 46.38 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.892 2.077 . . . . 0.0 110.932 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.17 -168.32 45.13 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.68 0.6 . . . . 0.0 112.611 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -138.42 169.32 18.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.534 1.134 . . . . 0.0 110.142 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -147.23 137.11 23.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.91 0.862 . . . . 0.0 109.791 175.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.13 5.75 50.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.197 1.799 . . . . 0.0 112.754 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 55' ' ' THR . 11.5 m -116.1 169.58 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 110.738 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.19 141.77 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.486 1.114 . . . . 0.0 109.495 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.67 151.48 61.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 0.0 111.619 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 164.41 35.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.124 3.216 . . . . 0.0 110.524 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 -34.34 10.17 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.704 -0.622 . . . . 0.0 112.001 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.6 136.14 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.862 1.21 . . . . 0.0 110.82 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.03 89.24 7.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.78 1.232 . . . . 0.0 109.754 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.46 166.43 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.668 2.245 . . . . 0.0 113.49 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.81 153.5 16.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.6 p 69.89 -9.15 0.73 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -115.69 123.87 49.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.251 1.82 . . . . 0.0 111.914 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.32 176.69 6.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.872 1.269 . . . . 0.0 110.128 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.14 173.08 6.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.656 0.782 . . . . 0.0 109.247 174.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -126.51 131.79 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.385 1.474 . . . . 0.0 110.042 175.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -148.67 163.81 36.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 111.334 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.1 m -151.39 173.88 14.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 110.903 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.27 132.57 3.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.885 1.707 . . . . 0.0 110.323 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 178.57 6.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.3 1.04 . . . . 0.0 110.17 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -64.12 -174.95 0.13 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.027 0.931 . . . . 0.0 109.881 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.34 -167.88 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 121.137 -0.977 . . . . 0.0 109.989 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -34.28 -42.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.794 2.037 . . . . 0.0 114.85 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -51.75 0.48 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.51 1.528 . . . . 0.0 113.781 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.02 6.07 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.426 3.418 . . . . 0.0 115.073 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 109.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.447 2.299 . . . . 0.0 111.496 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.09 70.06 3.86 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.079 1.752 . . . . 0.0 112.895 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -97.51 -81.12 0.43 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.315 1.046 . . . . 0.0 111.996 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.06 176.3 43.21 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.115 1.817 . . . . 0.0 110.319 -172.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -149.13 86.55 1.5 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.542 1.163 . . . . 0.0 109.08 174.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.8 t -132.58 118.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.266 1.426 . . . . 0.0 107.639 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -141.06 166.29 25.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.055 0.931 . . . . 0.0 110.971 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.73 155.98 40.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.1 177.09 10.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 110.32 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.35 40.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.579 1.151 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.66 118.72 27.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.713 1.205 . . . . 0.0 110.594 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.89 107.72 9.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.042 1.737 . . . . 0.0 109.229 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mtt -64.54 166.64 8.2 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.498 -0.751 . . . . 0.0 112.212 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 t -62.98 -19.13 64.02 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -82.35 -18.83 40.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 113.203 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.19 -0.72 54.33 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.165 1.364 . . . . 0.0 114.906 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -79.93 166.23 21.83 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.597 1.198 . . . . 0.0 109.948 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 m -123.03 149.82 43.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.938 0.875 . . . . 0.0 110.318 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.37 112.43 18.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 108.257 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.18 127.8 8.2 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 117' ' ' VAL . 10.2 m -134.57 131.99 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.106 0.953 . . . . 0.0 110.157 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.48 156.65 45.18 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.156 0.582 . . . . 0.0 112.192 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -126.72 158.81 35.5 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.739 1.215 . . . . 0.0 111.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 t -138.67 108.25 6.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.486 1.115 . . . . 0.0 111.166 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 38.5 t -109.74 98.1 31.7 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.633 1.973 . . . . 0.0 108.612 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.97 169.37 22.34 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.342 2.695 . . . . 0.0 112.844 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.65 -17.48 41.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.13 110.72 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.149 0.98 . . . . 0.0 110.741 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.4 -58.4 5.37 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.09 -1.006 . . . . 0.0 113.269 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.81 10.76 27.21 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.688 1.195 . . . . 0.0 114.129 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.15 0.56 5.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.189 1.796 . . . . 0.0 112.609 -175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -153.84 173.16 16.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.237 2.215 . . . . 0.0 110.01 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.2 m -138.57 170.02 16.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.587 1.155 . . . . 0.0 112.155 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -90.84 142.64 27.55 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.396 -0.815 . . . . 0.0 110.143 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -135.69 139.92 44.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 108.755 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -158.14 150.77 22.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.788 1.635 . . . . 0.0 109.322 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -151.36 154.65 37.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.79 1.236 . . . . 0.0 109.912 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 100' ' ' VAL . 61.8 t -145.05 121.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.514 1.525 . . . . 0.0 111.4 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -123.31 136.17 54.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.513 1.525 . . . . 0.0 110.627 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.71 116.38 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.919 2.088 . . . . 0.0 108.363 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -129.77 136.41 49.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.235 1.814 . . . . 0.0 112.54 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.5 p -79.99 79.36 6.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.09 1.356 . . . . 0.0 112.465 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.53 176.12 43.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.446 1.498 . . . . 0.0 112.355 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 104.11 16.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.584 1.954 . . . . 0.0 111.135 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -134.41 158.85 42.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.631 1.172 . . . . 0.0 111.371 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -136.75 164.77 27.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.092 1.757 . . . . 0.0 110.57 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.3 87.89 6.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.631 0.772 . . . . 0.0 111.2 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -102.27 -66.9 0.9 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 110.375 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -147.67 -75.0 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.677 1.991 . . . . 0.0 108.554 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.54 -37.17 88.07 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.357 0.979 . . . . 0.0 113.943 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -70.44 -52.97 18.42 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.145 0.972 . . . . 0.0 111.821 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.09 91.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.302 0.641 . . . . 0.0 111.381 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.92 -34.33 77.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.815 -0.612 . . . . 0.0 112.247 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -23.06 64.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.669 1.122 . . . . 0.0 112.177 175.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.54 -58.09 2.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 108.898 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.24 -56.96 15.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.899 -1.126 . . . . 0.0 111.803 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.33 -18.66 44.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 0.0 112.049 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.7 -68.9 1.45 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.346 0.974 . . . . 0.0 113.077 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.31 88.98 0.27 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 127.732 2.413 . . . . 0.0 108.599 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.17 142.06 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.609 1.539 . . . . 0.0 109.429 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -77.5 -9.68 59.05 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.13 107.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 128.931 2.892 . . . . 0.0 112.221 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.19 85.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.344 1.926 . . . . 0.0 114.214 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -89.25 22.99 2.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.504 2.321 . . . . 0.0 113.865 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.286 11.9 p30 50.47 33.6 8.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.871 2.068 . . . . 0.0 114.927 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.91 156.84 23.08 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.24 1.876 . . . . 0.0 111.965 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -69.16 114.07 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.801 -0.823 . . . . 0.0 111.282 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.29 121.65 43.53 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.026 1.73 . . . . 0.0 111.114 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.27 144.53 38.43 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.826 2.05 . . . . 0.0 110.126 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 133.7 13.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.29 1.036 . . . . 0.0 111.477 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.56 115.24 2.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.172 0.989 . . . . 0.0 111.192 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -29.87 1.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.71 1.204 . . . . 0.0 113.279 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.5 18.05 35.79 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.357 1.456 . . . . 0.0 114.427 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 59.09 13.31 2.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.923 2.089 . . . . 0.0 114.709 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -175.42 -69.16 0.05 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 126.658 2.075 . . . . 0.0 109.664 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -87.19 150.15 24.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.324 1.059 . . . . 0.0 111.95 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 172.33 13.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.46 1.904 . . . . 0.0 110.896 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.9 ptm -101.57 150.05 23.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.626 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -130.71 107.55 9.24 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.255 1.822 . . . . 0.0 107.473 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.48 176.98 19.13 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-O 121.748 0.638 . . . . 0.0 113.119 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.79 144.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 107.501 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -145.4 140.87 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.445 1.498 . . . . 0.0 108.439 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.34 162.26 13.42 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.89 1.676 . . . . 0.0 110.623 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.56 16.54 23.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.215 1.006 . . . . 0.0 113.405 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -107.6 172.74 6.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.861 2.064 . . . . 0.0 112.439 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.8 -46.54 94.31 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.431 1.015 . . . . 0.0 114.097 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.99 60.01 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.369 1.468 . . . . 0.0 113.026 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.12 144.86 40.4 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -89.01 147.95 24.01 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.909 0.884 . . . . 0.0 109.254 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.654 ' SD ' HD12 ' A' ' 31' ' ' ILE . 8.2 mtt -135.5 105.68 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.869 1.667 . . . . 0.0 110.068 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 17' ' ' LEU . 17.6 tt0 -124.86 143.17 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.871 -1.143 . . . . 0.0 109.515 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.24 106.04 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.88 1.272 . . . . 0.0 108.503 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -100.22 103.87 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.093 1.757 . . . . 0.0 108.713 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.0 136.94 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.132 0.573 . . . . 0.0 110.042 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 p -158.4 159.87 36.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 128.695 2.798 . . . . 0.0 113.455 176.818 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.651 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 59.6 161.31 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.887 2.475 . . . . 0.0 113.364 -166.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.4 46.71 93.82 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.036 -1.04 . . . . 0.0 115.091 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 p -155.11 -170.99 3.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.977 0.911 . . . . 0.0 111.75 -170.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 pt -118.82 144.01 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.786 2.034 . . . . 0.0 110.336 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.72 169.79 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.659 1.584 . . . . 0.0 112.065 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 125.35 25.05 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.728 1.211 . . . . 0.0 112.143 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.12 -28.75 73.92 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.389 0.995 . . . . 0.0 114.382 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.62 74.98 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.669 -0.901 . . . . 0.0 112.567 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -82.62 -22.8 34.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.466 1.106 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.48 120.23 10.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.984 1.714 . . . . 0.0 110.029 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -152.43 171.96 17.24 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.109 1.764 . . . . 0.0 110.009 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -50.94 -36.33 38.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 113.997 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.73 -35.5 76.52 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.741 -1.224 . . . . 0.0 112.988 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.04 -42.59 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.734 0.814 . . . . 0.0 110.248 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -51.34 -49.59 61.12 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.109 0.963 . . . . 0.0 111.755 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.47 -48.6 77.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.43 0.692 . . . . 0.0 111.986 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -56.87 -35.02 68.43 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.47 -56.84 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.073 1.349 . . . . 0.0 110.059 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.35 -41.75 94.28 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.201 1.4 . . . . 0.0 112.369 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -54.75 -49.36 71.04 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.949 0.9 . . . . 0.0 112.318 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -85.86 -32.42 21.72 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -54.23 35.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.392 1.477 . . . . 0.0 111.239 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.82 58.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.383 0.992 . . . . 0.0 112.462 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 139.6 7.34 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.925 1.29 . . . . 0.0 111.913 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 28' ' ' SER . 3.4 p -137.05 -163.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.036 1.334 . . . . 0.0 110.709 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.546 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -38.83 -44.9 1.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.19 1.796 . . . . 0.0 114.138 175.252 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -148.98 138.88 22.04 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.132 1.373 . . . . 0.0 110.93 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.02 151.63 16.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.869 1.668 . . . . 0.0 111.165 -172.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' A' ' 102' ' ' PHE . 14.5 pt -134.95 152.3 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.108 1.363 . . . . 0.0 109.4 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.52 117.92 33.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.341 1.457 . . . . 0.0 109.38 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.85 126.97 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.81 109.44 0.66 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.38 1.466 . . . . 0.0 112.455 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 171' ' ' ILE . 10.8 mt -107.54 101.9 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.763 1.225 . . . . 0.0 108.246 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.63 120.77 26.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.568 1.547 . . . . 0.0 112.62 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -84.99 102.49 13.23 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.1 1.36 . . . . 0.0 112.054 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.67 25.68 7.42 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 111.615 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -77.99 -19.94 53.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.784 1.634 . . . . 0.0 114.387 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.75 26.85 25.88 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 114.743 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.08 150.38 18.2 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.77 1.176 . . . . 0.0 113.959 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -71.14 140.27 50.53 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.439 -1.036 . . . . 0.0 112.918 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -114.35 164.41 13.98 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.47 1.108 . . . . 0.0 112.237 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 m -132.91 108.75 9.13 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.038 1.335 . . . . 0.0 109.714 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.87 131.49 46.4 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.22 -69.32 0.48 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.735 -0.603 . . . . 0.0 110.539 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.7 163.02 2.8 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.059 2.143 . . . . 0.0 111.076 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -110.86 122.88 48.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.225 1.81 . . . . 0.0 109.224 175.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -110.1 105.75 14.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.434 1.094 . . . . 0.0 111.629 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -73.92 115.02 12.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.817 1.247 . . . . 0.0 112.034 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -46.62 11.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.604 1.561 . . . . 0.0 111.495 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.8 m -139.15 157.0 46.72 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.932 2.093 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.0 -158.5 53.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.48 0.562 . . . . 0.0 112.631 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 76' ' ' ASP . 3.4 t -148.52 -168.8 3.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.068 -0.666 . . . . 0.0 112.323 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.2 p -142.26 178.67 7.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.105 2.162 . . . . 0.0 111.155 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.21 10.61 6.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.348 1.459 . . . . 0.0 111.971 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 ' CB ' ' A' ' 3' ' ' ALA . 6.8 m -139.2 169.18 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.184 2.593 . . . . 0.0 113.88 -168.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.43 132.57 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.788 2.035 . . . . 0.0 109.804 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.61 153.97 65.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 119.672 1.123 . . . . 0.0 111.842 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.5 165.45 30.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.824 3.016 . . . . 0.0 109.947 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.13 -33.67 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.414 -0.804 . . . . 0.0 112.153 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -115.11 133.72 55.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.509 1.524 . . . . 0.0 109.917 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.96 106.36 5.77 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.373 1.069 . . . . 0.0 110.121 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.71 163.35 35.59 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.776 1.651 . . . . 0.0 112.051 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.87 150.94 27.01 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.636 -0.665 . . . . 0.0 111.075 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 0.5 OUTLIER 76.96 -3.19 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.838 2.855 . . . . 0.0 114.17 -176.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -112.54 149.53 32.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.499 1.52 . . . . 0.0 109.372 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.23 157.72 29.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 109.916 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.7 pt? -94.38 176.81 6.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.883 0.849 . . . . 0.0 109.72 175.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.48 129.7 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.925 2.09 . . . . 0.0 109.16 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -149.12 168.94 21.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.624 0.77 . . . . 0.0 111.204 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -148.66 174.43 12.17 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.157 0.983 . . . . 0.0 111.255 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.3 118.7 0.85 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.1 1.333 . . . . 0.0 111.839 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -118.7 150.15 40.24 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.002 1.401 . . . . 0.0 112.379 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -70.16 116.08 10.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 54' ' ' THR . 10.2 m-20 42.85 -151.2 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.745 1.618 . . . . 0.0 113.533 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -75.05 -39.95 60.61 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.268 -1.52 . . . . 0.0 112.034 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.41 -62.08 0.37 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.21 1.386 . . . . 0.0 113.646 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.68 3.86 2.95 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 125.279 3.986 . . . . 0.0 115.601 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.56 132.31 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 127.646 2.379 . . . . 0.0 109.404 -174.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 69.85 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.303 1.441 . . . . 0.0 111.274 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -108.42 -71.21 0.77 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.364 1.065 . . . . 0.0 110.859 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.95 35.86 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.988 0.804 . . . . 0.0 112.164 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -135.38 112.18 10.14 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.765 1.226 . . . . 0.0 108.466 174.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 135.31 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.63 167.16 23.64 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.43 141.66 22.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 110.968 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.449 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -131.96 172.65 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.381 1.472 . . . . 0.0 109.151 -176.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.54 148.31 44.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -127.8 120.2 27.35 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.755 1.222 . . . . 0.0 110.779 -179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -82.69 125.11 30.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.614 . . . . 0.0 110.687 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.447 ' CE ' HD23 ' A' ' 98' ' ' LEU . 1.4 mtm -88.2 164.36 15.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.934 0.894 . . . . 0.0 112.953 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -60.52 -22.7 63.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.688 1.195 . . . . 0.0 113.634 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -81.98 -8.19 59.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.672 1.589 . . . . 0.0 113.272 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.23 65.56 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.928 1.251 . . . . 0.0 115.252 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.06 171.93 9.48 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.127 0.971 . . . . 0.0 110.979 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.6 m -133.74 146.43 50.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.059 0.944 . . . . 0.0 111.611 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CE ' ' A' ' 92' ' ' MET . 1.3 pp -117.45 130.61 56.58 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.432 1.093 . . . . 0.0 108.31 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.6 145.34 17.9 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.93 115.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.729 1.212 . . . . 0.0 109.005 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.512 ' HG3' ' H ' ' A' ' 116' ' ' ASP . 1.9 ptm -113.49 160.89 18.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.958 0.503 . . . . 0.0 112.086 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.46 141.62 39.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.554 1.142 . . . . 0.0 109.678 175.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 m -128.5 106.62 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.411 1.884 . . . . 0.0 108.801 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.2 101.59 53.67 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 126.487 1.915 . . . . 0.0 108.813 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.6 171.36 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.317 2.678 . . . . 0.0 111.977 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.02 -24.31 28.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.5 0.72 . . . . 0.0 112.023 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.49 116.32 32.15 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.267 1.427 . . . . 0.0 111.889 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -71.12 -59.3 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.32 10.54 29.33 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.103 -0.998 . . . . 0.0 113.612 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.76 -4.86 5.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.01 2.124 . . . . 0.0 112.615 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 160.49 39.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.837 2.455 . . . . 0.0 109.249 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.6 m -125.02 164.7 19.61 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.07 -1.019 . . . . 0.0 110.834 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -85.12 140.9 30.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.516 0.727 . . . . 0.0 109.884 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 156.94 47.63 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -161.93 140.73 9.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.501 1.52 . . . . 0.0 111.156 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 101' ' ' MET . 10.8 t70 -125.57 142.42 51.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.384 1.474 . . . . 0.0 109.214 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -138.36 113.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.345 1.458 . . . . 0.0 109.834 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.65 143.1 50.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.795 1.638 . . . . 0.0 108.845 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.28 118.59 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.661 1.984 . . . . 0.0 108.514 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -129.89 136.0 49.01 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.454 1.501 . . . . 0.0 112.426 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.1 p -70.32 84.77 0.57 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.483 1.913 . . . . 0.0 112.242 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.51 -174.12 44.44 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.451 1.024 . . . . 0.0 113.655 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -115.82 114.37 24.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.598 1.959 . . . . 0.0 110.151 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 159.65 40.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.984 0.913 . . . . 0.0 111.877 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 163.15 33.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.254 1.422 . . . . 0.0 111.27 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.33 89.09 0.2 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.255 1.422 . . . . 0.0 110.923 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.52 -61.33 1.61 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 109.88 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -71.89 0.19 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.245 1.418 . . . . 0.0 109.046 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.1 -32.54 72.96 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.981 0.8 . . . . 0.0 114.416 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -66.07 -53.2 41.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.082 0.941 . . . . 0.0 110.549 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -57.76 -39.83 78.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.455 0.702 . . . . 0.0 110.592 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -48.38 79.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -27.52 67.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.915 0.886 . . . . 0.0 112.923 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -82.7 -50.15 9.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.21 1.004 . . . . 0.0 110.127 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.15 -47.71 67.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.095 1.358 . . . . 0.0 113.7 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -88.81 -13.82 38.48 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.84 -83.15 0.05 OUTLIER Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.824 1.202 . . . . 0.0 112.197 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -168.12 72.75 0.88 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.013 1.725 . . . . 0.0 110.139 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.4 133.04 29.01 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.625 0.883 . . . . 0.0 110.336 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -61.42 158.34 14.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.046 1.338 . . . . 0.0 110.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -95.16 3.71 54.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -164.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 54.69 49.45 61.44 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.481 1.039 . . . . 0.0 112.946 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.91 20.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.41 2.284 . . . . 0.0 115.058 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.265 9.7 p30 48.79 38.45 11.88 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.362 2.265 . . . . 0.0 114.674 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.86 160.35 26.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.596 1.57 . . . . 0.0 112.731 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -68.75 127.12 31.94 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.137 0.975 . . . . 0.0 111.423 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -120.84 106.38 11.61 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.602 1.961 . . . . 0.0 109.464 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.74 150.12 43.01 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.893 1.277 . . . . 0.0 110.989 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 142.28 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.2 1.8 . . . . 0.0 110.241 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -61.53 132.41 53.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.111 0.564 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 tp -147.4 -37.24 0.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.52 25.66 4.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.04 1.305 . . . . 0.0 114.47 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.86 9.75 1.3 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.338 2.255 . . . . 0.0 115.492 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.96 -49.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.239 1.399 . . . . 0.0 112.18 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.88 156.63 18.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.854 0.835 . . . . 0.0 111.597 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 169.09 22.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.974 1.709 . . . . 0.0 112.06 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -94.77 138.8 32.11 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.214 1.006 . . . . 0.0 111.473 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -126.69 106.42 9.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.039 1.736 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.29 169.13 24.64 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 114.779 0.671 . . . . 0.0 114.779 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.92 143.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 125.951 1.7 . . . . 0.0 109.317 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.84 147.6 33.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.537 1.535 . . . . 0.0 108.06 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -96.08 171.58 8.53 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.241 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m -104.28 21.83 15.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.317 1.447 . . . . 0.0 112.458 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 -178.32 3.54 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 112.591 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.57 -36.52 78.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.99 0.805 . . . . 0.0 114.424 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.89 75.21 4.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.666 1.587 . . . . 0.0 111.023 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.91 73.06 1.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 112.251 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -43.99 141.14 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.585 1.954 . . . . 0.0 110.465 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 ttm -142.13 106.25 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.132 0.967 . . . . 0.0 110.566 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -124.2 139.67 53.7 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.432 HD13 HG12 ' A' ' 35' ' ' ILE . 3.8 mp -131.39 101.33 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.633 1.573 . . . . 0.0 108.964 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.71 104.78 16.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.363 1.865 . . . . 0.0 109.432 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -87.63 124.28 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 121.819 -0.551 . . . . 0.0 110.989 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.1 m -141.21 167.88 21.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 112.959 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 128.153 2.581 . . . . 0.0 112.686 175.126 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.647 0.261 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.35 158.05 0.06 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.699 2.8 . . . . 0.0 113.335 -166.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.84 44.59 96.92 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.296 -0.878 . . . . 0.0 114.1 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -144.74 -176.59 5.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.433 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.69 135.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.288 1.835 . . . . 0.0 110.616 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -141.06 167.0 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.382 1.473 . . . . 0.0 111.225 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.0 125.73 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.925 -1.109 . . . . 0.0 110.423 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.36 -21.14 59.53 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.897 0.761 . . . . 0.0 113.447 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.32 72.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.226 1.41 . . . . 0.0 112.049 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.63 -30.33 41.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.707 1.203 . . . . 0.0 112.762 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 tp -55.53 106.41 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.053 1.741 . . . . 0.0 111.151 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 m -149.88 166.98 27.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.543 1.537 . . . . 0.0 109.762 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -44.62 -39.28 4.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.968 1.707 . . . . 0.0 114.618 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.31 -36.02 76.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.12 -35.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.874 1.669 . . . . 0.0 110.618 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.9 mt -56.44 -52.22 65.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.902 0.774 . . . . 0.0 111.127 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -53.53 -39.82 64.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.973 0.806 . . . . 0.0 112.148 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -59.84 -32.44 70.69 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.547 1.139 . . . . 0.0 113.274 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 70' ' ' LEU . 32.0 t -63.97 -52.31 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 108.968 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.04 -41.16 74.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.021 0.528 . . . . 0.0 111.757 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.8 -56.7 18.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.485 1.114 . . . . 0.0 112.617 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.81 -38.6 46.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -21.79 66.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.262 1.025 . . . . 0.0 111.07 175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.46 73.09 0.96 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.037 1.303 . . . . 0.0 110.153 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -45.2 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.637 1.575 . . . . 0.0 112.449 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 28' ' ' SER . 2.5 p -76.07 -163.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.51 1.524 . . . . 0.0 110.22 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 27' ' ' VAL . 8.0 t -44.28 -33.95 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.606 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.05 134.36 13.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.179 1.791 . . . . 0.0 110.78 175.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.2 165.01 34.58 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.75 155.0 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.013 0.824 . . . . 0.0 111.731 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.23 115.58 30.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.005 0.922 . . . . 0.0 110.58 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.16 144.03 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.006 1.322 . . . . 0.0 110.948 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.36 0.77 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.92 0.771 . . . . 0.0 112.789 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.89 103.93 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.817 1.247 . . . . 0.0 110.438 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.32 124.31 27.96 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.699 1.6 . . . . 0.0 113.741 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.43 103.81 9.61 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.328 1.851 . . . . 0.0 113.954 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.25 36.49 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.803 2.041 . . . . 0.0 112.323 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.549 1.54 . . . . 0.0 113.662 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.59 11.63 49.29 Favored Glycine 0 CA--C 1.541 1.687 0 O-C-N 120.983 -1.073 . . . . 0.0 115.182 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.97 162.31 28.33 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.001 1.762 . . . . 0.0 113.051 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -76.57 137.67 39.68 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.601 1.16 . . . . 0.0 112.517 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 92' ' ' MET . 49.0 m0 -107.61 164.32 12.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.91 1.684 . . . . 0.0 111.574 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -131.01 111.75 12.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.767 1.227 . . . . 0.0 109.28 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.64 127.19 30.12 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.71 -68.14 0.41 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 176.99 172.47 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.903 2.481 . . . . 0.0 110.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.26 47.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.638 2.375 . . . . 0.0 109.514 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -123.96 109.93 14.16 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.282 1.033 . . . . 0.0 111.177 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -70.19 112.26 6.42 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 111.347 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -94.15 -32.94 13.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.714 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -142.58 148.99 38.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 109.646 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -175.46 47.76 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.549 1.071 . . . . 0.0 115.141 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.95 144.73 35.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.964 1.306 . . . . 0.0 111.93 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -102.26 167.25 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.944 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.72 -0.76 21.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.482 1.113 . . . . 0.0 112.587 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.91 -178.56 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.873 2.069 . . . . 0.0 112.568 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.38 139.54 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 110.696 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.71 146.33 79.82 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 118.856 0.753 . . . . 0.0 112.957 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.12 150.99 54.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.014 3.809 . . . . 0.0 111.608 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 16.9 tt0 -92.45 -22.21 19.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -123.54 126.85 47.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.575 1.55 . . . . 0.0 110.646 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.14 96.22 12.89 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 109.672 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.0 167.6 21.2 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.848 2.366 . . . . 0.0 113.444 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.87 158.0 8.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.194 -0.941 . . . . 0.0 109.925 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.271 7.3 t 59.45 6.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.154 2.181 . . . . 0.0 114.474 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -127.38 121.47 31.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.82 2.048 . . . . 0.0 110.102 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.4 171.63 8.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.248 1.019 . . . . 0.0 110.15 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -108.41 171.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -123.53 130.35 52.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.909 1.284 . . . . 0.0 109.872 174.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.55 171.16 17.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.885 0.85 . . . . 0.0 110.857 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.3 m -156.71 170.44 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.88 1.272 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.27 121.85 2.17 Favored Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.52 156.97 38.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.573 1.687 . . . . 0.0 109.564 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 12.7 ptpt -61.44 179.5 0.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.95 0.5 . . . . 0.0 111.176 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -67.7 -160.08 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 121.061 -1.024 . . . . 0.0 110.738 176.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.5 m -30.67 -51.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.429 1.892 . . . . 0.0 115.922 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.54 -60.64 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.769 1.176 . . . . 0.0 113.269 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.82 -7.7 21.74 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.398 3.399 . . . . 0.0 114.957 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 76' ' ' ASP . 15.0 m -74.34 123.55 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.441 1.896 . . . . 0.0 112.443 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.47 71.8 4.37 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.893 -1.13 . . . . 0.0 111.646 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.6 m -119.21 -85.32 0.65 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.419 1.088 . . . . 0.0 111.689 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.16 -178.59 33.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.874 1.226 . . . . 0.0 111.251 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.725 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -142.96 111.43 6.24 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.597 0.759 . . . . 0.0 112.728 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.84 122.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -142.03 150.43 41.28 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.969 0.908 . . . . 0.0 111.111 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.64 143.97 51.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 111.115 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' CD2' HG23 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -146.64 175.17 10.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.522 1.929 . . . . 0.0 111.721 -174.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -144.1 153.18 41.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.109 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 2.0 m-85 -133.8 117.37 16.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.604 1.562 . . . . 0.0 111.03 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -75.19 117.24 16.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 110.3 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . 0.414 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 17.3 mtm -74.25 161.96 29.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 112.156 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 t -60.87 -23.62 65.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.532 1.133 . . . . 0.0 113.519 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 m -78.63 -20.49 50.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 114.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.63 39.69 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.671 1.129 . . . . 0.0 115.777 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -87.42 171.34 10.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.564 1.145 . . . . 0.0 110.666 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 53.9 m -140.07 136.99 34.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.748 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.19 126.99 53.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.538 -0.755 . . . . 0.0 108.984 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.58 128.76 8.71 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.43 HG23 ' CD2' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -137.54 140.24 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.593 1.157 . . . . 0.0 110.345 178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.6 ptm -144.54 170.11 16.69 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.8 p90 -126.94 156.46 41.47 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.436 1.095 . . . . 0.0 111.142 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.7 t -140.07 123.72 17.25 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.406 1.482 . . . . 0.0 109.754 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.725 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 44.2 t -120.81 91.37 47.4 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 126.895 2.078 . . . . 0.0 107.686 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.24 143.39 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.399 2.733 . . . . 0.0 110.705 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.45 -41.08 85.29 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.103 0.561 . . . . 0.0 111.633 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.43 138.26 36.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 111.042 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.04 -72.01 0.37 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.458 -0.776 . . . . 0.0 111.457 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.67 -1.91 23.88 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.774 1.23 . . . . 0.0 113.639 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -5.84 6.22 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.811 2.044 . . . . 0.0 112.731 -164.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.38 149.47 28.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.822 2.449 . . . . 0.0 109.48 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -111.07 163.73 13.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.661 0.784 . . . . 0.0 110.14 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.96 137.86 32.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.419 1.088 . . . . 0.0 109.234 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -126.81 138.49 53.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.717 1.207 . . . . 0.0 111.571 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -150.02 146.21 26.85 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.28 -1.512 . . . . 0.0 111.335 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.91 154.89 45.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.975 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.38 115.44 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.397 1.479 . . . . 0.0 111.384 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -114.97 117.7 31.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 108.738 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mt -103.24 111.79 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.872 1.669 . . . . 0.0 107.587 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.14 162.83 34.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.475 0.71 . . . . 0.0 112.58 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -80.05 79.94 6.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.662 1.185 . . . . 0.0 112.275 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 -149.45 8.55 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.25 0.929 . . . . 0.0 113.509 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -131.26 84.51 2.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 128.322 2.649 . . . . 0.0 111.665 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.85 77.7 7.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.066 1.347 . . . . 0.0 111.827 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -65.11 164.43 13.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.608 0.763 . . . . 0.0 112.399 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.415 ' HB2' ' CD1' ' A' ' 131' ' ' TYR . . . -132.84 112.71 12.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.857 2.063 . . . . 0.0 110.211 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -111.35 -75.17 0.62 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -152.06 -74.94 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.953 1.701 . . . . 0.0 108.087 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.66 -11.15 62.13 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.072 1.32 . . . . 0.0 115.027 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -63.98 1.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 1.316 . . . . 0.0 107.612 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -63.55 -16.46 60.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -33.03 61.9 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.849 0.749 . . . . 0.0 110.731 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.24 -28.97 64.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.397 1.079 . . . . 0.0 112.908 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.79 -33.85 22.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.338 1.055 . . . . 0.0 110.003 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -75.83 -45.45 35.76 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.206 -0.934 . . . . 0.0 113.21 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -96.2 -16.9 21.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.877 0.871 . . . . 0.0 113.336 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -70.09 1.06 Allowed Glycine 0 N--CA 1.475 1.242 0 C-N-CA 124.104 0.859 . . . . 0.0 112.556 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 179.99 73.32 0.17 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 128.215 2.606 . . . . 0.0 111.072 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 158.19 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.769 1.646 . . . . 0.0 110.965 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.56 121.64 30.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.437 ' H ' ' NE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.45 158.43 35.76 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.328 -0.857 . . . . 0.0 112.163 175.806 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.21 70.79 1.02 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.514 1.531 . . . . 0.0 112.633 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.26 24.48 0.34 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.388 1.875 . . . . 0.0 113.853 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.2 p30 48.19 35.3 5.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.923 2.089 . . . . 0.0 114.901 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.96 156.46 23.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.057 1.313 . . . . 0.0 113.049 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -65.19 126.75 29.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.203 1.001 . . . . 0.0 110.538 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.57 105.58 9.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.804 1.642 . . . . 0.0 108.919 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.09 140.5 36.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.609 1.563 . . . . 0.0 111.419 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -160.7 137.82 9.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.006 . . . . 0.0 111.391 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -57.71 107.17 0.42 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.789 1.235 . . . . 0.0 112.309 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 tp -128.67 -30.23 2.32 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.046 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.93 22.16 7.08 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.656 1.122 . . . . 0.0 114.092 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.37 13.19 3.87 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.297 2.239 . . . . 0.0 115.091 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.38 -57.59 0.11 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.126 1.822 . . . . 0.0 111.65 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.2 mp -91.3 148.49 22.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.726 0.774 . . . . 0.0 110.606 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 169.5 17.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.512 1.525 . . . . 0.0 111.731 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 144.66 29.52 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.757 1.223 . . . . 0.0 110.37 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.88 102.06 6.61 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.742 2.017 . . . . 0.0 108.464 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.29 167.55 21.86 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.0 0.778 . . . . 0.0 112.93 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.1 tt -151.81 139.36 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.548 1.939 . . . . 0.0 108.527 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.7 ttm -142.29 139.63 31.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 78.2 p -88.14 169.68 11.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 110.977 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -87.15 11.36 14.15 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.098 -1.001 . . . . 0.0 113.615 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.92 170.44 10.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.147 2.179 . . . . 0.0 113.226 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.6 -73.6 0.72 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.937 1.256 . . . . 0.0 111.525 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.72 38.66 0.05 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.984 2.113 . . . . 0.0 114.808 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 176.13 4.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 0.0 113.301 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 mptt -129.8 145.53 51.57 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.008 1.323 . . . . 0.0 110.403 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.3 ttm -136.95 88.89 2.4 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.424 1.89 . . . . 0.0 110.672 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -83.42 157.46 22.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 111.044 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.91 116.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.101 1.76 . . . . 0.0 107.572 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.39 109.52 20.85 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.922 1.689 . . . . 0.0 108.4 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.24 147.16 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -127.93 170.99 12.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.214 1.805 . . . . 0.0 111.239 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.534 1.934 . . . . 0.0 113.381 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.413 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 48.2 169.79 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.916 2.086 . . . . 0.0 113.847 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.2 40.27 91.4 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 p -141.0 -170.94 3.15 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.561 1.144 . . . . 0.0 111.869 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.9 141.1 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.661 1.984 . . . . 0.0 111.024 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.499 HG12 HD21 ' A' ' 70' ' ' LEU . 1.9 pt -142.09 167.05 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.232 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.53 124.27 18.41 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.751 1.22 . . . . 0.0 112.033 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.67 -24.19 39.17 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.558 1.552 . . . . 0.0 114.055 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.95 70.31 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.474 1.11 . . . . 0.0 111.898 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.61 -19.9 44.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.714 1.605 . . . . 0.0 113.237 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD22 ' CB ' ' A' ' 68' ' ' ALA . 6.3 tp -66.97 105.99 1.8 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.241 1.416 . . . . 0.0 111.206 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 m -144.36 167.87 21.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.249 1.42 . . . . 0.0 109.676 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -46.81 -33.65 4.63 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.623 1.569 . . . . 0.0 113.251 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -58.91 -53.73 55.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.192 0.997 . . . . 0.0 111.128 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -40.5 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.945 0.898 . . . . 0.0 111.894 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 mt -59.65 -54.01 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.176 0.991 . . . . 0.0 111.759 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.55 -38.73 92.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -57.91 -48.45 79.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.256 1.022 . . . . 0.0 112.156 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -55.91 -47.58 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.367 1.067 . . . . 0.0 111.253 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.3 -42.47 95.58 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.45 1.1 . . . . 0.0 113.608 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.25 -47.77 84.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.768 0.427 . . . . 0.0 111.529 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.17 -39.18 72.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 tp -52.81 -57.27 10.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.91 2.084 . . . . 0.0 111.387 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.56 51.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.661 1.124 . . . . 0.0 112.896 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -37.65 127.69 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.514 1.926 . . . . 0.0 113.639 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 28' ' ' SER . 2.7 p -129.83 -169.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.102 1.761 . . . . 0.0 110.623 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.495 ' H ' HG22 ' A' ' 27' ' ' VAL . 28.1 m -43.63 -32.11 0.9 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.675 1.99 . . . . 0.0 115.06 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -141.69 145.91 35.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.422 1.889 . . . . 0.0 107.604 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -165.22 147.64 7.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.822 1.249 . . . . 0.0 110.432 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 2.1 pt -141.52 144.42 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.562 0.619 . . . . 0.0 111.16 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.2 116.27 30.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.243 1.017 . . . . 0.0 110.772 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 t -107.45 138.68 32.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 110.3 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.84 114.81 0.67 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.419 1.009 . . . . 0.0 112.196 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.73 104.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.436 1.094 . . . . 0.0 109.622 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -82.77 107.49 15.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.916 1.286 . . . . 0.0 112.258 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -84.12 71.38 10.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.984 1.314 . . . . 0.0 114.225 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.23 21.45 0.18 Allowed 'General case' 0 CA--C 1.558 1.286 0 O-C-N 119.778 -1.826 . . . . 0.0 115.118 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 p -57.85 -48.47 79.71 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.0 -17.36 6.0 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.565 2.031 . . . . 0.0 116.107 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.2 -104.04 1.89 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.931 1.866 . . . . 0.0 116.282 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.0 t -162.58 135.95 6.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.875 1.67 . . . . 0.0 111.671 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -115.04 167.43 10.82 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.793 1.637 . . . . 0.0 111.276 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.9 m -141.36 111.35 6.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.158 0.983 . . . . 0.0 110.292 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.33 133.8 55.6 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.895 -1.128 . . . . 0.0 108.429 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -70.88 -69.26 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -172.41 171.29 4.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 110.453 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -123.59 142.46 51.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.816 2.046 . . . . 0.0 109.301 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.55 121.0 18.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.532 1.133 . . . . 0.0 111.43 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -74.5 128.25 35.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.829 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -45.12 6.24 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.929 1.692 . . . . 0.0 111.66 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -141.58 153.97 45.15 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.186 1.794 . . . . 0.0 110.324 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.88 -170.05 53.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 121.493 0.496 . . . . 0.0 113.054 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 t -140.86 164.04 31.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 110.651 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.6 p -149.71 178.98 8.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.774 1.23 . . . . 0.0 111.18 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 25.99 4.12 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.456 1.102 . . . . 0.0 112.446 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -124.33 172.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.71 2.004 . . . . 0.0 113.535 -174.64 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 mt -137.02 151.59 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.246 2.219 . . . . 0.0 109.199 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -100.14 141.16 22.22 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 120.212 1.369 . . . . 0.0 110.935 176.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.05 160.45 47.24 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.94 3.094 . . . . 0.0 111.028 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -104.22 -46.23 4.48 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.328 -0.857 . . . . 0.0 112.073 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.59 132.38 46.01 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.082 1.31 . . . . 0.0 111.938 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.91 92.15 11.25 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.868 1.667 . . . . 0.0 110.2 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.31 160.66 37.83 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.118 1.879 . . . . 0.0 112.042 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -58.14 159.9 5.45 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.124 -0.985 . . . . 0.0 110.706 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p 68.67 8.7 6.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.583 1.953 . . . . 0.0 113.543 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -136.66 110.12 7.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.368 1.867 . . . . 0.0 111.99 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -84.1 164.75 19.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.606 0.762 . . . . 0.0 112.164 175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.53 173.54 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.214 0.606 . . . . 0.0 110.947 174.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.499 HD21 HG12 ' A' ' 7' ' ' ILE . 3.2 mm? -129.7 127.66 40.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.478 1.911 . . . . 0.0 107.82 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.49 154.98 41.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.882 0.873 . . . . 0.0 110.65 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -148.52 162.93 38.65 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 111.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.76 138.71 6.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.308 0.956 . . . . 0.0 111.953 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 167.57 19.91 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.823 0.849 . . . . 0.0 110.293 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -65.29 -179.62 0.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.044 0.538 . . . . 0.0 110.467 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.85 -179.95 0.23 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.63 -0.669 . . . . 0.0 110.642 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.4 m -24.65 -54.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 128.053 2.541 . . . . 0.0 116.166 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.79 -58.98 0.32 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.404 1.478 . . . . 0.0 112.797 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.91 0.09 7.66 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.779 3.653 . . . . 0.0 115.736 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.06 104.5 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.242 2.217 . . . . 0.0 112.008 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.94 77.87 1.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.632 1.573 . . . . 0.0 112.927 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.8 m -110.74 -82.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.004 1.321 . . . . 0.0 111.304 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 161.95 179.42 36.6 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.099 1.333 . . . . 0.0 111.886 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.82 114.88 10.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 110.026 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.48 130.35 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.21 167.84 25.73 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.731 0.777 . . . . 0.0 110.743 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.46 154.72 36.09 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.017 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.39 169.39 21.53 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.038 1.735 . . . . 0.0 110.838 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.15 140.53 47.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.697 1.199 . . . . 0.0 110.964 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -123.67 112.56 17.53 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.032 1.333 . . . . 0.0 111.763 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -76.66 115.68 16.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 110.738 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.5 mtm -78.98 162.68 25.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.95 0.9 . . . . 0.0 112.284 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -60.23 -19.84 56.27 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -79.71 -11.37 59.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.405 1.482 . . . . 0.0 113.007 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.27 2.49 65.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.887 1.232 . . . . 0.0 114.435 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.71 169.99 11.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.778 1.231 . . . . 0.0 110.608 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.5 m -135.98 154.69 51.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.441 1.096 . . . . 0.0 110.19 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 127.95 48.34 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.267 1.027 . . . . 0.0 109.726 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.22 114.47 4.13 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.24 126.07 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.233 1.013 . . . . 0.0 108.716 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -140.8 164.32 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.73 0.776 . . . . 0.0 112.285 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.0 p90 -140.63 151.4 44.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.767 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -130.5 116.31 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.948 1.699 . . . . 0.0 110.066 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.67 99.19 47.63 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.834 1.654 . . . . 0.0 108.77 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.76 169.08 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.31 2.674 . . . . 0.0 112.432 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -76.51 -18.61 58.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.452 0.701 . . . . 0.0 112.783 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.23 109.5 18.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.685 1.594 . . . . 0.0 110.81 -167.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -64.98 -65.41 0.68 Allowed 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.276 -0.89 . . . . 0.0 113.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -86.57 9.3 18.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.66 -6.15 6.92 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.715 2.006 . . . . 0.0 112.661 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 139.06 14.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.728 2.011 . . . . 0.0 110.141 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 t -95.94 164.51 12.69 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.625 -1.297 . . . . 0.0 112.375 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.63 159.02 25.48 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.604 0.762 . . . . 0.0 109.092 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -141.27 141.18 33.98 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.27 -0.894 . . . . 0.0 111.531 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.2 p-90 -156.14 148.62 23.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.247 1.419 . . . . 0.0 110.502 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -145.3 155.21 43.07 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.309 1.843 . . . . 0.0 109.39 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.14 116.35 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.38 1.872 . . . . 0.0 109.414 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -120.41 137.33 54.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.488 1.915 . . . . 0.0 109.298 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.7 mt -102.41 120.19 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.971 1.708 . . . . 0.0 108.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.93 147.9 51.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.493 1.517 . . . . 0.0 112.062 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 p -77.02 78.98 3.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.41 1.084 . . . . 0.0 112.574 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.28 158.48 8.47 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.076 0.846 . . . . 0.0 114.883 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 121.87 16.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.522 1.529 . . . . 0.0 112.793 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -136.63 85.54 2.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.143 1.777 . . . . 0.0 109.289 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -60.21 170.97 1.12 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.007 0.923 . . . . 0.0 111.407 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.26 92.79 4.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.627 0.771 . . . . 0.0 111.067 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -98.39 -68.75 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.548 0.739 . . . . 0.0 110.404 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.28 -70.08 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.557 1.143 . . . . 0.0 110.408 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.12 -25.05 76.38 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.059 0.838 . . . . 0.0 114.661 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -48.08 27.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.261 1.024 . . . . 0.0 110.48 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -37.34 81.79 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.099 0.959 . . . . 0.0 110.927 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -54.75 -33.35 61.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.15 -33.35 73.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.434 1.016 . . . . 0.0 112.706 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.49 -41.19 61.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.024 0.829 . . . . 0.0 110.313 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -65.36 -59.31 4.17 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.756 -1.215 . . . . 0.0 111.741 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -79.44 -19.55 49.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.189 1.396 . . . . 0.0 112.698 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -76.66 0.22 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.365 0.983 . . . . 0.0 112.598 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.37 84.15 1.59 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.67 1.188 . . . . 0.0 110.433 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.49 157.21 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.539 1.493 . . . . 0.0 111.262 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.71 4.98 49.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.684 1.194 . . . . 0.0 113.412 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.25 66.81 0.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 128.194 2.597 . . . . 0.0 113.438 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -33.48 90.77 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.398 2.904 . . . . 0.0 114.869 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -110.07 43.89 1.3 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.957 1.703 . . . . 0.0 110.349 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 58.18 42.57 21.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.548 1.539 . . . . 0.0 112.84 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.84 146.99 18.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 112.813 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -68.58 131.15 44.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.091 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -127.68 108.08 10.45 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.885 1.674 . . . . 0.0 109.293 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.31 153.09 35.49 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.285 1.434 . . . . 0.0 111.947 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -167.86 146.02 4.52 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.318 1.447 . . . . 0.0 111.004 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.67 125.5 25.99 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.443 0.565 . . . . 0.0 109.806 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.2 tp -141.01 -36.19 0.46 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.35 1.06 . . . . 0.0 112.834 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.72 20.02 5.68 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.685 1.136 . . . . 0.0 114.486 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.5 12.35 2.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.311 2.245 . . . . 0.0 115.286 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.91 -67.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.379 1.942 . . . . 0.0 110.605 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.06 147.78 27.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.925 0.89 . . . . 0.0 110.604 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.83 168.1 24.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.376 1.47 . . . . 0.0 111.924 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -96.15 139.14 32.75 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.717 0.807 . . . . 0.0 111.655 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -128.67 108.33 10.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.72 1.608 . . . . 0.0 108.427 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.46 167.67 25.74 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 121.951 0.75 . . . . 0.0 114.154 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.3 tt -149.09 142.94 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.847 2.059 . . . . 0.0 108.823 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.2 ttm -134.82 137.36 43.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.427 1.091 . . . . 0.0 108.801 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.53 156.19 33.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.6 1.16 . . . . 0.0 111.7 175.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.93 9.15 31.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.42 177.67 4.8 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.132 2.173 . . . . 0.0 112.293 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.16 55.68 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.835 0.731 . . . . 0.0 113.053 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -86.5 51.45 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.476 1.51 . . . . 0.0 113.694 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.95 17.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.777 1.231 . . . . 0.0 113.828 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.69 53.77 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 0.0 112.432 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.42 90.29 3.27 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.392 2.277 . . . . 0.0 110.954 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -84.55 143.14 29.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.86 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.42 122.49 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.458 1.903 . . . . 0.0 107.506 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -118.71 111.01 17.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.879 1.272 . . . . 0.0 109.759 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.3 mm -83.13 117.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.183 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m -89.29 174.8 7.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 0.0 111.75 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.313 1.845 . . . . 0.0 113.196 -177.417 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.22 168.08 0.57 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.36 36.11 63.28 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.563 -0.711 . . . . 0.0 113.825 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -150.82 -169.19 3.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.121 0.968 . . . . 0.0 111.152 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 63' ' ' VAL . 1.6 pt -129.71 137.63 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.538 1.935 . . . . 0.0 111.861 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pp -145.5 165.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.223 1.809 . . . . 0.0 111.472 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.22 126.7 19.64 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.155 0.982 . . . . 0.0 112.803 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.15 -21.09 30.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.087 1.327 . . . . 0.0 114.047 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.02 72.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.465 1.506 . . . . 0.0 112.324 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -34.71 66.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.386 1.074 . . . . 0.0 112.113 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.63 100.02 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.784 1.634 . . . . 0.0 112.25 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.9 m -143.08 172.01 13.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.629 1.572 . . . . 0.0 110.463 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' H ' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER -49.41 -39.74 33.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.594 1.558 . . . . 0.0 113.697 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.66 -41.97 91.77 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.598 -0.689 . . . . 0.0 112.521 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.38 -46.81 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.626 0.77 . . . . 0.0 110.044 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -53.35 -60.18 3.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.596 0.759 . . . . 0.0 111.036 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.45 -43.28 67.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.071 0.948 . . . . 0.0 112.371 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -59.43 -29.17 67.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.686 1.195 . . . . 0.0 113.533 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.3 -48.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.226 -1.546 . . . . 0.0 110.009 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.3 -34.81 66.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.959 0.504 . . . . 0.0 111.526 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.1 -57.69 6.31 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.86 -40.38 47.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.853 1.206 . . . . 0.0 114.06 -172.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.43 -23.38 66.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.346 1.058 . . . . 0.0 111.532 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 68.2 1.44 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.368 1.461 . . . . 0.0 111.214 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.35 127.83 4.67 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 110.774 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 -161.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.118 2.167 . . . . 0.0 110.049 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -41.21 -49.3 3.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.12 1.368 . . . . 0.0 113.508 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -146.31 137.16 24.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.333 1.453 . . . . 0.0 111.377 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -157.6 171.15 20.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.511 1.524 . . . . 0.0 113.952 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.83 163.21 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.456 1.102 . . . . 0.0 112.122 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.68 111.91 17.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.302 1.441 . . . . 0.0 110.471 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -97.11 145.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.649 1.58 . . . . 0.0 111.904 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.53 122.38 1.14 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.022 1.296 . . . . 0.0 111.33 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.78 112.74 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.185 1.492 . . . . 0.0 110.226 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.0 134.97 35.02 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.35 79.22 7.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.056 1.742 . . . . 0.0 113.243 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.86 2.6 53.79 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.3 t -65.55 -17.52 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.521 2.328 . . . . 0.0 114.72 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.71 4.3 89.32 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 114.74 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.58 161.31 23.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.551 1.548 . . . . 0.0 114.026 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 t -78.25 134.86 37.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.491 1.516 . . . . 0.0 112.037 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -112.12 168.08 9.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.864 2.066 . . . . 0.0 111.469 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -136.93 108.06 6.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 110.737 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.54 117.76 6.65 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.873 -1.142 . . . . 0.0 108.539 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.49 -64.46 0.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.774 0.829 . . . . 0.0 109.88 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -177.98 171.05 1.8 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.517 2.327 . . . . 0.0 110.874 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -124.72 138.82 54.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 109.096 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -128.43 110.22 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.234 1.414 . . . . 0.0 111.133 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -72.5 121.32 19.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.724 1.209 . . . . 0.0 111.477 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.77 -33.6 14.93 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.446 1.498 . . . . 0.0 112.926 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 t -145.04 162.32 37.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.598 1.559 . . . . 0.0 111.115 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.9 -160.68 29.68 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.727 0.651 . . . . 0.0 114.727 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -144.83 -178.73 6.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.444 1.498 . . . . 0.0 111.972 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -147.25 166.19 27.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.846 1.658 . . . . 0.0 110.617 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.64 6.97 20.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.591 1.156 . . . . 0.0 111.608 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.72 153.41 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 128.305 2.642 . . . . 0.0 111.038 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -122.04 140.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.502 1.521 . . . . 0.0 108.764 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.31 140.1 75.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.369 -0.832 . . . . 0.0 109.618 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 6' ' ' ILE . 69.4 Cg_endo -65.5 176.64 3.26 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.459 3.439 . . . . 0.0 110.956 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -119.19 -21.89 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.656 -1.278 . . . . 0.0 113.036 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -128.83 137.28 51.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.414 1.886 . . . . 0.0 109.792 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 6' ' ' ILE . 27.1 t -139.86 96.91 8.18 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.843 1.257 . . . . 0.0 109.715 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.88 168.57 18.36 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 112.557 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.27 159.83 5.69 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.578 -0.701 . . . . 0.0 110.148 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.273 5.6 t 57.66 15.62 2.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.638 1.975 . . . . 0.0 113.792 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -133.09 120.12 20.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.927 2.491 . . . . 0.0 110.371 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.87 163.54 13.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.674 1.19 . . . . 0.0 110.45 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.567 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.96 169.0 9.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.19 132.93 46.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.871 2.068 . . . . 0.0 108.893 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -153.13 164.04 38.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.799 1.24 . . . . 0.0 110.44 175.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 m -145.31 175.29 10.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.462 1.105 . . . . 0.0 111.207 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.58 103.66 0.24 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 125.176 1.37 . . . . 0.0 110.742 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 176.98 4.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.428 1.114 . . . . 0.0 111.572 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -66.59 -176.98 0.52 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.44 -177.02 0.27 Allowed 'General case' 0 CA--C 1.559 1.298 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -10.33 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 127.944 2.497 . . . . 0.0 116.521 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.43 -72.07 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.212 0.91 . . . . 0.0 113.038 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.99 84.07 1.72 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.757 3.638 . . . . 0.0 112.368 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.08 140.8 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.151 1.381 . . . . 0.0 112.256 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 64.59 0.84 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.015 1.326 . . . . 0.0 111.635 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.8 t -122.53 -97.22 0.45 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 110.855 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.514 ' H ' HG23 ' A' ' 82' ' ' THR . . . -174.74 -177.46 43.87 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.967 2.698 . . . . 0.0 110.883 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -141.29 99.46 3.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.111 1.364 . . . . 0.0 108.742 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' SER . 88.6 t -135.69 131.12 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.107 . . . . 0.0 108.584 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.1 166.9 31.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.57 0.748 . . . . 0.0 111.22 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.05 158.14 43.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.711 0.767 . . . . 0.0 112.42 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.46 171.18 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.648 1.979 . . . . 0.0 110.478 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.51 142.37 43.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.155 0.982 . . . . 0.0 111.174 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.567 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 1.1 m-85 -125.84 111.73 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.047 1.339 . . . . 0.0 111.33 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -73.61 114.35 11.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.004 1.321 . . . . 0.0 110.805 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.1 mtt -76.6 160.7 29.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.435 0.636 . . . . 0.0 111.364 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 t -61.66 -17.76 56.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.0 m -79.51 -13.33 59.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.014 1.726 . . . . 0.0 113.548 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.21 55.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.605 1.098 . . . . 0.0 114.835 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.88 173.43 11.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.242 1.017 . . . . 0.0 111.687 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 m -133.77 142.94 48.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.94 0.896 . . . . 0.0 108.587 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.92 125.72 54.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 108.932 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.62 148.46 24.95 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.8 130.55 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.312 1.045 . . . . 0.0 109.255 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.65 45.88 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 22.8 p90 -127.01 153.27 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.147 1.379 . . . . 0.0 110.696 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 85' ' ' VAL . 19.9 t -136.9 111.45 8.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.497 1.119 . . . . 0.0 111.49 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 32.1 t -115.02 102.18 54.75 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.51 1.924 . . . . 0.0 109.344 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.01 171.25 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.841 2.361 . . . . 0.0 112.542 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -72.39 -53.83 11.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.326 . . . . 0.0 110.632 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.01 107.48 7.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.227 3.411 . . . . 0.0 112.398 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.19 -60.16 3.79 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.274 1.03 . . . . 0.0 113.539 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.59 9.45 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -4.15 6.85 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.566 1.947 . . . . 0.0 112.456 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.2 146.04 26.61 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.395 2.278 . . . . 0.0 109.496 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.92 165.31 11.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.365 1.066 . . . . 0.0 111.869 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.44 156.93 18.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.666 -0.646 . . . . 0.0 110.112 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -140.5 146.14 37.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.35 0.66 . . . . 0.0 109.92 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -147.97 155.6 41.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.991 1.316 . . . . 0.0 110.021 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.56 138.23 20.93 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.846 -0.534 . . . . 0.0 111.62 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.7 t -147.74 103.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.334 1.854 . . . . 0.0 110.102 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -120.6 143.37 48.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.036 1.335 . . . . 0.0 110.065 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.51 111.6 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.249 1.819 . . . . 0.0 108.756 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -116.33 141.47 48.11 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.711 1.604 . . . . 0.0 111.853 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.7 p -72.48 80.55 1.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.288 1.435 . . . . 0.0 113.104 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.06 159.56 8.64 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.221 1.391 . . . . 0.0 113.321 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -73.79 133.94 43.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.466 0.707 . . . . 0.0 112.383 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -141.9 143.15 33.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.515 1.926 . . . . 0.0 111.215 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -99.32 -179.35 4.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.662 1.585 . . . . 0.0 110.942 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.9 95.9 4.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.206 1.803 . . . . 0.0 110.177 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.79 -71.08 0.78 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.903 1.281 . . . . 0.0 110.559 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.48 -69.79 0.24 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.323 1.849 . . . . 0.0 109.637 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.54 73.27 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.638 1.113 . . . . 0.0 115.241 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -84.2 -45.82 12.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.182 0.991 . . . . 0.0 110.872 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.15 -44.01 96.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.995 0.918 . . . . 0.0 112.393 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.77 -29.23 69.29 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.025 -1.047 . . . . 0.0 112.441 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -16.06 60.42 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.192 -0.943 . . . . 0.0 112.499 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.66 -55.58 2.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 108.44 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -69.03 -48.14 63.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -87.62 -15.21 37.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.746 0.819 . . . . 0.0 112.743 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.78 60.18 4.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.575 1.083 . . . . 0.0 114.208 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 42.75 76.97 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 127.046 2.138 . . . . 0.0 111.754 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.64 149.04 73.37 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.783 1.655 . . . . 0.0 110.827 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.89 156.7 36.12 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.951 0.881 . . . . 0.0 110.489 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 115.42 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 109.207 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.61 67.01 0.78 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.323 1.439 . . . . 0.0 113.511 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.75 25.36 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.786 2.034 . . . . 0.0 114.386 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 54.72 41.71 31.73 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.994 1.717 . . . . 0.0 113.063 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.4 167.51 24.15 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.656 2.074 . . . . 0.0 112.232 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -75.34 128.56 35.68 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.593 -0.945 . . . . 0.0 111.592 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -120.1 112.86 19.65 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.481 ' HG2' HH21 ' A' ' 156' ' ' ARG . 1.3 pm0 -153.88 148.59 26.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 111.507 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -161.88 147.08 13.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.038 1.335 . . . . 0.0 111.4 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -62.97 123.05 17.54 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.926 -0.484 . . . . 0.0 110.972 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -142.84 -31.6 0.5 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.263 1.025 . . . . 0.0 113.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.85 17.26 16.82 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.963 1.268 . . . . 0.0 114.541 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.2 t80 59.87 10.31 2.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.416 2.287 . . . . 0.0 114.697 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.9 -67.32 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.647 1.594 . . . . 0.0 110.606 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.35 156.54 16.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.577 0.703 . . . . 0.0 111.626 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.481 HH21 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -143.94 165.88 26.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.067 1.747 . . . . 0.0 112.719 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -92.44 133.59 35.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.85 1.26 . . . . 0.0 110.143 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -123.11 106.79 11.09 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.718 1.207 . . . . 0.0 109.339 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-O 122.38 0.989 . . . . 0.0 114.65 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.64 145.29 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.974 2.11 . . . . 0.0 108.186 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.8 131.3 33.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.234 1.814 . . . . 0.0 106.687 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 166.83 19.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.108 0.963 . . . . 0.0 112.079 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 m -95.13 11.6 31.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.661 1.584 . . . . 0.0 113.793 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.13 167.95 10.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 112.368 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.05 26.4 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 121.348 -0.845 . . . . 0.0 112.992 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.16 47.51 0.46 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.503 1.521 . . . . 0.0 113.715 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.46 161.39 27.82 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.716 -1.24 . . . . 0.0 113.44 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.08 133.99 55.47 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 108.913 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.1 ttp -128.53 110.46 12.3 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.494 1.518 . . . . 0.0 111.081 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -122.65 140.98 52.23 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.626 -0.671 . . . . 0.0 109.654 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.7 111.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.754 1.622 . . . . 0.0 109.729 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -100.44 105.37 16.84 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.409 1.484 . . . . 0.0 108.368 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.6 mm -74.06 136.23 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.0 t -151.09 167.18 28.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.956 . . . . 0.0 112.108 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.263 2.225 . . . . 0.0 110.344 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.625 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.21 150.33 39.22 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.111 -0.993 . . . . 0.0 111.381 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.94 34.18 87.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 p -142.52 -165.08 1.96 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.596 1.198 . . . . 0.0 111.539 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.36 144.1 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.891 1.676 . . . . 0.0 110.991 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.0 168.88 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.079 1.352 . . . . 0.0 112.18 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 120.67 7.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.105 1.362 . . . . 0.0 111.555 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.14 -25.36 64.37 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.156 0.884 . . . . 0.0 113.11 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.05 68.62 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.174 1.389 . . . . 0.0 113.078 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -96.29 -16.41 21.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.147 1.379 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.5 tp -68.64 107.22 2.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.15 1.38 . . . . 0.0 110.233 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -145.5 169.92 17.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.275 1.03 . . . . 0.0 109.883 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -50.85 -31.53 17.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.878 1.271 . . . . 0.0 113.703 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -61.74 -36.24 80.43 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.358 0.663 . . . . 0.0 112.567 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -39.97 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.782 1.233 . . . . 0.0 111.104 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.28 -47.84 77.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.031 0.932 . . . . 0.0 112.03 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.02 -49.32 76.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.061 0.544 . . . . 0.0 111.69 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -58.53 -36.79 74.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 34.2 t -63.79 -59.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.211 1.404 . . . . 0.0 111.237 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.43 -38.09 73.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.815 1.246 . . . . 0.0 112.141 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -41.33 67.52 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.008 0.822 . . . . 0.0 111.953 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.68 -37.07 65.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 57' ' ' VAL . 11.2 tp -48.39 -52.77 20.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.496 1.518 . . . . 0.0 111.638 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.15 58.67 0.15 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.699 1.143 . . . . 0.0 111.002 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 142.33 6.06 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.253 1.421 . . . . 0.0 112.444 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.78 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 109.711 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.3 m -45.0 -31.23 1.22 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.311 1.844 . . . . 0.0 115.525 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.93 134.89 17.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.487 1.515 . . . . 0.0 109.222 174.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.43 161.04 30.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.371 2.268 . . . . 0.0 110.628 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -139.21 166.22 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.732 1.613 . . . . 0.0 110.326 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.54 110.55 14.6 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.751 1.22 . . . . 0.0 110.866 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.91 138.6 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.8 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 112.18 0.54 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.535 1.064 . . . . 0.0 112.911 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.2 109.87 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.456 1.128 . . . . 0.0 109.214 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -87.81 110.76 20.73 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 112.41 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -71.45 98.1 1.76 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.271 1.428 . . . . 0.0 111.31 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.93 12.75 15.82 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.942 1.697 . . . . 0.0 113.34 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 t -62.68 -54.51 38.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.559 1.144 . . . . 0.0 114.001 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.3 2.36 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.949 1.261 . . . . 0.0 116.166 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.48 163.36 29.9 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.625 1.712 . . . . 0.0 114.03 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.4 p -74.09 138.85 44.22 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.108 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -112.76 167.73 10.25 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.304 1.442 . . . . 0.0 112.236 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -140.14 106.25 5.22 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.016 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 125.55 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.88 -1.138 . . . . 0.0 108.667 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.56 -62.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.636 1.174 . . . . 0.0 110.384 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -176.87 174.9 1.7 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.825 2.45 . . . . 0.0 110.644 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.8 146.6 50.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.223 2.209 . . . . 0.0 109.492 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.15 113.33 13.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.146 1.378 . . . . 0.0 111.406 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -73.49 122.92 22.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.78 1.232 . . . . 0.0 110.188 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.95 -38.6 7.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.825 1.65 . . . . 0.0 112.633 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 m -136.92 152.14 49.86 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.653 1.581 . . . . 0.0 109.929 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.13 50.05 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 123.925 0.774 . . . . 0.0 114.88 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -135.81 145.65 46.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 111.54 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -133.26 125.52 29.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.348 1.059 . . . . 0.0 108.747 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.4 -1.04 31.54 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.327 1.051 . . . . 0.0 112.943 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 3' ' ' ALA . 23.4 m -110.89 174.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.812 1.645 . . . . 0.0 113.045 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.11 139.88 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.917 1.687 . . . . 0.0 108.801 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 146.01 86.63 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-N 119.578 1.081 . . . . 0.0 110.86 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.35 167.17 25.99 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.575 3.516 . . . . 0.0 111.277 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -107.64 -24.27 11.81 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.416 -1.427 . . . . 0.0 113.487 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -125.81 133.3 52.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.433 1.493 . . . . 0.0 111.061 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.8 t -133.84 94.63 18.43 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.589 1.556 . . . . 0.0 109.891 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.26 161.36 34.52 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.595 1.53 . . . . 0.0 111.868 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -63.31 160.12 16.58 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.726 -0.609 . . . . 0.0 110.724 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 68.0 -0.85 1.92 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.045 2.138 . . . . 0.0 114.418 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.284 1.833 . . . . 0.0 111.738 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -128.5 160.79 31.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.971 1.308 . . . . 0.0 111.68 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.85 174.94 6.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 174.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.4 133.0 41.84 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.464 1.906 . . . . 0.0 108.394 174.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -153.99 164.19 38.84 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.112 0.965 . . . . 0.0 112.589 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -150.48 164.25 36.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.914 1.286 . . . . 0.0 111.014 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.97 118.1 1.08 Allowed Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.275 1.417 . . . . 0.0 111.067 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' C ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -129.33 161.56 29.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.714 1.257 . . . . 0.0 110.696 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -174.25 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.859 0.464 . . . . 0.0 110.102 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.96 -143.02 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 O-C-N 121.277 -0.89 . . . . 0.0 113.015 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -40.89 -38.33 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 119.044 -2.285 . . . . 0.0 114.796 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.26 -60.94 0.47 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.566 1.555 . . . . 0.0 112.774 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.22 -3.68 11.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.99 3.794 . . . . 0.0 116.156 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.8 160.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.438 1.095 . . . . 0.0 111.717 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.87 66.43 1.03 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.244 1.017 . . . . 0.0 111.24 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.6 m -126.72 -85.32 0.61 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.83 1.252 . . . . 0.0 112.049 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.59 -177.21 32.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.116 1.341 . . . . 0.0 112.33 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.525 ' HB2' ' C ' ' A' ' 74' ' ' ARG . . . -135.05 125.58 26.77 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.76 121.24 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -137.44 152.59 49.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.441 0.696 . . . . 0.0 110.737 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.7 47.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.82 0.848 . . . . 0.0 111.469 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 171.06 15.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.508 1.523 . . . . 0.0 110.307 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.52 138.09 50.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.159 0.983 . . . . 0.0 110.203 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.3 m-85 -119.31 118.61 31.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.709 1.204 . . . . 0.0 111.081 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -83.12 113.36 20.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.162 1.385 . . . . 0.0 110.787 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.5 mtt -70.15 162.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.057 0.943 . . . . 0.0 111.315 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.9 p -61.27 -22.63 65.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 114.102 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t -82.98 -14.57 53.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.46 1.904 . . . . 0.0 113.007 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.14 56.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.284 1.421 . . . . 0.0 115.069 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -80.18 164.34 23.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.618 1.167 . . . . 0.0 109.518 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.0 m -122.95 143.24 50.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.817 0.847 . . . . 0.0 110.193 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.55 115.7 23.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 128.34 8.43 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 117' ' ' VAL . 5.1 m -130.63 128.93 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.679 0.792 . . . . 0.0 109.539 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.11 154.8 49.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 175.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.3 p90 -134.05 153.9 51.5 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.701 1.201 . . . . 0.0 110.639 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.2 t -137.31 114.55 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.078 2.151 . . . . 0.0 108.931 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 21.8 t -111.76 95.2 27.16 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 128.683 2.793 . . . . 0.0 106.95 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.97 -168.66 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.509 2.14 . . . . 0.0 111.454 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -108.69 -43.46 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.995 0.918 . . . . 0.0 112.154 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.68 127.19 32.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.105 1.762 . . . . 0.0 112.36 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -58.22 3.44 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -100.25 11.55 39.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.255 1.422 . . . . 0.0 113.917 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.23 0.87 7.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.108 2.163 . . . . 0.0 111.917 -175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.43 178.36 10.24 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.753 2.421 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 t -154.8 164.78 38.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.223 1.409 . . . . 0.0 110.932 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 112.72 24.77 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.01 -1.056 . . . . 0.0 111.181 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.58 136.32 38.85 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -142.92 145.23 32.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.658 1.183 . . . . 0.0 111.214 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -137.0 139.37 41.37 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.391 1.077 . . . . 0.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 100' ' ' VAL . 84.8 t -136.06 110.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.121 1.768 . . . . 0.0 109.981 175.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -126.84 133.51 50.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.763 1.625 . . . . 0.0 110.189 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 mt -97.83 129.79 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.756 1.622 . . . . 0.0 108.592 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -133.63 144.18 49.07 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.822 . . . . 0.0 112.902 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 p -75.02 92.21 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.167 1.787 . . . . 0.0 113.102 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.7 -179.15 21.32 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.314 1.435 . . . . 0.0 112.483 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 145.21 25.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.626 1.17 . . . . 0.0 111.713 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -163.48 164.57 24.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.778 1.631 . . . . 0.0 111.002 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -140.55 156.16 46.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.243 1.417 . . . . 0.0 110.862 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 92.26 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.655 0.782 . . . . 0.0 111.019 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.67 -72.05 0.71 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.145 1.378 . . . . 0.0 110.583 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 -71.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 108.091 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.43 -42.93 57.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.379 0.99 . . . . 0.0 113.999 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.4 tpt -74.22 -50.08 20.67 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.498 1.149 . . . . 0.0 112.628 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -48.22 80.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.906 0.483 . . . . 0.0 110.061 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.16 -33.6 76.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.77 -28.68 70.15 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.508 1.504 . . . . 0.0 112.051 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.79 -40.21 12.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.562 0.745 . . . . 0.0 111.453 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -78.49 -42.32 29.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.427 -1.421 . . . . 0.0 114.104 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -96.29 -12.97 23.71 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.043 -1.036 . . . . 0.0 112.798 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.51 -77.22 0.16 Allowed Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.577 1.084 . . . . 0.0 112.083 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -175.06 69.05 0.27 Allowed Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 127.531 2.333 . . . . 0.0 110.608 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.76 130.38 18.02 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.789 0.993 . . . . 0.0 111.106 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.22 124.36 22.89 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 15.51 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.013 2.125 . . . . 0.0 114.425 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 52.97 59.1 9.84 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.3 1.429 . . . . 0.0 112.319 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.16 16.91 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 67.57 29.75 6.98 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.748 2.019 . . . . 0.0 112.97 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.1 158.16 23.79 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.809 1.671 . . . . 0.0 113.832 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -72.74 131.1 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.783 1.233 . . . . 0.0 112.034 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -122.88 108.48 13.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.747 2.019 . . . . 0.0 111.016 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.75 153.59 45.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.184 1.793 . . . . 0.0 110.782 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.99 138.99 1.35 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.63 1.172 . . . . 0.0 110.268 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -60.54 134.77 57.4 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.276 0.489 . . . . 0.0 111.403 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.54 -30.53 0.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.79 24.41 5.18 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.001 1.286 . . . . 0.0 114.623 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 t80 58.67 15.15 3.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.44 2.296 . . . . 0.0 114.708 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 176.42 -77.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.833 1.683 . . . . 0.0 110.976 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 174' ' ' SER . 3.2 mm? -77.35 145.8 37.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.401 1.081 . . . . 0.0 110.459 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.99 168.41 20.05 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.5 1.52 . . . . 0.0 112.162 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' MET . . . . . 0.41 ' HA ' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -81.48 142.54 32.82 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.912 1.285 . . . . 0.0 111.239 174.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -140.08 107.06 5.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.589 1.956 . . . . 0.0 108.523 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.6 168.02 26.02 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-O 121.503 0.502 . . . . 0.0 114.206 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.0 tt -143.49 142.82 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.322 1.849 . . . . 0.0 109.011 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.0 ttt -145.59 151.09 37.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.945 1.698 . . . . 0.0 108.479 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.8 p -88.26 165.07 15.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.425 0.69 . . . . 0.0 111.548 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.8 m -80.71 9.56 6.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 112.819 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.08 157.22 17.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.843 2.057 . . . . 0.0 111.382 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.01 3.16 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 119.311 0.959 . . . . 0.0 111.868 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.58 87.97 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.894 0.878 . . . . 0.0 109.507 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.92 146.86 50.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.0 1.32 . . . . 0.0 112.31 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -91.67 129.89 37.56 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.3 ttm -127.06 83.46 2.17 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.672 1.989 . . . . 0.0 109.503 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -89.07 144.48 26.11 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.677 -0.639 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 59.1 mt -127.23 124.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.954 1.702 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -114.09 107.23 15.36 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.173 1.789 . . . . 0.0 109.182 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 157' ' ' MET . 35.8 mm -88.95 103.94 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.633 0.73 . . . . 0.0 110.794 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.537 ' HA ' HD12 ' A' ' 155' ' ' LEU . 1.7 p -153.27 173.78 15.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.639 1.575 . . . . 0.0 112.571 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.347 1.859 . . . . 0.0 111.429 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . -41.73 146.11 0.27 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.051 1.74 . . . . 0.0 115.286 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.07 38.75 34.28 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.583 1.087 . . . . 0.0 113.985 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.0 p -145.25 -170.6 3.47 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 118.732 1.266 . . . . 0.0 111.895 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.4 pt -118.51 142.51 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.776 2.03 . . . . 0.0 110.479 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 pt -145.63 162.48 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.26 1.424 . . . . 0.0 111.813 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.36 126.5 27.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.725 0.81 . . . . 0.0 110.863 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.93 -23.08 60.98 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.299 0.952 . . . . 0.0 113.059 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.57 91.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.98 1.312 . . . . 0.0 112.085 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 m -79.92 -24.02 41.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.763 1.225 . . . . 0.0 113.541 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.32 97.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.062 1.345 . . . . 0.0 112.2 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -145.52 172.46 13.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.926 1.69 . . . . 0.0 110.17 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -46.56 -39.83 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.155 1.382 . . . . 0.0 114.6 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -56.62 -43.68 80.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.563 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.15 -45.2 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.274 1.03 . . . . 0.0 111.072 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 mt -56.05 -50.01 72.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.547 0.612 . . . . 0.0 111.492 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.33 -42.47 92.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -52.83 60.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 111.809 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.761 HG21 HD21 ' A' ' 70' ' ' LEU . 82.7 t -56.71 -49.21 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.728 1.211 . . . . 0.0 110.404 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -43.11 62.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.727 0.811 . . . . 0.0 112.399 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.4 -53.25 14.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.892 1.277 . . . . 0.0 112.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -72.41 -29.26 63.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.536 1.534 . . . . 0.0 114.254 -171.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.492 HD22 ' HZ1' ' A' ' 30' ' ' LYS . 7.0 tt -63.61 -53.93 43.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.591 1.557 . . . . 0.0 110.589 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.45 75.24 0.2 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.268 1.413 . . . . 0.0 111.926 -169.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 139.95 2.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.496 1.518 . . . . 0.0 111.887 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.05 -177.85 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 126.754 2.021 . . . . 0.0 109.725 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -45.78 -42.86 12.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.287 1.835 . . . . 0.0 115.151 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -148.79 141.37 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.31 1.444 . . . . 0.0 111.371 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HZ1' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -170.5 168.94 7.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.584 1.953 . . . . 0.0 112.32 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.13 161.15 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.613 1.165 . . . . 0.0 110.637 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.18 106.95 13.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.406 1.482 . . . . 0.0 109.882 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.48 140.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.333 1.453 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.58 120.56 1.0 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.706 1.146 . . . . 0.0 111.992 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -112.28 97.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 109.373 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 7.1 t70 -75.89 114.12 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.205 1.402 . . . . 0.0 113.513 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.09 96.75 9.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.267 1.427 . . . . 0.0 111.227 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -124.17 34.33 5.07 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.239 1.816 . . . . 0.0 110.186 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 t -80.34 -51.0 9.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.948 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.14 15.02 1.93 Allowed Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.83 160.6 32.57 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.53 1.665 . . . . 0.0 114.085 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.5 p -73.41 138.32 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.983 -0.716 . . . . 0.0 111.919 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.38 165.72 11.55 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.495 1.118 . . . . 0.0 111.457 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 m -133.78 115.58 14.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.084 1.354 . . . . 0.0 108.739 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 136.87 57.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.199 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -70.08 0.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -179.19 175.19 0.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.403 2.281 . . . . 0.0 110.285 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.1 147.16 51.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.377 2.271 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.17 109.79 9.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.912 1.285 . . . . 0.0 110.638 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -71.43 116.57 11.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.726 1.21 . . . . 0.0 110.779 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -45.86 9.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.655 1.182 . . . . 0.0 112.123 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.1 m -137.37 146.94 45.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.087 1.755 . . . . 0.0 110.457 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 76' ' ' ASP . . . 83.2 -163.98 41.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.682 0.658 . . . . 0.0 113.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.45 174.64 14.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.265 1.026 . . . . 0.0 111.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -143.94 173.23 11.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.195 0.998 . . . . 0.0 112.009 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.84 11.65 11.91 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.618 1.567 . . . . 0.0 112.061 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.57 166.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.226 2.21 . . . . 0.0 111.351 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.97 133.36 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.971 1.308 . . . . 0.0 109.943 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.94 152.67 90.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 119.533 1.06 . . . . 0.0 112.326 176.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.53 171.61 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.414 3.41 . . . . 0.0 110.313 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.0 tt0 -111.05 -18.87 12.93 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -124.62 131.18 53.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.85 1.66 . . . . 0.0 110.26 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.98 98.14 6.91 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.675 1.19 . . . . 0.0 109.639 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.67 164.82 25.15 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.728 1.619 . . . . 0.0 112.573 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -62.28 157.72 18.92 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.493 -0.754 . . . . 0.0 110.393 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p 68.67 -0.02 2.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.568 1.947 . . . . 0.0 114.248 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -125.45 145.81 49.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 110.723 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . . . -120.46 169.16 10.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.922 1.689 . . . . 0.0 110.826 176.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -104.22 177.52 4.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.876 0.846 . . . . 0.0 110.187 174.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.761 HD21 HG21 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -131.23 128.78 40.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.371 1.868 . . . . 0.0 108.747 176.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -149.22 163.8 36.6 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.512 0.725 . . . . 0.0 111.951 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -149.8 172.51 15.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.559 1.144 . . . . 0.0 111.199 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -157.67 106.19 0.29 Allowed Glycine 0 N--CA 1.47 0.922 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.735 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 162.97 14.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.07 1.348 . . . . 0.0 112.75 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.66 105.28 17.25 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.333 -0.855 . . . . 0.0 110.944 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 23.4 t0 33.26 -134.58 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.918 2.487 . . . . 0.0 112.928 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -39.58 80.94 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.164 -1.585 . . . . 0.0 112.138 174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.39 -62.28 0.53 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.566 1.555 . . . . 0.0 112.993 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.94 -3.71 7.52 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 125.001 3.801 . . . . 0.0 116.494 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.96 168.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.778 1.231 . . . . 0.0 112.267 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.22 68.61 1.41 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.652 1.181 . . . . 0.0 111.644 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -120.7 -89.35 0.61 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.258 1.423 . . . . 0.0 110.839 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.51 174.55 35.21 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.285 1.422 . . . . 0.0 111.315 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -133.19 111.77 11.16 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 110.122 175.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -139.34 120.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.83 168.21 20.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.841 0.857 . . . . 0.0 110.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.21 155.95 42.53 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.83 173.72 12.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.964 2.106 . . . . 0.0 110.716 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.96 149.7 45.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.275 1.03 . . . . 0.0 111.398 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -131.39 117.13 18.46 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.016 1.327 . . . . 0.0 111.624 -176.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -79.39 108.85 13.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.502 1.521 . . . . 0.0 110.213 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mtt -71.06 162.7 28.99 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.575 0.703 . . . . 0.0 111.612 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -59.69 -21.32 60.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.924 1.69 . . . . 0.0 113.956 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.5 m -79.93 -12.4 59.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.631 1.972 . . . . 0.0 113.208 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 6.2 65.73 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.94 1.257 . . . . 0.0 115.072 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -90.74 170.45 10.11 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.517 1.127 . . . . 0.0 110.496 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.6 m -131.68 149.38 52.5 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.136 0.969 . . . . 0.0 110.94 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 122.74 42.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.195 1.398 . . . . 0.0 109.037 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 139.4 24.4 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.15 122.16 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.781 1.291 . . . . 0.0 109.03 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.4 ptm -127.81 158.76 36.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.606 0.762 . . . . 0.0 112.109 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.7 p90 -131.78 150.74 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.213 1.405 . . . . 0.0 110.244 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.73 100.7 4.26 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.895 1.278 . . . . 0.0 110.524 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 42.2 t -94.69 104.27 13.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 127.332 2.253 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.08 169.69 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.147 2.565 . . . . 0.0 112.718 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -89.87 -37.0 14.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.68 111.65 23.96 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.895 1.678 . . . . 0.0 111.273 -163.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -66.8 -56.86 8.54 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.754 -1.216 . . . . 0.0 113.8 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -94.31 12.83 25.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.644 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.91 -14.76 3.08 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.328 1.851 . . . . 0.0 113.068 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.95 -179.32 6.28 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.832 3.253 . . . . 0.0 109.446 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.56 167.73 23.78 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.931 1.292 . . . . 0.0 111.016 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.57 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.586 -0.697 . . . . 0.0 111.188 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -139.67 147.73 41.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.741 1.216 . . . . 0.0 111.205 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.41 148.82 20.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -141.86 149.01 39.7 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.085 1.312 . . . . 0.0 111.603 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -143.97 86.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.559 1.543 . . . . 0.0 113.584 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -88.4 138.91 31.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.225 1.01 . . . . 0.0 108.504 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mt -108.23 114.65 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.547 1.539 . . . . 0.0 108.68 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -127.53 136.44 51.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.326 1.451 . . . . 0.0 112.464 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 p -78.08 84.28 4.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.284 1.434 . . . . 0.0 112.294 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.24 -175.45 37.86 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.3 0.952 . . . . 0.0 113.418 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -112.91 107.02 15.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.427 1.891 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -140.55 167.97 20.9 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.518 1.927 . . . . 0.0 111.344 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.92 166.97 26.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.973 1.709 . . . . 0.0 112.486 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.32 84.96 4.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.294 1.438 . . . . 0.0 111.232 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.28 -64.61 1.03 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.786 0.834 . . . . 0.0 110.843 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -152.2 -77.0 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.144 2.178 . . . . 0.0 108.501 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.6 -24.87 71.33 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.338 0.97 . . . . 0.0 115.022 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -56.49 4.66 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.667 1.234 . . . . 0.0 110.506 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.33 -38.89 78.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.485 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -58.42 -38.72 77.98 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.341 0.973 . . . . 0.0 112.668 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.01 -38.67 89.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.646 0.657 . . . . 0.0 111.904 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -34.34 64.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.456 0.702 . . . . 0.0 111.166 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.49 -47.87 37.78 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.52 -1.363 . . . . 0.0 112.823 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -94.6 -15.99 23.59 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.946 0.898 . . . . 0.0 113.285 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -70.64 0.9 Allowed Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.309 0.957 . . . . 0.0 112.664 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -178.17 77.47 0.23 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.807 2.443 . . . . 0.0 109.658 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.04 128.18 18.2 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.56 -1.361 . . . . 0.0 108.56 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.48 150.55 26.48 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.574 1.178 . . . . 0.0 110.311 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 120.61 28.02 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.462 1.105 . . . . 0.0 108.687 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.8 55.95 1.34 Allowed Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.197 1.379 . . . . 0.0 113.976 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.4 25.71 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.229 1.812 . . . . 0.0 115.462 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.267 12.0 p30 52.84 31.72 11.16 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.154 2.182 . . . . 0.0 114.57 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.77 175.9 18.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.721 2.105 . . . . 0.0 113.092 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -79.63 122.88 27.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.04 0.936 . . . . 0.0 111.759 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -114.34 116.2 28.58 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.431 1.892 . . . . 0.0 109.452 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -142.93 146.12 33.69 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.6 1.16 . . . . 0.0 110.777 175.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -147.19 121.53 9.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.874 1.27 . . . . 0.0 111.747 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.12 93.92 1.47 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.153 1.381 . . . . 0.0 112.269 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.24 8.82 0.94 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -94.68 21.6 42.35 Favored Glycine 0 N--CA 1.476 1.334 0 O-C-N 120.623 -1.298 . . . . 0.0 115.341 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 65.35 9.32 5.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.388 1.875 . . . . 0.0 115.022 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.65 -40.84 0.21 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.546 1.546 . . . . 0.0 113.997 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.42 150.53 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 110.388 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 167.16 21.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.815 0.846 . . . . 0.0 112.904 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.36 139.77 30.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 109.898 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -130.37 115.26 16.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.02 172.14 25.29 Favored Glycine 0 C--O 1.23 -0.12 0 CA-C-O 121.901 0.723 . . . . 0.0 113.494 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 tt -138.54 131.88 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 109.318 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 8.7 ttt -129.1 143.07 50.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.183 1.793 . . . . 0.0 107.021 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.29 154.16 19.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.071 1.749 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.6 m -92.59 27.26 2.36 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.108 1.363 . . . . 0.0 112.715 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.39 170.71 8.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.518 1.927 . . . . 0.0 111.58 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.41 -62.09 5.14 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.289 -0.882 . . . . 0.0 112.823 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.52 51.11 1.4 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.406 1.882 . . . . 0.0 111.73 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.63 175.85 3.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.69 1.596 . . . . 0.0 112.443 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -134.67 154.11 51.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.285 1.434 . . . . 0.0 109.161 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.6 ttp -142.69 85.31 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.164 0.986 . . . . 0.0 111.969 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.36 142.04 28.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.263 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 58.7 mt -125.18 123.52 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.605 1.962 . . . . 0.0 107.697 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.37 117.28 33.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.31 130.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.953 0.501 . . . . 0.0 110.452 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.3 m -144.5 167.82 21.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 112.89 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.645 2.378 . . . . 0.0 113.594 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 141.88 58.12 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.963 0.905 . . . . 0.0 112.576 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.68 40.29 85.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.304 0.954 . . . . 0.0 114.825 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.7 p -144.92 -171.48 3.64 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.163 0.982 . . . . 0.0 112.573 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.501 HG23 ' HG3' ' A' ' 60' ' ' PRO . 8.1 pt -127.0 138.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.214 2.205 . . . . 0.0 111.662 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 pt -148.1 170.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.109 1.764 . . . . 0.0 111.904 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.97 116.91 2.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.611 1.564 . . . . 0.0 112.335 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.78 -23.86 67.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.553 0.597 . . . . 0.0 113.266 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.49 81.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.521 1.128 . . . . 0.0 113.076 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -86.49 -13.16 46.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.798 1.239 . . . . 0.0 114.091 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.439 HD22 ' CB ' ' A' ' 68' ' ' ALA . 17.5 tp -68.95 113.65 6.54 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.23 1.012 . . . . 0.0 111.102 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -144.35 166.63 24.55 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 110.578 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.21 -37.29 22.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 114.64 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -60.75 -45.02 95.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.225 0.61 . . . . 0.0 111.79 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -57.07 -46.3 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.906 1.283 . . . . 0.0 110.492 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.8 -48.45 63.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.205 1.002 . . . . 0.0 112.594 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.35 -43.81 76.65 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.425 -0.797 . . . . 0.0 111.864 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.12 -40.76 74.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.201 1.4 . . . . 0.0 113.081 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 70' ' ' LEU . 53.1 t -52.9 -59.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.506 1.922 . . . . 0.0 109.984 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.39 -43.47 98.81 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.558 1.943 . . . . 0.0 112.757 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -51.15 -53.58 33.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.28 1.032 . . . . 0.0 112.086 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -78.4 -35.02 47.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -42.09 62.66 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.12 1.368 . . . . 0.0 111.074 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.09 58.69 0.87 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -59.32 171.65 0.75 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.737 1.215 . . . . 0.0 111.775 175.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -162.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.808 1.243 . . . . 0.0 110.324 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -46.65 -41.28 14.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.614 1.566 . . . . 0.0 112.96 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 137.16 49.1 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.637 1.575 . . . . 0.0 111.136 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 162.24 36.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 112.44 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG22 ' HB3' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -141.48 151.95 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.885 1.674 . . . . 0.0 109.592 174.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.87 126.69 50.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.917 1.687 . . . . 0.0 107.452 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.43 132.61 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.354 1.462 . . . . 0.0 110.217 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.62 119.98 1.34 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.071 1.319 . . . . 0.0 111.249 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 69' ' ' LEU . 12.2 mt -111.8 100.76 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -74.96 102.85 4.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.909 1.283 . . . . 0.0 111.502 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -70.98 96.47 1.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.916 0.887 . . . . 0.0 112.039 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.77 16.47 9.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.131 1.772 . . . . 0.0 112.592 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.1 p -67.84 -41.21 83.34 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.858 -1.151 . . . . 0.0 113.808 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 12.82 3.94 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.27 162.63 30.7 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.765 1.783 . . . . 0.0 114.347 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -71.29 132.69 45.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 0.0 112.87 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -106.61 163.6 12.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 111.6 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.7 m -129.72 114.05 15.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.683 1.193 . . . . 0.0 109.699 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.46 129.07 38.98 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.507 -0.746 . . . . 0.0 109.315 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -68.32 0.44 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.943 0.497 . . . . 0.0 109.868 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 179.41 173.56 0.83 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.63 2.372 . . . . 0.0 110.483 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -129.13 146.83 50.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.764 2.026 . . . . 0.0 109.308 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.89 115.92 15.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.292 1.437 . . . . 0.0 110.626 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -78.52 115.78 18.46 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.054 1.342 . . . . 0.0 111.037 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -92.93 -39.28 11.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.107 0.963 . . . . 0.0 112.795 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.3 m -141.63 151.79 43.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.84 2.056 . . . . 0.0 110.372 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.04 -171.57 54.43 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.749 0.69 . . . . 0.0 113.87 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -136.39 173.77 11.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.933 1.293 . . . . 0.0 112.275 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -143.34 171.01 14.7 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.752 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.67 10.2 8.39 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.697 1.199 . . . . 0.0 112.396 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.06 170.35 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.488 2.315 . . . . 0.0 113.362 -171.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.75 140.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 127.196 2.199 . . . . 0.0 109.731 -172.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -78.99 156.22 77.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.119 0.872 . . . . 0.0 111.858 176.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' HG23 ' A' ' 6' ' ' ILE . 39.1 Cg_endo -69.52 176.01 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.332 3.355 . . . . 0.0 110.457 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.8 tt0 -118.04 -22.84 7.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.198 -0.939 . . . . 0.0 113.077 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.9 123.18 41.88 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.7 1.6 . . . . 0.0 110.416 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.1 93.32 26.83 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.859 1.264 . . . . 0.0 110.298 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.9 165.32 21.65 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.328 2.019 . . . . 0.0 112.51 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.87 160.18 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.212 0.605 . . . . 0.0 110.19 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 t 56.41 13.74 1.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 128.365 2.666 . . . . 0.0 113.857 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.61 136.65 46.66 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 127.006 2.123 . . . . 0.0 109.653 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.439 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -117.84 161.07 20.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.381 1.072 . . . . 0.0 111.407 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -101.34 169.11 9.1 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.608 0.718 . . . . 0.0 109.709 174.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 20' ' ' VAL . 4.1 mm? -126.2 130.72 51.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.45 1.9 . . . . 0.0 107.951 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -147.51 162.44 39.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.523 1.129 . . . . 0.0 110.506 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 m -150.75 163.47 38.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.452 0.701 . . . . 0.0 110.798 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.95 115.69 0.7 Allowed Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.536 1.065 . . . . 0.0 110.896 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 174.18 5.98 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.709 1.254 . . . . 0.0 111.134 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -64.07 -172.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.685 0.794 . . . . 0.0 109.561 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.97 -174.13 0.07 Allowed 'General case' 0 CA--C 1.555 1.15 0 O-C-N 120.084 -1.635 . . . . 0.0 111.216 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -37.22 -41.6 0.4 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.421 1.888 . . . . 0.0 115.698 -172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.5 -57.52 0.42 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.235 1.398 . . . . 0.0 112.955 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.45 1.77 5.2 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.763 3.642 . . . . 0.0 115.154 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.31 109.47 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.345 2.258 . . . . 0.0 111.141 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.01 78.76 5.91 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.489 1.516 . . . . 0.0 112.372 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.0 m -100.96 -70.99 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.516 1.126 . . . . 0.0 111.321 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.45 41.86 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.073 1.32 . . . . 0.0 112.043 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.22 106.97 5.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.927 0.891 . . . . 0.0 109.797 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.35 123.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.805 -1.185 . . . . 0.0 108.668 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -147.38 169.94 18.4 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.642 0.734 . . . . 0.0 110.989 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.61 158.21 43.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.902 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.0 170.54 16.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.432 1.893 . . . . 0.0 110.311 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.87 155.79 49.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.911 0.885 . . . . 0.0 111.382 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.1 m-85 -136.13 121.95 19.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.019 1.328 . . . . 0.0 110.969 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.18 115.94 19.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.665 1.586 . . . . 0.0 110.483 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.83 161.98 30.14 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.647 0.779 . . . . 0.0 112.362 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -62.28 -23.39 66.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 113.403 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.9 m -78.33 -13.85 59.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.899 1.68 . . . . 0.0 113.581 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.15 60.27 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.796 1.188 . . . . 0.0 115.086 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -84.9 172.54 11.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.286 1.043 . . . . 0.0 109.896 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.1 m -131.92 152.71 50.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.735 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.82 135.37 53.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.441 1.097 . . . . 0.0 109.697 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 142.38 17.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.19 112.94 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 118.642 1.221 . . . . 0.0 109.518 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.87 150.44 46.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.144 0.578 . . . . 0.0 110.659 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.7 p90 -126.9 146.61 50.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.473 1.109 . . . . 0.0 109.672 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 t -131.16 110.89 11.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.54 1.136 . . . . 0.0 110.893 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 31' ' ' ILE . 2.8 t -115.0 102.1 54.74 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.363 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.78 163.86 34.8 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.897 2.398 . . . . 0.0 112.492 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.01 -26.77 59.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.34 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 112.96 24.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.351 -1.468 . . . . 0.0 111.255 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.25 -71.4 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.931 -1.105 . . . . 0.0 112.172 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.91 10.67 3.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.31 -3.42 4.95 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.896 . . . . 0.0 112.927 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.82 133.09 11.79 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.348 1.459 . . . . 0.0 110.926 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -84.62 171.93 12.01 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.285 -0.884 . . . . 0.0 111.805 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -100.78 151.34 21.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.123 1.369 . . . . 0.0 111.097 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.63 139.48 40.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.548 -0.72 . . . . 0.0 110.632 -172.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -151.71 150.78 30.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.965 1.706 . . . . 0.0 110.043 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -148.54 147.49 29.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.644 1.578 . . . . 0.0 109.189 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -143.98 109.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.146 1.778 . . . . 0.0 109.77 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -113.6 144.76 42.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 109.288 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.6 mt -109.75 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.537 1.935 . . . . 0.0 108.466 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.69 143.4 51.25 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.658 1.583 . . . . 0.0 112.239 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.2 m -79.06 85.69 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.009 1.324 . . . . 0.0 111.817 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.64 176.38 22.76 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.422 1.487 . . . . 0.0 112.328 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 149.14 37.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.176 0.991 . . . . 0.0 111.979 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -154.37 135.69 14.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.997 1.319 . . . . 0.0 111.134 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -98.4 -176.66 3.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.369 1.468 . . . . 0.0 111.534 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -139.21 100.83 4.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.946 1.698 . . . . 0.0 109.114 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -120.55 -72.24 0.7 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.692 1.197 . . . . 0.0 110.161 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -145.57 -64.22 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.907 1.283 . . . . 0.0 110.215 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.25 70.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.408 1.004 . . . . 0.0 114.557 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 tpp -90.67 -37.58 13.65 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.623 1.169 . . . . 0.0 112.988 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -41.09 93.24 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 111.135 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -59.74 -25.18 64.64 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -18.4 65.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.81 -37.72 9.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.997 1.319 . . . . 0.0 108.662 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -68.23 -47.45 67.78 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.786 -1.196 . . . . 0.0 113.628 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -99.22 -13.55 19.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 113.447 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.69 -63.65 4.55 Favored Glycine 0 N--CA 1.475 1.246 0 C-N-CA 124.074 0.845 . . . . 0.0 112.639 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.64 80.29 0.24 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 128.089 2.556 . . . . 0.0 109.104 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.8 135.49 32.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 108.706 -1.305 . . . . 0.0 108.706 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -71.28 -12.59 61.53 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.21 118.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.337 3.055 . . . . 0.0 112.688 -170.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.77 58.96 2.14 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.046 1.784 . . . . 0.0 113.925 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.09 22.35 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.435 2.294 . . . . 0.0 113.628 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.18 27.89 12.23 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.879 1.672 . . . . 0.0 113.328 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.27 135.96 9.31 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.787 1.661 . . . . 0.0 112.207 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -59.71 139.14 57.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 111.883 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -130.01 121.25 26.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.735 1.614 . . . . 0.0 110.528 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.74 154.82 40.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.97 1.708 . . . . 0.0 110.614 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -165.37 131.53 2.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.862 1.265 . . . . 0.0 110.874 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -62.85 112.15 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.308 1.043 . . . . 0.0 111.235 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.2 -24.94 1.39 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.397 1.079 . . . . 0.0 113.732 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.15 17.84 9.06 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.122 1.344 . . . . 0.0 114.96 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.14 16.81 4.1 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.97 2.108 . . . . 0.0 114.15 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.69 -65.18 0.06 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.93 1.252 . . . . 0.0 111.293 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -93.36 164.37 13.24 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.153 1.381 . . . . 0.0 112.454 176.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.47 30.58 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.544 1.938 . . . . 0.0 112.627 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.71 143.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.843 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -128.46 103.71 7.28 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.295 1.838 . . . . 0.0 107.874 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.41 169.48 21.26 Favored Glycine 0 N--CA 1.455 -0.067 0 CA-C-O 121.796 0.664 . . . . 0.0 113.218 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 146.63 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 123.893 0.877 . . . . 0.0 109.872 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.83 132.19 41.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.657 1.583 . . . . 0.0 107.861 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.6 p -85.95 164.09 17.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.612 0.765 . . . . 0.0 109.905 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.36 19.69 19.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.922 0.889 . . . . 0.0 112.967 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -106.05 -175.52 2.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 0.0 112.999 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.54 74.98 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.444 1.497 . . . . 0.0 114.413 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.46 92.45 5.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.446 1.498 . . . . 0.0 107.627 175.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' HG22 ' A' ' 31' ' ' ILE . . . -73.73 69.02 1.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.232 1.013 . . . . 0.0 111.733 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -53.11 129.95 32.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.728 -1.232 . . . . 0.0 110.954 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.7 ttm -134.61 123.83 24.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.131 1.772 . . . . 0.0 110.015 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -139.34 141.26 37.66 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.941 -1.099 . . . . 0.0 109.599 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.67 93.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.936 1.694 . . . . 0.0 109.167 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -86.0 109.26 18.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.043 0.937 . . . . 0.0 110.419 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.4 mm -91.57 116.42 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.751 0.82 . . . . 0.0 111.215 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -148.11 161.36 41.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.859 2.063 . . . . 0.0 110.581 174.976 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 20' ' ' VAL . 23.6 tp . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -62.22 146.31 51.16 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.19 -1.569 . . . . 0.0 111.379 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.68 39.6 40.02 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.666 0.65 . . . . 0.0 114.488 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.26 -169.35 3.03 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.555 1.177 . . . . 0.0 111.822 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.02 141.75 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.765 2.026 . . . . 0.0 109.844 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.28 173.93 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.569 1.548 . . . . 0.0 111.409 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.29 115.4 6.21 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.42 -30.78 65.35 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.448 -0.783 . . . . 0.0 112.808 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.29 69.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.246 -1.15 . . . . 0.0 113.345 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -90.48 -13.62 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.113 1.365 . . . . 0.0 113.39 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -68.14 113.01 5.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.968 0.907 . . . . 0.0 111.733 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -145.12 165.84 27.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.595 1.558 . . . . 0.0 109.737 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -45.91 -41.69 11.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.618 1.567 . . . . 0.0 114.487 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.54 -36.77 76.78 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.74 -44.48 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.818 0.847 . . . . 0.0 110.247 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.15 -42.64 86.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.782 0.833 . . . . 0.0 111.145 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.01 -40.13 71.98 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.133 -0.979 . . . . 0.0 113.21 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.36 -43.19 88.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.911 0.884 . . . . 0.0 111.924 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 2' ' ' LEU . 87.6 t -63.04 -51.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.716 -0.615 . . . . 0.0 111.215 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -53.2 -43.83 67.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.689 0.796 . . . . 0.0 112.628 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.48 -46.19 70.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 117.986 0.357 . . . . 0.0 111.857 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.4 -38.96 59.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.554 1.542 . . . . 0.0 113.863 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.586 HD12 ' CB ' ' A' ' 3' ' ' ALA . 8.4 tt -54.02 -40.14 66.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.421 1.089 . . . . 0.0 111.381 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.37 62.82 0.55 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.977 1.275 . . . . 0.0 111.737 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 133.53 3.13 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.034 1.333 . . . . 0.0 113.298 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 28' ' ' SER . 3.1 p -121.95 -163.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.388 1.875 . . . . 0.0 109.603 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.441 ' H ' HG22 ' A' ' 27' ' ' VAL . 7.4 m -39.39 -46.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.491 1.516 . . . . 0.0 114.938 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -147.97 126.31 12.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.95 2.1 . . . . 0.0 110.319 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' NZ ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -153.35 158.39 41.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.676 1.591 . . . . 0.0 111.832 176.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.18 173.72 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.725 1.21 . . . . 0.0 112.441 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.51 115.14 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.503 1.121 . . . . 0.0 110.525 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.26 143.74 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 111.213 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.39 125.61 1.8 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.407 1.004 . . . . 0.0 111.687 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 mt -130.39 112.28 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.532 1.666 . . . . 0.0 111.362 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.93 109.0 20.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.118 1.767 . . . . 0.0 111.796 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.14 109.27 19.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.789 1.28 . . . . 0.0 112.179 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -122.61 27.55 7.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.482 1.913 . . . . 0.0 111.176 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -81.71 -1.79 48.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.734 2.014 . . . . 0.0 114.553 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 12.62 83.97 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.934 -1.103 . . . . 0.0 114.492 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.54 145.36 12.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.422 1.487 . . . . 0.0 113.501 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -69.83 141.48 53.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.59 1.156 . . . . 0.0 112.811 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -112.07 162.59 15.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.54 1.936 . . . . 0.0 111.431 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 m -128.97 114.92 17.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.754 1.222 . . . . 0.0 109.328 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 122.72 18.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.704 -0.622 . . . . 0.0 110.146 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.4 HD21 ' CZ ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -65.67 -66.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.785 1.234 . . . . 0.0 109.855 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 176.43 173.76 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.884 2.874 . . . . 0.0 109.657 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 143.87 48.0 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.456 2.302 . . . . 0.0 109.217 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -136.25 112.32 9.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.04 0.936 . . . . 0.0 111.444 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -72.92 115.48 12.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.514 1.526 . . . . 0.0 111.487 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -89.87 -37.69 14.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.629 1.572 . . . . 0.0 112.756 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -146.46 159.46 43.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.382 2.273 . . . . 0.0 110.606 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.47 49.63 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 121.612 0.562 . . . . 0.0 113.386 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 t -140.42 148.03 40.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.526 1.13 . . . . 0.0 109.726 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 57' ' ' VAL . 18.0 m -138.58 138.79 38.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.418 1.087 . . . . 0.0 110.205 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.06 11.15 40.09 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.906 1.682 . . . . 0.0 112.854 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 55' ' ' THR . 32.8 m -126.48 169.63 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.74 2.016 . . . . 0.0 112.364 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.11 135.78 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.577 1.551 . . . . 0.0 109.758 -169.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -77.27 152.95 81.96 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.291 0.951 . . . . 0.0 112.379 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.41 174.17 8.65 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.555 3.504 . . . . 0.0 110.759 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -116.3 -17.56 10.72 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.13 -0.981 . . . . 0.0 113.173 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -124.59 130.38 52.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.285 1.834 . . . . 0.0 110.343 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.59 82.67 44.6 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.324 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.6 153.66 77.2 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.162 1.908 . . . . 0.0 111.427 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -53.31 148.42 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.545 0.738 . . . . 0.0 111.176 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 72.86 -0.95 3.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.953 2.501 . . . . 0.0 114.805 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -124.47 106.24 10.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.065 1.746 . . . . 0.0 112.391 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.59 160.0 25.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.55 170.05 8.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.129 0.572 . . . . 0.0 109.769 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -126.39 134.77 50.94 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 109.636 174.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.21 169.86 20.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.601 0.76 . . . . 0.0 111.642 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.4 m -151.21 171.58 17.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.509 1.524 . . . . 0.0 110.474 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.97 115.99 0.71 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.71 163.14 15.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.161 1.481 . . . . 0.0 111.18 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -65.41 -177.23 0.39 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 110.404 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.79 178.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.353 -0.842 . . . . 0.0 110.322 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -24.59 -53.34 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.175 2.59 . . . . 0.0 116.308 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.36 -62.75 0.26 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.604 1.573 . . . . 0.0 112.325 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.15 -1.27 8.52 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.711 3.607 . . . . 0.0 115.439 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.72 123.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.484 2.314 . . . . 0.0 110.453 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.51 81.5 2.97 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.351 1.46 . . . . 0.0 111.241 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 m -114.1 -80.89 0.6 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.985 1.314 . . . . 0.0 110.523 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.43 -177.34 41.95 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.238 1.399 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -139.14 110.61 7.03 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.054 1.342 . . . . 0.0 109.159 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.22 130.65 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.649 -0.657 . . . . 0.0 109.755 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 158.32 44.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 110.293 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.97 155.43 45.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.936 0.874 . . . . 0.0 111.636 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.71 168.03 25.59 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.416 1.886 . . . . 0.0 109.689 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.48 157.23 45.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.584 0.753 . . . . 0.0 110.868 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -138.95 118.5 12.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.702 0.801 . . . . 0.0 112.125 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CZ ' HD21 ' A' ' 46' ' ' LEU . 17.3 m-85 -75.59 121.83 23.01 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.649 0.78 . . . . 0.0 111.226 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -87.44 159.3 18.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.47 1.108 . . . . 0.0 110.123 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.7 p -63.83 -13.89 48.46 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -88.38 0.49 56.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.852 1.661 . . . . 0.0 113.05 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.12 82.96 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.695 1.141 . . . . 0.0 114.126 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.46 167.22 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.837 2.055 . . . . 0.0 110.644 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.0 m -130.99 153.62 49.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.027 1.331 . . . . 0.0 109.629 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.21 138.66 53.66 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.396 1.079 . . . . 0.0 109.587 175.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.25 139.08 15.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.94 125.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.229 1.015 . . . . 0.0 109.476 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.01 155.94 46.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.405 0.682 . . . . 0.0 112.016 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.97 144.22 49.0 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.691 1.197 . . . . 0.0 110.086 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.03 110.64 11.8 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 110.11 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.78 100.6 46.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 125.705 1.602 . . . . 0.0 109.655 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.03 163.93 34.3 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.277 1.985 . . . . 0.0 110.844 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.61 -47.25 76.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.726 0.811 . . . . 0.0 111.08 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.08 117.41 22.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.478 2.311 . . . . 0.0 111.958 -172.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.2 -70.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.113 -0.992 . . . . 0.0 112.646 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -82.5 11.19 5.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.48 5.42 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.134 2.174 . . . . 0.0 112.433 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -160.13 129.07 4.97 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.175 1.79 . . . . 0.0 110.718 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.9 m -90.94 168.13 11.91 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.567 -1.333 . . . . 0.0 113.214 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -89.67 155.74 19.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.149 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.405 ' CE3' ' HD2' ' A' ' 141' ' ' ARG . 0.9 OUTLIER -142.14 140.53 32.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.582 1.153 . . . . 0.0 109.284 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -156.63 146.69 21.12 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.318 1.447 . . . . 0.0 110.399 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -140.98 147.49 38.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.675 1.19 . . . . 0.0 110.072 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.3 t -146.01 90.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.032 1.333 . . . . 0.0 112.051 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.09 144.81 32.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.237 1.415 . . . . 0.0 110.526 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -108.33 123.34 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.293 2.237 . . . . 0.0 108.587 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -127.71 148.3 50.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.288 1.435 . . . . 0.0 112.955 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.2 p -74.08 87.82 1.9 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.578 1.951 . . . . 0.0 112.679 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.78 179.35 21.1 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.878 1.704 . . . . 0.0 112.387 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 140.83 29.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.441 1.497 . . . . 0.0 112.266 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.35 152.28 30.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.145 2.178 . . . . 0.0 110.411 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -131.53 153.37 49.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.457 1.903 . . . . 0.0 110.75 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.71 93.15 0.7 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.328 1.051 . . . . 0.0 111.762 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.3 -76.81 0.58 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 110.279 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -142.85 -67.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.393 2.277 . . . . 0.0 107.758 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.19 -30.97 75.25 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.618 1.104 . . . . 0.0 115.257 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -75.45 -57.89 3.61 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.437 1.619 . . . . 0.0 110.864 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -49.98 -49.6 49.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.58 1.152 . . . . 0.0 111.504 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -37.61 80.14 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.79 -27.34 67.93 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.649 1.113 . . . . 0.0 112.627 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.1 -46.83 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.743 0.817 . . . . 0.0 110.563 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -72.41 -49.02 36.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.835 -1.166 . . . . 0.0 113.773 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -91.83 -17.09 25.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.377 1.071 . . . . 0.0 113.046 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.99 -70.18 0.99 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.224 0.916 . . . . 0.0 112.8 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -179.66 75.48 0.19 Allowed Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 127.962 2.505 . . . . 0.0 110.618 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 131.71 19.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.812 1.674 . . . . 0.0 110.981 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 118.49 13.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.405 ' HD2' ' CE3' ' A' ' 114' ' ' TRP . 0.1 OUTLIER -63.58 123.48 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.898 178.327 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.75 69.84 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.733 1.635 . . . . 0.0 113.114 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.82 38.81 0.46 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.29 1.836 . . . . 0.0 111.841 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 54.44 41.79 31.76 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.83 1.652 . . . . 0.0 113.168 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.36 156.2 26.88 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.061 1.315 . . . . 0.0 113.418 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.15 134.38 51.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.156 0.983 . . . . 0.0 111.523 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.53 111.7 11.99 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.965 2.106 . . . . 0.0 108.902 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -147.91 146.78 29.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.017 1.727 . . . . 0.0 111.184 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 144.6 9.97 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.422 1.089 . . . . 0.0 111.208 175.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 137.09 58.24 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.841 0.457 . . . . 0.0 112.008 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.44 -30.37 0.06 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 113.646 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.9 16.3 55.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.078 1.323 . . . . 0.0 114.169 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.38 14.06 4.47 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.091 2.157 . . . . 0.0 114.965 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.25 -65.45 0.06 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.254 1.883 . . . . 0.0 110.816 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.28 156.34 16.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.905 0.882 . . . . 0.0 110.845 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -149.55 170.33 18.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.433 1.493 . . . . 0.0 112.397 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -89.23 145.49 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.964 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -137.95 106.13 5.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.528 1.931 . . . . 0.0 108.684 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.85 170.65 25.72 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-O 121.765 0.647 . . . . 0.0 113.972 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.14 148.29 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.847 2.059 . . . . 0.0 108.531 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.5 ttt -142.11 131.99 24.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.379 1.072 . . . . 0.0 108.607 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.06 160.81 31.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.052 1.341 . . . . 0.0 111.608 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.6 t -93.4 5.0 53.06 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.993 1.317 . . . . 0.0 113.362 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.74 174.52 5.84 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.712 2.005 . . . . 0.0 112.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.17 -56.77 21.93 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.011 0.815 . . . . 0.0 113.552 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.04 36.52 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.545 1.938 . . . . 0.0 113.685 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.38 32.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.599 1.159 . . . . 0.0 114.045 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -106.49 131.2 53.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.905 1.682 . . . . 0.0 109.504 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 34.2 ttp -128.01 95.27 4.14 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.843 1.257 . . . . 0.0 111.361 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -109.34 143.57 38.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.73 -0.606 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.45 107.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.759 2.023 . . . . 0.0 109.668 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 101.12 10.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.232 1.413 . . . . 0.0 109.795 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.66 129.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.872 -0.517 . . . . 0.0 110.654 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.99 171.97 18.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.002 0.921 . . . . 0.0 113.16 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 128.973 2.909 . . . . 0.0 112.837 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.24 147.05 38.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.553 -1.342 . . . . 0.0 111.88 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.94 34.33 81.81 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.605 0.622 . . . . 0.0 113.777 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -148.49 178.3 8.73 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.987 0.893 . . . . 0.0 111.501 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 69' ' ' LEU . 4.9 pt -128.35 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.489 1.516 . . . . 0.0 111.949 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 pt -144.84 167.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.804 1.642 . . . . 0.0 111.708 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.57 124.34 16.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.633 1.173 . . . . 0.0 112.173 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.95 -19.67 30.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 114.1 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.3 95.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.02 1.328 . . . . 0.0 111.692 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -35.28 25.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.321 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 68' ' ' ALA . 3.5 tp -52.44 100.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.081 1.752 . . . . 0.0 112.602 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -145.72 170.3 16.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.019 1.328 . . . . 0.0 109.793 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.88 -36.9 28.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.115 1.366 . . . . 0.0 113.702 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 -35.21 76.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.026 0.93 . . . . 0.0 113.305 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 20' ' ' VAL . 62.1 t -67.74 -46.71 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.644 1.178 . . . . 0.0 109.519 175.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.74 -44.84 73.93 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 112.412 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.5 -42.08 95.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.838 -0.539 . . . . 0.0 111.361 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -42.04 97.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.318 1.047 . . . . 0.0 111.407 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 2' ' ' LEU . 44.5 t -61.2 -54.47 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.599 1.159 . . . . 0.0 111.247 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.27 -49.48 61.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 0.0 111.569 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.99 -42.83 72.55 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.2 -38.06 44.14 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' HZ2' ' A' ' 30' ' ' LYS . 3.4 tt -54.71 -45.14 73.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.487 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.33 66.48 0.48 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.229 1.395 . . . . 0.0 111.564 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 124.21 1.11 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.542 1.537 . . . . 0.0 112.946 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -104.09 -159.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.688 1.595 . . . . 0.0 109.556 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.51 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -49.06 -30.59 6.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 114.117 176.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.27 135.11 11.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.143 1.777 . . . . 0.0 111.439 176.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HZ2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.77 165.25 35.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.755 1.222 . . . . 0.0 113.343 174.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.39 161.27 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.181 1.392 . . . . 0.0 109.099 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.49 125.73 51.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.068 1.347 . . . . 0.0 108.07 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.55 142.21 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.171 1.788 . . . . 0.0 110.388 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.46 122.51 1.32 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.948 0.785 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.53 111.69 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 118.336 1.068 . . . . 0.0 110.208 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.61 120.58 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.972 1.709 . . . . 0.0 113.798 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.39 90.39 1.29 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.089 1.756 . . . . 0.0 110.171 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -107.53 12.39 27.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 112.595 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -82.33 -34.63 28.47 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -171.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.63 17.35 10.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.241 0.928 . . . . 0.0 114.997 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.3 160.93 31.3 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 118.988 1.394 . . . . 0.0 114.844 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -74.08 134.42 42.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.805 1.242 . . . . 0.0 111.874 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.46 166.47 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.96 1.704 . . . . 0.0 111.26 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 m -133.93 113.24 11.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.986 1.315 . . . . 0.0 110.064 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 113.02 4.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.72 -64.46 0.93 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.674 1.19 . . . . 0.0 110.142 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -175.22 169.11 3.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.892 2.077 . . . . 0.0 111.459 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -122.12 139.03 54.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.977 2.111 . . . . 0.0 109.103 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.9 110.93 11.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.55 101.49 3.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.174 1.39 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -68.03 -42.33 80.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.46 1.504 . . . . 0.0 111.942 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.11 157.79 43.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.692 2.397 . . . . 0.0 111.144 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 -169.69 39.86 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 123.729 0.681 . . . . 0.0 114.574 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -136.77 173.3 11.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.056 1.342 . . . . 0.0 112.363 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.7 p -143.04 176.57 8.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 110.66 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -123.35 17.59 9.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.434 1.094 . . . . 0.0 112.193 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.07 175.51 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.985 2.114 . . . . 0.0 111.904 -168.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mt -139.04 133.72 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.014 1.326 . . . . 0.0 109.76 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.0 142.24 75.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.151 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.93 172.01 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.607 3.538 . . . . 0.0 110.811 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -115.39 -20.26 10.35 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.204 -1.56 . . . . 0.0 112.556 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -129.88 141.35 50.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.353 1.461 . . . . 0.0 110.297 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.03 95.5 5.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.92 161.53 32.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.556 1.504 . . . . 0.0 111.303 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.7 153.53 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.568 -0.707 . . . . 0.0 111.517 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -25.79 0.18 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.038 1.735 . . . . 0.0 113.384 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -89.03 121.15 31.09 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.133 1.333 . . . . 0.0 110.659 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.535 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -91.11 160.5 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 111.402 174.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -101.68 164.46 11.73 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.026 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.65 134.74 48.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.96 2.104 . . . . 0.0 109.01 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -147.42 171.18 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.962 1.305 . . . . 0.0 111.786 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -148.08 168.82 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.834 1.253 . . . . 0.0 110.831 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -146.43 116.38 0.87 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-O 118.036 -1.425 . . . . 0.0 110.602 175.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.09 163.81 15.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.704 1.252 . . . . 0.0 110.737 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -177.81 0.66 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.1 -175.25 0.2 Allowed 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.143 -0.973 . . . . 0.0 111.036 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 m -19.7 -56.58 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.187 2.995 . . . . 0.0 115.589 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.94 -63.08 0.3 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.424 1.488 . . . . 0.0 112.226 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 0.14 6.78 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.925 3.75 . . . . 0.0 115.972 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.38 122.87 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.888 1.675 . . . . 0.0 111.783 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.91 80.17 4.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.367 1.467 . . . . 0.0 111.713 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -104.91 -86.51 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.494 1.518 . . . . 0.0 110.789 177.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 82' ' ' THR . . . 174.24 179.94 45.18 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 127.41 2.433 . . . . 0.0 110.581 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -138.35 101.18 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.176 1.391 . . . . 0.0 109.966 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -140.77 126.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -149.95 164.94 34.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.351 -0.843 . . . . 0.0 110.8 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.6 155.93 40.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.961 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.23 168.02 27.39 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.968 1.307 . . . . 0.0 109.881 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 148.91 43.05 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.727 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -134.62 115.77 14.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.279 1.032 . . . . 0.0 111.165 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -69.62 118.5 12.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.404 1.482 . . . . 0.0 109.36 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -82.47 151.68 26.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.604 1.562 . . . . 0.0 110.404 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -58.33 -19.18 33.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 63.2 m -82.3 -12.28 58.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.484 1.914 . . . . 0.0 113.848 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.51 -10.6 42.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.298 1.428 . . . . 0.0 115.127 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.55 173.32 12.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.514 1.525 . . . . 0.0 110.737 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -137.63 142.76 41.2 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.698 1.199 . . . . 0.0 108.39 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.23 140.75 38.7 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.25 145.57 16.27 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -148.87 130.15 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 109.725 175.172 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.53 50.1 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.04 . . . . 0.0 110.296 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -123.21 152.99 40.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.037 1.335 . . . . 0.0 109.453 174.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.3 p -140.37 122.5 15.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.024 0.929 . . . . 0.0 110.626 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 23.7 t -119.75 108.15 39.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 126.407 1.883 . . . . 0.0 108.33 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.16 155.56 37.67 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.297 1.998 . . . . 0.0 111.493 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.68 -36.09 83.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.646 0.778 . . . . 0.0 110.76 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.99 114.68 27.31 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.785 2.434 . . . . 0.0 111.612 -171.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.0 -63.77 1.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.047 -1.033 . . . . 0.0 113.445 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -88.86 10.86 19.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -6.0 6.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.83 2.052 . . . . 0.0 112.743 -174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.35 179.35 8.62 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.835 2.454 . . . . 0.0 110.284 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -136.75 159.96 40.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.161 1.385 . . . . 0.0 110.955 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -79.63 155.33 28.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -136.83 151.61 49.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.75 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -161.6 157.73 25.15 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.675 1.19 . . . . 0.0 110.16 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 12.5 t70 -154.47 161.32 41.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.602 1.161 . . . . 0.0 110.245 174.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 100' ' ' VAL . 67.5 t -146.23 138.0 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.346 1.858 . . . . 0.0 109.921 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.87 46.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.055 1.742 . . . . 0.0 110.007 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.8 119.24 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.097 1.759 . . . . 0.0 108.71 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -127.92 139.4 52.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.465 1.906 . . . . 0.0 112.385 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.6 p -77.34 79.4 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.919 1.688 . . . . 0.0 112.525 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.75 174.78 32.05 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.979 . . . . 0.0 112.606 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 99.65 10.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.855 2.062 . . . . 0.0 110.593 -173.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.82 161.43 34.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.781 2.032 . . . . 0.0 111.464 -176.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.44 30.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.527 1.531 . . . . 0.0 111.301 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.41 87.96 0.64 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.128 0.971 . . . . 0.0 111.293 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.63 -64.16 1.12 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.999 1.32 . . . . 0.0 109.292 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -75.02 0.17 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.989 1.716 . . . . 0.0 108.543 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.41 93.98 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.804 1.192 . . . . 0.0 113.93 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.31 -46.42 76.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.299 1.049 . . . . 0.0 111.398 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.35 -43.66 93.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.575 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -62.35 -42.66 99.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.514 1.126 . . . . 0.0 112.338 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -16.71 35.11 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 113.153 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.43 -52.4 4.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.55 -43.09 97.63 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 112.794 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -98.46 -14.65 19.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.786 1.234 . . . . 0.0 113.591 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.48 4.16 Favored Glycine 0 N--CA 1.475 1.286 0 O-C-N 121.541 -0.724 . . . . 0.0 114.655 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 44.3 77.21 0.46 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.222 1.809 . . . . 0.0 111.78 -165.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.67 157.58 50.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.04 1.826 . . . . 0.0 111.01 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 116' ' ' ASP . 23.8 m-85 -90.28 2.9 54.99 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER 46.61 16.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 129.426 3.09 . . . . 0.0 116.848 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 45.69 62.98 3.01 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.176 0.893 . . . . 0.0 112.611 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.74 16.65 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.281 10.7 p30 49.17 33.69 5.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.409 2.283 . . . . 0.0 115.15 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.24 147.89 19.36 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.965 1.745 . . . . 0.0 111.06 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -64.98 116.06 6.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.362 0.665 . . . . 0.0 110.382 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 138.09 49.26 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.42 128.57 4.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.91 1.284 . . . . 0.0 111.333 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -137.86 119.57 15.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.299 1.04 . . . . 0.0 113.372 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.77 123.94 5.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.3 -24.48 0.08 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.77 22.34 14.5 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.958 1.266 . . . . 0.0 114.085 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.0 t80 58.43 14.8 3.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.566 2.346 . . . . 0.0 115.024 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.98 -64.03 0.05 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 125.456 1.503 . . . . 0.0 110.913 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.13 161.07 15.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.183 0.993 . . . . 0.0 111.149 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 174.44 10.51 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.886 2.074 . . . . 0.0 111.407 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -78.2 131.13 37.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.91 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -122.23 104.67 9.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.717 1.207 . . . . 0.0 108.696 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.38 165.41 27.48 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-O 122.401 1.0 . . . . 0.0 114.643 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.3 tt -146.9 141.54 20.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 127.573 2.349 . . . . 0.0 108.469 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.1 ttt -141.7 140.6 33.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.07 1.748 . . . . 0.0 106.371 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.99 163.14 19.07 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.436 0.694 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 9.77 13.54 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.03 1.332 . . . . 0.0 113.776 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.28 170.58 9.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.234 2.214 . . . . 0.0 112.663 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.34 -71.79 0.88 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.46 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.665 2.386 . . . . 0.0 115.995 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 158.49 8.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.168 2.187 . . . . 0.0 113.627 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.22 140.44 36.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.271 1.428 . . . . 0.0 110.685 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.2 ttm -133.48 135.4 44.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.999 1.719 . . . . 0.0 110.087 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -144.46 152.6 40.86 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.927 0.891 . . . . 0.0 109.225 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.1 mt -133.18 117.4 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.494 1.518 . . . . 0.0 108.453 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -106.59 113.78 27.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.795 1.638 . . . . 0.0 109.561 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.35 101.07 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 60.3 p -161.73 -179.56 7.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.426 1.891 . . . . 0.0 114.914 -174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 127.997 2.519 . . . . 0.0 115.408 -164.715 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.57 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 61.84 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.169 2.588 . . . . 0.0 113.082 -167.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.36 47.46 90.77 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 114.817 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.9 p -147.51 -174.65 4.59 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.33 1.052 . . . . 0.0 112.574 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -124.47 136.82 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.673 1.989 . . . . 0.0 111.041 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.53 174.21 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.476 1.51 . . . . 0.0 111.905 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.14 1.69 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.984 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 67' ' ' LYS . . . -64.14 -25.26 69.46 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.241 -0.912 . . . . 0.0 113.096 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.0 71.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.418 1.087 . . . . 0.0 112.549 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 m -83.63 -19.41 35.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.79 1.236 . . . . 0.0 113.374 175.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD22 ' CB ' ' A' ' 68' ' ' ALA . 16.2 tp -66.7 97.7 0.47 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.927 1.291 . . . . 0.0 111.688 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 14' ' ' PHE . 7.4 m -144.44 174.44 10.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.562 1.545 . . . . 0.0 109.508 -174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.524 ' HA ' HD12 ' A' ' 17' ' ' LEU . 1.4 t80 -49.05 -33.63 11.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.95 1.3 . . . . 0.0 114.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -64.23 -32.9 74.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -77.5 -30.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.224 1.41 . . . . 0.0 111.422 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 14' ' ' PHE . 52.6 mt -59.03 -52.84 64.02 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.92 -38.41 72.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.547 1.139 . . . . 0.0 111.666 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -58.88 -36.94 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.12 -46.49 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.332 0.969 . . . . 0.0 110.78 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -40.17 85.03 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.213 1.405 . . . . 0.0 110.418 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.35 -53.36 37.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.385 0.674 . . . . 0.0 112.813 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -48.72 41.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.496 -0.753 . . . . 0.0 112.766 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.701 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.1 tm? -63.32 -39.45 94.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.77 0.828 . . . . 0.0 111.7 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.74 69.53 0.8 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.137 1.351 . . . . 0.0 112.758 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.277 1.831 . . . . 0.0 112.376 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -84.03 -160.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.123 1.769 . . . . 0.0 110.421 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 27' ' ' VAL . 67.5 m -44.02 -35.01 1.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.987 1.715 . . . . 0.0 114.754 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -149.71 137.48 20.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.616 1.966 . . . . 0.0 110.221 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.701 ' HE3' HD12 ' A' ' 24' ' ' LEU . 5.7 tptp -165.85 143.17 5.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.556 1.542 . . . . 0.0 112.017 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.22 143.46 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.371 0.987 . . . . 0.0 111.443 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.99 118.57 36.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 108.867 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.64 139.67 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.984 0.913 . . . . 0.0 111.227 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.77 133.73 4.42 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.925 1.25 . . . . 0.0 111.596 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.26 99.3 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.028 0.931 . . . . 0.0 108.699 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -81.02 105.61 12.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.814 0.846 . . . . 0.0 111.142 -174.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -73.61 96.15 2.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 111.283 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.74 10.81 15.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 113.442 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.3 t -64.06 -55.06 24.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.911 1.284 . . . . 0.0 114.006 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.02 0.9 3.03 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.38 157.21 27.12 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 119.489 1.645 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -69.63 138.06 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.554 1.142 . . . . 0.0 113.129 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -115.26 166.05 12.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.551 1.54 . . . . 0.0 112.112 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -134.62 114.02 12.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.995 1.318 . . . . 0.0 110.295 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.49 124.29 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.959 -1.088 . . . . 0.0 108.994 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.41 -66.78 0.5 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 110.622 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.23 159.78 7.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.125 2.17 . . . . 0.0 110.558 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.08 122.92 47.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.478 1.911 . . . . 0.0 109.7 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.59 116.81 26.09 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.177 0.991 . . . . 0.0 111.829 -176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -71.49 114.2 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.177 1.391 . . . . 0.0 112.727 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -44.83 44.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.044 1.738 . . . . 0.0 110.591 174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 m -147.38 162.22 39.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.496 2.318 . . . . 0.0 111.574 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.67 -166.18 54.02 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.358 0.98 . . . . 0.0 113.934 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -147.32 173.32 12.7 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.889 -0.771 . . . . 0.0 111.954 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.57 HG22 ' HA2' ' A' ' 73' ' ' GLY . 5.1 p -143.82 -174.69 4.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.182 1.393 . . . . 0.0 111.479 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.07 13.46 6.22 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.286 1.034 . . . . 0.0 112.918 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 3' ' ' ALA . 7.9 m -136.45 170.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.898 2.079 . . . . 0.0 114.043 -169.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.33 133.35 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.915 1.686 . . . . 0.0 110.785 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 143.48 52.06 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.196 0.907 . . . . 0.0 111.713 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.79 146.36 59.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.655 3.57 . . . . 0.0 112.051 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -85.6 -26.74 25.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -113.63 128.03 56.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.216 1.371 . . . . 0.0 111.897 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.52 86.63 28.68 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.609 1.564 . . . . 0.0 110.137 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.73 162.12 36.01 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.303 2.002 . . . . 0.0 112.124 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -63.64 159.48 18.89 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.758 -0.589 . . . . 0.0 111.063 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p 68.45 -5.42 0.94 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.68 2.392 . . . . 0.0 114.444 -172.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.486 ' HA ' ' H ' ' A' ' 9' ' ' GLY . 73.9 mttt -116.31 165.44 13.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.581 1.952 . . . . 0.0 112.026 174.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.508 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -135.89 162.66 32.2 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.321 1.448 . . . . 0.0 111.272 174.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 167.02 10.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.292 0.567 . . . . 0.0 109.857 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.51 136.08 52.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.506 1.922 . . . . 0.0 108.764 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -150.17 166.29 30.3 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.185 0.994 . . . . 0.0 110.662 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -155.29 170.12 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.591 0.757 . . . . 0.0 112.447 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.57 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -160.15 145.0 10.6 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.748 1.166 . . . . 0.0 112.582 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -127.17 148.92 50.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.652 1.981 . . . . 0.0 110.981 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 9.4 pttp -67.36 121.11 15.02 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 38.24 -149.77 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 126.034 1.733 . . . . 0.0 114.381 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.7 m -88.17 -42.65 12.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.634 -1.291 . . . . 0.0 111.598 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.9 -61.16 0.37 Allowed Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.696 -1.058 . . . . 0.0 114.252 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.16 0.81 5.4 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.929 3.753 . . . . 0.0 115.27 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.76 135.72 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 127.677 2.391 . . . . 0.0 108.995 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 106' ' ' PHE . . . -119.14 80.95 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.627 1.571 . . . . 0.0 110.226 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.8 m -110.42 -66.7 1.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.726 1.211 . . . . 0.0 110.75 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.02 -179.64 33.58 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.731 0.681 . . . . 0.0 112.793 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -140.1 115.46 9.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 110.427 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.8 t -138.63 139.51 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.426 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -154.71 158.82 40.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.31 0.644 . . . . 0.0 109.863 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.67 139.81 22.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 111.919 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.73 176.43 8.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.573 1.949 . . . . 0.0 109.682 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.73 37.07 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.336 0.655 . . . . 0.0 112.125 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.44 113.02 15.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.686 1.194 . . . . 0.0 111.112 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -73.04 111.77 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.215 1.806 . . . . 0.0 110.747 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 mtt -71.68 161.42 31.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.724 0.81 . . . . 0.0 112.106 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.3 t -60.98 -26.08 67.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.118 0.967 . . . . 0.0 113.245 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -74.96 -12.1 60.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.622 1.569 . . . . 0.0 112.957 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.34 -2.86 59.48 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.665 1.602 . . . . 0.0 114.489 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.79 176.38 9.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.533 1.533 . . . . 0.0 109.664 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.9 m -136.56 148.71 47.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 0.0 110.241 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.33 134.89 54.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 108.637 175.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 144.04 19.03 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.26 121.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 118.445 1.122 . . . . 0.0 109.481 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -128.64 162.22 27.83 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.359 0.664 . . . . 0.0 112.668 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 3.8 p90 -131.4 150.89 51.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.875 1.27 . . . . 0.0 109.603 174.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 t -139.08 110.37 6.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.52 0.728 . . . . 0.0 110.383 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.8 t -99.59 100.01 9.91 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 127.897 2.479 . . . . 0.0 109.112 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.4 145.72 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.34 2.027 . . . . 0.0 111.372 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' A' ' 81' ' ' ALA . 23.6 t80 -72.89 -31.55 64.76 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.41 0.624 . . . . 0.0 110.167 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.73 114.85 28.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.522 2.329 . . . . 0.0 111.714 -165.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.01 -54.74 8.97 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -95.01 14.43 21.85 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -16.92 2.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.373 1.869 . . . . 0.0 113.06 -175.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.07 175.1 10.11 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.062 2.945 . . . . 0.0 109.497 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.8 m -136.01 171.0 15.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.438 1.495 . . . . 0.0 110.768 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -87.24 151.97 22.71 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.069 0.947 . . . . 0.0 109.964 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -138.78 142.02 38.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.231 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -159.6 163.2 35.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 111.154 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -163.71 147.19 10.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.395 1.478 . . . . 0.0 110.421 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.21 108.25 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.009 1.723 . . . . 0.0 109.529 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -111.76 149.11 32.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.041 1.736 . . . . 0.0 109.734 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.1 117.76 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.687 1.595 . . . . 0.0 108.898 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -125.21 135.88 53.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.145 1.778 . . . . 0.0 112.092 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -75.66 80.63 2.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.379 1.472 . . . . 0.0 112.792 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.14 167.63 14.5 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 115.207 0.843 . . . . 0.0 115.207 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -72.86 102.66 3.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.432 1.493 . . . . 0.0 111.665 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.51 132.45 31.22 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.318 1.847 . . . . 0.0 109.436 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 167.13 17.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.048 1.339 . . . . 0.0 111.837 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.64 88.54 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.598 1.559 . . . . 0.0 111.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -111.53 -64.38 1.29 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.776 1.23 . . . . 0.0 109.712 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -68.52 0.23 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.597 1.159 . . . . 0.0 109.139 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.77 90.62 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.682 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -52.77 33.27 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.086 1.443 . . . . 0.0 111.02 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.89 -44.43 78.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.253 1.021 . . . . 0.0 110.801 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.85 -39.38 94.08 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -22.32 61.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.453 1.101 . . . . 0.0 112.216 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.19 -58.86 2.47 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.431 1.492 . . . . 0.0 109.557 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -63.36 -57.63 9.73 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.295 -0.878 . . . . 0.0 111.248 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -82.26 -17.95 44.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.347 1.059 . . . . 0.0 112.247 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.21 56.51 4.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.935 0.778 . . . . 0.0 114.676 -172.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.49 83.28 0.23 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 126.444 1.898 . . . . 0.0 111.818 -166.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.48 151.27 83.41 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.132 1.888 . . . . 0.0 109.256 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.42 -2.9 57.93 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.1 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 129.179 2.992 . . . . 0.0 112.819 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -38.67 75.32 0.0 OUTLIER Glycine 0 CA--C 1.542 1.781 0 C-N-CA 128.319 2.866 . . . . 0.0 117.239 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -81.97 25.55 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.629 1.972 . . . . 0.0 114.668 -170.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.275 11.6 p30 52.44 24.79 3.15 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.178 2.191 . . . . 0.0 114.842 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.35 172.25 18.07 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 126.888 2.185 . . . . 0.0 113.189 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -79.69 117.89 21.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.727 1.211 . . . . 0.0 111.919 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.84 117.33 33.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.053 1.741 . . . . 0.0 109.526 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.9 134.55 17.59 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 111.293 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -148.09 127.77 13.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.608 1.163 . . . . 0.0 112.146 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.84 113.54 1.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.136 1.374 . . . . 0.0 113.016 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tt -137.1 -28.36 0.94 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.944 1.298 . . . . 0.0 113.385 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.11 18.24 33.0 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.883 1.23 . . . . 0.0 114.498 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.66 11.25 2.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.385 2.274 . . . . 0.0 114.785 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.69 -72.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 C-N-CA 126.101 1.81 . . . . 0.0 110.319 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.43 156.75 22.77 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.813 0.816 . . . . 0.0 111.632 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.62 170.87 18.64 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.599 1.56 . . . . 0.0 112.43 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.9 130.87 35.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.303 1.041 . . . . 0.0 109.401 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -125.71 101.32 6.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -134.45 168.76 23.35 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 121.963 0.757 . . . . 0.0 113.843 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.7 tt -143.74 141.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.343 1.857 . . . . 0.0 109.049 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.5 ttt -146.28 143.07 28.93 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.78 1.632 . . . . 0.0 107.501 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.7 p -97.53 173.22 7.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.22 1.008 . . . . 0.0 111.539 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.0 m -109.43 33.72 4.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.555 1.542 . . . . 0.0 112.392 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.8 175.08 5.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.248 1.419 . . . . 0.0 112.376 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.65 -47.47 91.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.177 0.894 . . . . 0.0 113.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -108.87 72.01 0.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.784 1.278 . . . . 0.0 111.633 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.5 175.01 7.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.918 1.287 . . . . 0.0 111.211 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.81 151.16 47.83 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 109.312 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.9 tpp -140.68 87.77 2.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.147 0.979 . . . . 0.0 111.736 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.38 148.78 23.34 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.984 0.514 . . . . 0.0 111.05 174.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.87 99.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.25 1.42 . . . . 0.0 111.19 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -83.76 108.16 16.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.798 1.639 . . . . 0.0 109.844 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 110.07 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.132 0.573 . . . . 0.0 110.86 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 55.4 m -147.29 161.33 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.921 1.289 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 128.211 2.604 . . . . 0.0 111.686 177.834 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.01 139.58 50.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.46 -1.4 . . . . 0.0 111.084 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.02 31.83 61.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -142.76 177.22 8.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 118.639 1.22 . . . . 0.0 112.398 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 60' ' ' PRO . 6.5 pt -125.51 144.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.448 1.499 . . . . 0.0 112.734 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -146.38 174.09 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.748 1.619 . . . . 0.0 112.236 177.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.52 121.01 8.68 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.023 1.329 . . . . 0.0 111.587 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.7 -21.74 44.31 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.111 1.339 . . . . 0.0 113.863 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.81 76.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.059 1.344 . . . . 0.0 111.931 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.9 m -88.51 -32.8 18.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.42 1.488 . . . . 0.0 112.361 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.6 tp -55.42 106.54 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.761 1.224 . . . . 0.0 111.623 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -146.29 168.98 19.73 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.825 1.25 . . . . 0.0 109.747 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.85 -37.87 14.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 114.05 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.85 -34.27 71.38 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 20' ' ' VAL . 46.9 t -72.51 -48.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.191 1.397 . . . . 0.0 110.198 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 170' ' ' GLN . 86.5 mt -54.31 -44.84 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 112.629 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.87 -45.5 77.89 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.963 0.505 . . . . 0.0 111.624 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -56.34 -41.54 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.821 1.649 . . . . 0.0 113.044 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 16' ' ' VAL . 67.0 t -50.07 -55.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.197 1.399 . . . . 0.0 111.193 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.17 -38.65 88.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 112.479 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -49.63 75.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.12 1.368 . . . . 0.0 110.741 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.01 -36.07 61.96 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.08 -50.94 69.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.66 1.584 . . . . 0.0 112.23 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 62.83 0.36 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.893 1.235 . . . . 0.0 112.328 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -45.94 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.617 2.367 . . . . 0.0 114.04 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.5 -166.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.591 1.956 . . . . 0.0 111.211 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -43.78 -41.34 4.89 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.819 2.047 . . . . 0.0 113.99 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -144.38 138.91 28.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.551 1.94 . . . . 0.0 108.84 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HE3' ' CB ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -167.34 146.39 5.04 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.234 2.214 . . . . 0.0 109.591 -172.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -137.92 160.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.608 1.163 . . . . 0.0 110.916 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.49 118.04 31.57 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.995 1.318 . . . . 0.0 109.034 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.4 139.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.87 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.65 118.14 0.88 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.921 0.772 . . . . 0.0 111.711 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.79 97.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.128 0.971 . . . . 0.0 108.461 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -76.96 117.51 18.63 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 0.0 111.403 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -92.77 101.7 14.09 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.976 0.894 . . . . 0.0 112.215 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -111.38 12.46 21.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.451 1.1 . . . . 0.0 113.489 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -56.42 -51.97 66.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.1 1.76 . . . . 0.0 114.36 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.42 4.83 0.74 Allowed Glycine 0 CA--C 1.538 1.526 0 N-CA-C 116.505 1.362 . . . . 0.0 116.505 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 166.85 32.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.642 1.721 . . . . 0.0 114.348 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 t -69.94 126.93 31.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.125 1.37 . . . . 0.0 112.401 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -98.99 165.33 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.63 1.572 . . . . 0.0 111.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 m -135.41 106.97 6.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.104 1.362 . . . . 0.0 109.574 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.23 132.33 52.38 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.66 -72.63 0.3 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.587 0.755 . . . . 0.0 110.291 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.51 165.33 8.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.499 1.92 . . . . 0.0 111.048 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -114.21 124.18 51.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.885 1.674 . . . . 0.0 109.772 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.21 108.77 19.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.549 1.14 . . . . 0.0 111.37 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -73.31 118.54 16.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.481 1.112 . . . . 0.0 110.896 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.62 12.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.769 1.228 . . . . 0.0 111.942 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -143.42 150.98 39.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.78 2.032 . . . . 0.0 111.397 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.29 51.7 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.183 0.897 . . . . 0.0 113.648 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -149.13 163.23 38.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.875 -0.779 . . . . 0.0 111.094 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -142.43 130.17 21.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.892 1.277 . . . . 0.0 110.095 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.01 2.9 54.63 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.546 1.538 . . . . 0.0 113.521 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.71 169.76 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.697 1.199 . . . . 0.0 111.134 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.07 131.53 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.203 1.001 . . . . 0.0 110.037 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -76.44 154.27 83.91 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 118.289 0.495 . . . . 0.0 111.169 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HG3' HG23 ' A' ' 6' ' ' ILE . 45.9 Cg_endo -70.93 167.76 25.02 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.365 3.377 . . . . 0.0 109.957 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.14 -16.75 12.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.061 -1.025 . . . . 0.0 112.952 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -128.99 144.0 51.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.483 1.513 . . . . 0.0 109.958 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 6' ' ' ILE . 26.5 t -143.52 99.48 5.28 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.674 1.19 . . . . 0.0 109.634 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.61 155.02 71.82 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.884 1.723 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -55.86 150.2 13.58 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.953 -0.467 . . . . 0.0 111.597 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 0.9 OUTLIER 68.83 -7.3 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.185 2.194 . . . . 0.0 115.417 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -101.58 141.71 34.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.402 1.455 . . . . 0.0 108.07 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -112.73 154.48 26.1 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.213 -0.929 . . . . 0.0 111.784 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -90.94 171.01 9.59 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.44 175.049 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -135.45 134.11 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.577 2.351 . . . . 0.0 107.364 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -150.19 162.35 40.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.766 1.626 . . . . 0.0 111.206 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.6 m -154.21 155.32 35.04 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.367 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 31' ' ' ILE . . . -150.42 143.65 10.93 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 121.2 -0.937 . . . . 0.0 113.411 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.06 163.63 29.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.779 1.232 . . . . 0.0 113.48 -172.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 99.32 7.86 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.699 1.237 . . . . 0.0 110.411 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 36.28 -131.0 0.1 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.87 2.468 . . . . 0.0 113.191 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -57.54 -53.67 55.57 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.806 -1.184 . . . . 0.0 112.73 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.22 -61.93 0.41 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.47 -8.72 23.91 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 124.433 3.422 . . . . 0.0 115.554 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.91 163.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.347 1.459 . . . . 0.0 112.836 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.64 74.51 1.01 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.056 1.342 . . . . 0.0 112.599 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 83' ' ' GLY . 2.8 t -106.99 -107.91 0.32 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.723 1.609 . . . . 0.0 109.76 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 82' ' ' THR . . . -171.57 174.88 45.14 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.628 2.537 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -136.82 93.13 2.81 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.067 1.347 . . . . 0.0 109.584 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.84 124.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.55 157.82 42.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.33 130.53 17.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.95 0.9 . . . . 0.0 110.916 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -131.58 176.44 8.32 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.734 1.613 . . . . 0.0 110.241 -172.396 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 150.35 44.79 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.466 0.651 . . . . 0.0 112.686 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -132.88 114.11 13.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 111.02 -175.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -79.54 123.54 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.219 1.408 . . . . 0.0 111.239 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 mtp -81.63 157.28 24.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.179 1.391 . . . . 0.0 112.257 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 p -62.2 -19.52 63.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.233 1.413 . . . . 0.0 114.757 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -84.06 -11.39 56.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.005 1.722 . . . . 0.0 113.755 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.85 -5.06 46.46 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.936 1.255 . . . . 0.0 115.11 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -76.12 171.82 13.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.654 1.182 . . . . 0.0 110.213 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 m -136.69 140.7 42.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.979 0.912 . . . . 0.0 110.158 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 123.51 50.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.51 139.08 18.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.14 122.18 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.711 1.205 . . . . 0.0 110.242 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.0 159.61 40.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -134.03 153.7 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.47 1.508 . . . . 0.0 110.913 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 t -137.1 104.79 5.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.574 1.55 . . . . 0.0 110.009 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 41.5 t -105.65 97.05 13.48 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 127.032 2.133 . . . . 0.0 108.475 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.57 167.05 28.23 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.773 2.316 . . . . 0.0 111.617 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -69.69 -45.27 68.66 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.614 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 114.59 26.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.573 1.549 . . . . 0.0 111.569 -165.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -65.76 -62.07 1.72 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.07 12.35 22.28 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -7.72 5.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.606 1.963 . . . . 0.0 112.568 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.68 139.92 19.42 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.458 2.303 . . . . 0.0 109.116 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 t -98.55 159.23 15.09 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -84.22 157.78 21.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.792 -0.567 . . . . 0.0 109.805 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -138.98 145.67 40.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.986 0.915 . . . . 0.0 110.819 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -155.32 148.21 24.46 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.864 1.265 . . . . 0.0 110.792 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.59 151.36 37.16 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.46 107.45 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.825 1.65 . . . . 0.0 109.77 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -115.86 148.03 40.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.221 1.408 . . . . 0.0 109.724 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.51 111.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.863 2.065 . . . . 0.0 109.241 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -118.33 145.13 45.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 0.0 112.349 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.6 t -73.35 90.11 1.64 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.385 1.074 . . . . 0.0 110.79 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.63 -174.23 42.04 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.476 0.56 . . . . 0.0 113.768 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 111.68 23.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.047 2.139 . . . . 0.0 110.908 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -147.84 156.56 42.84 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.312 -0.868 . . . . 0.0 111.655 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -140.38 167.4 22.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.522 1.529 . . . . 0.0 111.299 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.73 86.79 0.94 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.537 1.135 . . . . 0.0 111.555 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -111.18 -67.0 1.03 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 108.911 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -146.18 -67.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.849 1.26 . . . . 0.0 109.779 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.23 -36.62 90.12 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.961 0.791 . . . . 0.0 114.325 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.5 ttp -65.71 -48.26 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.791 1.295 . . . . 0.0 111.642 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.19 -49.42 75.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.674 0.79 . . . . 0.0 111.068 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -64.82 -37.33 87.26 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.37 -20.86 61.08 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.163 -1.585 . . . . 0.0 113.286 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.71 -50.41 5.39 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.484 1.513 . . . . 0.0 112.132 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -75.32 -57.16 4.06 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.587 1.085 . . . . 0.0 112.76 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.73 -19.35 49.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.337 1.455 . . . . 0.0 111.858 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.51 -90.14 0.05 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.003 1.287 . . . . 0.0 112.467 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.02 79.17 1.99 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.073 1.349 . . . . 0.0 110.598 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 150.1 52.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.689 1.593 . . . . 0.0 111.546 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 164.51 26.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.864 0.866 . . . . 0.0 109.171 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.76 118.61 36.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.143 1.377 . . . . 0.0 108.856 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.32 65.5 1.63 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.878 0.763 . . . . 0.0 112.627 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -82.52 18.69 1.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.437 1.895 . . . . 0.0 113.647 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 64.52 43.35 4.5 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.526 1.93 . . . . 0.0 112.63 -173.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.64 153.57 21.72 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.604 1.573 . . . . 0.0 113.652 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -70.15 133.57 47.24 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.613 1.165 . . . . 0.0 111.893 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.91 113.73 14.38 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.294 1.837 . . . . 0.0 110.158 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.58 153.7 41.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.684 1.594 . . . . 0.0 110.578 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -166.48 150.65 7.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.237 1.815 . . . . 0.0 110.23 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.09 127.48 32.28 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.164 0.893 . . . . 0.0 110.143 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 tt -135.48 -39.74 0.73 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.522 1.129 . . . . 0.0 112.09 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.85 20.98 10.25 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.008 1.29 . . . . 0.0 114.475 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.73 14.46 4.1 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.991 2.116 . . . . 0.0 114.668 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 177.3 -56.85 0.1 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.065 1.793 . . . . 0.0 110.955 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.43 153.69 21.71 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.904 0.859 . . . . 0.0 110.128 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.6 169.51 24.51 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.043 1.337 . . . . 0.0 112.331 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -100.89 140.85 34.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.661 1.184 . . . . 0.0 111.606 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -126.38 113.91 17.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -146.36 172.19 27.01 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-O 121.661 0.589 . . . . 0.0 113.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.8 tt -153.63 145.91 14.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 126.466 1.907 . . . . 0.0 108.316 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.3 ttm -140.96 137.91 33.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.223 1.009 . . . . 0.0 109.24 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.89 161.02 30.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.428 1.891 . . . . 0.0 112.187 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -33.95 23.15 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.335 -0.853 . . . . 0.0 113.269 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.13 172.62 6.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 112.536 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.22 -42.07 99.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.352 -0.843 . . . . 0.0 113.27 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.443 ' CB ' ' HE3' ' A' ' 30' ' ' LYS . 10.9 pt-20 -81.52 57.91 3.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.858 1.663 . . . . 0.0 113.908 178.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.74 170.61 9.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 124.02 15.73 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.025 -1.047 . . . . 0.0 112.559 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.02 91.17 3.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.699 2.0 . . . . 0.0 111.899 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 17' ' ' LEU . 4.1 tt0 -87.45 139.02 30.97 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.874 -0.516 . . . . 0.0 110.373 165.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.5 114.27 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.618 1.967 . . . . 0.0 108.37 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -110.01 108.52 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 110.177 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.8 mm -89.13 120.22 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.658 1.183 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 49.9 m -117.32 170.02 9.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.597 1.559 . . . . 0.0 112.789 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.895 2.078 . . . . 0.0 113.667 -179.4 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.58 54.56 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.205 -0.935 . . . . 0.0 111.578 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 41.34 11.99 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.301 0.953 . . . . 0.0 114.732 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.8 p -142.88 -169.67 3.06 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 119.194 1.497 . . . . 0.0 112.902 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 pt -122.99 127.25 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.615 2.366 . . . . 0.0 110.757 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.59 166.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.767 1.227 . . . . 0.0 111.787 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 110.91 1.96 Allowed 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.658 -1.277 . . . . 0.0 113.044 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -29.08 61.51 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.164 0.888 . . . . 0.0 113.752 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.97 74.49 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.267 -1.137 . . . . 0.0 112.834 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -89.59 -18.39 26.67 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.945 1.298 . . . . 0.0 113.291 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' A' ' 34' ' ' GLY . 15.8 tp -65.41 115.34 5.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.126 1.371 . . . . 0.0 110.481 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -142.94 166.3 25.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.553 1.141 . . . . 0.0 110.043 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -40.26 26.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.706 1.602 . . . . 0.0 113.927 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.35 -34.95 74.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.314 1.446 . . . . 0.0 113.267 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.01 -45.68 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 109.82 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.63 -45.9 66.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.029 0.931 . . . . 0.0 112.435 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.31 -47.8 78.07 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.93 -0.481 . . . . 0.0 112.253 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -53.54 -42.17 67.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.783 1.233 . . . . 0.0 112.683 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -54.22 -57.08 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.829 0.852 . . . . 0.0 111.216 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 30' ' ' LYS . 2.8 mp -61.49 -40.9 96.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.028 1.331 . . . . 0.0 112.671 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.98 -45.89 82.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.528 0.731 . . . . 0.0 112.164 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.98 -21.02 29.69 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.26 -45.65 87.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.713 2.005 . . . . 0.0 113.605 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 32.78 7.17 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 114.747 0.659 . . . . 0.0 114.747 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 174.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.831 2.052 . . . . 0.0 114.293 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.33 -162.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.177 1.791 . . . . 0.0 111.478 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -54.5 -24.63 21.37 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -123.75 141.69 51.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.191 1.796 . . . . 0.0 110.293 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.732 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -161.1 149.32 15.84 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.342 1.857 . . . . 0.0 111.555 -170.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.406 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 3.7 pt -143.41 145.93 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.795 1.638 . . . . 0.0 109.917 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.23 121.64 41.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.403 1.481 . . . . 0.0 108.029 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.96 136.46 50.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.108 1.763 . . . . 0.0 110.589 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.5 120.74 1.23 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.014 1.292 . . . . 0.0 111.829 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.56 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.262 1.425 . . . . 0.0 108.451 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 104.94 8.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.071 0.948 . . . . 0.0 112.095 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -73.61 96.89 2.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.484 0.714 . . . . 0.0 110.684 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -122.25 21.62 10.34 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.106 1.762 . . . . 0.0 112.08 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.6 t -71.53 -43.23 66.82 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.294 1.438 . . . . 0.0 113.687 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.03 16.83 3.17 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.925 1.726 . . . . 0.0 115.667 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.83 155.44 26.81 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 119.597 1.698 . . . . 0.0 115.057 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -68.45 132.02 46.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -105.12 165.25 11.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.504 1.522 . . . . 0.0 111.849 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 m -134.45 113.76 12.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.105 1.362 . . . . 0.0 108.921 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.5 136.6 57.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.155 -0.966 . . . . 0.0 109.557 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.29 -70.76 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -177.48 175.78 1.38 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.617 2.367 . . . . 0.0 110.082 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.26 150.02 50.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.171 2.188 . . . . 0.0 109.306 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 112.3 8.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.232 . . . . 0.0 110.256 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -71.69 121.39 18.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.487 1.115 . . . . 0.0 110.846 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -95.5 -43.54 7.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.106 0.963 . . . . 0.0 112.032 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.4 m -141.22 156.89 45.85 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.935 2.094 . . . . 0.0 110.299 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.1 -176.74 53.86 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.468 0.556 . . . . 0.0 113.508 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -137.67 164.44 28.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.602 1.161 . . . . 0.0 111.027 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -144.38 175.47 10.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.451 1.1 . . . . 0.0 111.76 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -134.23 17.05 3.75 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.367 1.067 . . . . 0.0 112.279 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.95 166.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.818 2.047 . . . . 0.0 112.565 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.96 134.14 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.833 1.653 . . . . 0.0 109.632 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 154.47 86.42 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.993 0.815 . . . . 0.0 112.339 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.42 172.47 13.23 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.452 3.435 . . . . 0.0 110.525 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -113.38 -21.41 10.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -125.62 125.81 43.72 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 110.675 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.97 95.0 19.45 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.034 1.333 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.04 160.33 34.53 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.876 1.717 . . . . 0.0 111.23 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.61 156.86 10.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.801 -0.562 . . . . 0.0 111.586 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m 75.13 -22.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.182 2.193 . . . . 0.0 112.892 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -100.68 141.66 33.24 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.547 1.939 . . . . 0.0 109.576 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.05 178.0 4.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.775 2.03 . . . . 0.0 109.558 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.28 175.92 5.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 109.796 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -129.28 124.37 34.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.633 1.573 . . . . 0.0 107.363 174.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -146.0 150.17 35.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.592 0.357 . . . . 0.0 110.723 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.4 m -147.35 158.93 44.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.35 0.595 . . . . 0.0 111.129 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.01 10.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.515 1.531 . . . . 0.0 111.183 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -131.72 168.91 16.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.524 1.53 . . . . 0.0 110.467 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.52 179.34 0.47 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.029 0.932 . . . . 0.0 110.098 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.94 -179.98 0.24 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 121.114 -0.991 . . . . 0.0 111.264 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -28.58 -49.64 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.375 2.67 . . . . 0.0 115.939 -172.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.58 -59.61 0.33 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.016 1.293 . . . . 0.0 112.677 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.77 -2.66 11.77 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.25 3.3 . . . . 0.0 115.067 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.71 124.2 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.462 1.505 . . . . 0.0 111.297 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.24 75.71 1.66 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.19 1.796 . . . . 0.0 111.786 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.8 m -100.58 -75.44 0.58 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.623 1.169 . . . . 0.0 111.244 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.57 -176.52 45.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.74 1.162 . . . . 0.0 112.253 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.54 105.29 5.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.695 1.198 . . . . 0.0 110.671 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.18 120.41 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.311 1.044 . . . . 0.0 108.585 -171.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.94 168.59 19.89 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.89 0.852 . . . . 0.0 111.526 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.57 156.25 43.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.077 0.951 . . . . 0.0 111.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.73 175.52 11.9 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.777 2.031 . . . . 0.0 110.66 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.35 43.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.897 0.879 . . . . 0.0 111.504 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -125.73 118.66 26.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 110.957 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.52 117.43 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.992 1.717 . . . . 0.0 110.309 176.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.9 mtm -75.58 162.6 28.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.487 0.66 . . . . 0.0 112.492 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -60.41 -21.55 62.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.928 1.291 . . . . 0.0 114.078 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -83.23 -12.19 57.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.05 2.14 . . . . 0.0 113.56 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.03 -1.56 57.78 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.475 1.512 . . . . 0.0 115.252 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.35 171.22 15.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.066 1.347 . . . . 0.0 110.143 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.0 m -131.59 148.34 52.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.746 0.818 . . . . 0.0 110.473 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.42 112.81 18.52 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.761 1.224 . . . . 0.0 108.237 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.44 141.9 29.43 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.25 127.69 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 109.191 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -140.72 162.97 34.15 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 17.9 p90 -140.43 159.93 41.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.84 1.256 . . . . 0.0 111.46 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -140.71 112.8 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.939 1.696 . . . . 0.0 109.351 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.33 101.06 54.3 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.265 1.826 . . . . 0.0 108.48 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 163.88 34.49 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.554 2.169 . . . . 0.0 111.756 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.59 -26.72 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.06 114.48 27.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.04 1.336 . . . . 0.0 111.506 -172.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.33 -57.17 4.02 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.325 1.05 . . . . 0.0 113.66 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.13 13.65 12.65 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.908 -1.12 . . . . 0.0 113.807 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.72 -19.26 2.36 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.241 1.816 . . . . 0.0 113.438 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -141.83 169.6 17.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.934 2.893 . . . . 0.0 108.753 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 t -132.95 161.21 34.89 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.017 -1.052 . . . . 0.0 109.867 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -88.53 161.32 17.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.793 0.806 . . . . 0.0 111.415 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -141.58 151.46 43.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.116 0.966 . . . . 0.0 110.688 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.5 p-90 -154.17 157.83 39.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.124 1.37 . . . . 0.0 110.492 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -150.83 146.92 26.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.922 2.089 . . . . 0.0 109.509 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.02 117.88 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.534 1.534 . . . . 0.0 108.797 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -122.42 140.13 53.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.818 1.247 . . . . 0.0 110.471 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -109.38 117.33 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.777 2.031 . . . . 0.0 108.525 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.79 145.43 50.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.164 1.386 . . . . 0.0 112.836 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 p -75.61 79.51 2.6 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.139 1.775 . . . . 0.0 112.661 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.03 173.54 23.92 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.147 1.356 . . . . 0.0 112.82 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 148.99 48.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.876 1.27 . . . . 0.0 111.683 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.8 112.69 2.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.433 1.093 . . . . 0.0 111.622 174.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.38 175.93 9.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.127 0.971 . . . . 0.0 110.564 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.56 99.08 4.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.825 1.65 . . . . 0.0 108.452 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.05 -70.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.108 0.963 . . . . 0.0 110.226 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -67.47 0.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.56 1.144 . . . . 0.0 110.84 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.66 -9.08 84.83 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.429 1.014 . . . . 0.0 115.252 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -43.65 9.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.518 1.127 . . . . 0.0 111.083 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -36.91 83.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.65 1.18 . . . . 0.0 111.299 175.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.74 -29.72 66.94 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.067 -1.02 . . . . 0.0 113.092 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -20.09 63.31 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.717 1.207 . . . . 0.0 112.816 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.08 -50.89 5.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.108 1.363 . . . . 0.0 109.196 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.06 -47.4 84.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -94.44 -13.87 25.78 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.045 0.938 . . . . 0.0 113.103 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.53 -62.85 5.43 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.547 1.07 . . . . 0.0 113.049 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -177.17 78.41 0.25 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 128.392 2.677 . . . . 0.0 108.694 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.3 157.62 60.6 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.493 1.462 . . . . 0.0 110.833 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.97 6.35 41.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.11 65.09 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.732 2.813 . . . . 0.0 113.617 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -44.02 101.56 0.03 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.399 1.952 . . . . 0.0 115.177 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.58 28.29 1.53 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.16 2.184 . . . . 0.0 113.314 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.55 52.75 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.251 1.821 . . . . 0.0 112.849 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -151.59 154.38 25.52 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.276 1.417 . . . . 0.0 113.178 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -62.95 117.05 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.642 1.177 . . . . 0.0 113.31 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -108.09 119.18 38.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.152 2.181 . . . . 0.0 110.966 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.94 133.01 15.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.151 0.98 . . . . 0.0 111.236 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -146.3 130.12 17.16 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.688 1.195 . . . . 0.0 111.981 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.85 107.98 0.79 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.048 1.339 . . . . 0.0 112.277 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.65 -32.34 3.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.009 1.324 . . . . 0.0 112.872 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.28 22.16 6.46 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.049 1.309 . . . . 0.0 114.821 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 56.84 8.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 115.631 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.64 -57.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.328 1.442 . . . . 0.0 111.413 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.64 156.53 17.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.832 0.825 . . . . 0.0 112.18 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.82 168.35 27.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.871 1.668 . . . . 0.0 112.21 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.5 141.46 28.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.878 0.871 . . . . 0.0 110.871 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.16 104.13 7.13 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.33 169.66 24.18 Favored Glycine 0 N--CA 1.454 -0.13 0 CA-C-O 121.888 0.716 . . . . 0.0 114.526 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.78 144.43 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.691 1.196 . . . . 0.0 109.312 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 ttt -141.94 130.16 22.21 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.777 1.231 . . . . 0.0 108.556 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.1 p -88.31 163.05 16.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 110.952 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -96.12 -22.47 17.3 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.45 172.95 4.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.492 1.517 . . . . 0.0 113.165 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.59 -41.8 42.92 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.344 1.45 . . . . 0.0 114.158 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.87 78.34 8.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 111.105 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.41 79.85 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.804 0.841 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.23 149.16 24.85 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 120.868 -1.145 . . . . 0.0 110.549 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.1 ttm -144.58 124.53 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.766 1.227 . . . . 0.0 109.975 -174.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -141.14 139.02 33.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.96 92.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.776 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.24 107.02 17.74 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.319 1.448 . . . . 0.0 108.553 174.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.79 131.37 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 0.0 110.73 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 p -154.51 165.4 36.55 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 128.468 2.707 . . . . 0.0 111.903 175.867 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 57' ' ' VAL . . . -68.27 148.52 50.68 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.806 -1.184 . . . . 0.0 112.287 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.81 36.85 91.32 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.84 0.733 . . . . 0.0 114.2 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -142.28 175.79 9.49 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.908 0.854 . . . . 0.0 112.34 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 pt -118.17 138.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.789 1.636 . . . . 0.0 111.38 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 2' ' ' LEU . 7.5 pt -146.76 174.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.12 1.768 . . . . 0.0 111.587 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 103.53 0.11 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 112.364 175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.42 -25.66 67.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.252 0.93 . . . . 0.0 113.9 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.88 14.79 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -117.43 7.31 12.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.804 1.641 . . . . 0.0 113.218 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 114.48 11.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.513 1.125 . . . . 0.0 112.199 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.6 m -146.25 172.55 13.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.261 1.425 . . . . 0.0 110.601 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.426 ' H ' HG22 ' A' ' 13' ' ' THR . 22.2 m-85 -48.41 -37.64 17.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.935 1.694 . . . . 0.0 114.188 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -56.41 -35.9 68.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.652 1.181 . . . . 0.0 113.302 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.79 -47.48 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.082 1.753 . . . . 0.0 109.643 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.59 -46.18 80.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.393 1.077 . . . . 0.0 113.237 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.16 -42.75 99.49 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.654 -0.654 . . . . 0.0 111.103 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -39.23 72.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.758 1.223 . . . . 0.0 113.516 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.5 -59.55 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.294 1.038 . . . . 0.0 110.601 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.72 -42.24 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.49 1.516 . . . . 0.0 112.406 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.17 -53.34 54.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.176 0.99 . . . . 0.0 112.167 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.35 -42.59 62.06 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.52 -52.38 22.84 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.379 1.872 . . . . 0.0 112.349 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.01 59.79 0.23 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.607 1.098 . . . . 0.0 112.552 -172.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 141.74 6.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.588 1.155 . . . . 0.0 112.516 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -160.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.771 1.628 . . . . 0.0 110.825 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -50.69 -31.91 17.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.238 1.415 . . . . 0.0 113.058 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -146.39 143.78 29.29 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.591 2.357 . . . . 0.0 110.237 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -164.69 153.54 12.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 128.078 2.551 . . . . 0.0 110.185 -173.226 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.518 ' CG2' HG21 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -146.08 150.3 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.822 1.649 . . . . 0.0 109.953 175.45 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.51 123.85 51.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.614 1.166 . . . . 0.0 110.777 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -116.48 123.85 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.602 1.561 . . . . 0.0 110.778 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.67 112.05 0.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.854 1.216 . . . . 0.0 112.3 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 mt -109.18 111.09 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.635 1.174 . . . . 0.0 109.427 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.93 131.15 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.947 0.899 . . . . 0.0 113.228 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.51 93.16 7.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.552 0.741 . . . . 0.0 110.572 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.94 20.37 11.58 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.411 1.485 . . . . 0.0 112.278 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -85.56 -40.94 15.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.815 1.646 . . . . 0.0 114.748 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 12.48 10.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 -173.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.99 161.14 29.46 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.336 1.568 . . . . 0.0 115.05 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -76.99 127.4 32.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.211 1.404 . . . . 0.0 112.122 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -102.86 162.12 13.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.322 1.449 . . . . 0.0 111.62 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -133.46 115.89 15.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.844 1.257 . . . . 0.0 109.439 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.18 137.16 57.44 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.005 -1.059 . . . . 0.0 110.355 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.27 -71.02 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -174.72 176.54 2.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.992 2.117 . . . . 0.0 110.563 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -124.95 154.69 40.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.953 2.101 . . . . 0.0 109.841 175.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.73 106.04 6.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.035 1.334 . . . . 0.0 110.564 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.85 105.02 5.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.791 1.237 . . . . 0.0 111.18 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -78.37 -51.94 9.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.937 1.295 . . . . 0.0 111.692 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -137.27 155.88 48.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.901 2.081 . . . . 0.0 110.361 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 -173.64 52.06 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.722 -0.611 . . . . 0.0 113.329 -174.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -134.88 176.32 8.76 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.641 1.176 . . . . 0.0 110.316 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -150.5 178.12 9.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.525 1.53 . . . . 0.0 110.479 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -139.3 18.15 2.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.179 1.391 . . . . 0.0 112.025 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 3' ' ' ALA . 9.0 m -134.6 171.76 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.892 2.077 . . . . 0.0 110.809 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mt -143.87 132.3 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.377 1.071 . . . . 0.0 109.463 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -75.55 150.17 84.33 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.587 0.63 . . . . 0.0 111.572 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.68 166.3 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.73 2.954 . . . . 0.0 109.928 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 58.3 tt0 -105.81 -30.01 9.67 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.312 -0.868 . . . . 0.0 111.572 174.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -117.26 127.81 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.547 1.139 . . . . 0.0 111.029 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.06 91.31 24.17 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.89 1.276 . . . . 0.0 108.911 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -63.19 162.79 25.24 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.34 2.027 . . . . 0.0 111.483 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -57.61 158.72 5.73 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 72.5 -35.42 0.33 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.941 2.097 . . . . 0.0 114.211 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -86.91 124.71 33.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.08 171.63 8.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.431 1.092 . . . . 0.0 109.493 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.84 163.26 13.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.53 133.27 48.38 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.248 1.819 . . . . 0.0 107.824 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.8 167.22 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 110.438 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -156.52 160.41 39.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.57 0.7 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 127.41 3.24 Favored Glycine 0 N--CA 1.462 0.415 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.32 167.16 15.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.223 1.012 . . . . 0.0 110.082 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 179.98 1.49 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 109.886 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -172.67 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.824 1.649 . . . . 0.0 111.357 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.1 m -25.94 -56.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 127.312 2.245 . . . . 0.0 115.238 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.43 -57.07 0.41 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.596 1.093 . . . . 0.0 113.831 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.79 -2.34 11.76 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.621 3.548 . . . . 0.0 115.574 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.66 130.84 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.96 1.704 . . . . 0.0 110.792 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.68 88.6 5.44 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.567 -1.333 . . . . 0.0 111.959 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.4 m -122.83 -86.51 0.65 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 111.522 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.41 -177.97 42.74 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.781 1.173 . . . . 0.0 112.938 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.52 108.65 6.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.063 0.945 . . . . 0.0 111.012 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.93 119.63 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.987 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.42 171.45 14.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.995 0.902 . . . . 0.0 111.587 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.09 40.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.312 1.045 . . . . 0.0 111.716 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.38 175.76 11.54 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.711 1.605 . . . . 0.0 110.415 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -133.95 140.87 47.04 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.833 1.253 . . . . 0.0 110.602 176.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -123.89 113.53 18.62 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.58 1.152 . . . . 0.0 111.356 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.39 118.71 15.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.765 1.626 . . . . 0.0 110.691 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.7 mtt -73.06 163.53 28.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 112.181 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -62.52 -21.03 65.22 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.76 1.224 . . . . 0.0 113.884 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.71 -16.22 39.71 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.76 1.624 . . . . 0.0 113.515 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.38 2.12 47.51 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.192 1.377 . . . . 0.0 115.647 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -86.23 173.53 9.71 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.738 1.215 . . . . 0.0 110.421 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.443 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 26.1 m -136.04 143.22 44.58 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.144 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.15 115.76 30.71 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 135.12 15.13 Favored Glycine 0 N--CA 1.463 0.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 117' ' ' VAL . 6.0 m -137.2 126.85 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 118.049 0.925 . . . . 0.0 109.704 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.3 153.65 51.1 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.717 0.807 . . . . 0.0 110.673 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 13.4 p90 -135.01 154.55 51.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.749 . . . . 0.0 111.991 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -137.08 109.55 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 110.773 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.518 HG21 ' CG2' ' A' ' 31' ' ' ILE . 58.4 t -110.7 106.17 57.58 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 124.527 1.131 . . . . 0.0 110.257 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.18 161.81 39.99 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.944 2.429 . . . . 0.0 112.007 174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.0 -28.23 64.27 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.783 0.833 . . . . 0.0 112.807 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.36 120.86 41.21 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.471 1.508 . . . . 0.0 110.955 -170.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -73.93 -63.91 1.12 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.81 9.23 19.71 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.884 -1.135 . . . . 0.0 114.031 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -5.62 6.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.259 2.224 . . . . 0.0 112.225 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 138.75 10.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.678 1.991 . . . . 0.0 109.583 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -103.27 159.56 15.45 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.07 -1.019 . . . . 0.0 110.031 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -80.23 161.69 25.03 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.866 -0.521 . . . . 0.0 109.738 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -139.51 143.53 37.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.708 0.803 . . . . 0.0 110.804 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -155.06 149.77 26.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.658 1.583 . . . . 0.0 110.239 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -149.01 154.72 39.75 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.993 1.717 . . . . 0.0 107.675 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 100' ' ' VAL . 66.7 t -147.37 116.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 126.87 2.068 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -123.39 148.15 46.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.542 1.537 . . . . 0.0 110.096 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 mt -110.97 112.57 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 108.821 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -127.39 136.39 51.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 112.2 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.1 p -76.67 81.68 3.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.324 1.45 . . . . 0.0 112.58 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.35 178.6 45.31 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.27 0.938 . . . . 0.0 113.645 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -111.78 104.99 13.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.497 1.919 . . . . 0.0 110.885 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -145.81 158.14 43.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.918 1.287 . . . . 0.0 111.228 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.25 163.97 29.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.125 1.37 . . . . 0.0 112.527 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.57 79.07 1.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.633 1.173 . . . . 0.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.21 -67.37 0.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.057 1.343 . . . . 0.0 109.576 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -149.3 -72.56 0.18 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.368 1.867 . . . . 0.0 108.801 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.9 64.59 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.94 1.257 . . . . 0.0 114.732 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.3 ttp -83.85 -57.83 3.05 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.288 1.044 . . . . 0.0 110.409 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -48.85 -49.83 37.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.083 1.353 . . . . 0.0 111.638 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -62.36 -32.25 73.01 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.01 -13.55 62.28 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.155 -0.965 . . . . 0.0 113.12 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.01 -47.96 5.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.445 1.498 . . . . 0.0 109.456 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.06 -61.51 2.0 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.637 -1.29 . . . . 0.0 112.35 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.58 -19.89 48.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 111.658 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.39 -80.91 0.07 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.334 1.445 . . . . 0.0 112.828 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.36 86.29 0.89 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.318 1.447 . . . . 0.0 110.529 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.62 160.2 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.696 1.597 . . . . 0.0 111.709 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.94 1.01 39.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.52 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 33.87 60.03 0.54 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.796 2.438 . . . . 0.0 114.25 176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -20.23 82.4 0.0 OUTLIER Glycine 0 N--CA 1.472 1.083 0 C-N-CA 129.409 3.385 . . . . 0.0 116.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.0 35.41 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.424 1.49 . . . . 0.0 112.052 -172.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 68.25 26.36 6.96 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.59 1.556 . . . . 0.0 112.245 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.89 146.01 18.0 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.552 1.549 . . . . 0.0 113.3 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -65.97 138.15 57.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.858 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.67 118.04 18.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.041 1.736 . . . . 0.0 110.641 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.97 145.64 32.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.296 1.438 . . . . 0.0 110.903 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -146.31 121.83 10.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.248 1.419 . . . . 0.0 110.549 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.09 91.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.682 1.593 . . . . 0.0 113.358 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.96 4.5 1.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.32 22.57 31.83 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.578 -1.326 . . . . 0.0 115.881 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.52 7.69 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.597 1.959 . . . . 0.0 115.39 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.38 -36.71 0.19 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.764 -1.21 . . . . 0.0 114.365 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.0 mp -129.48 147.64 51.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.02 1.328 . . . . 0.0 110.681 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 173.94 9.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.122 1.369 . . . . 0.0 111.956 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.17 139.96 38.48 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.69 1.596 . . . . 0.0 109.56 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -131.76 107.75 8.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.567 1.547 . . . . 0.0 108.086 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.9 171.57 19.17 Favored Glycine 0 CA--C 1.517 0.217 0 CA-C-O 121.382 0.434 . . . . 0.0 113.477 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.7 143.83 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 124.506 1.122 . . . . 0.0 109.215 176.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.9 ttm -144.17 140.16 29.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.882 1.673 . . . . 0.0 109.014 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.19 157.72 27.8 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.505 2.322 . . . . 0.0 111.562 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.83 5.91 26.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.309 -1.494 . . . . 0.0 114.801 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.43 177.53 4.82 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.703 2.001 . . . . 0.0 112.77 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.67 -67.87 1.99 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.368 0.985 . . . . 0.0 112.269 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 2.9 pt-20 -74.85 39.52 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.536 1.934 . . . . 0.0 115.223 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.03 138.94 58.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.378 1.071 . . . . 0.0 112.861 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.28 124.35 35.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 109.2 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 17.7 mtp -117.87 107.15 13.76 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.863 1.665 . . . . 0.0 109.971 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -114.96 151.4 34.17 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.521 -0.737 . . . . 0.0 111.358 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.8 96.62 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.733 1.613 . . . . 0.0 110.912 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -84.81 107.86 17.19 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.864 1.666 . . . . 0.0 109.919 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.3 mm -84.51 117.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.401 -0.812 . . . . 0.0 110.089 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 m -141.9 169.95 16.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.471 1.509 . . . . 0.0 113.195 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.355 1.862 . . . . 0.0 111.526 -178.047 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 HG21 ' A' ' 7' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 20' ' ' VAL . . . -71.45 156.38 39.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.696 -1.252 . . . . 0.0 111.484 174.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.06 36.87 90.41 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.33 -168.52 3.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 111.923 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.39 149.14 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.671 1.588 . . . . 0.0 111.29 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 2' ' ' LEU . 1.6 pt -151.25 169.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.343 1.857 . . . . 0.0 112.577 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.44 124.81 17.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.892 1.677 . . . . 0.0 111.755 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.9 48.38 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.284 0.945 . . . . 0.0 113.976 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.99 82.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.916 1.286 . . . . 0.0 112.49 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 -30.92 35.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.832 0.853 . . . . 0.0 112.385 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.61 HD22 ' CB ' ' A' ' 68' ' ' ALA . 7.8 tp -59.66 90.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.625 1.97 . . . . 0.0 113.635 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -146.73 169.29 19.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 0.0 109.368 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 17' ' ' LEU . 2.6 m-85 -43.98 -37.46 2.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.018 1.727 . . . . 0.0 114.735 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.2 -39.24 78.48 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.38 -42.05 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.665 . . . . 0.0 110.74 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.465 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.1 mt -53.79 -47.73 70.5 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.304 1.041 . . . . 0.0 111.386 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.16 -42.55 96.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.437 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -58.79 -39.28 80.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.177 1.391 . . . . 0.0 113.668 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 3' ' ' ALA . 54.2 t -62.8 -55.37 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.548 1.539 . . . . 0.0 109.867 175.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 32' ' ' ALA . 3.3 mp -55.68 -45.9 77.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 0.0 112.49 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.15 -38.04 81.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.05 -43.9 41.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 113.058 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.71 -53.87 41.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.502 1.521 . . . . 0.0 111.173 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.13 63.02 0.11 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.356 0.979 . . . . 0.0 112.516 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -42.89 127.95 4.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 110.653 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.79 -165.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.353 1.861 . . . . 0.0 110.212 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -48.99 -45.46 42.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.647 1.579 . . . . 0.0 114.358 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -139.3 129.7 25.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.469 1.907 . . . . 0.0 109.569 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.43 155.54 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.112 2.165 . . . . 0.0 110.049 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 102' ' ' PHE . 6.2 pt -137.17 162.49 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.173 0.989 . . . . 0.0 111.46 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -110.93 116.22 30.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.835 1.254 . . . . 0.0 109.529 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.63 142.95 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.709 1.203 . . . . 0.0 110.86 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.28 122.55 1.13 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.314 0.959 . . . . 0.0 111.953 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.0 mt -113.04 102.7 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.151 1.38 . . . . 0.0 108.654 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.61 111.81 19.45 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.72 0.808 . . . . 0.0 112.231 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -71.69 99.76 2.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.793 1.237 . . . . 0.0 111.117 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.68 14.31 15.34 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.26 1.824 . . . . 0.0 113.281 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.4 t -70.09 -45.59 66.67 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.93 8.08 5.29 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.234 1.397 . . . . 0.0 116.058 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.67 160.47 29.02 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 119.578 1.689 . . . . 0.0 113.634 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.9 p -73.96 138.87 44.47 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.722 -0.869 . . . . 0.0 112.185 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -112.84 167.05 10.81 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.777 1.231 . . . . 0.0 112.006 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -131.92 105.78 7.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.128 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.5 122.68 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.21 -66.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.34 163.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.211 2.604 . . . . 0.0 110.155 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -108.77 123.91 49.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.349 1.86 . . . . 0.0 110.4 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.95 111.71 19.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.301 1.041 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.26 124.34 26.91 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.993 1.317 . . . . 0.0 111.993 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -47.63 7.26 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.093 1.357 . . . . 0.0 112.241 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -135.37 149.17 49.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.537 1.935 . . . . 0.0 109.951 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.06 -157.5 50.18 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.891 -0.506 . . . . 0.0 113.09 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -152.86 -176.71 5.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.521 0.676 . . . . 0.0 112.2 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -141.97 173.95 11.04 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.183 1.793 . . . . 0.0 111.367 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -121.51 12.79 10.85 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.927 1.291 . . . . 0.0 112.229 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.31 176.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.047 2.139 . . . . 0.0 113.628 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.95 135.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.53 1.932 . . . . 0.0 109.776 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.01 142.48 41.66 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 118.765 0.711 . . . . 0.0 110.606 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.81 164.86 22.85 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.95 3.1 . . . . 0.0 111.117 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -107.55 -17.61 14.06 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.502 -0.749 . . . . 0.0 112.716 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.64 133.97 53.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.956 1.702 . . . . 0.0 111.097 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.88 88.04 23.69 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.896 1.678 . . . . 0.0 108.868 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.42 161.13 32.38 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.919 1.746 . . . . 0.0 112.06 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.44 153.66 34.63 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.407 -0.808 . . . . 0.0 111.448 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 p 66.23 5.04 3.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.692 1.997 . . . . 0.0 114.267 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -123.39 147.81 46.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.621 2.368 . . . . 0.0 110.108 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.61 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -126.57 160.44 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.647 1.179 . . . . 0.0 111.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.16 170.75 8.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.408 0.623 . . . . 0.0 110.335 175.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 20' ' ' VAL . 3.3 mm? -126.44 133.89 51.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.334 1.854 . . . . 0.0 108.877 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -152.82 162.44 41.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.191 1.397 . . . . 0.0 111.536 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -142.37 166.6 24.24 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.769 1.228 . . . . 0.0 110.972 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.75 115.24 0.77 Allowed Glycine 0 N--CA 1.472 1.092 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.769 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 156.22 20.92 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.18 1.49 . . . . 0.0 114.378 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -72.88 110.64 7.34 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.063 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 40.78 -151.19 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.69 1.596 . . . . 0.0 113.664 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -74.14 -49.57 23.17 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.958 -1.714 . . . . 0.0 111.286 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.91 -59.27 0.37 Allowed Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.665 1.126 . . . . 0.0 114.394 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.33 0.15 7.22 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.699 3.599 . . . . 0.0 114.984 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.32 132.48 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 127.599 2.36 . . . . 0.0 109.364 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.82 71.84 0.81 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.034 1.333 . . . . 0.0 110.516 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 m -97.27 -65.03 0.99 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.01 0.924 . . . . 0.0 110.895 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.61 176.41 35.52 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.988 1.28 . . . . 0.0 111.712 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -138.69 108.34 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.065 0.946 . . . . 0.0 110.479 175.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.36 138.9 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.96 0.904 . . . . 0.0 109.585 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.11 161.98 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.967 0.907 . . . . 0.0 110.779 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.43 20.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.786 0.803 . . . . 0.0 112.976 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -132.57 169.0 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.795 1.638 . . . . 0.0 109.446 -172.475 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.98 148.96 47.23 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.42 104.57 6.18 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 111.796 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -73.54 111.82 9.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.084 1.354 . . . . 0.0 111.639 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 160.41 30.72 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 112.317 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 p -60.99 -20.08 62.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 m -84.78 -16.09 42.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.524 1.93 . . . . 0.0 113.84 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.52 4.95 46.13 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.39 0.995 . . . . 0.0 115.565 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.51 165.31 13.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.449 1.5 . . . . 0.0 108.757 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -136.32 151.11 49.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 109.566 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.38 130.55 56.57 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.278 0.631 . . . . 0.0 110.354 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.21 138.74 18.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.5 t -136.02 118.0 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.354 1.062 . . . . 0.0 108.816 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptm -121.46 156.89 31.8 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -124.39 141.03 52.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.104 1.362 . . . . 0.0 108.852 174.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -130.63 104.37 7.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.907 0.883 . . . . 0.0 110.75 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 t -115.61 101.57 54.21 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.007 2.123 . . . . 0.0 109.119 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.39 168.07 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.273 1.982 . . . . 0.0 110.454 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -75.37 -41.33 56.69 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.707 -0.621 . . . . 0.0 110.32 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.35 121.86 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.637 1.175 . . . . 0.0 111.954 -166.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -72.83 -59.83 2.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -91.29 9.44 31.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -4.37 5.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.023 2.129 . . . . 0.0 112.538 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.71 158.34 36.76 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.791 2.436 . . . . 0.0 109.111 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 169.36 10.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.826 -1.171 . . . . 0.0 111.602 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.26 148.36 25.14 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.752 -0.592 . . . . 0.0 110.445 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.51 157.63 44.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.035 0.534 . . . . 0.0 112.351 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -161.67 136.83 7.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.411 1.484 . . . . 0.0 110.396 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.76 147.51 48.62 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.28 118.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.099 1.36 . . . . 0.0 110.623 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.23 138.23 53.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.1 1.76 . . . . 0.0 109.452 174.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.4 mt -109.37 119.66 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.178 1.791 . . . . 0.0 108.543 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 147.61 52.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 0.0 112.555 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 p -74.0 80.97 1.7 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.652 1.981 . . . . 0.0 112.27 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.29 -166.8 37.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.705 -0.622 . . . . 0.0 114.393 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -113.18 115.87 28.93 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.384 1.874 . . . . 0.0 111.361 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -134.09 83.76 2.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.043 2.537 . . . . 0.0 108.46 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 168.36 5.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.657 1.183 . . . . 0.0 110.95 177.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.19 99.04 8.5 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 111.15 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -106.67 -70.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.112 0.965 . . . . 0.0 110.706 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -150.0 -68.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.167 1.787 . . . . 0.0 109.811 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.39 -24.26 77.11 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.386 0.993 . . . . 0.0 114.893 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -76.33 -56.63 4.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.266 1.033 . . . . 0.0 109.82 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -35.51 63.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.859 0.864 . . . . 0.0 111.429 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.06 -34.0 54.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -61.43 -41.26 96.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.903 0.881 . . . . 0.0 111.093 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.79 -38.0 73.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.858 -1.152 . . . . 0.0 111.715 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -74.06 -51.73 14.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -88.0 -17.89 30.22 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 113.079 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.87 -80.24 0.08 OUTLIER Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.711 1.148 . . . . 0.0 112.066 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -170.15 74.78 0.63 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.74 1.616 . . . . 0.0 110.968 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.19 135.37 31.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 119.918 1.006 . . . . 0.0 109.788 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -60.19 156.86 14.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.743 1.217 . . . . 0.0 110.439 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -93.36 5.01 53.01 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -165.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 53.95 55.61 24.98 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.559 1.076 . . . . 0.0 112.654 -172.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.33 24.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.571 1.548 . . . . 0.0 114.901 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.252 10.1 p30 48.31 34.45 4.6 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.665 2.386 . . . . 0.0 115.021 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.38 159.62 26.75 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.912 1.72 . . . . 0.0 112.058 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -61.78 127.37 31.12 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 110.934 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -122.91 105.67 10.2 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.144 1.778 . . . . 0.0 109.637 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -138.38 137.12 36.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.579 1.952 . . . . 0.0 110.89 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -147.8 133.44 18.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.264 1.426 . . . . 0.0 110.964 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -58.9 123.96 18.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.995 0.518 . . . . 0.0 111.347 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 tt -147.6 -34.29 0.25 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.182 0.993 . . . . 0.0 112.342 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.71 19.7 5.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.182 1.372 . . . . 0.0 114.748 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 t80 60.06 9.27 1.75 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.799 2.44 . . . . 0.0 114.966 -175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.74 -71.38 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.403 1.478 . . . . 0.0 110.74 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.53 151.43 21.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.949 0.88 . . . . 0.0 111.419 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.55 171.32 14.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.72 1.608 . . . . 0.0 111.527 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -87.15 147.09 25.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.512 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -137.07 103.39 5.12 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.894 2.078 . . . . 0.0 108.506 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -133.02 169.43 22.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-O 121.593 0.552 . . . . 0.0 112.884 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.61 141.06 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.905 1.682 . . . . 0.0 108.769 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.4 ttt -144.35 140.48 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 171.94 14.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.098 0.959 . . . . 0.0 111.553 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.0 p -93.67 7.71 43.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.52 1.528 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.22 165.22 12.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.635 1.974 . . . . 0.0 112.063 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.87 -55.29 29.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.209 0.909 . . . . 0.0 113.784 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.09 59.39 2.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 113.251 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.06 171.81 7.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.905 1.282 . . . . 0.0 112.859 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.465 ' HB3' HD13 ' A' ' 17' ' ' LEU . 10.0 mptt -120.71 141.61 50.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 108.421 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.8 ttp -133.88 83.7 2.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.076 1.35 . . . . 0.0 111.014 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.39 158.17 20.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.452 0.644 . . . . 0.0 111.524 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.94 122.02 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.866 2.067 . . . . 0.0 108.419 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -113.39 103.81 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.571 2.348 . . . . 0.0 108.941 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.36 119.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.437 -0.79 . . . . 0.0 110.802 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 p -152.13 169.27 22.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.376 1.07 . . . . 0.0 112.956 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.729 2.411 . . . . 0.0 112.934 176.956 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -58.0 150.93 19.57 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.82 -1.175 . . . . 0.0 111.683 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.28 49.13 34.32 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.425 0.535 . . . . 0.0 113.687 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.5 p -146.78 -166.38 2.48 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.193 0.997 . . . . 0.0 112.115 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.02 132.26 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.68 2.392 . . . . 0.0 110.74 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 pt -142.46 170.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.461 1.504 . . . . 0.0 111.777 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 111.19 1.02 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.484 1.114 . . . . 0.0 112.185 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.25 -24.33 67.23 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.424 1.011 . . . . 0.0 113.363 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.61 78.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.786 1.234 . . . . 0.0 111.983 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.5 -24.83 22.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.82 1.248 . . . . 0.0 113.196 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.6 tp -59.23 110.36 1.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.266 1.426 . . . . 0.0 111.534 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 m -146.78 168.16 22.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.654 1.582 . . . . 0.0 109.669 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.23 1.812 . . . . 0.0 113.814 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -58.01 -35.8 71.77 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -73.63 -46.05 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.494 1.518 . . . . 0.0 109.859 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.5 mt -54.48 -44.88 73.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 0.0 113.008 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.17 -39.09 88.81 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.714 0.406 . . . . 0.0 111.927 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -50.21 74.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.013 1.325 . . . . 0.0 111.622 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 74.8 t -53.51 -50.04 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.766 1.226 . . . . 0.0 111.994 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 32' ' ' ALA . 5.7 mp -60.11 -41.87 93.53 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.212 1.005 . . . . 0.0 112.359 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -43.68 90.78 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 110.781 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.38 -31.01 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.163 1.785 . . . . 0.0 114.271 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.3 tp -66.81 -51.48 55.23 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.697 1.199 . . . . 0.0 110.014 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.25 54.62 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.103 1.335 . . . . 0.0 111.991 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -43.54 129.1 5.26 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.713 1.605 . . . . 0.0 112.817 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -164.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.183 1.393 . . . . 0.0 112.144 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.0 t -42.43 -33.02 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.993 2.517 . . . . 0.0 113.958 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -153.31 137.89 16.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.599 1.96 . . . . 0.0 109.804 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 155.69 20.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.688 2.395 . . . . 0.0 110.416 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -135.49 152.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.531 1.132 . . . . 0.0 109.509 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -111.06 122.75 48.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.171 0.988 . . . . 0.0 108.365 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.0 135.47 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.593 1.157 . . . . 0.0 110.803 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.33 129.55 3.39 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.177 0.894 . . . . 0.0 111.82 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mm -117.87 103.33 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.046 0.938 . . . . 0.0 109.742 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.96 122.45 27.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.899 1.28 . . . . 0.0 113.304 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.88 96.21 3.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.437 1.895 . . . . 0.0 112.02 175.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -123.83 30.81 6.05 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 112.137 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.7 t -91.96 -48.12 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.916 1.687 . . . . 0.0 114.142 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.07 17.73 4.02 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.288 0.947 . . . . 0.0 115.453 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.22 159.92 31.62 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.039 1.42 . . . . 0.0 114.125 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -70.51 135.83 48.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.079 0.952 . . . . 0.0 111.858 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -109.95 168.43 9.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.449 1.5 . . . . 0.0 111.382 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.3 m -134.61 107.14 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 109.108 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.64 124.96 24.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.911 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.89 -64.87 0.78 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.307 0.643 . . . . 0.0 109.966 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.63 172.24 0.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.825 2.45 . . . . 0.0 110.736 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.95 135.84 48.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.446 2.298 . . . . 0.0 110.105 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -124.3 114.83 20.08 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 111.361 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -72.0 106.95 4.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.485 1.514 . . . . 0.0 112.357 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -50.02 44.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.131 1.773 . . . . 0.0 110.71 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -136.0 155.95 49.48 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.518 1.527 . . . . 0.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.75 -156.51 39.85 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 123.042 0.353 . . . . 0.0 113.395 -172.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -154.21 -176.17 5.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 110.534 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 73' ' ' GLY . 17.2 p -139.37 -179.31 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.49 1.516 . . . . 0.0 111.384 174.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.63 12.87 13.24 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.639 1.176 . . . . 0.0 111.586 174.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 3' ' ' ALA . 3.0 m -132.13 175.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.154 1.781 . . . . 0.0 113.151 -170.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 134.86 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.392 1.477 . . . . 0.0 110.091 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.44 141.12 56.51 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.256 -0.902 . . . . 0.0 110.601 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.84 163.68 32.51 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.045 3.163 . . . . 0.0 111.091 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -104.83 -21.22 13.37 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.816 -1.178 . . . . 0.0 112.945 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -126.51 137.14 53.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.127 1.371 . . . . 0.0 110.155 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.54 97.99 7.31 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 110.257 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -64.57 162.12 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.682 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.88 154.3 9.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.615 -0.678 . . . . 0.0 111.584 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m 72.03 -23.55 0.19 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.978 1.711 . . . . 0.0 113.83 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -95.89 126.87 41.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.707 1.603 . . . . 0.0 110.714 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.41 171.94 8.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.009 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -110.24 169.07 8.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.47 133.47 52.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.516 1.527 . . . . 0.0 110.505 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.96 166.73 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.129 0.971 . . . . 0.0 111.09 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 p -160.46 170.22 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.53 1.132 . . . . 0.0 110.635 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -151.71 137.27 5.89 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.664 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.55 161.42 30.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.123 1.462 . . . . 0.0 112.529 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -70.7 113.03 7.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t0 32.31 -136.8 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.565 2.346 . . . . 0.0 114.138 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -61.64 -46.18 90.89 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.5 -1.375 . . . . 0.0 111.053 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.57 -58.58 0.45 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.025 -0.875 . . . . 0.0 115.079 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -71.77 8.08 1.41 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 125.207 3.938 . . . . 0.0 115.44 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.84 132.92 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.001 2.52 . . . . 0.0 110.561 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.63 88.45 3.07 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.544 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -114.77 -84.69 0.61 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.164 1.786 . . . . 0.0 110.866 178.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 82' ' ' THR . . . 172.61 173.68 39.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 127.262 2.363 . . . . 0.0 110.802 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.63 109.41 7.1 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.584 1.154 . . . . 0.0 109.442 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.49 126.71 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 120.789 -1.194 . . . . 0.0 108.259 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.35 169.01 24.71 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.78 157.78 43.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.17 0.988 . . . . 0.0 111.603 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.17 169.9 20.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.895 1.678 . . . . 0.0 110.657 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.98 146.67 41.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.048 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -127.78 115.82 19.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.906 1.283 . . . . 0.0 111.525 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -81.08 112.61 18.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.194 1.398 . . . . 0.0 111.0 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.8 mtp -74.01 158.06 35.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.963 0.905 . . . . 0.0 111.414 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -62.35 -18.85 62.53 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.7 m -80.23 -15.34 57.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 113.739 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.26 55.2 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.668 1.128 . . . . 0.0 115.194 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -85.62 166.7 16.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.194 0.998 . . . . 0.0 110.384 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -137.08 153.53 50.54 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 110.73 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.62 134.14 53.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 108.991 174.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.63 8.48 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 117' ' ' VAL . 2.6 m -126.76 137.29 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 117.537 0.668 . . . . 0.0 110.488 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.31 161.31 35.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.648 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.04 142.54 47.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.983 1.313 . . . . 0.0 109.516 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -127.16 114.25 17.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.757 1.623 . . . . 0.0 109.086 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.85 92.61 48.35 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.478 1.511 . . . . 0.0 108.931 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.29 167.97 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.165 2.576 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.42 -23.69 37.38 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.626 -0.671 . . . . 0.0 112.437 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.54 111.93 24.81 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.327 -1.483 . . . . 0.0 112.392 -165.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.21 -51.81 22.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.39 12.34 29.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.51 1.124 . . . . 0.0 113.575 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.14 -11.0 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.491 1.917 . . . . 0.0 112.716 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.32 175.92 11.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.722 2.809 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m -145.86 164.86 30.63 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.492 -1.38 . . . . 0.0 111.167 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.04 138.16 34.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 110.276 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 152.61 49.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.315 0.507 . . . . 0.0 112.063 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -159.32 146.76 17.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.423 1.889 . . . . 0.0 110.634 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.32 149.47 49.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.148 1.379 . . . . 0.0 110.154 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 100' ' ' VAL . 22.5 t -145.77 105.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.315 1.046 . . . . 0.0 111.481 177.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -117.42 134.03 55.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.111 1.364 . . . . 0.0 110.365 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -97.75 112.39 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.296 1.438 . . . . 0.0 109.355 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -115.17 147.83 39.79 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.873 1.669 . . . . 0.0 112.826 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 p -75.74 82.59 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.739 1.615 . . . . 0.0 112.881 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.81 -173.91 36.57 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.529 1.061 . . . . 0.0 113.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -112.4 130.82 55.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.471 1.509 . . . . 0.0 111.59 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -153.24 163.97 38.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.594 1.157 . . . . 0.0 112.2 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -139.36 148.87 43.47 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.603 1.561 . . . . 0.0 111.621 -171.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.99 90.69 0.64 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.245 1.018 . . . . 0.0 111.957 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.15 -68.57 0.92 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.517 1.527 . . . . 0.0 110.812 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -144.37 -76.19 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.533 1.933 . . . . 0.0 108.959 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.8 -28.54 73.51 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.381 0.991 . . . . 0.0 114.701 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -57.46 5.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.086 0.943 . . . . 0.0 109.576 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -52.25 -40.87 62.27 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.921 1.289 . . . . 0.0 111.107 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -55.48 -43.28 75.42 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.641 -0.662 . . . . 0.0 112.734 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 -19.43 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.977 -1.077 . . . . 0.0 112.346 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.4 mt -91.37 -55.57 3.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.557 1.543 . . . . 0.0 111.435 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -74.82 -46.32 37.47 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.341 -0.85 . . . . 0.0 113.029 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.17 -17.47 30.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.232 -0.917 . . . . 0.0 111.121 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.76 52.5 4.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.357 0.979 . . . . 0.0 114.132 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 36.05 72.44 0.77 Allowed Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.623 2.369 . . . . 0.0 114.133 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 140.14 57.76 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.936 1.757 . . . . 0.0 109.027 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 143.77 55.73 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.81 0.844 . . . . 0.0 109.528 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 12.88 21.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.831 1.252 . . . . 0.0 113.818 -166.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 58.32 57.68 18.54 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.204 0.907 . . . . 0.0 112.145 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -72.57 33.96 0.07 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.802 1.241 . . . . 0.0 114.217 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.0 p30 45.97 34.24 1.91 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.833 2.853 . . . . 0.0 115.791 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -145.66 167.41 27.61 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.031 1.776 . . . . 0.0 112.262 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.96 123.48 21.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.417 0.687 . . . . 0.0 110.53 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -119.71 116.75 26.59 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.082 1.753 . . . . 0.0 108.684 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.09 131.69 15.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.989 1.316 . . . . 0.0 110.735 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -141.84 122.58 14.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.717 1.207 . . . . 0.0 110.72 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.19 115.57 3.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.445 0.698 . . . . 0.0 111.486 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.48 -36.42 0.98 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -77.73 22.49 2.78 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.118 1.342 . . . . 0.0 114.672 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 t80 58.01 10.74 1.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.245 2.618 . . . . 0.0 115.177 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.86 -60.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.929 1.728 . . . . 0.0 110.178 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.83 150.29 21.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 122.062 0.935 . . . . 0.0 112.479 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 163.1 35.18 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.413 1.885 . . . . 0.0 111.402 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.12 151.39 29.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.436 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -143.44 110.98 5.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.502 1.921 . . . . 0.0 108.262 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.7 32.47 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-O 121.642 0.579 . . . . 0.0 114.071 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.79 141.04 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.081 1.752 . . . . 0.0 109.311 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.7 ttt -144.84 142.41 29.91 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.25 1.82 . . . . 0.0 107.887 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.22 165.71 22.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.955 0.902 . . . . 0.0 111.042 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.93 14.97 12.35 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.609 1.164 . . . . 0.0 112.875 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.26 167.52 11.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 111.661 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.92 -59.94 8.83 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.943 0.783 . . . . 0.0 114.492 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -76.4 40.85 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.443 1.497 . . . . 0.0 114.254 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.04 157.3 35.06 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.847 1.259 . . . . 0.0 112.702 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -103.11 140.49 37.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 108.43 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.9 ttp -132.04 116.53 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.582 1.553 . . . . 0.0 109.461 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 138.8 43.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.7 106.76 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.208 1.403 . . . . 0.0 108.556 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -94.81 105.34 17.26 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.966 2.106 . . . . 0.0 109.204 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.27 124.97 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.4 m -128.28 177.1 7.18 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.571 1.148 . . . . 0.0 111.771 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 128.261 2.625 . . . . 0.0 113.342 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -55.31 139.62 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.907 1.283 . . . . 0.0 111.985 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.79 40.85 8.54 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.099 0.857 . . . . 0.0 114.278 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 p -146.38 -165.69 2.28 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.571 1.185 . . . . 0.0 111.945 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.98 143.86 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.365 1.866 . . . . 0.0 110.487 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.19 165.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.297 . . . . 0.0 112.248 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 119.37 6.72 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.799 1.24 . . . . 0.0 111.066 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.07 -18.73 42.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.195 0.902 . . . . 0.0 113.897 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.92 -38.05 76.13 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.953 1.301 . . . . 0.0 111.735 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -31.33 27.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.843 1.257 . . . . 0.0 112.444 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.562 HD22 ' CB ' ' A' ' 68' ' ' ALA . 10.5 tp -50.02 100.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.61 1.964 . . . . 0.0 112.422 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -145.79 164.78 30.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.216 1.406 . . . . 0.0 109.843 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -46.95 -40.24 13.93 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.443 1.497 . . . . 0.0 114.125 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.54 -47.31 86.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.166 0.586 . . . . 0.0 112.197 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.1 t -57.0 -48.66 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.804 0.841 . . . . 0.0 109.547 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.32 -47.04 76.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.629 0.771 . . . . 0.0 112.669 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.05 -42.97 88.8 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.686 -0.633 . . . . 0.0 112.366 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.15 -42.46 77.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.299 1.44 . . . . 0.0 112.917 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' VAL . 89.1 t -51.77 -57.04 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.57 1.548 . . . . 0.0 109.721 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.501 HD23 ' HD2' ' A' ' 30' ' ' LYS . 5.0 mp -62.11 -38.22 88.07 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.618 1.567 . . . . 0.0 113.108 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -49.5 76.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.634 -0.666 . . . . 0.0 111.599 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.47 -15.83 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HH12 ' A' ' 74' ' ' ARG . 27.7 tp -65.39 -53.72 39.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.816 2.046 . . . . 0.0 112.841 175.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.55 29.57 7.74 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 174.82 0.14 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.928 2.091 . . . . 0.0 114.671 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 28' ' ' SER . 1.4 p -103.38 -168.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.487 1.915 . . . . 0.0 111.049 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 27' ' ' VAL . 66.1 m -49.59 -28.01 5.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.94 53.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.762 1.625 . . . . 0.0 109.601 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -171.43 146.19 2.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 112.154 -167.553 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -141.66 152.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.097 1.359 . . . . 0.0 110.167 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.61 114.4 24.04 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 109.661 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 t -102.08 137.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.845 1.258 . . . . 0.0 110.38 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.66 114.59 0.71 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.048 0.832 . . . . 0.0 113.384 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.72 106.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.47 1.108 . . . . 0.0 110.573 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -89.3 104.65 17.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.846 1.658 . . . . 0.0 112.306 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -72.98 105.46 4.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.125 1.77 . . . . 0.0 111.333 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.5 22.51 8.37 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.611 1.964 . . . . 0.0 112.606 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -84.8 -29.22 25.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.549 1.54 . . . . 0.0 114.679 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.64 20.4 8.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.047 1.784 . . . . 0.0 115.391 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.49 17.38 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 118.984 1.392 . . . . 0.0 114.408 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -66.36 141.12 58.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.169 0.988 . . . . 0.0 112.812 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -115.07 170.71 8.15 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.919 1.688 . . . . 0.0 111.499 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 m -135.39 110.2 8.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 108.912 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.37 50.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.52 -1.362 . . . . 0.0 109.969 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -71.11 -68.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.525 0.73 . . . . 0.0 109.791 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.92 174.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.677 2.391 . . . . 0.0 110.58 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -127.6 144.18 51.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.541 2.337 . . . . 0.0 108.797 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.19 110.97 11.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.546 1.139 . . . . 0.0 110.269 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.61 121.63 18.25 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.262 1.025 . . . . 0.0 111.165 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.27 -41.42 8.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.964 1.306 . . . . 0.0 112.372 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m -138.29 149.35 45.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.578 1.151 . . . . 0.0 110.685 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.07 54.2 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.158 0.408 . . . . 0.0 113.163 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -151.99 175.0 12.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.933 0.893 . . . . 0.0 111.196 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.556 HG22 ' HA2' ' A' ' 73' ' ' GLY . 23.7 p -140.45 177.11 8.24 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.236 1.414 . . . . 0.0 111.336 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -127.22 16.09 7.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.652 1.181 . . . . 0.0 112.684 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 3' ' ' ALA . 15.5 m -134.55 176.85 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.711 2.004 . . . . 0.0 112.745 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.25 137.07 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.484 1.914 . . . . 0.0 109.467 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.3 154.76 82.11 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 119.902 1.228 . . . . 0.0 112.333 176.098 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.97 165.32 31.59 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 124.026 3.15 . . . . 0.0 109.58 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.87 -18.02 14.04 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.1 144.13 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.492 1.517 . . . . 0.0 110.161 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.51 92.66 5.49 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.88 1.272 . . . . 0.0 110.287 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.16 155.26 66.1 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.769 1.646 . . . . 0.0 111.362 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.3 155.16 12.09 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.094 -0.379 . . . . 0.0 111.095 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m 74.4 -22.42 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.236 1.814 . . . . 0.0 113.027 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -99.47 146.38 26.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.925 1.69 . . . . 0.0 109.016 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -115.53 162.3 17.38 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.769 1.228 . . . . 0.0 111.934 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 167.78 10.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.446 174.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.75 126.74 43.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.899 2.48 . . . . 0.0 108.652 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -144.37 151.22 38.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.823 0.849 . . . . 0.0 110.97 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -155.76 157.51 36.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.733 0.813 . . . . 0.0 110.883 -174.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -150.4 166.66 30.15 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.199 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.458 HH12 HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -139.85 158.01 44.79 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.86 1.33 . . . . 0.0 113.064 -174.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 ptmm? -74.96 113.75 12.63 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 39.62 -147.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.646 1.578 . . . . 0.0 113.887 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.7 m -77.72 -47.73 18.38 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.496 -1.378 . . . . 0.0 111.334 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.85 -60.53 0.36 Allowed Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.819 -0.989 . . . . 0.0 114.455 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.29 -2.51 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.612 3.541 . . . . 0.0 114.974 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.42 142.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.007 1.723 . . . . 0.0 108.705 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.94 69.15 1.19 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 0.0 110.982 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.4 m -96.65 -61.62 1.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.144 0.978 . . . . 0.0 111.335 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.88 172.15 31.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.737 1.16 . . . . 0.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -134.96 111.45 9.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.744 1.218 . . . . 0.0 110.364 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.57 135.82 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.969 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.76 162.33 40.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.107 1.363 . . . . 0.0 110.594 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.51 40.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.406 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.12 171.66 13.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.247 1.819 . . . . 0.0 110.365 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -139.72 152.0 46.31 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.971 177.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -128.18 117.14 21.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 110.715 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -79.56 110.56 15.0 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.444 1.498 . . . . 0.0 110.872 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 73.8 mtm -78.77 160.07 27.59 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.8 p -60.75 -17.76 50.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -73.75 -14.53 61.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.956 . . . . 0.0 112.491 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.52 7.46 72.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.689 1.138 . . . . 0.0 113.982 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -92.85 163.61 13.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.019 1.328 . . . . 0.0 109.736 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.428 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 54.1 m -125.19 152.74 44.1 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.121 0.968 . . . . 0.0 109.802 175.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.94 131.95 53.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.765 0.826 . . . . 0.0 109.904 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.52 140.77 19.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.64 126.33 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.666 1.186 . . . . 0.0 109.283 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.86 157.21 45.61 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 112.058 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.79 139.42 53.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.143 1.377 . . . . 0.0 110.554 175.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 m -127.27 114.12 17.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.708 1.203 . . . . 0.0 109.76 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 98.7 t -119.05 99.77 50.8 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.322 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.81 172.23 16.69 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.235 1.957 . . . . 0.0 110.102 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.99 -59.51 2.69 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.297 -0.877 . . . . 0.0 111.418 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.32 122.22 17.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.757 2.023 . . . . 0.0 112.489 -167.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.54 -52.25 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.184 -0.948 . . . . 0.0 113.209 -175.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -87.89 -4.51 58.84 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.95 1.3 . . . . 0.0 113.465 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.8 -4.13 7.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 112.074 -164.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.43 167.58 29.55 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.741 2.816 . . . . 0.0 108.414 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.6 m -141.19 166.83 23.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -81.78 157.17 24.59 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.377 -0.827 . . . . 0.0 110.514 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -142.3 153.34 43.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.179 0.991 . . . . 0.0 110.587 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -152.16 159.8 43.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.564 1.546 . . . . 0.0 110.945 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.31 150.46 25.33 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -147.34 143.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 125.632 1.573 . . . . 0.0 110.354 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -149.04 146.55 27.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.168 1.787 . . . . 0.0 108.959 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.17 118.41 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.999 1.72 . . . . 0.0 108.89 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.81 148.3 44.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.768 1.627 . . . . 0.0 112.827 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.4 p -77.7 80.96 4.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.568 1.547 . . . . 0.0 112.912 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.84 179.98 27.94 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.081 1.324 . . . . 0.0 112.958 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 126.23 36.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.835 1.654 . . . . 0.0 111.367 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -135.29 147.38 49.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.116 2.166 . . . . 0.0 108.538 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -115.24 179.93 3.82 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.435 1.494 . . . . 0.0 110.063 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.47 94.02 4.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.163 0.985 . . . . 0.0 110.093 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.84 -69.95 0.79 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.931 0.893 . . . . 0.0 109.429 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -147.55 -69.4 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.984 1.314 . . . . 0.0 109.771 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.97 -28.8 73.94 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.457 1.027 . . . . 0.0 115.319 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -53.72 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.327 1.063 . . . . 0.0 110.249 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.48 -38.77 75.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.529 1.132 . . . . 0.0 111.148 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.98 -44.29 74.31 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.42 -0.8 . . . . 0.0 111.288 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -24.0 67.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.168 0.987 . . . . 0.0 113.128 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.09 -55.69 4.93 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.66 -48.25 81.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.998 1.319 . . . . 0.0 113.377 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -86.74 -11.72 50.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.7 0.8 . . . . 0.0 113.054 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.18 -71.69 0.69 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.104 0.859 . . . . 0.0 112.039 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.32 82.14 1.15 Allowed Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.604 1.561 . . . . 0.0 109.949 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.35 143.71 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.555 1.504 . . . . 0.0 110.885 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -81.37 4.46 20.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.01 1.324 . . . . 0.0 113.563 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 57.72 10.95 1.18 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.74 2.816 . . . . 0.0 116.067 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 48.5 47.78 28.78 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.943 1.258 . . . . 0.0 112.611 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.92 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.25 12.2 p30 48.71 27.55 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.736 2.815 . . . . 0.0 115.711 178.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.16 151.44 20.76 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.718 1.628 . . . . 0.0 112.236 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -57.89 131.08 49.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 111.938 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -124.22 114.19 19.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.335 1.854 . . . . 0.0 110.132 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.57 131.05 12.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.984 1.314 . . . . 0.0 111.986 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -144.57 126.0 14.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.34 1.856 . . . . 0.0 110.645 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.95 101.28 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.261 1.025 . . . . 0.0 113.051 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -124.92 -26.39 3.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.829 1.251 . . . . 0.0 113.467 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.45 13.97 43.35 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.926 1.251 . . . . 0.0 114.679 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 t80 61.0 7.77 1.65 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.619 2.367 . . . . 0.0 114.964 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.1 -57.46 0.04 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.075 1.321 . . . . 0.0 112.066 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.05 155.74 19.1 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.9 166.37 26.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.485 1.914 . . . . 0.0 112.169 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.07 135.29 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.079 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -125.72 101.7 6.99 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.03 169.42 22.11 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-O 121.565 0.536 . . . . 0.0 112.955 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 147.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 109.264 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 31.0 ttp -152.8 144.7 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.483 1.513 . . . . 0.0 107.259 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.2 p -86.65 163.01 17.63 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.865 0.84 . . . . 0.0 111.381 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.2 p -81.47 13.67 2.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.417 1.887 . . . . 0.0 113.121 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.38 151.69 35.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.028 2.531 . . . . 0.0 111.612 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.46 -57.21 16.3 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.145 0.879 . . . . 0.0 114.146 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.67 59.59 2.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 113.832 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.2 176.89 6.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.236 1.414 . . . . 0.0 113.989 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 136.05 48.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.339 1.856 . . . . 0.0 109.052 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.4 ttp -124.96 88.49 2.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.069 1.348 . . . . 0.0 110.801 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -83.67 153.8 24.03 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.553 -0.717 . . . . 0.0 111.746 165.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 57.9 mt -136.08 115.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.184 2.194 . . . . 0.0 106.893 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -113.12 97.14 6.32 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.434 1.894 . . . . 0.0 108.872 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.21 106.91 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.206 0.527 . . . . 0.0 110.748 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 m -139.82 -179.62 6.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.852 1.661 . . . . 0.0 112.041 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.147 1.779 . . . . 0.0 111.992 178.859 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.3 18.18 3.7 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.118 1.367 . . . . 0.0 113.087 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.28 145.48 39.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.778 -1.201 . . . . 0.0 111.472 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.69 34.68 62.7 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.942 0.782 . . . . 0.0 114.363 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -146.14 -174.17 4.37 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.284 1.042 . . . . 0.0 111.843 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' A' ' 69' ' ' LEU . 3.7 pt -126.72 143.49 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.682 1.593 . . . . 0.0 111.772 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.36 167.17 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.035 1.734 . . . . 0.0 112.253 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 116.43 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.964 1.306 . . . . 0.0 113.057 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.19 65.49 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.024 1.297 . . . . 0.0 113.141 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.77 -20.64 61.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.26 1.424 . . . . 0.0 113.448 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -110.35 -0.99 17.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.57 1.548 . . . . 0.0 112.834 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 tp -80.41 115.34 19.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.14 1.376 . . . . 0.0 112.013 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -142.2 169.18 18.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.232 1.413 . . . . 0.0 110.941 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.3 -40.96 50.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.865 1.666 . . . . 0.0 113.889 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.373 1.069 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.05 -45.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.019 1.728 . . . . 0.0 109.938 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 170' ' ' GLN . 83.3 mt -54.6 -47.06 73.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.385 0.674 . . . . 0.0 110.635 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.88 -52.6 63.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.636 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -48.26 -47.89 35.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.673 1.189 . . . . 0.0 112.658 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.83 -58.77 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.728 1.211 . . . . 0.0 111.853 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.442 HD11 ' HD3' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -62.21 -32.55 73.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.09 1.356 . . . . 0.0 113.076 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.47 -55.96 13.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.224 1.01 . . . . 0.0 111.229 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -24.71 61.39 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.52 -48.29 69.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.741 1.616 . . . . 0.0 110.887 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 60.39 0.27 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.634 1.588 . . . . 0.0 111.662 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -53.53 119.64 5.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.282 1.433 . . . . 0.0 112.301 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -169.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.014 1.726 . . . . 0.0 110.074 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m -41.07 -42.96 2.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.708 2.403 . . . . 0.0 112.874 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 mtm105 -143.0 144.52 32.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.377 1.871 . . . . 0.0 109.575 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -173.99 165.08 4.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.71 2.804 . . . . 0.0 110.743 -170.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.8 HD13 ' CD2' ' A' ' 102' ' ' PHE . 32.8 pt -139.95 173.04 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.536 1.534 . . . . 0.0 110.652 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.01 107.15 6.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.991 1.316 . . . . 0.0 110.752 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.69 137.67 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.983 1.313 . . . . 0.0 111.451 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.7 116.98 0.8 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.746 0.689 . . . . 0.0 113.216 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.27 105.55 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.318 1.059 . . . . 0.0 109.694 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -84.6 108.87 17.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.293 1.437 . . . . 0.0 112.92 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -75.49 97.96 3.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.342 1.457 . . . . 0.0 111.393 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 8.94 12.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.469 1.908 . . . . 0.0 113.041 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.2 m -64.44 -44.94 89.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.09 -0.9 5.75 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.163 1.363 . . . . 0.0 116.329 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.76 28.07 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.745 1.773 . . . . 0.0 114.316 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -74.88 139.14 42.93 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.492 1.117 . . . . 0.0 113.112 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -111.8 163.31 14.32 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.696 1.199 . . . . 0.0 112.249 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.2 m -131.07 108.04 9.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.085 1.354 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 110.79 3.54 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.023 0.929 . . . . 0.0 108.987 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.36 -63.9 1.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.699 1.6 . . . . 0.0 111.097 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.23 170.39 2.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.299 2.24 . . . . 0.0 111.152 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.7 139.3 53.66 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 127.308 2.243 . . . . 0.0 110.489 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -131.61 114.87 15.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.183 1.793 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.68 101.3 5.7 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.563 1.545 . . . . 0.0 111.808 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -68.01 -42.96 79.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.219 1.408 . . . . 0.0 112.944 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -146.48 154.1 41.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.99 1.716 . . . . 0.0 111.381 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.55 -163.96 54.51 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.818 -0.551 . . . . 0.0 112.7 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.49 161.26 41.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.904 0.882 . . . . 0.0 110.546 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.9 m -145.43 137.7 25.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 110.131 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.21 4.71 44.72 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.749 1.219 . . . . 0.0 113.353 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 55' ' ' THR . 9.0 m -120.53 175.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.33 1.852 . . . . 0.0 113.564 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.03 132.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 109.843 -172.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 142.82 81.56 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 121.663 -0.648 . . . . 0.0 110.332 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HG3' HG23 ' A' ' 6' ' ' ILE . 66.4 Cg_endo -66.73 175.22 5.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 125.091 3.861 . . . . 0.0 111.533 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.15 -26.27 8.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.079 -1.013 . . . . 0.0 112.69 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -124.02 130.56 52.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 0.0 111.001 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -133.38 88.15 35.88 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.288 1.435 . . . . 0.0 109.425 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.32 163.39 23.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.306 2.004 . . . . 0.0 112.277 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.61 158.05 19.19 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.393 -0.817 . . . . 0.0 111.703 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 66.03 4.14 2.92 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.51 2.324 . . . . 0.0 114.208 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -126.9 147.9 50.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.325 1.85 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.96 158.0 27.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.349 1.459 . . . . 0.0 110.993 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -96.91 167.61 10.98 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.29 132.16 47.11 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.934 1.694 . . . . 0.0 108.763 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.67 163.57 35.48 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.374 1.07 . . . . 0.0 111.925 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.7 m -143.08 177.17 8.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.185 1.394 . . . . 0.0 111.298 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.74 97.66 0.14 Allowed Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.729 -1.04 . . . . 0.0 113.307 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.95 166.21 10.58 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.982 1.391 . . . . 0.0 113.595 -173.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -86.38 101.35 13.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.71 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t0 39.65 -146.14 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 126.683 1.993 . . . . 0.0 112.405 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -61.76 -35.44 78.13 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 119.706 -1.871 . . . . 0.0 112.151 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.74 -58.86 0.53 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.299 1.428 . . . . 0.0 113.565 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.62 4.38 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.947 3.765 . . . . 0.0 115.382 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.05 126.04 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.124 2.169 . . . . 0.0 110.485 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.33 62.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.429 1.491 . . . . 0.0 112.556 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -66.31 0.91 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.691 1.596 . . . . 0.0 111.777 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 175.09 39.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.529 2.014 . . . . 0.0 110.334 -173.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.09 102.41 3.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.892 1.277 . . . . 0.0 107.937 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.97 134.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.036 1.734 . . . . 0.0 108.188 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.67 159.52 38.48 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 124.382 1.073 . . . . 0.0 110.068 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.8 146.46 33.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 110.858 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.05 169.15 21.9 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.2 1.8 . . . . 0.0 110.236 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.78 146.84 34.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.122 0.569 . . . . 0.0 111.703 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.83 118.83 23.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.824 0.85 . . . . 0.0 110.871 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 114.09 17.93 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.846 1.658 . . . . 0.0 110.274 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.7 mtt -70.72 162.47 29.0 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.491 0.662 . . . . 0.0 112.182 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t -60.18 -23.45 63.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.82 1.248 . . . . 0.0 113.722 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -10.69 56.21 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.535 1.534 . . . . 0.0 113.39 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.56 9.86 56.14 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.772 1.177 . . . . 0.0 115.179 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -87.06 171.72 10.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.372 1.086 . . . . 0.0 110.263 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.5 m -129.99 147.53 51.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.439 0.696 . . . . 0.0 110.961 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.08 111.75 16.32 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.26 139.54 28.21 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 117' ' ' VAL . 18.5 t -143.31 131.54 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.066 0.947 . . . . 0.0 109.84 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -143.77 160.51 40.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.93 -0.481 . . . . 0.0 111.77 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.8 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -127.18 153.05 46.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.894 1.278 . . . . 0.0 110.187 175.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -145.89 113.36 6.3 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.976 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.0 110.55 43.69 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 126.634 1.974 . . . . 0.0 108.224 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -79.33 175.27 10.95 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.486 2.791 . . . . 0.0 111.399 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -81.63 -40.94 22.19 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.814 -0.554 . . . . 0.0 111.269 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 112.51 24.33 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.476 -0.765 . . . . 0.0 112.789 -161.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.14 -54.85 41.02 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.17 17.16 24.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.14 1.376 . . . . 0.0 113.829 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.62 -3.57 2.62 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.286 1.834 . . . . 0.0 112.748 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -173.61 4.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.34 2.656 . . . . 0.0 109.692 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -152.58 160.65 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.492 1.517 . . . . 0.0 110.596 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.48 158.0 31.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.316 1.046 . . . . 0.0 110.214 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -143.68 151.88 40.64 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.283 -0.886 . . . . 0.0 111.932 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -164.38 154.55 14.47 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.952 1.701 . . . . 0.0 109.675 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -143.78 140.27 29.82 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.894 1.677 . . . . 0.0 108.8 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -139.21 124.37 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 128.952 2.901 . . . . 0.0 109.6 174.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -144.9 148.32 33.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.498 1.919 . . . . 0.0 109.894 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.92 113.53 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.827 1.651 . . . . 0.0 108.868 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -126.23 142.95 51.32 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.558 1.543 . . . . 0.0 112.939 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.0 p -75.34 92.67 2.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.14 . . . . 0.0 112.537 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.64 -167.88 39.83 Favored Glycine 0 N--CA 1.471 0.993 0 O-C-N 121.531 -0.731 . . . . 0.0 114.397 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 119.19 24.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.489 1.915 . . . . 0.0 111.398 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.22 156.11 40.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 111.133 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -137.93 161.87 35.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.34 1.456 . . . . 0.0 111.056 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 90.72 2.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.411 0.684 . . . . 0.0 111.15 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -110.23 -66.57 1.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.136 1.374 . . . . 0.0 109.135 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -70.92 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.58 1.552 . . . . 0.0 109.35 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.56 81.33 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.333 0.968 . . . . 0.0 114.333 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -69.6 -53.08 20.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.293 1.046 . . . . 0.0 110.78 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.25 -43.76 79.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.792 0.837 . . . . 0.0 110.428 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -62.6 -46.37 88.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -56.86 -19.94 20.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.722 1.146 . . . . 0.0 113.377 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.66 -59.13 2.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.227 1.411 . . . . 0.0 110.438 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.99 -56.55 19.82 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.299 1.04 . . . . 0.0 111.383 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -80.93 -16.66 52.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.198 1.399 . . . . 0.0 112.064 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.28 -77.17 0.25 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 0.0 113.271 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -162.41 90.75 1.33 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.935 1.694 . . . . 0.0 109.966 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.28 158.15 45.16 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.016 1.144 . . . . 0.0 110.492 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.74 5.84 50.39 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.74 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 130.145 3.378 . . . . 0.0 117.808 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.07 5.39 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.043 -1.035 . . . . 0.0 112.245 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -63.55 7.18 0.11 Allowed 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.347 11.3 p30 55.84 25.55 8.63 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.193 2.597 . . . . 0.0 116.424 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -139.58 165.44 25.82 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.456 1.979 . . . . 0.0 111.499 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -70.42 114.53 8.64 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.16 -1.2 . . . . 0.0 109.689 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 127.77 53.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.043 1.337 . . . . 0.0 109.975 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.08 139.34 21.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.185 1.394 . . . . 0.0 110.352 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -144.65 126.46 15.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.241 1.416 . . . . 0.0 109.921 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -62.1 117.6 6.22 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.805 0.442 . . . . 0.0 111.414 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -142.98 -26.62 0.59 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.486 1.114 . . . . 0.0 113.93 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.18 15.82 20.35 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.821 1.201 . . . . 0.0 114.469 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.45 10.62 1.92 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.829 2.452 . . . . 0.0 115.403 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.9 -47.6 0.05 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.274 1.416 . . . . 0.0 112.773 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.52 161.49 17.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 111.324 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 170.99 19.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 113.074 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.73 138.53 31.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.28 1.432 . . . . 0.0 109.487 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -130.5 109.07 10.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.761 1.624 . . . . 0.0 108.656 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.62 169.87 27.04 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.3 143.24 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 109.702 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.7 ttt -150.79 150.91 31.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.673 1.989 . . . . 0.0 107.352 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.0 p -101.13 165.47 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.599 0.76 . . . . 0.0 111.929 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.0 t -90.84 46.28 1.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.685 1.594 . . . . 0.0 110.051 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.57 158.16 42.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.33 1.452 . . . . 0.0 112.656 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.1 -45.55 93.79 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 121.439 -0.788 . . . . 0.0 113.089 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 64.02 2.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.737 1.615 . . . . 0.0 113.741 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -94.61 147.29 23.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -91.49 150.11 21.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.687 1.195 . . . . 0.0 107.963 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 36.2 ttp -143.72 91.84 2.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.389 0.995 . . . . 0.0 112.16 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 17' ' ' LEU . 35.0 tt0 -107.04 146.41 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.406 -0.809 . . . . 0.0 111.164 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.69 104.27 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.886 1.675 . . . . 0.0 109.426 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -99.2 90.42 4.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.81 2.044 . . . . 0.0 110.51 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.63 118.22 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.378 0.671 . . . . 0.0 110.137 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.5 p -146.41 166.17 27.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.994 1.318 . . . . 0.0 113.029 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.691 2.397 . . . . 0.0 111.7 176.218 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.88 -26.92 7.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.13 143.0 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.324 0.965 . . . . 0.0 112.442 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.86 43.46 8.94 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.051 0.834 . . . . 0.0 115.027 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.9 p -147.65 -166.77 2.61 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 119.064 1.432 . . . . 0.0 111.977 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 pt -117.26 139.46 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.295 2.238 . . . . 0.0 109.947 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 12' ' ' LEU . 20.3 pt -145.55 159.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.006 1.322 . . . . 0.0 111.732 174.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.68 128.96 39.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.048 1.339 . . . . 0.0 112.477 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.59 -24.35 76.25 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.588 0.613 . . . . 0.0 113.413 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.2 73.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.419 1.088 . . . . 0.0 111.395 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -74.11 -28.45 61.36 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.259 1.024 . . . . 0.0 112.896 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 7' ' ' ILE . 9.2 tt -67.26 114.57 6.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.274 1.429 . . . . 0.0 112.54 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 m -145.11 172.85 12.5 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.159 1.784 . . . . 0.0 110.157 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -42.17 37.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.38 1.472 . . . . 0.0 113.952 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.88 -35.91 79.73 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.13 -42.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.517 0.727 . . . . 0.0 110.29 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 170' ' ' GLN . 11.1 mt -55.52 -50.48 69.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.832 0.742 . . . . 0.0 112.092 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -39.99 90.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.153 0.581 . . . . 0.0 112.113 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -57.21 -43.44 82.79 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.009 1.324 . . . . 0.0 112.717 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 70' ' ' LEU . 77.4 t -62.22 -48.01 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.394 1.078 . . . . 0.0 111.325 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.5 mp -61.96 -42.82 99.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.171 0.988 . . . . 0.0 112.267 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.87 -31.79 71.84 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -77.0 -42.19 39.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.826 1.65 . . . . 0.0 113.82 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.64 -56.85 16.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.775 1.63 . . . . 0.0 111.59 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 64.61 0.09 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.029 1.3 . . . . 0.0 112.149 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -51.16 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.353 2.261 . . . . 0.0 112.421 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 28' ' ' SER . 3.8 p -90.42 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.096 1.758 . . . . 0.0 109.942 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 27' ' ' VAL . 19.4 m -44.2 -49.55 9.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.552 1.141 . . . . 0.0 112.083 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -139.45 146.57 40.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 112.727 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.4 150.93 11.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.046 2.538 . . . . 0.0 108.931 -169.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 21' ' ' LEU . 7.0 pt -139.72 153.95 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.822 1.249 . . . . 0.0 109.507 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.63 110.81 20.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.364 1.066 . . . . 0.0 109.878 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -105.31 128.74 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.892 0.877 . . . . 0.0 111.265 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.7 114.47 0.79 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.357 1.456 . . . . 0.0 112.094 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.86 104.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.515 1.126 . . . . 0.0 109.082 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.2 111.16 21.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.149 1.379 . . . . 0.0 111.15 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -84.54 96.42 9.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.41 1.084 . . . . 0.0 111.615 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.0 18.97 20.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.601 1.161 . . . . 0.0 113.167 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.0 p -63.87 -40.22 96.03 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.46 3.98 5.01 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.886 1.707 . . . . 0.0 115.854 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.06 30.47 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.767 1.783 . . . . 0.0 114.491 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -74.8 130.63 39.8 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 122.007 -0.701 . . . . 0.0 112.165 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.37 164.39 11.8 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.901 1.28 . . . . 0.0 111.277 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 m -133.82 110.32 9.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.458 1.503 . . . . 0.0 109.467 -176.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.1 133.3 55.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.75 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mt -75.23 -68.56 0.54 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.864 0.466 . . . . 0.0 109.866 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -179.44 173.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.502 2.321 . . . . 0.0 110.592 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.82 145.74 51.23 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.353 2.261 . . . . 0.0 109.515 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 115.65 15.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.971 0.908 . . . . 0.0 111.015 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -70.31 106.65 3.43 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 111.221 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -68.95 -47.53 65.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.434 1.494 . . . . 0.0 110.603 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -141.7 154.4 45.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.917 2.087 . . . . 0.0 110.703 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -163.52 54.62 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.834 -0.541 . . . . 0.0 113.353 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -151.66 177.91 9.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 111.998 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.0 p -144.48 178.65 7.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.376 1.47 . . . . 0.0 111.563 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.25 20.15 8.15 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.771 1.228 . . . . 0.0 112.008 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.86 172.21 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 126.721 2.008 . . . . 0.0 113.244 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 mt -143.38 135.59 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.027 1.731 . . . . 0.0 109.812 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 149.68 60.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 119.547 1.067 . . . . 0.0 112.1 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.21 155.51 56.29 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 124.249 3.299 . . . . 0.0 111.579 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -93.27 -23.64 18.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.977 -1.077 . . . . 0.0 113.424 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.95 141.13 49.93 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.931 -1.106 . . . . 0.0 110.648 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.0 102.77 5.73 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.643 1.177 . . . . 0.0 109.234 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.3 164.67 24.79 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.903 1.735 . . . . 0.0 111.637 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.78 163.67 9.02 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.957 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 66.27 -0.91 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 126.542 1.937 . . . . 0.0 114.151 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.96 -174.38 2.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.188 2.995 . . . . 0.0 110.81 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.31 172.85 17.23 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.651 2.38 . . . . 0.0 111.049 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.99 178.47 4.55 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.713 0.805 . . . . 0.0 109.737 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 20' ' ' VAL . 1.2 tp -134.88 131.9 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.886 2.074 . . . . 0.0 109.118 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -148.05 166.27 28.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.274 1.03 . . . . 0.0 110.486 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -149.44 174.85 12.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.152 0.981 . . . . 0.0 111.068 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.95 119.22 0.88 Allowed Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.39 1.471 . . . . 0.0 111.369 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.04 150.06 42.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.909 1.355 . . . . 0.0 112.393 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -69.7 107.6 3.54 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' CB ' HG23 ' A' ' 80' ' ' VAL . 7.3 m-20 40.06 -150.49 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 126.113 1.765 . . . . 0.0 113.122 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -77.83 -38.74 45.58 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.82 -1.8 . . . . 0.0 111.347 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.82 -56.23 0.51 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.628 -1.096 . . . . 0.0 114.78 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.54 -6.27 18.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.529 3.486 . . . . 0.0 114.825 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' CB ' ' A' ' 76' ' ' ASP . 9.7 m -122.8 139.96 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.268 1.827 . . . . 0.0 109.126 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.03 78.08 1.52 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.326 . . . . 0.0 110.77 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 80.6 m -102.73 -65.16 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.848 0.859 . . . . 0.0 111.318 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.18 172.07 29.13 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.752 1.644 . . . . 0.0 111.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.33 108.69 8.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.409 1.105 . . . . 0.0 110.541 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -137.81 131.32 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.44 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.179 0.592 . . . . 0.0 110.651 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.96 149.97 35.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.935 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.84 172.47 12.98 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.858 1.663 . . . . 0.0 110.651 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -138.95 150.44 45.9 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.249 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -128.37 114.37 16.76 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.66 1.184 . . . . 0.0 111.352 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -75.02 115.13 14.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.559 1.544 . . . . 0.0 110.801 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.99 157.9 34.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.195 0.998 . . . . 0.0 111.733 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 87.4 p -59.65 -20.22 54.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -81.56 -11.7 59.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.615 1.966 . . . . 0.0 113.44 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.58 60.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.089 1.328 . . . . 0.0 115.244 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.27 175.11 8.64 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.811 1.245 . . . . 0.0 110.863 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.515 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 18.9 m -141.73 147.75 37.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.725 0.774 . . . . 0.0 110.288 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.11 118.94 34.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.19 0.996 . . . . 0.0 108.34 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.33 142.3 22.88 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 117' ' ' VAL . 25.6 m -140.89 137.97 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.547 1.139 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.41 152.52 44.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.155 0.582 . . . . 0.0 110.879 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -125.88 142.22 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.684 1.193 . . . . 0.0 109.768 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.0 m -125.87 97.95 5.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.947 1.699 . . . . 0.0 110.309 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.2 112.31 58.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.674 1.59 . . . . 0.0 109.616 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -76.83 -173.08 1.61 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.336 3.357 . . . . 0.0 111.996 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.461 ' CD1' ' HE3' ' A' ' 75' ' ' LYS . 16.8 t80 -106.5 -13.04 15.44 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.37 1.068 . . . . 0.0 112.895 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -110.73 131.13 55.32 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 119.741 -1.849 . . . . 0.0 111.138 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -66.4 0.7 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.02 -1.05 . . . . 0.0 110.837 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -82.19 -3.98 56.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.51 -1.48 9.58 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.093 1.757 . . . . 0.0 112.699 -164.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -150.24 179.93 7.71 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 129.536 3.134 . . . . 0.0 108.887 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.9 t -142.48 163.57 32.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.938 1.695 . . . . 0.0 109.037 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -92.37 136.98 32.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.351 0.66 . . . . 0.0 109.227 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 151.1 46.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.096 0.959 . . . . 0.0 110.357 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -157.1 157.48 34.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.612 1.565 . . . . 0.0 110.632 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.13 155.23 43.19 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.624 -0.673 . . . . 0.0 109.909 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 100' ' ' VAL . 43.6 t -140.87 122.02 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.947 1.299 . . . . 0.0 109.751 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -124.86 145.3 49.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.66 1.584 . . . . 0.0 109.737 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.4 mt -115.5 120.39 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.755 2.022 . . . . 0.0 108.659 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -132.42 144.72 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.126 1.371 . . . . 0.0 112.13 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.8 p -80.39 77.97 7.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.635 1.174 . . . . 0.0 112.59 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.67 36.88 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.413 1.006 . . . . 0.0 113.818 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 116.78 26.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.754 1.622 . . . . 0.0 111.858 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -142.43 155.26 45.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.105 1.362 . . . . 0.0 109.445 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -133.05 161.91 33.12 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.78 1.232 . . . . 0.0 111.141 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.8 78.98 0.45 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.602 1.161 . . . . 0.0 111.337 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -101.86 -65.59 0.97 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.444 1.498 . . . . 0.0 110.244 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.55 -71.77 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.088 1.755 . . . . 0.0 109.233 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.4 -19.33 68.53 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.541 1.067 . . . . 0.0 114.603 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.34 -52.71 5.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.117 0.958 . . . . 0.0 111.574 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.44 -45.9 76.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.335 0.654 . . . . 0.0 111.775 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -35.37 72.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -22.85 66.98 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.283 -0.886 . . . . 0.0 113.244 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -93.71 -35.91 12.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.427 1.091 . . . . 0.0 110.89 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -76.26 -45.14 34.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.309 -1.494 . . . . 0.0 113.197 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -92.06 -14.87 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.929 1.292 . . . . 0.0 113.143 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.08 63.14 3.59 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.992 0.806 . . . . 0.0 113.706 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 31.97 73.75 0.5 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 127.598 2.359 . . . . 0.0 112.528 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.06 133.09 29.83 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.355 1.37 . . . . 0.0 110.895 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 124.8 23.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.31 31.98 0.34 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.385 1.874 . . . . 0.0 114.046 -176.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.39 62.96 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.51 1.529 . . . . 0.0 114.073 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.59 24.97 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.338 1.855 . . . . 0.0 114.703 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.9 p30 47.76 30.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.164 2.586 . . . . 0.0 116.852 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.93 139.19 7.57 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.997 1.76 . . . . 0.0 111.156 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -49.58 124.05 8.82 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.839 1.256 . . . . 0.0 113.129 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -110.41 120.83 43.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.105 2.162 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.79 138.76 17.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.729 1.212 . . . . 0.0 111.168 174.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -154.78 134.79 13.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 111.266 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -54.23 132.67 43.92 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.6 tp -156.32 -41.06 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.758 1.223 . . . . 0.0 112.51 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.93 31.66 2.79 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 114.082 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.47 11.99 1.36 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.355 2.262 . . . . 0.0 115.743 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 170.85 -43.21 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.349 1.452 . . . . 0.0 113.097 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.37 151.5 26.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.519 1.127 . . . . 0.0 110.657 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.88 170.19 16.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.539 1.136 . . . . 0.0 113.06 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -82.51 126.5 32.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.671 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -121.24 102.78 8.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.438 1.095 . . . . 0.0 108.36 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.91 171.45 25.47 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 143.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.074 0.95 . . . . 0.0 110.045 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.03 148.8 33.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.407 1.883 . . . . 0.0 108.216 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.3 p -107.74 162.37 14.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.463 1.905 . . . . 0.0 111.025 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.7 p -92.11 19.82 6.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.533 1.533 . . . . 0.0 113.542 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.73 175.06 5.62 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.28 2.232 . . . . 0.0 113.456 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.57 9.8 Favored Glycine 0 N--CA 1.475 1.249 0 C-N-CA 125.362 1.458 . . . . 0.0 112.401 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.39 73.51 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.037 1.335 . . . . 0.0 109.639 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.23 91.69 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.688 0.795 . . . . 0.0 111.298 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -56.76 149.89 17.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.072 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.4 tpp -151.08 96.26 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.871 0.843 . . . . 0.0 110.649 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 17' ' ' LEU . 54.6 tt0 -124.96 134.93 52.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.602 -1.311 . . . . 0.0 109.636 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.66 101.1 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.571 1.548 . . . . 0.0 109.664 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -99.32 99.89 10.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.288 1.835 . . . . 0.0 109.845 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -85.92 118.08 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.449 -0.782 . . . . 0.0 111.16 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.05 165.78 26.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.87 1.668 . . . . 0.0 113.038 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.039 2.136 . . . . 0.0 111.648 174.968 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.53 -0.77 42.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.59 143.03 53.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.023 0.929 . . . . 0.0 111.085 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.85 38.1 65.61 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -149.15 -169.73 3.45 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.425 1.113 . . . . 0.0 111.774 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 pt -126.47 153.27 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.974 1.71 . . . . 0.0 111.059 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 pt -148.94 170.0 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.824 1.65 . . . . 0.0 111.792 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.35 129.26 39.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.099 0.959 . . . . 0.0 109.601 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.34 42.05 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.947 1.26 . . . . 0.0 113.932 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.66 81.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.224 1.41 . . . . 0.0 112.267 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -32.58 32.34 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.94 1.296 . . . . 0.0 112.605 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 68' ' ' ALA . 5.9 tp -60.41 107.93 0.74 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.349 . . . . 0.0 111.896 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 m -149.37 168.17 24.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.755 1.222 . . . . 0.0 110.149 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -39.02 21.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.766 1.626 . . . . 0.0 114.222 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -59.38 -35.0 73.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.72 -44.02 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 110.474 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.52 -43.87 72.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.886 0.766 . . . . 0.0 112.226 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.16 -47.31 80.37 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.982 -0.449 . . . . 0.0 110.881 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -39.15 76.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.578 1.551 . . . . 0.0 114.0 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.19 -56.34 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.152 1.781 . . . . 0.0 109.598 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.41 -40.82 89.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.149 1.38 . . . . 0.0 112.646 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -56.52 -54.58 44.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 112.933 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.11 -42.0 89.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 tp -53.21 -55.54 23.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.03 1.732 . . . . 0.0 112.722 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.99 49.24 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.927 0.775 . . . . 0.0 114.12 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.91 123.71 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.561 1.944 . . . . 0.0 114.342 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.73 -161.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 127.086 2.154 . . . . 0.0 111.442 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 m -51.91 -34.07 39.86 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.807 1.643 . . . . 0.0 114.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -144.21 139.66 28.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.827 2.051 . . . . 0.0 108.932 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -162.73 148.32 12.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.574 1.949 . . . . 0.0 110.988 -174.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 104' ' ' VAL . 3.1 pt -138.35 151.79 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.14 0.976 . . . . 0.0 108.803 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.57 113.1 25.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.596 1.159 . . . . 0.0 109.866 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.75 130.4 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.693 0.797 . . . . 0.0 111.436 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.96 0.85 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.654 1.121 . . . . 0.0 112.759 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.11 101.54 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.846 1.258 . . . . 0.0 108.745 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -85.44 104.25 15.07 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.599 1.56 . . . . 0.0 111.696 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -82.79 104.35 12.96 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.572 1.149 . . . . 0.0 112.052 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.66 29.44 8.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.096 1.358 . . . . 0.0 112.331 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -84.02 -3.74 58.24 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.075 1.75 . . . . 0.0 114.747 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.21 14.64 80.12 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.505 -1.372 . . . . 0.0 114.287 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.65 20.23 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.445 1.498 . . . . 0.0 113.611 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.4 p -81.79 131.7 35.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.241 1.417 . . . . 0.0 112.527 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -108.35 164.43 12.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.741 1.216 . . . . 0.0 111.955 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -129.33 107.72 9.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.211 1.405 . . . . 0.0 110.082 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.27 117.82 10.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.309 -0.869 . . . . 0.0 109.985 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.03 -69.87 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.363 1.465 . . . . 0.0 111.223 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -170.95 164.41 7.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.531 1.932 . . . . 0.0 111.015 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -113.73 124.71 52.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.91 2.084 . . . . 0.0 110.068 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -108.21 109.75 21.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.546 1.138 . . . . 0.0 111.504 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -78.29 96.53 5.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.341 1.456 . . . . 0.0 112.053 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -66.07 -51.94 53.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.759 1.224 . . . . 0.0 112.003 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -138.63 141.48 39.11 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.822 2.049 . . . . 0.0 110.552 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.89 -171.46 42.91 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.32 0.486 . . . . 0.0 112.771 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.97 176.43 9.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.808 0.843 . . . . 0.0 111.984 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -142.65 -179.17 6.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.214 1.406 . . . . 0.0 111.355 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -137.52 22.89 2.94 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.915 1.286 . . . . 0.0 112.021 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.73 171.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.726 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.01 138.82 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 108.733 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -88.95 151.2 46.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.107 0.867 . . . . 0.0 111.426 177.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.67 165.73 26.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.741 2.96 . . . . 0.0 110.136 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -29.89 9.44 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.91 -1.119 . . . . 0.0 111.474 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.04 132.8 55.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.168 1.387 . . . . 0.0 111.044 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.45 81.94 47.47 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.051 1.74 . . . . 0.0 108.207 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.06 157.69 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 121.959 1.773 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -56.09 151.1 12.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.414 -0.803 . . . . 0.0 111.563 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 66.24 3.99 2.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.21 2.204 . . . . 0.0 115.257 -171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -130.95 99.13 4.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.146 1.779 . . . . 0.0 113.163 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.551 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -76.59 161.77 28.31 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.744 1.218 . . . . 0.0 112.628 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.91 170.89 7.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.911 0.885 . . . . 0.0 110.642 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.27 130.29 40.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.099 2.159 . . . . 0.0 107.877 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -149.12 161.48 41.88 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.307 1.443 . . . . 0.0 110.334 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -140.12 157.9 44.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.325 0.65 . . . . 0.0 111.512 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.07 118.69 1.4 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.579 1.561 . . . . 0.0 111.937 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.85 169.47 13.21 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.175 1.39 . . . . 0.0 112.011 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -99.89 111.61 23.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.891 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 t70 36.89 -145.72 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 128.637 2.775 . . . . 0.0 114.061 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 m -58.06 -57.56 12.31 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.942 -1.724 . . . . 0.0 111.941 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.8 -75.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.621 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.21 73.02 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 125.216 3.944 . . . . 0.0 113.042 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.6 159.64 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.091 1.756 . . . . 0.0 111.662 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.05 65.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.065 1.346 . . . . 0.0 111.766 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -127.1 -88.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.637 1.575 . . . . 0.0 110.389 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.6 172.99 32.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.526 1.536 . . . . 0.0 111.322 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.58 116.9 22.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.719 1.207 . . . . 0.0 109.385 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -142.5 128.29 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.599 1.16 . . . . 0.0 108.351 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -151.54 165.78 33.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.605 0.717 . . . . 0.0 110.67 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.62 139.56 20.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.298 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -134.42 175.85 9.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 -171.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.17 37.51 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.607 -0.683 . . . . 0.0 112.261 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.93 119.45 23.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.688 1.195 . . . . 0.0 110.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.59 112.07 17.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.461 1.904 . . . . 0.0 110.126 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -67.43 162.49 22.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.944 0.898 . . . . 0.0 111.749 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.9 p -59.59 -21.7 60.73 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 m -84.8 -14.95 46.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.511 1.925 . . . . 0.0 113.453 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.42 55.54 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.038 1.304 . . . . 0.0 115.447 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -82.01 165.36 20.74 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.482 1.141 . . . . 0.0 109.662 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.0 m -123.49 143.72 49.99 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 109.147 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -117.36 109.18 16.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.134 0.974 . . . . 0.0 109.354 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.65 114.24 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 117' ' ' VAL . 19.8 m -108.26 140.22 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.171 0.988 . . . . 0.0 110.991 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 135' ' ' TYR . 0.0 OUTLIER -141.39 155.25 45.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.338 0.655 . . . . 0.0 111.312 174.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -132.84 153.68 51.07 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.216 1.006 . . . . 0.0 111.516 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.3 t -137.39 115.03 11.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.403 1.081 . . . . 0.0 110.604 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.592 HG21 HG21 ' A' ' 31' ' ' ILE . 53.2 t -124.05 92.48 48.29 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 126.154 1.782 . . . . 0.0 108.579 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.76 171.6 17.89 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.081 2.521 . . . . 0.0 112.729 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -73.25 -55.95 5.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.514 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.75 122.0 22.6 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.36 1.464 . . . . 0.0 113.325 -161.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -67.22 -58.47 4.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -100.51 15.24 28.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.967 1.307 . . . . 0.0 114.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 0.31 4.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.856 2.063 . . . . 0.0 112.192 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.44 -179.02 7.37 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.419 2.288 . . . . 0.0 110.679 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -154.07 173.03 16.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.172 1.389 . . . . 0.0 112.076 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -95.8 147.54 23.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -134.86 142.48 46.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 110.545 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 30.0 p-90 -145.51 152.82 40.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.39 1.476 . . . . 0.0 109.411 174.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -153.63 145.8 23.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.739 1.216 . . . . 0.0 110.22 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 100' ' ' VAL . 71.7 t -143.28 112.88 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.261 1.825 . . . . 0.0 110.5 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.55 129.29 56.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.129 0.971 . . . . 0.0 109.518 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.52 112.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.223 1.809 . . . . 0.0 108.755 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -124.19 141.45 52.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.473 1.509 . . . . 0.0 112.354 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.3 p -77.1 78.66 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.96 1.304 . . . . 0.0 112.858 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.13 165.18 20.91 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.44 1.019 . . . . 0.0 113.245 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 140.16 57.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.761 1.624 . . . . 0.0 111.856 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -156.04 168.32 27.62 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.516 1.527 . . . . 0.0 110.444 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -142.08 -175.42 4.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.097 1.759 . . . . 0.0 109.714 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.2 111.36 16.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.34 -67.22 0.99 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.287 1.035 . . . . 0.0 109.238 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.33 -71.53 0.21 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.153 0.981 . . . . 0.0 110.594 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.34 -22.91 74.94 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.935 0.778 . . . . 0.0 114.61 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.2 tpp -74.22 -54.18 8.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -40.72 85.33 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.565 1.146 . . . . 0.0 111.666 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.63 -36.24 66.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.352 1.461 . . . . 0.0 111.812 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -21.58 66.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.324 1.05 . . . . 0.0 113.113 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.67 -43.25 10.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 108.558 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.458 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 8.3 t80 -66.67 -49.74 65.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.866 -1.147 . . . . 0.0 113.669 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.56 -12.74 31.02 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.22 -66.91 2.5 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 124.191 0.9 . . . . 0.0 112.869 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.49 77.96 0.27 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.374 2.67 . . . . 0.0 108.928 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.4 143.44 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.509 1.473 . . . . 0.0 108.315 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -79.44 -11.78 59.9 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.7 129.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.054 3.342 . . . . 0.0 112.529 -173.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.36 62.09 0.6 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.05 2.262 . . . . 0.0 114.377 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -78.51 29.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.067 1.747 . . . . 0.0 114.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.253 10.9 p30 50.13 30.46 4.25 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 174.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.27 152.17 20.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.027 1.775 . . . . 0.0 111.017 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -64.37 112.67 3.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.03 123.51 49.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.053 1.741 . . . . 0.0 111.062 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -149.1 154.17 38.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.703 2.001 . . . . 0.0 111.836 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.39 135.85 10.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.308 1.043 . . . . 0.0 111.15 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.49 127.47 31.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.002 0.521 . . . . 0.0 111.447 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.1 tp -149.67 -27.99 0.26 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -84.29 18.76 21.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.998 1.285 . . . . 0.0 114.553 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.47 10.04 1.72 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.477 2.311 . . . . 0.0 115.438 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.85 -61.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.118 1.818 . . . . 0.0 110.579 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.1 159.78 15.52 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.796 0.838 . . . . 0.0 112.476 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 169.3 25.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.847 1.659 . . . . 0.0 112.82 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.491 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.3 pmm? -88.54 133.79 34.05 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.004 0.922 . . . . 0.0 112.011 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.16 107.24 9.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.329 1.452 . . . . 0.0 107.68 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -136.24 175.31 21.0 Favored Glycine 0 C--N 1.325 -0.077 0 CA-C-O 121.941 0.745 . . . . 0.0 113.441 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.65 141.49 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.82 1.648 . . . . 0.0 108.074 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.7 ttt -144.23 130.59 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 161.54 25.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.346 1.058 . . . . 0.0 110.095 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.55 24.91 6.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.403 1.481 . . . . 0.0 113.278 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.76 171.7 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.235 1.814 . . . . 0.0 112.269 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.44 -54.54 36.34 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.621 -0.674 . . . . 0.0 113.192 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.7 pt-20 -88.91 47.55 1.51 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.04 1.736 . . . . 0.0 113.777 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.18 141.49 57.33 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.895 0.855 . . . . 0.0 113.103 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -96.0 136.93 35.8 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 108.757 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.6 ttp -134.62 95.37 3.35 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.775 1.23 . . . . 0.0 111.733 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -108.72 145.38 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.915 -0.491 . . . . 0.0 110.465 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.26 112.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 125.764 1.626 . . . . 0.0 108.138 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -99.39 108.15 20.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.14 1.776 . . . . 0.0 108.765 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 157' ' ' MET . 33.3 mm -92.44 109.66 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.691 . . . . 0.0 110.266 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.39 171.32 14.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 111.996 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 127.637 2.375 . . . . 0.0 110.385 175.028 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 119.83 -0.128 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -32.28 24.05 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.746 -0.596 . . . . 0.0 112.084 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.18 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.02 40.66 9.15 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.933 1.254 . . . . 0.0 114.81 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -145.51 -166.29 2.4 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.309 1.555 . . . . 0.0 112.639 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.11 140.14 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.319 2.248 . . . . 0.0 110.1 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -145.1 170.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.177 1.391 . . . . 0.0 111.987 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.76 111.39 5.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.759 -1.213 . . . . 0.0 110.898 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.91 -25.23 67.57 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.981 0.8 . . . . 0.0 113.302 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.42 -23.68 64.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.956 1.303 . . . . 0.0 114.08 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.02 1.16 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.111 1.364 . . . . 0.0 113.319 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.51 117.16 12.71 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.097 1.759 . . . . 0.0 111.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -145.84 169.0 19.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.577 1.551 . . . . 0.0 110.157 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.64 -41.33 42.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.128 1.371 . . . . 0.0 114.141 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -58.39 -42.59 87.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.644 0.777 . . . . 0.0 112.109 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.37 -46.75 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.447 1.099 . . . . 0.0 111.382 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 170' ' ' GLN . 33.7 mt -54.92 -49.85 70.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.736 0.814 . . . . 0.0 111.474 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -41.26 96.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -53.45 -45.35 69.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.091 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 70' ' ' LEU . 85.3 t -56.84 -56.89 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.0 mp -58.99 -33.87 71.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.258 1.423 . . . . 0.0 113.953 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -55.77 30.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.816 1.246 . . . . 0.0 110.277 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -15.36 60.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -30.6 56.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.448 1.099 . . . . 0.0 111.9 174.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 44.51 47.84 8.75 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.452 1.977 . . . . 0.0 113.959 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.73 175.84 1.03 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.356 1.462 . . . . 0.0 114.48 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -172.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 126.146 1.778 . . . . 0.0 110.922 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 m -48.92 -27.92 3.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.133 1.373 . . . . 0.0 114.591 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -127.36 149.86 49.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.753 1.221 . . . . 0.0 111.277 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.27 154.38 8.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.319 2.248 . . . . 0.0 109.899 -175.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.654 HD12 ' SD ' ' A' ' 169' ' ' MET . 13.9 pt -144.6 147.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.993 1.717 . . . . 0.0 109.083 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.23 105.59 13.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.67 1.188 . . . . 0.0 110.008 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.14 135.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.73 1.612 . . . . 0.0 111.569 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.06 115.4 0.69 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.979 1.276 . . . . 0.0 112.62 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.4 mt -106.63 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.337 1.455 . . . . 0.0 109.16 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.38 122.49 24.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.729 1.612 . . . . 0.0 113.845 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -77.34 90.52 3.78 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.195 1.798 . . . . 0.0 111.458 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.46 17.8 14.47 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.401 1.48 . . . . 0.0 112.635 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -76.48 -38.64 55.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 9.79 13.63 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.931 1.253 . . . . 0.0 115.568 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.06 166.19 29.39 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 119.466 1.633 . . . . 0.0 114.946 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -81.66 130.89 35.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.35 1.46 . . . . 0.0 112.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 m0 -106.58 161.35 14.7 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.683 1.193 . . . . 0.0 111.04 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.8 m -129.58 110.35 11.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.252 1.421 . . . . 0.0 109.051 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.41 130.19 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.053 -1.029 . . . . 0.0 109.792 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.23 -70.3 0.37 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 109.942 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -174.06 175.86 2.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.045 2.138 . . . . 0.0 110.549 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.03 154.87 42.37 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.728 2.011 . . . . 0.0 110.277 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.52 108.05 5.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.06 1.344 . . . . 0.0 111.022 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -74.33 105.91 5.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.101 1.361 . . . . 0.0 111.12 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -45.74 54.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.183 0.993 . . . . 0.0 111.503 175.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.0 m -140.19 156.76 46.38 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.892 2.077 . . . . 0.0 110.932 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.17 -168.32 45.13 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.68 0.6 . . . . 0.0 112.611 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -138.42 169.32 18.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.534 1.134 . . . . 0.0 110.142 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -147.23 137.11 23.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.91 0.862 . . . . 0.0 109.791 175.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.13 5.75 50.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.197 1.799 . . . . 0.0 112.754 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 55' ' ' THR . 11.5 m -116.1 169.58 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 110.738 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.19 141.77 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.486 1.114 . . . . 0.0 109.495 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.67 151.48 61.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 0.0 111.619 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 164.41 35.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.124 3.216 . . . . 0.0 110.524 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 -34.34 10.17 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.704 -0.622 . . . . 0.0 112.001 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.6 136.14 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.862 1.21 . . . . 0.0 110.82 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.03 89.24 7.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.78 1.232 . . . . 0.0 109.754 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.46 166.43 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.668 2.245 . . . . 0.0 113.49 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.81 153.5 16.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.6 p 69.89 -9.15 0.73 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -115.69 123.87 49.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.251 1.82 . . . . 0.0 111.914 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.32 176.69 6.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.872 1.269 . . . . 0.0 110.128 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.14 173.08 6.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.656 0.782 . . . . 0.0 109.247 174.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -126.51 131.79 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.385 1.474 . . . . 0.0 110.042 175.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -148.67 163.81 36.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 111.334 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.1 m -151.39 173.88 14.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 110.903 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.27 132.57 3.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.885 1.707 . . . . 0.0 110.323 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 178.57 6.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.3 1.04 . . . . 0.0 110.17 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -64.12 -174.95 0.13 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.027 0.931 . . . . 0.0 109.881 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.34 -167.88 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 121.137 -0.977 . . . . 0.0 109.989 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -34.28 -42.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.794 2.037 . . . . 0.0 114.85 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -51.75 0.48 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.51 1.528 . . . . 0.0 113.781 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.02 6.07 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.426 3.418 . . . . 0.0 115.073 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 109.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.447 2.299 . . . . 0.0 111.496 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.09 70.06 3.86 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.079 1.752 . . . . 0.0 112.895 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -97.51 -81.12 0.43 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.315 1.046 . . . . 0.0 111.996 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.06 176.3 43.21 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.115 1.817 . . . . 0.0 110.319 -172.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -149.13 86.55 1.5 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.542 1.163 . . . . 0.0 109.08 174.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.8 t -132.58 118.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.266 1.426 . . . . 0.0 107.639 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -141.06 166.29 25.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.055 0.931 . . . . 0.0 110.971 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.73 155.98 40.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.1 177.09 10.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 110.32 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.35 40.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.579 1.151 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.66 118.72 27.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.713 1.205 . . . . 0.0 110.594 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.89 107.72 9.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.042 1.737 . . . . 0.0 109.229 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mtt -64.54 166.64 8.2 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.498 -0.751 . . . . 0.0 112.212 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 t -62.98 -19.13 64.02 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -82.35 -18.83 40.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 113.203 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.19 -0.72 54.33 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.165 1.364 . . . . 0.0 114.906 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -79.93 166.23 21.83 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.597 1.198 . . . . 0.0 109.948 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 m -123.03 149.82 43.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.938 0.875 . . . . 0.0 110.318 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.37 112.43 18.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 108.257 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.18 127.8 8.2 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 117' ' ' VAL . 10.2 m -134.57 131.99 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.106 0.953 . . . . 0.0 110.157 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.48 156.65 45.18 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.156 0.582 . . . . 0.0 112.192 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -126.72 158.81 35.5 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.739 1.215 . . . . 0.0 111.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 t -138.67 108.25 6.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.486 1.115 . . . . 0.0 111.166 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 38.5 t -109.74 98.1 31.7 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.633 1.973 . . . . 0.0 108.612 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.97 169.37 22.34 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.342 2.695 . . . . 0.0 112.844 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.65 -17.48 41.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.13 110.72 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.149 0.98 . . . . 0.0 110.741 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.4 -58.4 5.37 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.09 -1.006 . . . . 0.0 113.269 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.81 10.76 27.21 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.688 1.195 . . . . 0.0 114.129 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.15 0.56 5.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.189 1.796 . . . . 0.0 112.609 -175.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -153.84 173.16 16.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.237 2.215 . . . . 0.0 110.01 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.2 m -138.57 170.02 16.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.587 1.155 . . . . 0.0 112.155 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -90.84 142.64 27.55 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.396 -0.815 . . . . 0.0 110.143 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -135.69 139.92 44.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 108.755 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -158.14 150.77 22.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.788 1.635 . . . . 0.0 109.322 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -151.36 154.65 37.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.79 1.236 . . . . 0.0 109.912 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 100' ' ' VAL . 61.8 t -145.05 121.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.514 1.525 . . . . 0.0 111.4 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -123.31 136.17 54.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.513 1.525 . . . . 0.0 110.627 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.71 116.38 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.919 2.088 . . . . 0.0 108.363 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -129.77 136.41 49.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.235 1.814 . . . . 0.0 112.54 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.5 p -79.99 79.36 6.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.09 1.356 . . . . 0.0 112.465 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.53 176.12 43.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.446 1.498 . . . . 0.0 112.355 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 104.11 16.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.584 1.954 . . . . 0.0 111.135 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -134.41 158.85 42.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.631 1.172 . . . . 0.0 111.371 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -136.75 164.77 27.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.092 1.757 . . . . 0.0 110.57 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.3 87.89 6.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.631 0.772 . . . . 0.0 111.2 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -102.27 -66.9 0.9 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 110.375 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -147.67 -75.0 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.677 1.991 . . . . 0.0 108.554 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.54 -37.17 88.07 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.357 0.979 . . . . 0.0 113.943 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -70.44 -52.97 18.42 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.145 0.972 . . . . 0.0 111.821 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.09 91.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.302 0.641 . . . . 0.0 111.381 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.92 -34.33 77.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.815 -0.612 . . . . 0.0 112.247 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -23.06 64.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.669 1.122 . . . . 0.0 112.177 175.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.54 -58.09 2.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 108.898 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.24 -56.96 15.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.899 -1.126 . . . . 0.0 111.803 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.33 -18.66 44.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 0.0 112.049 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.7 -68.9 1.45 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.346 0.974 . . . . 0.0 113.077 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.31 88.98 0.27 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 127.732 2.413 . . . . 0.0 108.599 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.17 142.06 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.609 1.539 . . . . 0.0 109.429 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -77.5 -9.68 59.05 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.13 107.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 128.931 2.892 . . . . 0.0 112.221 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.19 85.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.344 1.926 . . . . 0.0 114.214 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -89.25 22.99 2.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.504 2.321 . . . . 0.0 113.865 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.286 11.9 p30 50.47 33.6 8.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.871 2.068 . . . . 0.0 114.927 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.91 156.84 23.08 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.24 1.876 . . . . 0.0 111.965 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -69.16 114.07 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.801 -0.823 . . . . 0.0 111.282 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.29 121.65 43.53 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.026 1.73 . . . . 0.0 111.114 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.27 144.53 38.43 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.826 2.05 . . . . 0.0 110.126 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 133.7 13.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.29 1.036 . . . . 0.0 111.477 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.56 115.24 2.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.172 0.989 . . . . 0.0 111.192 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -29.87 1.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.71 1.204 . . . . 0.0 113.279 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.5 18.05 35.79 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.357 1.456 . . . . 0.0 114.427 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 59.09 13.31 2.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.923 2.089 . . . . 0.0 114.709 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -175.42 -69.16 0.05 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 126.658 2.075 . . . . 0.0 109.664 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -87.19 150.15 24.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.324 1.059 . . . . 0.0 111.95 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 172.33 13.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.46 1.904 . . . . 0.0 110.896 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.9 ptm -101.57 150.05 23.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.626 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -130.71 107.55 9.24 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.255 1.822 . . . . 0.0 107.473 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.48 176.98 19.13 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-O 121.748 0.638 . . . . 0.0 113.119 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.79 144.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 107.501 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -145.4 140.87 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.445 1.498 . . . . 0.0 108.439 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.34 162.26 13.42 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.89 1.676 . . . . 0.0 110.623 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.56 16.54 23.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.215 1.006 . . . . 0.0 113.405 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -107.6 172.74 6.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.861 2.064 . . . . 0.0 112.439 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.8 -46.54 94.31 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.431 1.015 . . . . 0.0 114.097 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.99 60.01 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.369 1.468 . . . . 0.0 113.026 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.12 144.86 40.4 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -89.01 147.95 24.01 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.909 0.884 . . . . 0.0 109.254 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.654 ' SD ' HD12 ' A' ' 31' ' ' ILE . 8.2 mtt -135.5 105.68 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.869 1.667 . . . . 0.0 110.068 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 17' ' ' LEU . 17.6 tt0 -124.86 143.17 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.871 -1.143 . . . . 0.0 109.515 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.24 106.04 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.88 1.272 . . . . 0.0 108.503 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -100.22 103.87 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.093 1.757 . . . . 0.0 108.713 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.0 136.94 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.132 0.573 . . . . 0.0 110.042 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 p -158.4 159.87 36.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 128.695 2.798 . . . . 0.0 113.455 176.818 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.537 ' C ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -150.43 -46.77 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.54 -1.35 . . . . 0.0 111.847 -175.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.651 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 59.6 161.31 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.887 2.475 . . . . 0.0 113.364 -166.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.4 46.71 93.82 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.036 -1.04 . . . . 0.0 115.091 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 p -155.11 -170.99 3.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.977 0.911 . . . . 0.0 111.75 -170.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 pt -118.82 144.01 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.786 2.034 . . . . 0.0 110.336 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.72 169.79 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.659 1.584 . . . . 0.0 112.065 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 125.35 25.05 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.728 1.211 . . . . 0.0 112.143 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.12 -28.75 73.92 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.389 0.995 . . . . 0.0 114.382 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.62 74.98 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.669 -0.901 . . . . 0.0 112.567 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -82.62 -22.8 34.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.466 1.106 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.48 120.23 10.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.984 1.714 . . . . 0.0 110.029 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -152.43 171.96 17.24 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.109 1.764 . . . . 0.0 110.009 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -50.94 -36.33 38.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 113.997 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.73 -35.5 76.52 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.741 -1.224 . . . . 0.0 112.988 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.04 -42.59 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.734 0.814 . . . . 0.0 110.248 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -51.34 -49.59 61.12 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.109 0.963 . . . . 0.0 111.755 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.47 -48.6 77.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.43 0.692 . . . . 0.0 111.986 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -56.87 -35.02 68.43 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.47 -56.84 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.073 1.349 . . . . 0.0 110.059 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.35 -41.75 94.28 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.201 1.4 . . . . 0.0 112.369 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -54.75 -49.36 71.04 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.949 0.9 . . . . 0.0 112.318 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -85.86 -32.42 21.72 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -54.23 35.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.392 1.477 . . . . 0.0 111.239 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.82 58.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.383 0.992 . . . . 0.0 112.462 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 139.6 7.34 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.925 1.29 . . . . 0.0 111.913 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 28' ' ' SER . 3.4 p -137.05 -163.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.036 1.334 . . . . 0.0 110.709 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.546 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -38.83 -44.9 1.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.19 1.796 . . . . 0.0 114.138 175.252 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -148.98 138.88 22.04 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.132 1.373 . . . . 0.0 110.93 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.02 151.63 16.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.869 1.668 . . . . 0.0 111.165 -172.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' A' ' 102' ' ' PHE . 14.5 pt -134.95 152.3 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.108 1.363 . . . . 0.0 109.4 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.52 117.92 33.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.341 1.457 . . . . 0.0 109.38 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.85 126.97 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.81 109.44 0.66 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.38 1.466 . . . . 0.0 112.455 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 171' ' ' ILE . 10.8 mt -107.54 101.9 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.763 1.225 . . . . 0.0 108.246 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.63 120.77 26.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.568 1.547 . . . . 0.0 112.62 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -84.99 102.49 13.23 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.1 1.36 . . . . 0.0 112.054 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.67 25.68 7.42 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 111.615 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -77.99 -19.94 53.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.784 1.634 . . . . 0.0 114.387 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.75 26.85 25.88 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 114.743 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.08 150.38 18.2 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.77 1.176 . . . . 0.0 113.959 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -71.14 140.27 50.53 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.439 -1.036 . . . . 0.0 112.918 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -114.35 164.41 13.98 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.47 1.108 . . . . 0.0 112.237 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 m -132.91 108.75 9.13 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.038 1.335 . . . . 0.0 109.714 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.87 131.49 46.4 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.22 -69.32 0.48 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.735 -0.603 . . . . 0.0 110.539 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.7 163.02 2.8 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.059 2.143 . . . . 0.0 111.076 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -110.86 122.88 48.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.225 1.81 . . . . 0.0 109.224 175.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -110.1 105.75 14.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.434 1.094 . . . . 0.0 111.629 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -73.92 115.02 12.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.817 1.247 . . . . 0.0 112.034 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -46.62 11.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.604 1.561 . . . . 0.0 111.495 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.8 m -139.15 157.0 46.72 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.932 2.093 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.0 -158.5 53.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.48 0.562 . . . . 0.0 112.631 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 76' ' ' ASP . 3.4 t -148.52 -168.8 3.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.068 -0.666 . . . . 0.0 112.323 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.2 p -142.26 178.67 7.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.105 2.162 . . . . 0.0 111.155 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.21 10.61 6.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.348 1.459 . . . . 0.0 111.971 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 ' CB ' ' A' ' 3' ' ' ALA . 6.8 m -139.2 169.18 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.184 2.593 . . . . 0.0 113.88 -168.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.43 132.57 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.788 2.035 . . . . 0.0 109.804 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.61 153.97 65.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 119.672 1.123 . . . . 0.0 111.842 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.5 165.45 30.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.824 3.016 . . . . 0.0 109.947 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.13 -33.67 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.414 -0.804 . . . . 0.0 112.153 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -115.11 133.72 55.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.509 1.524 . . . . 0.0 109.917 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.96 106.36 5.77 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.373 1.069 . . . . 0.0 110.121 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.71 163.35 35.59 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.776 1.651 . . . . 0.0 112.051 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.87 150.94 27.01 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.636 -0.665 . . . . 0.0 111.075 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 0.5 OUTLIER 76.96 -3.19 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.838 2.855 . . . . 0.0 114.17 -176.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -112.54 149.53 32.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.499 1.52 . . . . 0.0 109.372 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.23 157.72 29.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 109.916 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.7 pt? -94.38 176.81 6.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.883 0.849 . . . . 0.0 109.72 175.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.48 129.7 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.925 2.09 . . . . 0.0 109.16 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -149.12 168.94 21.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.624 0.77 . . . . 0.0 111.204 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -148.66 174.43 12.17 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.157 0.983 . . . . 0.0 111.255 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.3 118.7 0.85 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.1 1.333 . . . . 0.0 111.839 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -118.7 150.15 40.24 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.002 1.401 . . . . 0.0 112.379 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -70.16 116.08 10.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 54' ' ' THR . 10.2 m-20 42.85 -151.2 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.745 1.618 . . . . 0.0 113.533 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -75.05 -39.95 60.61 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.268 -1.52 . . . . 0.0 112.034 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.41 -62.08 0.37 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.21 1.386 . . . . 0.0 113.646 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.68 3.86 2.95 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 125.279 3.986 . . . . 0.0 115.601 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.56 132.31 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 127.646 2.379 . . . . 0.0 109.404 -174.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 69.85 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.303 1.441 . . . . 0.0 111.274 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -108.42 -71.21 0.77 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.364 1.065 . . . . 0.0 110.859 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.95 35.86 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.988 0.804 . . . . 0.0 112.164 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -135.38 112.18 10.14 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.765 1.226 . . . . 0.0 108.466 174.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 135.31 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.63 167.16 23.64 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.43 141.66 22.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 110.968 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.449 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -131.96 172.65 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.381 1.472 . . . . 0.0 109.151 -176.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.54 148.31 44.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -127.8 120.2 27.35 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.755 1.222 . . . . 0.0 110.779 -179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -82.69 125.11 30.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.614 . . . . 0.0 110.687 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.447 ' CE ' HD23 ' A' ' 98' ' ' LEU . 1.4 mtm -88.2 164.36 15.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.934 0.894 . . . . 0.0 112.953 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -60.52 -22.7 63.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.688 1.195 . . . . 0.0 113.634 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -81.98 -8.19 59.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.672 1.589 . . . . 0.0 113.272 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.23 65.56 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.928 1.251 . . . . 0.0 115.252 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.06 171.93 9.48 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.127 0.971 . . . . 0.0 110.979 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.6 m -133.74 146.43 50.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.059 0.944 . . . . 0.0 111.611 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CE ' ' A' ' 92' ' ' MET . 1.3 pp -117.45 130.61 56.58 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.432 1.093 . . . . 0.0 108.31 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.6 145.34 17.9 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.93 115.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.729 1.212 . . . . 0.0 109.005 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.512 ' HG3' ' H ' ' A' ' 116' ' ' ASP . 1.9 ptm -113.49 160.89 18.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.958 0.503 . . . . 0.0 112.086 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.46 141.62 39.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.554 1.142 . . . . 0.0 109.678 175.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 m -128.5 106.62 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.411 1.884 . . . . 0.0 108.801 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.2 101.59 53.67 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 126.487 1.915 . . . . 0.0 108.813 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.6 171.36 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.317 2.678 . . . . 0.0 111.977 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.02 -24.31 28.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.5 0.72 . . . . 0.0 112.023 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.49 116.32 32.15 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.267 1.427 . . . . 0.0 111.889 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -71.12 -59.3 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.32 10.54 29.33 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.103 -0.998 . . . . 0.0 113.612 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.76 -4.86 5.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.01 2.124 . . . . 0.0 112.615 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 160.49 39.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.837 2.455 . . . . 0.0 109.249 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.6 m -125.02 164.7 19.61 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.07 -1.019 . . . . 0.0 110.834 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -85.12 140.9 30.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.516 0.727 . . . . 0.0 109.884 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 156.94 47.63 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -161.93 140.73 9.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.501 1.52 . . . . 0.0 111.156 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 101' ' ' MET . 10.8 t70 -125.57 142.42 51.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.384 1.474 . . . . 0.0 109.214 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -138.36 113.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.345 1.458 . . . . 0.0 109.834 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.65 143.1 50.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.795 1.638 . . . . 0.0 108.845 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.28 118.59 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.661 1.984 . . . . 0.0 108.514 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -129.89 136.0 49.01 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.454 1.501 . . . . 0.0 112.426 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.1 p -70.32 84.77 0.57 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.483 1.913 . . . . 0.0 112.242 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.51 -174.12 44.44 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.451 1.024 . . . . 0.0 113.655 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -115.82 114.37 24.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.598 1.959 . . . . 0.0 110.151 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 159.65 40.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.984 0.913 . . . . 0.0 111.877 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 163.15 33.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.254 1.422 . . . . 0.0 111.27 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.33 89.09 0.2 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.255 1.422 . . . . 0.0 110.923 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.52 -61.33 1.61 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 109.88 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -71.89 0.19 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.245 1.418 . . . . 0.0 109.046 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.1 -32.54 72.96 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.981 0.8 . . . . 0.0 114.416 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -66.07 -53.2 41.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.082 0.941 . . . . 0.0 110.549 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -57.76 -39.83 78.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.455 0.702 . . . . 0.0 110.592 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -48.38 79.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -27.52 67.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.915 0.886 . . . . 0.0 112.923 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -82.7 -50.15 9.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.21 1.004 . . . . 0.0 110.127 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.15 -47.71 67.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.095 1.358 . . . . 0.0 113.7 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -88.81 -13.82 38.48 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.84 -83.15 0.05 OUTLIER Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.824 1.202 . . . . 0.0 112.197 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -168.12 72.75 0.88 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.013 1.725 . . . . 0.0 110.139 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.4 133.04 29.01 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.625 0.883 . . . . 0.0 110.336 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -61.42 158.34 14.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.046 1.338 . . . . 0.0 110.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -95.16 3.71 54.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -164.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 54.69 49.45 61.44 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.481 1.039 . . . . 0.0 112.946 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.91 20.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.41 2.284 . . . . 0.0 115.058 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.265 9.7 p30 48.79 38.45 11.88 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.362 2.265 . . . . 0.0 114.674 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.86 160.35 26.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.596 1.57 . . . . 0.0 112.731 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -68.75 127.12 31.94 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.137 0.975 . . . . 0.0 111.423 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -120.84 106.38 11.61 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.602 1.961 . . . . 0.0 109.464 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.74 150.12 43.01 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.893 1.277 . . . . 0.0 110.989 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 142.28 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.2 1.8 . . . . 0.0 110.241 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -61.53 132.41 53.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.111 0.564 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 tp -147.4 -37.24 0.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.52 25.66 4.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.04 1.305 . . . . 0.0 114.47 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.86 9.75 1.3 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.338 2.255 . . . . 0.0 115.492 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.96 -49.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.239 1.399 . . . . 0.0 112.18 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.88 156.63 18.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.854 0.835 . . . . 0.0 111.597 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 169.09 22.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.974 1.709 . . . . 0.0 112.06 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -94.77 138.8 32.11 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.214 1.006 . . . . 0.0 111.473 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -126.69 106.42 9.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.039 1.736 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.29 169.13 24.64 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 114.779 0.671 . . . . 0.0 114.779 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.92 143.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 125.951 1.7 . . . . 0.0 109.317 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.84 147.6 33.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.537 1.535 . . . . 0.0 108.06 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -96.08 171.58 8.53 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.241 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m -104.28 21.83 15.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.317 1.447 . . . . 0.0 112.458 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 -178.32 3.54 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 112.591 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.57 -36.52 78.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.99 0.805 . . . . 0.0 114.424 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.89 75.21 4.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.666 1.587 . . . . 0.0 111.023 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.91 73.06 1.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 112.251 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -43.99 141.14 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.585 1.954 . . . . 0.0 110.465 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 ttm -142.13 106.25 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.132 0.967 . . . . 0.0 110.566 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -124.2 139.67 53.7 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.432 HD13 HG12 ' A' ' 35' ' ' ILE . 3.8 mp -131.39 101.33 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.633 1.573 . . . . 0.0 108.964 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.71 104.78 16.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.363 1.865 . . . . 0.0 109.432 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -87.63 124.28 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 121.819 -0.551 . . . . 0.0 110.989 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.1 m -141.21 167.88 21.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 112.959 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 128.153 2.581 . . . . 0.0 112.686 175.126 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.1 -51.77 0.07 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.579 -1.326 . . . . 0.0 110.783 -171.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.35 158.05 0.06 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.699 2.8 . . . . 0.0 113.335 -166.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.84 44.59 96.92 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.296 -0.878 . . . . 0.0 114.1 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -144.74 -176.59 5.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.433 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.69 135.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.288 1.835 . . . . 0.0 110.616 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -141.06 167.0 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.382 1.473 . . . . 0.0 111.225 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.0 125.73 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.925 -1.109 . . . . 0.0 110.423 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.36 -21.14 59.53 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.897 0.761 . . . . 0.0 113.447 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.32 72.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.226 1.41 . . . . 0.0 112.049 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.63 -30.33 41.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.707 1.203 . . . . 0.0 112.762 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 tp -55.53 106.41 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.053 1.741 . . . . 0.0 111.151 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 m -149.88 166.98 27.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.543 1.537 . . . . 0.0 109.762 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -44.62 -39.28 4.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.968 1.707 . . . . 0.0 114.618 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.31 -36.02 76.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.12 -35.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.874 1.669 . . . . 0.0 110.618 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.9 mt -56.44 -52.22 65.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.902 0.774 . . . . 0.0 111.127 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -53.53 -39.82 64.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.973 0.806 . . . . 0.0 112.148 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 14.0 mmtm -59.84 -32.44 70.69 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.547 1.139 . . . . 0.0 113.274 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 70' ' ' LEU . 32.0 t -63.97 -52.31 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 108.968 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.04 -41.16 74.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.021 0.528 . . . . 0.0 111.757 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.8 -56.7 18.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.485 1.114 . . . . 0.0 112.617 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.81 -38.6 46.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -21.79 66.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.262 1.025 . . . . 0.0 111.07 175.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.46 73.09 0.96 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.037 1.303 . . . . 0.0 110.153 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -45.2 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.637 1.575 . . . . 0.0 112.449 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 28' ' ' SER . 2.5 p -76.07 -163.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.51 1.524 . . . . 0.0 110.22 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 27' ' ' VAL . 8.0 t -44.28 -33.95 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.606 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.05 134.36 13.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.179 1.791 . . . . 0.0 110.78 175.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.2 165.01 34.58 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.75 155.0 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.013 0.824 . . . . 0.0 111.731 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.23 115.58 30.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.005 0.922 . . . . 0.0 110.58 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.16 144.03 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.006 1.322 . . . . 0.0 110.948 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.36 0.77 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.92 0.771 . . . . 0.0 112.789 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.89 103.93 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.817 1.247 . . . . 0.0 110.438 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.32 124.31 27.96 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.699 1.6 . . . . 0.0 113.741 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.43 103.81 9.61 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.328 1.851 . . . . 0.0 113.954 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.25 36.49 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.803 2.041 . . . . 0.0 112.323 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.549 1.54 . . . . 0.0 113.662 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.59 11.63 49.29 Favored Glycine 0 CA--C 1.541 1.687 0 O-C-N 120.983 -1.073 . . . . 0.0 115.182 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.97 162.31 28.33 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.001 1.762 . . . . 0.0 113.051 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -76.57 137.67 39.68 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.601 1.16 . . . . 0.0 112.517 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 92' ' ' MET . 49.0 m0 -107.61 164.32 12.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.91 1.684 . . . . 0.0 111.574 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -131.01 111.75 12.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.767 1.227 . . . . 0.0 109.28 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.64 127.19 30.12 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.71 -68.14 0.41 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 176.99 172.47 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.903 2.481 . . . . 0.0 110.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.26 47.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.638 2.375 . . . . 0.0 109.514 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -123.96 109.93 14.16 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.282 1.033 . . . . 0.0 111.177 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -70.19 112.26 6.42 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 111.347 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -94.15 -32.94 13.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.714 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -142.58 148.99 38.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 109.646 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -175.46 47.76 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.549 1.071 . . . . 0.0 115.141 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.95 144.73 35.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.964 1.306 . . . . 0.0 111.93 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -102.26 167.25 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.944 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.72 -0.76 21.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.482 1.113 . . . . 0.0 112.587 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.91 -178.56 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.873 2.069 . . . . 0.0 112.568 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.38 139.54 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 110.696 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.71 146.33 79.82 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 118.856 0.753 . . . . 0.0 112.957 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.12 150.99 54.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.014 3.809 . . . . 0.0 111.608 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 16.9 tt0 -92.45 -22.21 19.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -123.54 126.85 47.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.575 1.55 . . . . 0.0 110.646 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.14 96.22 12.89 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 109.672 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.0 167.6 21.2 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.848 2.366 . . . . 0.0 113.444 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.87 158.0 8.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.194 -0.941 . . . . 0.0 109.925 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.271 7.3 t 59.45 6.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.154 2.181 . . . . 0.0 114.474 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -127.38 121.47 31.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.82 2.048 . . . . 0.0 110.102 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.4 171.63 8.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.248 1.019 . . . . 0.0 110.15 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -108.41 171.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -123.53 130.35 52.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.909 1.284 . . . . 0.0 109.872 174.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.55 171.16 17.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.885 0.85 . . . . 0.0 110.857 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.3 m -156.71 170.44 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.88 1.272 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.27 121.85 2.17 Favored Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.52 156.97 38.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.573 1.687 . . . . 0.0 109.564 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 12.7 ptpt -61.44 179.5 0.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.95 0.5 . . . . 0.0 111.176 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -67.7 -160.08 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 121.061 -1.024 . . . . 0.0 110.738 176.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.5 m -30.67 -51.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.429 1.892 . . . . 0.0 115.922 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.54 -60.64 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.769 1.176 . . . . 0.0 113.269 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.82 -7.7 21.74 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.398 3.399 . . . . 0.0 114.957 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 76' ' ' ASP . 15.0 m -74.34 123.55 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.441 1.896 . . . . 0.0 112.443 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.47 71.8 4.37 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.893 -1.13 . . . . 0.0 111.646 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.6 m -119.21 -85.32 0.65 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.419 1.088 . . . . 0.0 111.689 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.16 -178.59 33.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.874 1.226 . . . . 0.0 111.251 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.725 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -142.96 111.43 6.24 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.597 0.759 . . . . 0.0 112.728 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.84 122.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -142.03 150.43 41.28 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.969 0.908 . . . . 0.0 111.111 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.64 143.97 51.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 111.115 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' CD2' HG23 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -146.64 175.17 10.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.522 1.929 . . . . 0.0 111.721 -174.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -144.1 153.18 41.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.109 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 2.0 m-85 -133.8 117.37 16.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.604 1.562 . . . . 0.0 111.03 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -75.19 117.24 16.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 110.3 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.414 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 17.3 mtm -74.25 161.96 29.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 112.156 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 t -60.87 -23.62 65.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.532 1.133 . . . . 0.0 113.519 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 m -78.63 -20.49 50.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 114.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.63 39.69 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.671 1.129 . . . . 0.0 115.777 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -87.42 171.34 10.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.564 1.145 . . . . 0.0 110.666 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 53.9 m -140.07 136.99 34.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.748 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.19 126.99 53.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.538 -0.755 . . . . 0.0 108.984 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.58 128.76 8.71 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.43 HG23 ' CD2' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -137.54 140.24 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.593 1.157 . . . . 0.0 110.345 178.307 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.6 ptm -144.54 170.11 16.69 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.8 p90 -126.94 156.46 41.47 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.436 1.095 . . . . 0.0 111.142 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.7 t -140.07 123.72 17.25 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.406 1.482 . . . . 0.0 109.754 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.725 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 44.2 t -120.81 91.37 47.4 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 126.895 2.078 . . . . 0.0 107.686 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.24 143.39 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.399 2.733 . . . . 0.0 110.705 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.45 -41.08 85.29 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.103 0.561 . . . . 0.0 111.633 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.43 138.26 36.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 111.042 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.04 -72.01 0.37 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.458 -0.776 . . . . 0.0 111.457 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.67 -1.91 23.88 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.774 1.23 . . . . 0.0 113.639 -173.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -5.84 6.22 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.811 2.044 . . . . 0.0 112.731 -164.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.38 149.47 28.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.822 2.449 . . . . 0.0 109.48 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -111.07 163.73 13.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.661 0.784 . . . . 0.0 110.14 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.96 137.86 32.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.419 1.088 . . . . 0.0 109.234 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -126.81 138.49 53.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.717 1.207 . . . . 0.0 111.571 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -150.02 146.21 26.85 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.28 -1.512 . . . . 0.0 111.335 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.91 154.89 45.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.975 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.38 115.44 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.397 1.479 . . . . 0.0 111.384 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -114.97 117.7 31.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 108.738 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mt -103.24 111.79 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.872 1.669 . . . . 0.0 107.587 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.14 162.83 34.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.475 0.71 . . . . 0.0 112.58 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -80.05 79.94 6.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.662 1.185 . . . . 0.0 112.275 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 -149.45 8.55 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.25 0.929 . . . . 0.0 113.509 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -131.26 84.51 2.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 128.322 2.649 . . . . 0.0 111.665 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.85 77.7 7.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.066 1.347 . . . . 0.0 111.827 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -65.11 164.43 13.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.608 0.763 . . . . 0.0 112.399 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.415 ' HB2' ' CD1' ' A' ' 131' ' ' TYR . . . -132.84 112.71 12.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.857 2.063 . . . . 0.0 110.211 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -111.35 -75.17 0.62 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -152.06 -74.94 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.953 1.701 . . . . 0.0 108.087 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.66 -11.15 62.13 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.072 1.32 . . . . 0.0 115.027 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -63.98 1.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 1.316 . . . . 0.0 107.612 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -63.55 -16.46 60.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -33.03 61.9 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.849 0.749 . . . . 0.0 110.731 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.24 -28.97 64.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.397 1.079 . . . . 0.0 112.908 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.79 -33.85 22.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.338 1.055 . . . . 0.0 110.003 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -75.83 -45.45 35.76 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.206 -0.934 . . . . 0.0 113.21 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -96.2 -16.9 21.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.877 0.871 . . . . 0.0 113.336 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -70.09 1.06 Allowed Glycine 0 N--CA 1.475 1.242 0 C-N-CA 124.104 0.859 . . . . 0.0 112.556 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 179.99 73.32 0.17 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 128.215 2.606 . . . . 0.0 111.072 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 158.19 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.769 1.646 . . . . 0.0 110.965 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.56 121.64 30.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.437 ' H ' ' NE ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.45 158.43 35.76 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.328 -0.857 . . . . 0.0 112.163 175.806 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.21 70.79 1.02 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.514 1.531 . . . . 0.0 112.633 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.26 24.48 0.34 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.388 1.875 . . . . 0.0 113.853 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.2 p30 48.19 35.3 5.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.923 2.089 . . . . 0.0 114.901 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.96 156.46 23.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.057 1.313 . . . . 0.0 113.049 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -65.19 126.75 29.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.203 1.001 . . . . 0.0 110.538 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.57 105.58 9.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.804 1.642 . . . . 0.0 108.919 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.09 140.5 36.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.609 1.563 . . . . 0.0 111.419 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -160.7 137.82 9.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.006 . . . . 0.0 111.391 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -57.71 107.17 0.42 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.789 1.235 . . . . 0.0 112.309 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 tp -128.67 -30.23 2.32 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.046 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.93 22.16 7.08 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.656 1.122 . . . . 0.0 114.092 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.37 13.19 3.87 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.297 2.239 . . . . 0.0 115.091 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.38 -57.59 0.11 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.126 1.822 . . . . 0.0 111.65 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.2 mp -91.3 148.49 22.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.726 0.774 . . . . 0.0 110.606 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 169.5 17.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.512 1.525 . . . . 0.0 111.731 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 144.66 29.52 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.757 1.223 . . . . 0.0 110.37 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.88 102.06 6.61 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.742 2.017 . . . . 0.0 108.464 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.29 167.55 21.86 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.0 0.778 . . . . 0.0 112.93 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.1 tt -151.81 139.36 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.548 1.939 . . . . 0.0 108.527 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.7 ttm -142.29 139.63 31.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 78.2 p -88.14 169.68 11.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 110.977 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -87.15 11.36 14.15 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.098 -1.001 . . . . 0.0 113.615 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.92 170.44 10.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.147 2.179 . . . . 0.0 113.226 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.6 -73.6 0.72 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.937 1.256 . . . . 0.0 111.525 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.72 38.66 0.05 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.984 2.113 . . . . 0.0 114.808 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 176.13 4.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 0.0 113.301 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 mptt -129.8 145.53 51.57 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.008 1.323 . . . . 0.0 110.403 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.3 ttm -136.95 88.89 2.4 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.424 1.89 . . . . 0.0 110.672 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -83.42 157.46 22.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 111.044 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.91 116.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.101 1.76 . . . . 0.0 107.572 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.39 109.52 20.85 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.922 1.689 . . . . 0.0 108.4 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.24 147.16 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -127.93 170.99 12.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.214 1.805 . . . . 0.0 111.239 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.534 1.934 . . . . 0.0 113.381 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 tp -92.85 -103.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.413 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 48.2 169.79 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.916 2.086 . . . . 0.0 113.847 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.2 40.27 91.4 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 p -141.0 -170.94 3.15 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.561 1.144 . . . . 0.0 111.869 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.9 141.1 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.661 1.984 . . . . 0.0 111.024 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.499 HG12 HD21 ' A' ' 70' ' ' LEU . 1.9 pt -142.09 167.05 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.232 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.53 124.27 18.41 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.751 1.22 . . . . 0.0 112.033 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.67 -24.19 39.17 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.558 1.552 . . . . 0.0 114.055 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.95 70.31 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.474 1.11 . . . . 0.0 111.898 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.61 -19.9 44.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.714 1.605 . . . . 0.0 113.237 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD22 ' CB ' ' A' ' 68' ' ' ALA . 6.3 tp -66.97 105.99 1.8 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.241 1.416 . . . . 0.0 111.206 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 m -144.36 167.87 21.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.249 1.42 . . . . 0.0 109.676 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -46.81 -33.65 4.63 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.623 1.569 . . . . 0.0 113.251 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -58.91 -53.73 55.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.192 0.997 . . . . 0.0 111.128 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -40.5 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.945 0.898 . . . . 0.0 111.894 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 mt -59.65 -54.01 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.176 0.991 . . . . 0.0 111.759 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.55 -38.73 92.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -57.91 -48.45 79.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.256 1.022 . . . . 0.0 112.156 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -55.91 -47.58 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.367 1.067 . . . . 0.0 111.253 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.3 -42.47 95.58 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.45 1.1 . . . . 0.0 113.608 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.25 -47.77 84.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.768 0.427 . . . . 0.0 111.529 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.17 -39.18 72.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 tp -52.81 -57.27 10.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.91 2.084 . . . . 0.0 111.387 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.56 51.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.661 1.124 . . . . 0.0 112.896 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -37.65 127.69 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.514 1.926 . . . . 0.0 113.639 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 28' ' ' SER . 2.7 p -129.83 -169.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.102 1.761 . . . . 0.0 110.623 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.495 ' H ' HG22 ' A' ' 27' ' ' VAL . 28.1 m -43.63 -32.11 0.9 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.675 1.99 . . . . 0.0 115.06 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -141.69 145.91 35.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.422 1.889 . . . . 0.0 107.604 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -165.22 147.64 7.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.822 1.249 . . . . 0.0 110.432 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 2.1 pt -141.52 144.42 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.562 0.619 . . . . 0.0 111.16 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.2 116.27 30.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.243 1.017 . . . . 0.0 110.772 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 t -107.45 138.68 32.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 110.3 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.84 114.81 0.67 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.419 1.009 . . . . 0.0 112.196 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.73 104.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.436 1.094 . . . . 0.0 109.622 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -82.77 107.49 15.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.916 1.286 . . . . 0.0 112.258 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -84.12 71.38 10.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.984 1.314 . . . . 0.0 114.225 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.23 21.45 0.18 Allowed 'General case' 0 CA--C 1.558 1.286 0 O-C-N 119.778 -1.826 . . . . 0.0 115.118 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 p -57.85 -48.47 79.71 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.0 -17.36 6.0 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.565 2.031 . . . . 0.0 116.107 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.2 -104.04 1.89 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.931 1.866 . . . . 0.0 116.282 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.0 t -162.58 135.95 6.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.875 1.67 . . . . 0.0 111.671 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -115.04 167.43 10.82 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.793 1.637 . . . . 0.0 111.276 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.9 m -141.36 111.35 6.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.158 0.983 . . . . 0.0 110.292 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.33 133.8 55.6 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.895 -1.128 . . . . 0.0 108.429 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -70.88 -69.26 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -172.41 171.29 4.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 110.453 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -123.59 142.46 51.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.816 2.046 . . . . 0.0 109.301 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.55 121.0 18.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.532 1.133 . . . . 0.0 111.43 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -74.5 128.25 35.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.829 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -45.12 6.24 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.929 1.692 . . . . 0.0 111.66 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -141.58 153.97 45.15 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.186 1.794 . . . . 0.0 110.324 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.88 -170.05 53.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 121.493 0.496 . . . . 0.0 113.054 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 t -140.86 164.04 31.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 110.651 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.6 p -149.71 178.98 8.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.774 1.23 . . . . 0.0 111.18 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 25.99 4.12 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.456 1.102 . . . . 0.0 112.446 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -124.33 172.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.71 2.004 . . . . 0.0 113.535 -174.64 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 mt -137.02 151.59 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.246 2.219 . . . . 0.0 109.199 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -100.14 141.16 22.22 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 120.212 1.369 . . . . 0.0 110.935 176.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.05 160.45 47.24 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.94 3.094 . . . . 0.0 111.028 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -104.22 -46.23 4.48 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.328 -0.857 . . . . 0.0 112.073 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.59 132.38 46.01 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.082 1.31 . . . . 0.0 111.938 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.91 92.15 11.25 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.868 1.667 . . . . 0.0 110.2 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.31 160.66 37.83 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.118 1.879 . . . . 0.0 112.042 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -58.14 159.9 5.45 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.124 -0.985 . . . . 0.0 110.706 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p 68.67 8.7 6.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.583 1.953 . . . . 0.0 113.543 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -136.66 110.12 7.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.368 1.867 . . . . 0.0 111.99 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -84.1 164.75 19.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.606 0.762 . . . . 0.0 112.164 175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.53 173.54 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.214 0.606 . . . . 0.0 110.947 174.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.499 HD21 HG12 ' A' ' 7' ' ' ILE . 3.2 mm? -129.7 127.66 40.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.478 1.911 . . . . 0.0 107.82 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.49 154.98 41.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.882 0.873 . . . . 0.0 110.65 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -148.52 162.93 38.65 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 111.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.76 138.71 6.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.308 0.956 . . . . 0.0 111.953 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 167.57 19.91 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.823 0.849 . . . . 0.0 110.293 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -65.29 -179.62 0.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.044 0.538 . . . . 0.0 110.467 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.85 -179.95 0.23 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.63 -0.669 . . . . 0.0 110.642 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.4 m -24.65 -54.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 128.053 2.541 . . . . 0.0 116.166 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.79 -58.98 0.32 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.404 1.478 . . . . 0.0 112.797 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.91 0.09 7.66 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.779 3.653 . . . . 0.0 115.736 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.06 104.5 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.242 2.217 . . . . 0.0 112.008 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.94 77.87 1.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.632 1.573 . . . . 0.0 112.927 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.8 m -110.74 -82.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.004 1.321 . . . . 0.0 111.304 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 161.95 179.42 36.6 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.099 1.333 . . . . 0.0 111.886 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.82 114.88 10.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 110.026 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.48 130.35 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.21 167.84 25.73 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.731 0.777 . . . . 0.0 110.743 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.46 154.72 36.09 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.017 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.39 169.39 21.53 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.038 1.735 . . . . 0.0 110.838 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.15 140.53 47.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.697 1.199 . . . . 0.0 110.964 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -123.67 112.56 17.53 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.032 1.333 . . . . 0.0 111.763 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -76.66 115.68 16.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 110.738 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.5 mtm -78.98 162.68 25.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.95 0.9 . . . . 0.0 112.284 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -60.23 -19.84 56.27 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -79.71 -11.37 59.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.405 1.482 . . . . 0.0 113.007 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.27 2.49 65.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.887 1.232 . . . . 0.0 114.435 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.71 169.99 11.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.778 1.231 . . . . 0.0 110.608 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.5 m -135.98 154.69 51.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.441 1.096 . . . . 0.0 110.19 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 127.95 48.34 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.267 1.027 . . . . 0.0 109.726 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.22 114.47 4.13 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.24 126.07 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.233 1.013 . . . . 0.0 108.716 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -140.8 164.32 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.73 0.776 . . . . 0.0 112.285 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.0 p90 -140.63 151.4 44.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.767 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -130.5 116.31 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.948 1.699 . . . . 0.0 110.066 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.67 99.19 47.63 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.834 1.654 . . . . 0.0 108.77 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.76 169.08 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.31 2.674 . . . . 0.0 112.432 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -76.51 -18.61 58.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.452 0.701 . . . . 0.0 112.783 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.23 109.5 18.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.685 1.594 . . . . 0.0 110.81 -167.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -64.98 -65.41 0.68 Allowed 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.276 -0.89 . . . . 0.0 113.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -86.57 9.3 18.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.66 -6.15 6.92 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.715 2.006 . . . . 0.0 112.661 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 139.06 14.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.728 2.011 . . . . 0.0 110.141 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 t -95.94 164.51 12.69 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.625 -1.297 . . . . 0.0 112.375 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.63 159.02 25.48 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.604 0.762 . . . . 0.0 109.092 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -141.27 141.18 33.98 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.27 -0.894 . . . . 0.0 111.531 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.2 p-90 -156.14 148.62 23.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.247 1.419 . . . . 0.0 110.502 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -145.3 155.21 43.07 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.309 1.843 . . . . 0.0 109.39 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.14 116.35 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.38 1.872 . . . . 0.0 109.414 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -120.41 137.33 54.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.488 1.915 . . . . 0.0 109.298 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.7 mt -102.41 120.19 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.971 1.708 . . . . 0.0 108.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.93 147.9 51.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.493 1.517 . . . . 0.0 112.062 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 p -77.02 78.98 3.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.41 1.084 . . . . 0.0 112.574 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.28 158.48 8.47 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.076 0.846 . . . . 0.0 114.883 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 121.87 16.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.522 1.529 . . . . 0.0 112.793 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -136.63 85.54 2.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.143 1.777 . . . . 0.0 109.289 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -60.21 170.97 1.12 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.007 0.923 . . . . 0.0 111.407 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.26 92.79 4.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.627 0.771 . . . . 0.0 111.067 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -98.39 -68.75 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.548 0.739 . . . . 0.0 110.404 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.28 -70.08 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.557 1.143 . . . . 0.0 110.408 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.12 -25.05 76.38 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.059 0.838 . . . . 0.0 114.661 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -48.08 27.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.261 1.024 . . . . 0.0 110.48 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -37.34 81.79 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.099 0.959 . . . . 0.0 110.927 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -54.75 -33.35 61.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.15 -33.35 73.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.434 1.016 . . . . 0.0 112.706 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.49 -41.19 61.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.024 0.829 . . . . 0.0 110.313 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -65.36 -59.31 4.17 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.756 -1.215 . . . . 0.0 111.741 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -79.44 -19.55 49.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.189 1.396 . . . . 0.0 112.698 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -76.66 0.22 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.365 0.983 . . . . 0.0 112.598 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.37 84.15 1.59 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.67 1.188 . . . . 0.0 110.433 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.49 157.21 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.539 1.493 . . . . 0.0 111.262 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.71 4.98 49.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.684 1.194 . . . . 0.0 113.412 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.25 66.81 0.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 128.194 2.597 . . . . 0.0 113.438 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -33.48 90.77 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.398 2.904 . . . . 0.0 114.869 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -110.07 43.89 1.3 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.957 1.703 . . . . 0.0 110.349 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 58.18 42.57 21.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.548 1.539 . . . . 0.0 112.84 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.84 146.99 18.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 112.813 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -68.58 131.15 44.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.091 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -127.68 108.08 10.45 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.885 1.674 . . . . 0.0 109.293 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.31 153.09 35.49 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.285 1.434 . . . . 0.0 111.947 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -167.86 146.02 4.52 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.318 1.447 . . . . 0.0 111.004 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.67 125.5 25.99 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.443 0.565 . . . . 0.0 109.806 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.2 tp -141.01 -36.19 0.46 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.35 1.06 . . . . 0.0 112.834 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.72 20.02 5.68 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.685 1.136 . . . . 0.0 114.486 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.5 12.35 2.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.311 2.245 . . . . 0.0 115.286 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.91 -67.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.379 1.942 . . . . 0.0 110.605 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.06 147.78 27.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.925 0.89 . . . . 0.0 110.604 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.83 168.1 24.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.376 1.47 . . . . 0.0 111.924 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -96.15 139.14 32.75 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.717 0.807 . . . . 0.0 111.655 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -128.67 108.33 10.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.72 1.608 . . . . 0.0 108.427 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.46 167.67 25.74 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 121.951 0.75 . . . . 0.0 114.154 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.3 tt -149.09 142.94 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.847 2.059 . . . . 0.0 108.823 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.2 ttm -134.82 137.36 43.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.427 1.091 . . . . 0.0 108.801 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.53 156.19 33.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.6 1.16 . . . . 0.0 111.7 175.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.93 9.15 31.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.42 177.67 4.8 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.132 2.173 . . . . 0.0 112.293 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.16 55.68 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.835 0.731 . . . . 0.0 113.053 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -86.5 51.45 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.476 1.51 . . . . 0.0 113.694 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.95 17.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.777 1.231 . . . . 0.0 113.828 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.69 53.77 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 0.0 112.432 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.42 90.29 3.27 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.392 2.277 . . . . 0.0 110.954 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -84.55 143.14 29.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.86 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.42 122.49 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.458 1.903 . . . . 0.0 107.506 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -118.71 111.01 17.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.879 1.272 . . . . 0.0 109.759 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.3 mm -83.13 117.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.183 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m -89.29 174.8 7.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 0.0 111.75 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.313 1.845 . . . . 0.0 113.196 -177.417 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 68.17 19.63 9.11 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.22 168.08 0.57 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.36 36.11 63.28 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.563 -0.711 . . . . 0.0 113.825 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -150.82 -169.19 3.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.121 0.968 . . . . 0.0 111.152 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 63' ' ' VAL . 1.6 pt -129.71 137.63 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.538 1.935 . . . . 0.0 111.861 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pp -145.5 165.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.223 1.809 . . . . 0.0 111.472 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.22 126.7 19.64 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.155 0.982 . . . . 0.0 112.803 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.15 -21.09 30.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.087 1.327 . . . . 0.0 114.047 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.02 72.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.465 1.506 . . . . 0.0 112.324 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -34.71 66.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.386 1.074 . . . . 0.0 112.113 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.63 100.02 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.784 1.634 . . . . 0.0 112.25 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.9 m -143.08 172.01 13.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.629 1.572 . . . . 0.0 110.463 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' H ' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER -49.41 -39.74 33.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.594 1.558 . . . . 0.0 113.697 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.66 -41.97 91.77 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.598 -0.689 . . . . 0.0 112.521 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.38 -46.81 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.626 0.77 . . . . 0.0 110.044 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -53.35 -60.18 3.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.596 0.759 . . . . 0.0 111.036 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.45 -43.28 67.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.071 0.948 . . . . 0.0 112.371 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -59.43 -29.17 67.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.686 1.195 . . . . 0.0 113.533 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.3 -48.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.226 -1.546 . . . . 0.0 110.009 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.3 -34.81 66.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.959 0.504 . . . . 0.0 111.526 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.1 -57.69 6.31 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.86 -40.38 47.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.853 1.206 . . . . 0.0 114.06 -172.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.43 -23.38 66.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.346 1.058 . . . . 0.0 111.532 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 68.2 1.44 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.368 1.461 . . . . 0.0 111.214 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.35 127.83 4.67 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 110.774 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 -161.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.118 2.167 . . . . 0.0 110.049 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -41.21 -49.3 3.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.12 1.368 . . . . 0.0 113.508 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -146.31 137.16 24.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.333 1.453 . . . . 0.0 111.377 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -157.6 171.15 20.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.511 1.524 . . . . 0.0 113.952 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.83 163.21 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.456 1.102 . . . . 0.0 112.122 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.68 111.91 17.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.302 1.441 . . . . 0.0 110.471 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -97.11 145.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.649 1.58 . . . . 0.0 111.904 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.53 122.38 1.14 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.022 1.296 . . . . 0.0 111.33 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.78 112.74 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.185 1.492 . . . . 0.0 110.226 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.0 134.97 35.02 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.35 79.22 7.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.056 1.742 . . . . 0.0 113.243 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.86 2.6 53.79 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.3 t -65.55 -17.52 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.521 2.328 . . . . 0.0 114.72 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.71 4.3 89.32 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 114.74 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.58 161.31 23.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.551 1.548 . . . . 0.0 114.026 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 t -78.25 134.86 37.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.491 1.516 . . . . 0.0 112.037 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -112.12 168.08 9.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.864 2.066 . . . . 0.0 111.469 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -136.93 108.06 6.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 110.737 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.54 117.76 6.65 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.873 -1.142 . . . . 0.0 108.539 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.49 -64.46 0.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.774 0.829 . . . . 0.0 109.88 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -177.98 171.05 1.8 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.517 2.327 . . . . 0.0 110.874 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -124.72 138.82 54.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 109.096 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -128.43 110.22 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.234 1.414 . . . . 0.0 111.133 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -72.5 121.32 19.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.724 1.209 . . . . 0.0 111.477 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.77 -33.6 14.93 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.446 1.498 . . . . 0.0 112.926 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 t -145.04 162.32 37.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.598 1.559 . . . . 0.0 111.115 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.9 -160.68 29.68 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.727 0.651 . . . . 0.0 114.727 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -144.83 -178.73 6.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.444 1.498 . . . . 0.0 111.972 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -147.25 166.19 27.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.846 1.658 . . . . 0.0 110.617 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.64 6.97 20.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.591 1.156 . . . . 0.0 111.608 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.72 153.41 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 128.305 2.642 . . . . 0.0 111.038 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -122.04 140.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.502 1.521 . . . . 0.0 108.764 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.31 140.1 75.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.369 -0.832 . . . . 0.0 109.618 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 6' ' ' ILE . 69.4 Cg_endo -65.5 176.64 3.26 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.459 3.439 . . . . 0.0 110.956 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -119.19 -21.89 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.656 -1.278 . . . . 0.0 113.036 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -128.83 137.28 51.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.414 1.886 . . . . 0.0 109.792 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 6' ' ' ILE . 27.1 t -139.86 96.91 8.18 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.843 1.257 . . . . 0.0 109.715 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.88 168.57 18.36 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 112.557 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.27 159.83 5.69 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.578 -0.701 . . . . 0.0 110.148 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.273 5.6 t 57.66 15.62 2.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.638 1.975 . . . . 0.0 113.792 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -133.09 120.12 20.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.927 2.491 . . . . 0.0 110.371 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.87 163.54 13.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.674 1.19 . . . . 0.0 110.45 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.567 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.96 169.0 9.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.19 132.93 46.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.871 2.068 . . . . 0.0 108.893 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -153.13 164.04 38.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.799 1.24 . . . . 0.0 110.44 175.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 m -145.31 175.29 10.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.462 1.105 . . . . 0.0 111.207 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.58 103.66 0.24 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 125.176 1.37 . . . . 0.0 110.742 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 176.98 4.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.428 1.114 . . . . 0.0 111.572 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -66.59 -176.98 0.52 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.44 -177.02 0.27 Allowed 'General case' 0 CA--C 1.559 1.298 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -10.33 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 127.944 2.497 . . . . 0.0 116.521 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.43 -72.07 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.212 0.91 . . . . 0.0 113.038 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.99 84.07 1.72 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.757 3.638 . . . . 0.0 112.368 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.08 140.8 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.151 1.381 . . . . 0.0 112.256 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 64.59 0.84 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.015 1.326 . . . . 0.0 111.635 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.8 t -122.53 -97.22 0.45 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 110.855 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.514 ' H ' HG23 ' A' ' 82' ' ' THR . . . -174.74 -177.46 43.87 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.967 2.698 . . . . 0.0 110.883 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -141.29 99.46 3.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.111 1.364 . . . . 0.0 108.742 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' SER . 88.6 t -135.69 131.12 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.107 . . . . 0.0 108.584 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.1 166.9 31.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.57 0.748 . . . . 0.0 111.22 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.05 158.14 43.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.711 0.767 . . . . 0.0 112.42 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.46 171.18 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.648 1.979 . . . . 0.0 110.478 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.51 142.37 43.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.155 0.982 . . . . 0.0 111.174 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.567 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 1.1 m-85 -125.84 111.73 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.047 1.339 . . . . 0.0 111.33 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -73.61 114.35 11.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.004 1.321 . . . . 0.0 110.805 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.1 mtt -76.6 160.7 29.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.435 0.636 . . . . 0.0 111.364 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 t -61.66 -17.76 56.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.0 m -79.51 -13.33 59.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.014 1.726 . . . . 0.0 113.548 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.21 55.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.605 1.098 . . . . 0.0 114.835 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.88 173.43 11.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.242 1.017 . . . . 0.0 111.687 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 m -133.77 142.94 48.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.94 0.896 . . . . 0.0 108.587 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.92 125.72 54.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 108.932 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.62 148.46 24.95 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.8 130.55 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.312 1.045 . . . . 0.0 109.255 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.65 45.88 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 22.8 p90 -127.01 153.27 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.147 1.379 . . . . 0.0 110.696 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 85' ' ' VAL . 19.9 t -136.9 111.45 8.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.497 1.119 . . . . 0.0 111.49 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 32.1 t -115.02 102.18 54.75 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.51 1.924 . . . . 0.0 109.344 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.01 171.25 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.841 2.361 . . . . 0.0 112.542 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -72.39 -53.83 11.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.326 . . . . 0.0 110.632 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.01 107.48 7.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.227 3.411 . . . . 0.0 112.398 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.19 -60.16 3.79 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.274 1.03 . . . . 0.0 113.539 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.59 9.45 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -4.15 6.85 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.566 1.947 . . . . 0.0 112.456 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.2 146.04 26.61 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.395 2.278 . . . . 0.0 109.496 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.92 165.31 11.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.365 1.066 . . . . 0.0 111.869 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.44 156.93 18.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.666 -0.646 . . . . 0.0 110.112 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -140.5 146.14 37.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.35 0.66 . . . . 0.0 109.92 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -147.97 155.6 41.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.991 1.316 . . . . 0.0 110.021 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.56 138.23 20.93 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.846 -0.534 . . . . 0.0 111.62 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.7 t -147.74 103.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.334 1.854 . . . . 0.0 110.102 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -120.6 143.37 48.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.036 1.335 . . . . 0.0 110.065 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.51 111.6 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.249 1.819 . . . . 0.0 108.756 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -116.33 141.47 48.11 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.711 1.604 . . . . 0.0 111.853 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.7 p -72.48 80.55 1.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.288 1.435 . . . . 0.0 113.104 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.06 159.56 8.64 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.221 1.391 . . . . 0.0 113.321 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -73.79 133.94 43.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.466 0.707 . . . . 0.0 112.383 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -141.9 143.15 33.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.515 1.926 . . . . 0.0 111.215 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -99.32 -179.35 4.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.662 1.585 . . . . 0.0 110.942 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.9 95.9 4.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.206 1.803 . . . . 0.0 110.177 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.79 -71.08 0.78 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.903 1.281 . . . . 0.0 110.559 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.48 -69.79 0.24 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.323 1.849 . . . . 0.0 109.637 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.54 73.27 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.638 1.113 . . . . 0.0 115.241 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -84.2 -45.82 12.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.182 0.991 . . . . 0.0 110.872 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.15 -44.01 96.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.995 0.918 . . . . 0.0 112.393 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.77 -29.23 69.29 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.025 -1.047 . . . . 0.0 112.441 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -16.06 60.42 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.192 -0.943 . . . . 0.0 112.499 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.66 -55.58 2.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 108.44 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -69.03 -48.14 63.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -87.62 -15.21 37.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.746 0.819 . . . . 0.0 112.743 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.78 60.18 4.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.575 1.083 . . . . 0.0 114.208 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 42.75 76.97 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 127.046 2.138 . . . . 0.0 111.754 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.64 149.04 73.37 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.783 1.655 . . . . 0.0 110.827 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.89 156.7 36.12 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.951 0.881 . . . . 0.0 110.489 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 115.42 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 109.207 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.61 67.01 0.78 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.323 1.439 . . . . 0.0 113.511 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.75 25.36 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.786 2.034 . . . . 0.0 114.386 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 54.72 41.71 31.73 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.994 1.717 . . . . 0.0 113.063 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.4 167.51 24.15 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.656 2.074 . . . . 0.0 112.232 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -75.34 128.56 35.68 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.593 -0.945 . . . . 0.0 111.592 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -120.1 112.86 19.65 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.481 ' HG2' HH21 ' A' ' 156' ' ' ARG . 1.3 pm0 -153.88 148.59 26.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 111.507 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -161.88 147.08 13.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.038 1.335 . . . . 0.0 111.4 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -62.97 123.05 17.54 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.926 -0.484 . . . . 0.0 110.972 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -142.84 -31.6 0.5 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.263 1.025 . . . . 0.0 113.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.85 17.26 16.82 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.963 1.268 . . . . 0.0 114.541 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.2 t80 59.87 10.31 2.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.416 2.287 . . . . 0.0 114.697 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.9 -67.32 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.647 1.594 . . . . 0.0 110.606 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.35 156.54 16.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.577 0.703 . . . . 0.0 111.626 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.481 HH21 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -143.94 165.88 26.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.067 1.747 . . . . 0.0 112.719 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -92.44 133.59 35.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.85 1.26 . . . . 0.0 110.143 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -123.11 106.79 11.09 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.718 1.207 . . . . 0.0 109.339 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-O 122.38 0.989 . . . . 0.0 114.65 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.64 145.29 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.974 2.11 . . . . 0.0 108.186 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.8 131.3 33.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.234 1.814 . . . . 0.0 106.687 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 166.83 19.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.108 0.963 . . . . 0.0 112.079 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 m -95.13 11.6 31.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.661 1.584 . . . . 0.0 113.793 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.13 167.95 10.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 112.368 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.05 26.4 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 121.348 -0.845 . . . . 0.0 112.992 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.16 47.51 0.46 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.503 1.521 . . . . 0.0 113.715 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.46 161.39 27.82 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.716 -1.24 . . . . 0.0 113.44 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.08 133.99 55.47 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 108.913 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.1 ttp -128.53 110.46 12.3 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.494 1.518 . . . . 0.0 111.081 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -122.65 140.98 52.23 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.626 -0.671 . . . . 0.0 109.654 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.7 111.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.754 1.622 . . . . 0.0 109.729 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -100.44 105.37 16.84 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.409 1.484 . . . . 0.0 108.368 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.6 mm -74.06 136.23 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.0 t -151.09 167.18 28.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.956 . . . . 0.0 112.108 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.263 2.225 . . . . 0.0 110.344 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.66 2.92 18.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.654 1.182 . . . . 0.0 113.424 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.625 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.21 150.33 39.22 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.111 -0.993 . . . . 0.0 111.381 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.94 34.18 87.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 p -142.52 -165.08 1.96 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.596 1.198 . . . . 0.0 111.539 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.36 144.1 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.891 1.676 . . . . 0.0 110.991 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.0 168.88 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.079 1.352 . . . . 0.0 112.18 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 120.67 7.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.105 1.362 . . . . 0.0 111.555 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.14 -25.36 64.37 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.156 0.884 . . . . 0.0 113.11 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.05 68.62 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.174 1.389 . . . . 0.0 113.078 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -96.29 -16.41 21.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.147 1.379 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.5 tp -68.64 107.22 2.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.15 1.38 . . . . 0.0 110.233 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -145.5 169.92 17.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.275 1.03 . . . . 0.0 109.883 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -50.85 -31.53 17.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.878 1.271 . . . . 0.0 113.703 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -61.74 -36.24 80.43 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.358 0.663 . . . . 0.0 112.567 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -39.97 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.782 1.233 . . . . 0.0 111.104 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.28 -47.84 77.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.031 0.932 . . . . 0.0 112.03 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.02 -49.32 76.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.061 0.544 . . . . 0.0 111.69 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -58.53 -36.79 74.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 34.2 t -63.79 -59.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.211 1.404 . . . . 0.0 111.237 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.43 -38.09 73.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.815 1.246 . . . . 0.0 112.141 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -41.33 67.52 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.008 0.822 . . . . 0.0 111.953 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.68 -37.07 65.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 57' ' ' VAL . 11.2 tp -48.39 -52.77 20.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.496 1.518 . . . . 0.0 111.638 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.15 58.67 0.15 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.699 1.143 . . . . 0.0 111.002 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 142.33 6.06 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.253 1.421 . . . . 0.0 112.444 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.78 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 109.711 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.3 m -45.0 -31.23 1.22 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.311 1.844 . . . . 0.0 115.525 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.497 HH11 ' HG2' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.93 134.89 17.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.487 1.515 . . . . 0.0 109.222 174.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.43 161.04 30.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.371 2.268 . . . . 0.0 110.628 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -139.21 166.22 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.732 1.613 . . . . 0.0 110.326 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.54 110.55 14.6 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.751 1.22 . . . . 0.0 110.866 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.91 138.6 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.8 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 112.18 0.54 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.535 1.064 . . . . 0.0 112.911 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.2 109.87 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.456 1.128 . . . . 0.0 109.214 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -87.81 110.76 20.73 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 112.41 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -71.45 98.1 1.76 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.271 1.428 . . . . 0.0 111.31 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.93 12.75 15.82 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.942 1.697 . . . . 0.0 113.34 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 t -62.68 -54.51 38.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.559 1.144 . . . . 0.0 114.001 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.3 2.36 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.949 1.261 . . . . 0.0 116.166 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.48 163.36 29.9 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.625 1.712 . . . . 0.0 114.03 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.4 p -74.09 138.85 44.22 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.108 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -112.76 167.73 10.25 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.304 1.442 . . . . 0.0 112.236 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -140.14 106.25 5.22 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.016 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 125.55 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.88 -1.138 . . . . 0.0 108.667 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.56 -62.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.636 1.174 . . . . 0.0 110.384 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -176.87 174.9 1.7 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.825 2.45 . . . . 0.0 110.644 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.8 146.6 50.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.223 2.209 . . . . 0.0 109.492 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.15 113.33 13.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.146 1.378 . . . . 0.0 111.406 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -73.49 122.92 22.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.78 1.232 . . . . 0.0 110.188 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.95 -38.6 7.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.825 1.65 . . . . 0.0 112.633 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 m -136.92 152.14 49.86 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.653 1.581 . . . . 0.0 109.929 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.13 50.05 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 123.925 0.774 . . . . 0.0 114.88 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -135.81 145.65 46.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 111.54 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -133.26 125.52 29.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.348 1.059 . . . . 0.0 108.747 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.4 -1.04 31.54 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.327 1.051 . . . . 0.0 112.943 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 3' ' ' ALA . 23.4 m -110.89 174.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.812 1.645 . . . . 0.0 113.045 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.11 139.88 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.917 1.687 . . . . 0.0 108.801 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 146.01 86.63 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-N 119.578 1.081 . . . . 0.0 110.86 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.35 167.17 25.99 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.575 3.516 . . . . 0.0 111.277 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -107.64 -24.27 11.81 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.416 -1.427 . . . . 0.0 113.487 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -125.81 133.3 52.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.433 1.493 . . . . 0.0 111.061 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.8 t -133.84 94.63 18.43 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.589 1.556 . . . . 0.0 109.891 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.26 161.36 34.52 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.595 1.53 . . . . 0.0 111.868 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -63.31 160.12 16.58 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.726 -0.609 . . . . 0.0 110.724 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 68.0 -0.85 1.92 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.045 2.138 . . . . 0.0 114.418 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.284 1.833 . . . . 0.0 111.738 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -128.5 160.79 31.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.971 1.308 . . . . 0.0 111.68 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.85 174.94 6.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 174.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.4 133.0 41.84 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.464 1.906 . . . . 0.0 108.394 174.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -153.99 164.19 38.84 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.112 0.965 . . . . 0.0 112.589 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -150.48 164.25 36.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.914 1.286 . . . . 0.0 111.014 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.97 118.1 1.08 Allowed Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.275 1.417 . . . . 0.0 111.067 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' C ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -129.33 161.56 29.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.714 1.257 . . . . 0.0 110.696 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -174.25 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.859 0.464 . . . . 0.0 110.102 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.96 -143.02 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 O-C-N 121.277 -0.89 . . . . 0.0 113.015 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -40.89 -38.33 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 119.044 -2.285 . . . . 0.0 114.796 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.26 -60.94 0.47 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.566 1.555 . . . . 0.0 112.774 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.22 -3.68 11.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.99 3.794 . . . . 0.0 116.156 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.8 160.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.438 1.095 . . . . 0.0 111.717 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.87 66.43 1.03 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.244 1.017 . . . . 0.0 111.24 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.6 m -126.72 -85.32 0.61 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.83 1.252 . . . . 0.0 112.049 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.59 -177.21 32.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.116 1.341 . . . . 0.0 112.33 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.525 ' HB2' ' C ' ' A' ' 74' ' ' ARG . . . -135.05 125.58 26.77 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.76 121.24 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -137.44 152.59 49.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.441 0.696 . . . . 0.0 110.737 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.7 47.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.82 0.848 . . . . 0.0 111.469 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 171.06 15.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.508 1.523 . . . . 0.0 110.307 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.52 138.09 50.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.159 0.983 . . . . 0.0 110.203 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.3 m-85 -119.31 118.61 31.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.709 1.204 . . . . 0.0 111.081 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -83.12 113.36 20.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.162 1.385 . . . . 0.0 110.787 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.5 mtt -70.15 162.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.057 0.943 . . . . 0.0 111.315 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.9 p -61.27 -22.63 65.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 114.102 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t -82.98 -14.57 53.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.46 1.904 . . . . 0.0 113.007 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.14 56.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.284 1.421 . . . . 0.0 115.069 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -80.18 164.34 23.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.618 1.167 . . . . 0.0 109.518 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.0 m -122.95 143.24 50.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.817 0.847 . . . . 0.0 110.193 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.55 115.7 23.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 128.34 8.43 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 117' ' ' VAL . 5.1 m -130.63 128.93 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.679 0.792 . . . . 0.0 109.539 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.11 154.8 49.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 175.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.3 p90 -134.05 153.9 51.5 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.701 1.201 . . . . 0.0 110.639 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.2 t -137.31 114.55 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.078 2.151 . . . . 0.0 108.931 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 21.8 t -111.76 95.2 27.16 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 128.683 2.793 . . . . 0.0 106.95 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.97 -168.66 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.509 2.14 . . . . 0.0 111.454 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -108.69 -43.46 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.995 0.918 . . . . 0.0 112.154 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.68 127.19 32.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.105 1.762 . . . . 0.0 112.36 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -58.22 3.44 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -100.25 11.55 39.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.255 1.422 . . . . 0.0 113.917 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.23 0.87 7.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.108 2.163 . . . . 0.0 111.917 -175.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.43 178.36 10.24 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.753 2.421 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 t -154.8 164.78 38.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.223 1.409 . . . . 0.0 110.932 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 112.72 24.77 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.01 -1.056 . . . . 0.0 111.181 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.58 136.32 38.85 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -142.92 145.23 32.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.658 1.183 . . . . 0.0 111.214 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -137.0 139.37 41.37 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.391 1.077 . . . . 0.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 100' ' ' VAL . 84.8 t -136.06 110.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.121 1.768 . . . . 0.0 109.981 175.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -126.84 133.51 50.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.763 1.625 . . . . 0.0 110.189 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 mt -97.83 129.79 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.756 1.622 . . . . 0.0 108.592 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -133.63 144.18 49.07 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.822 . . . . 0.0 112.902 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 p -75.02 92.21 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.167 1.787 . . . . 0.0 113.102 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.7 -179.15 21.32 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.314 1.435 . . . . 0.0 112.483 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 145.21 25.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.626 1.17 . . . . 0.0 111.713 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -163.48 164.57 24.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.778 1.631 . . . . 0.0 111.002 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -140.55 156.16 46.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.243 1.417 . . . . 0.0 110.862 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 92.26 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.655 0.782 . . . . 0.0 111.019 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.67 -72.05 0.71 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.145 1.378 . . . . 0.0 110.583 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 -71.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 108.091 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.43 -42.93 57.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.379 0.99 . . . . 0.0 113.999 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.4 tpt -74.22 -50.08 20.67 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.498 1.149 . . . . 0.0 112.628 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -48.22 80.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.906 0.483 . . . . 0.0 110.061 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.16 -33.6 76.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.77 -28.68 70.15 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.508 1.504 . . . . 0.0 112.051 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.79 -40.21 12.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.562 0.745 . . . . 0.0 111.453 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -78.49 -42.32 29.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.427 -1.421 . . . . 0.0 114.104 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -96.29 -12.97 23.71 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.043 -1.036 . . . . 0.0 112.798 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.51 -77.22 0.16 Allowed Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.577 1.084 . . . . 0.0 112.083 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -175.06 69.05 0.27 Allowed Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 127.531 2.333 . . . . 0.0 110.608 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.76 130.38 18.02 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.789 0.993 . . . . 0.0 111.106 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.22 124.36 22.89 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 15.51 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.013 2.125 . . . . 0.0 114.425 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 52.97 59.1 9.84 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.3 1.429 . . . . 0.0 112.319 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.16 16.91 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 67.57 29.75 6.98 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.748 2.019 . . . . 0.0 112.97 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.1 158.16 23.79 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.809 1.671 . . . . 0.0 113.832 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -72.74 131.1 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.783 1.233 . . . . 0.0 112.034 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -122.88 108.48 13.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.747 2.019 . . . . 0.0 111.016 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.75 153.59 45.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.184 1.793 . . . . 0.0 110.782 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.99 138.99 1.35 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.63 1.172 . . . . 0.0 110.268 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -60.54 134.77 57.4 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.276 0.489 . . . . 0.0 111.403 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.54 -30.53 0.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.79 24.41 5.18 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.001 1.286 . . . . 0.0 114.623 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 t80 58.67 15.15 3.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.44 2.296 . . . . 0.0 114.708 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 176.42 -77.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.833 1.683 . . . . 0.0 110.976 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 174' ' ' SER . 3.2 mm? -77.35 145.8 37.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.401 1.081 . . . . 0.0 110.459 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.99 168.41 20.05 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.5 1.52 . . . . 0.0 112.162 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.41 ' HA ' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -81.48 142.54 32.82 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.912 1.285 . . . . 0.0 111.239 174.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -140.08 107.06 5.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.589 1.956 . . . . 0.0 108.523 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.6 168.02 26.02 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-O 121.503 0.502 . . . . 0.0 114.206 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.0 tt -143.49 142.82 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.322 1.849 . . . . 0.0 109.011 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.0 ttt -145.59 151.09 37.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.945 1.698 . . . . 0.0 108.479 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.8 p -88.26 165.07 15.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.425 0.69 . . . . 0.0 111.548 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.8 m -80.71 9.56 6.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 112.819 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.08 157.22 17.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.843 2.057 . . . . 0.0 111.382 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.01 3.16 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 119.311 0.959 . . . . 0.0 111.868 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.58 87.97 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.894 0.878 . . . . 0.0 109.507 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.92 146.86 50.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.0 1.32 . . . . 0.0 112.31 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -91.67 129.89 37.56 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.3 ttm -127.06 83.46 2.17 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.672 1.989 . . . . 0.0 109.503 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -89.07 144.48 26.11 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.677 -0.639 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 59.1 mt -127.23 124.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.954 1.702 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -114.09 107.23 15.36 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.173 1.789 . . . . 0.0 109.182 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 157' ' ' MET . 35.8 mm -88.95 103.94 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.633 0.73 . . . . 0.0 110.794 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.537 ' HA ' HD12 ' A' ' 155' ' ' LEU . 1.7 p -153.27 173.78 15.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.639 1.575 . . . . 0.0 112.571 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.347 1.859 . . . . 0.0 111.429 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.877 -0.106 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -36.19 11.52 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.81 0.844 . . . . 0.0 113.119 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . -41.73 146.11 0.27 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.051 1.74 . . . . 0.0 115.286 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.07 38.75 34.28 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.583 1.087 . . . . 0.0 113.985 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.0 p -145.25 -170.6 3.47 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 118.732 1.266 . . . . 0.0 111.895 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.4 pt -118.51 142.51 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.776 2.03 . . . . 0.0 110.479 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 pt -145.63 162.48 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.26 1.424 . . . . 0.0 111.813 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.36 126.5 27.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.725 0.81 . . . . 0.0 110.863 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.93 -23.08 60.98 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.299 0.952 . . . . 0.0 113.059 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.57 91.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.98 1.312 . . . . 0.0 112.085 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 m -79.92 -24.02 41.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.763 1.225 . . . . 0.0 113.541 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.32 97.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.062 1.345 . . . . 0.0 112.2 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -145.52 172.46 13.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.926 1.69 . . . . 0.0 110.17 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -46.56 -39.83 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.155 1.382 . . . . 0.0 114.6 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -56.62 -43.68 80.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.563 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.15 -45.2 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.274 1.03 . . . . 0.0 111.072 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 mt -56.05 -50.01 72.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.547 0.612 . . . . 0.0 111.492 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.33 -42.47 92.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -52.83 60.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 111.809 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.761 HG21 HD21 ' A' ' 70' ' ' LEU . 82.7 t -56.71 -49.21 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.728 1.211 . . . . 0.0 110.404 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -43.11 62.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.727 0.811 . . . . 0.0 112.399 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.4 -53.25 14.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.892 1.277 . . . . 0.0 112.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -72.41 -29.26 63.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.536 1.534 . . . . 0.0 114.254 -171.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD22 ' HZ1' ' A' ' 30' ' ' LYS . 7.0 tt -63.61 -53.93 43.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.591 1.557 . . . . 0.0 110.589 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.45 75.24 0.2 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.268 1.413 . . . . 0.0 111.926 -169.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 139.95 2.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.496 1.518 . . . . 0.0 111.887 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.05 -177.85 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 126.754 2.021 . . . . 0.0 109.725 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -45.78 -42.86 12.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.287 1.835 . . . . 0.0 115.151 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -148.79 141.37 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.31 1.444 . . . . 0.0 111.371 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HZ1' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -170.5 168.94 7.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.584 1.953 . . . . 0.0 112.32 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.13 161.15 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.613 1.165 . . . . 0.0 110.637 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.18 106.95 13.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.406 1.482 . . . . 0.0 109.882 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.48 140.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.333 1.453 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.58 120.56 1.0 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.706 1.146 . . . . 0.0 111.992 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -112.28 97.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 109.373 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 7.1 t70 -75.89 114.12 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.205 1.402 . . . . 0.0 113.513 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.09 96.75 9.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.267 1.427 . . . . 0.0 111.227 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -124.17 34.33 5.07 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.239 1.816 . . . . 0.0 110.186 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 t -80.34 -51.0 9.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.948 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.14 15.02 1.93 Allowed Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.83 160.6 32.57 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.53 1.665 . . . . 0.0 114.085 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.5 p -73.41 138.32 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.983 -0.716 . . . . 0.0 111.919 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.38 165.72 11.55 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.495 1.118 . . . . 0.0 111.457 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 m -133.78 115.58 14.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.084 1.354 . . . . 0.0 108.739 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 136.87 57.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.199 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -70.08 0.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -179.19 175.19 0.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.403 2.281 . . . . 0.0 110.285 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.1 147.16 51.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.377 2.271 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.17 109.79 9.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.912 1.285 . . . . 0.0 110.638 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -71.43 116.57 11.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.726 1.21 . . . . 0.0 110.779 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -45.86 9.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.655 1.182 . . . . 0.0 112.123 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.1 m -137.37 146.94 45.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.087 1.755 . . . . 0.0 110.457 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 76' ' ' ASP . . . 83.2 -163.98 41.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.682 0.658 . . . . 0.0 113.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.45 174.64 14.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.265 1.026 . . . . 0.0 111.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -143.94 173.23 11.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.195 0.998 . . . . 0.0 112.009 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.84 11.65 11.91 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.618 1.567 . . . . 0.0 112.061 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.57 166.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.226 2.21 . . . . 0.0 111.351 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.97 133.36 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.971 1.308 . . . . 0.0 109.943 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.94 152.67 90.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 119.533 1.06 . . . . 0.0 112.326 176.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.53 171.61 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.414 3.41 . . . . 0.0 110.313 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.0 tt0 -111.05 -18.87 12.93 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -124.62 131.18 53.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.85 1.66 . . . . 0.0 110.26 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.98 98.14 6.91 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.675 1.19 . . . . 0.0 109.639 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.67 164.82 25.15 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.728 1.619 . . . . 0.0 112.573 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -62.28 157.72 18.92 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.493 -0.754 . . . . 0.0 110.393 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p 68.67 -0.02 2.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.568 1.947 . . . . 0.0 114.248 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -125.45 145.81 49.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 110.723 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . . . -120.46 169.16 10.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.922 1.689 . . . . 0.0 110.826 176.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -104.22 177.52 4.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.876 0.846 . . . . 0.0 110.187 174.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.761 HD21 HG21 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -131.23 128.78 40.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.371 1.868 . . . . 0.0 108.747 176.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -149.22 163.8 36.6 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.512 0.725 . . . . 0.0 111.951 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -149.8 172.51 15.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.559 1.144 . . . . 0.0 111.199 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -157.67 106.19 0.29 Allowed Glycine 0 N--CA 1.47 0.922 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.735 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 162.97 14.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.07 1.348 . . . . 0.0 112.75 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.66 105.28 17.25 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.333 -0.855 . . . . 0.0 110.944 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 23.4 t0 33.26 -134.58 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.918 2.487 . . . . 0.0 112.928 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -39.58 80.94 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.164 -1.585 . . . . 0.0 112.138 174.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.39 -62.28 0.53 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.566 1.555 . . . . 0.0 112.993 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.94 -3.71 7.52 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 125.001 3.801 . . . . 0.0 116.494 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.96 168.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.778 1.231 . . . . 0.0 112.267 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.22 68.61 1.41 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.652 1.181 . . . . 0.0 111.644 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -120.7 -89.35 0.61 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.258 1.423 . . . . 0.0 110.839 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.51 174.55 35.21 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.285 1.422 . . . . 0.0 111.315 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -133.19 111.77 11.16 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 110.122 175.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -139.34 120.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.83 168.21 20.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.841 0.857 . . . . 0.0 110.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.21 155.95 42.53 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.83 173.72 12.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.964 2.106 . . . . 0.0 110.716 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.96 149.7 45.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.275 1.03 . . . . 0.0 111.398 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -131.39 117.13 18.46 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.016 1.327 . . . . 0.0 111.624 -176.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -79.39 108.85 13.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.502 1.521 . . . . 0.0 110.213 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mtt -71.06 162.7 28.99 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.575 0.703 . . . . 0.0 111.612 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -59.69 -21.32 60.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.924 1.69 . . . . 0.0 113.956 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.5 m -79.93 -12.4 59.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.631 1.972 . . . . 0.0 113.208 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 6.2 65.73 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.94 1.257 . . . . 0.0 115.072 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -90.74 170.45 10.11 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.517 1.127 . . . . 0.0 110.496 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.6 m -131.68 149.38 52.5 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.136 0.969 . . . . 0.0 110.94 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 122.74 42.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.195 1.398 . . . . 0.0 109.037 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 139.4 24.4 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.15 122.16 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.781 1.291 . . . . 0.0 109.03 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.4 ptm -127.81 158.76 36.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.606 0.762 . . . . 0.0 112.109 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.7 p90 -131.78 150.74 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.213 1.405 . . . . 0.0 110.244 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.73 100.7 4.26 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.895 1.278 . . . . 0.0 110.524 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 42.2 t -94.69 104.27 13.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 127.332 2.253 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.08 169.69 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.147 2.565 . . . . 0.0 112.718 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -89.87 -37.0 14.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.68 111.65 23.96 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.895 1.678 . . . . 0.0 111.273 -163.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -66.8 -56.86 8.54 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.754 -1.216 . . . . 0.0 113.8 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -94.31 12.83 25.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.644 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.91 -14.76 3.08 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.328 1.851 . . . . 0.0 113.068 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.95 -179.32 6.28 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.832 3.253 . . . . 0.0 109.446 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.56 167.73 23.78 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.931 1.292 . . . . 0.0 111.016 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.57 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.586 -0.697 . . . . 0.0 111.188 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -139.67 147.73 41.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.741 1.216 . . . . 0.0 111.205 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.41 148.82 20.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -141.86 149.01 39.7 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.085 1.312 . . . . 0.0 111.603 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -143.97 86.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.559 1.543 . . . . 0.0 113.584 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -88.4 138.91 31.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.225 1.01 . . . . 0.0 108.504 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mt -108.23 114.65 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.547 1.539 . . . . 0.0 108.68 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -127.53 136.44 51.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.326 1.451 . . . . 0.0 112.464 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 p -78.08 84.28 4.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.284 1.434 . . . . 0.0 112.294 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.24 -175.45 37.86 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.3 0.952 . . . . 0.0 113.418 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -112.91 107.02 15.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.427 1.891 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -140.55 167.97 20.9 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.518 1.927 . . . . 0.0 111.344 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.92 166.97 26.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.973 1.709 . . . . 0.0 112.486 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.32 84.96 4.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.294 1.438 . . . . 0.0 111.232 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.28 -64.61 1.03 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.786 0.834 . . . . 0.0 110.843 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -152.2 -77.0 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.144 2.178 . . . . 0.0 108.501 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.6 -24.87 71.33 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.338 0.97 . . . . 0.0 115.022 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -56.49 4.66 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.667 1.234 . . . . 0.0 110.506 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.33 -38.89 78.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.485 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -58.42 -38.72 77.98 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.341 0.973 . . . . 0.0 112.668 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.01 -38.67 89.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.646 0.657 . . . . 0.0 111.904 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -34.34 64.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.456 0.702 . . . . 0.0 111.166 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.49 -47.87 37.78 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.52 -1.363 . . . . 0.0 112.823 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -94.6 -15.99 23.59 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.946 0.898 . . . . 0.0 113.285 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -70.64 0.9 Allowed Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.309 0.957 . . . . 0.0 112.664 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -178.17 77.47 0.23 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.807 2.443 . . . . 0.0 109.658 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.04 128.18 18.2 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.56 -1.361 . . . . 0.0 108.56 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.48 150.55 26.48 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.574 1.178 . . . . 0.0 110.311 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 120.61 28.02 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.462 1.105 . . . . 0.0 108.687 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.8 55.95 1.34 Allowed Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.197 1.379 . . . . 0.0 113.976 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.4 25.71 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.229 1.812 . . . . 0.0 115.462 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.267 12.0 p30 52.84 31.72 11.16 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.154 2.182 . . . . 0.0 114.57 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.77 175.9 18.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.721 2.105 . . . . 0.0 113.092 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -79.63 122.88 27.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.04 0.936 . . . . 0.0 111.759 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -114.34 116.2 28.58 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.431 1.892 . . . . 0.0 109.452 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -142.93 146.12 33.69 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.6 1.16 . . . . 0.0 110.777 175.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -147.19 121.53 9.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.874 1.27 . . . . 0.0 111.747 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.12 93.92 1.47 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.153 1.381 . . . . 0.0 112.269 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.24 8.82 0.94 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -94.68 21.6 42.35 Favored Glycine 0 N--CA 1.476 1.334 0 O-C-N 120.623 -1.298 . . . . 0.0 115.341 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 65.35 9.32 5.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.388 1.875 . . . . 0.0 115.022 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.65 -40.84 0.21 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.546 1.546 . . . . 0.0 113.997 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.42 150.53 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 110.388 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 167.16 21.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.815 0.846 . . . . 0.0 112.904 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.36 139.77 30.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 109.898 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -130.37 115.26 16.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.02 172.14 25.29 Favored Glycine 0 C--O 1.23 -0.12 0 CA-C-O 121.901 0.723 . . . . 0.0 113.494 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 tt -138.54 131.88 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 109.318 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 8.7 ttt -129.1 143.07 50.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.183 1.793 . . . . 0.0 107.021 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.29 154.16 19.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.071 1.749 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.6 m -92.59 27.26 2.36 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.108 1.363 . . . . 0.0 112.715 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.39 170.71 8.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.518 1.927 . . . . 0.0 111.58 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.41 -62.09 5.14 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.289 -0.882 . . . . 0.0 112.823 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.52 51.11 1.4 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.406 1.882 . . . . 0.0 111.73 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.63 175.85 3.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.69 1.596 . . . . 0.0 112.443 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -134.67 154.11 51.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.285 1.434 . . . . 0.0 109.161 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.6 ttp -142.69 85.31 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.164 0.986 . . . . 0.0 111.969 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.36 142.04 28.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.263 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 58.7 mt -125.18 123.52 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.605 1.962 . . . . 0.0 107.697 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.37 117.28 33.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.31 130.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.953 0.501 . . . . 0.0 110.452 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.3 m -144.5 167.82 21.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 112.89 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.645 2.378 . . . . 0.0 113.594 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.06 -4.01 33.41 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 141.88 58.12 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.963 0.905 . . . . 0.0 112.576 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.68 40.29 85.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.304 0.954 . . . . 0.0 114.825 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.7 p -144.92 -171.48 3.64 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.163 0.982 . . . . 0.0 112.573 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.501 HG23 ' HG3' ' A' ' 60' ' ' PRO . 8.1 pt -127.0 138.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.214 2.205 . . . . 0.0 111.662 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 pt -148.1 170.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.109 1.764 . . . . 0.0 111.904 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.97 116.91 2.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.611 1.564 . . . . 0.0 112.335 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.78 -23.86 67.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.553 0.597 . . . . 0.0 113.266 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.49 81.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.521 1.128 . . . . 0.0 113.076 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -86.49 -13.16 46.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.798 1.239 . . . . 0.0 114.091 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.439 HD22 ' CB ' ' A' ' 68' ' ' ALA . 17.5 tp -68.95 113.65 6.54 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.23 1.012 . . . . 0.0 111.102 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -144.35 166.63 24.55 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 110.578 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.21 -37.29 22.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 114.64 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -60.75 -45.02 95.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.225 0.61 . . . . 0.0 111.79 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -57.07 -46.3 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.906 1.283 . . . . 0.0 110.492 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.8 -48.45 63.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.205 1.002 . . . . 0.0 112.594 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.35 -43.81 76.65 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.425 -0.797 . . . . 0.0 111.864 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.12 -40.76 74.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.201 1.4 . . . . 0.0 113.081 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 70' ' ' LEU . 53.1 t -52.9 -59.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.506 1.922 . . . . 0.0 109.984 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.39 -43.47 98.81 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.558 1.943 . . . . 0.0 112.757 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -51.15 -53.58 33.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.28 1.032 . . . . 0.0 112.086 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -78.4 -35.02 47.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -42.09 62.66 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.12 1.368 . . . . 0.0 111.074 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.09 58.69 0.87 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -59.32 171.65 0.75 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.737 1.215 . . . . 0.0 111.775 175.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -162.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.808 1.243 . . . . 0.0 110.324 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -46.65 -41.28 14.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.614 1.566 . . . . 0.0 112.96 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 137.16 49.1 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.637 1.575 . . . . 0.0 111.136 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 162.24 36.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 112.44 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG22 ' HB3' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -141.48 151.95 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.885 1.674 . . . . 0.0 109.592 174.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.87 126.69 50.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.917 1.687 . . . . 0.0 107.452 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.43 132.61 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.354 1.462 . . . . 0.0 110.217 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.62 119.98 1.34 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.071 1.319 . . . . 0.0 111.249 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 69' ' ' LEU . 12.2 mt -111.8 100.76 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -74.96 102.85 4.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.909 1.283 . . . . 0.0 111.502 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -70.98 96.47 1.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.916 0.887 . . . . 0.0 112.039 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.77 16.47 9.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.131 1.772 . . . . 0.0 112.592 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.1 p -67.84 -41.21 83.34 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.858 -1.151 . . . . 0.0 113.808 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 12.82 3.94 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.27 162.63 30.7 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.765 1.783 . . . . 0.0 114.347 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -71.29 132.69 45.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 0.0 112.87 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -106.61 163.6 12.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 111.6 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.7 m -129.72 114.05 15.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.683 1.193 . . . . 0.0 109.699 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.46 129.07 38.98 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.507 -0.746 . . . . 0.0 109.315 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -68.32 0.44 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.943 0.497 . . . . 0.0 109.868 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 179.41 173.56 0.83 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.63 2.372 . . . . 0.0 110.483 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -129.13 146.83 50.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.764 2.026 . . . . 0.0 109.308 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.89 115.92 15.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.292 1.437 . . . . 0.0 110.626 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -78.52 115.78 18.46 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.054 1.342 . . . . 0.0 111.037 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -92.93 -39.28 11.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.107 0.963 . . . . 0.0 112.795 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.3 m -141.63 151.79 43.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.84 2.056 . . . . 0.0 110.372 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.04 -171.57 54.43 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.749 0.69 . . . . 0.0 113.87 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -136.39 173.77 11.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.933 1.293 . . . . 0.0 112.275 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -143.34 171.01 14.7 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.752 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.67 10.2 8.39 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.697 1.199 . . . . 0.0 112.396 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.06 170.35 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.488 2.315 . . . . 0.0 113.362 -171.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.75 140.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 127.196 2.199 . . . . 0.0 109.731 -172.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -78.99 156.22 77.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.119 0.872 . . . . 0.0 111.858 176.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' HG23 ' A' ' 6' ' ' ILE . 39.1 Cg_endo -69.52 176.01 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.332 3.355 . . . . 0.0 110.457 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.8 tt0 -118.04 -22.84 7.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.198 -0.939 . . . . 0.0 113.077 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.9 123.18 41.88 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.7 1.6 . . . . 0.0 110.416 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.1 93.32 26.83 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.859 1.264 . . . . 0.0 110.298 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.9 165.32 21.65 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.328 2.019 . . . . 0.0 112.51 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.87 160.18 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.212 0.605 . . . . 0.0 110.19 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 t 56.41 13.74 1.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 128.365 2.666 . . . . 0.0 113.857 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.61 136.65 46.66 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 127.006 2.123 . . . . 0.0 109.653 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.439 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -117.84 161.07 20.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.381 1.072 . . . . 0.0 111.407 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -101.34 169.11 9.1 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.608 0.718 . . . . 0.0 109.709 174.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 20' ' ' VAL . 4.1 mm? -126.2 130.72 51.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.45 1.9 . . . . 0.0 107.951 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -147.51 162.44 39.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.523 1.129 . . . . 0.0 110.506 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 m -150.75 163.47 38.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.452 0.701 . . . . 0.0 110.798 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.95 115.69 0.7 Allowed Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.536 1.065 . . . . 0.0 110.896 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 174.18 5.98 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.709 1.254 . . . . 0.0 111.134 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -64.07 -172.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.685 0.794 . . . . 0.0 109.561 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.97 -174.13 0.07 Allowed 'General case' 0 CA--C 1.555 1.15 0 O-C-N 120.084 -1.635 . . . . 0.0 111.216 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -37.22 -41.6 0.4 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.421 1.888 . . . . 0.0 115.698 -172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.5 -57.52 0.42 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.235 1.398 . . . . 0.0 112.955 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.45 1.77 5.2 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.763 3.642 . . . . 0.0 115.154 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.31 109.47 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.345 2.258 . . . . 0.0 111.141 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.01 78.76 5.91 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.489 1.516 . . . . 0.0 112.372 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.0 m -100.96 -70.99 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.516 1.126 . . . . 0.0 111.321 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.45 41.86 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.073 1.32 . . . . 0.0 112.043 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.22 106.97 5.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.927 0.891 . . . . 0.0 109.797 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.35 123.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.805 -1.185 . . . . 0.0 108.668 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -147.38 169.94 18.4 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.642 0.734 . . . . 0.0 110.989 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.61 158.21 43.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.902 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.0 170.54 16.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.432 1.893 . . . . 0.0 110.311 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.87 155.79 49.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.911 0.885 . . . . 0.0 111.382 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.1 m-85 -136.13 121.95 19.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.019 1.328 . . . . 0.0 110.969 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.18 115.94 19.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.665 1.586 . . . . 0.0 110.483 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.83 161.98 30.14 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.647 0.779 . . . . 0.0 112.362 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -62.28 -23.39 66.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 113.403 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.9 m -78.33 -13.85 59.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.899 1.68 . . . . 0.0 113.581 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.15 60.27 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.796 1.188 . . . . 0.0 115.086 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -84.9 172.54 11.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.286 1.043 . . . . 0.0 109.896 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.1 m -131.92 152.71 50.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.735 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.82 135.37 53.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.441 1.097 . . . . 0.0 109.697 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 142.38 17.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.19 112.94 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 118.642 1.221 . . . . 0.0 109.518 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.87 150.44 46.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.144 0.578 . . . . 0.0 110.659 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.7 p90 -126.9 146.61 50.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.473 1.109 . . . . 0.0 109.672 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 t -131.16 110.89 11.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.54 1.136 . . . . 0.0 110.893 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 31' ' ' ILE . 2.8 t -115.0 102.1 54.74 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.363 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.78 163.86 34.8 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.897 2.398 . . . . 0.0 112.492 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.01 -26.77 59.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.34 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 112.96 24.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.351 -1.468 . . . . 0.0 111.255 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.25 -71.4 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.931 -1.105 . . . . 0.0 112.172 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.91 10.67 3.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.31 -3.42 4.95 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.896 . . . . 0.0 112.927 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.82 133.09 11.79 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.348 1.459 . . . . 0.0 110.926 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -84.62 171.93 12.01 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.285 -0.884 . . . . 0.0 111.805 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -100.78 151.34 21.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.123 1.369 . . . . 0.0 111.097 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.63 139.48 40.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.548 -0.72 . . . . 0.0 110.632 -172.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -151.71 150.78 30.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.965 1.706 . . . . 0.0 110.043 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -148.54 147.49 29.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.644 1.578 . . . . 0.0 109.189 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -143.98 109.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.146 1.778 . . . . 0.0 109.77 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -113.6 144.76 42.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 109.288 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.6 mt -109.75 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.537 1.935 . . . . 0.0 108.466 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.69 143.4 51.25 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.658 1.583 . . . . 0.0 112.239 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.2 m -79.06 85.69 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.009 1.324 . . . . 0.0 111.817 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.64 176.38 22.76 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.422 1.487 . . . . 0.0 112.328 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 149.14 37.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.176 0.991 . . . . 0.0 111.979 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -154.37 135.69 14.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.997 1.319 . . . . 0.0 111.134 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -98.4 -176.66 3.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.369 1.468 . . . . 0.0 111.534 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -139.21 100.83 4.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.946 1.698 . . . . 0.0 109.114 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -120.55 -72.24 0.7 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.692 1.197 . . . . 0.0 110.161 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -145.57 -64.22 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.907 1.283 . . . . 0.0 110.215 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.25 70.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.408 1.004 . . . . 0.0 114.557 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 tpp -90.67 -37.58 13.65 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.623 1.169 . . . . 0.0 112.988 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -41.09 93.24 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 111.135 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -59.74 -25.18 64.64 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -18.4 65.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.81 -37.72 9.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.997 1.319 . . . . 0.0 108.662 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -68.23 -47.45 67.78 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.786 -1.196 . . . . 0.0 113.628 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -99.22 -13.55 19.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 113.447 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.69 -63.65 4.55 Favored Glycine 0 N--CA 1.475 1.246 0 C-N-CA 124.074 0.845 . . . . 0.0 112.639 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.64 80.29 0.24 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 128.089 2.556 . . . . 0.0 109.104 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.8 135.49 32.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 108.706 -1.305 . . . . 0.0 108.706 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -71.28 -12.59 61.53 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.21 118.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.337 3.055 . . . . 0.0 112.688 -170.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.77 58.96 2.14 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.046 1.784 . . . . 0.0 113.925 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.09 22.35 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.435 2.294 . . . . 0.0 113.628 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.18 27.89 12.23 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.879 1.672 . . . . 0.0 113.328 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.27 135.96 9.31 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.787 1.661 . . . . 0.0 112.207 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -59.71 139.14 57.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 111.883 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -130.01 121.25 26.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.735 1.614 . . . . 0.0 110.528 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.74 154.82 40.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.97 1.708 . . . . 0.0 110.614 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -165.37 131.53 2.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.862 1.265 . . . . 0.0 110.874 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -62.85 112.15 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.308 1.043 . . . . 0.0 111.235 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.2 -24.94 1.39 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.397 1.079 . . . . 0.0 113.732 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.15 17.84 9.06 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.122 1.344 . . . . 0.0 114.96 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.14 16.81 4.1 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.97 2.108 . . . . 0.0 114.15 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.69 -65.18 0.06 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.93 1.252 . . . . 0.0 111.293 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -93.36 164.37 13.24 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.153 1.381 . . . . 0.0 112.454 176.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.47 30.58 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.544 1.938 . . . . 0.0 112.627 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.71 143.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.843 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -128.46 103.71 7.28 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.295 1.838 . . . . 0.0 107.874 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.41 169.48 21.26 Favored Glycine 0 N--CA 1.455 -0.067 0 CA-C-O 121.796 0.664 . . . . 0.0 113.218 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 146.63 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 123.893 0.877 . . . . 0.0 109.872 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.83 132.19 41.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.657 1.583 . . . . 0.0 107.861 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.6 p -85.95 164.09 17.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.612 0.765 . . . . 0.0 109.905 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.36 19.69 19.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.922 0.889 . . . . 0.0 112.967 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -106.05 -175.52 2.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 0.0 112.999 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.54 74.98 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.444 1.497 . . . . 0.0 114.413 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.46 92.45 5.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.446 1.498 . . . . 0.0 107.627 175.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' HG22 ' A' ' 31' ' ' ILE . . . -73.73 69.02 1.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.232 1.013 . . . . 0.0 111.733 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -53.11 129.95 32.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.728 -1.232 . . . . 0.0 110.954 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.7 ttm -134.61 123.83 24.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.131 1.772 . . . . 0.0 110.015 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -139.34 141.26 37.66 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.941 -1.099 . . . . 0.0 109.599 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.67 93.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.936 1.694 . . . . 0.0 109.167 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -86.0 109.26 18.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.043 0.937 . . . . 0.0 110.419 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.4 mm -91.57 116.42 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.751 0.82 . . . . 0.0 111.215 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -148.11 161.36 41.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.859 2.063 . . . . 0.0 110.581 174.976 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.887 -0.102 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 20' ' ' VAL . 23.6 tp -97.15 -6.33 35.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.495 1.118 . . . . 0.0 113.271 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -62.22 146.31 51.16 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.19 -1.569 . . . . 0.0 111.379 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.68 39.6 40.02 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.666 0.65 . . . . 0.0 114.488 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.26 -169.35 3.03 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.555 1.177 . . . . 0.0 111.822 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.02 141.75 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.765 2.026 . . . . 0.0 109.844 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.28 173.93 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.569 1.548 . . . . 0.0 111.409 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.29 115.4 6.21 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.42 -30.78 65.35 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.448 -0.783 . . . . 0.0 112.808 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.29 69.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.246 -1.15 . . . . 0.0 113.345 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -90.48 -13.62 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.113 1.365 . . . . 0.0 113.39 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -68.14 113.01 5.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.968 0.907 . . . . 0.0 111.733 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -145.12 165.84 27.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.595 1.558 . . . . 0.0 109.737 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -45.91 -41.69 11.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.618 1.567 . . . . 0.0 114.487 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.54 -36.77 76.78 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.74 -44.48 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.818 0.847 . . . . 0.0 110.247 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.15 -42.64 86.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.782 0.833 . . . . 0.0 111.145 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.01 -40.13 71.98 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.133 -0.979 . . . . 0.0 113.21 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.36 -43.19 88.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.911 0.884 . . . . 0.0 111.924 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 2' ' ' LEU . 87.6 t -63.04 -51.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.716 -0.615 . . . . 0.0 111.215 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -53.2 -43.83 67.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.689 0.796 . . . . 0.0 112.628 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.48 -46.19 70.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 117.986 0.357 . . . . 0.0 111.857 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.4 -38.96 59.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.554 1.542 . . . . 0.0 113.863 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.586 HD12 ' CB ' ' A' ' 3' ' ' ALA . 8.4 tt -54.02 -40.14 66.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.421 1.089 . . . . 0.0 111.381 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.37 62.82 0.55 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.977 1.275 . . . . 0.0 111.737 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 133.53 3.13 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.034 1.333 . . . . 0.0 113.298 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 28' ' ' SER . 3.1 p -121.95 -163.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.388 1.875 . . . . 0.0 109.603 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.441 ' H ' HG22 ' A' ' 27' ' ' VAL . 7.4 m -39.39 -46.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.491 1.516 . . . . 0.0 114.938 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -147.97 126.31 12.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.95 2.1 . . . . 0.0 110.319 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' NZ ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -153.35 158.39 41.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.676 1.591 . . . . 0.0 111.832 176.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.18 173.72 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.725 1.21 . . . . 0.0 112.441 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.51 115.14 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.503 1.121 . . . . 0.0 110.525 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.26 143.74 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 111.213 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.39 125.61 1.8 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.407 1.004 . . . . 0.0 111.687 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 mt -130.39 112.28 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.532 1.666 . . . . 0.0 111.362 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.93 109.0 20.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.118 1.767 . . . . 0.0 111.796 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.14 109.27 19.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.789 1.28 . . . . 0.0 112.179 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -122.61 27.55 7.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.482 1.913 . . . . 0.0 111.176 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -81.71 -1.79 48.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.734 2.014 . . . . 0.0 114.553 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 12.62 83.97 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.934 -1.103 . . . . 0.0 114.492 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.54 145.36 12.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.422 1.487 . . . . 0.0 113.501 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -69.83 141.48 53.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.59 1.156 . . . . 0.0 112.811 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -112.07 162.59 15.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.54 1.936 . . . . 0.0 111.431 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 m -128.97 114.92 17.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.754 1.222 . . . . 0.0 109.328 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 122.72 18.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.704 -0.622 . . . . 0.0 110.146 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.4 HD21 ' CZ ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -65.67 -66.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.785 1.234 . . . . 0.0 109.855 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 176.43 173.76 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.884 2.874 . . . . 0.0 109.657 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 143.87 48.0 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.456 2.302 . . . . 0.0 109.217 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -136.25 112.32 9.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.04 0.936 . . . . 0.0 111.444 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -72.92 115.48 12.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.514 1.526 . . . . 0.0 111.487 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -89.87 -37.69 14.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.629 1.572 . . . . 0.0 112.756 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -146.46 159.46 43.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.382 2.273 . . . . 0.0 110.606 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.47 49.63 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 121.612 0.562 . . . . 0.0 113.386 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 t -140.42 148.03 40.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.526 1.13 . . . . 0.0 109.726 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 57' ' ' VAL . 18.0 m -138.58 138.79 38.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.418 1.087 . . . . 0.0 110.205 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.06 11.15 40.09 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.906 1.682 . . . . 0.0 112.854 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 55' ' ' THR . 32.8 m -126.48 169.63 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.74 2.016 . . . . 0.0 112.364 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.11 135.78 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.577 1.551 . . . . 0.0 109.758 -169.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -77.27 152.95 81.96 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.291 0.951 . . . . 0.0 112.379 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.41 174.17 8.65 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.555 3.504 . . . . 0.0 110.759 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -116.3 -17.56 10.72 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.13 -0.981 . . . . 0.0 113.173 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -124.59 130.38 52.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.285 1.834 . . . . 0.0 110.343 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.59 82.67 44.6 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.324 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.6 153.66 77.2 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.162 1.908 . . . . 0.0 111.427 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -53.31 148.42 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.545 0.738 . . . . 0.0 111.176 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 72.86 -0.95 3.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.953 2.501 . . . . 0.0 114.805 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -124.47 106.24 10.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.065 1.746 . . . . 0.0 112.391 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.59 160.0 25.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.55 170.05 8.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.129 0.572 . . . . 0.0 109.769 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -126.39 134.77 50.94 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 109.636 174.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.21 169.86 20.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.601 0.76 . . . . 0.0 111.642 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.4 m -151.21 171.58 17.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.509 1.524 . . . . 0.0 110.474 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.97 115.99 0.71 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.71 163.14 15.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.161 1.481 . . . . 0.0 111.18 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -65.41 -177.23 0.39 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 110.404 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.79 178.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.353 -0.842 . . . . 0.0 110.322 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -24.59 -53.34 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.175 2.59 . . . . 0.0 116.308 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.36 -62.75 0.26 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.604 1.573 . . . . 0.0 112.325 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.15 -1.27 8.52 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.711 3.607 . . . . 0.0 115.439 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.72 123.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.484 2.314 . . . . 0.0 110.453 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.51 81.5 2.97 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.351 1.46 . . . . 0.0 111.241 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 m -114.1 -80.89 0.6 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.985 1.314 . . . . 0.0 110.523 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.43 -177.34 41.95 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.238 1.399 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -139.14 110.61 7.03 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.054 1.342 . . . . 0.0 109.159 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.22 130.65 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.649 -0.657 . . . . 0.0 109.755 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 158.32 44.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 110.293 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.97 155.43 45.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.936 0.874 . . . . 0.0 111.636 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.71 168.03 25.59 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.416 1.886 . . . . 0.0 109.689 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.48 157.23 45.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.584 0.753 . . . . 0.0 110.868 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -138.95 118.5 12.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.702 0.801 . . . . 0.0 112.125 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CZ ' HD21 ' A' ' 46' ' ' LEU . 17.3 m-85 -75.59 121.83 23.01 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.649 0.78 . . . . 0.0 111.226 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -87.44 159.3 18.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.47 1.108 . . . . 0.0 110.123 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.7 p -63.83 -13.89 48.46 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -88.38 0.49 56.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.852 1.661 . . . . 0.0 113.05 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.12 82.96 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.695 1.141 . . . . 0.0 114.126 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.46 167.22 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.837 2.055 . . . . 0.0 110.644 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.0 m -130.99 153.62 49.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.027 1.331 . . . . 0.0 109.629 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.21 138.66 53.66 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.396 1.079 . . . . 0.0 109.587 175.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.25 139.08 15.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.94 125.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.229 1.015 . . . . 0.0 109.476 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.01 155.94 46.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.405 0.682 . . . . 0.0 112.016 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.97 144.22 49.0 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.691 1.197 . . . . 0.0 110.086 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.03 110.64 11.8 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 110.11 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.78 100.6 46.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 125.705 1.602 . . . . 0.0 109.655 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.03 163.93 34.3 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.277 1.985 . . . . 0.0 110.844 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.61 -47.25 76.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.726 0.811 . . . . 0.0 111.08 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.08 117.41 22.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.478 2.311 . . . . 0.0 111.958 -172.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.2 -70.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.113 -0.992 . . . . 0.0 112.646 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -82.5 11.19 5.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.48 5.42 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.134 2.174 . . . . 0.0 112.433 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -160.13 129.07 4.97 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.175 1.79 . . . . 0.0 110.718 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.9 m -90.94 168.13 11.91 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.567 -1.333 . . . . 0.0 113.214 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -89.67 155.74 19.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.149 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.405 ' CE3' ' HD2' ' A' ' 141' ' ' ARG . 0.9 OUTLIER -142.14 140.53 32.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.582 1.153 . . . . 0.0 109.284 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -156.63 146.69 21.12 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.318 1.447 . . . . 0.0 110.399 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -140.98 147.49 38.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.675 1.19 . . . . 0.0 110.072 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.3 t -146.01 90.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.032 1.333 . . . . 0.0 112.051 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.09 144.81 32.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.237 1.415 . . . . 0.0 110.526 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -108.33 123.34 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.293 2.237 . . . . 0.0 108.587 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -127.71 148.3 50.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.288 1.435 . . . . 0.0 112.955 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.2 p -74.08 87.82 1.9 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.578 1.951 . . . . 0.0 112.679 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.78 179.35 21.1 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.878 1.704 . . . . 0.0 112.387 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 140.83 29.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.441 1.497 . . . . 0.0 112.266 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.35 152.28 30.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.145 2.178 . . . . 0.0 110.411 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -131.53 153.37 49.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.457 1.903 . . . . 0.0 110.75 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.71 93.15 0.7 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.328 1.051 . . . . 0.0 111.762 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.3 -76.81 0.58 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 110.279 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -142.85 -67.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.393 2.277 . . . . 0.0 107.758 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.19 -30.97 75.25 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.618 1.104 . . . . 0.0 115.257 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -75.45 -57.89 3.61 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.437 1.619 . . . . 0.0 110.864 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -49.98 -49.6 49.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.58 1.152 . . . . 0.0 111.504 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -37.61 80.14 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.79 -27.34 67.93 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.649 1.113 . . . . 0.0 112.627 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.1 -46.83 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.743 0.817 . . . . 0.0 110.563 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -72.41 -49.02 36.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.835 -1.166 . . . . 0.0 113.773 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -91.83 -17.09 25.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.377 1.071 . . . . 0.0 113.046 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.99 -70.18 0.99 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.224 0.916 . . . . 0.0 112.8 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -179.66 75.48 0.19 Allowed Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 127.962 2.505 . . . . 0.0 110.618 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 131.71 19.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.812 1.674 . . . . 0.0 110.981 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 118.49 13.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.405 ' HD2' ' CE3' ' A' ' 114' ' ' TRP . 0.1 OUTLIER -63.58 123.48 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.898 178.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.75 69.84 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.733 1.635 . . . . 0.0 113.114 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.82 38.81 0.46 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.29 1.836 . . . . 0.0 111.841 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 54.44 41.79 31.76 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.83 1.652 . . . . 0.0 113.168 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.36 156.2 26.88 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.061 1.315 . . . . 0.0 113.418 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.15 134.38 51.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.156 0.983 . . . . 0.0 111.523 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.53 111.7 11.99 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.965 2.106 . . . . 0.0 108.902 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -147.91 146.78 29.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.017 1.727 . . . . 0.0 111.184 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 144.6 9.97 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.422 1.089 . . . . 0.0 111.208 175.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 137.09 58.24 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.841 0.457 . . . . 0.0 112.008 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.44 -30.37 0.06 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 113.646 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.9 16.3 55.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.078 1.323 . . . . 0.0 114.169 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.38 14.06 4.47 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.091 2.157 . . . . 0.0 114.965 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.25 -65.45 0.06 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.254 1.883 . . . . 0.0 110.816 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.28 156.34 16.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.905 0.882 . . . . 0.0 110.845 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -149.55 170.33 18.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.433 1.493 . . . . 0.0 112.397 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -89.23 145.49 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.964 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -137.95 106.13 5.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.528 1.931 . . . . 0.0 108.684 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.85 170.65 25.72 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-O 121.765 0.647 . . . . 0.0 113.972 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.14 148.29 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.847 2.059 . . . . 0.0 108.531 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.5 ttt -142.11 131.99 24.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.379 1.072 . . . . 0.0 108.607 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.06 160.81 31.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.052 1.341 . . . . 0.0 111.608 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.6 t -93.4 5.0 53.06 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.993 1.317 . . . . 0.0 113.362 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.74 174.52 5.84 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.712 2.005 . . . . 0.0 112.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.17 -56.77 21.93 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.011 0.815 . . . . 0.0 113.552 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.04 36.52 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.545 1.938 . . . . 0.0 113.685 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.38 32.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.599 1.159 . . . . 0.0 114.045 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -106.49 131.2 53.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.905 1.682 . . . . 0.0 109.504 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 34.2 ttp -128.01 95.27 4.14 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.843 1.257 . . . . 0.0 111.361 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -109.34 143.57 38.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.73 -0.606 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.45 107.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.759 2.023 . . . . 0.0 109.668 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 101.12 10.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.232 1.413 . . . . 0.0 109.795 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.66 129.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.872 -0.517 . . . . 0.0 110.654 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.99 171.97 18.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.002 0.921 . . . . 0.0 113.16 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 128.973 2.909 . . . . 0.0 112.837 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -104.68 6.17 34.07 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.836 1.254 . . . . 0.0 113.175 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.24 147.05 38.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.553 -1.342 . . . . 0.0 111.88 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.94 34.33 81.81 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.605 0.622 . . . . 0.0 113.777 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -148.49 178.3 8.73 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.987 0.893 . . . . 0.0 111.501 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 69' ' ' LEU . 4.9 pt -128.35 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.489 1.516 . . . . 0.0 111.949 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 pt -144.84 167.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.804 1.642 . . . . 0.0 111.708 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.57 124.34 16.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.633 1.173 . . . . 0.0 112.173 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.95 -19.67 30.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 114.1 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.3 95.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.02 1.328 . . . . 0.0 111.692 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -35.28 25.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.321 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 68' ' ' ALA . 3.5 tp -52.44 100.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.081 1.752 . . . . 0.0 112.602 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -145.72 170.3 16.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.019 1.328 . . . . 0.0 109.793 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.88 -36.9 28.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.115 1.366 . . . . 0.0 113.702 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 -35.21 76.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.026 0.93 . . . . 0.0 113.305 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 20' ' ' VAL . 62.1 t -67.74 -46.71 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.644 1.178 . . . . 0.0 109.519 175.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.74 -44.84 73.93 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 112.412 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.5 -42.08 95.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.838 -0.539 . . . . 0.0 111.361 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -42.04 97.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.318 1.047 . . . . 0.0 111.407 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 2' ' ' LEU . 44.5 t -61.2 -54.47 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.599 1.159 . . . . 0.0 111.247 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.27 -49.48 61.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 0.0 111.569 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.99 -42.83 72.55 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.2 -38.06 44.14 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' HZ2' ' A' ' 30' ' ' LYS . 3.4 tt -54.71 -45.14 73.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.487 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.33 66.48 0.48 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.229 1.395 . . . . 0.0 111.564 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 124.21 1.11 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.542 1.537 . . . . 0.0 112.946 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -104.09 -159.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.688 1.595 . . . . 0.0 109.556 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.51 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -49.06 -30.59 6.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 114.117 176.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.27 135.11 11.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.143 1.777 . . . . 0.0 111.439 176.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HZ2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.77 165.25 35.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.755 1.222 . . . . 0.0 113.343 174.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.39 161.27 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.181 1.392 . . . . 0.0 109.099 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.49 125.73 51.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.068 1.347 . . . . 0.0 108.07 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.55 142.21 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.171 1.788 . . . . 0.0 110.388 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.46 122.51 1.32 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.948 0.785 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.53 111.69 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 118.336 1.068 . . . . 0.0 110.208 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.61 120.58 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.972 1.709 . . . . 0.0 113.798 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.39 90.39 1.29 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.089 1.756 . . . . 0.0 110.171 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -107.53 12.39 27.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 112.595 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -82.33 -34.63 28.47 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -171.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.63 17.35 10.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.241 0.928 . . . . 0.0 114.997 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.3 160.93 31.3 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 118.988 1.394 . . . . 0.0 114.844 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -74.08 134.42 42.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.805 1.242 . . . . 0.0 111.874 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.46 166.47 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.96 1.704 . . . . 0.0 111.26 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 m -133.93 113.24 11.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.986 1.315 . . . . 0.0 110.064 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 113.02 4.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.72 -64.46 0.93 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.674 1.19 . . . . 0.0 110.142 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -175.22 169.11 3.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.892 2.077 . . . . 0.0 111.459 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -122.12 139.03 54.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.977 2.111 . . . . 0.0 109.103 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.9 110.93 11.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.55 101.49 3.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.174 1.39 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -68.03 -42.33 80.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.46 1.504 . . . . 0.0 111.942 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.11 157.79 43.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.692 2.397 . . . . 0.0 111.144 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 -169.69 39.86 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 123.729 0.681 . . . . 0.0 114.574 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -136.77 173.3 11.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.056 1.342 . . . . 0.0 112.363 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.7 p -143.04 176.57 8.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 110.66 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -123.35 17.59 9.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.434 1.094 . . . . 0.0 112.193 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.07 175.51 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.985 2.114 . . . . 0.0 111.904 -168.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mt -139.04 133.72 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.014 1.326 . . . . 0.0 109.76 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.0 142.24 75.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.151 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.93 172.01 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.607 3.538 . . . . 0.0 110.811 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -115.39 -20.26 10.35 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.204 -1.56 . . . . 0.0 112.556 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -129.88 141.35 50.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.353 1.461 . . . . 0.0 110.297 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.03 95.5 5.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.92 161.53 32.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.556 1.504 . . . . 0.0 111.303 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.7 153.53 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.568 -0.707 . . . . 0.0 111.517 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -25.79 0.18 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.038 1.735 . . . . 0.0 113.384 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -89.03 121.15 31.09 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.133 1.333 . . . . 0.0 110.659 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.535 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -91.11 160.5 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 111.402 174.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -101.68 164.46 11.73 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.026 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.65 134.74 48.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.96 2.104 . . . . 0.0 109.01 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -147.42 171.18 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.962 1.305 . . . . 0.0 111.786 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -148.08 168.82 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.834 1.253 . . . . 0.0 110.831 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -146.43 116.38 0.87 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-O 118.036 -1.425 . . . . 0.0 110.602 175.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.09 163.81 15.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.704 1.252 . . . . 0.0 110.737 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -177.81 0.66 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.1 -175.25 0.2 Allowed 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.143 -0.973 . . . . 0.0 111.036 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 m -19.7 -56.58 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.187 2.995 . . . . 0.0 115.589 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.94 -63.08 0.3 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.424 1.488 . . . . 0.0 112.226 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 0.14 6.78 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.925 3.75 . . . . 0.0 115.972 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.38 122.87 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.888 1.675 . . . . 0.0 111.783 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.91 80.17 4.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.367 1.467 . . . . 0.0 111.713 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -104.91 -86.51 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.494 1.518 . . . . 0.0 110.789 177.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 82' ' ' THR . . . 174.24 179.94 45.18 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 127.41 2.433 . . . . 0.0 110.581 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -138.35 101.18 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.176 1.391 . . . . 0.0 109.966 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -140.77 126.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -149.95 164.94 34.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.351 -0.843 . . . . 0.0 110.8 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.6 155.93 40.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.961 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.23 168.02 27.39 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.968 1.307 . . . . 0.0 109.881 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 148.91 43.05 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.727 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -134.62 115.77 14.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.279 1.032 . . . . 0.0 111.165 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -69.62 118.5 12.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.404 1.482 . . . . 0.0 109.36 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -82.47 151.68 26.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.604 1.562 . . . . 0.0 110.404 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -58.33 -19.18 33.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 63.2 m -82.3 -12.28 58.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.484 1.914 . . . . 0.0 113.848 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.51 -10.6 42.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.298 1.428 . . . . 0.0 115.127 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.55 173.32 12.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.514 1.525 . . . . 0.0 110.737 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -137.63 142.76 41.2 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.698 1.199 . . . . 0.0 108.39 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.23 140.75 38.7 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.25 145.57 16.27 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -148.87 130.15 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 109.725 175.172 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.53 50.1 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.04 . . . . 0.0 110.296 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -123.21 152.99 40.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.037 1.335 . . . . 0.0 109.453 174.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.3 p -140.37 122.5 15.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.024 0.929 . . . . 0.0 110.626 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 23.7 t -119.75 108.15 39.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 126.407 1.883 . . . . 0.0 108.33 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.16 155.56 37.67 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.297 1.998 . . . . 0.0 111.493 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.68 -36.09 83.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.646 0.778 . . . . 0.0 110.76 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.99 114.68 27.31 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.785 2.434 . . . . 0.0 111.612 -171.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.0 -63.77 1.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.047 -1.033 . . . . 0.0 113.445 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -88.86 10.86 19.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -6.0 6.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.83 2.052 . . . . 0.0 112.743 -174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.35 179.35 8.62 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.835 2.454 . . . . 0.0 110.284 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -136.75 159.96 40.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.161 1.385 . . . . 0.0 110.955 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -79.63 155.33 28.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -136.83 151.61 49.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.75 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -161.6 157.73 25.15 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.675 1.19 . . . . 0.0 110.16 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 12.5 t70 -154.47 161.32 41.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.602 1.161 . . . . 0.0 110.245 174.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 100' ' ' VAL . 67.5 t -146.23 138.0 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.346 1.858 . . . . 0.0 109.921 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.87 46.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.055 1.742 . . . . 0.0 110.007 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.8 119.24 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.097 1.759 . . . . 0.0 108.71 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -127.92 139.4 52.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.465 1.906 . . . . 0.0 112.385 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.6 p -77.34 79.4 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.919 1.688 . . . . 0.0 112.525 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.75 174.78 32.05 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.979 . . . . 0.0 112.606 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 99.65 10.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.855 2.062 . . . . 0.0 110.593 -173.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.82 161.43 34.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.781 2.032 . . . . 0.0 111.464 -176.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.44 30.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.527 1.531 . . . . 0.0 111.301 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.41 87.96 0.64 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.128 0.971 . . . . 0.0 111.293 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.63 -64.16 1.12 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.999 1.32 . . . . 0.0 109.292 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -75.02 0.17 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.989 1.716 . . . . 0.0 108.543 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.41 93.98 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.804 1.192 . . . . 0.0 113.93 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.31 -46.42 76.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.299 1.049 . . . . 0.0 111.398 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.35 -43.66 93.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.575 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -62.35 -42.66 99.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.514 1.126 . . . . 0.0 112.338 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -16.71 35.11 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 113.153 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.43 -52.4 4.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.55 -43.09 97.63 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 112.794 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -98.46 -14.65 19.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.786 1.234 . . . . 0.0 113.591 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.48 4.16 Favored Glycine 0 N--CA 1.475 1.286 0 O-C-N 121.541 -0.724 . . . . 0.0 114.655 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 44.3 77.21 0.46 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.222 1.809 . . . . 0.0 111.78 -165.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.67 157.58 50.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.04 1.826 . . . . 0.0 111.01 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 116' ' ' ASP . 23.8 m-85 -90.28 2.9 54.99 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER 46.61 16.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 129.426 3.09 . . . . 0.0 116.848 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 45.69 62.98 3.01 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.176 0.893 . . . . 0.0 112.611 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.74 16.65 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.281 10.7 p30 49.17 33.69 5.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.409 2.283 . . . . 0.0 115.15 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.24 147.89 19.36 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.965 1.745 . . . . 0.0 111.06 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -64.98 116.06 6.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.362 0.665 . . . . 0.0 110.382 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 138.09 49.26 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.42 128.57 4.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.91 1.284 . . . . 0.0 111.333 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -137.86 119.57 15.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.299 1.04 . . . . 0.0 113.372 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.77 123.94 5.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.3 -24.48 0.08 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.77 22.34 14.5 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.958 1.266 . . . . 0.0 114.085 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.0 t80 58.43 14.8 3.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.566 2.346 . . . . 0.0 115.024 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.98 -64.03 0.05 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 125.456 1.503 . . . . 0.0 110.913 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.13 161.07 15.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.183 0.993 . . . . 0.0 111.149 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 174.44 10.51 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.886 2.074 . . . . 0.0 111.407 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -78.2 131.13 37.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.91 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -122.23 104.67 9.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.717 1.207 . . . . 0.0 108.696 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.38 165.41 27.48 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-O 122.401 1.0 . . . . 0.0 114.643 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.3 tt -146.9 141.54 20.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 127.573 2.349 . . . . 0.0 108.469 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.1 ttt -141.7 140.6 33.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.07 1.748 . . . . 0.0 106.371 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.99 163.14 19.07 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.436 0.694 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 9.77 13.54 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.03 1.332 . . . . 0.0 113.776 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.28 170.58 9.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.234 2.214 . . . . 0.0 112.663 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.34 -71.79 0.88 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.46 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.665 2.386 . . . . 0.0 115.995 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 158.49 8.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.168 2.187 . . . . 0.0 113.627 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.22 140.44 36.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.271 1.428 . . . . 0.0 110.685 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.2 ttm -133.48 135.4 44.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.999 1.719 . . . . 0.0 110.087 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -144.46 152.6 40.86 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.927 0.891 . . . . 0.0 109.225 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.1 mt -133.18 117.4 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.494 1.518 . . . . 0.0 108.453 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -106.59 113.78 27.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.795 1.638 . . . . 0.0 109.561 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.35 101.07 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 60.3 p -161.73 -179.56 7.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.426 1.891 . . . . 0.0 114.914 -174.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 127.997 2.519 . . . . 0.0 115.408 -164.715 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.149 0.5 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.33 -55.42 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.69 1.596 . . . . 0.0 110.1 -176.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.57 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 61.84 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.169 2.588 . . . . 0.0 113.082 -167.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.36 47.46 90.77 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 114.817 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.9 p -147.51 -174.65 4.59 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.33 1.052 . . . . 0.0 112.574 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -124.47 136.82 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.673 1.989 . . . . 0.0 111.041 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.53 174.21 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.476 1.51 . . . . 0.0 111.905 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.14 1.69 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.984 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 67' ' ' LYS . . . -64.14 -25.26 69.46 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.241 -0.912 . . . . 0.0 113.096 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.0 71.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.418 1.087 . . . . 0.0 112.549 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 m -83.63 -19.41 35.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.79 1.236 . . . . 0.0 113.374 175.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD22 ' CB ' ' A' ' 68' ' ' ALA . 16.2 tp -66.7 97.7 0.47 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.927 1.291 . . . . 0.0 111.688 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 14' ' ' PHE . 7.4 m -144.44 174.44 10.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.562 1.545 . . . . 0.0 109.508 -174.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.524 ' HA ' HD12 ' A' ' 17' ' ' LEU . 1.4 t80 -49.05 -33.63 11.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.95 1.3 . . . . 0.0 114.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -64.23 -32.9 74.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -77.5 -30.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.224 1.41 . . . . 0.0 111.422 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 14' ' ' PHE . 52.6 mt -59.03 -52.84 64.02 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.92 -38.41 72.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.547 1.139 . . . . 0.0 111.666 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -58.88 -36.94 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.12 -46.49 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.332 0.969 . . . . 0.0 110.78 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -40.17 85.03 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.213 1.405 . . . . 0.0 110.418 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.35 -53.36 37.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.385 0.674 . . . . 0.0 112.813 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -48.72 41.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.496 -0.753 . . . . 0.0 112.766 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.701 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.1 tm? -63.32 -39.45 94.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.77 0.828 . . . . 0.0 111.7 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.74 69.53 0.8 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.137 1.351 . . . . 0.0 112.758 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.277 1.831 . . . . 0.0 112.376 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -84.03 -160.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.123 1.769 . . . . 0.0 110.421 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 27' ' ' VAL . 67.5 m -44.02 -35.01 1.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.987 1.715 . . . . 0.0 114.754 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -149.71 137.48 20.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.616 1.966 . . . . 0.0 110.221 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.701 ' HE3' HD12 ' A' ' 24' ' ' LEU . 5.7 tptp -165.85 143.17 5.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.556 1.542 . . . . 0.0 112.017 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.22 143.46 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.371 0.987 . . . . 0.0 111.443 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.99 118.57 36.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 108.867 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.64 139.67 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.984 0.913 . . . . 0.0 111.227 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.77 133.73 4.42 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.925 1.25 . . . . 0.0 111.596 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.26 99.3 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.028 0.931 . . . . 0.0 108.699 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -81.02 105.61 12.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.814 0.846 . . . . 0.0 111.142 -174.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -73.61 96.15 2.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 111.283 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.74 10.81 15.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 113.442 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.3 t -64.06 -55.06 24.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.911 1.284 . . . . 0.0 114.006 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.02 0.9 3.03 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.38 157.21 27.12 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 119.489 1.645 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -69.63 138.06 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.554 1.142 . . . . 0.0 113.129 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -115.26 166.05 12.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.551 1.54 . . . . 0.0 112.112 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -134.62 114.02 12.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.995 1.318 . . . . 0.0 110.295 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.49 124.29 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.959 -1.088 . . . . 0.0 108.994 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.41 -66.78 0.5 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 110.622 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.23 159.78 7.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.125 2.17 . . . . 0.0 110.558 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.08 122.92 47.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.478 1.911 . . . . 0.0 109.7 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.59 116.81 26.09 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.177 0.991 . . . . 0.0 111.829 -176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -71.49 114.2 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.177 1.391 . . . . 0.0 112.727 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -44.83 44.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.044 1.738 . . . . 0.0 110.591 174.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 m -147.38 162.22 39.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.496 2.318 . . . . 0.0 111.574 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.67 -166.18 54.02 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.358 0.98 . . . . 0.0 113.934 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -147.32 173.32 12.7 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.889 -0.771 . . . . 0.0 111.954 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.57 HG22 ' HA2' ' A' ' 73' ' ' GLY . 5.1 p -143.82 -174.69 4.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.182 1.393 . . . . 0.0 111.479 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.07 13.46 6.22 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.286 1.034 . . . . 0.0 112.918 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 3' ' ' ALA . 7.9 m -136.45 170.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.898 2.079 . . . . 0.0 114.043 -169.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.33 133.35 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.915 1.686 . . . . 0.0 110.785 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 143.48 52.06 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.196 0.907 . . . . 0.0 111.713 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.79 146.36 59.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.655 3.57 . . . . 0.0 112.051 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -85.6 -26.74 25.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -113.63 128.03 56.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.216 1.371 . . . . 0.0 111.897 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.52 86.63 28.68 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.609 1.564 . . . . 0.0 110.137 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.73 162.12 36.01 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.303 2.002 . . . . 0.0 112.124 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -63.64 159.48 18.89 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.758 -0.589 . . . . 0.0 111.063 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p 68.45 -5.42 0.94 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.68 2.392 . . . . 0.0 114.444 -172.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.486 ' HA ' ' H ' ' A' ' 9' ' ' GLY . 73.9 mttt -116.31 165.44 13.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.581 1.952 . . . . 0.0 112.026 174.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.508 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -135.89 162.66 32.2 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.321 1.448 . . . . 0.0 111.272 174.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 167.02 10.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.292 0.567 . . . . 0.0 109.857 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.51 136.08 52.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.506 1.922 . . . . 0.0 108.764 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -150.17 166.29 30.3 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.185 0.994 . . . . 0.0 110.662 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -155.29 170.12 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.591 0.757 . . . . 0.0 112.447 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.57 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -160.15 145.0 10.6 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.748 1.166 . . . . 0.0 112.582 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -127.17 148.92 50.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.652 1.981 . . . . 0.0 110.981 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 9.4 pttp -67.36 121.11 15.02 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 38.24 -149.77 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 126.034 1.733 . . . . 0.0 114.381 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.7 m -88.17 -42.65 12.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.634 -1.291 . . . . 0.0 111.598 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.9 -61.16 0.37 Allowed Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.696 -1.058 . . . . 0.0 114.252 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.16 0.81 5.4 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.929 3.753 . . . . 0.0 115.27 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.76 135.72 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 127.677 2.391 . . . . 0.0 108.995 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 106' ' ' PHE . . . -119.14 80.95 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.627 1.571 . . . . 0.0 110.226 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.8 m -110.42 -66.7 1.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.726 1.211 . . . . 0.0 110.75 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.02 -179.64 33.58 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.731 0.681 . . . . 0.0 112.793 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -140.1 115.46 9.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 110.427 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.8 t -138.63 139.51 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.426 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -154.71 158.82 40.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.31 0.644 . . . . 0.0 109.863 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.67 139.81 22.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 111.919 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.73 176.43 8.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.573 1.949 . . . . 0.0 109.682 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.73 37.07 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.336 0.655 . . . . 0.0 112.125 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.44 113.02 15.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.686 1.194 . . . . 0.0 111.112 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -73.04 111.77 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.215 1.806 . . . . 0.0 110.747 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 mtt -71.68 161.42 31.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.724 0.81 . . . . 0.0 112.106 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.3 t -60.98 -26.08 67.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.118 0.967 . . . . 0.0 113.245 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -74.96 -12.1 60.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.622 1.569 . . . . 0.0 112.957 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.34 -2.86 59.48 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.665 1.602 . . . . 0.0 114.489 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.79 176.38 9.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.533 1.533 . . . . 0.0 109.664 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.9 m -136.56 148.71 47.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 0.0 110.241 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.33 134.89 54.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 108.637 175.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 144.04 19.03 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.26 121.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 118.445 1.122 . . . . 0.0 109.481 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -128.64 162.22 27.83 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.359 0.664 . . . . 0.0 112.668 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 3.8 p90 -131.4 150.89 51.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.875 1.27 . . . . 0.0 109.603 174.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 t -139.08 110.37 6.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.52 0.728 . . . . 0.0 110.383 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.8 t -99.59 100.01 9.91 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 127.897 2.479 . . . . 0.0 109.112 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.4 145.72 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.34 2.027 . . . . 0.0 111.372 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' A' ' 81' ' ' ALA . 23.6 t80 -72.89 -31.55 64.76 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.41 0.624 . . . . 0.0 110.167 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.73 114.85 28.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.522 2.329 . . . . 0.0 111.714 -165.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.01 -54.74 8.97 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -95.01 14.43 21.85 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -16.92 2.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.373 1.869 . . . . 0.0 113.06 -175.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.07 175.1 10.11 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.062 2.945 . . . . 0.0 109.497 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.8 m -136.01 171.0 15.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.438 1.495 . . . . 0.0 110.768 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -87.24 151.97 22.71 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.069 0.947 . . . . 0.0 109.964 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -138.78 142.02 38.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.231 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -159.6 163.2 35.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 111.154 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -163.71 147.19 10.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.395 1.478 . . . . 0.0 110.421 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.21 108.25 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.009 1.723 . . . . 0.0 109.529 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -111.76 149.11 32.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.041 1.736 . . . . 0.0 109.734 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.1 117.76 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.687 1.595 . . . . 0.0 108.898 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -125.21 135.88 53.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.145 1.778 . . . . 0.0 112.092 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -75.66 80.63 2.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.379 1.472 . . . . 0.0 112.792 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.14 167.63 14.5 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 115.207 0.843 . . . . 0.0 115.207 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -72.86 102.66 3.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.432 1.493 . . . . 0.0 111.665 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.51 132.45 31.22 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.318 1.847 . . . . 0.0 109.436 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 167.13 17.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.048 1.339 . . . . 0.0 111.837 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.64 88.54 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.598 1.559 . . . . 0.0 111.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -111.53 -64.38 1.29 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.776 1.23 . . . . 0.0 109.712 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -68.52 0.23 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.597 1.159 . . . . 0.0 109.139 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.77 90.62 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.682 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -52.77 33.27 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.086 1.443 . . . . 0.0 111.02 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.89 -44.43 78.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.253 1.021 . . . . 0.0 110.801 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.85 -39.38 94.08 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -22.32 61.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.453 1.101 . . . . 0.0 112.216 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.19 -58.86 2.47 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.431 1.492 . . . . 0.0 109.557 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -63.36 -57.63 9.73 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.295 -0.878 . . . . 0.0 111.248 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -82.26 -17.95 44.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.347 1.059 . . . . 0.0 112.247 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.21 56.51 4.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.935 0.778 . . . . 0.0 114.676 -172.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.49 83.28 0.23 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 126.444 1.898 . . . . 0.0 111.818 -166.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.48 151.27 83.41 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.132 1.888 . . . . 0.0 109.256 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.42 -2.9 57.93 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.1 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 129.179 2.992 . . . . 0.0 112.819 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -38.67 75.32 0.0 OUTLIER Glycine 0 CA--C 1.542 1.781 0 C-N-CA 128.319 2.866 . . . . 0.0 117.239 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -81.97 25.55 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.629 1.972 . . . . 0.0 114.668 -170.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.275 11.6 p30 52.44 24.79 3.15 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.178 2.191 . . . . 0.0 114.842 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.35 172.25 18.07 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 126.888 2.185 . . . . 0.0 113.189 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -79.69 117.89 21.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.727 1.211 . . . . 0.0 111.919 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.84 117.33 33.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.053 1.741 . . . . 0.0 109.526 175.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.9 134.55 17.59 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 111.293 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -148.09 127.77 13.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.608 1.163 . . . . 0.0 112.146 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.84 113.54 1.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.136 1.374 . . . . 0.0 113.016 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tt -137.1 -28.36 0.94 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.944 1.298 . . . . 0.0 113.385 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.11 18.24 33.0 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.883 1.23 . . . . 0.0 114.498 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.66 11.25 2.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.385 2.274 . . . . 0.0 114.785 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.69 -72.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 C-N-CA 126.101 1.81 . . . . 0.0 110.319 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.43 156.75 22.77 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.813 0.816 . . . . 0.0 111.632 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.62 170.87 18.64 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.599 1.56 . . . . 0.0 112.43 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.9 130.87 35.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.303 1.041 . . . . 0.0 109.401 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -125.71 101.32 6.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -134.45 168.76 23.35 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 121.963 0.757 . . . . 0.0 113.843 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.7 tt -143.74 141.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.343 1.857 . . . . 0.0 109.049 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.5 ttt -146.28 143.07 28.93 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.78 1.632 . . . . 0.0 107.501 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.7 p -97.53 173.22 7.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.22 1.008 . . . . 0.0 111.539 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.0 m -109.43 33.72 4.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.555 1.542 . . . . 0.0 112.392 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.8 175.08 5.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.248 1.419 . . . . 0.0 112.376 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.65 -47.47 91.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.177 0.894 . . . . 0.0 113.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -108.87 72.01 0.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.784 1.278 . . . . 0.0 111.633 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.5 175.01 7.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.918 1.287 . . . . 0.0 111.211 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.81 151.16 47.83 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 109.312 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.9 tpp -140.68 87.77 2.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.147 0.979 . . . . 0.0 111.736 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.38 148.78 23.34 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.984 0.514 . . . . 0.0 111.05 174.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.87 99.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.25 1.42 . . . . 0.0 111.19 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -83.76 108.16 16.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.798 1.639 . . . . 0.0 109.844 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 110.07 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.132 0.573 . . . . 0.0 110.86 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 55.4 m -147.29 161.33 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.921 1.289 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 128.211 2.604 . . . . 0.0 111.686 177.834 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.79 11.07 22.56 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.504 1.122 . . . . 0.0 112.59 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.01 139.58 50.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.46 -1.4 . . . . 0.0 111.084 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.02 31.83 61.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -142.76 177.22 8.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 118.639 1.22 . . . . 0.0 112.398 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 60' ' ' PRO . 6.5 pt -125.51 144.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.448 1.499 . . . . 0.0 112.734 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -146.38 174.09 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.748 1.619 . . . . 0.0 112.236 177.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.52 121.01 8.68 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.023 1.329 . . . . 0.0 111.587 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.7 -21.74 44.31 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.111 1.339 . . . . 0.0 113.863 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.81 76.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.059 1.344 . . . . 0.0 111.931 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.9 m -88.51 -32.8 18.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.42 1.488 . . . . 0.0 112.361 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.6 tp -55.42 106.54 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.761 1.224 . . . . 0.0 111.623 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -146.29 168.98 19.73 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.825 1.25 . . . . 0.0 109.747 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.85 -37.87 14.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 114.05 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.85 -34.27 71.38 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 20' ' ' VAL . 46.9 t -72.51 -48.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.191 1.397 . . . . 0.0 110.198 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 170' ' ' GLN . 86.5 mt -54.31 -44.84 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 112.629 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.87 -45.5 77.89 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.963 0.505 . . . . 0.0 111.624 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -56.34 -41.54 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.821 1.649 . . . . 0.0 113.044 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 16' ' ' VAL . 67.0 t -50.07 -55.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.197 1.399 . . . . 0.0 111.193 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.17 -38.65 88.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 112.479 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -49.63 75.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.12 1.368 . . . . 0.0 110.741 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.01 -36.07 61.96 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.08 -50.94 69.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.66 1.584 . . . . 0.0 112.23 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 62.83 0.36 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.893 1.235 . . . . 0.0 112.328 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -45.94 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.617 2.367 . . . . 0.0 114.04 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.5 -166.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.591 1.956 . . . . 0.0 111.211 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -43.78 -41.34 4.89 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.819 2.047 . . . . 0.0 113.99 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -144.38 138.91 28.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.551 1.94 . . . . 0.0 108.84 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HE3' ' CB ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -167.34 146.39 5.04 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.234 2.214 . . . . 0.0 109.591 -172.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -137.92 160.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.608 1.163 . . . . 0.0 110.916 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.49 118.04 31.57 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.995 1.318 . . . . 0.0 109.034 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.4 139.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.87 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.65 118.14 0.88 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.921 0.772 . . . . 0.0 111.711 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.79 97.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.128 0.971 . . . . 0.0 108.461 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -76.96 117.51 18.63 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 0.0 111.403 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -92.77 101.7 14.09 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.976 0.894 . . . . 0.0 112.215 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -111.38 12.46 21.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.451 1.1 . . . . 0.0 113.489 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -56.42 -51.97 66.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.1 1.76 . . . . 0.0 114.36 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.42 4.83 0.74 Allowed Glycine 0 CA--C 1.538 1.526 0 N-CA-C 116.505 1.362 . . . . 0.0 116.505 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 166.85 32.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.642 1.721 . . . . 0.0 114.348 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 t -69.94 126.93 31.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.125 1.37 . . . . 0.0 112.401 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -98.99 165.33 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.63 1.572 . . . . 0.0 111.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 m -135.41 106.97 6.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.104 1.362 . . . . 0.0 109.574 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.23 132.33 52.38 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.66 -72.63 0.3 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.587 0.755 . . . . 0.0 110.291 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.51 165.33 8.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.499 1.92 . . . . 0.0 111.048 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -114.21 124.18 51.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.885 1.674 . . . . 0.0 109.772 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.21 108.77 19.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.549 1.14 . . . . 0.0 111.37 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -73.31 118.54 16.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.481 1.112 . . . . 0.0 110.896 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.62 12.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.769 1.228 . . . . 0.0 111.942 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -143.42 150.98 39.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.78 2.032 . . . . 0.0 111.397 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.29 51.7 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.183 0.897 . . . . 0.0 113.648 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -149.13 163.23 38.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.875 -0.779 . . . . 0.0 111.094 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -142.43 130.17 21.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.892 1.277 . . . . 0.0 110.095 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.01 2.9 54.63 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.546 1.538 . . . . 0.0 113.521 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.71 169.76 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.697 1.199 . . . . 0.0 111.134 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.07 131.53 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.203 1.001 . . . . 0.0 110.037 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -76.44 154.27 83.91 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 118.289 0.495 . . . . 0.0 111.169 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HG3' HG23 ' A' ' 6' ' ' ILE . 45.9 Cg_endo -70.93 167.76 25.02 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.365 3.377 . . . . 0.0 109.957 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.14 -16.75 12.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.061 -1.025 . . . . 0.0 112.952 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -128.99 144.0 51.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.483 1.513 . . . . 0.0 109.958 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 6' ' ' ILE . 26.5 t -143.52 99.48 5.28 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.674 1.19 . . . . 0.0 109.634 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.61 155.02 71.82 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.884 1.723 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -55.86 150.2 13.58 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.953 -0.467 . . . . 0.0 111.597 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 0.9 OUTLIER 68.83 -7.3 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.185 2.194 . . . . 0.0 115.417 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -101.58 141.71 34.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.402 1.455 . . . . 0.0 108.07 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -112.73 154.48 26.1 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.213 -0.929 . . . . 0.0 111.784 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -90.94 171.01 9.59 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.44 175.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -135.45 134.11 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.577 2.351 . . . . 0.0 107.364 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -150.19 162.35 40.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.766 1.626 . . . . 0.0 111.206 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.6 m -154.21 155.32 35.04 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.367 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 31' ' ' ILE . . . -150.42 143.65 10.93 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 121.2 -0.937 . . . . 0.0 113.411 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.06 163.63 29.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.779 1.232 . . . . 0.0 113.48 -172.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 99.32 7.86 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.699 1.237 . . . . 0.0 110.411 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 36.28 -131.0 0.1 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.87 2.468 . . . . 0.0 113.191 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -57.54 -53.67 55.57 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.806 -1.184 . . . . 0.0 112.73 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.22 -61.93 0.41 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.47 -8.72 23.91 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 124.433 3.422 . . . . 0.0 115.554 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.91 163.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.347 1.459 . . . . 0.0 112.836 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.64 74.51 1.01 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.056 1.342 . . . . 0.0 112.599 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 83' ' ' GLY . 2.8 t -106.99 -107.91 0.32 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.723 1.609 . . . . 0.0 109.76 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 82' ' ' THR . . . -171.57 174.88 45.14 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.628 2.537 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -136.82 93.13 2.81 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.067 1.347 . . . . 0.0 109.584 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.84 124.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.55 157.82 42.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.33 130.53 17.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.95 0.9 . . . . 0.0 110.916 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -131.58 176.44 8.32 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.734 1.613 . . . . 0.0 110.241 -172.396 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 150.35 44.79 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.466 0.651 . . . . 0.0 112.686 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -132.88 114.11 13.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 111.02 -175.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -79.54 123.54 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.219 1.408 . . . . 0.0 111.239 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 mtp -81.63 157.28 24.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.179 1.391 . . . . 0.0 112.257 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 p -62.2 -19.52 63.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.233 1.413 . . . . 0.0 114.757 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -84.06 -11.39 56.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.005 1.722 . . . . 0.0 113.755 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.85 -5.06 46.46 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.936 1.255 . . . . 0.0 115.11 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -76.12 171.82 13.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.654 1.182 . . . . 0.0 110.213 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 m -136.69 140.7 42.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.979 0.912 . . . . 0.0 110.158 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 123.51 50.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.51 139.08 18.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.14 122.18 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.711 1.205 . . . . 0.0 110.242 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.0 159.61 40.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -134.03 153.7 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.47 1.508 . . . . 0.0 110.913 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 t -137.1 104.79 5.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.574 1.55 . . . . 0.0 110.009 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 41.5 t -105.65 97.05 13.48 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 127.032 2.133 . . . . 0.0 108.475 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.57 167.05 28.23 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.773 2.316 . . . . 0.0 111.617 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -69.69 -45.27 68.66 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.614 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 114.59 26.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.573 1.549 . . . . 0.0 111.569 -165.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -65.76 -62.07 1.72 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.07 12.35 22.28 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -7.72 5.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.606 1.963 . . . . 0.0 112.568 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.68 139.92 19.42 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.458 2.303 . . . . 0.0 109.116 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 t -98.55 159.23 15.09 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -84.22 157.78 21.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.792 -0.567 . . . . 0.0 109.805 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -138.98 145.67 40.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.986 0.915 . . . . 0.0 110.819 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -155.32 148.21 24.46 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.864 1.265 . . . . 0.0 110.792 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.59 151.36 37.16 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.46 107.45 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.825 1.65 . . . . 0.0 109.77 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -115.86 148.03 40.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.221 1.408 . . . . 0.0 109.724 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.51 111.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.863 2.065 . . . . 0.0 109.241 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -118.33 145.13 45.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 0.0 112.349 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.6 t -73.35 90.11 1.64 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.385 1.074 . . . . 0.0 110.79 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.63 -174.23 42.04 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.476 0.56 . . . . 0.0 113.768 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 111.68 23.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.047 2.139 . . . . 0.0 110.908 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -147.84 156.56 42.84 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.312 -0.868 . . . . 0.0 111.655 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -140.38 167.4 22.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.522 1.529 . . . . 0.0 111.299 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.73 86.79 0.94 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.537 1.135 . . . . 0.0 111.555 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -111.18 -67.0 1.03 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 108.911 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -146.18 -67.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.849 1.26 . . . . 0.0 109.779 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.23 -36.62 90.12 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.961 0.791 . . . . 0.0 114.325 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.5 ttp -65.71 -48.26 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.791 1.295 . . . . 0.0 111.642 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.19 -49.42 75.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.674 0.79 . . . . 0.0 111.068 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -64.82 -37.33 87.26 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.37 -20.86 61.08 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.163 -1.585 . . . . 0.0 113.286 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.71 -50.41 5.39 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.484 1.513 . . . . 0.0 112.132 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -75.32 -57.16 4.06 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.587 1.085 . . . . 0.0 112.76 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.73 -19.35 49.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.337 1.455 . . . . 0.0 111.858 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.51 -90.14 0.05 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.003 1.287 . . . . 0.0 112.467 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.02 79.17 1.99 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.073 1.349 . . . . 0.0 110.598 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 150.1 52.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.689 1.593 . . . . 0.0 111.546 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 164.51 26.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.864 0.866 . . . . 0.0 109.171 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.76 118.61 36.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.143 1.377 . . . . 0.0 108.856 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.32 65.5 1.63 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.878 0.763 . . . . 0.0 112.627 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -82.52 18.69 1.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.437 1.895 . . . . 0.0 113.647 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 64.52 43.35 4.5 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.526 1.93 . . . . 0.0 112.63 -173.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.64 153.57 21.72 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.604 1.573 . . . . 0.0 113.652 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -70.15 133.57 47.24 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.613 1.165 . . . . 0.0 111.893 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.91 113.73 14.38 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.294 1.837 . . . . 0.0 110.158 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.58 153.7 41.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.684 1.594 . . . . 0.0 110.578 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -166.48 150.65 7.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.237 1.815 . . . . 0.0 110.23 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.09 127.48 32.28 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.164 0.893 . . . . 0.0 110.143 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 tt -135.48 -39.74 0.73 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.522 1.129 . . . . 0.0 112.09 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.85 20.98 10.25 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.008 1.29 . . . . 0.0 114.475 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.73 14.46 4.1 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.991 2.116 . . . . 0.0 114.668 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 177.3 -56.85 0.1 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.065 1.793 . . . . 0.0 110.955 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.43 153.69 21.71 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.904 0.859 . . . . 0.0 110.128 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.6 169.51 24.51 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.043 1.337 . . . . 0.0 112.331 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -100.89 140.85 34.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.661 1.184 . . . . 0.0 111.606 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -126.38 113.91 17.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -146.36 172.19 27.01 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-O 121.661 0.589 . . . . 0.0 113.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.8 tt -153.63 145.91 14.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 126.466 1.907 . . . . 0.0 108.316 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.3 ttm -140.96 137.91 33.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.223 1.009 . . . . 0.0 109.24 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.89 161.02 30.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.428 1.891 . . . . 0.0 112.187 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -33.95 23.15 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.335 -0.853 . . . . 0.0 113.269 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.13 172.62 6.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 112.536 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.22 -42.07 99.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.352 -0.843 . . . . 0.0 113.27 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.443 ' CB ' ' HE3' ' A' ' 30' ' ' LYS . 10.9 pt-20 -81.52 57.91 3.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.858 1.663 . . . . 0.0 113.908 178.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.74 170.61 9.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 124.02 15.73 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.025 -1.047 . . . . 0.0 112.559 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.02 91.17 3.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.699 2.0 . . . . 0.0 111.899 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 17' ' ' LEU . 4.1 tt0 -87.45 139.02 30.97 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.874 -0.516 . . . . 0.0 110.373 165.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.5 114.27 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.618 1.967 . . . . 0.0 108.37 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -110.01 108.52 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 110.177 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.8 mm -89.13 120.22 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.658 1.183 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 49.9 m -117.32 170.02 9.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.597 1.559 . . . . 0.0 112.789 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.895 2.078 . . . . 0.0 113.667 -179.4 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.33 -14.34 21.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.58 54.56 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.205 -0.935 . . . . 0.0 111.578 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 41.34 11.99 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.301 0.953 . . . . 0.0 114.732 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.8 p -142.88 -169.67 3.06 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 119.194 1.497 . . . . 0.0 112.902 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 pt -122.99 127.25 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.615 2.366 . . . . 0.0 110.757 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.59 166.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.767 1.227 . . . . 0.0 111.787 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 110.91 1.96 Allowed 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.658 -1.277 . . . . 0.0 113.044 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -29.08 61.51 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.164 0.888 . . . . 0.0 113.752 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.97 74.49 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.267 -1.137 . . . . 0.0 112.834 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -89.59 -18.39 26.67 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.945 1.298 . . . . 0.0 113.291 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' A' ' 34' ' ' GLY . 15.8 tp -65.41 115.34 5.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.126 1.371 . . . . 0.0 110.481 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -142.94 166.3 25.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.553 1.141 . . . . 0.0 110.043 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -40.26 26.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.706 1.602 . . . . 0.0 113.927 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.35 -34.95 74.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.314 1.446 . . . . 0.0 113.267 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.01 -45.68 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 109.82 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.63 -45.9 66.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.029 0.931 . . . . 0.0 112.435 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.31 -47.8 78.07 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.93 -0.481 . . . . 0.0 112.253 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -53.54 -42.17 67.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.783 1.233 . . . . 0.0 112.683 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -54.22 -57.08 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.829 0.852 . . . . 0.0 111.216 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 30' ' ' LYS . 2.8 mp -61.49 -40.9 96.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.028 1.331 . . . . 0.0 112.671 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.98 -45.89 82.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.528 0.731 . . . . 0.0 112.164 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.98 -21.02 29.69 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.26 -45.65 87.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.713 2.005 . . . . 0.0 113.605 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 32.78 7.17 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 114.747 0.659 . . . . 0.0 114.747 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 174.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.831 2.052 . . . . 0.0 114.293 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.33 -162.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.177 1.791 . . . . 0.0 111.478 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -54.5 -24.63 21.37 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -123.75 141.69 51.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.191 1.796 . . . . 0.0 110.293 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.732 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -161.1 149.32 15.84 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.342 1.857 . . . . 0.0 111.555 -170.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.406 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 3.7 pt -143.41 145.93 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.795 1.638 . . . . 0.0 109.917 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.23 121.64 41.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.403 1.481 . . . . 0.0 108.029 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.96 136.46 50.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.108 1.763 . . . . 0.0 110.589 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.5 120.74 1.23 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.014 1.292 . . . . 0.0 111.829 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.56 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.262 1.425 . . . . 0.0 108.451 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 104.94 8.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.071 0.948 . . . . 0.0 112.095 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -73.61 96.89 2.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.484 0.714 . . . . 0.0 110.684 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -122.25 21.62 10.34 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.106 1.762 . . . . 0.0 112.08 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.6 t -71.53 -43.23 66.82 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.294 1.438 . . . . 0.0 113.687 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.03 16.83 3.17 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.925 1.726 . . . . 0.0 115.667 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.83 155.44 26.81 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 119.597 1.698 . . . . 0.0 115.057 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -68.45 132.02 46.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -105.12 165.25 11.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.504 1.522 . . . . 0.0 111.849 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 m -134.45 113.76 12.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.105 1.362 . . . . 0.0 108.921 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.5 136.6 57.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.155 -0.966 . . . . 0.0 109.557 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.29 -70.76 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -177.48 175.78 1.38 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.617 2.367 . . . . 0.0 110.082 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.26 150.02 50.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.171 2.188 . . . . 0.0 109.306 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 112.3 8.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.232 . . . . 0.0 110.256 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -71.69 121.39 18.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.487 1.115 . . . . 0.0 110.846 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -95.5 -43.54 7.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.106 0.963 . . . . 0.0 112.032 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.4 m -141.22 156.89 45.85 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.935 2.094 . . . . 0.0 110.299 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.1 -176.74 53.86 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.468 0.556 . . . . 0.0 113.508 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -137.67 164.44 28.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.602 1.161 . . . . 0.0 111.027 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -144.38 175.47 10.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.451 1.1 . . . . 0.0 111.76 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -134.23 17.05 3.75 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.367 1.067 . . . . 0.0 112.279 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.95 166.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.818 2.047 . . . . 0.0 112.565 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.96 134.14 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.833 1.653 . . . . 0.0 109.632 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 154.47 86.42 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.993 0.815 . . . . 0.0 112.339 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.42 172.47 13.23 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.452 3.435 . . . . 0.0 110.525 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -113.38 -21.41 10.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -125.62 125.81 43.72 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 110.675 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.97 95.0 19.45 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.034 1.333 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.04 160.33 34.53 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.876 1.717 . . . . 0.0 111.23 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.61 156.86 10.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.801 -0.562 . . . . 0.0 111.586 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m 75.13 -22.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.182 2.193 . . . . 0.0 112.892 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -100.68 141.66 33.24 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.547 1.939 . . . . 0.0 109.576 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.05 178.0 4.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.775 2.03 . . . . 0.0 109.558 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.28 175.92 5.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 109.796 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -129.28 124.37 34.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.633 1.573 . . . . 0.0 107.363 174.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -146.0 150.17 35.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.592 0.357 . . . . 0.0 110.723 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.4 m -147.35 158.93 44.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.35 0.595 . . . . 0.0 111.129 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.01 10.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.515 1.531 . . . . 0.0 111.183 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -131.72 168.91 16.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.524 1.53 . . . . 0.0 110.467 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.52 179.34 0.47 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.029 0.932 . . . . 0.0 110.098 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.94 -179.98 0.24 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 121.114 -0.991 . . . . 0.0 111.264 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -28.58 -49.64 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.375 2.67 . . . . 0.0 115.939 -172.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.58 -59.61 0.33 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.016 1.293 . . . . 0.0 112.677 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.77 -2.66 11.77 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.25 3.3 . . . . 0.0 115.067 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.71 124.2 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.462 1.505 . . . . 0.0 111.297 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.24 75.71 1.66 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.19 1.796 . . . . 0.0 111.786 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.8 m -100.58 -75.44 0.58 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.623 1.169 . . . . 0.0 111.244 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.57 -176.52 45.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.74 1.162 . . . . 0.0 112.253 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.54 105.29 5.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.695 1.198 . . . . 0.0 110.671 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.18 120.41 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.311 1.044 . . . . 0.0 108.585 -171.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.94 168.59 19.89 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.89 0.852 . . . . 0.0 111.526 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.57 156.25 43.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.077 0.951 . . . . 0.0 111.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.73 175.52 11.9 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.777 2.031 . . . . 0.0 110.66 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.35 43.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.897 0.879 . . . . 0.0 111.504 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -125.73 118.66 26.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 110.957 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.52 117.43 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.992 1.717 . . . . 0.0 110.309 176.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.9 mtm -75.58 162.6 28.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.487 0.66 . . . . 0.0 112.492 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -60.41 -21.55 62.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.928 1.291 . . . . 0.0 114.078 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -83.23 -12.19 57.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.05 2.14 . . . . 0.0 113.56 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.03 -1.56 57.78 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.475 1.512 . . . . 0.0 115.252 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.35 171.22 15.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.066 1.347 . . . . 0.0 110.143 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.0 m -131.59 148.34 52.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.746 0.818 . . . . 0.0 110.473 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.42 112.81 18.52 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.761 1.224 . . . . 0.0 108.237 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.44 141.9 29.43 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.25 127.69 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 109.191 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -140.72 162.97 34.15 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 17.9 p90 -140.43 159.93 41.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.84 1.256 . . . . 0.0 111.46 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -140.71 112.8 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.939 1.696 . . . . 0.0 109.351 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.33 101.06 54.3 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.265 1.826 . . . . 0.0 108.48 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 163.88 34.49 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.554 2.169 . . . . 0.0 111.756 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.59 -26.72 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.06 114.48 27.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.04 1.336 . . . . 0.0 111.506 -172.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.33 -57.17 4.02 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.325 1.05 . . . . 0.0 113.66 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.13 13.65 12.65 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.908 -1.12 . . . . 0.0 113.807 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.72 -19.26 2.36 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.241 1.816 . . . . 0.0 113.438 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -141.83 169.6 17.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.934 2.893 . . . . 0.0 108.753 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 t -132.95 161.21 34.89 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.017 -1.052 . . . . 0.0 109.867 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -88.53 161.32 17.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.793 0.806 . . . . 0.0 111.415 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -141.58 151.46 43.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.116 0.966 . . . . 0.0 110.688 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.5 p-90 -154.17 157.83 39.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.124 1.37 . . . . 0.0 110.492 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -150.83 146.92 26.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.922 2.089 . . . . 0.0 109.509 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.02 117.88 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.534 1.534 . . . . 0.0 108.797 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -122.42 140.13 53.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.818 1.247 . . . . 0.0 110.471 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -109.38 117.33 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.777 2.031 . . . . 0.0 108.525 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.79 145.43 50.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.164 1.386 . . . . 0.0 112.836 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 p -75.61 79.51 2.6 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.139 1.775 . . . . 0.0 112.661 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.03 173.54 23.92 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.147 1.356 . . . . 0.0 112.82 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 148.99 48.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.876 1.27 . . . . 0.0 111.683 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.8 112.69 2.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.433 1.093 . . . . 0.0 111.622 174.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.38 175.93 9.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.127 0.971 . . . . 0.0 110.564 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.56 99.08 4.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.825 1.65 . . . . 0.0 108.452 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.05 -70.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.108 0.963 . . . . 0.0 110.226 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -67.47 0.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.56 1.144 . . . . 0.0 110.84 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.66 -9.08 84.83 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.429 1.014 . . . . 0.0 115.252 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -43.65 9.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.518 1.127 . . . . 0.0 111.083 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -36.91 83.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.65 1.18 . . . . 0.0 111.299 175.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.74 -29.72 66.94 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.067 -1.02 . . . . 0.0 113.092 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -20.09 63.31 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.717 1.207 . . . . 0.0 112.816 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.08 -50.89 5.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.108 1.363 . . . . 0.0 109.196 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.06 -47.4 84.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -94.44 -13.87 25.78 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.045 0.938 . . . . 0.0 113.103 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.53 -62.85 5.43 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.547 1.07 . . . . 0.0 113.049 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -177.17 78.41 0.25 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 128.392 2.677 . . . . 0.0 108.694 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.3 157.62 60.6 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.493 1.462 . . . . 0.0 110.833 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.97 6.35 41.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.11 65.09 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.732 2.813 . . . . 0.0 113.617 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -44.02 101.56 0.03 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.399 1.952 . . . . 0.0 115.177 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.58 28.29 1.53 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.16 2.184 . . . . 0.0 113.314 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.55 52.75 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.251 1.821 . . . . 0.0 112.849 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -151.59 154.38 25.52 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.276 1.417 . . . . 0.0 113.178 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -62.95 117.05 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.642 1.177 . . . . 0.0 113.31 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -108.09 119.18 38.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.152 2.181 . . . . 0.0 110.966 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.94 133.01 15.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.151 0.98 . . . . 0.0 111.236 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -146.3 130.12 17.16 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.688 1.195 . . . . 0.0 111.981 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.85 107.98 0.79 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.048 1.339 . . . . 0.0 112.277 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.65 -32.34 3.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.009 1.324 . . . . 0.0 112.872 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.28 22.16 6.46 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.049 1.309 . . . . 0.0 114.821 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 56.84 8.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 115.631 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.64 -57.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.328 1.442 . . . . 0.0 111.413 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.64 156.53 17.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.832 0.825 . . . . 0.0 112.18 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.82 168.35 27.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.871 1.668 . . . . 0.0 112.21 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.5 141.46 28.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.878 0.871 . . . . 0.0 110.871 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.16 104.13 7.13 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.33 169.66 24.18 Favored Glycine 0 N--CA 1.454 -0.13 0 CA-C-O 121.888 0.716 . . . . 0.0 114.526 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.78 144.43 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.691 1.196 . . . . 0.0 109.312 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 ttt -141.94 130.16 22.21 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.777 1.231 . . . . 0.0 108.556 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.1 p -88.31 163.05 16.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 110.952 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -96.12 -22.47 17.3 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.45 172.95 4.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.492 1.517 . . . . 0.0 113.165 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.59 -41.8 42.92 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.344 1.45 . . . . 0.0 114.158 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.87 78.34 8.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 111.105 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.41 79.85 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.804 0.841 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.23 149.16 24.85 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 120.868 -1.145 . . . . 0.0 110.549 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.1 ttm -144.58 124.53 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.766 1.227 . . . . 0.0 109.975 -174.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -141.14 139.02 33.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.96 92.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.776 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.24 107.02 17.74 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.319 1.448 . . . . 0.0 108.553 174.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.79 131.37 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 0.0 110.73 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 p -154.51 165.4 36.55 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 128.468 2.707 . . . . 0.0 111.903 175.867 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -94.98 8.81 41.67 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 112.87 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 57' ' ' VAL . . . -68.27 148.52 50.68 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.806 -1.184 . . . . 0.0 112.287 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.81 36.85 91.32 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.84 0.733 . . . . 0.0 114.2 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -142.28 175.79 9.49 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.908 0.854 . . . . 0.0 112.34 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 pt -118.17 138.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.789 1.636 . . . . 0.0 111.38 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 2' ' ' LEU . 7.5 pt -146.76 174.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.12 1.768 . . . . 0.0 111.587 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 103.53 0.11 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 112.364 175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.42 -25.66 67.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.252 0.93 . . . . 0.0 113.9 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.88 14.79 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -117.43 7.31 12.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.804 1.641 . . . . 0.0 113.218 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 114.48 11.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.513 1.125 . . . . 0.0 112.199 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.6 m -146.25 172.55 13.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.261 1.425 . . . . 0.0 110.601 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.426 ' H ' HG22 ' A' ' 13' ' ' THR . 22.2 m-85 -48.41 -37.64 17.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.935 1.694 . . . . 0.0 114.188 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -56.41 -35.9 68.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.652 1.181 . . . . 0.0 113.302 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.79 -47.48 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.082 1.753 . . . . 0.0 109.643 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.59 -46.18 80.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.393 1.077 . . . . 0.0 113.237 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.16 -42.75 99.49 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.654 -0.654 . . . . 0.0 111.103 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -39.23 72.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.758 1.223 . . . . 0.0 113.516 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.5 -59.55 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.294 1.038 . . . . 0.0 110.601 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.72 -42.24 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.49 1.516 . . . . 0.0 112.406 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.17 -53.34 54.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.176 0.99 . . . . 0.0 112.167 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.35 -42.59 62.06 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.52 -52.38 22.84 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.379 1.872 . . . . 0.0 112.349 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.01 59.79 0.23 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.607 1.098 . . . . 0.0 112.552 -172.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 141.74 6.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.588 1.155 . . . . 0.0 112.516 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -160.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.771 1.628 . . . . 0.0 110.825 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -50.69 -31.91 17.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.238 1.415 . . . . 0.0 113.058 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -146.39 143.78 29.29 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.591 2.357 . . . . 0.0 110.237 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -164.69 153.54 12.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 128.078 2.551 . . . . 0.0 110.185 -173.226 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.518 ' CG2' HG21 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -146.08 150.3 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.822 1.649 . . . . 0.0 109.953 175.45 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.51 123.85 51.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.614 1.166 . . . . 0.0 110.777 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -116.48 123.85 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.602 1.561 . . . . 0.0 110.778 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.67 112.05 0.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.854 1.216 . . . . 0.0 112.3 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 mt -109.18 111.09 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.635 1.174 . . . . 0.0 109.427 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.93 131.15 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.947 0.899 . . . . 0.0 113.228 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.51 93.16 7.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.552 0.741 . . . . 0.0 110.572 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.94 20.37 11.58 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.411 1.485 . . . . 0.0 112.278 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -85.56 -40.94 15.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.815 1.646 . . . . 0.0 114.748 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 12.48 10.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 -173.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.99 161.14 29.46 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.336 1.568 . . . . 0.0 115.05 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -76.99 127.4 32.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.211 1.404 . . . . 0.0 112.122 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -102.86 162.12 13.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.322 1.449 . . . . 0.0 111.62 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -133.46 115.89 15.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.844 1.257 . . . . 0.0 109.439 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.18 137.16 57.44 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.005 -1.059 . . . . 0.0 110.355 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.27 -71.02 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -174.72 176.54 2.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.992 2.117 . . . . 0.0 110.563 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -124.95 154.69 40.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.953 2.101 . . . . 0.0 109.841 175.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.73 106.04 6.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.035 1.334 . . . . 0.0 110.564 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.85 105.02 5.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.791 1.237 . . . . 0.0 111.18 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -78.37 -51.94 9.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.937 1.295 . . . . 0.0 111.692 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -137.27 155.88 48.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.901 2.081 . . . . 0.0 110.361 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 -173.64 52.06 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.722 -0.611 . . . . 0.0 113.329 -174.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -134.88 176.32 8.76 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.641 1.176 . . . . 0.0 110.316 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -150.5 178.12 9.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.525 1.53 . . . . 0.0 110.479 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -139.3 18.15 2.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.179 1.391 . . . . 0.0 112.025 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 3' ' ' ALA . 9.0 m -134.6 171.76 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.892 2.077 . . . . 0.0 110.809 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mt -143.87 132.3 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.377 1.071 . . . . 0.0 109.463 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -75.55 150.17 84.33 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.587 0.63 . . . . 0.0 111.572 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.68 166.3 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.73 2.954 . . . . 0.0 109.928 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 58.3 tt0 -105.81 -30.01 9.67 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.312 -0.868 . . . . 0.0 111.572 174.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -117.26 127.81 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.547 1.139 . . . . 0.0 111.029 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.06 91.31 24.17 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.89 1.276 . . . . 0.0 108.911 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -63.19 162.79 25.24 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.34 2.027 . . . . 0.0 111.483 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -57.61 158.72 5.73 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 72.5 -35.42 0.33 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.941 2.097 . . . . 0.0 114.211 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -86.91 124.71 33.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.08 171.63 8.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.431 1.092 . . . . 0.0 109.493 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.84 163.26 13.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.53 133.27 48.38 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.248 1.819 . . . . 0.0 107.824 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.8 167.22 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 110.438 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -156.52 160.41 39.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.57 0.7 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 127.41 3.24 Favored Glycine 0 N--CA 1.462 0.415 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.32 167.16 15.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.223 1.012 . . . . 0.0 110.082 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 179.98 1.49 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 109.886 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -172.67 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.824 1.649 . . . . 0.0 111.357 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.1 m -25.94 -56.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 127.312 2.245 . . . . 0.0 115.238 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.43 -57.07 0.41 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.596 1.093 . . . . 0.0 113.831 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.79 -2.34 11.76 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.621 3.548 . . . . 0.0 115.574 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.66 130.84 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.96 1.704 . . . . 0.0 110.792 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.68 88.6 5.44 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.567 -1.333 . . . . 0.0 111.959 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.4 m -122.83 -86.51 0.65 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 111.522 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.41 -177.97 42.74 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.781 1.173 . . . . 0.0 112.938 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.52 108.65 6.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.063 0.945 . . . . 0.0 111.012 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.93 119.63 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.987 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.42 171.45 14.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.995 0.902 . . . . 0.0 111.587 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.09 40.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.312 1.045 . . . . 0.0 111.716 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.38 175.76 11.54 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.711 1.605 . . . . 0.0 110.415 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -133.95 140.87 47.04 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.833 1.253 . . . . 0.0 110.602 176.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -123.89 113.53 18.62 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.58 1.152 . . . . 0.0 111.356 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.39 118.71 15.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.765 1.626 . . . . 0.0 110.691 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.7 mtt -73.06 163.53 28.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 112.181 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -62.52 -21.03 65.22 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.76 1.224 . . . . 0.0 113.884 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.71 -16.22 39.71 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.76 1.624 . . . . 0.0 113.515 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.38 2.12 47.51 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.192 1.377 . . . . 0.0 115.647 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -86.23 173.53 9.71 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.738 1.215 . . . . 0.0 110.421 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.443 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 26.1 m -136.04 143.22 44.58 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.144 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.15 115.76 30.71 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 135.12 15.13 Favored Glycine 0 N--CA 1.463 0.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 117' ' ' VAL . 6.0 m -137.2 126.85 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 118.049 0.925 . . . . 0.0 109.704 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.3 153.65 51.1 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.717 0.807 . . . . 0.0 110.673 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 13.4 p90 -135.01 154.55 51.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.749 . . . . 0.0 111.991 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -137.08 109.55 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 110.773 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.518 HG21 ' CG2' ' A' ' 31' ' ' ILE . 58.4 t -110.7 106.17 57.58 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 124.527 1.131 . . . . 0.0 110.257 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.18 161.81 39.99 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.944 2.429 . . . . 0.0 112.007 174.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.0 -28.23 64.27 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.783 0.833 . . . . 0.0 112.807 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.36 120.86 41.21 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.471 1.508 . . . . 0.0 110.955 -170.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -73.93 -63.91 1.12 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.81 9.23 19.71 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.884 -1.135 . . . . 0.0 114.031 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -5.62 6.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.259 2.224 . . . . 0.0 112.225 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 138.75 10.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.678 1.991 . . . . 0.0 109.583 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -103.27 159.56 15.45 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.07 -1.019 . . . . 0.0 110.031 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -80.23 161.69 25.03 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.866 -0.521 . . . . 0.0 109.738 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -139.51 143.53 37.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.708 0.803 . . . . 0.0 110.804 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -155.06 149.77 26.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.658 1.583 . . . . 0.0 110.239 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -149.01 154.72 39.75 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.993 1.717 . . . . 0.0 107.675 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 100' ' ' VAL . 66.7 t -147.37 116.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 126.87 2.068 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -123.39 148.15 46.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.542 1.537 . . . . 0.0 110.096 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 mt -110.97 112.57 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 108.821 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -127.39 136.39 51.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 112.2 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.1 p -76.67 81.68 3.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.324 1.45 . . . . 0.0 112.58 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.35 178.6 45.31 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.27 0.938 . . . . 0.0 113.645 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -111.78 104.99 13.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.497 1.919 . . . . 0.0 110.885 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -145.81 158.14 43.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.918 1.287 . . . . 0.0 111.228 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.25 163.97 29.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.125 1.37 . . . . 0.0 112.527 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.57 79.07 1.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.633 1.173 . . . . 0.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.21 -67.37 0.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.057 1.343 . . . . 0.0 109.576 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -149.3 -72.56 0.18 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.368 1.867 . . . . 0.0 108.801 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.9 64.59 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.94 1.257 . . . . 0.0 114.732 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.3 ttp -83.85 -57.83 3.05 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.288 1.044 . . . . 0.0 110.409 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -48.85 -49.83 37.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.083 1.353 . . . . 0.0 111.638 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -62.36 -32.25 73.01 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.01 -13.55 62.28 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.155 -0.965 . . . . 0.0 113.12 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.01 -47.96 5.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.445 1.498 . . . . 0.0 109.456 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.06 -61.51 2.0 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.637 -1.29 . . . . 0.0 112.35 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.58 -19.89 48.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 111.658 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.39 -80.91 0.07 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.334 1.445 . . . . 0.0 112.828 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.36 86.29 0.89 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.318 1.447 . . . . 0.0 110.529 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.62 160.2 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.696 1.597 . . . . 0.0 111.709 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.94 1.01 39.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.52 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 33.87 60.03 0.54 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.796 2.438 . . . . 0.0 114.25 176.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -20.23 82.4 0.0 OUTLIER Glycine 0 N--CA 1.472 1.083 0 C-N-CA 129.409 3.385 . . . . 0.0 116.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.0 35.41 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.424 1.49 . . . . 0.0 112.052 -172.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 68.25 26.36 6.96 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.59 1.556 . . . . 0.0 112.245 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.89 146.01 18.0 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.552 1.549 . . . . 0.0 113.3 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -65.97 138.15 57.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.858 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.67 118.04 18.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.041 1.736 . . . . 0.0 110.641 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.97 145.64 32.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.296 1.438 . . . . 0.0 110.903 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -146.31 121.83 10.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.248 1.419 . . . . 0.0 110.549 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.09 91.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.682 1.593 . . . . 0.0 113.358 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.96 4.5 1.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.32 22.57 31.83 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.578 -1.326 . . . . 0.0 115.881 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.52 7.69 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.597 1.959 . . . . 0.0 115.39 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.38 -36.71 0.19 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.764 -1.21 . . . . 0.0 114.365 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.0 mp -129.48 147.64 51.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.02 1.328 . . . . 0.0 110.681 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 173.94 9.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.122 1.369 . . . . 0.0 111.956 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.17 139.96 38.48 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.69 1.596 . . . . 0.0 109.56 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -131.76 107.75 8.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.567 1.547 . . . . 0.0 108.086 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.9 171.57 19.17 Favored Glycine 0 CA--C 1.517 0.217 0 CA-C-O 121.382 0.434 . . . . 0.0 113.477 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.7 143.83 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 124.506 1.122 . . . . 0.0 109.215 176.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.9 ttm -144.17 140.16 29.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.882 1.673 . . . . 0.0 109.014 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.19 157.72 27.8 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.505 2.322 . . . . 0.0 111.562 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.83 5.91 26.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.309 -1.494 . . . . 0.0 114.801 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.43 177.53 4.82 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.703 2.001 . . . . 0.0 112.77 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.67 -67.87 1.99 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.368 0.985 . . . . 0.0 112.269 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 2.9 pt-20 -74.85 39.52 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.536 1.934 . . . . 0.0 115.223 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.03 138.94 58.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.378 1.071 . . . . 0.0 112.861 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.28 124.35 35.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 109.2 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 17.7 mtp -117.87 107.15 13.76 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.863 1.665 . . . . 0.0 109.971 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -114.96 151.4 34.17 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.521 -0.737 . . . . 0.0 111.358 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.8 96.62 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.733 1.613 . . . . 0.0 110.912 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -84.81 107.86 17.19 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.864 1.666 . . . . 0.0 109.919 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.3 mm -84.51 117.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.401 -0.812 . . . . 0.0 110.089 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 m -141.9 169.95 16.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.471 1.509 . . . . 0.0 113.195 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.355 1.862 . . . . 0.0 111.526 -178.047 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 HG21 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -107.36 -2.98 20.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.589 1.556 . . . . 0.0 112.704 177.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 20' ' ' VAL . . . -71.45 156.38 39.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.696 -1.252 . . . . 0.0 111.484 174.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.06 36.87 90.41 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.33 -168.52 3.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 111.923 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.39 149.14 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.671 1.588 . . . . 0.0 111.29 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 2' ' ' LEU . 1.6 pt -151.25 169.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.343 1.857 . . . . 0.0 112.577 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.44 124.81 17.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.892 1.677 . . . . 0.0 111.755 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.9 48.38 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.284 0.945 . . . . 0.0 113.976 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.99 82.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.916 1.286 . . . . 0.0 112.49 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 -30.92 35.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.832 0.853 . . . . 0.0 112.385 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.61 HD22 ' CB ' ' A' ' 68' ' ' ALA . 7.8 tp -59.66 90.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.625 1.97 . . . . 0.0 113.635 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -146.73 169.29 19.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 0.0 109.368 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 17' ' ' LEU . 2.6 m-85 -43.98 -37.46 2.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.018 1.727 . . . . 0.0 114.735 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.2 -39.24 78.48 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.38 -42.05 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.665 . . . . 0.0 110.74 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.465 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.1 mt -53.79 -47.73 70.5 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.304 1.041 . . . . 0.0 111.386 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.16 -42.55 96.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.437 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -58.79 -39.28 80.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.177 1.391 . . . . 0.0 113.668 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 3' ' ' ALA . 54.2 t -62.8 -55.37 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.548 1.539 . . . . 0.0 109.867 175.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 32' ' ' ALA . 3.3 mp -55.68 -45.9 77.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 0.0 112.49 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.15 -38.04 81.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.05 -43.9 41.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 113.058 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.71 -53.87 41.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.502 1.521 . . . . 0.0 111.173 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.13 63.02 0.11 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.356 0.979 . . . . 0.0 112.516 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -42.89 127.95 4.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 110.653 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.79 -165.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.353 1.861 . . . . 0.0 110.212 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -48.99 -45.46 42.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.647 1.579 . . . . 0.0 114.358 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -139.3 129.7 25.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.469 1.907 . . . . 0.0 109.569 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.43 155.54 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.112 2.165 . . . . 0.0 110.049 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 102' ' ' PHE . 6.2 pt -137.17 162.49 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.173 0.989 . . . . 0.0 111.46 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -110.93 116.22 30.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.835 1.254 . . . . 0.0 109.529 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.63 142.95 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.709 1.203 . . . . 0.0 110.86 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.28 122.55 1.13 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.314 0.959 . . . . 0.0 111.953 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.0 mt -113.04 102.7 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.151 1.38 . . . . 0.0 108.654 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.61 111.81 19.45 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.72 0.808 . . . . 0.0 112.231 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -71.69 99.76 2.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.793 1.237 . . . . 0.0 111.117 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.68 14.31 15.34 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.26 1.824 . . . . 0.0 113.281 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.4 t -70.09 -45.59 66.67 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.93 8.08 5.29 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.234 1.397 . . . . 0.0 116.058 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.67 160.47 29.02 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 119.578 1.689 . . . . 0.0 113.634 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.9 p -73.96 138.87 44.47 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.722 -0.869 . . . . 0.0 112.185 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -112.84 167.05 10.81 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.777 1.231 . . . . 0.0 112.006 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -131.92 105.78 7.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.128 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.5 122.68 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.21 -66.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.34 163.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.211 2.604 . . . . 0.0 110.155 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -108.77 123.91 49.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.349 1.86 . . . . 0.0 110.4 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.95 111.71 19.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.301 1.041 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.26 124.34 26.91 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.993 1.317 . . . . 0.0 111.993 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -47.63 7.26 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.093 1.357 . . . . 0.0 112.241 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -135.37 149.17 49.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.537 1.935 . . . . 0.0 109.951 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.06 -157.5 50.18 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.891 -0.506 . . . . 0.0 113.09 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -152.86 -176.71 5.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.521 0.676 . . . . 0.0 112.2 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -141.97 173.95 11.04 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.183 1.793 . . . . 0.0 111.367 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -121.51 12.79 10.85 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.927 1.291 . . . . 0.0 112.229 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.31 176.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.047 2.139 . . . . 0.0 113.628 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.95 135.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.53 1.932 . . . . 0.0 109.776 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.01 142.48 41.66 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 118.765 0.711 . . . . 0.0 110.606 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.81 164.86 22.85 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.95 3.1 . . . . 0.0 111.117 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -107.55 -17.61 14.06 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.502 -0.749 . . . . 0.0 112.716 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.64 133.97 53.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.956 1.702 . . . . 0.0 111.097 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.88 88.04 23.69 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.896 1.678 . . . . 0.0 108.868 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.42 161.13 32.38 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.919 1.746 . . . . 0.0 112.06 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.44 153.66 34.63 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.407 -0.808 . . . . 0.0 111.448 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 p 66.23 5.04 3.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.692 1.997 . . . . 0.0 114.267 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -123.39 147.81 46.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.621 2.368 . . . . 0.0 110.108 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.61 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -126.57 160.44 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.647 1.179 . . . . 0.0 111.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.16 170.75 8.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.408 0.623 . . . . 0.0 110.335 175.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 20' ' ' VAL . 3.3 mm? -126.44 133.89 51.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.334 1.854 . . . . 0.0 108.877 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -152.82 162.44 41.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.191 1.397 . . . . 0.0 111.536 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -142.37 166.6 24.24 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.769 1.228 . . . . 0.0 110.972 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.75 115.24 0.77 Allowed Glycine 0 N--CA 1.472 1.092 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.769 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 156.22 20.92 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.18 1.49 . . . . 0.0 114.378 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -72.88 110.64 7.34 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.063 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 40.78 -151.19 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.69 1.596 . . . . 0.0 113.664 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -74.14 -49.57 23.17 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.958 -1.714 . . . . 0.0 111.286 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.91 -59.27 0.37 Allowed Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.665 1.126 . . . . 0.0 114.394 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.33 0.15 7.22 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.699 3.599 . . . . 0.0 114.984 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.32 132.48 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 127.599 2.36 . . . . 0.0 109.364 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.82 71.84 0.81 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.034 1.333 . . . . 0.0 110.516 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 m -97.27 -65.03 0.99 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.01 0.924 . . . . 0.0 110.895 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.61 176.41 35.52 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.988 1.28 . . . . 0.0 111.712 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -138.69 108.34 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.065 0.946 . . . . 0.0 110.479 175.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.36 138.9 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.96 0.904 . . . . 0.0 109.585 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.11 161.98 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.967 0.907 . . . . 0.0 110.779 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.43 20.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.786 0.803 . . . . 0.0 112.976 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -132.57 169.0 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.795 1.638 . . . . 0.0 109.446 -172.475 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.98 148.96 47.23 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.42 104.57 6.18 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 111.796 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -73.54 111.82 9.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.084 1.354 . . . . 0.0 111.639 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 160.41 30.72 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 112.317 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 p -60.99 -20.08 62.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 m -84.78 -16.09 42.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.524 1.93 . . . . 0.0 113.84 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.52 4.95 46.13 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.39 0.995 . . . . 0.0 115.565 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.51 165.31 13.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.449 1.5 . . . . 0.0 108.757 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -136.32 151.11 49.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 109.566 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.38 130.55 56.57 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.278 0.631 . . . . 0.0 110.354 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.21 138.74 18.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.5 t -136.02 118.0 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.354 1.062 . . . . 0.0 108.816 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptm -121.46 156.89 31.8 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 174.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -124.39 141.03 52.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.104 1.362 . . . . 0.0 108.852 174.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -130.63 104.37 7.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.907 0.883 . . . . 0.0 110.75 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 t -115.61 101.57 54.21 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.007 2.123 . . . . 0.0 109.119 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.39 168.07 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.273 1.982 . . . . 0.0 110.454 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -75.37 -41.33 56.69 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.707 -0.621 . . . . 0.0 110.32 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.35 121.86 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.637 1.175 . . . . 0.0 111.954 -166.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -72.83 -59.83 2.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -91.29 9.44 31.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -4.37 5.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.023 2.129 . . . . 0.0 112.538 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.71 158.34 36.76 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.791 2.436 . . . . 0.0 109.111 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 169.36 10.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.826 -1.171 . . . . 0.0 111.602 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.26 148.36 25.14 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.752 -0.592 . . . . 0.0 110.445 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.51 157.63 44.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.035 0.534 . . . . 0.0 112.351 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -161.67 136.83 7.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.411 1.484 . . . . 0.0 110.396 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.76 147.51 48.62 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.28 118.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.099 1.36 . . . . 0.0 110.623 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.23 138.23 53.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.1 1.76 . . . . 0.0 109.452 174.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.4 mt -109.37 119.66 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.178 1.791 . . . . 0.0 108.543 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 147.61 52.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 0.0 112.555 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 p -74.0 80.97 1.7 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.652 1.981 . . . . 0.0 112.27 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.29 -166.8 37.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.705 -0.622 . . . . 0.0 114.393 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -113.18 115.87 28.93 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.384 1.874 . . . . 0.0 111.361 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -134.09 83.76 2.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.043 2.537 . . . . 0.0 108.46 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 168.36 5.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.657 1.183 . . . . 0.0 110.95 177.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.19 99.04 8.5 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 111.15 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -106.67 -70.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.112 0.965 . . . . 0.0 110.706 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -150.0 -68.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.167 1.787 . . . . 0.0 109.811 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.39 -24.26 77.11 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.386 0.993 . . . . 0.0 114.893 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -76.33 -56.63 4.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.266 1.033 . . . . 0.0 109.82 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -35.51 63.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.859 0.864 . . . . 0.0 111.429 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.06 -34.0 54.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -61.43 -41.26 96.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.903 0.881 . . . . 0.0 111.093 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.79 -38.0 73.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.858 -1.152 . . . . 0.0 111.715 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -74.06 -51.73 14.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -88.0 -17.89 30.22 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 113.079 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.87 -80.24 0.08 OUTLIER Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.711 1.148 . . . . 0.0 112.066 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -170.15 74.78 0.63 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.74 1.616 . . . . 0.0 110.968 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.19 135.37 31.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 119.918 1.006 . . . . 0.0 109.788 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -60.19 156.86 14.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.743 1.217 . . . . 0.0 110.439 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -93.36 5.01 53.01 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -165.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 53.95 55.61 24.98 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.559 1.076 . . . . 0.0 112.654 -172.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.33 24.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.571 1.548 . . . . 0.0 114.901 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.252 10.1 p30 48.31 34.45 4.6 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.665 2.386 . . . . 0.0 115.021 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.38 159.62 26.75 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.912 1.72 . . . . 0.0 112.058 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -61.78 127.37 31.12 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 110.934 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -122.91 105.67 10.2 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.144 1.778 . . . . 0.0 109.637 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -138.38 137.12 36.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.579 1.952 . . . . 0.0 110.89 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -147.8 133.44 18.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.264 1.426 . . . . 0.0 110.964 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -58.9 123.96 18.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.995 0.518 . . . . 0.0 111.347 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 tt -147.6 -34.29 0.25 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.182 0.993 . . . . 0.0 112.342 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.71 19.7 5.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.182 1.372 . . . . 0.0 114.748 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 t80 60.06 9.27 1.75 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.799 2.44 . . . . 0.0 114.966 -175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.74 -71.38 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.403 1.478 . . . . 0.0 110.74 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.53 151.43 21.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.949 0.88 . . . . 0.0 111.419 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.55 171.32 14.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.72 1.608 . . . . 0.0 111.527 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -87.15 147.09 25.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.512 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -137.07 103.39 5.12 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.894 2.078 . . . . 0.0 108.506 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -133.02 169.43 22.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-O 121.593 0.552 . . . . 0.0 112.884 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.61 141.06 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.905 1.682 . . . . 0.0 108.769 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.4 ttt -144.35 140.48 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 171.94 14.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.098 0.959 . . . . 0.0 111.553 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.0 p -93.67 7.71 43.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.52 1.528 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.22 165.22 12.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.635 1.974 . . . . 0.0 112.063 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.87 -55.29 29.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.209 0.909 . . . . 0.0 113.784 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.09 59.39 2.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 113.251 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.06 171.81 7.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.905 1.282 . . . . 0.0 112.859 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.465 ' HB3' HD13 ' A' ' 17' ' ' LEU . 10.0 mptt -120.71 141.61 50.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 108.421 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.8 ttp -133.88 83.7 2.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.076 1.35 . . . . 0.0 111.014 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.39 158.17 20.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.452 0.644 . . . . 0.0 111.524 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.94 122.02 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.866 2.067 . . . . 0.0 108.419 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -113.39 103.81 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.571 2.348 . . . . 0.0 108.941 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.36 119.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.437 -0.79 . . . . 0.0 110.802 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 p -152.13 169.27 22.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.376 1.07 . . . . 0.0 112.956 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.729 2.411 . . . . 0.0 112.934 176.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 119.979 -0.058 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 -23.23 7.56 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.11 1.364 . . . . 0.0 113.058 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -58.0 150.93 19.57 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.82 -1.175 . . . . 0.0 111.683 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.28 49.13 34.32 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.425 0.535 . . . . 0.0 113.687 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.5 p -146.78 -166.38 2.48 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.193 0.997 . . . . 0.0 112.115 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.02 132.26 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.68 2.392 . . . . 0.0 110.74 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 pt -142.46 170.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.461 1.504 . . . . 0.0 111.777 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 111.19 1.02 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.484 1.114 . . . . 0.0 112.185 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.25 -24.33 67.23 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.424 1.011 . . . . 0.0 113.363 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.61 78.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.786 1.234 . . . . 0.0 111.983 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.5 -24.83 22.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.82 1.248 . . . . 0.0 113.196 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.6 tp -59.23 110.36 1.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.266 1.426 . . . . 0.0 111.534 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 m -146.78 168.16 22.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.654 1.582 . . . . 0.0 109.669 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.23 1.812 . . . . 0.0 113.814 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -58.01 -35.8 71.77 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -73.63 -46.05 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.494 1.518 . . . . 0.0 109.859 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.5 mt -54.48 -44.88 73.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 0.0 113.008 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.17 -39.09 88.81 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.714 0.406 . . . . 0.0 111.927 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -50.21 74.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.013 1.325 . . . . 0.0 111.622 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 74.8 t -53.51 -50.04 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.766 1.226 . . . . 0.0 111.994 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 32' ' ' ALA . 5.7 mp -60.11 -41.87 93.53 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.212 1.005 . . . . 0.0 112.359 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -43.68 90.78 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 110.781 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.38 -31.01 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.163 1.785 . . . . 0.0 114.271 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.3 tp -66.81 -51.48 55.23 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.697 1.199 . . . . 0.0 110.014 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.25 54.62 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.103 1.335 . . . . 0.0 111.991 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -43.54 129.1 5.26 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.713 1.605 . . . . 0.0 112.817 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -164.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.183 1.393 . . . . 0.0 112.144 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.0 t -42.43 -33.02 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.993 2.517 . . . . 0.0 113.958 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -153.31 137.89 16.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.599 1.96 . . . . 0.0 109.804 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 155.69 20.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.688 2.395 . . . . 0.0 110.416 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -135.49 152.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.531 1.132 . . . . 0.0 109.509 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -111.06 122.75 48.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.171 0.988 . . . . 0.0 108.365 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.0 135.47 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.593 1.157 . . . . 0.0 110.803 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.33 129.55 3.39 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.177 0.894 . . . . 0.0 111.82 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mm -117.87 103.33 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.046 0.938 . . . . 0.0 109.742 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.96 122.45 27.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.899 1.28 . . . . 0.0 113.304 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.88 96.21 3.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.437 1.895 . . . . 0.0 112.02 175.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -123.83 30.81 6.05 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 112.137 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.7 t -91.96 -48.12 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.916 1.687 . . . . 0.0 114.142 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.07 17.73 4.02 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.288 0.947 . . . . 0.0 115.453 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.22 159.92 31.62 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.039 1.42 . . . . 0.0 114.125 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -70.51 135.83 48.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.079 0.952 . . . . 0.0 111.858 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -109.95 168.43 9.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.449 1.5 . . . . 0.0 111.382 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.3 m -134.61 107.14 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 109.108 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.64 124.96 24.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.911 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.89 -64.87 0.78 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.307 0.643 . . . . 0.0 109.966 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.63 172.24 0.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.825 2.45 . . . . 0.0 110.736 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.95 135.84 48.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.446 2.298 . . . . 0.0 110.105 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -124.3 114.83 20.08 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 111.361 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -72.0 106.95 4.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.485 1.514 . . . . 0.0 112.357 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -50.02 44.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.131 1.773 . . . . 0.0 110.71 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -136.0 155.95 49.48 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.518 1.527 . . . . 0.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.75 -156.51 39.85 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 123.042 0.353 . . . . 0.0 113.395 -172.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -154.21 -176.17 5.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 110.534 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 73' ' ' GLY . 17.2 p -139.37 -179.31 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.49 1.516 . . . . 0.0 111.384 174.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.63 12.87 13.24 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.639 1.176 . . . . 0.0 111.586 174.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 3' ' ' ALA . 3.0 m -132.13 175.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.154 1.781 . . . . 0.0 113.151 -170.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 134.86 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.392 1.477 . . . . 0.0 110.091 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.44 141.12 56.51 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.256 -0.902 . . . . 0.0 110.601 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.84 163.68 32.51 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.045 3.163 . . . . 0.0 111.091 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -104.83 -21.22 13.37 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.816 -1.178 . . . . 0.0 112.945 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -126.51 137.14 53.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.127 1.371 . . . . 0.0 110.155 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.54 97.99 7.31 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 110.257 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -64.57 162.12 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.682 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.88 154.3 9.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.615 -0.678 . . . . 0.0 111.584 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m 72.03 -23.55 0.19 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.978 1.711 . . . . 0.0 113.83 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -95.89 126.87 41.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.707 1.603 . . . . 0.0 110.714 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.41 171.94 8.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.009 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -110.24 169.07 8.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.47 133.47 52.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.516 1.527 . . . . 0.0 110.505 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.96 166.73 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.129 0.971 . . . . 0.0 111.09 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 p -160.46 170.22 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.53 1.132 . . . . 0.0 110.635 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -151.71 137.27 5.89 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.664 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.55 161.42 30.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.123 1.462 . . . . 0.0 112.529 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -70.7 113.03 7.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t0 32.31 -136.8 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.565 2.346 . . . . 0.0 114.138 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -61.64 -46.18 90.89 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.5 -1.375 . . . . 0.0 111.053 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.57 -58.58 0.45 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.025 -0.875 . . . . 0.0 115.079 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -71.77 8.08 1.41 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 125.207 3.938 . . . . 0.0 115.44 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.84 132.92 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.001 2.52 . . . . 0.0 110.561 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.63 88.45 3.07 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.544 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -114.77 -84.69 0.61 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.164 1.786 . . . . 0.0 110.866 178.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 82' ' ' THR . . . 172.61 173.68 39.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 127.262 2.363 . . . . 0.0 110.802 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.63 109.41 7.1 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.584 1.154 . . . . 0.0 109.442 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.49 126.71 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 120.789 -1.194 . . . . 0.0 108.259 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.35 169.01 24.71 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.78 157.78 43.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.17 0.988 . . . . 0.0 111.603 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.17 169.9 20.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.895 1.678 . . . . 0.0 110.657 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.98 146.67 41.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.048 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -127.78 115.82 19.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.906 1.283 . . . . 0.0 111.525 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -81.08 112.61 18.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.194 1.398 . . . . 0.0 111.0 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.8 mtp -74.01 158.06 35.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.963 0.905 . . . . 0.0 111.414 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -62.35 -18.85 62.53 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.7 m -80.23 -15.34 57.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 113.739 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.26 55.2 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.668 1.128 . . . . 0.0 115.194 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -85.62 166.7 16.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.194 0.998 . . . . 0.0 110.384 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -137.08 153.53 50.54 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 110.73 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.62 134.14 53.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 108.991 174.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.63 8.48 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 117' ' ' VAL . 2.6 m -126.76 137.29 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 117.537 0.668 . . . . 0.0 110.488 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.31 161.31 35.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.648 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.04 142.54 47.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.983 1.313 . . . . 0.0 109.516 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -127.16 114.25 17.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.757 1.623 . . . . 0.0 109.086 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.85 92.61 48.35 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.478 1.511 . . . . 0.0 108.931 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.29 167.97 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.165 2.576 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.42 -23.69 37.38 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.626 -0.671 . . . . 0.0 112.437 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.54 111.93 24.81 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.327 -1.483 . . . . 0.0 112.392 -165.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.21 -51.81 22.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.39 12.34 29.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.51 1.124 . . . . 0.0 113.575 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.14 -11.0 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.491 1.917 . . . . 0.0 112.716 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.32 175.92 11.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.722 2.809 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m -145.86 164.86 30.63 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.492 -1.38 . . . . 0.0 111.167 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.04 138.16 34.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 110.276 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 152.61 49.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.315 0.507 . . . . 0.0 112.063 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -159.32 146.76 17.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.423 1.889 . . . . 0.0 110.634 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.32 149.47 49.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.148 1.379 . . . . 0.0 110.154 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 100' ' ' VAL . 22.5 t -145.77 105.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.315 1.046 . . . . 0.0 111.481 177.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -117.42 134.03 55.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.111 1.364 . . . . 0.0 110.365 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -97.75 112.39 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.296 1.438 . . . . 0.0 109.355 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -115.17 147.83 39.79 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.873 1.669 . . . . 0.0 112.826 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 p -75.74 82.59 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.739 1.615 . . . . 0.0 112.881 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.81 -173.91 36.57 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.529 1.061 . . . . 0.0 113.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -112.4 130.82 55.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.471 1.509 . . . . 0.0 111.59 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -153.24 163.97 38.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.594 1.157 . . . . 0.0 112.2 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -139.36 148.87 43.47 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.603 1.561 . . . . 0.0 111.621 -171.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.99 90.69 0.64 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.245 1.018 . . . . 0.0 111.957 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.15 -68.57 0.92 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.517 1.527 . . . . 0.0 110.812 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -144.37 -76.19 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.533 1.933 . . . . 0.0 108.959 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.8 -28.54 73.51 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.381 0.991 . . . . 0.0 114.701 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -57.46 5.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.086 0.943 . . . . 0.0 109.576 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -52.25 -40.87 62.27 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.921 1.289 . . . . 0.0 111.107 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -55.48 -43.28 75.42 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.641 -0.662 . . . . 0.0 112.734 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 -19.43 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.977 -1.077 . . . . 0.0 112.346 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.4 mt -91.37 -55.57 3.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.557 1.543 . . . . 0.0 111.435 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -74.82 -46.32 37.47 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.341 -0.85 . . . . 0.0 113.029 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.17 -17.47 30.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.232 -0.917 . . . . 0.0 111.121 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.76 52.5 4.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.357 0.979 . . . . 0.0 114.132 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 36.05 72.44 0.77 Allowed Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.623 2.369 . . . . 0.0 114.133 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 140.14 57.76 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.936 1.757 . . . . 0.0 109.027 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 143.77 55.73 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.81 0.844 . . . . 0.0 109.528 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 12.88 21.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.831 1.252 . . . . 0.0 113.818 -166.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 58.32 57.68 18.54 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.204 0.907 . . . . 0.0 112.145 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -72.57 33.96 0.07 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.802 1.241 . . . . 0.0 114.217 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.0 p30 45.97 34.24 1.91 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.833 2.853 . . . . 0.0 115.791 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -145.66 167.41 27.61 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.031 1.776 . . . . 0.0 112.262 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.96 123.48 21.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.417 0.687 . . . . 0.0 110.53 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -119.71 116.75 26.59 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.082 1.753 . . . . 0.0 108.684 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.09 131.69 15.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.989 1.316 . . . . 0.0 110.735 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -141.84 122.58 14.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.717 1.207 . . . . 0.0 110.72 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.19 115.57 3.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.445 0.698 . . . . 0.0 111.486 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.48 -36.42 0.98 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -77.73 22.49 2.78 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.118 1.342 . . . . 0.0 114.672 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 t80 58.01 10.74 1.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.245 2.618 . . . . 0.0 115.177 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.86 -60.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.929 1.728 . . . . 0.0 110.178 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.83 150.29 21.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 122.062 0.935 . . . . 0.0 112.479 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 163.1 35.18 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.413 1.885 . . . . 0.0 111.402 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.12 151.39 29.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.436 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -143.44 110.98 5.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.502 1.921 . . . . 0.0 108.262 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.7 32.47 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-O 121.642 0.579 . . . . 0.0 114.071 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.79 141.04 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.081 1.752 . . . . 0.0 109.311 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.7 ttt -144.84 142.41 29.91 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.25 1.82 . . . . 0.0 107.887 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.22 165.71 22.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.955 0.902 . . . . 0.0 111.042 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.93 14.97 12.35 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.609 1.164 . . . . 0.0 112.875 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.26 167.52 11.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 111.661 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.92 -59.94 8.83 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.943 0.783 . . . . 0.0 114.492 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -76.4 40.85 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.443 1.497 . . . . 0.0 114.254 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.04 157.3 35.06 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.847 1.259 . . . . 0.0 112.702 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -103.11 140.49 37.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 108.43 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.9 ttp -132.04 116.53 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.582 1.553 . . . . 0.0 109.461 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 138.8 43.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.7 106.76 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.208 1.403 . . . . 0.0 108.556 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -94.81 105.34 17.26 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.966 2.106 . . . . 0.0 109.204 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.27 124.97 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.4 m -128.28 177.1 7.18 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.571 1.148 . . . . 0.0 111.771 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 128.261 2.625 . . . . 0.0 113.342 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 119.946 -0.073 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.97 -17.18 16.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.389 1.076 . . . . 0.0 113.284 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -55.31 139.62 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.907 1.283 . . . . 0.0 111.985 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.79 40.85 8.54 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.099 0.857 . . . . 0.0 114.278 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 p -146.38 -165.69 2.28 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.571 1.185 . . . . 0.0 111.945 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.98 143.86 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.365 1.866 . . . . 0.0 110.487 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.19 165.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.297 . . . . 0.0 112.248 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 119.37 6.72 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.799 1.24 . . . . 0.0 111.066 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.07 -18.73 42.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.195 0.902 . . . . 0.0 113.897 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.92 -38.05 76.13 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.953 1.301 . . . . 0.0 111.735 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -31.33 27.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.843 1.257 . . . . 0.0 112.444 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.562 HD22 ' CB ' ' A' ' 68' ' ' ALA . 10.5 tp -50.02 100.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.61 1.964 . . . . 0.0 112.422 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -145.79 164.78 30.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.216 1.406 . . . . 0.0 109.843 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -46.95 -40.24 13.93 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.443 1.497 . . . . 0.0 114.125 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.54 -47.31 86.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.166 0.586 . . . . 0.0 112.197 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.1 t -57.0 -48.66 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.804 0.841 . . . . 0.0 109.547 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.32 -47.04 76.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.629 0.771 . . . . 0.0 112.669 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.05 -42.97 88.8 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.686 -0.633 . . . . 0.0 112.366 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.15 -42.46 77.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.299 1.44 . . . . 0.0 112.917 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' VAL . 89.1 t -51.77 -57.04 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.57 1.548 . . . . 0.0 109.721 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.501 HD23 ' HD2' ' A' ' 30' ' ' LYS . 5.0 mp -62.11 -38.22 88.07 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.618 1.567 . . . . 0.0 113.108 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -49.5 76.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.634 -0.666 . . . . 0.0 111.599 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.47 -15.83 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HH12 ' A' ' 74' ' ' ARG . 27.7 tp -65.39 -53.72 39.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.816 2.046 . . . . 0.0 112.841 175.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.55 29.57 7.74 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 174.82 0.14 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.928 2.091 . . . . 0.0 114.671 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 28' ' ' SER . 1.4 p -103.38 -168.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.487 1.915 . . . . 0.0 111.049 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 27' ' ' VAL . 66.1 m -49.59 -28.01 5.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.94 53.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.762 1.625 . . . . 0.0 109.601 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -171.43 146.19 2.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 112.154 -167.553 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -141.66 152.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.097 1.359 . . . . 0.0 110.167 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.61 114.4 24.04 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 109.661 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 t -102.08 137.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.845 1.258 . . . . 0.0 110.38 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.66 114.59 0.71 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.048 0.832 . . . . 0.0 113.384 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.72 106.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.47 1.108 . . . . 0.0 110.573 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -89.3 104.65 17.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.846 1.658 . . . . 0.0 112.306 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -72.98 105.46 4.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.125 1.77 . . . . 0.0 111.333 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.5 22.51 8.37 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.611 1.964 . . . . 0.0 112.606 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -84.8 -29.22 25.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.549 1.54 . . . . 0.0 114.679 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.64 20.4 8.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.047 1.784 . . . . 0.0 115.391 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.49 17.38 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 118.984 1.392 . . . . 0.0 114.408 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -66.36 141.12 58.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.169 0.988 . . . . 0.0 112.812 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -115.07 170.71 8.15 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.919 1.688 . . . . 0.0 111.499 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 m -135.39 110.2 8.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 108.912 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.37 50.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.52 -1.362 . . . . 0.0 109.969 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -71.11 -68.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.525 0.73 . . . . 0.0 109.791 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.92 174.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.677 2.391 . . . . 0.0 110.58 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -127.6 144.18 51.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.541 2.337 . . . . 0.0 108.797 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.19 110.97 11.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.546 1.139 . . . . 0.0 110.269 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.61 121.63 18.25 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.262 1.025 . . . . 0.0 111.165 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.27 -41.42 8.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.964 1.306 . . . . 0.0 112.372 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m -138.29 149.35 45.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.578 1.151 . . . . 0.0 110.685 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.07 54.2 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.158 0.408 . . . . 0.0 113.163 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -151.99 175.0 12.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.933 0.893 . . . . 0.0 111.196 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.556 HG22 ' HA2' ' A' ' 73' ' ' GLY . 23.7 p -140.45 177.11 8.24 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.236 1.414 . . . . 0.0 111.336 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -127.22 16.09 7.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.652 1.181 . . . . 0.0 112.684 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 3' ' ' ALA . 15.5 m -134.55 176.85 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.711 2.004 . . . . 0.0 112.745 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.25 137.07 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.484 1.914 . . . . 0.0 109.467 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.3 154.76 82.11 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 119.902 1.228 . . . . 0.0 112.333 176.098 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.97 165.32 31.59 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 124.026 3.15 . . . . 0.0 109.58 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.87 -18.02 14.04 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.1 144.13 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.492 1.517 . . . . 0.0 110.161 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.51 92.66 5.49 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.88 1.272 . . . . 0.0 110.287 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.16 155.26 66.1 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.769 1.646 . . . . 0.0 111.362 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.3 155.16 12.09 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.094 -0.379 . . . . 0.0 111.095 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m 74.4 -22.42 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.236 1.814 . . . . 0.0 113.027 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -99.47 146.38 26.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.925 1.69 . . . . 0.0 109.016 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.562 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -115.53 162.3 17.38 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.769 1.228 . . . . 0.0 111.934 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 167.78 10.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.446 174.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.75 126.74 43.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.899 2.48 . . . . 0.0 108.652 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -144.37 151.22 38.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.823 0.849 . . . . 0.0 110.97 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -155.76 157.51 36.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.733 0.813 . . . . 0.0 110.883 -174.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -150.4 166.66 30.15 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.199 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.458 HH12 HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -139.85 158.01 44.79 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.86 1.33 . . . . 0.0 113.064 -174.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 ptmm? -74.96 113.75 12.63 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 39.62 -147.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.646 1.578 . . . . 0.0 113.887 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.7 m -77.72 -47.73 18.38 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.496 -1.378 . . . . 0.0 111.334 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.85 -60.53 0.36 Allowed Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.819 -0.989 . . . . 0.0 114.455 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.29 -2.51 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.612 3.541 . . . . 0.0 114.974 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.42 142.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.007 1.723 . . . . 0.0 108.705 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.94 69.15 1.19 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 0.0 110.982 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.4 m -96.65 -61.62 1.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.144 0.978 . . . . 0.0 111.335 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.88 172.15 31.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.737 1.16 . . . . 0.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -134.96 111.45 9.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.744 1.218 . . . . 0.0 110.364 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.57 135.82 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.969 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.76 162.33 40.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.107 1.363 . . . . 0.0 110.594 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.51 40.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.406 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.12 171.66 13.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.247 1.819 . . . . 0.0 110.365 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -139.72 152.0 46.31 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.971 177.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -128.18 117.14 21.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 110.715 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -79.56 110.56 15.0 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.444 1.498 . . . . 0.0 110.872 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 73.8 mtm -78.77 160.07 27.59 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.8 p -60.75 -17.76 50.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -73.75 -14.53 61.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.956 . . . . 0.0 112.491 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.52 7.46 72.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.689 1.138 . . . . 0.0 113.982 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -92.85 163.61 13.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.019 1.328 . . . . 0.0 109.736 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.428 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 54.1 m -125.19 152.74 44.1 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.121 0.968 . . . . 0.0 109.802 175.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.94 131.95 53.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.765 0.826 . . . . 0.0 109.904 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.52 140.77 19.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.64 126.33 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.666 1.186 . . . . 0.0 109.283 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.86 157.21 45.61 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 112.058 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.79 139.42 53.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.143 1.377 . . . . 0.0 110.554 175.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 m -127.27 114.12 17.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.708 1.203 . . . . 0.0 109.76 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 98.7 t -119.05 99.77 50.8 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.322 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.81 172.23 16.69 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.235 1.957 . . . . 0.0 110.102 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.99 -59.51 2.69 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.297 -0.877 . . . . 0.0 111.418 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.32 122.22 17.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.757 2.023 . . . . 0.0 112.489 -167.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.54 -52.25 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.184 -0.948 . . . . 0.0 113.209 -175.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -87.89 -4.51 58.84 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.95 1.3 . . . . 0.0 113.465 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.8 -4.13 7.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 112.074 -164.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.43 167.58 29.55 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.741 2.816 . . . . 0.0 108.414 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.6 m -141.19 166.83 23.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -81.78 157.17 24.59 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.377 -0.827 . . . . 0.0 110.514 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -142.3 153.34 43.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.179 0.991 . . . . 0.0 110.587 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -152.16 159.8 43.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.564 1.546 . . . . 0.0 110.945 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.31 150.46 25.33 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -147.34 143.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 125.632 1.573 . . . . 0.0 110.354 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -149.04 146.55 27.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.168 1.787 . . . . 0.0 108.959 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.17 118.41 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.999 1.72 . . . . 0.0 108.89 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.81 148.3 44.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.768 1.627 . . . . 0.0 112.827 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.4 p -77.7 80.96 4.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.568 1.547 . . . . 0.0 112.912 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.84 179.98 27.94 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.081 1.324 . . . . 0.0 112.958 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 126.23 36.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.835 1.654 . . . . 0.0 111.367 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -135.29 147.38 49.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.116 2.166 . . . . 0.0 108.538 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -115.24 179.93 3.82 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.435 1.494 . . . . 0.0 110.063 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.47 94.02 4.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.163 0.985 . . . . 0.0 110.093 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.84 -69.95 0.79 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.931 0.893 . . . . 0.0 109.429 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -147.55 -69.4 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.984 1.314 . . . . 0.0 109.771 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.97 -28.8 73.94 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.457 1.027 . . . . 0.0 115.319 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -53.72 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.327 1.063 . . . . 0.0 110.249 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.48 -38.77 75.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.529 1.132 . . . . 0.0 111.148 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.98 -44.29 74.31 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.42 -0.8 . . . . 0.0 111.288 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -24.0 67.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.168 0.987 . . . . 0.0 113.128 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.09 -55.69 4.93 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.66 -48.25 81.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.998 1.319 . . . . 0.0 113.377 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -86.74 -11.72 50.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.7 0.8 . . . . 0.0 113.054 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.18 -71.69 0.69 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.104 0.859 . . . . 0.0 112.039 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.32 82.14 1.15 Allowed Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.604 1.561 . . . . 0.0 109.949 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.35 143.71 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.555 1.504 . . . . 0.0 110.885 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -81.37 4.46 20.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.01 1.324 . . . . 0.0 113.563 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 57.72 10.95 1.18 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.74 2.816 . . . . 0.0 116.067 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 48.5 47.78 28.78 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.943 1.258 . . . . 0.0 112.611 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.92 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.25 12.2 p30 48.71 27.55 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.736 2.815 . . . . 0.0 115.711 178.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.16 151.44 20.76 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.718 1.628 . . . . 0.0 112.236 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -57.89 131.08 49.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 111.938 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -124.22 114.19 19.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.335 1.854 . . . . 0.0 110.132 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.57 131.05 12.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.984 1.314 . . . . 0.0 111.986 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -144.57 126.0 14.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.34 1.856 . . . . 0.0 110.645 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.95 101.28 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.261 1.025 . . . . 0.0 113.051 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -124.92 -26.39 3.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.829 1.251 . . . . 0.0 113.467 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.45 13.97 43.35 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.926 1.251 . . . . 0.0 114.679 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 t80 61.0 7.77 1.65 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.619 2.367 . . . . 0.0 114.964 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.1 -57.46 0.04 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.075 1.321 . . . . 0.0 112.066 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.05 155.74 19.1 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.9 166.37 26.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.485 1.914 . . . . 0.0 112.169 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.07 135.29 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.079 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -125.72 101.7 6.99 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.03 169.42 22.11 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-O 121.565 0.536 . . . . 0.0 112.955 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 147.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 109.264 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 31.0 ttp -152.8 144.7 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.483 1.513 . . . . 0.0 107.259 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.2 p -86.65 163.01 17.63 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.865 0.84 . . . . 0.0 111.381 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.2 p -81.47 13.67 2.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.417 1.887 . . . . 0.0 113.121 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.38 151.69 35.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.028 2.531 . . . . 0.0 111.612 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.46 -57.21 16.3 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.145 0.879 . . . . 0.0 114.146 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.67 59.59 2.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 113.832 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.2 176.89 6.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.236 1.414 . . . . 0.0 113.989 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 136.05 48.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.339 1.856 . . . . 0.0 109.052 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.4 ttp -124.96 88.49 2.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.069 1.348 . . . . 0.0 110.801 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -83.67 153.8 24.03 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.553 -0.717 . . . . 0.0 111.746 165.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 57.9 mt -136.08 115.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.184 2.194 . . . . 0.0 106.893 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -113.12 97.14 6.32 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.434 1.894 . . . . 0.0 108.872 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.21 106.91 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.206 0.527 . . . . 0.0 110.748 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 m -139.82 -179.62 6.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.852 1.661 . . . . 0.0 112.041 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.147 1.779 . . . . 0.0 111.992 178.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 CA--C 1.55 0.974 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.28 145.48 39.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.778 -1.201 . . . . 0.0 111.472 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.69 34.68 62.7 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.942 0.782 . . . . 0.0 114.363 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -146.14 -174.17 4.37 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.284 1.042 . . . . 0.0 111.843 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' A' ' 69' ' ' LEU . 3.7 pt -126.72 143.49 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.682 1.593 . . . . 0.0 111.772 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.36 167.17 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.035 1.734 . . . . 0.0 112.253 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 116.43 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.964 1.306 . . . . 0.0 113.057 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.19 65.49 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.024 1.297 . . . . 0.0 113.141 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.77 -20.64 61.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.26 1.424 . . . . 0.0 113.448 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -110.35 -0.99 17.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.57 1.548 . . . . 0.0 112.834 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 tp -80.41 115.34 19.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.14 1.376 . . . . 0.0 112.013 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -142.2 169.18 18.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.232 1.413 . . . . 0.0 110.941 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.3 -40.96 50.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.865 1.666 . . . . 0.0 113.889 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.373 1.069 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.05 -45.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.019 1.728 . . . . 0.0 109.938 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 170' ' ' GLN . 83.3 mt -54.6 -47.06 73.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.385 0.674 . . . . 0.0 110.635 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.88 -52.6 63.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.636 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -48.26 -47.89 35.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.673 1.189 . . . . 0.0 112.658 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.83 -58.77 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.728 1.211 . . . . 0.0 111.853 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.442 HD11 ' HD3' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -62.21 -32.55 73.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.09 1.356 . . . . 0.0 113.076 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.47 -55.96 13.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.224 1.01 . . . . 0.0 111.229 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -24.71 61.39 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.52 -48.29 69.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.741 1.616 . . . . 0.0 110.887 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 60.39 0.27 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.634 1.588 . . . . 0.0 111.662 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -53.53 119.64 5.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.282 1.433 . . . . 0.0 112.301 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -169.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.014 1.726 . . . . 0.0 110.074 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m -41.07 -42.96 2.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.708 2.403 . . . . 0.0 112.874 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 mtm105 -143.0 144.52 32.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.377 1.871 . . . . 0.0 109.575 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -173.99 165.08 4.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.71 2.804 . . . . 0.0 110.743 -170.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.8 HD13 ' CD2' ' A' ' 102' ' ' PHE . 32.8 pt -139.95 173.04 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.536 1.534 . . . . 0.0 110.652 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.01 107.15 6.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.991 1.316 . . . . 0.0 110.752 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.69 137.67 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.983 1.313 . . . . 0.0 111.451 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.7 116.98 0.8 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.746 0.689 . . . . 0.0 113.216 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.27 105.55 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.318 1.059 . . . . 0.0 109.694 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -84.6 108.87 17.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.293 1.437 . . . . 0.0 112.92 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -75.49 97.96 3.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.342 1.457 . . . . 0.0 111.393 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 8.94 12.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.469 1.908 . . . . 0.0 113.041 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.2 m -64.44 -44.94 89.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.09 -0.9 5.75 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.163 1.363 . . . . 0.0 116.329 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.76 28.07 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.745 1.773 . . . . 0.0 114.316 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -74.88 139.14 42.93 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.492 1.117 . . . . 0.0 113.112 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -111.8 163.31 14.32 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.696 1.199 . . . . 0.0 112.249 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.2 m -131.07 108.04 9.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.085 1.354 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 110.79 3.54 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.023 0.929 . . . . 0.0 108.987 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.36 -63.9 1.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.699 1.6 . . . . 0.0 111.097 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.23 170.39 2.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.299 2.24 . . . . 0.0 111.152 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.7 139.3 53.66 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 127.308 2.243 . . . . 0.0 110.489 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -131.61 114.87 15.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.183 1.793 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.68 101.3 5.7 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.563 1.545 . . . . 0.0 111.808 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -68.01 -42.96 79.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.219 1.408 . . . . 0.0 112.944 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -146.48 154.1 41.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.99 1.716 . . . . 0.0 111.381 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.55 -163.96 54.51 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.818 -0.551 . . . . 0.0 112.7 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.49 161.26 41.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.904 0.882 . . . . 0.0 110.546 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.9 m -145.43 137.7 25.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 110.131 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.21 4.71 44.72 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.749 1.219 . . . . 0.0 113.353 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 55' ' ' THR . 9.0 m -120.53 175.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.33 1.852 . . . . 0.0 113.564 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.03 132.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 109.843 -172.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 142.82 81.56 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 121.663 -0.648 . . . . 0.0 110.332 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HG3' HG23 ' A' ' 6' ' ' ILE . 66.4 Cg_endo -66.73 175.22 5.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 125.091 3.861 . . . . 0.0 111.533 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.15 -26.27 8.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.079 -1.013 . . . . 0.0 112.69 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -124.02 130.56 52.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 0.0 111.001 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -133.38 88.15 35.88 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.288 1.435 . . . . 0.0 109.425 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.32 163.39 23.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.306 2.004 . . . . 0.0 112.277 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.61 158.05 19.19 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.393 -0.817 . . . . 0.0 111.703 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 66.03 4.14 2.92 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.51 2.324 . . . . 0.0 114.208 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -126.9 147.9 50.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.325 1.85 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.96 158.0 27.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.349 1.459 . . . . 0.0 110.993 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -96.91 167.61 10.98 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.29 132.16 47.11 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.934 1.694 . . . . 0.0 108.763 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.67 163.57 35.48 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.374 1.07 . . . . 0.0 111.925 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.7 m -143.08 177.17 8.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.185 1.394 . . . . 0.0 111.298 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.74 97.66 0.14 Allowed Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.729 -1.04 . . . . 0.0 113.307 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.95 166.21 10.58 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.982 1.391 . . . . 0.0 113.595 -173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -86.38 101.35 13.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.71 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t0 39.65 -146.14 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 126.683 1.993 . . . . 0.0 112.405 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -61.76 -35.44 78.13 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 119.706 -1.871 . . . . 0.0 112.151 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.74 -58.86 0.53 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.299 1.428 . . . . 0.0 113.565 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.62 4.38 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.947 3.765 . . . . 0.0 115.382 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.05 126.04 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.124 2.169 . . . . 0.0 110.485 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.33 62.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.429 1.491 . . . . 0.0 112.556 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -66.31 0.91 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.691 1.596 . . . . 0.0 111.777 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 175.09 39.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.529 2.014 . . . . 0.0 110.334 -173.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.09 102.41 3.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.892 1.277 . . . . 0.0 107.937 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.97 134.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.036 1.734 . . . . 0.0 108.188 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.67 159.52 38.48 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 124.382 1.073 . . . . 0.0 110.068 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.8 146.46 33.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 110.858 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.05 169.15 21.9 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.2 1.8 . . . . 0.0 110.236 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.78 146.84 34.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.122 0.569 . . . . 0.0 111.703 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.83 118.83 23.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.824 0.85 . . . . 0.0 110.871 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 114.09 17.93 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.846 1.658 . . . . 0.0 110.274 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.7 mtt -70.72 162.47 29.0 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.491 0.662 . . . . 0.0 112.182 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t -60.18 -23.45 63.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.82 1.248 . . . . 0.0 113.722 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -10.69 56.21 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.535 1.534 . . . . 0.0 113.39 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.56 9.86 56.14 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.772 1.177 . . . . 0.0 115.179 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -87.06 171.72 10.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.372 1.086 . . . . 0.0 110.263 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.5 m -129.99 147.53 51.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.439 0.696 . . . . 0.0 110.961 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.08 111.75 16.32 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.26 139.54 28.21 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 117' ' ' VAL . 18.5 t -143.31 131.54 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.066 0.947 . . . . 0.0 109.84 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -143.77 160.51 40.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.93 -0.481 . . . . 0.0 111.77 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.8 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -127.18 153.05 46.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.894 1.278 . . . . 0.0 110.187 175.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -145.89 113.36 6.3 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.976 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.0 110.55 43.69 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 126.634 1.974 . . . . 0.0 108.224 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -79.33 175.27 10.95 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.486 2.791 . . . . 0.0 111.399 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -81.63 -40.94 22.19 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.814 -0.554 . . . . 0.0 111.269 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 112.51 24.33 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.476 -0.765 . . . . 0.0 112.789 -161.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.14 -54.85 41.02 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.17 17.16 24.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.14 1.376 . . . . 0.0 113.829 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.62 -3.57 2.62 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.286 1.834 . . . . 0.0 112.748 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -173.61 4.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.34 2.656 . . . . 0.0 109.692 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -152.58 160.65 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.492 1.517 . . . . 0.0 110.596 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.48 158.0 31.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.316 1.046 . . . . 0.0 110.214 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -143.68 151.88 40.64 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.283 -0.886 . . . . 0.0 111.932 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -164.38 154.55 14.47 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.952 1.701 . . . . 0.0 109.675 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -143.78 140.27 29.82 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.894 1.677 . . . . 0.0 108.8 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -139.21 124.37 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 128.952 2.901 . . . . 0.0 109.6 174.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -144.9 148.32 33.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.498 1.919 . . . . 0.0 109.894 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.92 113.53 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.827 1.651 . . . . 0.0 108.868 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -126.23 142.95 51.32 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.558 1.543 . . . . 0.0 112.939 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.0 p -75.34 92.67 2.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.14 . . . . 0.0 112.537 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.64 -167.88 39.83 Favored Glycine 0 N--CA 1.471 0.993 0 O-C-N 121.531 -0.731 . . . . 0.0 114.397 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 119.19 24.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.489 1.915 . . . . 0.0 111.398 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.22 156.11 40.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 111.133 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -137.93 161.87 35.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.34 1.456 . . . . 0.0 111.056 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 90.72 2.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.411 0.684 . . . . 0.0 111.15 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -110.23 -66.57 1.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.136 1.374 . . . . 0.0 109.135 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -70.92 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.58 1.552 . . . . 0.0 109.35 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.56 81.33 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.333 0.968 . . . . 0.0 114.333 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -69.6 -53.08 20.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.293 1.046 . . . . 0.0 110.78 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.25 -43.76 79.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.792 0.837 . . . . 0.0 110.428 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -62.6 -46.37 88.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -56.86 -19.94 20.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.722 1.146 . . . . 0.0 113.377 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.66 -59.13 2.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.227 1.411 . . . . 0.0 110.438 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.99 -56.55 19.82 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.299 1.04 . . . . 0.0 111.383 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -80.93 -16.66 52.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.198 1.399 . . . . 0.0 112.064 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.28 -77.17 0.25 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 0.0 113.271 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -162.41 90.75 1.33 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.935 1.694 . . . . 0.0 109.966 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.28 158.15 45.16 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.016 1.144 . . . . 0.0 110.492 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.74 5.84 50.39 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.74 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 130.145 3.378 . . . . 0.0 117.808 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.07 5.39 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.043 -1.035 . . . . 0.0 112.245 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -63.55 7.18 0.11 Allowed 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.347 11.3 p30 55.84 25.55 8.63 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.193 2.597 . . . . 0.0 116.424 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -139.58 165.44 25.82 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.456 1.979 . . . . 0.0 111.499 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -70.42 114.53 8.64 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.16 -1.2 . . . . 0.0 109.689 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 127.77 53.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.043 1.337 . . . . 0.0 109.975 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.08 139.34 21.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.185 1.394 . . . . 0.0 110.352 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -144.65 126.46 15.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.241 1.416 . . . . 0.0 109.921 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -62.1 117.6 6.22 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.805 0.442 . . . . 0.0 111.414 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -142.98 -26.62 0.59 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.486 1.114 . . . . 0.0 113.93 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.18 15.82 20.35 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.821 1.201 . . . . 0.0 114.469 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.45 10.62 1.92 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.829 2.452 . . . . 0.0 115.403 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.9 -47.6 0.05 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.274 1.416 . . . . 0.0 112.773 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.52 161.49 17.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 111.324 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 170.99 19.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 113.074 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.73 138.53 31.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.28 1.432 . . . . 0.0 109.487 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -130.5 109.07 10.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.761 1.624 . . . . 0.0 108.656 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.62 169.87 27.04 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.3 143.24 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 109.702 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.7 ttt -150.79 150.91 31.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.673 1.989 . . . . 0.0 107.352 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.0 p -101.13 165.47 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.599 0.76 . . . . 0.0 111.929 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.0 t -90.84 46.28 1.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.685 1.594 . . . . 0.0 110.051 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.57 158.16 42.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.33 1.452 . . . . 0.0 112.656 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.1 -45.55 93.79 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 121.439 -0.788 . . . . 0.0 113.089 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 64.02 2.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.737 1.615 . . . . 0.0 113.741 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -94.61 147.29 23.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -91.49 150.11 21.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.687 1.195 . . . . 0.0 107.963 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 36.2 ttp -143.72 91.84 2.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.389 0.995 . . . . 0.0 112.16 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 17' ' ' LEU . 35.0 tt0 -107.04 146.41 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.406 -0.809 . . . . 0.0 111.164 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.69 104.27 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.886 1.675 . . . . 0.0 109.426 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -99.2 90.42 4.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.81 2.044 . . . . 0.0 110.51 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.63 118.22 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.378 0.671 . . . . 0.0 110.137 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.5 p -146.41 166.17 27.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.994 1.318 . . . . 0.0 113.029 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.691 2.397 . . . . 0.0 111.7 176.218 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.13 143.0 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.324 0.965 . . . . 0.0 112.442 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.86 43.46 8.94 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.051 0.834 . . . . 0.0 115.027 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.9 p -147.65 -166.77 2.61 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 119.064 1.432 . . . . 0.0 111.977 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 pt -117.26 139.46 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.295 2.238 . . . . 0.0 109.947 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 12' ' ' LEU . 20.3 pt -145.55 159.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.006 1.322 . . . . 0.0 111.732 174.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.68 128.96 39.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.048 1.339 . . . . 0.0 112.477 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.59 -24.35 76.25 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.588 0.613 . . . . 0.0 113.413 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.2 73.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.419 1.088 . . . . 0.0 111.395 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -74.11 -28.45 61.36 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.259 1.024 . . . . 0.0 112.896 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 7' ' ' ILE . 9.2 tt -67.26 114.57 6.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.274 1.429 . . . . 0.0 112.54 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 m -145.11 172.85 12.5 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.159 1.784 . . . . 0.0 110.157 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -42.17 37.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.38 1.472 . . . . 0.0 113.952 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.88 -35.91 79.73 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.13 -42.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.517 0.727 . . . . 0.0 110.29 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 170' ' ' GLN . 11.1 mt -55.52 -50.48 69.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.832 0.742 . . . . 0.0 112.092 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -39.99 90.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.153 0.581 . . . . 0.0 112.113 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -57.21 -43.44 82.79 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.009 1.324 . . . . 0.0 112.717 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 70' ' ' LEU . 77.4 t -62.22 -48.01 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.394 1.078 . . . . 0.0 111.325 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.5 mp -61.96 -42.82 99.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.171 0.988 . . . . 0.0 112.267 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.87 -31.79 71.84 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -77.0 -42.19 39.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.826 1.65 . . . . 0.0 113.82 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.64 -56.85 16.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.775 1.63 . . . . 0.0 111.59 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 64.61 0.09 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.029 1.3 . . . . 0.0 112.149 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -51.16 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.353 2.261 . . . . 0.0 112.421 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 28' ' ' SER . 3.8 p -90.42 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.096 1.758 . . . . 0.0 109.942 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 27' ' ' VAL . 19.4 m -44.2 -49.55 9.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.552 1.141 . . . . 0.0 112.083 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -139.45 146.57 40.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 112.727 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.4 150.93 11.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.046 2.538 . . . . 0.0 108.931 -169.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 21' ' ' LEU . 7.0 pt -139.72 153.95 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.822 1.249 . . . . 0.0 109.507 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.63 110.81 20.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.364 1.066 . . . . 0.0 109.878 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -105.31 128.74 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.892 0.877 . . . . 0.0 111.265 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.7 114.47 0.79 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.357 1.456 . . . . 0.0 112.094 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.86 104.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.515 1.126 . . . . 0.0 109.082 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.2 111.16 21.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.149 1.379 . . . . 0.0 111.15 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -84.54 96.42 9.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.41 1.084 . . . . 0.0 111.615 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.0 18.97 20.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.601 1.161 . . . . 0.0 113.167 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.0 p -63.87 -40.22 96.03 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.406 ' H ' ' ND2' ' A' ' 65' ' ' ASN . . . 129.46 3.98 5.01 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.886 1.707 . . . . 0.0 115.854 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.06 30.47 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.767 1.783 . . . . 0.0 114.491 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -74.8 130.63 39.8 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 122.007 -0.701 . . . . 0.0 112.165 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.37 164.39 11.8 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.901 1.28 . . . . 0.0 111.277 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 m -133.82 110.32 9.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.458 1.503 . . . . 0.0 109.467 -176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.1 133.3 55.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.75 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mt -75.23 -68.56 0.54 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.864 0.466 . . . . 0.0 109.866 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -179.44 173.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.502 2.321 . . . . 0.0 110.592 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.82 145.74 51.23 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.353 2.261 . . . . 0.0 109.515 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 115.65 15.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.971 0.908 . . . . 0.0 111.015 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -70.31 106.65 3.43 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 111.221 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -68.95 -47.53 65.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.434 1.494 . . . . 0.0 110.603 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -141.7 154.4 45.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.917 2.087 . . . . 0.0 110.703 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -163.52 54.62 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.834 -0.541 . . . . 0.0 113.353 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -151.66 177.91 9.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 111.998 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.0 p -144.48 178.65 7.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.376 1.47 . . . . 0.0 111.563 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.25 20.15 8.15 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.771 1.228 . . . . 0.0 112.008 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.86 172.21 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 126.721 2.008 . . . . 0.0 113.244 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 mt -143.38 135.59 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.027 1.731 . . . . 0.0 109.812 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 149.68 60.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 119.547 1.067 . . . . 0.0 112.1 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.21 155.51 56.29 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 124.249 3.299 . . . . 0.0 111.579 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -93.27 -23.64 18.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.977 -1.077 . . . . 0.0 113.424 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.95 141.13 49.93 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.931 -1.106 . . . . 0.0 110.648 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.0 102.77 5.73 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.643 1.177 . . . . 0.0 109.234 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.3 164.67 24.79 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.903 1.735 . . . . 0.0 111.637 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 40' ' ' GLY . 13.1 t-20 -62.78 163.67 9.02 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.957 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 66.27 -0.91 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 126.542 1.937 . . . . 0.0 114.151 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.96 -174.38 2.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.188 2.995 . . . . 0.0 110.81 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.31 172.85 17.23 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.651 2.38 . . . . 0.0 111.049 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.99 178.47 4.55 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.713 0.805 . . . . 0.0 109.737 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 20' ' ' VAL . 1.2 tp -134.88 131.9 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.886 2.074 . . . . 0.0 109.118 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -148.05 166.27 28.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.274 1.03 . . . . 0.0 110.486 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -149.44 174.85 12.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.152 0.981 . . . . 0.0 111.068 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.95 119.22 0.88 Allowed Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.39 1.471 . . . . 0.0 111.369 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.04 150.06 42.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.909 1.355 . . . . 0.0 112.393 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -69.7 107.6 3.54 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.419 ' CB ' HG23 ' A' ' 80' ' ' VAL . 7.3 m-20 40.06 -150.49 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 126.113 1.765 . . . . 0.0 113.122 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -77.83 -38.74 45.58 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.82 -1.8 . . . . 0.0 111.347 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.82 -56.23 0.51 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.628 -1.096 . . . . 0.0 114.78 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.54 -6.27 18.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.529 3.486 . . . . 0.0 114.825 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' CB ' ' A' ' 76' ' ' ASP . 9.7 m -122.8 139.96 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.268 1.827 . . . . 0.0 109.126 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.03 78.08 1.52 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.326 . . . . 0.0 110.77 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 80.6 m -102.73 -65.16 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.848 0.859 . . . . 0.0 111.318 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.18 172.07 29.13 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.752 1.644 . . . . 0.0 111.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.33 108.69 8.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.409 1.105 . . . . 0.0 110.541 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -137.81 131.32 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.44 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.179 0.592 . . . . 0.0 110.651 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.96 149.97 35.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.935 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.84 172.47 12.98 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.858 1.663 . . . . 0.0 110.651 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -138.95 150.44 45.9 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.249 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -128.37 114.37 16.76 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.66 1.184 . . . . 0.0 111.352 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -75.02 115.13 14.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.559 1.544 . . . . 0.0 110.801 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.99 157.9 34.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.195 0.998 . . . . 0.0 111.733 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 87.4 p -59.65 -20.22 54.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -81.56 -11.7 59.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.615 1.966 . . . . 0.0 113.44 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.58 60.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.089 1.328 . . . . 0.0 115.244 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.27 175.11 8.64 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.811 1.245 . . . . 0.0 110.863 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.515 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 18.9 m -141.73 147.75 37.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.725 0.774 . . . . 0.0 110.288 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.11 118.94 34.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.19 0.996 . . . . 0.0 108.34 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.33 142.3 22.88 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 117' ' ' VAL . 25.6 m -140.89 137.97 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.547 1.139 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.41 152.52 44.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.155 0.582 . . . . 0.0 110.879 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -125.88 142.22 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.684 1.193 . . . . 0.0 109.768 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.0 m -125.87 97.95 5.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.947 1.699 . . . . 0.0 110.309 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.2 112.31 58.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.674 1.59 . . . . 0.0 109.616 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -76.83 -173.08 1.61 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.336 3.357 . . . . 0.0 111.996 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.461 ' CD1' ' HE3' ' A' ' 75' ' ' LYS . 16.8 t80 -106.5 -13.04 15.44 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.37 1.068 . . . . 0.0 112.895 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -110.73 131.13 55.32 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 119.741 -1.849 . . . . 0.0 111.138 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -66.4 0.7 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.02 -1.05 . . . . 0.0 110.837 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -82.19 -3.98 56.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.51 -1.48 9.58 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.093 1.757 . . . . 0.0 112.699 -164.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -150.24 179.93 7.71 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 129.536 3.134 . . . . 0.0 108.887 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.9 t -142.48 163.57 32.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.938 1.695 . . . . 0.0 109.037 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -92.37 136.98 32.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.351 0.66 . . . . 0.0 109.227 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 151.1 46.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.096 0.959 . . . . 0.0 110.357 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -157.1 157.48 34.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.612 1.565 . . . . 0.0 110.632 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.13 155.23 43.19 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.624 -0.673 . . . . 0.0 109.909 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 100' ' ' VAL . 43.6 t -140.87 122.02 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.947 1.299 . . . . 0.0 109.751 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -124.86 145.3 49.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.66 1.584 . . . . 0.0 109.737 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.4 mt -115.5 120.39 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.755 2.022 . . . . 0.0 108.659 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -132.42 144.72 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.126 1.371 . . . . 0.0 112.13 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.8 p -80.39 77.97 7.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.635 1.174 . . . . 0.0 112.59 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.67 36.88 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.413 1.006 . . . . 0.0 113.818 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 116.78 26.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.754 1.622 . . . . 0.0 111.858 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -142.43 155.26 45.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.105 1.362 . . . . 0.0 109.445 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -133.05 161.91 33.12 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.78 1.232 . . . . 0.0 111.141 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.8 78.98 0.45 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.602 1.161 . . . . 0.0 111.337 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -101.86 -65.59 0.97 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.444 1.498 . . . . 0.0 110.244 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.55 -71.77 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.088 1.755 . . . . 0.0 109.233 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.4 -19.33 68.53 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.541 1.067 . . . . 0.0 114.603 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.34 -52.71 5.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.117 0.958 . . . . 0.0 111.574 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.44 -45.9 76.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.335 0.654 . . . . 0.0 111.775 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -35.37 72.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -22.85 66.98 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.283 -0.886 . . . . 0.0 113.244 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -93.71 -35.91 12.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.427 1.091 . . . . 0.0 110.89 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -76.26 -45.14 34.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.309 -1.494 . . . . 0.0 113.197 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -92.06 -14.87 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.929 1.292 . . . . 0.0 113.143 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.08 63.14 3.59 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.992 0.806 . . . . 0.0 113.706 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 31.97 73.75 0.5 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 127.598 2.359 . . . . 0.0 112.528 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.06 133.09 29.83 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.355 1.37 . . . . 0.0 110.895 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 124.8 23.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.31 31.98 0.34 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.385 1.874 . . . . 0.0 114.046 -176.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.39 62.96 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.51 1.529 . . . . 0.0 114.073 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.59 24.97 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.338 1.855 . . . . 0.0 114.703 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.9 p30 47.76 30.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.164 2.586 . . . . 0.0 116.852 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.93 139.19 7.57 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.997 1.76 . . . . 0.0 111.156 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -49.58 124.05 8.82 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.839 1.256 . . . . 0.0 113.129 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -110.41 120.83 43.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.105 2.162 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.79 138.76 17.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.729 1.212 . . . . 0.0 111.168 174.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -154.78 134.79 13.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 111.266 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -54.23 132.67 43.92 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.6 tp -156.32 -41.06 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.758 1.223 . . . . 0.0 112.51 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.93 31.66 2.79 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 114.082 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.47 11.99 1.36 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.355 2.262 . . . . 0.0 115.743 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 170.85 -43.21 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.349 1.452 . . . . 0.0 113.097 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.37 151.5 26.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.519 1.127 . . . . 0.0 110.657 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.88 170.19 16.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.539 1.136 . . . . 0.0 113.06 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -82.51 126.5 32.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.671 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -121.24 102.78 8.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.438 1.095 . . . . 0.0 108.36 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.91 171.45 25.47 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 143.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.074 0.95 . . . . 0.0 110.045 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.03 148.8 33.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.407 1.883 . . . . 0.0 108.216 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.3 p -107.74 162.37 14.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.463 1.905 . . . . 0.0 111.025 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.7 p -92.11 19.82 6.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.533 1.533 . . . . 0.0 113.542 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.73 175.06 5.62 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.28 2.232 . . . . 0.0 113.456 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.57 9.8 Favored Glycine 0 N--CA 1.475 1.249 0 C-N-CA 125.362 1.458 . . . . 0.0 112.401 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.39 73.51 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.037 1.335 . . . . 0.0 109.639 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.23 91.69 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.688 0.795 . . . . 0.0 111.298 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -56.76 149.89 17.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.072 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.4 tpp -151.08 96.26 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.871 0.843 . . . . 0.0 110.649 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 17' ' ' LEU . 54.6 tt0 -124.96 134.93 52.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.602 -1.311 . . . . 0.0 109.636 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.66 101.1 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.571 1.548 . . . . 0.0 109.664 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -99.32 99.89 10.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.288 1.835 . . . . 0.0 109.845 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -85.92 118.08 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.449 -0.782 . . . . 0.0 111.16 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.05 165.78 26.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.87 1.668 . . . . 0.0 113.038 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.039 2.136 . . . . 0.0 111.648 174.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.59 143.03 53.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.023 0.929 . . . . 0.0 111.085 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.85 38.1 65.61 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -149.15 -169.73 3.45 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.425 1.113 . . . . 0.0 111.774 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 pt -126.47 153.27 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.974 1.71 . . . . 0.0 111.059 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 pt -148.94 170.0 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.824 1.65 . . . . 0.0 111.792 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.35 129.26 39.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.099 0.959 . . . . 0.0 109.601 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.34 42.05 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.947 1.26 . . . . 0.0 113.932 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.66 81.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.224 1.41 . . . . 0.0 112.267 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -32.58 32.34 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.94 1.296 . . . . 0.0 112.605 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 68' ' ' ALA . 5.9 tp -60.41 107.93 0.74 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.349 . . . . 0.0 111.896 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 m -149.37 168.17 24.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.755 1.222 . . . . 0.0 110.149 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -39.02 21.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.766 1.626 . . . . 0.0 114.222 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -59.38 -35.0 73.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.72 -44.02 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 110.474 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.52 -43.87 72.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.886 0.766 . . . . 0.0 112.226 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.16 -47.31 80.37 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.982 -0.449 . . . . 0.0 110.881 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -39.15 76.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.578 1.551 . . . . 0.0 114.0 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.19 -56.34 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.152 1.781 . . . . 0.0 109.598 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.41 -40.82 89.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.149 1.38 . . . . 0.0 112.646 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -56.52 -54.58 44.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 112.933 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.11 -42.0 89.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 tp -53.21 -55.54 23.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.03 1.732 . . . . 0.0 112.722 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.99 49.24 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.927 0.775 . . . . 0.0 114.12 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.91 123.71 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.561 1.944 . . . . 0.0 114.342 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.73 -161.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 127.086 2.154 . . . . 0.0 111.442 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 m -51.91 -34.07 39.86 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.807 1.643 . . . . 0.0 114.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -144.21 139.66 28.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.827 2.051 . . . . 0.0 108.932 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -162.73 148.32 12.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.574 1.949 . . . . 0.0 110.988 -174.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 104' ' ' VAL . 3.1 pt -138.35 151.79 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.14 0.976 . . . . 0.0 108.803 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.57 113.1 25.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.596 1.159 . . . . 0.0 109.866 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.75 130.4 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.693 0.797 . . . . 0.0 111.436 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.96 0.85 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.654 1.121 . . . . 0.0 112.759 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.11 101.54 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.846 1.258 . . . . 0.0 108.745 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -85.44 104.25 15.07 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.599 1.56 . . . . 0.0 111.696 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -82.79 104.35 12.96 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.572 1.149 . . . . 0.0 112.052 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.66 29.44 8.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.096 1.358 . . . . 0.0 112.331 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -84.02 -3.74 58.24 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.075 1.75 . . . . 0.0 114.747 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.21 14.64 80.12 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.505 -1.372 . . . . 0.0 114.287 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.65 20.23 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.445 1.498 . . . . 0.0 113.611 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.4 p -81.79 131.7 35.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.241 1.417 . . . . 0.0 112.527 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -108.35 164.43 12.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.741 1.216 . . . . 0.0 111.955 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -129.33 107.72 9.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.211 1.405 . . . . 0.0 110.082 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.27 117.82 10.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.309 -0.869 . . . . 0.0 109.985 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.03 -69.87 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.363 1.465 . . . . 0.0 111.223 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -170.95 164.41 7.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.531 1.932 . . . . 0.0 111.015 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -113.73 124.71 52.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.91 2.084 . . . . 0.0 110.068 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -108.21 109.75 21.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.546 1.138 . . . . 0.0 111.504 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -78.29 96.53 5.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.341 1.456 . . . . 0.0 112.053 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -66.07 -51.94 53.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.759 1.224 . . . . 0.0 112.003 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -138.63 141.48 39.11 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.822 2.049 . . . . 0.0 110.552 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.89 -171.46 42.91 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.32 0.486 . . . . 0.0 112.771 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.97 176.43 9.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.808 0.843 . . . . 0.0 111.984 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -142.65 -179.17 6.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.214 1.406 . . . . 0.0 111.355 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -137.52 22.89 2.94 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.915 1.286 . . . . 0.0 112.021 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.73 171.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.726 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.01 138.82 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 108.733 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -88.95 151.2 46.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.107 0.867 . . . . 0.0 111.426 177.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.67 165.73 26.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.741 2.96 . . . . 0.0 110.136 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -29.89 9.44 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.91 -1.119 . . . . 0.0 111.474 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.04 132.8 55.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.168 1.387 . . . . 0.0 111.044 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.45 81.94 47.47 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.051 1.74 . . . . 0.0 108.207 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.06 157.69 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 121.959 1.773 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -56.09 151.1 12.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.414 -0.803 . . . . 0.0 111.563 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 66.24 3.99 2.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.21 2.204 . . . . 0.0 115.257 -171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -130.95 99.13 4.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.146 1.779 . . . . 0.0 113.163 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.551 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -76.59 161.77 28.31 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.744 1.218 . . . . 0.0 112.628 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.91 170.89 7.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.911 0.885 . . . . 0.0 110.642 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.27 130.29 40.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.099 2.159 . . . . 0.0 107.877 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -149.12 161.48 41.88 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.307 1.443 . . . . 0.0 110.334 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -140.12 157.9 44.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.325 0.65 . . . . 0.0 111.512 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.07 118.69 1.4 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.579 1.561 . . . . 0.0 111.937 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.85 169.47 13.21 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.175 1.39 . . . . 0.0 112.011 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -99.89 111.61 23.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.891 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 t70 36.89 -145.72 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 128.637 2.775 . . . . 0.0 114.061 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 m -58.06 -57.56 12.31 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.942 -1.724 . . . . 0.0 111.941 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.8 -75.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.621 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.21 73.02 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 125.216 3.944 . . . . 0.0 113.042 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.6 159.64 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.091 1.756 . . . . 0.0 111.662 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.05 65.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.065 1.346 . . . . 0.0 111.766 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -127.1 -88.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.637 1.575 . . . . 0.0 110.389 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.6 172.99 32.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.526 1.536 . . . . 0.0 111.322 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.58 116.9 22.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.719 1.207 . . . . 0.0 109.385 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -142.5 128.29 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.599 1.16 . . . . 0.0 108.351 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -151.54 165.78 33.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.605 0.717 . . . . 0.0 110.67 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.62 139.56 20.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.298 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -134.42 175.85 9.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 -171.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.17 37.51 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.607 -0.683 . . . . 0.0 112.261 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.93 119.45 23.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.688 1.195 . . . . 0.0 110.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.59 112.07 17.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.461 1.904 . . . . 0.0 110.126 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -67.43 162.49 22.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.944 0.898 . . . . 0.0 111.749 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.9 p -59.59 -21.7 60.73 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 m -84.8 -14.95 46.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.511 1.925 . . . . 0.0 113.453 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.42 55.54 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.038 1.304 . . . . 0.0 115.447 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -82.01 165.36 20.74 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.482 1.141 . . . . 0.0 109.662 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.0 m -123.49 143.72 49.99 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 109.147 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -117.36 109.18 16.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.134 0.974 . . . . 0.0 109.354 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.65 114.24 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 117' ' ' VAL . 19.8 m -108.26 140.22 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.171 0.988 . . . . 0.0 110.991 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 135' ' ' TYR . 0.0 OUTLIER -141.39 155.25 45.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.338 0.655 . . . . 0.0 111.312 174.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -132.84 153.68 51.07 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.216 1.006 . . . . 0.0 111.516 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.3 t -137.39 115.03 11.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.403 1.081 . . . . 0.0 110.604 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.592 HG21 HG21 ' A' ' 31' ' ' ILE . 53.2 t -124.05 92.48 48.29 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 126.154 1.782 . . . . 0.0 108.579 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.76 171.6 17.89 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.081 2.521 . . . . 0.0 112.729 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -73.25 -55.95 5.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.514 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.75 122.0 22.6 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.36 1.464 . . . . 0.0 113.325 -161.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -67.22 -58.47 4.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -100.51 15.24 28.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.967 1.307 . . . . 0.0 114.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 0.31 4.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.856 2.063 . . . . 0.0 112.192 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.44 -179.02 7.37 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.419 2.288 . . . . 0.0 110.679 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -154.07 173.03 16.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.172 1.389 . . . . 0.0 112.076 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -95.8 147.54 23.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -134.86 142.48 46.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 110.545 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.442 ' CZ2' ' CD2' ' A' ' 147' ' ' HIS . 30.0 p-90 -145.51 152.82 40.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.39 1.476 . . . . 0.0 109.411 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -153.63 145.8 23.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.739 1.216 . . . . 0.0 110.22 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 100' ' ' VAL . 71.7 t -143.28 112.88 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.261 1.825 . . . . 0.0 110.5 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.55 129.29 56.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.129 0.971 . . . . 0.0 109.518 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.52 112.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.223 1.809 . . . . 0.0 108.755 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -124.19 141.45 52.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.473 1.509 . . . . 0.0 112.354 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.3 p -77.1 78.66 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.96 1.304 . . . . 0.0 112.858 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.13 165.18 20.91 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.44 1.019 . . . . 0.0 113.245 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 140.16 57.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.761 1.624 . . . . 0.0 111.856 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -156.04 168.32 27.62 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.516 1.527 . . . . 0.0 110.444 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -142.08 -175.42 4.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.097 1.759 . . . . 0.0 109.714 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.2 111.36 16.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.34 -67.22 0.99 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.287 1.035 . . . . 0.0 109.238 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.33 -71.53 0.21 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.153 0.981 . . . . 0.0 110.594 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.34 -22.91 74.94 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.935 0.778 . . . . 0.0 114.61 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.2 tpp -74.22 -54.18 8.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -40.72 85.33 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.565 1.146 . . . . 0.0 111.666 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.63 -36.24 66.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.352 1.461 . . . . 0.0 111.812 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -21.58 66.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.324 1.05 . . . . 0.0 113.113 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.67 -43.25 10.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 108.558 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.458 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 8.3 t80 -66.67 -49.74 65.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.866 -1.147 . . . . 0.0 113.669 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.56 -12.74 31.02 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.22 -66.91 2.5 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 124.191 0.9 . . . . 0.0 112.869 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.49 77.96 0.27 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.374 2.67 . . . . 0.0 108.928 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.4 143.44 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.509 1.473 . . . . 0.0 108.315 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -79.44 -11.78 59.9 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.7 129.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.054 3.342 . . . . 0.0 112.529 -173.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.36 62.09 0.6 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.05 2.262 . . . . 0.0 114.377 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -78.51 29.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.067 1.747 . . . . 0.0 114.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.253 10.9 p30 50.13 30.46 4.25 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 174.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.27 152.17 20.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.027 1.775 . . . . 0.0 111.017 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -64.37 112.67 3.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.442 ' CD2' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -110.03 123.51 49.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.053 1.741 . . . . 0.0 111.062 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -149.1 154.17 38.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.703 2.001 . . . . 0.0 111.836 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.39 135.85 10.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.308 1.043 . . . . 0.0 111.15 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.49 127.47 31.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.002 0.521 . . . . 0.0 111.447 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.1 tp -149.67 -27.99 0.26 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -84.29 18.76 21.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.998 1.285 . . . . 0.0 114.553 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.47 10.04 1.72 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.477 2.311 . . . . 0.0 115.438 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.85 -61.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.118 1.818 . . . . 0.0 110.579 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.1 159.78 15.52 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.796 0.838 . . . . 0.0 112.476 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 169.3 25.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.847 1.659 . . . . 0.0 112.82 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.491 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.3 pmm? -88.54 133.79 34.05 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.004 0.922 . . . . 0.0 112.011 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.16 107.24 9.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.329 1.452 . . . . 0.0 107.68 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -136.24 175.31 21.0 Favored Glycine 0 C--N 1.325 -0.077 0 CA-C-O 121.941 0.745 . . . . 0.0 113.441 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.65 141.49 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.82 1.648 . . . . 0.0 108.074 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.7 ttt -144.23 130.59 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 161.54 25.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.346 1.058 . . . . 0.0 110.095 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.55 24.91 6.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.403 1.481 . . . . 0.0 113.278 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.76 171.7 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.235 1.814 . . . . 0.0 112.269 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.44 -54.54 36.34 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.621 -0.674 . . . . 0.0 113.192 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.7 pt-20 -88.91 47.55 1.51 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.04 1.736 . . . . 0.0 113.777 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.18 141.49 57.33 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.895 0.855 . . . . 0.0 113.103 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -96.0 136.93 35.8 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 108.757 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.6 ttp -134.62 95.37 3.35 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.775 1.23 . . . . 0.0 111.733 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -108.72 145.38 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.915 -0.491 . . . . 0.0 110.465 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.26 112.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 125.764 1.626 . . . . 0.0 108.138 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -99.39 108.15 20.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.14 1.776 . . . . 0.0 108.765 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 157' ' ' MET . 33.3 mm -92.44 109.66 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.691 . . . . 0.0 110.266 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.39 171.32 14.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 111.996 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 127.637 2.375 . . . . 0.0 110.385 175.028 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.18 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.02 40.66 9.15 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.933 1.254 . . . . 0.0 114.81 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -145.51 -166.29 2.4 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.309 1.555 . . . . 0.0 112.639 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.11 140.14 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.319 2.248 . . . . 0.0 110.1 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -145.1 170.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.177 1.391 . . . . 0.0 111.987 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.76 111.39 5.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.759 -1.213 . . . . 0.0 110.898 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.91 -25.23 67.57 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.981 0.8 . . . . 0.0 113.302 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.42 -23.68 64.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.956 1.303 . . . . 0.0 114.08 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.02 1.16 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.111 1.364 . . . . 0.0 113.319 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.51 117.16 12.71 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.097 1.759 . . . . 0.0 111.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -145.84 169.0 19.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.577 1.551 . . . . 0.0 110.157 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.64 -41.33 42.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.128 1.371 . . . . 0.0 114.141 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -58.39 -42.59 87.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.644 0.777 . . . . 0.0 112.109 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.37 -46.75 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.447 1.099 . . . . 0.0 111.382 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 170' ' ' GLN . 33.7 mt -54.92 -49.85 70.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.736 0.814 . . . . 0.0 111.474 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -41.26 96.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -53.45 -45.35 69.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.091 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 70' ' ' LEU . 85.3 t -56.84 -56.89 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.0 mp -58.99 -33.87 71.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.258 1.423 . . . . 0.0 113.953 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -55.77 30.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.816 1.246 . . . . 0.0 110.277 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -15.36 60.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -30.6 56.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.448 1.099 . . . . 0.0 111.9 174.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 44.51 47.84 8.75 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.452 1.977 . . . . 0.0 113.959 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.73 175.84 1.03 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.356 1.462 . . . . 0.0 114.48 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -172.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 126.146 1.778 . . . . 0.0 110.922 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 m -48.92 -27.92 3.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.133 1.373 . . . . 0.0 114.591 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -127.36 149.86 49.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.753 1.221 . . . . 0.0 111.277 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.27 154.38 8.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.319 2.248 . . . . 0.0 109.899 -175.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.654 HD12 ' SD ' ' A' ' 169' ' ' MET . 13.9 pt -144.6 147.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.993 1.717 . . . . 0.0 109.083 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.23 105.59 13.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.67 1.188 . . . . 0.0 110.008 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.14 135.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.73 1.612 . . . . 0.0 111.569 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.06 115.4 0.69 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.979 1.276 . . . . 0.0 112.62 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.4 mt -106.63 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.337 1.455 . . . . 0.0 109.16 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.38 122.49 24.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.729 1.612 . . . . 0.0 113.845 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -77.34 90.52 3.78 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.195 1.798 . . . . 0.0 111.458 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.46 17.8 14.47 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.401 1.48 . . . . 0.0 112.635 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -76.48 -38.64 55.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 9.79 13.63 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.931 1.253 . . . . 0.0 115.568 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.06 166.19 29.39 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 119.466 1.633 . . . . 0.0 114.946 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -81.66 130.89 35.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.35 1.46 . . . . 0.0 112.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 m0 -106.58 161.35 14.7 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.683 1.193 . . . . 0.0 111.04 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.8 m -129.58 110.35 11.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.252 1.421 . . . . 0.0 109.051 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.41 130.19 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.053 -1.029 . . . . 0.0 109.792 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.23 -70.3 0.37 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 109.942 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -174.06 175.86 2.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.045 2.138 . . . . 0.0 110.549 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.03 154.87 42.37 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.728 2.011 . . . . 0.0 110.277 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.52 108.05 5.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.06 1.344 . . . . 0.0 111.022 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -74.33 105.91 5.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.101 1.361 . . . . 0.0 111.12 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -45.74 54.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.183 0.993 . . . . 0.0 111.503 175.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.0 m -140.19 156.76 46.38 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.892 2.077 . . . . 0.0 110.932 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.17 -168.32 45.13 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.68 0.6 . . . . 0.0 112.611 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -138.42 169.32 18.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.534 1.134 . . . . 0.0 110.142 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -147.23 137.11 23.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.91 0.862 . . . . 0.0 109.791 175.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.13 5.75 50.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.197 1.799 . . . . 0.0 112.754 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 55' ' ' THR . 11.5 m -116.1 169.58 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 110.738 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.19 141.77 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.486 1.114 . . . . 0.0 109.495 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.67 151.48 61.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 0.0 111.619 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 164.41 35.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.124 3.216 . . . . 0.0 110.524 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 -34.34 10.17 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.704 -0.622 . . . . 0.0 112.001 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.6 136.14 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.862 1.21 . . . . 0.0 110.82 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.03 89.24 7.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.78 1.232 . . . . 0.0 109.754 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.46 166.43 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.668 2.245 . . . . 0.0 113.49 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -58.81 153.5 16.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.6 p 69.89 -9.15 0.73 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -115.69 123.87 49.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.251 1.82 . . . . 0.0 111.914 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.32 176.69 6.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.872 1.269 . . . . 0.0 110.128 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.14 173.08 6.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.656 0.782 . . . . 0.0 109.247 174.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -126.51 131.79 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.385 1.474 . . . . 0.0 110.042 175.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -148.67 163.81 36.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 111.334 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.1 m -151.39 173.88 14.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 110.903 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.27 132.57 3.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.885 1.707 . . . . 0.0 110.323 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 178.57 6.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.3 1.04 . . . . 0.0 110.17 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -64.12 -174.95 0.13 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.027 0.931 . . . . 0.0 109.881 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.34 -167.88 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 121.137 -0.977 . . . . 0.0 109.989 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -34.28 -42.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.794 2.037 . . . . 0.0 114.85 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -51.75 0.48 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.51 1.528 . . . . 0.0 113.781 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.02 6.07 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.426 3.418 . . . . 0.0 115.073 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 109.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.447 2.299 . . . . 0.0 111.496 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.09 70.06 3.86 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.079 1.752 . . . . 0.0 112.895 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -97.51 -81.12 0.43 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.315 1.046 . . . . 0.0 111.996 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.06 176.3 43.21 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.115 1.817 . . . . 0.0 110.319 -172.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -149.13 86.55 1.5 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.542 1.163 . . . . 0.0 109.08 174.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.8 t -132.58 118.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.266 1.426 . . . . 0.0 107.639 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -141.06 166.29 25.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.055 0.931 . . . . 0.0 110.971 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.73 155.98 40.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.1 177.09 10.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 110.32 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.35 40.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.579 1.151 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.66 118.72 27.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.713 1.205 . . . . 0.0 110.594 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.89 107.72 9.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.042 1.737 . . . . 0.0 109.229 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mtt -64.54 166.64 8.2 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.498 -0.751 . . . . 0.0 112.212 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 t -62.98 -19.13 64.02 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -82.35 -18.83 40.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 113.203 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.19 -0.72 54.33 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.165 1.364 . . . . 0.0 114.906 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -79.93 166.23 21.83 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.597 1.198 . . . . 0.0 109.948 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 m -123.03 149.82 43.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.938 0.875 . . . . 0.0 110.318 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.37 112.43 18.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 108.257 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.18 127.8 8.2 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 117' ' ' VAL . 10.2 m -134.57 131.99 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.106 0.953 . . . . 0.0 110.157 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.48 156.65 45.18 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.156 0.582 . . . . 0.0 112.192 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -126.72 158.81 35.5 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.739 1.215 . . . . 0.0 111.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 t -138.67 108.25 6.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.486 1.115 . . . . 0.0 111.166 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 38.5 t -109.74 98.1 31.7 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.633 1.973 . . . . 0.0 108.612 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.97 169.37 22.34 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.342 2.695 . . . . 0.0 112.844 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.65 -17.48 41.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.13 110.72 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.149 0.98 . . . . 0.0 110.741 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.4 -58.4 5.37 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.09 -1.006 . . . . 0.0 113.269 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.81 10.76 27.21 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.688 1.195 . . . . 0.0 114.129 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.15 0.56 5.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.189 1.796 . . . . 0.0 112.609 -175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -153.84 173.16 16.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.237 2.215 . . . . 0.0 110.01 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.2 m -138.57 170.02 16.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.587 1.155 . . . . 0.0 112.155 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -90.84 142.64 27.55 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.396 -0.815 . . . . 0.0 110.143 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -135.69 139.92 44.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 108.755 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -158.14 150.77 22.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.788 1.635 . . . . 0.0 109.322 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -151.36 154.65 37.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.79 1.236 . . . . 0.0 109.912 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 100' ' ' VAL . 61.8 t -145.05 121.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.514 1.525 . . . . 0.0 111.4 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -123.31 136.17 54.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.513 1.525 . . . . 0.0 110.627 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.71 116.38 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.919 2.088 . . . . 0.0 108.363 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -129.77 136.41 49.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.235 1.814 . . . . 0.0 112.54 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.5 p -79.99 79.36 6.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.09 1.356 . . . . 0.0 112.465 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.53 176.12 43.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.446 1.498 . . . . 0.0 112.355 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 104.11 16.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.584 1.954 . . . . 0.0 111.135 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -134.41 158.85 42.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.631 1.172 . . . . 0.0 111.371 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -136.75 164.77 27.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.092 1.757 . . . . 0.0 110.57 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.3 87.89 6.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.631 0.772 . . . . 0.0 111.2 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -102.27 -66.9 0.9 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 110.375 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -147.67 -75.0 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.677 1.991 . . . . 0.0 108.554 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.54 -37.17 88.07 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.357 0.979 . . . . 0.0 113.943 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -70.44 -52.97 18.42 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.145 0.972 . . . . 0.0 111.821 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.09 91.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.302 0.641 . . . . 0.0 111.381 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.92 -34.33 77.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.815 -0.612 . . . . 0.0 112.247 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -23.06 64.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.669 1.122 . . . . 0.0 112.177 175.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.54 -58.09 2.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 108.898 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.24 -56.96 15.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.899 -1.126 . . . . 0.0 111.803 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.33 -18.66 44.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 0.0 112.049 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.7 -68.9 1.45 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.346 0.974 . . . . 0.0 113.077 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.31 88.98 0.27 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 127.732 2.413 . . . . 0.0 108.599 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.17 142.06 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.609 1.539 . . . . 0.0 109.429 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -77.5 -9.68 59.05 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.13 107.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 128.931 2.892 . . . . 0.0 112.221 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.19 85.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.344 1.926 . . . . 0.0 114.214 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -89.25 22.99 2.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.504 2.321 . . . . 0.0 113.865 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.286 11.9 p30 50.47 33.6 8.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.871 2.068 . . . . 0.0 114.927 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.91 156.84 23.08 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.24 1.876 . . . . 0.0 111.965 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -69.16 114.07 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.801 -0.823 . . . . 0.0 111.282 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.29 121.65 43.53 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.026 1.73 . . . . 0.0 111.114 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.27 144.53 38.43 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.826 2.05 . . . . 0.0 110.126 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 133.7 13.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.29 1.036 . . . . 0.0 111.477 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.56 115.24 2.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.172 0.989 . . . . 0.0 111.192 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -29.87 1.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.71 1.204 . . . . 0.0 113.279 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.5 18.05 35.79 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.357 1.456 . . . . 0.0 114.427 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 59.09 13.31 2.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.923 2.089 . . . . 0.0 114.709 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -175.42 -69.16 0.05 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 126.658 2.075 . . . . 0.0 109.664 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -87.19 150.15 24.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.324 1.059 . . . . 0.0 111.95 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 172.33 13.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.46 1.904 . . . . 0.0 110.896 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.9 ptm -101.57 150.05 23.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.626 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -130.71 107.55 9.24 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.255 1.822 . . . . 0.0 107.473 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.48 176.98 19.13 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-O 121.748 0.638 . . . . 0.0 113.119 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.79 144.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 107.501 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -145.4 140.87 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.445 1.498 . . . . 0.0 108.439 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.34 162.26 13.42 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.89 1.676 . . . . 0.0 110.623 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.56 16.54 23.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.215 1.006 . . . . 0.0 113.405 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -107.6 172.74 6.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.861 2.064 . . . . 0.0 112.439 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.8 -46.54 94.31 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.431 1.015 . . . . 0.0 114.097 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.99 60.01 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.369 1.468 . . . . 0.0 113.026 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.12 144.86 40.4 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -89.01 147.95 24.01 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.909 0.884 . . . . 0.0 109.254 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.654 ' SD ' HD12 ' A' ' 31' ' ' ILE . 8.2 mtt -135.5 105.68 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.869 1.667 . . . . 0.0 110.068 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 17' ' ' LEU . 17.6 tt0 -124.86 143.17 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.871 -1.143 . . . . 0.0 109.515 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.24 106.04 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.88 1.272 . . . . 0.0 108.503 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -100.22 103.87 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.093 1.757 . . . . 0.0 108.713 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.0 136.94 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.132 0.573 . . . . 0.0 110.042 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 p -158.4 159.87 36.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 128.695 2.798 . . . . 0.0 113.455 176.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.651 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 59.6 161.31 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.887 2.475 . . . . 0.0 113.364 -166.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.4 46.71 93.82 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.036 -1.04 . . . . 0.0 115.091 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 p -155.11 -170.99 3.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.977 0.911 . . . . 0.0 111.75 -170.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 pt -118.82 144.01 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.786 2.034 . . . . 0.0 110.336 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.72 169.79 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.659 1.584 . . . . 0.0 112.065 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 125.35 25.05 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.728 1.211 . . . . 0.0 112.143 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.12 -28.75 73.92 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.389 0.995 . . . . 0.0 114.382 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.62 74.98 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.669 -0.901 . . . . 0.0 112.567 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -82.62 -22.8 34.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.466 1.106 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.48 120.23 10.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.984 1.714 . . . . 0.0 110.029 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -152.43 171.96 17.24 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.109 1.764 . . . . 0.0 110.009 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -50.94 -36.33 38.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 113.997 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.73 -35.5 76.52 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.741 -1.224 . . . . 0.0 112.988 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.04 -42.59 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.734 0.814 . . . . 0.0 110.248 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -51.34 -49.59 61.12 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.109 0.963 . . . . 0.0 111.755 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.47 -48.6 77.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.43 0.692 . . . . 0.0 111.986 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -56.87 -35.02 68.43 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.47 -56.84 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.073 1.349 . . . . 0.0 110.059 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.35 -41.75 94.28 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.201 1.4 . . . . 0.0 112.369 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -54.75 -49.36 71.04 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.949 0.9 . . . . 0.0 112.318 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -85.86 -32.42 21.72 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -54.23 35.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.392 1.477 . . . . 0.0 111.239 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.82 58.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.383 0.992 . . . . 0.0 112.462 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 139.6 7.34 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.925 1.29 . . . . 0.0 111.913 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 28' ' ' SER . 3.4 p -137.05 -163.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.036 1.334 . . . . 0.0 110.709 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.546 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -38.83 -44.9 1.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.19 1.796 . . . . 0.0 114.138 175.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -148.98 138.88 22.04 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.132 1.373 . . . . 0.0 110.93 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.02 151.63 16.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.869 1.668 . . . . 0.0 111.165 -172.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' A' ' 102' ' ' PHE . 14.5 pt -134.95 152.3 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.108 1.363 . . . . 0.0 109.4 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.52 117.92 33.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.341 1.457 . . . . 0.0 109.38 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.85 126.97 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.81 109.44 0.66 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.38 1.466 . . . . 0.0 112.455 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 171' ' ' ILE . 10.8 mt -107.54 101.9 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.763 1.225 . . . . 0.0 108.246 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.63 120.77 26.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.568 1.547 . . . . 0.0 112.62 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -84.99 102.49 13.23 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.1 1.36 . . . . 0.0 112.054 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.67 25.68 7.42 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 111.615 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -77.99 -19.94 53.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.784 1.634 . . . . 0.0 114.387 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.75 26.85 25.88 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 114.743 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.08 150.38 18.2 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.77 1.176 . . . . 0.0 113.959 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -71.14 140.27 50.53 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.439 -1.036 . . . . 0.0 112.918 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -114.35 164.41 13.98 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.47 1.108 . . . . 0.0 112.237 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 m -132.91 108.75 9.13 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.038 1.335 . . . . 0.0 109.714 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.87 131.49 46.4 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.22 -69.32 0.48 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.735 -0.603 . . . . 0.0 110.539 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.7 163.02 2.8 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.059 2.143 . . . . 0.0 111.076 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -110.86 122.88 48.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.225 1.81 . . . . 0.0 109.224 175.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -110.1 105.75 14.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.434 1.094 . . . . 0.0 111.629 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -73.92 115.02 12.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.817 1.247 . . . . 0.0 112.034 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -46.62 11.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.604 1.561 . . . . 0.0 111.495 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.8 m -139.15 157.0 46.72 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.932 2.093 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.0 -158.5 53.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.48 0.562 . . . . 0.0 112.631 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 76' ' ' ASP . 3.4 t -148.52 -168.8 3.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.068 -0.666 . . . . 0.0 112.323 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.2 p -142.26 178.67 7.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.105 2.162 . . . . 0.0 111.155 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.21 10.61 6.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.348 1.459 . . . . 0.0 111.971 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 ' CB ' ' A' ' 3' ' ' ALA . 6.8 m -139.2 169.18 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.184 2.593 . . . . 0.0 113.88 -168.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.43 132.57 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.788 2.035 . . . . 0.0 109.804 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.61 153.97 65.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 119.672 1.123 . . . . 0.0 111.842 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.5 165.45 30.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.824 3.016 . . . . 0.0 109.947 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.13 -33.67 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.414 -0.804 . . . . 0.0 112.153 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -115.11 133.72 55.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.509 1.524 . . . . 0.0 109.917 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.96 106.36 5.77 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.373 1.069 . . . . 0.0 110.121 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.71 163.35 35.59 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.776 1.651 . . . . 0.0 112.051 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.87 150.94 27.01 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.636 -0.665 . . . . 0.0 111.075 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 0.5 OUTLIER 76.96 -3.19 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.838 2.855 . . . . 0.0 114.17 -176.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -112.54 149.53 32.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.499 1.52 . . . . 0.0 109.372 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.23 157.72 29.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 109.916 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.7 pt? -94.38 176.81 6.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.883 0.849 . . . . 0.0 109.72 175.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.48 129.7 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.925 2.09 . . . . 0.0 109.16 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -149.12 168.94 21.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.624 0.77 . . . . 0.0 111.204 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -148.66 174.43 12.17 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.157 0.983 . . . . 0.0 111.255 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.3 118.7 0.85 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.1 1.333 . . . . 0.0 111.839 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -118.7 150.15 40.24 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.002 1.401 . . . . 0.0 112.379 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -70.16 116.08 10.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 54' ' ' THR . 10.2 m-20 42.85 -151.2 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.745 1.618 . . . . 0.0 113.533 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -75.05 -39.95 60.61 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.268 -1.52 . . . . 0.0 112.034 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.41 -62.08 0.37 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.21 1.386 . . . . 0.0 113.646 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.68 3.86 2.95 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 125.279 3.986 . . . . 0.0 115.601 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.56 132.31 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 127.646 2.379 . . . . 0.0 109.404 -174.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 69.85 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.303 1.441 . . . . 0.0 111.274 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -108.42 -71.21 0.77 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.364 1.065 . . . . 0.0 110.859 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.95 35.86 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.988 0.804 . . . . 0.0 112.164 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -135.38 112.18 10.14 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.765 1.226 . . . . 0.0 108.466 174.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 135.31 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.63 167.16 23.64 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.43 141.66 22.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 110.968 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.449 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -131.96 172.65 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.381 1.472 . . . . 0.0 109.151 -176.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.54 148.31 44.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -127.8 120.2 27.35 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.755 1.222 . . . . 0.0 110.779 -179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -82.69 125.11 30.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.614 . . . . 0.0 110.687 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.447 ' CE ' HD23 ' A' ' 98' ' ' LEU . 1.4 mtm -88.2 164.36 15.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.934 0.894 . . . . 0.0 112.953 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -60.52 -22.7 63.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.688 1.195 . . . . 0.0 113.634 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -81.98 -8.19 59.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.672 1.589 . . . . 0.0 113.272 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.23 65.56 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.928 1.251 . . . . 0.0 115.252 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.06 171.93 9.48 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.127 0.971 . . . . 0.0 110.979 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.6 m -133.74 146.43 50.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.059 0.944 . . . . 0.0 111.611 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CE ' ' A' ' 92' ' ' MET . 1.3 pp -117.45 130.61 56.58 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.432 1.093 . . . . 0.0 108.31 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.6 145.34 17.9 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.93 115.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.729 1.212 . . . . 0.0 109.005 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.512 ' HG3' ' H ' ' A' ' 116' ' ' ASP . 1.9 ptm -113.49 160.89 18.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.958 0.503 . . . . 0.0 112.086 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.46 141.62 39.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.554 1.142 . . . . 0.0 109.678 175.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 m -128.5 106.62 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.411 1.884 . . . . 0.0 108.801 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.2 101.59 53.67 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 126.487 1.915 . . . . 0.0 108.813 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.6 171.36 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.317 2.678 . . . . 0.0 111.977 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.02 -24.31 28.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.5 0.72 . . . . 0.0 112.023 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.49 116.32 32.15 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.267 1.427 . . . . 0.0 111.889 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -71.12 -59.3 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.32 10.54 29.33 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.103 -0.998 . . . . 0.0 113.612 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.76 -4.86 5.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.01 2.124 . . . . 0.0 112.615 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 160.49 39.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.837 2.455 . . . . 0.0 109.249 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.6 m -125.02 164.7 19.61 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.07 -1.019 . . . . 0.0 110.834 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -85.12 140.9 30.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.516 0.727 . . . . 0.0 109.884 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 156.94 47.63 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -161.93 140.73 9.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.501 1.52 . . . . 0.0 111.156 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 101' ' ' MET . 10.8 t70 -125.57 142.42 51.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.384 1.474 . . . . 0.0 109.214 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -138.36 113.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.345 1.458 . . . . 0.0 109.834 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.65 143.1 50.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.795 1.638 . . . . 0.0 108.845 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.28 118.59 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.661 1.984 . . . . 0.0 108.514 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -129.89 136.0 49.01 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.454 1.501 . . . . 0.0 112.426 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.1 p -70.32 84.77 0.57 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.483 1.913 . . . . 0.0 112.242 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.51 -174.12 44.44 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.451 1.024 . . . . 0.0 113.655 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -115.82 114.37 24.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.598 1.959 . . . . 0.0 110.151 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 159.65 40.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.984 0.913 . . . . 0.0 111.877 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 163.15 33.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.254 1.422 . . . . 0.0 111.27 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.33 89.09 0.2 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.255 1.422 . . . . 0.0 110.923 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.52 -61.33 1.61 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 109.88 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -71.89 0.19 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.245 1.418 . . . . 0.0 109.046 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.1 -32.54 72.96 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.981 0.8 . . . . 0.0 114.416 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -66.07 -53.2 41.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.082 0.941 . . . . 0.0 110.549 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -57.76 -39.83 78.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.455 0.702 . . . . 0.0 110.592 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -48.38 79.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -27.52 67.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.915 0.886 . . . . 0.0 112.923 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -82.7 -50.15 9.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.21 1.004 . . . . 0.0 110.127 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.15 -47.71 67.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.095 1.358 . . . . 0.0 113.7 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -88.81 -13.82 38.48 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.84 -83.15 0.05 OUTLIER Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.824 1.202 . . . . 0.0 112.197 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -168.12 72.75 0.88 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.013 1.725 . . . . 0.0 110.139 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.4 133.04 29.01 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.625 0.883 . . . . 0.0 110.336 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -61.42 158.34 14.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.046 1.338 . . . . 0.0 110.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -95.16 3.71 54.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -164.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 54.69 49.45 61.44 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.481 1.039 . . . . 0.0 112.946 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.91 20.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.41 2.284 . . . . 0.0 115.058 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.265 9.7 p30 48.79 38.45 11.88 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.362 2.265 . . . . 0.0 114.674 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.86 160.35 26.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.596 1.57 . . . . 0.0 112.731 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -68.75 127.12 31.94 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.137 0.975 . . . . 0.0 111.423 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -120.84 106.38 11.61 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.602 1.961 . . . . 0.0 109.464 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.74 150.12 43.01 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.893 1.277 . . . . 0.0 110.989 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 142.28 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.2 1.8 . . . . 0.0 110.241 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -61.53 132.41 53.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.111 0.564 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 tp -147.4 -37.24 0.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.52 25.66 4.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.04 1.305 . . . . 0.0 114.47 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.86 9.75 1.3 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.338 2.255 . . . . 0.0 115.492 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.96 -49.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.239 1.399 . . . . 0.0 112.18 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.88 156.63 18.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.854 0.835 . . . . 0.0 111.597 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 169.09 22.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.974 1.709 . . . . 0.0 112.06 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -94.77 138.8 32.11 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.214 1.006 . . . . 0.0 111.473 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -126.69 106.42 9.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.039 1.736 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.29 169.13 24.64 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 114.779 0.671 . . . . 0.0 114.779 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.92 143.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 125.951 1.7 . . . . 0.0 109.317 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.84 147.6 33.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.537 1.535 . . . . 0.0 108.06 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -96.08 171.58 8.53 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.241 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m -104.28 21.83 15.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.317 1.447 . . . . 0.0 112.458 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 -178.32 3.54 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 112.591 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.57 -36.52 78.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.99 0.805 . . . . 0.0 114.424 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.89 75.21 4.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.666 1.587 . . . . 0.0 111.023 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.91 73.06 1.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 112.251 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -43.99 141.14 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.585 1.954 . . . . 0.0 110.465 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 ttm -142.13 106.25 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.132 0.967 . . . . 0.0 110.566 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -124.2 139.67 53.7 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.432 HD13 HG12 ' A' ' 35' ' ' ILE . 3.8 mp -131.39 101.33 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.633 1.573 . . . . 0.0 108.964 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.71 104.78 16.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.363 1.865 . . . . 0.0 109.432 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -87.63 124.28 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 121.819 -0.551 . . . . 0.0 110.989 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.1 m -141.21 167.88 21.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 112.959 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 128.153 2.581 . . . . 0.0 112.686 175.126 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.647 0.261 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.35 158.05 0.06 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.699 2.8 . . . . 0.0 113.335 -166.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.84 44.59 96.92 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.296 -0.878 . . . . 0.0 114.1 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -144.74 -176.59 5.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.433 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.69 135.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.288 1.835 . . . . 0.0 110.616 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -141.06 167.0 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.382 1.473 . . . . 0.0 111.225 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.0 125.73 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.925 -1.109 . . . . 0.0 110.423 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.36 -21.14 59.53 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.897 0.761 . . . . 0.0 113.447 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.32 72.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.226 1.41 . . . . 0.0 112.049 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.63 -30.33 41.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.707 1.203 . . . . 0.0 112.762 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 tp -55.53 106.41 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.053 1.741 . . . . 0.0 111.151 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 m -149.88 166.98 27.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.543 1.537 . . . . 0.0 109.762 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -44.62 -39.28 4.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.968 1.707 . . . . 0.0 114.618 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.31 -36.02 76.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.12 -35.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.874 1.669 . . . . 0.0 110.618 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.9 mt -56.44 -52.22 65.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.902 0.774 . . . . 0.0 111.127 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -53.53 -39.82 64.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.973 0.806 . . . . 0.0 112.148 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmtm -59.84 -32.44 70.69 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.547 1.139 . . . . 0.0 113.274 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 70' ' ' LEU . 32.0 t -63.97 -52.31 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 108.968 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.04 -41.16 74.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.021 0.528 . . . . 0.0 111.757 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.8 -56.7 18.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.485 1.114 . . . . 0.0 112.617 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.81 -38.6 46.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -21.79 66.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.262 1.025 . . . . 0.0 111.07 175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.46 73.09 0.96 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.037 1.303 . . . . 0.0 110.153 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -45.2 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.637 1.575 . . . . 0.0 112.449 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 28' ' ' SER . 2.5 p -76.07 -163.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.51 1.524 . . . . 0.0 110.22 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 27' ' ' VAL . 8.0 t -44.28 -33.95 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.606 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.05 134.36 13.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.179 1.791 . . . . 0.0 110.78 175.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.2 165.01 34.58 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.75 155.0 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.013 0.824 . . . . 0.0 111.731 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.23 115.58 30.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.005 0.922 . . . . 0.0 110.58 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.16 144.03 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.006 1.322 . . . . 0.0 110.948 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.36 0.77 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.92 0.771 . . . . 0.0 112.789 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.89 103.93 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.817 1.247 . . . . 0.0 110.438 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.32 124.31 27.96 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.699 1.6 . . . . 0.0 113.741 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.43 103.81 9.61 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.328 1.851 . . . . 0.0 113.954 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.25 36.49 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.803 2.041 . . . . 0.0 112.323 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.549 1.54 . . . . 0.0 113.662 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.59 11.63 49.29 Favored Glycine 0 CA--C 1.541 1.687 0 O-C-N 120.983 -1.073 . . . . 0.0 115.182 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.97 162.31 28.33 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.001 1.762 . . . . 0.0 113.051 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -76.57 137.67 39.68 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.601 1.16 . . . . 0.0 112.517 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 92' ' ' MET . 49.0 m0 -107.61 164.32 12.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.91 1.684 . . . . 0.0 111.574 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -131.01 111.75 12.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.767 1.227 . . . . 0.0 109.28 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.64 127.19 30.12 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.71 -68.14 0.41 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 176.99 172.47 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.903 2.481 . . . . 0.0 110.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.26 47.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.638 2.375 . . . . 0.0 109.514 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -123.96 109.93 14.16 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.282 1.033 . . . . 0.0 111.177 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -70.19 112.26 6.42 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 111.347 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -94.15 -32.94 13.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.714 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -142.58 148.99 38.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 109.646 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -175.46 47.76 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.549 1.071 . . . . 0.0 115.141 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.95 144.73 35.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.964 1.306 . . . . 0.0 111.93 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -102.26 167.25 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.944 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.72 -0.76 21.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.482 1.113 . . . . 0.0 112.587 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.91 -178.56 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.873 2.069 . . . . 0.0 112.568 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.38 139.54 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 110.696 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.71 146.33 79.82 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 118.856 0.753 . . . . 0.0 112.957 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.12 150.99 54.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.014 3.809 . . . . 0.0 111.608 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 16.9 tt0 -92.45 -22.21 19.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -123.54 126.85 47.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.575 1.55 . . . . 0.0 110.646 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.14 96.22 12.89 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 109.672 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.0 167.6 21.2 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.848 2.366 . . . . 0.0 113.444 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.87 158.0 8.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.194 -0.941 . . . . 0.0 109.925 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.271 7.3 t 59.45 6.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.154 2.181 . . . . 0.0 114.474 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -127.38 121.47 31.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.82 2.048 . . . . 0.0 110.102 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.4 171.63 8.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.248 1.019 . . . . 0.0 110.15 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -108.41 171.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -123.53 130.35 52.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.909 1.284 . . . . 0.0 109.872 174.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.55 171.16 17.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.885 0.85 . . . . 0.0 110.857 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.3 m -156.71 170.44 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.88 1.272 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.27 121.85 2.17 Favored Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.52 156.97 38.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.573 1.687 . . . . 0.0 109.564 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 12.7 ptpt -61.44 179.5 0.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.95 0.5 . . . . 0.0 111.176 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -67.7 -160.08 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 121.061 -1.024 . . . . 0.0 110.738 176.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.5 m -30.67 -51.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.429 1.892 . . . . 0.0 115.922 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.54 -60.64 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.769 1.176 . . . . 0.0 113.269 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.82 -7.7 21.74 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.398 3.399 . . . . 0.0 114.957 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 76' ' ' ASP . 15.0 m -74.34 123.55 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.441 1.896 . . . . 0.0 112.443 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.47 71.8 4.37 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.893 -1.13 . . . . 0.0 111.646 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.6 m -119.21 -85.32 0.65 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.419 1.088 . . . . 0.0 111.689 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.16 -178.59 33.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.874 1.226 . . . . 0.0 111.251 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.725 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -142.96 111.43 6.24 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.597 0.759 . . . . 0.0 112.728 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.84 122.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -142.03 150.43 41.28 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.969 0.908 . . . . 0.0 111.111 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.64 143.97 51.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 111.115 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' CD2' HG23 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -146.64 175.17 10.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.522 1.929 . . . . 0.0 111.721 -174.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -144.1 153.18 41.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.109 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 2.0 m-85 -133.8 117.37 16.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.604 1.562 . . . . 0.0 111.03 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -75.19 117.24 16.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 110.3 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . 0.414 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 17.3 mtm -74.25 161.96 29.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 112.156 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 t -60.87 -23.62 65.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.532 1.133 . . . . 0.0 113.519 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 m -78.63 -20.49 50.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 114.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.63 39.69 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.671 1.129 . . . . 0.0 115.777 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -87.42 171.34 10.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.564 1.145 . . . . 0.0 110.666 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 53.9 m -140.07 136.99 34.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.748 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.19 126.99 53.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.538 -0.755 . . . . 0.0 108.984 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.58 128.76 8.71 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.43 HG23 ' CD2' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -137.54 140.24 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.593 1.157 . . . . 0.0 110.345 178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.6 ptm -144.54 170.11 16.69 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.8 p90 -126.94 156.46 41.47 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.436 1.095 . . . . 0.0 111.142 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.7 t -140.07 123.72 17.25 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.406 1.482 . . . . 0.0 109.754 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.725 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 44.2 t -120.81 91.37 47.4 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 126.895 2.078 . . . . 0.0 107.686 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.24 143.39 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.399 2.733 . . . . 0.0 110.705 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.45 -41.08 85.29 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.103 0.561 . . . . 0.0 111.633 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.43 138.26 36.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 111.042 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.04 -72.01 0.37 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.458 -0.776 . . . . 0.0 111.457 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -1.91 23.88 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.774 1.23 . . . . 0.0 113.639 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -5.84 6.22 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.811 2.044 . . . . 0.0 112.731 -164.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.38 149.47 28.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.822 2.449 . . . . 0.0 109.48 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -111.07 163.73 13.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.661 0.784 . . . . 0.0 110.14 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.96 137.86 32.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.419 1.088 . . . . 0.0 109.234 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -126.81 138.49 53.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.717 1.207 . . . . 0.0 111.571 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -150.02 146.21 26.85 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.28 -1.512 . . . . 0.0 111.335 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.91 154.89 45.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.975 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.38 115.44 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.397 1.479 . . . . 0.0 111.384 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -114.97 117.7 31.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 108.738 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mt -103.24 111.79 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.872 1.669 . . . . 0.0 107.587 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.14 162.83 34.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.475 0.71 . . . . 0.0 112.58 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -80.05 79.94 6.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.662 1.185 . . . . 0.0 112.275 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 -149.45 8.55 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.25 0.929 . . . . 0.0 113.509 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -131.26 84.51 2.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 128.322 2.649 . . . . 0.0 111.665 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.85 77.7 7.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.066 1.347 . . . . 0.0 111.827 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -65.11 164.43 13.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.608 0.763 . . . . 0.0 112.399 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.415 ' HB2' ' CD1' ' A' ' 131' ' ' TYR . . . -132.84 112.71 12.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.857 2.063 . . . . 0.0 110.211 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -111.35 -75.17 0.62 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -152.06 -74.94 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.953 1.701 . . . . 0.0 108.087 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.66 -11.15 62.13 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.072 1.32 . . . . 0.0 115.027 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -63.98 1.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 1.316 . . . . 0.0 107.612 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -63.55 -16.46 60.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -33.03 61.9 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.849 0.749 . . . . 0.0 110.731 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.24 -28.97 64.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.397 1.079 . . . . 0.0 112.908 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.79 -33.85 22.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.338 1.055 . . . . 0.0 110.003 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -75.83 -45.45 35.76 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.206 -0.934 . . . . 0.0 113.21 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -96.2 -16.9 21.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.877 0.871 . . . . 0.0 113.336 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -70.09 1.06 Allowed Glycine 0 N--CA 1.475 1.242 0 C-N-CA 124.104 0.859 . . . . 0.0 112.556 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 179.99 73.32 0.17 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 128.215 2.606 . . . . 0.0 111.072 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 158.19 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.769 1.646 . . . . 0.0 110.965 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.56 121.64 30.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.437 ' NE ' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.45 158.43 35.76 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.328 -0.857 . . . . 0.0 112.163 175.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.21 70.79 1.02 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.514 1.531 . . . . 0.0 112.633 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.26 24.48 0.34 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.388 1.875 . . . . 0.0 113.853 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.2 p30 48.19 35.3 5.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.923 2.089 . . . . 0.0 114.901 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.96 156.46 23.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.057 1.313 . . . . 0.0 113.049 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -65.19 126.75 29.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.203 1.001 . . . . 0.0 110.538 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.57 105.58 9.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.804 1.642 . . . . 0.0 108.919 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.09 140.5 36.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.609 1.563 . . . . 0.0 111.419 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -160.7 137.82 9.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.006 . . . . 0.0 111.391 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -57.71 107.17 0.42 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.789 1.235 . . . . 0.0 112.309 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 tp -128.67 -30.23 2.32 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.046 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.93 22.16 7.08 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.656 1.122 . . . . 0.0 114.092 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.37 13.19 3.87 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.297 2.239 . . . . 0.0 115.091 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.38 -57.59 0.11 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.126 1.822 . . . . 0.0 111.65 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.2 mp -91.3 148.49 22.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.726 0.774 . . . . 0.0 110.606 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 169.5 17.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.512 1.525 . . . . 0.0 111.731 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 144.66 29.52 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.757 1.223 . . . . 0.0 110.37 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.88 102.06 6.61 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.742 2.017 . . . . 0.0 108.464 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.29 167.55 21.86 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.0 0.778 . . . . 0.0 112.93 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.1 tt -151.81 139.36 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.548 1.939 . . . . 0.0 108.527 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.7 ttm -142.29 139.63 31.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 78.2 p -88.14 169.68 11.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 110.977 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -87.15 11.36 14.15 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.098 -1.001 . . . . 0.0 113.615 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.92 170.44 10.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.147 2.179 . . . . 0.0 113.226 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.6 -73.6 0.72 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.937 1.256 . . . . 0.0 111.525 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.72 38.66 0.05 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.984 2.113 . . . . 0.0 114.808 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 176.13 4.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 0.0 113.301 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 mptt -129.8 145.53 51.57 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.008 1.323 . . . . 0.0 110.403 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.3 ttm -136.95 88.89 2.4 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.424 1.89 . . . . 0.0 110.672 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -83.42 157.46 22.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 111.044 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.91 116.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.101 1.76 . . . . 0.0 107.572 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.39 109.52 20.85 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.922 1.689 . . . . 0.0 108.4 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.24 147.16 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -127.93 170.99 12.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.214 1.805 . . . . 0.0 111.239 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.534 1.934 . . . . 0.0 113.381 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.413 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 48.2 169.79 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.916 2.086 . . . . 0.0 113.847 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.2 40.27 91.4 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 p -141.0 -170.94 3.15 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.561 1.144 . . . . 0.0 111.869 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.9 141.1 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.661 1.984 . . . . 0.0 111.024 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.499 HG12 HD21 ' A' ' 70' ' ' LEU . 1.9 pt -142.09 167.05 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.232 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.53 124.27 18.41 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.751 1.22 . . . . 0.0 112.033 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.67 -24.19 39.17 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.558 1.552 . . . . 0.0 114.055 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.95 70.31 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.474 1.11 . . . . 0.0 111.898 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.61 -19.9 44.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.714 1.605 . . . . 0.0 113.237 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.531 HD22 ' CB ' ' A' ' 68' ' ' ALA . 6.3 tp -66.97 105.99 1.8 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.241 1.416 . . . . 0.0 111.206 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 m -144.36 167.87 21.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.249 1.42 . . . . 0.0 109.676 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -46.81 -33.65 4.63 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.623 1.569 . . . . 0.0 113.251 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -58.91 -53.73 55.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.192 0.997 . . . . 0.0 111.128 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -40.5 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.945 0.898 . . . . 0.0 111.894 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 mt -59.65 -54.01 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.176 0.991 . . . . 0.0 111.759 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.55 -38.73 92.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -57.91 -48.45 79.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.256 1.022 . . . . 0.0 112.156 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -55.91 -47.58 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.367 1.067 . . . . 0.0 111.253 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.3 -42.47 95.58 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.45 1.1 . . . . 0.0 113.608 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.25 -47.77 84.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.768 0.427 . . . . 0.0 111.529 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.17 -39.18 72.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 tp -52.81 -57.27 10.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.91 2.084 . . . . 0.0 111.387 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.56 51.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.661 1.124 . . . . 0.0 112.896 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -37.65 127.69 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.514 1.926 . . . . 0.0 113.639 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 28' ' ' SER . 2.7 p -129.83 -169.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.102 1.761 . . . . 0.0 110.623 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.495 ' H ' HG22 ' A' ' 27' ' ' VAL . 28.1 m -43.63 -32.11 0.9 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.675 1.99 . . . . 0.0 115.06 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -141.69 145.91 35.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.422 1.889 . . . . 0.0 107.604 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -165.22 147.64 7.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.822 1.249 . . . . 0.0 110.432 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 2.1 pt -141.52 144.42 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.562 0.619 . . . . 0.0 111.16 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.2 116.27 30.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.243 1.017 . . . . 0.0 110.772 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 t -107.45 138.68 32.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 110.3 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.84 114.81 0.67 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.419 1.009 . . . . 0.0 112.196 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.73 104.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.436 1.094 . . . . 0.0 109.622 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -82.77 107.49 15.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.916 1.286 . . . . 0.0 112.258 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -84.12 71.38 10.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.984 1.314 . . . . 0.0 114.225 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.23 21.45 0.18 Allowed 'General case' 0 CA--C 1.558 1.286 0 O-C-N 119.778 -1.826 . . . . 0.0 115.118 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 p -57.85 -48.47 79.71 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.0 -17.36 6.0 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.565 2.031 . . . . 0.0 116.107 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.2 -104.04 1.89 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.931 1.866 . . . . 0.0 116.282 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.0 t -162.58 135.95 6.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.875 1.67 . . . . 0.0 111.671 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -115.04 167.43 10.82 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.793 1.637 . . . . 0.0 111.276 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.9 m -141.36 111.35 6.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.158 0.983 . . . . 0.0 110.292 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.33 133.8 55.6 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.895 -1.128 . . . . 0.0 108.429 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -70.88 -69.26 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -172.41 171.29 4.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 110.453 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -123.59 142.46 51.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.816 2.046 . . . . 0.0 109.301 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.55 121.0 18.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.532 1.133 . . . . 0.0 111.43 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -74.5 128.25 35.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.829 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -45.12 6.24 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.929 1.692 . . . . 0.0 111.66 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -141.58 153.97 45.15 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.186 1.794 . . . . 0.0 110.324 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.88 -170.05 53.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 121.493 0.496 . . . . 0.0 113.054 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 t -140.86 164.04 31.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 110.651 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.6 p -149.71 178.98 8.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.774 1.23 . . . . 0.0 111.18 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 25.99 4.12 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.456 1.102 . . . . 0.0 112.446 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -124.33 172.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.71 2.004 . . . . 0.0 113.535 -174.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 mt -137.02 151.59 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.246 2.219 . . . . 0.0 109.199 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -100.14 141.16 22.22 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 120.212 1.369 . . . . 0.0 110.935 176.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.05 160.45 47.24 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.94 3.094 . . . . 0.0 111.028 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -104.22 -46.23 4.48 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.328 -0.857 . . . . 0.0 112.073 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.59 132.38 46.01 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.082 1.31 . . . . 0.0 111.938 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.91 92.15 11.25 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.868 1.667 . . . . 0.0 110.2 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.31 160.66 37.83 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.118 1.879 . . . . 0.0 112.042 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -58.14 159.9 5.45 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.124 -0.985 . . . . 0.0 110.706 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p 68.67 8.7 6.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.583 1.953 . . . . 0.0 113.543 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -136.66 110.12 7.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.368 1.867 . . . . 0.0 111.99 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -84.1 164.75 19.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.606 0.762 . . . . 0.0 112.164 175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.53 173.54 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.214 0.606 . . . . 0.0 110.947 174.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.499 HD21 HG12 ' A' ' 7' ' ' ILE . 3.2 mm? -129.7 127.66 40.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.478 1.911 . . . . 0.0 107.82 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.49 154.98 41.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.882 0.873 . . . . 0.0 110.65 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -148.52 162.93 38.65 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 111.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.76 138.71 6.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.308 0.956 . . . . 0.0 111.953 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 167.57 19.91 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.823 0.849 . . . . 0.0 110.293 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -65.29 -179.62 0.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.044 0.538 . . . . 0.0 110.467 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.85 -179.95 0.23 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.63 -0.669 . . . . 0.0 110.642 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.4 m -24.65 -54.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 128.053 2.541 . . . . 0.0 116.166 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.79 -58.98 0.32 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.404 1.478 . . . . 0.0 112.797 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.91 0.09 7.66 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.779 3.653 . . . . 0.0 115.736 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.06 104.5 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.242 2.217 . . . . 0.0 112.008 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.94 77.87 1.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.632 1.573 . . . . 0.0 112.927 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.8 m -110.74 -82.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.004 1.321 . . . . 0.0 111.304 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 161.95 179.42 36.6 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.099 1.333 . . . . 0.0 111.886 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.82 114.88 10.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 110.026 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.48 130.35 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.21 167.84 25.73 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.731 0.777 . . . . 0.0 110.743 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.46 154.72 36.09 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.017 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.39 169.39 21.53 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.038 1.735 . . . . 0.0 110.838 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.15 140.53 47.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.697 1.199 . . . . 0.0 110.964 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -123.67 112.56 17.53 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.032 1.333 . . . . 0.0 111.763 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -76.66 115.68 16.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 110.738 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.5 mtm -78.98 162.68 25.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.95 0.9 . . . . 0.0 112.284 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -60.23 -19.84 56.27 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -79.71 -11.37 59.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.405 1.482 . . . . 0.0 113.007 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.27 2.49 65.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.887 1.232 . . . . 0.0 114.435 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.71 169.99 11.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.778 1.231 . . . . 0.0 110.608 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.5 m -135.98 154.69 51.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.441 1.096 . . . . 0.0 110.19 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 127.95 48.34 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.267 1.027 . . . . 0.0 109.726 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.22 114.47 4.13 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.24 126.07 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.233 1.013 . . . . 0.0 108.716 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -140.8 164.32 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.73 0.776 . . . . 0.0 112.285 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.0 p90 -140.63 151.4 44.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.767 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -130.5 116.31 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.948 1.699 . . . . 0.0 110.066 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.67 99.19 47.63 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.834 1.654 . . . . 0.0 108.77 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.76 169.08 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.31 2.674 . . . . 0.0 112.432 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -76.51 -18.61 58.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.452 0.701 . . . . 0.0 112.783 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.23 109.5 18.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.685 1.594 . . . . 0.0 110.81 -167.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -64.98 -65.41 0.68 Allowed 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.276 -0.89 . . . . 0.0 113.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -86.57 9.3 18.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.66 -6.15 6.92 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.715 2.006 . . . . 0.0 112.661 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 139.06 14.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.728 2.011 . . . . 0.0 110.141 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 t -95.94 164.51 12.69 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.625 -1.297 . . . . 0.0 112.375 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.63 159.02 25.48 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.604 0.762 . . . . 0.0 109.092 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -141.27 141.18 33.98 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.27 -0.894 . . . . 0.0 111.531 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.2 p-90 -156.14 148.62 23.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.247 1.419 . . . . 0.0 110.502 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -145.3 155.21 43.07 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.309 1.843 . . . . 0.0 109.39 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.14 116.35 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.38 1.872 . . . . 0.0 109.414 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -120.41 137.33 54.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.488 1.915 . . . . 0.0 109.298 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.7 mt -102.41 120.19 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.971 1.708 . . . . 0.0 108.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.93 147.9 51.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.493 1.517 . . . . 0.0 112.062 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 p -77.02 78.98 3.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.41 1.084 . . . . 0.0 112.574 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.28 158.48 8.47 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.076 0.846 . . . . 0.0 114.883 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 121.87 16.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.522 1.529 . . . . 0.0 112.793 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -136.63 85.54 2.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.143 1.777 . . . . 0.0 109.289 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -60.21 170.97 1.12 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.007 0.923 . . . . 0.0 111.407 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.26 92.79 4.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.627 0.771 . . . . 0.0 111.067 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -98.39 -68.75 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.548 0.739 . . . . 0.0 110.404 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.28 -70.08 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.557 1.143 . . . . 0.0 110.408 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.12 -25.05 76.38 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.059 0.838 . . . . 0.0 114.661 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -48.08 27.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.261 1.024 . . . . 0.0 110.48 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -37.34 81.79 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.099 0.959 . . . . 0.0 110.927 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -54.75 -33.35 61.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.15 -33.35 73.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.434 1.016 . . . . 0.0 112.706 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.49 -41.19 61.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.024 0.829 . . . . 0.0 110.313 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -65.36 -59.31 4.17 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.756 -1.215 . . . . 0.0 111.741 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -79.44 -19.55 49.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.189 1.396 . . . . 0.0 112.698 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -76.66 0.22 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.365 0.983 . . . . 0.0 112.598 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.37 84.15 1.59 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.67 1.188 . . . . 0.0 110.433 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.49 157.21 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.539 1.493 . . . . 0.0 111.262 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.71 4.98 49.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.684 1.194 . . . . 0.0 113.412 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.25 66.81 0.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 128.194 2.597 . . . . 0.0 113.438 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -33.48 90.77 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.398 2.904 . . . . 0.0 114.869 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -110.07 43.89 1.3 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.957 1.703 . . . . 0.0 110.349 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 58.18 42.57 21.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.548 1.539 . . . . 0.0 112.84 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.84 146.99 18.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 112.813 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -68.58 131.15 44.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.091 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -127.68 108.08 10.45 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.885 1.674 . . . . 0.0 109.293 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.31 153.09 35.49 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.285 1.434 . . . . 0.0 111.947 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -167.86 146.02 4.52 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.318 1.447 . . . . 0.0 111.004 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.67 125.5 25.99 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.443 0.565 . . . . 0.0 109.806 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.2 tp -141.01 -36.19 0.46 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.35 1.06 . . . . 0.0 112.834 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.72 20.02 5.68 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.685 1.136 . . . . 0.0 114.486 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.5 12.35 2.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.311 2.245 . . . . 0.0 115.286 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.91 -67.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.379 1.942 . . . . 0.0 110.605 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.06 147.78 27.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.925 0.89 . . . . 0.0 110.604 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.83 168.1 24.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.376 1.47 . . . . 0.0 111.924 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -96.15 139.14 32.75 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.717 0.807 . . . . 0.0 111.655 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -128.67 108.33 10.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.72 1.608 . . . . 0.0 108.427 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.46 167.67 25.74 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 121.951 0.75 . . . . 0.0 114.154 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.3 tt -149.09 142.94 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.847 2.059 . . . . 0.0 108.823 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.2 ttm -134.82 137.36 43.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.427 1.091 . . . . 0.0 108.801 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.53 156.19 33.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.6 1.16 . . . . 0.0 111.7 175.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.93 9.15 31.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.42 177.67 4.8 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.132 2.173 . . . . 0.0 112.293 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.16 55.68 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.835 0.731 . . . . 0.0 113.053 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -86.5 51.45 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.476 1.51 . . . . 0.0 113.694 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.95 17.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.777 1.231 . . . . 0.0 113.828 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.69 53.77 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 0.0 112.432 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.42 90.29 3.27 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.392 2.277 . . . . 0.0 110.954 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -84.55 143.14 29.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.86 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.42 122.49 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.458 1.903 . . . . 0.0 107.506 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -118.71 111.01 17.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.879 1.272 . . . . 0.0 109.759 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.3 mm -83.13 117.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.183 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m -89.29 174.8 7.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 0.0 111.75 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.313 1.845 . . . . 0.0 113.196 -177.417 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.22 168.08 0.57 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.36 36.11 63.28 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.563 -0.711 . . . . 0.0 113.825 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -150.82 -169.19 3.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.121 0.968 . . . . 0.0 111.152 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 63' ' ' VAL . 1.6 pt -129.71 137.63 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.538 1.935 . . . . 0.0 111.861 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pp -145.5 165.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.223 1.809 . . . . 0.0 111.472 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.22 126.7 19.64 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.155 0.982 . . . . 0.0 112.803 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.15 -21.09 30.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.087 1.327 . . . . 0.0 114.047 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.02 72.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.465 1.506 . . . . 0.0 112.324 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -34.71 66.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.386 1.074 . . . . 0.0 112.113 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.63 100.02 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.784 1.634 . . . . 0.0 112.25 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.9 m -143.08 172.01 13.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.629 1.572 . . . . 0.0 110.463 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' H ' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER -49.41 -39.74 33.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.594 1.558 . . . . 0.0 113.697 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.66 -41.97 91.77 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.598 -0.689 . . . . 0.0 112.521 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.38 -46.81 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.626 0.77 . . . . 0.0 110.044 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -53.35 -60.18 3.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.596 0.759 . . . . 0.0 111.036 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.45 -43.28 67.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.071 0.948 . . . . 0.0 112.371 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -59.43 -29.17 67.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.686 1.195 . . . . 0.0 113.533 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.3 -48.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.226 -1.546 . . . . 0.0 110.009 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.3 -34.81 66.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.959 0.504 . . . . 0.0 111.526 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.1 -57.69 6.31 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.86 -40.38 47.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.853 1.206 . . . . 0.0 114.06 -172.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.43 -23.38 66.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.346 1.058 . . . . 0.0 111.532 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 68.2 1.44 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.368 1.461 . . . . 0.0 111.214 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.35 127.83 4.67 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 110.774 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 -161.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.118 2.167 . . . . 0.0 110.049 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -41.21 -49.3 3.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.12 1.368 . . . . 0.0 113.508 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -146.31 137.16 24.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.333 1.453 . . . . 0.0 111.377 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -157.6 171.15 20.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.511 1.524 . . . . 0.0 113.952 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.83 163.21 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.456 1.102 . . . . 0.0 112.122 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.68 111.91 17.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.302 1.441 . . . . 0.0 110.471 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -97.11 145.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.649 1.58 . . . . 0.0 111.904 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.53 122.38 1.14 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.022 1.296 . . . . 0.0 111.33 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.78 112.74 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.185 1.492 . . . . 0.0 110.226 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.0 134.97 35.02 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.35 79.22 7.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.056 1.742 . . . . 0.0 113.243 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.86 2.6 53.79 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.3 t -65.55 -17.52 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.521 2.328 . . . . 0.0 114.72 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.71 4.3 89.32 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 114.74 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.58 161.31 23.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.551 1.548 . . . . 0.0 114.026 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 t -78.25 134.86 37.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.491 1.516 . . . . 0.0 112.037 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -112.12 168.08 9.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.864 2.066 . . . . 0.0 111.469 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -136.93 108.06 6.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 110.737 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.54 117.76 6.65 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.873 -1.142 . . . . 0.0 108.539 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.49 -64.46 0.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.774 0.829 . . . . 0.0 109.88 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -177.98 171.05 1.8 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.517 2.327 . . . . 0.0 110.874 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -124.72 138.82 54.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 109.096 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -128.43 110.22 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.234 1.414 . . . . 0.0 111.133 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -72.5 121.32 19.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.724 1.209 . . . . 0.0 111.477 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.77 -33.6 14.93 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.446 1.498 . . . . 0.0 112.926 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 t -145.04 162.32 37.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.598 1.559 . . . . 0.0 111.115 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.9 -160.68 29.68 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.727 0.651 . . . . 0.0 114.727 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -144.83 -178.73 6.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.444 1.498 . . . . 0.0 111.972 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -147.25 166.19 27.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.846 1.658 . . . . 0.0 110.617 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.64 6.97 20.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.591 1.156 . . . . 0.0 111.608 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.72 153.41 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 128.305 2.642 . . . . 0.0 111.038 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -122.04 140.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.502 1.521 . . . . 0.0 108.764 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.31 140.1 75.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.369 -0.832 . . . . 0.0 109.618 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 6' ' ' ILE . 69.4 Cg_endo -65.5 176.64 3.26 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.459 3.439 . . . . 0.0 110.956 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -119.19 -21.89 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.656 -1.278 . . . . 0.0 113.036 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -128.83 137.28 51.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.414 1.886 . . . . 0.0 109.792 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 6' ' ' ILE . 27.1 t -139.86 96.91 8.18 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.843 1.257 . . . . 0.0 109.715 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.88 168.57 18.36 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 112.557 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.27 159.83 5.69 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.578 -0.701 . . . . 0.0 110.148 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.273 5.6 t 57.66 15.62 2.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.638 1.975 . . . . 0.0 113.792 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -133.09 120.12 20.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.927 2.491 . . . . 0.0 110.371 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.87 163.54 13.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.674 1.19 . . . . 0.0 110.45 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.567 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.96 169.0 9.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.19 132.93 46.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.871 2.068 . . . . 0.0 108.893 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -153.13 164.04 38.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.799 1.24 . . . . 0.0 110.44 175.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 m -145.31 175.29 10.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.462 1.105 . . . . 0.0 111.207 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.58 103.66 0.24 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 125.176 1.37 . . . . 0.0 110.742 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 176.98 4.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.428 1.114 . . . . 0.0 111.572 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -66.59 -176.98 0.52 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.44 -177.02 0.27 Allowed 'General case' 0 CA--C 1.559 1.298 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -10.33 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 127.944 2.497 . . . . 0.0 116.521 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.43 -72.07 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.212 0.91 . . . . 0.0 113.038 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.99 84.07 1.72 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.757 3.638 . . . . 0.0 112.368 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.08 140.8 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.151 1.381 . . . . 0.0 112.256 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 64.59 0.84 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.015 1.326 . . . . 0.0 111.635 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.8 t -122.53 -97.22 0.45 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 110.855 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.514 ' H ' HG23 ' A' ' 82' ' ' THR . . . -174.74 -177.46 43.87 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.967 2.698 . . . . 0.0 110.883 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -141.29 99.46 3.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.111 1.364 . . . . 0.0 108.742 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' SER . 88.6 t -135.69 131.12 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.107 . . . . 0.0 108.584 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.1 166.9 31.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.57 0.748 . . . . 0.0 111.22 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.05 158.14 43.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.711 0.767 . . . . 0.0 112.42 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.46 171.18 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.648 1.979 . . . . 0.0 110.478 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.51 142.37 43.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.155 0.982 . . . . 0.0 111.174 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.567 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 1.1 m-85 -125.84 111.73 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.047 1.339 . . . . 0.0 111.33 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -73.61 114.35 11.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.004 1.321 . . . . 0.0 110.805 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.1 mtt -76.6 160.7 29.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.435 0.636 . . . . 0.0 111.364 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 t -61.66 -17.76 56.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.0 m -79.51 -13.33 59.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.014 1.726 . . . . 0.0 113.548 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.21 55.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.605 1.098 . . . . 0.0 114.835 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.88 173.43 11.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.242 1.017 . . . . 0.0 111.687 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 m -133.77 142.94 48.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.94 0.896 . . . . 0.0 108.587 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.92 125.72 54.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 108.932 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.62 148.46 24.95 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.8 130.55 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.312 1.045 . . . . 0.0 109.255 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.65 45.88 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 22.8 p90 -127.01 153.27 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.147 1.379 . . . . 0.0 110.696 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 85' ' ' VAL . 19.9 t -136.9 111.45 8.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.497 1.119 . . . . 0.0 111.49 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 32.1 t -115.02 102.18 54.75 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.51 1.924 . . . . 0.0 109.344 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.01 171.25 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.841 2.361 . . . . 0.0 112.542 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -72.39 -53.83 11.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.326 . . . . 0.0 110.632 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.01 107.48 7.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.227 3.411 . . . . 0.0 112.398 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.19 -60.16 3.79 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.274 1.03 . . . . 0.0 113.539 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.59 9.45 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -4.15 6.85 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.566 1.947 . . . . 0.0 112.456 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.2 146.04 26.61 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.395 2.278 . . . . 0.0 109.496 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.92 165.31 11.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.365 1.066 . . . . 0.0 111.869 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.44 156.93 18.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.666 -0.646 . . . . 0.0 110.112 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -140.5 146.14 37.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.35 0.66 . . . . 0.0 109.92 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -147.97 155.6 41.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.991 1.316 . . . . 0.0 110.021 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.56 138.23 20.93 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.846 -0.534 . . . . 0.0 111.62 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.7 t -147.74 103.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.334 1.854 . . . . 0.0 110.102 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -120.6 143.37 48.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.036 1.335 . . . . 0.0 110.065 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.51 111.6 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.249 1.819 . . . . 0.0 108.756 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -116.33 141.47 48.11 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.711 1.604 . . . . 0.0 111.853 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.7 p -72.48 80.55 1.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.288 1.435 . . . . 0.0 113.104 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.06 159.56 8.64 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.221 1.391 . . . . 0.0 113.321 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -73.79 133.94 43.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.466 0.707 . . . . 0.0 112.383 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -141.9 143.15 33.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.515 1.926 . . . . 0.0 111.215 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -99.32 -179.35 4.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.662 1.585 . . . . 0.0 110.942 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.9 95.9 4.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.206 1.803 . . . . 0.0 110.177 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.79 -71.08 0.78 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.903 1.281 . . . . 0.0 110.559 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.48 -69.79 0.24 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.323 1.849 . . . . 0.0 109.637 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.54 73.27 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.638 1.113 . . . . 0.0 115.241 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -84.2 -45.82 12.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.182 0.991 . . . . 0.0 110.872 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.15 -44.01 96.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.995 0.918 . . . . 0.0 112.393 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.77 -29.23 69.29 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.025 -1.047 . . . . 0.0 112.441 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -16.06 60.42 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.192 -0.943 . . . . 0.0 112.499 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.66 -55.58 2.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 108.44 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -69.03 -48.14 63.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -87.62 -15.21 37.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.746 0.819 . . . . 0.0 112.743 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.78 60.18 4.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.575 1.083 . . . . 0.0 114.208 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 42.75 76.97 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 127.046 2.138 . . . . 0.0 111.754 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.64 149.04 73.37 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.783 1.655 . . . . 0.0 110.827 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.89 156.7 36.12 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.951 0.881 . . . . 0.0 110.489 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 115.42 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 109.207 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.61 67.01 0.78 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.323 1.439 . . . . 0.0 113.511 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.75 25.36 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.786 2.034 . . . . 0.0 114.386 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 54.72 41.71 31.73 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.994 1.717 . . . . 0.0 113.063 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.4 167.51 24.15 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.656 2.074 . . . . 0.0 112.232 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -75.34 128.56 35.68 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.593 -0.945 . . . . 0.0 111.592 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -120.1 112.86 19.65 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.481 ' HG2' HH21 ' A' ' 156' ' ' ARG . 1.3 pm0 -153.88 148.59 26.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 111.507 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -161.88 147.08 13.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.038 1.335 . . . . 0.0 111.4 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -62.97 123.05 17.54 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.926 -0.484 . . . . 0.0 110.972 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -142.84 -31.6 0.5 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.263 1.025 . . . . 0.0 113.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.85 17.26 16.82 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.963 1.268 . . . . 0.0 114.541 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.2 t80 59.87 10.31 2.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.416 2.287 . . . . 0.0 114.697 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.9 -67.32 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.647 1.594 . . . . 0.0 110.606 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.35 156.54 16.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.577 0.703 . . . . 0.0 111.626 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.481 HH21 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -143.94 165.88 26.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.067 1.747 . . . . 0.0 112.719 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -92.44 133.59 35.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.85 1.26 . . . . 0.0 110.143 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -123.11 106.79 11.09 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.718 1.207 . . . . 0.0 109.339 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-O 122.38 0.989 . . . . 0.0 114.65 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.64 145.29 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.974 2.11 . . . . 0.0 108.186 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.8 131.3 33.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.234 1.814 . . . . 0.0 106.687 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 166.83 19.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.108 0.963 . . . . 0.0 112.079 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 m -95.13 11.6 31.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.661 1.584 . . . . 0.0 113.793 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.13 167.95 10.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 112.368 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.05 26.4 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 121.348 -0.845 . . . . 0.0 112.992 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.16 47.51 0.46 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.503 1.521 . . . . 0.0 113.715 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.46 161.39 27.82 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.716 -1.24 . . . . 0.0 113.44 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.08 133.99 55.47 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 108.913 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.1 ttp -128.53 110.46 12.3 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.494 1.518 . . . . 0.0 111.081 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -122.65 140.98 52.23 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.626 -0.671 . . . . 0.0 109.654 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.7 111.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.754 1.622 . . . . 0.0 109.729 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -100.44 105.37 16.84 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.409 1.484 . . . . 0.0 108.368 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.6 mm -74.06 136.23 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.0 t -151.09 167.18 28.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.956 . . . . 0.0 112.108 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.263 2.225 . . . . 0.0 110.344 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.625 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.21 150.33 39.22 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.111 -0.993 . . . . 0.0 111.381 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.94 34.18 87.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 p -142.52 -165.08 1.96 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.596 1.198 . . . . 0.0 111.539 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.36 144.1 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.891 1.676 . . . . 0.0 110.991 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.0 168.88 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.079 1.352 . . . . 0.0 112.18 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 120.67 7.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.105 1.362 . . . . 0.0 111.555 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.14 -25.36 64.37 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.156 0.884 . . . . 0.0 113.11 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.05 68.62 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.174 1.389 . . . . 0.0 113.078 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -96.29 -16.41 21.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.147 1.379 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.5 tp -68.64 107.22 2.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.15 1.38 . . . . 0.0 110.233 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -145.5 169.92 17.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.275 1.03 . . . . 0.0 109.883 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -50.85 -31.53 17.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.878 1.271 . . . . 0.0 113.703 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -61.74 -36.24 80.43 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.358 0.663 . . . . 0.0 112.567 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -39.97 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.782 1.233 . . . . 0.0 111.104 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.28 -47.84 77.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.031 0.932 . . . . 0.0 112.03 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.02 -49.32 76.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.061 0.544 . . . . 0.0 111.69 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -58.53 -36.79 74.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 34.2 t -63.79 -59.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.211 1.404 . . . . 0.0 111.237 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.43 -38.09 73.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.815 1.246 . . . . 0.0 112.141 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -41.33 67.52 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.008 0.822 . . . . 0.0 111.953 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.68 -37.07 65.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 57' ' ' VAL . 11.2 tp -48.39 -52.77 20.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.496 1.518 . . . . 0.0 111.638 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.15 58.67 0.15 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.699 1.143 . . . . 0.0 111.002 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 142.33 6.06 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.253 1.421 . . . . 0.0 112.444 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.78 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 109.711 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.3 m -45.0 -31.23 1.22 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.311 1.844 . . . . 0.0 115.525 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.93 134.89 17.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.487 1.515 . . . . 0.0 109.222 174.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.43 161.04 30.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.371 2.268 . . . . 0.0 110.628 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -139.21 166.22 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.732 1.613 . . . . 0.0 110.326 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.54 110.55 14.6 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.751 1.22 . . . . 0.0 110.866 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.91 138.6 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.8 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 112.18 0.54 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.535 1.064 . . . . 0.0 112.911 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.2 109.87 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.456 1.128 . . . . 0.0 109.214 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -87.81 110.76 20.73 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 112.41 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -71.45 98.1 1.76 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.271 1.428 . . . . 0.0 111.31 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.93 12.75 15.82 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.942 1.697 . . . . 0.0 113.34 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 t -62.68 -54.51 38.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.559 1.144 . . . . 0.0 114.001 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.3 2.36 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.949 1.261 . . . . 0.0 116.166 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.48 163.36 29.9 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.625 1.712 . . . . 0.0 114.03 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.4 p -74.09 138.85 44.22 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.108 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -112.76 167.73 10.25 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.304 1.442 . . . . 0.0 112.236 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -140.14 106.25 5.22 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.016 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 125.55 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.88 -1.138 . . . . 0.0 108.667 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.56 -62.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.636 1.174 . . . . 0.0 110.384 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -176.87 174.9 1.7 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.825 2.45 . . . . 0.0 110.644 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.8 146.6 50.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.223 2.209 . . . . 0.0 109.492 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.15 113.33 13.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.146 1.378 . . . . 0.0 111.406 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -73.49 122.92 22.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.78 1.232 . . . . 0.0 110.188 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.95 -38.6 7.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.825 1.65 . . . . 0.0 112.633 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 m -136.92 152.14 49.86 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.653 1.581 . . . . 0.0 109.929 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.13 50.05 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 123.925 0.774 . . . . 0.0 114.88 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -135.81 145.65 46.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 111.54 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -133.26 125.52 29.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.348 1.059 . . . . 0.0 108.747 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.4 -1.04 31.54 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.327 1.051 . . . . 0.0 112.943 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 3' ' ' ALA . 23.4 m -110.89 174.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.812 1.645 . . . . 0.0 113.045 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.11 139.88 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.917 1.687 . . . . 0.0 108.801 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 146.01 86.63 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-N 119.578 1.081 . . . . 0.0 110.86 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.35 167.17 25.99 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.575 3.516 . . . . 0.0 111.277 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -107.64 -24.27 11.81 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.416 -1.427 . . . . 0.0 113.487 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -125.81 133.3 52.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.433 1.493 . . . . 0.0 111.061 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.8 t -133.84 94.63 18.43 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.589 1.556 . . . . 0.0 109.891 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.26 161.36 34.52 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.595 1.53 . . . . 0.0 111.868 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -63.31 160.12 16.58 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.726 -0.609 . . . . 0.0 110.724 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 68.0 -0.85 1.92 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.045 2.138 . . . . 0.0 114.418 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.284 1.833 . . . . 0.0 111.738 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -128.5 160.79 31.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.971 1.308 . . . . 0.0 111.68 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.85 174.94 6.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 174.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.4 133.0 41.84 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.464 1.906 . . . . 0.0 108.394 174.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -153.99 164.19 38.84 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.112 0.965 . . . . 0.0 112.589 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -150.48 164.25 36.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.914 1.286 . . . . 0.0 111.014 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.97 118.1 1.08 Allowed Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.275 1.417 . . . . 0.0 111.067 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' C ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -129.33 161.56 29.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.714 1.257 . . . . 0.0 110.696 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -174.25 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.859 0.464 . . . . 0.0 110.102 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.96 -143.02 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 O-C-N 121.277 -0.89 . . . . 0.0 113.015 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -40.89 -38.33 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 119.044 -2.285 . . . . 0.0 114.796 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.26 -60.94 0.47 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.566 1.555 . . . . 0.0 112.774 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.22 -3.68 11.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.99 3.794 . . . . 0.0 116.156 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.8 160.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.438 1.095 . . . . 0.0 111.717 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.87 66.43 1.03 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.244 1.017 . . . . 0.0 111.24 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.6 m -126.72 -85.32 0.61 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.83 1.252 . . . . 0.0 112.049 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.59 -177.21 32.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.116 1.341 . . . . 0.0 112.33 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.525 ' HB2' ' C ' ' A' ' 74' ' ' ARG . . . -135.05 125.58 26.77 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.76 121.24 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -137.44 152.59 49.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.441 0.696 . . . . 0.0 110.737 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.7 47.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.82 0.848 . . . . 0.0 111.469 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 171.06 15.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.508 1.523 . . . . 0.0 110.307 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.52 138.09 50.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.159 0.983 . . . . 0.0 110.203 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.3 m-85 -119.31 118.61 31.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.709 1.204 . . . . 0.0 111.081 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -83.12 113.36 20.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.162 1.385 . . . . 0.0 110.787 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.5 mtt -70.15 162.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.057 0.943 . . . . 0.0 111.315 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.9 p -61.27 -22.63 65.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 114.102 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t -82.98 -14.57 53.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.46 1.904 . . . . 0.0 113.007 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.14 56.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.284 1.421 . . . . 0.0 115.069 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -80.18 164.34 23.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.618 1.167 . . . . 0.0 109.518 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.0 m -122.95 143.24 50.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.817 0.847 . . . . 0.0 110.193 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.55 115.7 23.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 128.34 8.43 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 117' ' ' VAL . 5.1 m -130.63 128.93 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.679 0.792 . . . . 0.0 109.539 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.11 154.8 49.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 175.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.3 p90 -134.05 153.9 51.5 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.701 1.201 . . . . 0.0 110.639 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.2 t -137.31 114.55 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.078 2.151 . . . . 0.0 108.931 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 21.8 t -111.76 95.2 27.16 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 128.683 2.793 . . . . 0.0 106.95 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.97 -168.66 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.509 2.14 . . . . 0.0 111.454 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -108.69 -43.46 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.995 0.918 . . . . 0.0 112.154 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.68 127.19 32.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.105 1.762 . . . . 0.0 112.36 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -58.22 3.44 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -100.25 11.55 39.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.255 1.422 . . . . 0.0 113.917 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.23 0.87 7.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.108 2.163 . . . . 0.0 111.917 -175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.43 178.36 10.24 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.753 2.421 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 t -154.8 164.78 38.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.223 1.409 . . . . 0.0 110.932 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 112.72 24.77 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.01 -1.056 . . . . 0.0 111.181 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.58 136.32 38.85 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -142.92 145.23 32.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.658 1.183 . . . . 0.0 111.214 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -137.0 139.37 41.37 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.391 1.077 . . . . 0.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 100' ' ' VAL . 84.8 t -136.06 110.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.121 1.768 . . . . 0.0 109.981 175.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -126.84 133.51 50.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.763 1.625 . . . . 0.0 110.189 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 mt -97.83 129.79 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.756 1.622 . . . . 0.0 108.592 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -133.63 144.18 49.07 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.822 . . . . 0.0 112.902 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 p -75.02 92.21 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.167 1.787 . . . . 0.0 113.102 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.7 -179.15 21.32 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.314 1.435 . . . . 0.0 112.483 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 145.21 25.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.626 1.17 . . . . 0.0 111.713 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -163.48 164.57 24.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.778 1.631 . . . . 0.0 111.002 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -140.55 156.16 46.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.243 1.417 . . . . 0.0 110.862 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 92.26 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.655 0.782 . . . . 0.0 111.019 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.67 -72.05 0.71 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.145 1.378 . . . . 0.0 110.583 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 -71.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 108.091 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.43 -42.93 57.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.379 0.99 . . . . 0.0 113.999 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.4 tpt -74.22 -50.08 20.67 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.498 1.149 . . . . 0.0 112.628 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -48.22 80.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.906 0.483 . . . . 0.0 110.061 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.16 -33.6 76.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.77 -28.68 70.15 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.508 1.504 . . . . 0.0 112.051 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.79 -40.21 12.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.562 0.745 . . . . 0.0 111.453 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -78.49 -42.32 29.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.427 -1.421 . . . . 0.0 114.104 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -96.29 -12.97 23.71 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.043 -1.036 . . . . 0.0 112.798 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.51 -77.22 0.16 Allowed Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.577 1.084 . . . . 0.0 112.083 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -175.06 69.05 0.27 Allowed Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 127.531 2.333 . . . . 0.0 110.608 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.76 130.38 18.02 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.789 0.993 . . . . 0.0 111.106 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.22 124.36 22.89 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 15.51 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.013 2.125 . . . . 0.0 114.425 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 52.97 59.1 9.84 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.3 1.429 . . . . 0.0 112.319 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.16 16.91 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 67.57 29.75 6.98 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.748 2.019 . . . . 0.0 112.97 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.1 158.16 23.79 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.809 1.671 . . . . 0.0 113.832 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -72.74 131.1 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.783 1.233 . . . . 0.0 112.034 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -122.88 108.48 13.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.747 2.019 . . . . 0.0 111.016 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.75 153.59 45.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.184 1.793 . . . . 0.0 110.782 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.99 138.99 1.35 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.63 1.172 . . . . 0.0 110.268 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -60.54 134.77 57.4 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.276 0.489 . . . . 0.0 111.403 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.54 -30.53 0.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.79 24.41 5.18 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.001 1.286 . . . . 0.0 114.623 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 t80 58.67 15.15 3.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.44 2.296 . . . . 0.0 114.708 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 176.42 -77.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.833 1.683 . . . . 0.0 110.976 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 174' ' ' SER . 3.2 mm? -77.35 145.8 37.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.401 1.081 . . . . 0.0 110.459 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.99 168.41 20.05 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.5 1.52 . . . . 0.0 112.162 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . 0.41 ' HA ' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -81.48 142.54 32.82 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.912 1.285 . . . . 0.0 111.239 174.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -140.08 107.06 5.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.589 1.956 . . . . 0.0 108.523 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.6 168.02 26.02 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-O 121.503 0.502 . . . . 0.0 114.206 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.0 tt -143.49 142.82 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.322 1.849 . . . . 0.0 109.011 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.0 ttt -145.59 151.09 37.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.945 1.698 . . . . 0.0 108.479 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.8 p -88.26 165.07 15.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.425 0.69 . . . . 0.0 111.548 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.8 m -80.71 9.56 6.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 112.819 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.08 157.22 17.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.843 2.057 . . . . 0.0 111.382 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.01 3.16 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 119.311 0.959 . . . . 0.0 111.868 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.58 87.97 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.894 0.878 . . . . 0.0 109.507 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.92 146.86 50.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.0 1.32 . . . . 0.0 112.31 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -91.67 129.89 37.56 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.3 ttm -127.06 83.46 2.17 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.672 1.989 . . . . 0.0 109.503 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -89.07 144.48 26.11 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.677 -0.639 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 59.1 mt -127.23 124.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.954 1.702 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -114.09 107.23 15.36 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.173 1.789 . . . . 0.0 109.182 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 157' ' ' MET . 35.8 mm -88.95 103.94 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.633 0.73 . . . . 0.0 110.794 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.537 ' HA ' HD12 ' A' ' 155' ' ' LEU . 1.7 p -153.27 173.78 15.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.639 1.575 . . . . 0.0 112.571 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.347 1.859 . . . . 0.0 111.429 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.477 0.875 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . -41.73 146.11 0.27 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.051 1.74 . . . . 0.0 115.286 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.07 38.75 34.28 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.583 1.087 . . . . 0.0 113.985 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.0 p -145.25 -170.6 3.47 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 118.732 1.266 . . . . 0.0 111.895 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.4 pt -118.51 142.51 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.776 2.03 . . . . 0.0 110.479 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 pt -145.63 162.48 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.26 1.424 . . . . 0.0 111.813 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.36 126.5 27.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.725 0.81 . . . . 0.0 110.863 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.93 -23.08 60.98 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.299 0.952 . . . . 0.0 113.059 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.57 91.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.98 1.312 . . . . 0.0 112.085 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 m -79.92 -24.02 41.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.763 1.225 . . . . 0.0 113.541 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.32 97.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.062 1.345 . . . . 0.0 112.2 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -145.52 172.46 13.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.926 1.69 . . . . 0.0 110.17 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -46.56 -39.83 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.155 1.382 . . . . 0.0 114.6 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -56.62 -43.68 80.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.563 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.15 -45.2 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.274 1.03 . . . . 0.0 111.072 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 mt -56.05 -50.01 72.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.547 0.612 . . . . 0.0 111.492 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.33 -42.47 92.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -52.83 60.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 111.809 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.761 HG21 HD21 ' A' ' 70' ' ' LEU . 82.7 t -56.71 -49.21 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.728 1.211 . . . . 0.0 110.404 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -43.11 62.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.727 0.811 . . . . 0.0 112.399 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.4 -53.25 14.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.892 1.277 . . . . 0.0 112.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -72.41 -29.26 63.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.536 1.534 . . . . 0.0 114.254 -171.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.492 HD22 ' HZ1' ' A' ' 30' ' ' LYS . 7.0 tt -63.61 -53.93 43.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.591 1.557 . . . . 0.0 110.589 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.45 75.24 0.2 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.268 1.413 . . . . 0.0 111.926 -169.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 139.95 2.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.496 1.518 . . . . 0.0 111.887 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.05 -177.85 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 126.754 2.021 . . . . 0.0 109.725 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -45.78 -42.86 12.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.287 1.835 . . . . 0.0 115.151 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -148.79 141.37 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.31 1.444 . . . . 0.0 111.371 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HZ1' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -170.5 168.94 7.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.584 1.953 . . . . 0.0 112.32 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.13 161.15 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.613 1.165 . . . . 0.0 110.637 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.18 106.95 13.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.406 1.482 . . . . 0.0 109.882 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.48 140.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.333 1.453 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.58 120.56 1.0 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.706 1.146 . . . . 0.0 111.992 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -112.28 97.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 109.373 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 7.1 t70 -75.89 114.12 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.205 1.402 . . . . 0.0 113.513 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.09 96.75 9.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.267 1.427 . . . . 0.0 111.227 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -124.17 34.33 5.07 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.239 1.816 . . . . 0.0 110.186 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 t -80.34 -51.0 9.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.948 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.14 15.02 1.93 Allowed Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.83 160.6 32.57 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.53 1.665 . . . . 0.0 114.085 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.5 p -73.41 138.32 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.983 -0.716 . . . . 0.0 111.919 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.38 165.72 11.55 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.495 1.118 . . . . 0.0 111.457 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 m -133.78 115.58 14.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.084 1.354 . . . . 0.0 108.739 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 136.87 57.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.199 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -70.08 0.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -179.19 175.19 0.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.403 2.281 . . . . 0.0 110.285 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.1 147.16 51.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.377 2.271 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.17 109.79 9.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.912 1.285 . . . . 0.0 110.638 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -71.43 116.57 11.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.726 1.21 . . . . 0.0 110.779 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -45.86 9.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.655 1.182 . . . . 0.0 112.123 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.1 m -137.37 146.94 45.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.087 1.755 . . . . 0.0 110.457 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 76' ' ' ASP . . . 83.2 -163.98 41.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.682 0.658 . . . . 0.0 113.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.45 174.64 14.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.265 1.026 . . . . 0.0 111.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -143.94 173.23 11.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.195 0.998 . . . . 0.0 112.009 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.84 11.65 11.91 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.618 1.567 . . . . 0.0 112.061 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.57 166.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.226 2.21 . . . . 0.0 111.351 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.97 133.36 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.971 1.308 . . . . 0.0 109.943 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.94 152.67 90.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 119.533 1.06 . . . . 0.0 112.326 176.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.53 171.61 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.414 3.41 . . . . 0.0 110.313 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.0 tt0 -111.05 -18.87 12.93 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -124.62 131.18 53.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.85 1.66 . . . . 0.0 110.26 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.98 98.14 6.91 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.675 1.19 . . . . 0.0 109.639 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.67 164.82 25.15 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.728 1.619 . . . . 0.0 112.573 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -62.28 157.72 18.92 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.493 -0.754 . . . . 0.0 110.393 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p 68.67 -0.02 2.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.568 1.947 . . . . 0.0 114.248 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -125.45 145.81 49.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 110.723 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . . . -120.46 169.16 10.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.922 1.689 . . . . 0.0 110.826 176.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -104.22 177.52 4.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.876 0.846 . . . . 0.0 110.187 174.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.761 HD21 HG21 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -131.23 128.78 40.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.371 1.868 . . . . 0.0 108.747 176.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -149.22 163.8 36.6 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.512 0.725 . . . . 0.0 111.951 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -149.8 172.51 15.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.559 1.144 . . . . 0.0 111.199 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -157.67 106.19 0.29 Allowed Glycine 0 N--CA 1.47 0.922 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.735 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 162.97 14.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.07 1.348 . . . . 0.0 112.75 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.66 105.28 17.25 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.333 -0.855 . . . . 0.0 110.944 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 23.4 t0 33.26 -134.58 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.918 2.487 . . . . 0.0 112.928 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -39.58 80.94 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.164 -1.585 . . . . 0.0 112.138 174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.39 -62.28 0.53 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.566 1.555 . . . . 0.0 112.993 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.94 -3.71 7.52 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 125.001 3.801 . . . . 0.0 116.494 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.96 168.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.778 1.231 . . . . 0.0 112.267 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.22 68.61 1.41 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.652 1.181 . . . . 0.0 111.644 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -120.7 -89.35 0.61 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.258 1.423 . . . . 0.0 110.839 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.51 174.55 35.21 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.285 1.422 . . . . 0.0 111.315 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -133.19 111.77 11.16 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 110.122 175.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -139.34 120.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.83 168.21 20.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.841 0.857 . . . . 0.0 110.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.21 155.95 42.53 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.83 173.72 12.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.964 2.106 . . . . 0.0 110.716 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.96 149.7 45.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.275 1.03 . . . . 0.0 111.398 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -131.39 117.13 18.46 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.016 1.327 . . . . 0.0 111.624 -176.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -79.39 108.85 13.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.502 1.521 . . . . 0.0 110.213 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mtt -71.06 162.7 28.99 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.575 0.703 . . . . 0.0 111.612 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -59.69 -21.32 60.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.924 1.69 . . . . 0.0 113.956 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.5 m -79.93 -12.4 59.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.631 1.972 . . . . 0.0 113.208 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 6.2 65.73 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.94 1.257 . . . . 0.0 115.072 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -90.74 170.45 10.11 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.517 1.127 . . . . 0.0 110.496 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.6 m -131.68 149.38 52.5 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.136 0.969 . . . . 0.0 110.94 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 122.74 42.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.195 1.398 . . . . 0.0 109.037 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 139.4 24.4 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.15 122.16 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.781 1.291 . . . . 0.0 109.03 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.4 ptm -127.81 158.76 36.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.606 0.762 . . . . 0.0 112.109 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.7 p90 -131.78 150.74 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.213 1.405 . . . . 0.0 110.244 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.73 100.7 4.26 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.895 1.278 . . . . 0.0 110.524 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 42.2 t -94.69 104.27 13.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 127.332 2.253 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.08 169.69 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.147 2.565 . . . . 0.0 112.718 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -89.87 -37.0 14.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.68 111.65 23.96 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.895 1.678 . . . . 0.0 111.273 -163.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -66.8 -56.86 8.54 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.754 -1.216 . . . . 0.0 113.8 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -94.31 12.83 25.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.644 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.91 -14.76 3.08 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.328 1.851 . . . . 0.0 113.068 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.95 -179.32 6.28 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.832 3.253 . . . . 0.0 109.446 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.56 167.73 23.78 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.931 1.292 . . . . 0.0 111.016 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.57 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.586 -0.697 . . . . 0.0 111.188 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -139.67 147.73 41.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.741 1.216 . . . . 0.0 111.205 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.41 148.82 20.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -141.86 149.01 39.7 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.085 1.312 . . . . 0.0 111.603 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -143.97 86.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.559 1.543 . . . . 0.0 113.584 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -88.4 138.91 31.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.225 1.01 . . . . 0.0 108.504 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mt -108.23 114.65 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.547 1.539 . . . . 0.0 108.68 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -127.53 136.44 51.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.326 1.451 . . . . 0.0 112.464 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 p -78.08 84.28 4.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.284 1.434 . . . . 0.0 112.294 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.24 -175.45 37.86 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.3 0.952 . . . . 0.0 113.418 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -112.91 107.02 15.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.427 1.891 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -140.55 167.97 20.9 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.518 1.927 . . . . 0.0 111.344 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.92 166.97 26.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.973 1.709 . . . . 0.0 112.486 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.32 84.96 4.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.294 1.438 . . . . 0.0 111.232 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.28 -64.61 1.03 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.786 0.834 . . . . 0.0 110.843 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -152.2 -77.0 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.144 2.178 . . . . 0.0 108.501 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.6 -24.87 71.33 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.338 0.97 . . . . 0.0 115.022 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -56.49 4.66 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.667 1.234 . . . . 0.0 110.506 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.33 -38.89 78.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.485 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -58.42 -38.72 77.98 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.341 0.973 . . . . 0.0 112.668 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.01 -38.67 89.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.646 0.657 . . . . 0.0 111.904 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -34.34 64.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.456 0.702 . . . . 0.0 111.166 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.49 -47.87 37.78 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.52 -1.363 . . . . 0.0 112.823 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -94.6 -15.99 23.59 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.946 0.898 . . . . 0.0 113.285 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -70.64 0.9 Allowed Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.309 0.957 . . . . 0.0 112.664 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -178.17 77.47 0.23 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.807 2.443 . . . . 0.0 109.658 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.04 128.18 18.2 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.56 -1.361 . . . . 0.0 108.56 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.48 150.55 26.48 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.574 1.178 . . . . 0.0 110.311 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 120.61 28.02 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.462 1.105 . . . . 0.0 108.687 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.8 55.95 1.34 Allowed Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.197 1.379 . . . . 0.0 113.976 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.4 25.71 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.229 1.812 . . . . 0.0 115.462 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.267 12.0 p30 52.84 31.72 11.16 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.154 2.182 . . . . 0.0 114.57 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.77 175.9 18.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.721 2.105 . . . . 0.0 113.092 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -79.63 122.88 27.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.04 0.936 . . . . 0.0 111.759 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -114.34 116.2 28.58 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.431 1.892 . . . . 0.0 109.452 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -142.93 146.12 33.69 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.6 1.16 . . . . 0.0 110.777 175.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -147.19 121.53 9.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.874 1.27 . . . . 0.0 111.747 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.12 93.92 1.47 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.153 1.381 . . . . 0.0 112.269 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.24 8.82 0.94 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -94.68 21.6 42.35 Favored Glycine 0 N--CA 1.476 1.334 0 O-C-N 120.623 -1.298 . . . . 0.0 115.341 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 65.35 9.32 5.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.388 1.875 . . . . 0.0 115.022 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.65 -40.84 0.21 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.546 1.546 . . . . 0.0 113.997 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.42 150.53 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 110.388 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 167.16 21.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.815 0.846 . . . . 0.0 112.904 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.36 139.77 30.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 109.898 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -130.37 115.26 16.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.02 172.14 25.29 Favored Glycine 0 C--O 1.23 -0.12 0 CA-C-O 121.901 0.723 . . . . 0.0 113.494 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 tt -138.54 131.88 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 109.318 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 8.7 ttt -129.1 143.07 50.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.183 1.793 . . . . 0.0 107.021 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.29 154.16 19.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.071 1.749 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.6 m -92.59 27.26 2.36 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.108 1.363 . . . . 0.0 112.715 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.39 170.71 8.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.518 1.927 . . . . 0.0 111.58 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.41 -62.09 5.14 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.289 -0.882 . . . . 0.0 112.823 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.52 51.11 1.4 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.406 1.882 . . . . 0.0 111.73 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.63 175.85 3.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.69 1.596 . . . . 0.0 112.443 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -134.67 154.11 51.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.285 1.434 . . . . 0.0 109.161 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.6 ttp -142.69 85.31 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.164 0.986 . . . . 0.0 111.969 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.36 142.04 28.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.263 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 58.7 mt -125.18 123.52 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.605 1.962 . . . . 0.0 107.697 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.37 117.28 33.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.31 130.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.953 0.501 . . . . 0.0 110.452 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.3 m -144.5 167.82 21.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 112.89 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.645 2.378 . . . . 0.0 113.594 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mm? . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 141.88 58.12 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.963 0.905 . . . . 0.0 112.576 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.68 40.29 85.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.304 0.954 . . . . 0.0 114.825 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.7 p -144.92 -171.48 3.64 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.163 0.982 . . . . 0.0 112.573 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.501 HG23 ' HG3' ' A' ' 60' ' ' PRO . 8.1 pt -127.0 138.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.214 2.205 . . . . 0.0 111.662 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 pt -148.1 170.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.109 1.764 . . . . 0.0 111.904 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.97 116.91 2.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.611 1.564 . . . . 0.0 112.335 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.78 -23.86 67.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.553 0.597 . . . . 0.0 113.266 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.49 81.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.521 1.128 . . . . 0.0 113.076 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -86.49 -13.16 46.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.798 1.239 . . . . 0.0 114.091 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.439 HD22 ' CB ' ' A' ' 68' ' ' ALA . 17.5 tp -68.95 113.65 6.54 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.23 1.012 . . . . 0.0 111.102 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -144.35 166.63 24.55 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 110.578 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.21 -37.29 22.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 114.64 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -60.75 -45.02 95.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.225 0.61 . . . . 0.0 111.79 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -57.07 -46.3 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.906 1.283 . . . . 0.0 110.492 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.8 -48.45 63.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.205 1.002 . . . . 0.0 112.594 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.35 -43.81 76.65 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.425 -0.797 . . . . 0.0 111.864 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.12 -40.76 74.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.201 1.4 . . . . 0.0 113.081 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 70' ' ' LEU . 53.1 t -52.9 -59.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.506 1.922 . . . . 0.0 109.984 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.39 -43.47 98.81 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.558 1.943 . . . . 0.0 112.757 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -51.15 -53.58 33.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.28 1.032 . . . . 0.0 112.086 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -78.4 -35.02 47.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -42.09 62.66 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.12 1.368 . . . . 0.0 111.074 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.09 58.69 0.87 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -59.32 171.65 0.75 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.737 1.215 . . . . 0.0 111.775 175.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -162.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.808 1.243 . . . . 0.0 110.324 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -46.65 -41.28 14.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.614 1.566 . . . . 0.0 112.96 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 137.16 49.1 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.637 1.575 . . . . 0.0 111.136 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 162.24 36.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 112.44 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG22 ' HB3' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -141.48 151.95 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.885 1.674 . . . . 0.0 109.592 174.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.87 126.69 50.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.917 1.687 . . . . 0.0 107.452 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.43 132.61 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.354 1.462 . . . . 0.0 110.217 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.62 119.98 1.34 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.071 1.319 . . . . 0.0 111.249 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 69' ' ' LEU . 12.2 mt -111.8 100.76 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -74.96 102.85 4.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.909 1.283 . . . . 0.0 111.502 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -70.98 96.47 1.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.916 0.887 . . . . 0.0 112.039 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.77 16.47 9.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.131 1.772 . . . . 0.0 112.592 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.1 p -67.84 -41.21 83.34 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.858 -1.151 . . . . 0.0 113.808 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 12.82 3.94 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.27 162.63 30.7 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.765 1.783 . . . . 0.0 114.347 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -71.29 132.69 45.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 0.0 112.87 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -106.61 163.6 12.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 111.6 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.7 m -129.72 114.05 15.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.683 1.193 . . . . 0.0 109.699 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.46 129.07 38.98 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.507 -0.746 . . . . 0.0 109.315 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -68.32 0.44 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.943 0.497 . . . . 0.0 109.868 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 179.41 173.56 0.83 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.63 2.372 . . . . 0.0 110.483 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -129.13 146.83 50.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.764 2.026 . . . . 0.0 109.308 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.89 115.92 15.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.292 1.437 . . . . 0.0 110.626 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -78.52 115.78 18.46 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.054 1.342 . . . . 0.0 111.037 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -92.93 -39.28 11.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.107 0.963 . . . . 0.0 112.795 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.3 m -141.63 151.79 43.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.84 2.056 . . . . 0.0 110.372 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.04 -171.57 54.43 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.749 0.69 . . . . 0.0 113.87 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -136.39 173.77 11.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.933 1.293 . . . . 0.0 112.275 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -143.34 171.01 14.7 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.752 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.67 10.2 8.39 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.697 1.199 . . . . 0.0 112.396 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.06 170.35 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.488 2.315 . . . . 0.0 113.362 -171.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.75 140.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 127.196 2.199 . . . . 0.0 109.731 -172.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -78.99 156.22 77.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.119 0.872 . . . . 0.0 111.858 176.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' HG23 ' A' ' 6' ' ' ILE . 39.1 Cg_endo -69.52 176.01 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.332 3.355 . . . . 0.0 110.457 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.8 tt0 -118.04 -22.84 7.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.198 -0.939 . . . . 0.0 113.077 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.9 123.18 41.88 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.7 1.6 . . . . 0.0 110.416 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.1 93.32 26.83 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.859 1.264 . . . . 0.0 110.298 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.9 165.32 21.65 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.328 2.019 . . . . 0.0 112.51 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.87 160.18 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.212 0.605 . . . . 0.0 110.19 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 t 56.41 13.74 1.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 128.365 2.666 . . . . 0.0 113.857 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.61 136.65 46.66 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 127.006 2.123 . . . . 0.0 109.653 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.439 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -117.84 161.07 20.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.381 1.072 . . . . 0.0 111.407 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -101.34 169.11 9.1 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.608 0.718 . . . . 0.0 109.709 174.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 20' ' ' VAL . 4.1 mm? -126.2 130.72 51.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.45 1.9 . . . . 0.0 107.951 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -147.51 162.44 39.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.523 1.129 . . . . 0.0 110.506 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 m -150.75 163.47 38.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.452 0.701 . . . . 0.0 110.798 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.95 115.69 0.7 Allowed Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.536 1.065 . . . . 0.0 110.896 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 174.18 5.98 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.709 1.254 . . . . 0.0 111.134 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -64.07 -172.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.685 0.794 . . . . 0.0 109.561 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.97 -174.13 0.07 Allowed 'General case' 0 CA--C 1.555 1.15 0 O-C-N 120.084 -1.635 . . . . 0.0 111.216 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -37.22 -41.6 0.4 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.421 1.888 . . . . 0.0 115.698 -172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.5 -57.52 0.42 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.235 1.398 . . . . 0.0 112.955 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.45 1.77 5.2 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.763 3.642 . . . . 0.0 115.154 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.31 109.47 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.345 2.258 . . . . 0.0 111.141 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.01 78.76 5.91 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.489 1.516 . . . . 0.0 112.372 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.0 m -100.96 -70.99 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.516 1.126 . . . . 0.0 111.321 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.45 41.86 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.073 1.32 . . . . 0.0 112.043 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.22 106.97 5.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.927 0.891 . . . . 0.0 109.797 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.35 123.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.805 -1.185 . . . . 0.0 108.668 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -147.38 169.94 18.4 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.642 0.734 . . . . 0.0 110.989 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.61 158.21 43.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.902 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.0 170.54 16.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.432 1.893 . . . . 0.0 110.311 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.87 155.79 49.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.911 0.885 . . . . 0.0 111.382 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.1 m-85 -136.13 121.95 19.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.019 1.328 . . . . 0.0 110.969 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.18 115.94 19.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.665 1.586 . . . . 0.0 110.483 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.83 161.98 30.14 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.647 0.779 . . . . 0.0 112.362 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -62.28 -23.39 66.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 113.403 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.9 m -78.33 -13.85 59.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.899 1.68 . . . . 0.0 113.581 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.15 60.27 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.796 1.188 . . . . 0.0 115.086 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -84.9 172.54 11.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.286 1.043 . . . . 0.0 109.896 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.1 m -131.92 152.71 50.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.735 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.82 135.37 53.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.441 1.097 . . . . 0.0 109.697 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 142.38 17.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.19 112.94 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 118.642 1.221 . . . . 0.0 109.518 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.87 150.44 46.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.144 0.578 . . . . 0.0 110.659 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.7 p90 -126.9 146.61 50.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.473 1.109 . . . . 0.0 109.672 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 t -131.16 110.89 11.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.54 1.136 . . . . 0.0 110.893 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 31' ' ' ILE . 2.8 t -115.0 102.1 54.74 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.363 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.78 163.86 34.8 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.897 2.398 . . . . 0.0 112.492 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.01 -26.77 59.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.34 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 112.96 24.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.351 -1.468 . . . . 0.0 111.255 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.25 -71.4 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.931 -1.105 . . . . 0.0 112.172 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.91 10.67 3.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.31 -3.42 4.95 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.896 . . . . 0.0 112.927 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.82 133.09 11.79 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.348 1.459 . . . . 0.0 110.926 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -84.62 171.93 12.01 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.285 -0.884 . . . . 0.0 111.805 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -100.78 151.34 21.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.123 1.369 . . . . 0.0 111.097 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.63 139.48 40.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.548 -0.72 . . . . 0.0 110.632 -172.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -151.71 150.78 30.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.965 1.706 . . . . 0.0 110.043 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -148.54 147.49 29.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.644 1.578 . . . . 0.0 109.189 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -143.98 109.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.146 1.778 . . . . 0.0 109.77 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -113.6 144.76 42.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 109.288 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.6 mt -109.75 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.537 1.935 . . . . 0.0 108.466 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.69 143.4 51.25 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.658 1.583 . . . . 0.0 112.239 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.2 m -79.06 85.69 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.009 1.324 . . . . 0.0 111.817 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.64 176.38 22.76 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.422 1.487 . . . . 0.0 112.328 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 149.14 37.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.176 0.991 . . . . 0.0 111.979 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -154.37 135.69 14.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.997 1.319 . . . . 0.0 111.134 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -98.4 -176.66 3.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.369 1.468 . . . . 0.0 111.534 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -139.21 100.83 4.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.946 1.698 . . . . 0.0 109.114 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -120.55 -72.24 0.7 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.692 1.197 . . . . 0.0 110.161 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -145.57 -64.22 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.907 1.283 . . . . 0.0 110.215 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.25 70.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.408 1.004 . . . . 0.0 114.557 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 tpp -90.67 -37.58 13.65 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.623 1.169 . . . . 0.0 112.988 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -41.09 93.24 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 111.135 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -59.74 -25.18 64.64 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -18.4 65.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.81 -37.72 9.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.997 1.319 . . . . 0.0 108.662 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -68.23 -47.45 67.78 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.786 -1.196 . . . . 0.0 113.628 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -99.22 -13.55 19.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 113.447 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.69 -63.65 4.55 Favored Glycine 0 N--CA 1.475 1.246 0 C-N-CA 124.074 0.845 . . . . 0.0 112.639 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.64 80.29 0.24 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 128.089 2.556 . . . . 0.0 109.104 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.8 135.49 32.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 108.706 -1.305 . . . . 0.0 108.706 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -71.28 -12.59 61.53 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.21 118.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.337 3.055 . . . . 0.0 112.688 -170.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.77 58.96 2.14 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.046 1.784 . . . . 0.0 113.925 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.09 22.35 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.435 2.294 . . . . 0.0 113.628 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.18 27.89 12.23 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.879 1.672 . . . . 0.0 113.328 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.27 135.96 9.31 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.787 1.661 . . . . 0.0 112.207 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -59.71 139.14 57.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 111.883 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -130.01 121.25 26.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.735 1.614 . . . . 0.0 110.528 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.74 154.82 40.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.97 1.708 . . . . 0.0 110.614 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -165.37 131.53 2.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.862 1.265 . . . . 0.0 110.874 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -62.85 112.15 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.308 1.043 . . . . 0.0 111.235 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.2 -24.94 1.39 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.397 1.079 . . . . 0.0 113.732 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.15 17.84 9.06 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.122 1.344 . . . . 0.0 114.96 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.14 16.81 4.1 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.97 2.108 . . . . 0.0 114.15 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.69 -65.18 0.06 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.93 1.252 . . . . 0.0 111.293 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -93.36 164.37 13.24 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.153 1.381 . . . . 0.0 112.454 176.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.47 30.58 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.544 1.938 . . . . 0.0 112.627 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.71 143.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.843 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -128.46 103.71 7.28 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.295 1.838 . . . . 0.0 107.874 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.41 169.48 21.26 Favored Glycine 0 N--CA 1.455 -0.067 0 CA-C-O 121.796 0.664 . . . . 0.0 113.218 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 146.63 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 123.893 0.877 . . . . 0.0 109.872 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.83 132.19 41.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.657 1.583 . . . . 0.0 107.861 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.6 p -85.95 164.09 17.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.612 0.765 . . . . 0.0 109.905 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.36 19.69 19.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.922 0.889 . . . . 0.0 112.967 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -106.05 -175.52 2.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 0.0 112.999 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.54 74.98 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.444 1.497 . . . . 0.0 114.413 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.46 92.45 5.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.446 1.498 . . . . 0.0 107.627 175.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' HG22 ' A' ' 31' ' ' ILE . . . -73.73 69.02 1.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.232 1.013 . . . . 0.0 111.733 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -53.11 129.95 32.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.728 -1.232 . . . . 0.0 110.954 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.7 ttm -134.61 123.83 24.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.131 1.772 . . . . 0.0 110.015 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -139.34 141.26 37.66 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.941 -1.099 . . . . 0.0 109.599 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.67 93.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.936 1.694 . . . . 0.0 109.167 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -86.0 109.26 18.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.043 0.937 . . . . 0.0 110.419 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.4 mm -91.57 116.42 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.751 0.82 . . . . 0.0 111.215 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -148.11 161.36 41.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.859 2.063 . . . . 0.0 110.581 174.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 20' ' ' VAL . 23.6 tp . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -62.22 146.31 51.16 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.19 -1.569 . . . . 0.0 111.379 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.68 39.6 40.02 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.666 0.65 . . . . 0.0 114.488 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.26 -169.35 3.03 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.555 1.177 . . . . 0.0 111.822 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.02 141.75 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.765 2.026 . . . . 0.0 109.844 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.28 173.93 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.569 1.548 . . . . 0.0 111.409 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.29 115.4 6.21 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.42 -30.78 65.35 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.448 -0.783 . . . . 0.0 112.808 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.29 69.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.246 -1.15 . . . . 0.0 113.345 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -90.48 -13.62 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.113 1.365 . . . . 0.0 113.39 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -68.14 113.01 5.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.968 0.907 . . . . 0.0 111.733 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -145.12 165.84 27.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.595 1.558 . . . . 0.0 109.737 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -45.91 -41.69 11.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.618 1.567 . . . . 0.0 114.487 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.54 -36.77 76.78 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.74 -44.48 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.818 0.847 . . . . 0.0 110.247 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.15 -42.64 86.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.782 0.833 . . . . 0.0 111.145 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.01 -40.13 71.98 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.133 -0.979 . . . . 0.0 113.21 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.36 -43.19 88.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.911 0.884 . . . . 0.0 111.924 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 2' ' ' LEU . 87.6 t -63.04 -51.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.716 -0.615 . . . . 0.0 111.215 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -53.2 -43.83 67.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.689 0.796 . . . . 0.0 112.628 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.48 -46.19 70.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 117.986 0.357 . . . . 0.0 111.857 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.4 -38.96 59.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.554 1.542 . . . . 0.0 113.863 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.586 HD12 ' CB ' ' A' ' 3' ' ' ALA . 8.4 tt -54.02 -40.14 66.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.421 1.089 . . . . 0.0 111.381 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.37 62.82 0.55 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.977 1.275 . . . . 0.0 111.737 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 133.53 3.13 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.034 1.333 . . . . 0.0 113.298 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 28' ' ' SER . 3.1 p -121.95 -163.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.388 1.875 . . . . 0.0 109.603 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.441 ' H ' HG22 ' A' ' 27' ' ' VAL . 7.4 m -39.39 -46.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.491 1.516 . . . . 0.0 114.938 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -147.97 126.31 12.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.95 2.1 . . . . 0.0 110.319 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' NZ ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -153.35 158.39 41.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.676 1.591 . . . . 0.0 111.832 176.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.18 173.72 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.725 1.21 . . . . 0.0 112.441 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.51 115.14 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.503 1.121 . . . . 0.0 110.525 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.26 143.74 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 111.213 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.39 125.61 1.8 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.407 1.004 . . . . 0.0 111.687 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 mt -130.39 112.28 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.532 1.666 . . . . 0.0 111.362 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.93 109.0 20.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.118 1.767 . . . . 0.0 111.796 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -87.14 109.27 19.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.789 1.28 . . . . 0.0 112.179 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -122.61 27.55 7.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.482 1.913 . . . . 0.0 111.176 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -81.71 -1.79 48.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.734 2.014 . . . . 0.0 114.553 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 12.62 83.97 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.934 -1.103 . . . . 0.0 114.492 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.54 145.36 12.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.422 1.487 . . . . 0.0 113.501 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -69.83 141.48 53.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.59 1.156 . . . . 0.0 112.811 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -112.07 162.59 15.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.54 1.936 . . . . 0.0 111.431 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 m -128.97 114.92 17.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.754 1.222 . . . . 0.0 109.328 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 122.72 18.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.704 -0.622 . . . . 0.0 110.146 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.4 HD21 ' CZ ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -65.67 -66.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.785 1.234 . . . . 0.0 109.855 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 176.43 173.76 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.884 2.874 . . . . 0.0 109.657 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 143.87 48.0 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.456 2.302 . . . . 0.0 109.217 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -136.25 112.32 9.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.04 0.936 . . . . 0.0 111.444 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -72.92 115.48 12.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.514 1.526 . . . . 0.0 111.487 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -89.87 -37.69 14.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.629 1.572 . . . . 0.0 112.756 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -146.46 159.46 43.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.382 2.273 . . . . 0.0 110.606 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.47 49.63 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 121.612 0.562 . . . . 0.0 113.386 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 t -140.42 148.03 40.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.526 1.13 . . . . 0.0 109.726 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 57' ' ' VAL . 18.0 m -138.58 138.79 38.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.418 1.087 . . . . 0.0 110.205 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.06 11.15 40.09 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.906 1.682 . . . . 0.0 112.854 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 55' ' ' THR . 32.8 m -126.48 169.63 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.74 2.016 . . . . 0.0 112.364 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.11 135.78 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.577 1.551 . . . . 0.0 109.758 -169.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -77.27 152.95 81.96 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.291 0.951 . . . . 0.0 112.379 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.41 174.17 8.65 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.555 3.504 . . . . 0.0 110.759 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -116.3 -17.56 10.72 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.13 -0.981 . . . . 0.0 113.173 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -124.59 130.38 52.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.285 1.834 . . . . 0.0 110.343 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.59 82.67 44.6 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.324 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.6 153.66 77.2 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.162 1.908 . . . . 0.0 111.427 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -53.31 148.42 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.545 0.738 . . . . 0.0 111.176 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 72.86 -0.95 3.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.953 2.501 . . . . 0.0 114.805 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -124.47 106.24 10.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.065 1.746 . . . . 0.0 112.391 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.59 160.0 25.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.55 170.05 8.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.129 0.572 . . . . 0.0 109.769 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -126.39 134.77 50.94 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 109.636 174.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.21 169.86 20.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.601 0.76 . . . . 0.0 111.642 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.4 m -151.21 171.58 17.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.509 1.524 . . . . 0.0 110.474 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.97 115.99 0.71 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.71 163.14 15.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.161 1.481 . . . . 0.0 111.18 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -65.41 -177.23 0.39 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 110.404 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.79 178.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.353 -0.842 . . . . 0.0 110.322 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -24.59 -53.34 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.175 2.59 . . . . 0.0 116.308 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.36 -62.75 0.26 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.604 1.573 . . . . 0.0 112.325 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.15 -1.27 8.52 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.711 3.607 . . . . 0.0 115.439 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.72 123.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.484 2.314 . . . . 0.0 110.453 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.51 81.5 2.97 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.351 1.46 . . . . 0.0 111.241 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 m -114.1 -80.89 0.6 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.985 1.314 . . . . 0.0 110.523 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.43 -177.34 41.95 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.238 1.399 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -139.14 110.61 7.03 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.054 1.342 . . . . 0.0 109.159 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.22 130.65 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.649 -0.657 . . . . 0.0 109.755 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 158.32 44.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 110.293 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.97 155.43 45.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.936 0.874 . . . . 0.0 111.636 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.71 168.03 25.59 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.416 1.886 . . . . 0.0 109.689 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.48 157.23 45.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.584 0.753 . . . . 0.0 110.868 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -138.95 118.5 12.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.702 0.801 . . . . 0.0 112.125 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CZ ' HD21 ' A' ' 46' ' ' LEU . 17.3 m-85 -75.59 121.83 23.01 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.649 0.78 . . . . 0.0 111.226 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -87.44 159.3 18.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.47 1.108 . . . . 0.0 110.123 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.7 p -63.83 -13.89 48.46 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -88.38 0.49 56.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.852 1.661 . . . . 0.0 113.05 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.12 82.96 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.695 1.141 . . . . 0.0 114.126 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.46 167.22 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.837 2.055 . . . . 0.0 110.644 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.0 m -130.99 153.62 49.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.027 1.331 . . . . 0.0 109.629 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.21 138.66 53.66 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.396 1.079 . . . . 0.0 109.587 175.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.25 139.08 15.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.94 125.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.229 1.015 . . . . 0.0 109.476 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.01 155.94 46.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.405 0.682 . . . . 0.0 112.016 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.97 144.22 49.0 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.691 1.197 . . . . 0.0 110.086 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.03 110.64 11.8 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 110.11 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.78 100.6 46.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 125.705 1.602 . . . . 0.0 109.655 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.03 163.93 34.3 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.277 1.985 . . . . 0.0 110.844 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.61 -47.25 76.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.726 0.811 . . . . 0.0 111.08 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.08 117.41 22.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.478 2.311 . . . . 0.0 111.958 -172.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.2 -70.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.113 -0.992 . . . . 0.0 112.646 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -82.5 11.19 5.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.48 5.42 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.134 2.174 . . . . 0.0 112.433 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -160.13 129.07 4.97 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.175 1.79 . . . . 0.0 110.718 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.9 m -90.94 168.13 11.91 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.567 -1.333 . . . . 0.0 113.214 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -89.67 155.74 19.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.149 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.405 ' CE3' ' HD2' ' A' ' 141' ' ' ARG . 0.9 OUTLIER -142.14 140.53 32.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.582 1.153 . . . . 0.0 109.284 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -156.63 146.69 21.12 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.318 1.447 . . . . 0.0 110.399 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -140.98 147.49 38.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.675 1.19 . . . . 0.0 110.072 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.3 t -146.01 90.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.032 1.333 . . . . 0.0 112.051 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.09 144.81 32.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.237 1.415 . . . . 0.0 110.526 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -108.33 123.34 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.293 2.237 . . . . 0.0 108.587 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -127.71 148.3 50.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.288 1.435 . . . . 0.0 112.955 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.2 p -74.08 87.82 1.9 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.578 1.951 . . . . 0.0 112.679 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.78 179.35 21.1 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.878 1.704 . . . . 0.0 112.387 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 140.83 29.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.441 1.497 . . . . 0.0 112.266 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.35 152.28 30.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.145 2.178 . . . . 0.0 110.411 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -131.53 153.37 49.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.457 1.903 . . . . 0.0 110.75 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.71 93.15 0.7 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.328 1.051 . . . . 0.0 111.762 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.3 -76.81 0.58 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 110.279 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -142.85 -67.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.393 2.277 . . . . 0.0 107.758 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.19 -30.97 75.25 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.618 1.104 . . . . 0.0 115.257 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -75.45 -57.89 3.61 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.437 1.619 . . . . 0.0 110.864 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -49.98 -49.6 49.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.58 1.152 . . . . 0.0 111.504 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -37.61 80.14 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.79 -27.34 67.93 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.649 1.113 . . . . 0.0 112.627 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.1 -46.83 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.743 0.817 . . . . 0.0 110.563 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -72.41 -49.02 36.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.835 -1.166 . . . . 0.0 113.773 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -91.83 -17.09 25.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.377 1.071 . . . . 0.0 113.046 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.99 -70.18 0.99 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.224 0.916 . . . . 0.0 112.8 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -179.66 75.48 0.19 Allowed Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 127.962 2.505 . . . . 0.0 110.618 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 131.71 19.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.812 1.674 . . . . 0.0 110.981 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 118.49 13.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.405 ' HD2' ' CE3' ' A' ' 114' ' ' TRP . 0.1 OUTLIER -63.58 123.48 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.898 178.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.75 69.84 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.733 1.635 . . . . 0.0 113.114 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.82 38.81 0.46 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.29 1.836 . . . . 0.0 111.841 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 54.44 41.79 31.76 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.83 1.652 . . . . 0.0 113.168 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.36 156.2 26.88 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.061 1.315 . . . . 0.0 113.418 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.15 134.38 51.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.156 0.983 . . . . 0.0 111.523 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.53 111.7 11.99 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.965 2.106 . . . . 0.0 108.902 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -147.91 146.78 29.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.017 1.727 . . . . 0.0 111.184 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 144.6 9.97 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.422 1.089 . . . . 0.0 111.208 175.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 137.09 58.24 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.841 0.457 . . . . 0.0 112.008 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.44 -30.37 0.06 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 113.646 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.9 16.3 55.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.078 1.323 . . . . 0.0 114.169 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.38 14.06 4.47 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.091 2.157 . . . . 0.0 114.965 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.25 -65.45 0.06 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.254 1.883 . . . . 0.0 110.816 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.28 156.34 16.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.905 0.882 . . . . 0.0 110.845 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -149.55 170.33 18.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.433 1.493 . . . . 0.0 112.397 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -89.23 145.49 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.964 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -137.95 106.13 5.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.528 1.931 . . . . 0.0 108.684 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.85 170.65 25.72 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-O 121.765 0.647 . . . . 0.0 113.972 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.14 148.29 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.847 2.059 . . . . 0.0 108.531 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.5 ttt -142.11 131.99 24.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.379 1.072 . . . . 0.0 108.607 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.06 160.81 31.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.052 1.341 . . . . 0.0 111.608 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.6 t -93.4 5.0 53.06 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.993 1.317 . . . . 0.0 113.362 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.74 174.52 5.84 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.712 2.005 . . . . 0.0 112.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.17 -56.77 21.93 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.011 0.815 . . . . 0.0 113.552 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.04 36.52 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.545 1.938 . . . . 0.0 113.685 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.38 32.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.599 1.159 . . . . 0.0 114.045 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -106.49 131.2 53.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.905 1.682 . . . . 0.0 109.504 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 34.2 ttp -128.01 95.27 4.14 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.843 1.257 . . . . 0.0 111.361 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -109.34 143.57 38.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.73 -0.606 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.45 107.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.759 2.023 . . . . 0.0 109.668 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 101.12 10.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.232 1.413 . . . . 0.0 109.795 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.66 129.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.872 -0.517 . . . . 0.0 110.654 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.99 171.97 18.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.002 0.921 . . . . 0.0 113.16 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 128.973 2.909 . . . . 0.0 112.837 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.24 147.05 38.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.553 -1.342 . . . . 0.0 111.88 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.94 34.33 81.81 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.605 0.622 . . . . 0.0 113.777 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -148.49 178.3 8.73 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.987 0.893 . . . . 0.0 111.501 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 69' ' ' LEU . 4.9 pt -128.35 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.489 1.516 . . . . 0.0 111.949 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 pt -144.84 167.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.804 1.642 . . . . 0.0 111.708 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.57 124.34 16.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.633 1.173 . . . . 0.0 112.173 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.95 -19.67 30.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 114.1 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.3 95.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.02 1.328 . . . . 0.0 111.692 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -35.28 25.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.321 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 68' ' ' ALA . 3.5 tp -52.44 100.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.081 1.752 . . . . 0.0 112.602 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -145.72 170.3 16.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.019 1.328 . . . . 0.0 109.793 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.88 -36.9 28.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.115 1.366 . . . . 0.0 113.702 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 -35.21 76.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.026 0.93 . . . . 0.0 113.305 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 20' ' ' VAL . 62.1 t -67.74 -46.71 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.644 1.178 . . . . 0.0 109.519 175.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.74 -44.84 73.93 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 112.412 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.5 -42.08 95.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.838 -0.539 . . . . 0.0 111.361 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -42.04 97.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.318 1.047 . . . . 0.0 111.407 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 2' ' ' LEU . 44.5 t -61.2 -54.47 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.599 1.159 . . . . 0.0 111.247 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.27 -49.48 61.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 0.0 111.569 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.99 -42.83 72.55 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.2 -38.06 44.14 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' HZ2' ' A' ' 30' ' ' LYS . 3.4 tt -54.71 -45.14 73.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.487 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.33 66.48 0.48 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.229 1.395 . . . . 0.0 111.564 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 124.21 1.11 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.542 1.537 . . . . 0.0 112.946 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -104.09 -159.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.688 1.595 . . . . 0.0 109.556 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.51 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -49.06 -30.59 6.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 114.117 176.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.27 135.11 11.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.143 1.777 . . . . 0.0 111.439 176.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HZ2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.77 165.25 35.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.755 1.222 . . . . 0.0 113.343 174.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.39 161.27 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.181 1.392 . . . . 0.0 109.099 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.49 125.73 51.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.068 1.347 . . . . 0.0 108.07 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.55 142.21 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.171 1.788 . . . . 0.0 110.388 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.46 122.51 1.32 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.948 0.785 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.53 111.69 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 118.336 1.068 . . . . 0.0 110.208 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.61 120.58 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.972 1.709 . . . . 0.0 113.798 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.39 90.39 1.29 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.089 1.756 . . . . 0.0 110.171 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -107.53 12.39 27.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 112.595 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -82.33 -34.63 28.47 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -171.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.63 17.35 10.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.241 0.928 . . . . 0.0 114.997 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.3 160.93 31.3 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 118.988 1.394 . . . . 0.0 114.844 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -74.08 134.42 42.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.805 1.242 . . . . 0.0 111.874 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.46 166.47 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.96 1.704 . . . . 0.0 111.26 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 m -133.93 113.24 11.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.986 1.315 . . . . 0.0 110.064 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 113.02 4.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.72 -64.46 0.93 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.674 1.19 . . . . 0.0 110.142 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -175.22 169.11 3.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.892 2.077 . . . . 0.0 111.459 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -122.12 139.03 54.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.977 2.111 . . . . 0.0 109.103 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.9 110.93 11.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.55 101.49 3.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.174 1.39 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -68.03 -42.33 80.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.46 1.504 . . . . 0.0 111.942 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.11 157.79 43.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.692 2.397 . . . . 0.0 111.144 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 -169.69 39.86 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 123.729 0.681 . . . . 0.0 114.574 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -136.77 173.3 11.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.056 1.342 . . . . 0.0 112.363 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.7 p -143.04 176.57 8.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 110.66 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -123.35 17.59 9.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.434 1.094 . . . . 0.0 112.193 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.07 175.51 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.985 2.114 . . . . 0.0 111.904 -168.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mt -139.04 133.72 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.014 1.326 . . . . 0.0 109.76 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.0 142.24 75.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.151 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.93 172.01 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.607 3.538 . . . . 0.0 110.811 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -115.39 -20.26 10.35 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.204 -1.56 . . . . 0.0 112.556 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -129.88 141.35 50.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.353 1.461 . . . . 0.0 110.297 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.03 95.5 5.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.92 161.53 32.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.556 1.504 . . . . 0.0 111.303 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.7 153.53 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.568 -0.707 . . . . 0.0 111.517 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -25.79 0.18 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.038 1.735 . . . . 0.0 113.384 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -89.03 121.15 31.09 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.133 1.333 . . . . 0.0 110.659 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.535 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -91.11 160.5 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 111.402 174.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -101.68 164.46 11.73 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.026 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.65 134.74 48.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.96 2.104 . . . . 0.0 109.01 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -147.42 171.18 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.962 1.305 . . . . 0.0 111.786 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -148.08 168.82 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.834 1.253 . . . . 0.0 110.831 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -146.43 116.38 0.87 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-O 118.036 -1.425 . . . . 0.0 110.602 175.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.09 163.81 15.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.704 1.252 . . . . 0.0 110.737 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -177.81 0.66 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.1 -175.25 0.2 Allowed 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.143 -0.973 . . . . 0.0 111.036 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 m -19.7 -56.58 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.187 2.995 . . . . 0.0 115.589 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.94 -63.08 0.3 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.424 1.488 . . . . 0.0 112.226 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 0.14 6.78 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.925 3.75 . . . . 0.0 115.972 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.38 122.87 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.888 1.675 . . . . 0.0 111.783 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.91 80.17 4.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.367 1.467 . . . . 0.0 111.713 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -104.91 -86.51 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.494 1.518 . . . . 0.0 110.789 177.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 82' ' ' THR . . . 174.24 179.94 45.18 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 127.41 2.433 . . . . 0.0 110.581 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -138.35 101.18 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.176 1.391 . . . . 0.0 109.966 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -140.77 126.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -149.95 164.94 34.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.351 -0.843 . . . . 0.0 110.8 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.6 155.93 40.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.961 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.23 168.02 27.39 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.968 1.307 . . . . 0.0 109.881 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 148.91 43.05 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.727 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -134.62 115.77 14.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.279 1.032 . . . . 0.0 111.165 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -69.62 118.5 12.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.404 1.482 . . . . 0.0 109.36 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -82.47 151.68 26.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.604 1.562 . . . . 0.0 110.404 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -58.33 -19.18 33.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 63.2 m -82.3 -12.28 58.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.484 1.914 . . . . 0.0 113.848 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.51 -10.6 42.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.298 1.428 . . . . 0.0 115.127 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.55 173.32 12.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.514 1.525 . . . . 0.0 110.737 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -137.63 142.76 41.2 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.698 1.199 . . . . 0.0 108.39 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.23 140.75 38.7 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.25 145.57 16.27 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -148.87 130.15 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 109.725 175.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.53 50.1 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.04 . . . . 0.0 110.296 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -123.21 152.99 40.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.037 1.335 . . . . 0.0 109.453 174.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.3 p -140.37 122.5 15.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.024 0.929 . . . . 0.0 110.626 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 23.7 t -119.75 108.15 39.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 126.407 1.883 . . . . 0.0 108.33 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.16 155.56 37.67 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.297 1.998 . . . . 0.0 111.493 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.68 -36.09 83.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.646 0.778 . . . . 0.0 110.76 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.99 114.68 27.31 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.785 2.434 . . . . 0.0 111.612 -171.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.0 -63.77 1.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.047 -1.033 . . . . 0.0 113.445 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -88.86 10.86 19.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -6.0 6.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.83 2.052 . . . . 0.0 112.743 -174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.35 179.35 8.62 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.835 2.454 . . . . 0.0 110.284 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -136.75 159.96 40.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.161 1.385 . . . . 0.0 110.955 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -79.63 155.33 28.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -136.83 151.61 49.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.75 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -161.6 157.73 25.15 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.675 1.19 . . . . 0.0 110.16 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 12.5 t70 -154.47 161.32 41.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.602 1.161 . . . . 0.0 110.245 174.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 100' ' ' VAL . 67.5 t -146.23 138.0 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.346 1.858 . . . . 0.0 109.921 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.87 46.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.055 1.742 . . . . 0.0 110.007 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.8 119.24 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.097 1.759 . . . . 0.0 108.71 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -127.92 139.4 52.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.465 1.906 . . . . 0.0 112.385 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.6 p -77.34 79.4 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.919 1.688 . . . . 0.0 112.525 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.75 174.78 32.05 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.979 . . . . 0.0 112.606 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 99.65 10.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.855 2.062 . . . . 0.0 110.593 -173.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.82 161.43 34.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.781 2.032 . . . . 0.0 111.464 -176.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.44 30.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.527 1.531 . . . . 0.0 111.301 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.41 87.96 0.64 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.128 0.971 . . . . 0.0 111.293 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.63 -64.16 1.12 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.999 1.32 . . . . 0.0 109.292 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -75.02 0.17 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.989 1.716 . . . . 0.0 108.543 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.41 93.98 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.804 1.192 . . . . 0.0 113.93 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.31 -46.42 76.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.299 1.049 . . . . 0.0 111.398 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.35 -43.66 93.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.575 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -62.35 -42.66 99.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.514 1.126 . . . . 0.0 112.338 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -16.71 35.11 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 113.153 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.43 -52.4 4.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.55 -43.09 97.63 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 112.794 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -98.46 -14.65 19.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.786 1.234 . . . . 0.0 113.591 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.48 4.16 Favored Glycine 0 N--CA 1.475 1.286 0 O-C-N 121.541 -0.724 . . . . 0.0 114.655 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 44.3 77.21 0.46 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.222 1.809 . . . . 0.0 111.78 -165.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.67 157.58 50.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.04 1.826 . . . . 0.0 111.01 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 116' ' ' ASP . 23.8 m-85 -90.28 2.9 54.99 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER 46.61 16.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 129.426 3.09 . . . . 0.0 116.848 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 45.69 62.98 3.01 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.176 0.893 . . . . 0.0 112.611 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.74 16.65 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.281 10.7 p30 49.17 33.69 5.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.409 2.283 . . . . 0.0 115.15 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.24 147.89 19.36 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.965 1.745 . . . . 0.0 111.06 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -64.98 116.06 6.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.362 0.665 . . . . 0.0 110.382 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 138.09 49.26 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.42 128.57 4.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.91 1.284 . . . . 0.0 111.333 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -137.86 119.57 15.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.299 1.04 . . . . 0.0 113.372 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.77 123.94 5.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.3 -24.48 0.08 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.77 22.34 14.5 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.958 1.266 . . . . 0.0 114.085 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.0 t80 58.43 14.8 3.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.566 2.346 . . . . 0.0 115.024 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.98 -64.03 0.05 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 125.456 1.503 . . . . 0.0 110.913 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.13 161.07 15.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.183 0.993 . . . . 0.0 111.149 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 174.44 10.51 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.886 2.074 . . . . 0.0 111.407 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -78.2 131.13 37.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.91 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -122.23 104.67 9.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.717 1.207 . . . . 0.0 108.696 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.38 165.41 27.48 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-O 122.401 1.0 . . . . 0.0 114.643 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.3 tt -146.9 141.54 20.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 127.573 2.349 . . . . 0.0 108.469 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.1 ttt -141.7 140.6 33.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.07 1.748 . . . . 0.0 106.371 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.99 163.14 19.07 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.436 0.694 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 9.77 13.54 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.03 1.332 . . . . 0.0 113.776 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.28 170.58 9.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.234 2.214 . . . . 0.0 112.663 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.34 -71.79 0.88 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.46 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.665 2.386 . . . . 0.0 115.995 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 158.49 8.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.168 2.187 . . . . 0.0 113.627 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.22 140.44 36.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.271 1.428 . . . . 0.0 110.685 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.2 ttm -133.48 135.4 44.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.999 1.719 . . . . 0.0 110.087 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -144.46 152.6 40.86 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.927 0.891 . . . . 0.0 109.225 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.1 mt -133.18 117.4 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.494 1.518 . . . . 0.0 108.453 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -106.59 113.78 27.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.795 1.638 . . . . 0.0 109.561 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.35 101.07 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 60.3 p -161.73 -179.56 7.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.426 1.891 . . . . 0.0 114.914 -174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 127.997 2.519 . . . . 0.0 115.408 -164.715 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.57 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 61.84 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.169 2.588 . . . . 0.0 113.082 -167.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.36 47.46 90.77 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 114.817 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.9 p -147.51 -174.65 4.59 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.33 1.052 . . . . 0.0 112.574 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -124.47 136.82 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.673 1.989 . . . . 0.0 111.041 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.53 174.21 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.476 1.51 . . . . 0.0 111.905 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.14 1.69 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.984 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 67' ' ' LYS . . . -64.14 -25.26 69.46 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.241 -0.912 . . . . 0.0 113.096 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.0 71.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.418 1.087 . . . . 0.0 112.549 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 m -83.63 -19.41 35.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.79 1.236 . . . . 0.0 113.374 175.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.508 HD22 ' CB ' ' A' ' 68' ' ' ALA . 16.2 tp -66.7 97.7 0.47 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.927 1.291 . . . . 0.0 111.688 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 14' ' ' PHE . 7.4 m -144.44 174.44 10.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.562 1.545 . . . . 0.0 109.508 -174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.524 ' HA ' HD12 ' A' ' 17' ' ' LEU . 1.4 t80 -49.05 -33.63 11.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.95 1.3 . . . . 0.0 114.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -64.23 -32.9 74.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -77.5 -30.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.224 1.41 . . . . 0.0 111.422 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 14' ' ' PHE . 52.6 mt -59.03 -52.84 64.02 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.92 -38.41 72.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.547 1.139 . . . . 0.0 111.666 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -58.88 -36.94 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.12 -46.49 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.332 0.969 . . . . 0.0 110.78 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -40.17 85.03 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.213 1.405 . . . . 0.0 110.418 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.35 -53.36 37.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.385 0.674 . . . . 0.0 112.813 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -48.72 41.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.496 -0.753 . . . . 0.0 112.766 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.701 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.1 tm? -63.32 -39.45 94.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.77 0.828 . . . . 0.0 111.7 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.74 69.53 0.8 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.137 1.351 . . . . 0.0 112.758 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.277 1.831 . . . . 0.0 112.376 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -84.03 -160.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.123 1.769 . . . . 0.0 110.421 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 27' ' ' VAL . 67.5 m -44.02 -35.01 1.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.987 1.715 . . . . 0.0 114.754 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -149.71 137.48 20.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.616 1.966 . . . . 0.0 110.221 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.701 ' HE3' HD12 ' A' ' 24' ' ' LEU . 5.7 tptp -165.85 143.17 5.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.556 1.542 . . . . 0.0 112.017 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.22 143.46 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.371 0.987 . . . . 0.0 111.443 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.99 118.57 36.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 108.867 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.64 139.67 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.984 0.913 . . . . 0.0 111.227 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.77 133.73 4.42 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.925 1.25 . . . . 0.0 111.596 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.26 99.3 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.028 0.931 . . . . 0.0 108.699 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -81.02 105.61 12.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.814 0.846 . . . . 0.0 111.142 -174.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -73.61 96.15 2.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 111.283 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.74 10.81 15.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 113.442 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.3 t -64.06 -55.06 24.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.911 1.284 . . . . 0.0 114.006 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.02 0.9 3.03 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.38 157.21 27.12 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 119.489 1.645 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -69.63 138.06 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.554 1.142 . . . . 0.0 113.129 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -115.26 166.05 12.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.551 1.54 . . . . 0.0 112.112 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -134.62 114.02 12.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.995 1.318 . . . . 0.0 110.295 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.49 124.29 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.959 -1.088 . . . . 0.0 108.994 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.41 -66.78 0.5 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 110.622 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.23 159.78 7.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.125 2.17 . . . . 0.0 110.558 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.08 122.92 47.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.478 1.911 . . . . 0.0 109.7 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.59 116.81 26.09 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.177 0.991 . . . . 0.0 111.829 -176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -71.49 114.2 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.177 1.391 . . . . 0.0 112.727 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -44.83 44.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.044 1.738 . . . . 0.0 110.591 174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 m -147.38 162.22 39.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.496 2.318 . . . . 0.0 111.574 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.67 -166.18 54.02 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.358 0.98 . . . . 0.0 113.934 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -147.32 173.32 12.7 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.889 -0.771 . . . . 0.0 111.954 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.57 HG22 ' HA2' ' A' ' 73' ' ' GLY . 5.1 p -143.82 -174.69 4.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.182 1.393 . . . . 0.0 111.479 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.07 13.46 6.22 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.286 1.034 . . . . 0.0 112.918 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 3' ' ' ALA . 7.9 m -136.45 170.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.898 2.079 . . . . 0.0 114.043 -169.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.33 133.35 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.915 1.686 . . . . 0.0 110.785 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 143.48 52.06 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.196 0.907 . . . . 0.0 111.713 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.79 146.36 59.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.655 3.57 . . . . 0.0 112.051 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -85.6 -26.74 25.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -113.63 128.03 56.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.216 1.371 . . . . 0.0 111.897 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.52 86.63 28.68 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.609 1.564 . . . . 0.0 110.137 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.73 162.12 36.01 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.303 2.002 . . . . 0.0 112.124 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -63.64 159.48 18.89 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.758 -0.589 . . . . 0.0 111.063 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p 68.45 -5.42 0.94 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.68 2.392 . . . . 0.0 114.444 -172.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.486 ' HA ' ' H ' ' A' ' 9' ' ' GLY . 73.9 mttt -116.31 165.44 13.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.581 1.952 . . . . 0.0 112.026 174.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.508 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -135.89 162.66 32.2 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.321 1.448 . . . . 0.0 111.272 174.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 167.02 10.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.292 0.567 . . . . 0.0 109.857 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.51 136.08 52.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.506 1.922 . . . . 0.0 108.764 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -150.17 166.29 30.3 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.185 0.994 . . . . 0.0 110.662 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -155.29 170.12 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.591 0.757 . . . . 0.0 112.447 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.57 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -160.15 145.0 10.6 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.748 1.166 . . . . 0.0 112.582 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -127.17 148.92 50.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.652 1.981 . . . . 0.0 110.981 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 9.4 pttp -67.36 121.11 15.02 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 38.24 -149.77 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 126.034 1.733 . . . . 0.0 114.381 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.7 m -88.17 -42.65 12.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.634 -1.291 . . . . 0.0 111.598 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.9 -61.16 0.37 Allowed Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.696 -1.058 . . . . 0.0 114.252 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.16 0.81 5.4 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.929 3.753 . . . . 0.0 115.27 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.76 135.72 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 127.677 2.391 . . . . 0.0 108.995 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 106' ' ' PHE . . . -119.14 80.95 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.627 1.571 . . . . 0.0 110.226 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.8 m -110.42 -66.7 1.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.726 1.211 . . . . 0.0 110.75 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.02 -179.64 33.58 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.731 0.681 . . . . 0.0 112.793 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -140.1 115.46 9.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 110.427 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.8 t -138.63 139.51 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.426 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -154.71 158.82 40.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.31 0.644 . . . . 0.0 109.863 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.67 139.81 22.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 111.919 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.73 176.43 8.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.573 1.949 . . . . 0.0 109.682 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.73 37.07 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.336 0.655 . . . . 0.0 112.125 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.44 113.02 15.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.686 1.194 . . . . 0.0 111.112 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -73.04 111.77 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.215 1.806 . . . . 0.0 110.747 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 mtt -71.68 161.42 31.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.724 0.81 . . . . 0.0 112.106 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.3 t -60.98 -26.08 67.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.118 0.967 . . . . 0.0 113.245 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -74.96 -12.1 60.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.622 1.569 . . . . 0.0 112.957 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.34 -2.86 59.48 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.665 1.602 . . . . 0.0 114.489 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.79 176.38 9.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.533 1.533 . . . . 0.0 109.664 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.9 m -136.56 148.71 47.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 0.0 110.241 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.33 134.89 54.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 108.637 175.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 144.04 19.03 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.26 121.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 118.445 1.122 . . . . 0.0 109.481 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -128.64 162.22 27.83 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.359 0.664 . . . . 0.0 112.668 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 3.8 p90 -131.4 150.89 51.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.875 1.27 . . . . 0.0 109.603 174.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 t -139.08 110.37 6.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.52 0.728 . . . . 0.0 110.383 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.8 t -99.59 100.01 9.91 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 127.897 2.479 . . . . 0.0 109.112 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.4 145.72 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.34 2.027 . . . . 0.0 111.372 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' A' ' 81' ' ' ALA . 23.6 t80 -72.89 -31.55 64.76 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.41 0.624 . . . . 0.0 110.167 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.73 114.85 28.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.522 2.329 . . . . 0.0 111.714 -165.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.01 -54.74 8.97 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -95.01 14.43 21.85 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -16.92 2.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.373 1.869 . . . . 0.0 113.06 -175.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.07 175.1 10.11 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.062 2.945 . . . . 0.0 109.497 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.8 m -136.01 171.0 15.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.438 1.495 . . . . 0.0 110.768 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -87.24 151.97 22.71 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.069 0.947 . . . . 0.0 109.964 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -138.78 142.02 38.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.231 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -159.6 163.2 35.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 111.154 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -163.71 147.19 10.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.395 1.478 . . . . 0.0 110.421 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.21 108.25 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.009 1.723 . . . . 0.0 109.529 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -111.76 149.11 32.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.041 1.736 . . . . 0.0 109.734 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.1 117.76 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.687 1.595 . . . . 0.0 108.898 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -125.21 135.88 53.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.145 1.778 . . . . 0.0 112.092 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -75.66 80.63 2.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.379 1.472 . . . . 0.0 112.792 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.14 167.63 14.5 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 115.207 0.843 . . . . 0.0 115.207 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -72.86 102.66 3.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.432 1.493 . . . . 0.0 111.665 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.51 132.45 31.22 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.318 1.847 . . . . 0.0 109.436 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 167.13 17.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.048 1.339 . . . . 0.0 111.837 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.64 88.54 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.598 1.559 . . . . 0.0 111.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -111.53 -64.38 1.29 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.776 1.23 . . . . 0.0 109.712 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -68.52 0.23 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.597 1.159 . . . . 0.0 109.139 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.77 90.62 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.682 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -52.77 33.27 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.086 1.443 . . . . 0.0 111.02 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.89 -44.43 78.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.253 1.021 . . . . 0.0 110.801 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.85 -39.38 94.08 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -22.32 61.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.453 1.101 . . . . 0.0 112.216 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.19 -58.86 2.47 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.431 1.492 . . . . 0.0 109.557 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -63.36 -57.63 9.73 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.295 -0.878 . . . . 0.0 111.248 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -82.26 -17.95 44.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.347 1.059 . . . . 0.0 112.247 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.21 56.51 4.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.935 0.778 . . . . 0.0 114.676 -172.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.49 83.28 0.23 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 126.444 1.898 . . . . 0.0 111.818 -166.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.48 151.27 83.41 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.132 1.888 . . . . 0.0 109.256 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.42 -2.9 57.93 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.1 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 129.179 2.992 . . . . 0.0 112.819 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -38.67 75.32 0.0 OUTLIER Glycine 0 CA--C 1.542 1.781 0 C-N-CA 128.319 2.866 . . . . 0.0 117.239 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -81.97 25.55 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.629 1.972 . . . . 0.0 114.668 -170.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.275 11.6 p30 52.44 24.79 3.15 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.178 2.191 . . . . 0.0 114.842 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.35 172.25 18.07 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 126.888 2.185 . . . . 0.0 113.189 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -79.69 117.89 21.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.727 1.211 . . . . 0.0 111.919 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -104.84 117.33 33.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.053 1.741 . . . . 0.0 109.526 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.9 134.55 17.59 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 111.293 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -148.09 127.77 13.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.608 1.163 . . . . 0.0 112.146 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.84 113.54 1.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.136 1.374 . . . . 0.0 113.016 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tt -137.1 -28.36 0.94 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.944 1.298 . . . . 0.0 113.385 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.11 18.24 33.0 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.883 1.23 . . . . 0.0 114.498 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.66 11.25 2.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.385 2.274 . . . . 0.0 114.785 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.69 -72.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 C-N-CA 126.101 1.81 . . . . 0.0 110.319 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.43 156.75 22.77 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.813 0.816 . . . . 0.0 111.632 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.62 170.87 18.64 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.599 1.56 . . . . 0.0 112.43 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.9 130.87 35.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.303 1.041 . . . . 0.0 109.401 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -125.71 101.32 6.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -134.45 168.76 23.35 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 121.963 0.757 . . . . 0.0 113.843 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.7 tt -143.74 141.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.343 1.857 . . . . 0.0 109.049 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.5 ttt -146.28 143.07 28.93 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.78 1.632 . . . . 0.0 107.501 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.7 p -97.53 173.22 7.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.22 1.008 . . . . 0.0 111.539 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.0 m -109.43 33.72 4.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.555 1.542 . . . . 0.0 112.392 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.8 175.08 5.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.248 1.419 . . . . 0.0 112.376 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.65 -47.47 91.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.177 0.894 . . . . 0.0 113.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -108.87 72.01 0.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.784 1.278 . . . . 0.0 111.633 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.5 175.01 7.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.918 1.287 . . . . 0.0 111.211 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.81 151.16 47.83 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 109.312 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.9 tpp -140.68 87.77 2.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.147 0.979 . . . . 0.0 111.736 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.38 148.78 23.34 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.984 0.514 . . . . 0.0 111.05 174.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.87 99.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.25 1.42 . . . . 0.0 111.19 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -83.76 108.16 16.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.798 1.639 . . . . 0.0 109.844 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 110.07 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.132 0.573 . . . . 0.0 110.86 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 55.4 m -147.29 161.33 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.921 1.289 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 128.211 2.604 . . . . 0.0 111.686 177.834 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.01 139.58 50.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.46 -1.4 . . . . 0.0 111.084 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.02 31.83 61.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -142.76 177.22 8.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 118.639 1.22 . . . . 0.0 112.398 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 60' ' ' PRO . 6.5 pt -125.51 144.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.448 1.499 . . . . 0.0 112.734 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -146.38 174.09 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.748 1.619 . . . . 0.0 112.236 177.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.52 121.01 8.68 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.023 1.329 . . . . 0.0 111.587 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.7 -21.74 44.31 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.111 1.339 . . . . 0.0 113.863 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.81 76.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.059 1.344 . . . . 0.0 111.931 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.9 m -88.51 -32.8 18.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.42 1.488 . . . . 0.0 112.361 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.6 tp -55.42 106.54 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.761 1.224 . . . . 0.0 111.623 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -146.29 168.98 19.73 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.825 1.25 . . . . 0.0 109.747 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.85 -37.87 14.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 114.05 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.85 -34.27 71.38 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 20' ' ' VAL . 46.9 t -72.51 -48.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.191 1.397 . . . . 0.0 110.198 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 170' ' ' GLN . 86.5 mt -54.31 -44.84 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 112.629 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.87 -45.5 77.89 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.963 0.505 . . . . 0.0 111.624 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -56.34 -41.54 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.821 1.649 . . . . 0.0 113.044 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 16' ' ' VAL . 67.0 t -50.07 -55.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.197 1.399 . . . . 0.0 111.193 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.17 -38.65 88.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 112.479 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -49.63 75.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.12 1.368 . . . . 0.0 110.741 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.01 -36.07 61.96 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.08 -50.94 69.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.66 1.584 . . . . 0.0 112.23 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 62.83 0.36 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.893 1.235 . . . . 0.0 112.328 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -45.94 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.617 2.367 . . . . 0.0 114.04 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.5 -166.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.591 1.956 . . . . 0.0 111.211 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -43.78 -41.34 4.89 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.819 2.047 . . . . 0.0 113.99 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -144.38 138.91 28.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.551 1.94 . . . . 0.0 108.84 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HE3' ' CB ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -167.34 146.39 5.04 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.234 2.214 . . . . 0.0 109.591 -172.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -137.92 160.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.608 1.163 . . . . 0.0 110.916 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.49 118.04 31.57 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.995 1.318 . . . . 0.0 109.034 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.4 139.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.87 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.65 118.14 0.88 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.921 0.772 . . . . 0.0 111.711 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.79 97.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.128 0.971 . . . . 0.0 108.461 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -76.96 117.51 18.63 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 0.0 111.403 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -92.77 101.7 14.09 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.976 0.894 . . . . 0.0 112.215 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -111.38 12.46 21.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.451 1.1 . . . . 0.0 113.489 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -56.42 -51.97 66.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.1 1.76 . . . . 0.0 114.36 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.42 4.83 0.74 Allowed Glycine 0 CA--C 1.538 1.526 0 N-CA-C 116.505 1.362 . . . . 0.0 116.505 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 166.85 32.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.642 1.721 . . . . 0.0 114.348 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 t -69.94 126.93 31.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.125 1.37 . . . . 0.0 112.401 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -98.99 165.33 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.63 1.572 . . . . 0.0 111.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 m -135.41 106.97 6.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.104 1.362 . . . . 0.0 109.574 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.23 132.33 52.38 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.66 -72.63 0.3 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.587 0.755 . . . . 0.0 110.291 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.51 165.33 8.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.499 1.92 . . . . 0.0 111.048 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -114.21 124.18 51.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.885 1.674 . . . . 0.0 109.772 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.21 108.77 19.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.549 1.14 . . . . 0.0 111.37 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -73.31 118.54 16.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.481 1.112 . . . . 0.0 110.896 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.62 12.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.769 1.228 . . . . 0.0 111.942 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -143.42 150.98 39.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.78 2.032 . . . . 0.0 111.397 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.29 51.7 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.183 0.897 . . . . 0.0 113.648 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -149.13 163.23 38.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.875 -0.779 . . . . 0.0 111.094 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -142.43 130.17 21.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.892 1.277 . . . . 0.0 110.095 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.01 2.9 54.63 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.546 1.538 . . . . 0.0 113.521 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.71 169.76 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.697 1.199 . . . . 0.0 111.134 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.07 131.53 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.203 1.001 . . . . 0.0 110.037 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -76.44 154.27 83.91 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 118.289 0.495 . . . . 0.0 111.169 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HG3' HG23 ' A' ' 6' ' ' ILE . 45.9 Cg_endo -70.93 167.76 25.02 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.365 3.377 . . . . 0.0 109.957 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.14 -16.75 12.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.061 -1.025 . . . . 0.0 112.952 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -128.99 144.0 51.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.483 1.513 . . . . 0.0 109.958 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 6' ' ' ILE . 26.5 t -143.52 99.48 5.28 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.674 1.19 . . . . 0.0 109.634 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.61 155.02 71.82 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.884 1.723 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -55.86 150.2 13.58 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.953 -0.467 . . . . 0.0 111.597 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 0.9 OUTLIER 68.83 -7.3 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.185 2.194 . . . . 0.0 115.417 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -101.58 141.71 34.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.402 1.455 . . . . 0.0 108.07 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -112.73 154.48 26.1 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.213 -0.929 . . . . 0.0 111.784 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -90.94 171.01 9.59 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.44 175.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -135.45 134.11 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.577 2.351 . . . . 0.0 107.364 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -150.19 162.35 40.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.766 1.626 . . . . 0.0 111.206 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.6 m -154.21 155.32 35.04 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.367 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 31' ' ' ILE . . . -150.42 143.65 10.93 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 121.2 -0.937 . . . . 0.0 113.411 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.06 163.63 29.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.779 1.232 . . . . 0.0 113.48 -172.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 99.32 7.86 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.699 1.237 . . . . 0.0 110.411 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 36.28 -131.0 0.1 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.87 2.468 . . . . 0.0 113.191 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -57.54 -53.67 55.57 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.806 -1.184 . . . . 0.0 112.73 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.22 -61.93 0.41 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.47 -8.72 23.91 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 124.433 3.422 . . . . 0.0 115.554 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.91 163.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.347 1.459 . . . . 0.0 112.836 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.64 74.51 1.01 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.056 1.342 . . . . 0.0 112.599 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 83' ' ' GLY . 2.8 t -106.99 -107.91 0.32 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.723 1.609 . . . . 0.0 109.76 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 82' ' ' THR . . . -171.57 174.88 45.14 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.628 2.537 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -136.82 93.13 2.81 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.067 1.347 . . . . 0.0 109.584 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.84 124.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.55 157.82 42.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.33 130.53 17.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.95 0.9 . . . . 0.0 110.916 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -131.58 176.44 8.32 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.734 1.613 . . . . 0.0 110.241 -172.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 150.35 44.79 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.466 0.651 . . . . 0.0 112.686 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -132.88 114.11 13.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 111.02 -175.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -79.54 123.54 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.219 1.408 . . . . 0.0 111.239 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 mtp -81.63 157.28 24.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.179 1.391 . . . . 0.0 112.257 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 p -62.2 -19.52 63.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.233 1.413 . . . . 0.0 114.757 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -84.06 -11.39 56.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.005 1.722 . . . . 0.0 113.755 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.85 -5.06 46.46 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.936 1.255 . . . . 0.0 115.11 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -76.12 171.82 13.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.654 1.182 . . . . 0.0 110.213 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 m -136.69 140.7 42.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.979 0.912 . . . . 0.0 110.158 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 123.51 50.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.51 139.08 18.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.14 122.18 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.711 1.205 . . . . 0.0 110.242 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.0 159.61 40.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -134.03 153.7 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.47 1.508 . . . . 0.0 110.913 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 t -137.1 104.79 5.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.574 1.55 . . . . 0.0 110.009 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 41.5 t -105.65 97.05 13.48 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 127.032 2.133 . . . . 0.0 108.475 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.57 167.05 28.23 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.773 2.316 . . . . 0.0 111.617 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -69.69 -45.27 68.66 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.614 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 114.59 26.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.573 1.549 . . . . 0.0 111.569 -165.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -65.76 -62.07 1.72 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.07 12.35 22.28 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -7.72 5.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.606 1.963 . . . . 0.0 112.568 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.68 139.92 19.42 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.458 2.303 . . . . 0.0 109.116 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 t -98.55 159.23 15.09 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -84.22 157.78 21.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.792 -0.567 . . . . 0.0 109.805 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -138.98 145.67 40.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.986 0.915 . . . . 0.0 110.819 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -155.32 148.21 24.46 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.864 1.265 . . . . 0.0 110.792 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.59 151.36 37.16 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.46 107.45 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.825 1.65 . . . . 0.0 109.77 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -115.86 148.03 40.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.221 1.408 . . . . 0.0 109.724 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.51 111.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.863 2.065 . . . . 0.0 109.241 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -118.33 145.13 45.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 0.0 112.349 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.6 t -73.35 90.11 1.64 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.385 1.074 . . . . 0.0 110.79 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.63 -174.23 42.04 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.476 0.56 . . . . 0.0 113.768 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 111.68 23.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.047 2.139 . . . . 0.0 110.908 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -147.84 156.56 42.84 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.312 -0.868 . . . . 0.0 111.655 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -140.38 167.4 22.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.522 1.529 . . . . 0.0 111.299 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.73 86.79 0.94 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.537 1.135 . . . . 0.0 111.555 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -111.18 -67.0 1.03 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 108.911 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.18 -67.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.849 1.26 . . . . 0.0 109.779 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.23 -36.62 90.12 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.961 0.791 . . . . 0.0 114.325 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.5 ttp -65.71 -48.26 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.791 1.295 . . . . 0.0 111.642 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.19 -49.42 75.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.674 0.79 . . . . 0.0 111.068 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -64.82 -37.33 87.26 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.37 -20.86 61.08 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.163 -1.585 . . . . 0.0 113.286 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.71 -50.41 5.39 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.484 1.513 . . . . 0.0 112.132 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -75.32 -57.16 4.06 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.587 1.085 . . . . 0.0 112.76 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.73 -19.35 49.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.337 1.455 . . . . 0.0 111.858 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.51 -90.14 0.05 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.003 1.287 . . . . 0.0 112.467 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.02 79.17 1.99 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.073 1.349 . . . . 0.0 110.598 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 150.1 52.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.689 1.593 . . . . 0.0 111.546 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 164.51 26.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.864 0.866 . . . . 0.0 109.171 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.76 118.61 36.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.143 1.377 . . . . 0.0 108.856 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.32 65.5 1.63 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.878 0.763 . . . . 0.0 112.627 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -82.52 18.69 1.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.437 1.895 . . . . 0.0 113.647 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 64.52 43.35 4.5 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.526 1.93 . . . . 0.0 112.63 -173.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.64 153.57 21.72 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.604 1.573 . . . . 0.0 113.652 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -70.15 133.57 47.24 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.613 1.165 . . . . 0.0 111.893 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.91 113.73 14.38 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.294 1.837 . . . . 0.0 110.158 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.58 153.7 41.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.684 1.594 . . . . 0.0 110.578 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -166.48 150.65 7.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.237 1.815 . . . . 0.0 110.23 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.09 127.48 32.28 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.164 0.893 . . . . 0.0 110.143 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 tt -135.48 -39.74 0.73 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.522 1.129 . . . . 0.0 112.09 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.85 20.98 10.25 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.008 1.29 . . . . 0.0 114.475 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.73 14.46 4.1 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.991 2.116 . . . . 0.0 114.668 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 177.3 -56.85 0.1 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.065 1.793 . . . . 0.0 110.955 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.43 153.69 21.71 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.904 0.859 . . . . 0.0 110.128 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.6 169.51 24.51 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.043 1.337 . . . . 0.0 112.331 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -100.89 140.85 34.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.661 1.184 . . . . 0.0 111.606 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -126.38 113.91 17.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -146.36 172.19 27.01 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-O 121.661 0.589 . . . . 0.0 113.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.8 tt -153.63 145.91 14.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 126.466 1.907 . . . . 0.0 108.316 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.3 ttm -140.96 137.91 33.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.223 1.009 . . . . 0.0 109.24 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.89 161.02 30.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.428 1.891 . . . . 0.0 112.187 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -33.95 23.15 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.335 -0.853 . . . . 0.0 113.269 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.13 172.62 6.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 112.536 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.22 -42.07 99.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.352 -0.843 . . . . 0.0 113.27 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.443 ' CB ' ' HE3' ' A' ' 30' ' ' LYS . 10.9 pt-20 -81.52 57.91 3.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.858 1.663 . . . . 0.0 113.908 178.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.74 170.61 9.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 124.02 15.73 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.025 -1.047 . . . . 0.0 112.559 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.02 91.17 3.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.699 2.0 . . . . 0.0 111.899 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 17' ' ' LEU . 4.1 tt0 -87.45 139.02 30.97 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.874 -0.516 . . . . 0.0 110.373 165.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.5 114.27 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.618 1.967 . . . . 0.0 108.37 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -110.01 108.52 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 110.177 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.8 mm -89.13 120.22 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.658 1.183 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 49.9 m -117.32 170.02 9.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.597 1.559 . . . . 0.0 112.789 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.895 2.078 . . . . 0.0 113.667 -179.4 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.58 54.56 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.205 -0.935 . . . . 0.0 111.578 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 41.34 11.99 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.301 0.953 . . . . 0.0 114.732 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.8 p -142.88 -169.67 3.06 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 119.194 1.497 . . . . 0.0 112.902 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 pt -122.99 127.25 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.615 2.366 . . . . 0.0 110.757 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.59 166.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.767 1.227 . . . . 0.0 111.787 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 110.91 1.96 Allowed 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.658 -1.277 . . . . 0.0 113.044 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -29.08 61.51 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.164 0.888 . . . . 0.0 113.752 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.97 74.49 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.267 -1.137 . . . . 0.0 112.834 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -89.59 -18.39 26.67 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.945 1.298 . . . . 0.0 113.291 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' A' ' 34' ' ' GLY . 15.8 tp -65.41 115.34 5.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.126 1.371 . . . . 0.0 110.481 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -142.94 166.3 25.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.553 1.141 . . . . 0.0 110.043 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -40.26 26.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.706 1.602 . . . . 0.0 113.927 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.35 -34.95 74.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.314 1.446 . . . . 0.0 113.267 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.01 -45.68 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 109.82 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.63 -45.9 66.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.029 0.931 . . . . 0.0 112.435 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.31 -47.8 78.07 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.93 -0.481 . . . . 0.0 112.253 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -53.54 -42.17 67.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.783 1.233 . . . . 0.0 112.683 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -54.22 -57.08 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.829 0.852 . . . . 0.0 111.216 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 30' ' ' LYS . 2.8 mp -61.49 -40.9 96.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.028 1.331 . . . . 0.0 112.671 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.98 -45.89 82.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.528 0.731 . . . . 0.0 112.164 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.98 -21.02 29.69 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.26 -45.65 87.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.713 2.005 . . . . 0.0 113.605 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 32.78 7.17 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 114.747 0.659 . . . . 0.0 114.747 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 174.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.831 2.052 . . . . 0.0 114.293 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.33 -162.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.177 1.791 . . . . 0.0 111.478 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -54.5 -24.63 21.37 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -123.75 141.69 51.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.191 1.796 . . . . 0.0 110.293 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.732 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -161.1 149.32 15.84 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.342 1.857 . . . . 0.0 111.555 -170.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.406 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 3.7 pt -143.41 145.93 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.795 1.638 . . . . 0.0 109.917 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.23 121.64 41.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.403 1.481 . . . . 0.0 108.029 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.96 136.46 50.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.108 1.763 . . . . 0.0 110.589 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.5 120.74 1.23 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.014 1.292 . . . . 0.0 111.829 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.56 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.262 1.425 . . . . 0.0 108.451 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 104.94 8.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.071 0.948 . . . . 0.0 112.095 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -73.61 96.89 2.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.484 0.714 . . . . 0.0 110.684 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -122.25 21.62 10.34 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.106 1.762 . . . . 0.0 112.08 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.6 t -71.53 -43.23 66.82 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.294 1.438 . . . . 0.0 113.687 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.03 16.83 3.17 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.925 1.726 . . . . 0.0 115.667 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.83 155.44 26.81 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 119.597 1.698 . . . . 0.0 115.057 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -68.45 132.02 46.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -105.12 165.25 11.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.504 1.522 . . . . 0.0 111.849 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 m -134.45 113.76 12.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.105 1.362 . . . . 0.0 108.921 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.5 136.6 57.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.155 -0.966 . . . . 0.0 109.557 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.29 -70.76 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -177.48 175.78 1.38 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.617 2.367 . . . . 0.0 110.082 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.26 150.02 50.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.171 2.188 . . . . 0.0 109.306 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 112.3 8.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.232 . . . . 0.0 110.256 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -71.69 121.39 18.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.487 1.115 . . . . 0.0 110.846 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -95.5 -43.54 7.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.106 0.963 . . . . 0.0 112.032 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.4 m -141.22 156.89 45.85 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.935 2.094 . . . . 0.0 110.299 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.1 -176.74 53.86 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.468 0.556 . . . . 0.0 113.508 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -137.67 164.44 28.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.602 1.161 . . . . 0.0 111.027 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -144.38 175.47 10.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.451 1.1 . . . . 0.0 111.76 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -134.23 17.05 3.75 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.367 1.067 . . . . 0.0 112.279 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.95 166.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.818 2.047 . . . . 0.0 112.565 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.96 134.14 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.833 1.653 . . . . 0.0 109.632 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 154.47 86.42 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.993 0.815 . . . . 0.0 112.339 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.42 172.47 13.23 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.452 3.435 . . . . 0.0 110.525 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -113.38 -21.41 10.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -125.62 125.81 43.72 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 110.675 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.97 95.0 19.45 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.034 1.333 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.04 160.33 34.53 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.876 1.717 . . . . 0.0 111.23 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.61 156.86 10.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.801 -0.562 . . . . 0.0 111.586 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m 75.13 -22.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.182 2.193 . . . . 0.0 112.892 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -100.68 141.66 33.24 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.547 1.939 . . . . 0.0 109.576 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.05 178.0 4.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.775 2.03 . . . . 0.0 109.558 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.28 175.92 5.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 109.796 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -129.28 124.37 34.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.633 1.573 . . . . 0.0 107.363 174.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -146.0 150.17 35.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.592 0.357 . . . . 0.0 110.723 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.4 m -147.35 158.93 44.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.35 0.595 . . . . 0.0 111.129 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.01 10.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.515 1.531 . . . . 0.0 111.183 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -131.72 168.91 16.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.524 1.53 . . . . 0.0 110.467 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.52 179.34 0.47 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.029 0.932 . . . . 0.0 110.098 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.94 -179.98 0.24 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 121.114 -0.991 . . . . 0.0 111.264 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -28.58 -49.64 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.375 2.67 . . . . 0.0 115.939 -172.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.58 -59.61 0.33 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.016 1.293 . . . . 0.0 112.677 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.77 -2.66 11.77 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.25 3.3 . . . . 0.0 115.067 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.71 124.2 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.462 1.505 . . . . 0.0 111.297 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.24 75.71 1.66 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.19 1.796 . . . . 0.0 111.786 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.8 m -100.58 -75.44 0.58 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.623 1.169 . . . . 0.0 111.244 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.57 -176.52 45.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.74 1.162 . . . . 0.0 112.253 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.54 105.29 5.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.695 1.198 . . . . 0.0 110.671 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.18 120.41 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.311 1.044 . . . . 0.0 108.585 -171.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.94 168.59 19.89 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.89 0.852 . . . . 0.0 111.526 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.57 156.25 43.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.077 0.951 . . . . 0.0 111.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.73 175.52 11.9 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.777 2.031 . . . . 0.0 110.66 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.35 43.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.897 0.879 . . . . 0.0 111.504 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -125.73 118.66 26.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 110.957 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.52 117.43 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.992 1.717 . . . . 0.0 110.309 176.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.9 mtm -75.58 162.6 28.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.487 0.66 . . . . 0.0 112.492 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -60.41 -21.55 62.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.928 1.291 . . . . 0.0 114.078 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -83.23 -12.19 57.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.05 2.14 . . . . 0.0 113.56 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.03 -1.56 57.78 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.475 1.512 . . . . 0.0 115.252 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.35 171.22 15.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.066 1.347 . . . . 0.0 110.143 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.0 m -131.59 148.34 52.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.746 0.818 . . . . 0.0 110.473 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.42 112.81 18.52 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.761 1.224 . . . . 0.0 108.237 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.44 141.9 29.43 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.25 127.69 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 109.191 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -140.72 162.97 34.15 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 17.9 p90 -140.43 159.93 41.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.84 1.256 . . . . 0.0 111.46 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -140.71 112.8 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.939 1.696 . . . . 0.0 109.351 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.33 101.06 54.3 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.265 1.826 . . . . 0.0 108.48 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 163.88 34.49 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.554 2.169 . . . . 0.0 111.756 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.59 -26.72 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.06 114.48 27.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.04 1.336 . . . . 0.0 111.506 -172.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.33 -57.17 4.02 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.325 1.05 . . . . 0.0 113.66 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.13 13.65 12.65 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.908 -1.12 . . . . 0.0 113.807 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.72 -19.26 2.36 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.241 1.816 . . . . 0.0 113.438 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -141.83 169.6 17.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.934 2.893 . . . . 0.0 108.753 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 t -132.95 161.21 34.89 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.017 -1.052 . . . . 0.0 109.867 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -88.53 161.32 17.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.793 0.806 . . . . 0.0 111.415 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -141.58 151.46 43.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.116 0.966 . . . . 0.0 110.688 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.5 p-90 -154.17 157.83 39.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.124 1.37 . . . . 0.0 110.492 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -150.83 146.92 26.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.922 2.089 . . . . 0.0 109.509 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.02 117.88 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.534 1.534 . . . . 0.0 108.797 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -122.42 140.13 53.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.818 1.247 . . . . 0.0 110.471 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -109.38 117.33 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.777 2.031 . . . . 0.0 108.525 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.79 145.43 50.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.164 1.386 . . . . 0.0 112.836 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 p -75.61 79.51 2.6 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.139 1.775 . . . . 0.0 112.661 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.03 173.54 23.92 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.147 1.356 . . . . 0.0 112.82 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 148.99 48.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.876 1.27 . . . . 0.0 111.683 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.8 112.69 2.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.433 1.093 . . . . 0.0 111.622 174.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.38 175.93 9.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.127 0.971 . . . . 0.0 110.564 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.56 99.08 4.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.825 1.65 . . . . 0.0 108.452 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.05 -70.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.108 0.963 . . . . 0.0 110.226 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -67.47 0.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.56 1.144 . . . . 0.0 110.84 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.66 -9.08 84.83 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.429 1.014 . . . . 0.0 115.252 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -43.65 9.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.518 1.127 . . . . 0.0 111.083 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -36.91 83.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.65 1.18 . . . . 0.0 111.299 175.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.74 -29.72 66.94 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.067 -1.02 . . . . 0.0 113.092 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -20.09 63.31 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.717 1.207 . . . . 0.0 112.816 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.08 -50.89 5.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.108 1.363 . . . . 0.0 109.196 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.06 -47.4 84.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -94.44 -13.87 25.78 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.045 0.938 . . . . 0.0 113.103 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.53 -62.85 5.43 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.547 1.07 . . . . 0.0 113.049 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -177.17 78.41 0.25 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 128.392 2.677 . . . . 0.0 108.694 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.3 157.62 60.6 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.493 1.462 . . . . 0.0 110.833 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.97 6.35 41.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.11 65.09 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.732 2.813 . . . . 0.0 113.617 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -44.02 101.56 0.03 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.399 1.952 . . . . 0.0 115.177 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.58 28.29 1.53 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.16 2.184 . . . . 0.0 113.314 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.55 52.75 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.251 1.821 . . . . 0.0 112.849 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -151.59 154.38 25.52 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.276 1.417 . . . . 0.0 113.178 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -62.95 117.05 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.642 1.177 . . . . 0.0 113.31 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -108.09 119.18 38.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.152 2.181 . . . . 0.0 110.966 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.94 133.01 15.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.151 0.98 . . . . 0.0 111.236 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -146.3 130.12 17.16 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.688 1.195 . . . . 0.0 111.981 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.85 107.98 0.79 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.048 1.339 . . . . 0.0 112.277 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.65 -32.34 3.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.009 1.324 . . . . 0.0 112.872 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.28 22.16 6.46 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.049 1.309 . . . . 0.0 114.821 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 56.84 8.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 115.631 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.64 -57.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.328 1.442 . . . . 0.0 111.413 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.64 156.53 17.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.832 0.825 . . . . 0.0 112.18 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.82 168.35 27.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.871 1.668 . . . . 0.0 112.21 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.5 141.46 28.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.878 0.871 . . . . 0.0 110.871 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.16 104.13 7.13 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.33 169.66 24.18 Favored Glycine 0 N--CA 1.454 -0.13 0 CA-C-O 121.888 0.716 . . . . 0.0 114.526 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.78 144.43 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.691 1.196 . . . . 0.0 109.312 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 ttt -141.94 130.16 22.21 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.777 1.231 . . . . 0.0 108.556 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.1 p -88.31 163.05 16.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 110.952 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -96.12 -22.47 17.3 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.45 172.95 4.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.492 1.517 . . . . 0.0 113.165 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.59 -41.8 42.92 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.344 1.45 . . . . 0.0 114.158 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.87 78.34 8.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 111.105 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.41 79.85 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.804 0.841 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.23 149.16 24.85 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 120.868 -1.145 . . . . 0.0 110.549 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.1 ttm -144.58 124.53 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.766 1.227 . . . . 0.0 109.975 -174.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -141.14 139.02 33.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.96 92.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.776 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.24 107.02 17.74 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.319 1.448 . . . . 0.0 108.553 174.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.79 131.37 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 0.0 110.73 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 p -154.51 165.4 36.55 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 128.468 2.707 . . . . 0.0 111.903 175.867 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 57' ' ' VAL . . . -68.27 148.52 50.68 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.806 -1.184 . . . . 0.0 112.287 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.81 36.85 91.32 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.84 0.733 . . . . 0.0 114.2 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -142.28 175.79 9.49 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.908 0.854 . . . . 0.0 112.34 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 pt -118.17 138.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.789 1.636 . . . . 0.0 111.38 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 2' ' ' LEU . 7.5 pt -146.76 174.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.12 1.768 . . . . 0.0 111.587 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 103.53 0.11 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 112.364 175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.42 -25.66 67.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.252 0.93 . . . . 0.0 113.9 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.88 14.79 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -117.43 7.31 12.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.804 1.641 . . . . 0.0 113.218 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 114.48 11.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.513 1.125 . . . . 0.0 112.199 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.6 m -146.25 172.55 13.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.261 1.425 . . . . 0.0 110.601 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.426 ' H ' HG22 ' A' ' 13' ' ' THR . 22.2 m-85 -48.41 -37.64 17.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.935 1.694 . . . . 0.0 114.188 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -56.41 -35.9 68.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.652 1.181 . . . . 0.0 113.302 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.79 -47.48 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.082 1.753 . . . . 0.0 109.643 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.59 -46.18 80.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.393 1.077 . . . . 0.0 113.237 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.16 -42.75 99.49 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.654 -0.654 . . . . 0.0 111.103 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -39.23 72.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.758 1.223 . . . . 0.0 113.516 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.5 -59.55 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.294 1.038 . . . . 0.0 110.601 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.72 -42.24 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.49 1.516 . . . . 0.0 112.406 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.17 -53.34 54.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.176 0.99 . . . . 0.0 112.167 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.35 -42.59 62.06 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.52 -52.38 22.84 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.379 1.872 . . . . 0.0 112.349 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.01 59.79 0.23 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.607 1.098 . . . . 0.0 112.552 -172.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 141.74 6.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.588 1.155 . . . . 0.0 112.516 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -160.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.771 1.628 . . . . 0.0 110.825 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -50.69 -31.91 17.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.238 1.415 . . . . 0.0 113.058 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -146.39 143.78 29.29 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.591 2.357 . . . . 0.0 110.237 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -164.69 153.54 12.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 128.078 2.551 . . . . 0.0 110.185 -173.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.518 ' CG2' HG21 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -146.08 150.3 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.822 1.649 . . . . 0.0 109.953 175.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.51 123.85 51.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.614 1.166 . . . . 0.0 110.777 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -116.48 123.85 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.602 1.561 . . . . 0.0 110.778 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.67 112.05 0.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.854 1.216 . . . . 0.0 112.3 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 mt -109.18 111.09 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.635 1.174 . . . . 0.0 109.427 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.93 131.15 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.947 0.899 . . . . 0.0 113.228 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.51 93.16 7.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.552 0.741 . . . . 0.0 110.572 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.94 20.37 11.58 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.411 1.485 . . . . 0.0 112.278 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -85.56 -40.94 15.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.815 1.646 . . . . 0.0 114.748 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 12.48 10.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 -173.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.99 161.14 29.46 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.336 1.568 . . . . 0.0 115.05 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -76.99 127.4 32.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.211 1.404 . . . . 0.0 112.122 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -102.86 162.12 13.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.322 1.449 . . . . 0.0 111.62 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -133.46 115.89 15.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.844 1.257 . . . . 0.0 109.439 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.18 137.16 57.44 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.005 -1.059 . . . . 0.0 110.355 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.27 -71.02 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -174.72 176.54 2.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.992 2.117 . . . . 0.0 110.563 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -124.95 154.69 40.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.953 2.101 . . . . 0.0 109.841 175.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.73 106.04 6.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.035 1.334 . . . . 0.0 110.564 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.85 105.02 5.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.791 1.237 . . . . 0.0 111.18 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -78.37 -51.94 9.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.937 1.295 . . . . 0.0 111.692 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -137.27 155.88 48.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.901 2.081 . . . . 0.0 110.361 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 -173.64 52.06 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.722 -0.611 . . . . 0.0 113.329 -174.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -134.88 176.32 8.76 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.641 1.176 . . . . 0.0 110.316 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -150.5 178.12 9.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.525 1.53 . . . . 0.0 110.479 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -139.3 18.15 2.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.179 1.391 . . . . 0.0 112.025 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 3' ' ' ALA . 9.0 m -134.6 171.76 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.892 2.077 . . . . 0.0 110.809 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mt -143.87 132.3 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.377 1.071 . . . . 0.0 109.463 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -75.55 150.17 84.33 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.587 0.63 . . . . 0.0 111.572 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.68 166.3 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.73 2.954 . . . . 0.0 109.928 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 58.3 tt0 -105.81 -30.01 9.67 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.312 -0.868 . . . . 0.0 111.572 174.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -117.26 127.81 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.547 1.139 . . . . 0.0 111.029 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.06 91.31 24.17 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.89 1.276 . . . . 0.0 108.911 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -63.19 162.79 25.24 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.34 2.027 . . . . 0.0 111.483 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -57.61 158.72 5.73 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 72.5 -35.42 0.33 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.941 2.097 . . . . 0.0 114.211 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -86.91 124.71 33.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.08 171.63 8.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.431 1.092 . . . . 0.0 109.493 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.84 163.26 13.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.53 133.27 48.38 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.248 1.819 . . . . 0.0 107.824 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.8 167.22 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 110.438 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -156.52 160.41 39.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.57 0.7 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 127.41 3.24 Favored Glycine 0 N--CA 1.462 0.415 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.32 167.16 15.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.223 1.012 . . . . 0.0 110.082 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 179.98 1.49 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 109.886 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -172.67 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.824 1.649 . . . . 0.0 111.357 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.1 m -25.94 -56.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 127.312 2.245 . . . . 0.0 115.238 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.43 -57.07 0.41 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.596 1.093 . . . . 0.0 113.831 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.79 -2.34 11.76 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.621 3.548 . . . . 0.0 115.574 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.66 130.84 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.96 1.704 . . . . 0.0 110.792 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.68 88.6 5.44 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.567 -1.333 . . . . 0.0 111.959 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.4 m -122.83 -86.51 0.65 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 111.522 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.41 -177.97 42.74 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.781 1.173 . . . . 0.0 112.938 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.52 108.65 6.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.063 0.945 . . . . 0.0 111.012 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.93 119.63 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.987 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.42 171.45 14.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.995 0.902 . . . . 0.0 111.587 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.09 40.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.312 1.045 . . . . 0.0 111.716 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.38 175.76 11.54 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.711 1.605 . . . . 0.0 110.415 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -133.95 140.87 47.04 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.833 1.253 . . . . 0.0 110.602 176.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -123.89 113.53 18.62 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.58 1.152 . . . . 0.0 111.356 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.39 118.71 15.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.765 1.626 . . . . 0.0 110.691 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.7 mtt -73.06 163.53 28.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 112.181 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -62.52 -21.03 65.22 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.76 1.224 . . . . 0.0 113.884 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.71 -16.22 39.71 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.76 1.624 . . . . 0.0 113.515 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.38 2.12 47.51 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.192 1.377 . . . . 0.0 115.647 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -86.23 173.53 9.71 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.738 1.215 . . . . 0.0 110.421 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.443 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 26.1 m -136.04 143.22 44.58 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.144 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.15 115.76 30.71 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 135.12 15.13 Favored Glycine 0 N--CA 1.463 0.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 117' ' ' VAL . 6.0 m -137.2 126.85 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 118.049 0.925 . . . . 0.0 109.704 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.3 153.65 51.1 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.717 0.807 . . . . 0.0 110.673 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 13.4 p90 -135.01 154.55 51.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.749 . . . . 0.0 111.991 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -137.08 109.55 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 110.773 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.518 HG21 ' CG2' ' A' ' 31' ' ' ILE . 58.4 t -110.7 106.17 57.58 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 124.527 1.131 . . . . 0.0 110.257 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.18 161.81 39.99 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.944 2.429 . . . . 0.0 112.007 174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.0 -28.23 64.27 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.783 0.833 . . . . 0.0 112.807 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.36 120.86 41.21 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.471 1.508 . . . . 0.0 110.955 -170.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -73.93 -63.91 1.12 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.81 9.23 19.71 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.884 -1.135 . . . . 0.0 114.031 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -5.62 6.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.259 2.224 . . . . 0.0 112.225 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 138.75 10.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.678 1.991 . . . . 0.0 109.583 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -103.27 159.56 15.45 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.07 -1.019 . . . . 0.0 110.031 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -80.23 161.69 25.03 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.866 -0.521 . . . . 0.0 109.738 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -139.51 143.53 37.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.708 0.803 . . . . 0.0 110.804 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -155.06 149.77 26.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.658 1.583 . . . . 0.0 110.239 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -149.01 154.72 39.75 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.993 1.717 . . . . 0.0 107.675 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 100' ' ' VAL . 66.7 t -147.37 116.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 126.87 2.068 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -123.39 148.15 46.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.542 1.537 . . . . 0.0 110.096 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 mt -110.97 112.57 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 108.821 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -127.39 136.39 51.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 112.2 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.1 p -76.67 81.68 3.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.324 1.45 . . . . 0.0 112.58 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.35 178.6 45.31 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.27 0.938 . . . . 0.0 113.645 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -111.78 104.99 13.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.497 1.919 . . . . 0.0 110.885 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -145.81 158.14 43.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.918 1.287 . . . . 0.0 111.228 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.25 163.97 29.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.125 1.37 . . . . 0.0 112.527 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.57 79.07 1.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.633 1.173 . . . . 0.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.21 -67.37 0.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.057 1.343 . . . . 0.0 109.576 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -149.3 -72.56 0.18 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.368 1.867 . . . . 0.0 108.801 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.9 64.59 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.94 1.257 . . . . 0.0 114.732 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.3 ttp -83.85 -57.83 3.05 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.288 1.044 . . . . 0.0 110.409 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -48.85 -49.83 37.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.083 1.353 . . . . 0.0 111.638 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -62.36 -32.25 73.01 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.01 -13.55 62.28 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.155 -0.965 . . . . 0.0 113.12 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.01 -47.96 5.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.445 1.498 . . . . 0.0 109.456 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.06 -61.51 2.0 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.637 -1.29 . . . . 0.0 112.35 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.58 -19.89 48.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 111.658 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.39 -80.91 0.07 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.334 1.445 . . . . 0.0 112.828 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.36 86.29 0.89 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.318 1.447 . . . . 0.0 110.529 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.62 160.2 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.696 1.597 . . . . 0.0 111.709 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.94 1.01 39.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.52 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 33.87 60.03 0.54 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.796 2.438 . . . . 0.0 114.25 176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -20.23 82.4 0.0 OUTLIER Glycine 0 N--CA 1.472 1.083 0 C-N-CA 129.409 3.385 . . . . 0.0 116.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.0 35.41 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.424 1.49 . . . . 0.0 112.052 -172.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 68.25 26.36 6.96 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.59 1.556 . . . . 0.0 112.245 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.89 146.01 18.0 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.552 1.549 . . . . 0.0 113.3 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -65.97 138.15 57.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.858 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.67 118.04 18.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.041 1.736 . . . . 0.0 110.641 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.97 145.64 32.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.296 1.438 . . . . 0.0 110.903 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -146.31 121.83 10.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.248 1.419 . . . . 0.0 110.549 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.09 91.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.682 1.593 . . . . 0.0 113.358 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.96 4.5 1.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.32 22.57 31.83 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.578 -1.326 . . . . 0.0 115.881 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.52 7.69 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.597 1.959 . . . . 0.0 115.39 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.38 -36.71 0.19 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.764 -1.21 . . . . 0.0 114.365 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.0 mp -129.48 147.64 51.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.02 1.328 . . . . 0.0 110.681 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 173.94 9.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.122 1.369 . . . . 0.0 111.956 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.17 139.96 38.48 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.69 1.596 . . . . 0.0 109.56 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -131.76 107.75 8.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.567 1.547 . . . . 0.0 108.086 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.9 171.57 19.17 Favored Glycine 0 CA--C 1.517 0.217 0 CA-C-O 121.382 0.434 . . . . 0.0 113.477 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.7 143.83 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 124.506 1.122 . . . . 0.0 109.215 176.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.9 ttm -144.17 140.16 29.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.882 1.673 . . . . 0.0 109.014 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.19 157.72 27.8 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.505 2.322 . . . . 0.0 111.562 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.83 5.91 26.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.309 -1.494 . . . . 0.0 114.801 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.43 177.53 4.82 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.703 2.001 . . . . 0.0 112.77 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.67 -67.87 1.99 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.368 0.985 . . . . 0.0 112.269 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 2.9 pt-20 -74.85 39.52 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.536 1.934 . . . . 0.0 115.223 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.03 138.94 58.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.378 1.071 . . . . 0.0 112.861 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.28 124.35 35.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 109.2 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 17.7 mtp -117.87 107.15 13.76 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.863 1.665 . . . . 0.0 109.971 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -114.96 151.4 34.17 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.521 -0.737 . . . . 0.0 111.358 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.8 96.62 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.733 1.613 . . . . 0.0 110.912 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -84.81 107.86 17.19 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.864 1.666 . . . . 0.0 109.919 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.3 mm -84.51 117.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.401 -0.812 . . . . 0.0 110.089 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 m -141.9 169.95 16.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.471 1.509 . . . . 0.0 113.195 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.355 1.862 . . . . 0.0 111.526 -178.047 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 HG21 ' A' ' 7' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.546 0.821 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 20' ' ' VAL . . . -71.45 156.38 39.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.696 -1.252 . . . . 0.0 111.484 174.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.06 36.87 90.41 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.33 -168.52 3.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 111.923 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.39 149.14 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.671 1.588 . . . . 0.0 111.29 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 2' ' ' LEU . 1.6 pt -151.25 169.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.343 1.857 . . . . 0.0 112.577 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.44 124.81 17.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.892 1.677 . . . . 0.0 111.755 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.9 48.38 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.284 0.945 . . . . 0.0 113.976 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.99 82.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.916 1.286 . . . . 0.0 112.49 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 -30.92 35.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.832 0.853 . . . . 0.0 112.385 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.61 HD22 ' CB ' ' A' ' 68' ' ' ALA . 7.8 tp -59.66 90.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.625 1.97 . . . . 0.0 113.635 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -146.73 169.29 19.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 0.0 109.368 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 17' ' ' LEU . 2.6 m-85 -43.98 -37.46 2.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.018 1.727 . . . . 0.0 114.735 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.2 -39.24 78.48 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.38 -42.05 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.665 . . . . 0.0 110.74 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.465 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.1 mt -53.79 -47.73 70.5 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.304 1.041 . . . . 0.0 111.386 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.16 -42.55 96.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.437 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -58.79 -39.28 80.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.177 1.391 . . . . 0.0 113.668 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 3' ' ' ALA . 54.2 t -62.8 -55.37 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.548 1.539 . . . . 0.0 109.867 175.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 32' ' ' ALA . 3.3 mp -55.68 -45.9 77.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 0.0 112.49 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.15 -38.04 81.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.05 -43.9 41.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 113.058 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.71 -53.87 41.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.502 1.521 . . . . 0.0 111.173 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.13 63.02 0.11 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.356 0.979 . . . . 0.0 112.516 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -42.89 127.95 4.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 110.653 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.79 -165.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.353 1.861 . . . . 0.0 110.212 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -48.99 -45.46 42.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.647 1.579 . . . . 0.0 114.358 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -139.3 129.7 25.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.469 1.907 . . . . 0.0 109.569 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.43 155.54 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.112 2.165 . . . . 0.0 110.049 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 102' ' ' PHE . 6.2 pt -137.17 162.49 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.173 0.989 . . . . 0.0 111.46 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -110.93 116.22 30.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.835 1.254 . . . . 0.0 109.529 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.63 142.95 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.709 1.203 . . . . 0.0 110.86 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.28 122.55 1.13 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.314 0.959 . . . . 0.0 111.953 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.0 mt -113.04 102.7 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.151 1.38 . . . . 0.0 108.654 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.61 111.81 19.45 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.72 0.808 . . . . 0.0 112.231 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -71.69 99.76 2.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.793 1.237 . . . . 0.0 111.117 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.68 14.31 15.34 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.26 1.824 . . . . 0.0 113.281 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.4 t -70.09 -45.59 66.67 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.93 8.08 5.29 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.234 1.397 . . . . 0.0 116.058 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.67 160.47 29.02 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 119.578 1.689 . . . . 0.0 113.634 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.9 p -73.96 138.87 44.47 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.722 -0.869 . . . . 0.0 112.185 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -112.84 167.05 10.81 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.777 1.231 . . . . 0.0 112.006 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -131.92 105.78 7.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.128 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.5 122.68 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.21 -66.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.34 163.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.211 2.604 . . . . 0.0 110.155 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -108.77 123.91 49.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.349 1.86 . . . . 0.0 110.4 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.95 111.71 19.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.301 1.041 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.26 124.34 26.91 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.993 1.317 . . . . 0.0 111.993 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -47.63 7.26 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.093 1.357 . . . . 0.0 112.241 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -135.37 149.17 49.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.537 1.935 . . . . 0.0 109.951 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.06 -157.5 50.18 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.891 -0.506 . . . . 0.0 113.09 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -152.86 -176.71 5.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.521 0.676 . . . . 0.0 112.2 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -141.97 173.95 11.04 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.183 1.793 . . . . 0.0 111.367 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -121.51 12.79 10.85 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.927 1.291 . . . . 0.0 112.229 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.31 176.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.047 2.139 . . . . 0.0 113.628 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.95 135.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.53 1.932 . . . . 0.0 109.776 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.01 142.48 41.66 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 118.765 0.711 . . . . 0.0 110.606 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.81 164.86 22.85 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.95 3.1 . . . . 0.0 111.117 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -107.55 -17.61 14.06 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.502 -0.749 . . . . 0.0 112.716 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.64 133.97 53.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.956 1.702 . . . . 0.0 111.097 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.88 88.04 23.69 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.896 1.678 . . . . 0.0 108.868 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.42 161.13 32.38 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.919 1.746 . . . . 0.0 112.06 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.44 153.66 34.63 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.407 -0.808 . . . . 0.0 111.448 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 p 66.23 5.04 3.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.692 1.997 . . . . 0.0 114.267 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -123.39 147.81 46.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.621 2.368 . . . . 0.0 110.108 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.61 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -126.57 160.44 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.647 1.179 . . . . 0.0 111.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.16 170.75 8.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.408 0.623 . . . . 0.0 110.335 175.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 20' ' ' VAL . 3.3 mm? -126.44 133.89 51.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.334 1.854 . . . . 0.0 108.877 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -152.82 162.44 41.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.191 1.397 . . . . 0.0 111.536 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -142.37 166.6 24.24 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.769 1.228 . . . . 0.0 110.972 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.75 115.24 0.77 Allowed Glycine 0 N--CA 1.472 1.092 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.769 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 156.22 20.92 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.18 1.49 . . . . 0.0 114.378 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -72.88 110.64 7.34 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 40.78 -151.19 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.69 1.596 . . . . 0.0 113.664 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -74.14 -49.57 23.17 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.958 -1.714 . . . . 0.0 111.286 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.91 -59.27 0.37 Allowed Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.665 1.126 . . . . 0.0 114.394 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.33 0.15 7.22 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.699 3.599 . . . . 0.0 114.984 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.32 132.48 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 127.599 2.36 . . . . 0.0 109.364 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.82 71.84 0.81 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.034 1.333 . . . . 0.0 110.516 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 m -97.27 -65.03 0.99 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.01 0.924 . . . . 0.0 110.895 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.61 176.41 35.52 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.988 1.28 . . . . 0.0 111.712 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -138.69 108.34 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.065 0.946 . . . . 0.0 110.479 175.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.36 138.9 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.96 0.904 . . . . 0.0 109.585 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.11 161.98 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.967 0.907 . . . . 0.0 110.779 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.43 20.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.786 0.803 . . . . 0.0 112.976 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -132.57 169.0 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.795 1.638 . . . . 0.0 109.446 -172.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.98 148.96 47.23 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.42 104.57 6.18 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 111.796 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -73.54 111.82 9.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.084 1.354 . . . . 0.0 111.639 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 160.41 30.72 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 112.317 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 p -60.99 -20.08 62.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 m -84.78 -16.09 42.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.524 1.93 . . . . 0.0 113.84 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.52 4.95 46.13 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.39 0.995 . . . . 0.0 115.565 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.51 165.31 13.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.449 1.5 . . . . 0.0 108.757 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -136.32 151.11 49.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 109.566 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.38 130.55 56.57 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.278 0.631 . . . . 0.0 110.354 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.21 138.74 18.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.5 t -136.02 118.0 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.354 1.062 . . . . 0.0 108.816 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptm -121.46 156.89 31.8 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -124.39 141.03 52.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.104 1.362 . . . . 0.0 108.852 174.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -130.63 104.37 7.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.907 0.883 . . . . 0.0 110.75 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 t -115.61 101.57 54.21 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.007 2.123 . . . . 0.0 109.119 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.39 168.07 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.273 1.982 . . . . 0.0 110.454 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -75.37 -41.33 56.69 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.707 -0.621 . . . . 0.0 110.32 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.35 121.86 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.637 1.175 . . . . 0.0 111.954 -166.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -72.83 -59.83 2.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -91.29 9.44 31.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -4.37 5.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.023 2.129 . . . . 0.0 112.538 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.71 158.34 36.76 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.791 2.436 . . . . 0.0 109.111 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 169.36 10.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.826 -1.171 . . . . 0.0 111.602 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.26 148.36 25.14 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.752 -0.592 . . . . 0.0 110.445 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.51 157.63 44.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.035 0.534 . . . . 0.0 112.351 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -161.67 136.83 7.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.411 1.484 . . . . 0.0 110.396 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.76 147.51 48.62 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.28 118.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.099 1.36 . . . . 0.0 110.623 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.23 138.23 53.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.1 1.76 . . . . 0.0 109.452 174.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.4 mt -109.37 119.66 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.178 1.791 . . . . 0.0 108.543 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 147.61 52.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 0.0 112.555 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 p -74.0 80.97 1.7 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.652 1.981 . . . . 0.0 112.27 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.29 -166.8 37.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.705 -0.622 . . . . 0.0 114.393 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -113.18 115.87 28.93 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.384 1.874 . . . . 0.0 111.361 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -134.09 83.76 2.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.043 2.537 . . . . 0.0 108.46 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 168.36 5.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.657 1.183 . . . . 0.0 110.95 177.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.19 99.04 8.5 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 111.15 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -106.67 -70.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.112 0.965 . . . . 0.0 110.706 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -150.0 -68.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.167 1.787 . . . . 0.0 109.811 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.39 -24.26 77.11 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.386 0.993 . . . . 0.0 114.893 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -76.33 -56.63 4.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.266 1.033 . . . . 0.0 109.82 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -35.51 63.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.859 0.864 . . . . 0.0 111.429 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.06 -34.0 54.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -61.43 -41.26 96.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.903 0.881 . . . . 0.0 111.093 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.79 -38.0 73.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.858 -1.152 . . . . 0.0 111.715 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -74.06 -51.73 14.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -88.0 -17.89 30.22 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 113.079 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.87 -80.24 0.08 OUTLIER Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.711 1.148 . . . . 0.0 112.066 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -170.15 74.78 0.63 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.74 1.616 . . . . 0.0 110.968 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.19 135.37 31.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 119.918 1.006 . . . . 0.0 109.788 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -60.19 156.86 14.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.743 1.217 . . . . 0.0 110.439 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -93.36 5.01 53.01 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -165.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 53.95 55.61 24.98 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.559 1.076 . . . . 0.0 112.654 -172.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.33 24.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.571 1.548 . . . . 0.0 114.901 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.252 10.1 p30 48.31 34.45 4.6 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.665 2.386 . . . . 0.0 115.021 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.38 159.62 26.75 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.912 1.72 . . . . 0.0 112.058 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -61.78 127.37 31.12 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 110.934 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -122.91 105.67 10.2 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.144 1.778 . . . . 0.0 109.637 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -138.38 137.12 36.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.579 1.952 . . . . 0.0 110.89 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -147.8 133.44 18.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.264 1.426 . . . . 0.0 110.964 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -58.9 123.96 18.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.995 0.518 . . . . 0.0 111.347 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 tt -147.6 -34.29 0.25 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.182 0.993 . . . . 0.0 112.342 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.71 19.7 5.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.182 1.372 . . . . 0.0 114.748 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 t80 60.06 9.27 1.75 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.799 2.44 . . . . 0.0 114.966 -175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.74 -71.38 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.403 1.478 . . . . 0.0 110.74 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.53 151.43 21.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.949 0.88 . . . . 0.0 111.419 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.55 171.32 14.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.72 1.608 . . . . 0.0 111.527 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -87.15 147.09 25.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.512 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -137.07 103.39 5.12 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.894 2.078 . . . . 0.0 108.506 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -133.02 169.43 22.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-O 121.593 0.552 . . . . 0.0 112.884 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.61 141.06 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.905 1.682 . . . . 0.0 108.769 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.4 ttt -144.35 140.48 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 171.94 14.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.098 0.959 . . . . 0.0 111.553 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.0 p -93.67 7.71 43.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.52 1.528 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.22 165.22 12.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.635 1.974 . . . . 0.0 112.063 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.87 -55.29 29.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.209 0.909 . . . . 0.0 113.784 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.09 59.39 2.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 113.251 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.06 171.81 7.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.905 1.282 . . . . 0.0 112.859 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.465 ' HB3' HD13 ' A' ' 17' ' ' LEU . 10.0 mptt -120.71 141.61 50.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 108.421 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.8 ttp -133.88 83.7 2.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.076 1.35 . . . . 0.0 111.014 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.39 158.17 20.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.452 0.644 . . . . 0.0 111.524 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.94 122.02 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.866 2.067 . . . . 0.0 108.419 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -113.39 103.81 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.571 2.348 . . . . 0.0 108.941 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.36 119.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.437 -0.79 . . . . 0.0 110.802 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 p -152.13 169.27 22.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.376 1.07 . . . . 0.0 112.956 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.729 2.411 . . . . 0.0 112.934 176.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -58.0 150.93 19.57 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.82 -1.175 . . . . 0.0 111.683 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.28 49.13 34.32 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.425 0.535 . . . . 0.0 113.687 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.5 p -146.78 -166.38 2.48 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.193 0.997 . . . . 0.0 112.115 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.02 132.26 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.68 2.392 . . . . 0.0 110.74 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 pt -142.46 170.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.461 1.504 . . . . 0.0 111.777 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 111.19 1.02 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.484 1.114 . . . . 0.0 112.185 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.25 -24.33 67.23 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.424 1.011 . . . . 0.0 113.363 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.61 78.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.786 1.234 . . . . 0.0 111.983 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.5 -24.83 22.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.82 1.248 . . . . 0.0 113.196 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.6 tp -59.23 110.36 1.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.266 1.426 . . . . 0.0 111.534 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 m -146.78 168.16 22.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.654 1.582 . . . . 0.0 109.669 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.23 1.812 . . . . 0.0 113.814 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -58.01 -35.8 71.77 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -73.63 -46.05 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.494 1.518 . . . . 0.0 109.859 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.5 mt -54.48 -44.88 73.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 0.0 113.008 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.17 -39.09 88.81 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.714 0.406 . . . . 0.0 111.927 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -50.21 74.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.013 1.325 . . . . 0.0 111.622 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 74.8 t -53.51 -50.04 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.766 1.226 . . . . 0.0 111.994 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 32' ' ' ALA . 5.7 mp -60.11 -41.87 93.53 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.212 1.005 . . . . 0.0 112.359 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -43.68 90.78 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 110.781 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.38 -31.01 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.163 1.785 . . . . 0.0 114.271 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.3 tp -66.81 -51.48 55.23 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.697 1.199 . . . . 0.0 110.014 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.25 54.62 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.103 1.335 . . . . 0.0 111.991 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -43.54 129.1 5.26 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.713 1.605 . . . . 0.0 112.817 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -164.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.183 1.393 . . . . 0.0 112.144 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.0 t -42.43 -33.02 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.993 2.517 . . . . 0.0 113.958 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -153.31 137.89 16.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.599 1.96 . . . . 0.0 109.804 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 155.69 20.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.688 2.395 . . . . 0.0 110.416 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -135.49 152.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.531 1.132 . . . . 0.0 109.509 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -111.06 122.75 48.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.171 0.988 . . . . 0.0 108.365 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.0 135.47 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.593 1.157 . . . . 0.0 110.803 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.33 129.55 3.39 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.177 0.894 . . . . 0.0 111.82 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mm -117.87 103.33 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.046 0.938 . . . . 0.0 109.742 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.96 122.45 27.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.899 1.28 . . . . 0.0 113.304 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.88 96.21 3.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.437 1.895 . . . . 0.0 112.02 175.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -123.83 30.81 6.05 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 112.137 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.7 t -91.96 -48.12 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.916 1.687 . . . . 0.0 114.142 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.07 17.73 4.02 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.288 0.947 . . . . 0.0 115.453 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.22 159.92 31.62 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.039 1.42 . . . . 0.0 114.125 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -70.51 135.83 48.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.079 0.952 . . . . 0.0 111.858 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -109.95 168.43 9.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.449 1.5 . . . . 0.0 111.382 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.3 m -134.61 107.14 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 109.108 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.64 124.96 24.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.911 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.89 -64.87 0.78 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.307 0.643 . . . . 0.0 109.966 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.63 172.24 0.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.825 2.45 . . . . 0.0 110.736 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.95 135.84 48.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.446 2.298 . . . . 0.0 110.105 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -124.3 114.83 20.08 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 111.361 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -72.0 106.95 4.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.485 1.514 . . . . 0.0 112.357 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -50.02 44.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.131 1.773 . . . . 0.0 110.71 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -136.0 155.95 49.48 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.518 1.527 . . . . 0.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.75 -156.51 39.85 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 123.042 0.353 . . . . 0.0 113.395 -172.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -154.21 -176.17 5.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 110.534 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 73' ' ' GLY . 17.2 p -139.37 -179.31 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.49 1.516 . . . . 0.0 111.384 174.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.63 12.87 13.24 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.639 1.176 . . . . 0.0 111.586 174.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 3' ' ' ALA . 3.0 m -132.13 175.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.154 1.781 . . . . 0.0 113.151 -170.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 134.86 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.392 1.477 . . . . 0.0 110.091 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.44 141.12 56.51 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.256 -0.902 . . . . 0.0 110.601 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.84 163.68 32.51 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.045 3.163 . . . . 0.0 111.091 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -104.83 -21.22 13.37 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.816 -1.178 . . . . 0.0 112.945 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -126.51 137.14 53.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.127 1.371 . . . . 0.0 110.155 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.54 97.99 7.31 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 110.257 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -64.57 162.12 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.682 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.88 154.3 9.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.615 -0.678 . . . . 0.0 111.584 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m 72.03 -23.55 0.19 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.978 1.711 . . . . 0.0 113.83 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -95.89 126.87 41.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.707 1.603 . . . . 0.0 110.714 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.41 171.94 8.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.009 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -110.24 169.07 8.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.47 133.47 52.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.516 1.527 . . . . 0.0 110.505 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.96 166.73 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.129 0.971 . . . . 0.0 111.09 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 p -160.46 170.22 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.53 1.132 . . . . 0.0 110.635 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -151.71 137.27 5.89 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.664 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.55 161.42 30.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.123 1.462 . . . . 0.0 112.529 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -70.7 113.03 7.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t0 32.31 -136.8 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.565 2.346 . . . . 0.0 114.138 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -61.64 -46.18 90.89 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.5 -1.375 . . . . 0.0 111.053 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.57 -58.58 0.45 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.025 -0.875 . . . . 0.0 115.079 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -71.77 8.08 1.41 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 125.207 3.938 . . . . 0.0 115.44 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.84 132.92 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.001 2.52 . . . . 0.0 110.561 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.63 88.45 3.07 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.544 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -114.77 -84.69 0.61 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.164 1.786 . . . . 0.0 110.866 178.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 82' ' ' THR . . . 172.61 173.68 39.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 127.262 2.363 . . . . 0.0 110.802 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.63 109.41 7.1 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.584 1.154 . . . . 0.0 109.442 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.49 126.71 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 120.789 -1.194 . . . . 0.0 108.259 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.35 169.01 24.71 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.78 157.78 43.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.17 0.988 . . . . 0.0 111.603 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.17 169.9 20.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.895 1.678 . . . . 0.0 110.657 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.98 146.67 41.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.048 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -127.78 115.82 19.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.906 1.283 . . . . 0.0 111.525 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -81.08 112.61 18.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.194 1.398 . . . . 0.0 111.0 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.8 mtp -74.01 158.06 35.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.963 0.905 . . . . 0.0 111.414 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -62.35 -18.85 62.53 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.7 m -80.23 -15.34 57.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 113.739 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.26 55.2 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.668 1.128 . . . . 0.0 115.194 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -85.62 166.7 16.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.194 0.998 . . . . 0.0 110.384 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -137.08 153.53 50.54 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 110.73 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.62 134.14 53.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 108.991 174.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.63 8.48 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 117' ' ' VAL . 2.6 m -126.76 137.29 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 117.537 0.668 . . . . 0.0 110.488 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.31 161.31 35.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.648 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.04 142.54 47.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.983 1.313 . . . . 0.0 109.516 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -127.16 114.25 17.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.757 1.623 . . . . 0.0 109.086 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.85 92.61 48.35 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.478 1.511 . . . . 0.0 108.931 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.29 167.97 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.165 2.576 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.42 -23.69 37.38 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.626 -0.671 . . . . 0.0 112.437 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.54 111.93 24.81 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.327 -1.483 . . . . 0.0 112.392 -165.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.21 -51.81 22.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.39 12.34 29.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.51 1.124 . . . . 0.0 113.575 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.14 -11.0 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.491 1.917 . . . . 0.0 112.716 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.32 175.92 11.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.722 2.809 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m -145.86 164.86 30.63 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.492 -1.38 . . . . 0.0 111.167 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.04 138.16 34.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 110.276 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 152.61 49.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.315 0.507 . . . . 0.0 112.063 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -159.32 146.76 17.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.423 1.889 . . . . 0.0 110.634 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.32 149.47 49.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.148 1.379 . . . . 0.0 110.154 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 100' ' ' VAL . 22.5 t -145.77 105.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.315 1.046 . . . . 0.0 111.481 177.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -117.42 134.03 55.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.111 1.364 . . . . 0.0 110.365 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -97.75 112.39 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.296 1.438 . . . . 0.0 109.355 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -115.17 147.83 39.79 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.873 1.669 . . . . 0.0 112.826 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 p -75.74 82.59 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.739 1.615 . . . . 0.0 112.881 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.81 -173.91 36.57 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.529 1.061 . . . . 0.0 113.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -112.4 130.82 55.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.471 1.509 . . . . 0.0 111.59 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -153.24 163.97 38.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.594 1.157 . . . . 0.0 112.2 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -139.36 148.87 43.47 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.603 1.561 . . . . 0.0 111.621 -171.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.99 90.69 0.64 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.245 1.018 . . . . 0.0 111.957 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.15 -68.57 0.92 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.517 1.527 . . . . 0.0 110.812 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -144.37 -76.19 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.533 1.933 . . . . 0.0 108.959 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.8 -28.54 73.51 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.381 0.991 . . . . 0.0 114.701 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -57.46 5.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.086 0.943 . . . . 0.0 109.576 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -52.25 -40.87 62.27 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.921 1.289 . . . . 0.0 111.107 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -55.48 -43.28 75.42 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.641 -0.662 . . . . 0.0 112.734 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 -19.43 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.977 -1.077 . . . . 0.0 112.346 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.4 mt -91.37 -55.57 3.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.557 1.543 . . . . 0.0 111.435 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -74.82 -46.32 37.47 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.341 -0.85 . . . . 0.0 113.029 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.17 -17.47 30.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.232 -0.917 . . . . 0.0 111.121 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.76 52.5 4.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.357 0.979 . . . . 0.0 114.132 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 36.05 72.44 0.77 Allowed Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.623 2.369 . . . . 0.0 114.133 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 140.14 57.76 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.936 1.757 . . . . 0.0 109.027 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 143.77 55.73 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.81 0.844 . . . . 0.0 109.528 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 12.88 21.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.831 1.252 . . . . 0.0 113.818 -166.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 58.32 57.68 18.54 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.204 0.907 . . . . 0.0 112.145 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -72.57 33.96 0.07 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.802 1.241 . . . . 0.0 114.217 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.0 p30 45.97 34.24 1.91 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.833 2.853 . . . . 0.0 115.791 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -145.66 167.41 27.61 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.031 1.776 . . . . 0.0 112.262 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.96 123.48 21.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.417 0.687 . . . . 0.0 110.53 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -119.71 116.75 26.59 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.082 1.753 . . . . 0.0 108.684 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.09 131.69 15.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.989 1.316 . . . . 0.0 110.735 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -141.84 122.58 14.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.717 1.207 . . . . 0.0 110.72 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.19 115.57 3.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.445 0.698 . . . . 0.0 111.486 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.48 -36.42 0.98 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -77.73 22.49 2.78 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.118 1.342 . . . . 0.0 114.672 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 t80 58.01 10.74 1.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.245 2.618 . . . . 0.0 115.177 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.86 -60.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.929 1.728 . . . . 0.0 110.178 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.83 150.29 21.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 122.062 0.935 . . . . 0.0 112.479 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 163.1 35.18 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.413 1.885 . . . . 0.0 111.402 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.12 151.39 29.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.436 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -143.44 110.98 5.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.502 1.921 . . . . 0.0 108.262 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.7 32.47 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-O 121.642 0.579 . . . . 0.0 114.071 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.79 141.04 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.081 1.752 . . . . 0.0 109.311 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.7 ttt -144.84 142.41 29.91 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.25 1.82 . . . . 0.0 107.887 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.22 165.71 22.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.955 0.902 . . . . 0.0 111.042 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.93 14.97 12.35 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.609 1.164 . . . . 0.0 112.875 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.26 167.52 11.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 111.661 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.92 -59.94 8.83 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.943 0.783 . . . . 0.0 114.492 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -76.4 40.85 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.443 1.497 . . . . 0.0 114.254 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.04 157.3 35.06 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.847 1.259 . . . . 0.0 112.702 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -103.11 140.49 37.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 108.43 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.9 ttp -132.04 116.53 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.582 1.553 . . . . 0.0 109.461 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 138.8 43.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.7 106.76 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.208 1.403 . . . . 0.0 108.556 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -94.81 105.34 17.26 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.966 2.106 . . . . 0.0 109.204 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.27 124.97 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.4 m -128.28 177.1 7.18 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.571 1.148 . . . . 0.0 111.771 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 128.261 2.625 . . . . 0.0 113.342 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -55.31 139.62 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.907 1.283 . . . . 0.0 111.985 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.79 40.85 8.54 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.099 0.857 . . . . 0.0 114.278 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 p -146.38 -165.69 2.28 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.571 1.185 . . . . 0.0 111.945 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.98 143.86 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.365 1.866 . . . . 0.0 110.487 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.19 165.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.297 . . . . 0.0 112.248 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 119.37 6.72 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.799 1.24 . . . . 0.0 111.066 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.07 -18.73 42.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.195 0.902 . . . . 0.0 113.897 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.92 -38.05 76.13 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.953 1.301 . . . . 0.0 111.735 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -31.33 27.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.843 1.257 . . . . 0.0 112.444 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.562 HD22 ' CB ' ' A' ' 68' ' ' ALA . 10.5 tp -50.02 100.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.61 1.964 . . . . 0.0 112.422 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -145.79 164.78 30.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.216 1.406 . . . . 0.0 109.843 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -46.95 -40.24 13.93 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.443 1.497 . . . . 0.0 114.125 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.54 -47.31 86.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.166 0.586 . . . . 0.0 112.197 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.1 t -57.0 -48.66 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.804 0.841 . . . . 0.0 109.547 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.32 -47.04 76.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.629 0.771 . . . . 0.0 112.669 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.05 -42.97 88.8 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.686 -0.633 . . . . 0.0 112.366 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.15 -42.46 77.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.299 1.44 . . . . 0.0 112.917 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' VAL . 89.1 t -51.77 -57.04 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.57 1.548 . . . . 0.0 109.721 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.501 HD23 ' HD2' ' A' ' 30' ' ' LYS . 5.0 mp -62.11 -38.22 88.07 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.618 1.567 . . . . 0.0 113.108 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -49.5 76.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.634 -0.666 . . . . 0.0 111.599 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.47 -15.83 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HH12 ' A' ' 74' ' ' ARG . 27.7 tp -65.39 -53.72 39.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.816 2.046 . . . . 0.0 112.841 175.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.55 29.57 7.74 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 174.82 0.14 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.928 2.091 . . . . 0.0 114.671 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 28' ' ' SER . 1.4 p -103.38 -168.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.487 1.915 . . . . 0.0 111.049 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 27' ' ' VAL . 66.1 m -49.59 -28.01 5.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.94 53.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.762 1.625 . . . . 0.0 109.601 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -171.43 146.19 2.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 112.154 -167.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -141.66 152.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.097 1.359 . . . . 0.0 110.167 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.61 114.4 24.04 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 109.661 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 t -102.08 137.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.845 1.258 . . . . 0.0 110.38 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.66 114.59 0.71 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.048 0.832 . . . . 0.0 113.384 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.72 106.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.47 1.108 . . . . 0.0 110.573 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -89.3 104.65 17.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.846 1.658 . . . . 0.0 112.306 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -72.98 105.46 4.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.125 1.77 . . . . 0.0 111.333 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.5 22.51 8.37 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.611 1.964 . . . . 0.0 112.606 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -84.8 -29.22 25.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.549 1.54 . . . . 0.0 114.679 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.64 20.4 8.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.047 1.784 . . . . 0.0 115.391 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.49 17.38 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 118.984 1.392 . . . . 0.0 114.408 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -66.36 141.12 58.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.169 0.988 . . . . 0.0 112.812 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -115.07 170.71 8.15 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.919 1.688 . . . . 0.0 111.499 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 m -135.39 110.2 8.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 108.912 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.37 50.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.52 -1.362 . . . . 0.0 109.969 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -71.11 -68.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.525 0.73 . . . . 0.0 109.791 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.92 174.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.677 2.391 . . . . 0.0 110.58 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -127.6 144.18 51.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.541 2.337 . . . . 0.0 108.797 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.19 110.97 11.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.546 1.139 . . . . 0.0 110.269 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.61 121.63 18.25 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.262 1.025 . . . . 0.0 111.165 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.27 -41.42 8.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.964 1.306 . . . . 0.0 112.372 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m -138.29 149.35 45.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.578 1.151 . . . . 0.0 110.685 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.07 54.2 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.158 0.408 . . . . 0.0 113.163 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -151.99 175.0 12.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.933 0.893 . . . . 0.0 111.196 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.556 HG22 ' HA2' ' A' ' 73' ' ' GLY . 23.7 p -140.45 177.11 8.24 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.236 1.414 . . . . 0.0 111.336 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -127.22 16.09 7.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.652 1.181 . . . . 0.0 112.684 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 3' ' ' ALA . 15.5 m -134.55 176.85 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.711 2.004 . . . . 0.0 112.745 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.25 137.07 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.484 1.914 . . . . 0.0 109.467 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.3 154.76 82.11 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 119.902 1.228 . . . . 0.0 112.333 176.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.97 165.32 31.59 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 124.026 3.15 . . . . 0.0 109.58 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.87 -18.02 14.04 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.1 144.13 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.492 1.517 . . . . 0.0 110.161 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.51 92.66 5.49 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.88 1.272 . . . . 0.0 110.287 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.16 155.26 66.1 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.769 1.646 . . . . 0.0 111.362 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.3 155.16 12.09 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.094 -0.379 . . . . 0.0 111.095 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m 74.4 -22.42 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.236 1.814 . . . . 0.0 113.027 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -99.47 146.38 26.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.925 1.69 . . . . 0.0 109.016 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.562 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -115.53 162.3 17.38 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.769 1.228 . . . . 0.0 111.934 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 167.78 10.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.446 174.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.75 126.74 43.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.899 2.48 . . . . 0.0 108.652 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -144.37 151.22 38.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.823 0.849 . . . . 0.0 110.97 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -155.76 157.51 36.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.733 0.813 . . . . 0.0 110.883 -174.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -150.4 166.66 30.15 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.199 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.458 HH12 HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -139.85 158.01 44.79 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.86 1.33 . . . . 0.0 113.064 -174.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 ptmm? -74.96 113.75 12.63 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 39.62 -147.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.646 1.578 . . . . 0.0 113.887 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.7 m -77.72 -47.73 18.38 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.496 -1.378 . . . . 0.0 111.334 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.85 -60.53 0.36 Allowed Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.819 -0.989 . . . . 0.0 114.455 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.29 -2.51 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.612 3.541 . . . . 0.0 114.974 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.42 142.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.007 1.723 . . . . 0.0 108.705 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.94 69.15 1.19 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 0.0 110.982 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.4 m -96.65 -61.62 1.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.144 0.978 . . . . 0.0 111.335 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.88 172.15 31.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.737 1.16 . . . . 0.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -134.96 111.45 9.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.744 1.218 . . . . 0.0 110.364 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.57 135.82 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.969 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.76 162.33 40.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.107 1.363 . . . . 0.0 110.594 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.51 40.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.406 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.12 171.66 13.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.247 1.819 . . . . 0.0 110.365 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -139.72 152.0 46.31 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.971 177.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -128.18 117.14 21.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 110.715 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -79.56 110.56 15.0 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.444 1.498 . . . . 0.0 110.872 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 73.8 mtm -78.77 160.07 27.59 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.8 p -60.75 -17.76 50.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -73.75 -14.53 61.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.956 . . . . 0.0 112.491 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.52 7.46 72.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.689 1.138 . . . . 0.0 113.982 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -92.85 163.61 13.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.019 1.328 . . . . 0.0 109.736 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.428 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 54.1 m -125.19 152.74 44.1 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.121 0.968 . . . . 0.0 109.802 175.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.94 131.95 53.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.765 0.826 . . . . 0.0 109.904 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.52 140.77 19.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.64 126.33 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.666 1.186 . . . . 0.0 109.283 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.86 157.21 45.61 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 112.058 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.79 139.42 53.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.143 1.377 . . . . 0.0 110.554 175.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 m -127.27 114.12 17.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.708 1.203 . . . . 0.0 109.76 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 98.7 t -119.05 99.77 50.8 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.322 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.81 172.23 16.69 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.235 1.957 . . . . 0.0 110.102 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.99 -59.51 2.69 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.297 -0.877 . . . . 0.0 111.418 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.32 122.22 17.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.757 2.023 . . . . 0.0 112.489 -167.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.54 -52.25 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.184 -0.948 . . . . 0.0 113.209 -175.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -87.89 -4.51 58.84 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.95 1.3 . . . . 0.0 113.465 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.8 -4.13 7.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 112.074 -164.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.43 167.58 29.55 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.741 2.816 . . . . 0.0 108.414 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.6 m -141.19 166.83 23.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -81.78 157.17 24.59 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.377 -0.827 . . . . 0.0 110.514 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -142.3 153.34 43.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.179 0.991 . . . . 0.0 110.587 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -152.16 159.8 43.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.564 1.546 . . . . 0.0 110.945 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.31 150.46 25.33 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -147.34 143.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 125.632 1.573 . . . . 0.0 110.354 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -149.04 146.55 27.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.168 1.787 . . . . 0.0 108.959 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.17 118.41 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.999 1.72 . . . . 0.0 108.89 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.81 148.3 44.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.768 1.627 . . . . 0.0 112.827 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.4 p -77.7 80.96 4.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.568 1.547 . . . . 0.0 112.912 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.84 179.98 27.94 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.081 1.324 . . . . 0.0 112.958 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 126.23 36.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.835 1.654 . . . . 0.0 111.367 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -135.29 147.38 49.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.116 2.166 . . . . 0.0 108.538 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -115.24 179.93 3.82 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.435 1.494 . . . . 0.0 110.063 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.47 94.02 4.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.163 0.985 . . . . 0.0 110.093 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.84 -69.95 0.79 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.931 0.893 . . . . 0.0 109.429 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -147.55 -69.4 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.984 1.314 . . . . 0.0 109.771 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.97 -28.8 73.94 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.457 1.027 . . . . 0.0 115.319 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -53.72 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.327 1.063 . . . . 0.0 110.249 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.48 -38.77 75.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.529 1.132 . . . . 0.0 111.148 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.98 -44.29 74.31 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.42 -0.8 . . . . 0.0 111.288 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -24.0 67.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.168 0.987 . . . . 0.0 113.128 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.09 -55.69 4.93 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.66 -48.25 81.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.998 1.319 . . . . 0.0 113.377 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -86.74 -11.72 50.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.7 0.8 . . . . 0.0 113.054 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.18 -71.69 0.69 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.104 0.859 . . . . 0.0 112.039 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.32 82.14 1.15 Allowed Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.604 1.561 . . . . 0.0 109.949 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.35 143.71 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.555 1.504 . . . . 0.0 110.885 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.442 ' HB3' ' CD2' ' A' ' 147' ' ' HIS . 38.8 m-85 -81.37 4.46 20.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.01 1.324 . . . . 0.0 113.563 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 57.72 10.95 1.18 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.74 2.816 . . . . 0.0 116.067 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 48.5 47.78 28.78 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.943 1.258 . . . . 0.0 112.611 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.92 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.25 12.2 p30 48.71 27.55 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.736 2.815 . . . . 0.0 115.711 178.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.16 151.44 20.76 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.718 1.628 . . . . 0.0 112.236 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -57.89 131.08 49.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 111.938 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.442 ' CD2' ' HB3' ' A' ' 140' ' ' TYR . 32.5 m-70 -124.22 114.19 19.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.335 1.854 . . . . 0.0 110.132 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.57 131.05 12.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.984 1.314 . . . . 0.0 111.986 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -144.57 126.0 14.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.34 1.856 . . . . 0.0 110.645 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.95 101.28 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.261 1.025 . . . . 0.0 113.051 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -124.92 -26.39 3.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.829 1.251 . . . . 0.0 113.467 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.45 13.97 43.35 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.926 1.251 . . . . 0.0 114.679 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 t80 61.0 7.77 1.65 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.619 2.367 . . . . 0.0 114.964 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.1 -57.46 0.04 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.075 1.321 . . . . 0.0 112.066 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.05 155.74 19.1 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.9 166.37 26.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.485 1.914 . . . . 0.0 112.169 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.07 135.29 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.079 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -125.72 101.7 6.99 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.03 169.42 22.11 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-O 121.565 0.536 . . . . 0.0 112.955 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 147.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 109.264 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 31.0 ttp -152.8 144.7 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.483 1.513 . . . . 0.0 107.259 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.2 p -86.65 163.01 17.63 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.865 0.84 . . . . 0.0 111.381 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.2 p -81.47 13.67 2.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.417 1.887 . . . . 0.0 113.121 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.38 151.69 35.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.028 2.531 . . . . 0.0 111.612 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.46 -57.21 16.3 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.145 0.879 . . . . 0.0 114.146 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.67 59.59 2.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 113.832 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.2 176.89 6.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.236 1.414 . . . . 0.0 113.989 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 136.05 48.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.339 1.856 . . . . 0.0 109.052 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.4 ttp -124.96 88.49 2.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.069 1.348 . . . . 0.0 110.801 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -83.67 153.8 24.03 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.553 -0.717 . . . . 0.0 111.746 165.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 57.9 mt -136.08 115.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.184 2.194 . . . . 0.0 106.893 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -113.12 97.14 6.32 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.434 1.894 . . . . 0.0 108.872 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.21 106.91 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.206 0.527 . . . . 0.0 110.748 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 m -139.82 -179.62 6.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.852 1.661 . . . . 0.0 112.041 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.147 1.779 . . . . 0.0 111.992 178.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 mt -134.3 18.18 3.7 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.118 1.367 . . . . 0.0 113.087 -178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.28 145.48 39.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.778 -1.201 . . . . 0.0 111.472 176.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.69 34.68 62.7 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 123.942 0.782 . . . . 0.0 114.363 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.9 p -146.14 -174.17 4.37 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 118.284 1.042 . . . . 0.0 111.843 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG22 ' HA ' ' A' ' 69' ' ' LEU . 3.7 pt -126.72 143.49 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.682 1.593 . . . . 0.0 111.772 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.36 167.17 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 126.035 1.734 . . . . 0.0 112.253 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 116.43 3.55 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.964 1.306 . . . . 0.0 113.057 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.49 -27.19 65.49 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.024 1.297 . . . . 0.0 113.141 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.77 -20.64 61.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.26 1.424 . . . . 0.0 113.448 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -110.35 -0.99 17.4 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.57 1.548 . . . . 0.0 112.834 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.7 tp -80.41 115.34 19.89 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.14 1.376 . . . . 0.0 112.013 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -142.2 169.18 18.06 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 125.232 1.413 . . . . 0.0 110.941 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.3 -40.96 50.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.865 1.666 . . . . 0.0 113.889 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -60.28 -32.05 70.82 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.373 1.069 . . . . 0.0 113.439 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.9 t -75.05 -45.31 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.019 1.728 . . . . 0.0 109.938 177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 170' ' ' GLN . 83.3 mt -54.6 -47.06 73.84 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.385 0.674 . . . . 0.0 110.635 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.88 -52.6 63.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.636 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -48.26 -47.89 35.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.673 1.189 . . . . 0.0 112.658 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -55.83 -58.77 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 124.728 1.211 . . . . 0.0 111.853 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.442 HD11 ' HD3' ' A' ' 30' ' ' LYS . 0.2 OUTLIER -62.21 -32.55 73.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.09 1.356 . . . . 0.0 113.076 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -66.47 -55.96 13.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.224 1.01 . . . . 0.0 111.229 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.27 -24.71 61.39 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tp -53.52 -48.29 69.17 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.741 1.616 . . . . 0.0 110.887 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.87 60.39 0.27 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 125.634 1.588 . . . . 0.0 111.662 -169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 ptmt -53.53 119.64 5.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.282 1.433 . . . . 0.0 112.301 175.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.62 -169.95 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.014 1.726 . . . . 0.0 110.074 174.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m -41.07 -42.96 2.09 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 127.708 2.403 . . . . 0.0 112.874 177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 35.8 mtm105 -143.0 144.52 32.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.377 1.871 . . . . 0.0 109.575 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.442 ' HD3' HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -173.99 165.08 4.24 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 128.71 2.804 . . . . 0.0 110.743 -170.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.8 HD13 ' CD2' ' A' ' 102' ' ' PHE . 32.8 pt -139.95 173.04 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 125.536 1.534 . . . . 0.0 110.652 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.01 107.15 6.34 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.991 1.316 . . . . 0.0 110.752 174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 t -98.69 137.67 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.983 1.313 . . . . 0.0 111.451 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.7 116.98 0.8 Allowed Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.746 0.689 . . . . 0.0 113.216 175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.3 mt -112.27 105.55 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 118.318 1.059 . . . . 0.0 109.694 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -84.6 108.87 17.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.293 1.437 . . . . 0.0 112.92 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -75.49 97.96 3.82 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.342 1.457 . . . . 0.0 111.393 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.2 8.94 12.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.469 1.908 . . . . 0.0 113.041 176.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.2 m -64.44 -44.94 89.58 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.09 -0.9 5.75 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.163 1.363 . . . . 0.0 116.329 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.85 161.76 28.07 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 119.745 1.773 . . . . 0.0 114.316 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 61.0 p -74.88 139.14 42.93 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.492 1.117 . . . . 0.0 113.112 -173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -111.8 163.31 14.32 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.696 1.199 . . . . 0.0 112.249 -178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.2 m -131.07 108.04 9.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.085 1.354 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.05 110.79 3.54 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.023 0.929 . . . . 0.0 108.987 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 mt -57.36 -63.9 1.07 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.699 1.6 . . . . 0.0 111.097 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.23 170.39 2.63 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 127.299 2.24 . . . . 0.0 111.152 175.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -125.7 139.3 53.66 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 127.308 2.243 . . . . 0.0 110.489 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -131.61 114.87 15.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.183 1.793 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.68 101.3 5.7 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.563 1.545 . . . . 0.0 111.808 175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.7 mtp180 -68.01 -42.96 79.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.219 1.408 . . . . 0.0 112.944 174.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.5 m -146.48 154.1 41.18 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.99 1.716 . . . . 0.0 111.381 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 74.55 -163.96 54.51 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.818 -0.551 . . . . 0.0 112.7 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.49 161.26 41.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.904 0.882 . . . . 0.0 110.546 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.9 m -145.43 137.7 25.72 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.331 1.052 . . . . 0.0 110.131 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -88.21 4.71 44.72 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.749 1.219 . . . . 0.0 113.353 -175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.516 ' H ' HG22 ' A' ' 55' ' ' THR . 9.0 m -120.53 175.35 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 126.33 1.852 . . . . 0.0 113.564 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -139.03 132.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.097 1.759 . . . . 0.0 109.843 -172.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 142.82 81.56 Favored Pre-proline 0 CA--C 1.552 1.044 0 O-C-N 121.663 -0.648 . . . . 0.0 110.332 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HG3' HG23 ' A' ' 6' ' ' ILE . 66.4 Cg_endo -66.73 175.22 5.54 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 125.091 3.861 . . . . 0.0 111.533 175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -113.15 -26.27 8.52 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.079 -1.013 . . . . 0.0 112.69 174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -124.02 130.56 52.77 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.425 1.09 . . . . 0.0 111.001 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.4 t -133.38 88.15 35.88 Favored Pre-proline 0 N--CA 1.474 0.734 0 C-N-CA 125.288 1.435 . . . . 0.0 109.425 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.32 163.39 23.61 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.306 2.004 . . . . 0.0 112.277 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -62.61 158.05 19.19 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.393 -0.817 . . . . 0.0 111.703 175.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 66.03 4.14 2.92 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 127.51 2.324 . . . . 0.0 114.208 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -126.9 147.9 50.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.325 1.85 . . . . 0.0 110.763 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.96 158.0 27.63 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.349 1.459 . . . . 0.0 110.993 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -96.91 167.61 10.98 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.29 132.16 47.11 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.934 1.694 . . . . 0.0 108.763 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.67 163.57 35.48 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.374 1.07 . . . . 0.0 111.925 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 51.7 m -143.08 177.17 8.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.185 1.394 . . . . 0.0 111.298 -178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.74 97.66 0.14 Allowed Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.729 -1.04 . . . . 0.0 113.307 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.95 166.21 10.58 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.982 1.391 . . . . 0.0 113.595 -173.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.6 pttt -86.38 101.35 13.04 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.064 0.946 . . . . 0.0 110.71 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.4 t0 39.65 -146.14 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 126.683 1.993 . . . . 0.0 112.405 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -61.76 -35.44 78.13 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 119.706 -1.871 . . . . 0.0 112.151 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 143.74 -58.86 0.53 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.299 1.428 . . . . 0.0 113.565 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.62 4.38 2.16 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 124.947 3.765 . . . . 0.0 115.382 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.05 126.04 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.124 2.169 . . . . 0.0 110.485 -173.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.33 62.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.429 1.491 . . . . 0.0 112.556 -169.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -66.31 0.91 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.691 1.596 . . . . 0.0 111.777 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 170.88 175.09 39.23 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 126.529 2.014 . . . . 0.0 110.334 -173.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -150.09 102.41 3.1 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.892 1.277 . . . . 0.0 107.937 174.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 41.0 t -144.97 134.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.036 1.734 . . . . 0.0 108.188 -172.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -156.67 159.52 38.48 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 124.382 1.073 . . . . 0.0 110.068 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.8 146.46 33.11 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 110.858 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.05 169.15 21.9 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.2 1.8 . . . . 0.0 110.236 -173.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.78 146.84 34.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.122 0.569 . . . . 0.0 111.703 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -128.83 118.83 23.39 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.824 0.85 . . . . 0.0 110.871 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.27 114.09 17.93 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.846 1.658 . . . . 0.0 110.274 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 18.7 mtt -70.72 162.47 29.0 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.491 0.662 . . . . 0.0 112.182 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.3 t -60.18 -23.45 63.98 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.82 1.248 . . . . 0.0 113.722 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -10.69 56.21 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.535 1.534 . . . . 0.0 113.39 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.56 9.86 56.14 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.772 1.177 . . . . 0.0 115.179 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -87.06 171.72 10.51 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.372 1.086 . . . . 0.0 110.263 174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 67.5 m -129.99 147.53 51.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.439 0.696 . . . . 0.0 110.961 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.08 111.75 16.32 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.26 139.54 28.21 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.566 HG22 HG12 ' A' ' 117' ' ' VAL . 18.5 t -143.31 131.54 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.066 0.947 . . . . 0.0 109.84 177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -143.77 160.51 40.61 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.93 -0.481 . . . . 0.0 111.77 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.8 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.3 OUTLIER -127.18 153.05 46.55 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.894 1.278 . . . . 0.0 110.187 175.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 m -145.89 113.36 6.3 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.976 174.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.0 110.55 43.69 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 126.634 1.974 . . . . 0.0 108.224 175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -79.33 175.27 10.95 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.486 2.791 . . . . 0.0 111.399 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -81.63 -40.94 22.19 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.814 -0.554 . . . . 0.0 111.269 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 112.51 24.33 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 121.476 -0.765 . . . . 0.0 112.789 -161.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -60.14 -54.85 41.02 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -103.17 17.16 24.72 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.14 1.376 . . . . 0.0 113.829 -176.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.62 -3.57 2.62 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.286 1.834 . . . . 0.0 112.748 -176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.25 -173.61 4.55 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 128.34 2.656 . . . . 0.0 109.692 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.9 t -152.58 160.65 43.19 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.492 1.517 . . . . 0.0 110.596 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -76.48 158.0 31.67 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.316 1.046 . . . . 0.0 110.214 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -143.68 151.88 40.64 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.283 -0.886 . . . . 0.0 111.932 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -164.38 154.55 14.47 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.952 1.701 . . . . 0.0 109.675 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -143.78 140.27 29.82 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.894 1.677 . . . . 0.0 108.8 176.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.566 HG12 HG22 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -139.21 124.37 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 128.952 2.901 . . . . 0.0 109.6 174.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -144.9 148.32 33.76 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.498 1.919 . . . . 0.0 109.894 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 30.5 mt -109.92 113.53 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.827 1.651 . . . . 0.0 108.868 177.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -126.23 142.95 51.32 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.558 1.543 . . . . 0.0 112.939 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 74.0 p -75.34 92.67 2.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.14 . . . . 0.0 112.537 -178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.64 -167.88 39.83 Favored Glycine 0 N--CA 1.471 0.993 0 O-C-N 121.531 -0.731 . . . . 0.0 114.397 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 119.19 24.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.489 1.915 . . . . 0.0 111.398 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.22 156.11 40.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.052 1.741 . . . . 0.0 111.133 -176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.4 ptp180 -137.93 161.87 35.53 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.34 1.456 . . . . 0.0 111.056 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -74.12 90.72 2.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.411 0.684 . . . . 0.0 111.15 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -110.23 -66.57 1.06 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.136 1.374 . . . . 0.0 109.135 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.5 -70.92 0.21 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.58 1.552 . . . . 0.0 109.35 175.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.91 -31.56 81.33 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.333 0.968 . . . . 0.0 114.333 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.8 tmm? -69.6 -53.08 20.53 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 118.293 1.046 . . . . 0.0 110.78 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -56.25 -43.76 79.0 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.792 0.837 . . . . 0.0 110.428 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -62.6 -46.37 88.6 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 174.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -56.86 -19.94 20.21 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.722 1.146 . . . . 0.0 113.377 176.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 mp -91.66 -59.13 2.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.227 1.411 . . . . 0.0 110.438 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -60.99 -56.55 19.82 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.299 1.04 . . . . 0.0 111.383 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -80.93 -16.66 52.92 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.198 1.399 . . . . 0.0 112.064 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.28 -77.17 0.25 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.692 1.139 . . . . 0.0 113.271 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -162.41 90.75 1.33 Allowed Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.935 1.694 . . . . 0.0 109.966 174.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.28 158.15 45.16 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 121.016 1.144 . . . . 0.0 110.492 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -95.74 5.84 50.39 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.309 0.0 OUTLIER 48.74 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 130.145 3.378 . . . . 0.0 117.808 177.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 59.99 63.07 5.39 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 121.043 -1.035 . . . . 0.0 112.245 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -63.55 7.18 0.11 Allowed 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.347 11.3 p30 55.84 25.55 8.63 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.193 2.597 . . . . 0.0 116.424 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -139.58 165.44 25.82 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 126.456 1.979 . . . . 0.0 111.499 175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -70.42 114.53 8.64 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.16 -1.2 . . . . 0.0 109.689 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.48 127.77 53.91 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.043 1.337 . . . . 0.0 109.975 174.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.08 139.34 21.28 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.185 1.394 . . . . 0.0 110.352 174.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -144.65 126.46 15.29 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.241 1.416 . . . . 0.0 109.921 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -62.1 117.6 6.22 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 122.805 0.442 . . . . 0.0 111.414 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.4 tp -142.98 -26.62 0.59 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.486 1.114 . . . . 0.0 113.93 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.18 15.82 20.35 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.821 1.201 . . . . 0.0 114.469 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 59.45 10.62 1.92 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.829 2.452 . . . . 0.0 115.403 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.9 -47.6 0.05 OUTLIER Glycine 0 CA--C 1.526 0.746 0 C-N-CA 125.274 1.416 . . . . 0.0 112.773 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.6 mp -113.52 161.49 17.31 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.685 1.194 . . . . 0.0 111.324 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.08 170.99 19.83 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.497 1.119 . . . . 0.0 113.074 174.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.73 138.53 31.39 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.28 1.432 . . . . 0.0 109.487 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -130.5 109.07 10.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.761 1.624 . . . . 0.0 108.656 175.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.62 169.87 27.04 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 114.666 0.626 . . . . 0.0 114.666 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.1 tt -146.3 143.24 21.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 126.173 1.789 . . . . 0.0 109.702 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 10.7 ttt -150.79 150.91 31.56 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.673 1.989 . . . . 0.0 107.352 174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 82.0 p -101.13 165.47 11.29 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.599 0.76 . . . . 0.0 111.929 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 26.0 t -90.84 46.28 1.31 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.685 1.594 . . . . 0.0 110.051 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -132.57 158.16 42.88 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.33 1.452 . . . . 0.0 112.656 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -58.1 -45.55 93.79 Favored Glycine 0 CA--C 1.532 1.095 0 O-C-N 121.439 -0.788 . . . . 0.0 113.089 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.31 64.02 2.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.737 1.615 . . . . 0.0 113.741 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -94.61 147.29 23.44 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -91.49 150.11 21.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.687 1.195 . . . . 0.0 107.963 174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 36.2 ttp -143.72 91.84 2.28 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.389 0.995 . . . . 0.0 112.16 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.408 ' HB2' HD11 ' A' ' 17' ' ' LEU . 35.0 tt0 -107.04 146.41 31.2 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.406 -0.809 . . . . 0.0 111.164 177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.8 mp -132.69 104.27 7.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.886 1.675 . . . . 0.0 109.426 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -99.2 90.42 4.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.81 2.044 . . . . 0.0 110.51 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.0 mm -73.63 118.22 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.378 0.671 . . . . 0.0 110.137 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.5 p -146.41 166.17 27.16 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.994 1.318 . . . . 0.0 113.029 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 127.691 2.397 . . . . 0.0 111.7 176.218 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.88 -26.92 7.17 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.13 143.0 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 119.324 0.965 . . . . 0.0 112.442 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.86 43.46 8.94 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.051 0.834 . . . . 0.0 115.027 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.9 p -147.65 -166.77 2.61 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 119.064 1.432 . . . . 0.0 111.977 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 pt -117.26 139.46 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 127.295 2.238 . . . . 0.0 109.947 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.404 HD11 HD12 ' A' ' 12' ' ' LEU . 20.3 pt -145.55 159.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 125.006 1.322 . . . . 0.0 111.732 174.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.68 128.96 39.68 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.048 1.339 . . . . 0.0 112.477 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.59 -24.35 76.25 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.588 0.613 . . . . 0.0 113.413 -176.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.2 73.01 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.419 1.088 . . . . 0.0 111.395 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.5 t -74.11 -28.45 61.36 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.259 1.024 . . . . 0.0 112.896 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.404 HD12 HD11 ' A' ' 7' ' ' ILE . 9.2 tt -67.26 114.57 6.08 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.274 1.429 . . . . 0.0 112.54 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.6 m -145.11 172.85 12.5 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.159 1.784 . . . . 0.0 110.157 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -42.17 37.03 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.38 1.472 . . . . 0.0 113.952 177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -61.88 -35.91 79.73 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.13 -42.75 97.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.517 0.727 . . . . 0.0 110.29 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 170' ' ' GLN . 11.1 mt -55.52 -50.48 69.86 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 118.832 0.742 . . . . 0.0 112.092 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.02 -39.99 90.71 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.153 0.581 . . . . 0.0 112.113 176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 tptt -57.21 -43.44 82.79 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.009 1.324 . . . . 0.0 112.717 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.403 HG21 HD21 ' A' ' 70' ' ' LEU . 77.4 t -62.22 -48.01 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.394 1.078 . . . . 0.0 111.325 176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.5 mp -61.96 -42.82 99.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.171 0.988 . . . . 0.0 112.267 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.87 -31.79 71.84 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -77.0 -42.19 39.69 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.826 1.65 . . . . 0.0 113.82 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.64 -56.85 16.63 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.775 1.63 . . . . 0.0 111.59 175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.03 64.61 0.09 OUTLIER Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.029 1.3 . . . . 0.0 112.149 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.7 ptmm? -51.16 96.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 127.353 2.261 . . . . 0.0 112.421 175.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 28' ' ' SER . 3.8 p -90.42 -159.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.096 1.758 . . . . 0.0 109.942 -177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.501 ' H ' HG22 ' A' ' 27' ' ' VAL . 19.4 m -44.2 -49.55 9.11 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.552 1.141 . . . . 0.0 112.083 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.3 mtt85 -139.45 146.57 40.23 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 112.727 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.4 150.93 11.04 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.046 2.538 . . . . 0.0 108.931 -169.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.416 ' O ' HD11 ' A' ' 21' ' ' LEU . 7.0 pt -139.72 153.95 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.822 1.249 . . . . 0.0 109.507 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.63 110.81 20.82 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.364 1.066 . . . . 0.0 109.878 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.7 t -105.31 128.74 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 C-N-CA 123.892 0.877 . . . . 0.0 111.265 178.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.7 114.47 0.79 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.357 1.456 . . . . 0.0 112.094 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.3 mt -112.86 104.44 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.515 1.126 . . . . 0.0 109.082 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.2 111.16 21.33 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.149 1.379 . . . . 0.0 111.15 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -84.54 96.42 9.14 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.41 1.084 . . . . 0.0 111.615 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.0 18.97 20.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.601 1.161 . . . . 0.0 113.167 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 95.0 p -63.87 -40.22 96.03 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.406 ' H ' ' ND2' ' A' ' 65' ' ' ASN . . . 129.46 3.98 5.01 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.886 1.707 . . . . 0.0 115.854 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.66 165.06 30.47 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.767 1.783 . . . . 0.0 114.491 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 p -74.8 130.63 39.8 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 122.007 -0.701 . . . . 0.0 112.165 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -101.37 164.39 11.8 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.901 1.28 . . . . 0.0 111.277 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.6 m -133.82 110.32 9.69 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.458 1.503 . . . . 0.0 109.467 -176.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.621 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.1 133.3 55.09 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.11 -0.994 . . . . 0.0 109.75 174.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mt -75.23 -68.56 0.54 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.864 0.466 . . . . 0.0 109.866 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -179.44 173.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.502 2.321 . . . . 0.0 110.592 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -132.82 145.74 51.23 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 127.353 2.261 . . . . 0.0 109.515 174.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 115.65 15.79 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.971 0.908 . . . . 0.0 111.015 174.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -70.31 106.65 3.43 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.603 1.161 . . . . 0.0 111.221 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.4 tpt85 -68.95 -47.53 65.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.434 1.494 . . . . 0.0 110.603 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -141.7 154.4 45.29 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.917 2.087 . . . . 0.0 110.703 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -163.52 54.62 Favored Glycine 0 CA--C 1.532 1.111 0 O-C-N 121.834 -0.541 . . . . 0.0 113.353 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.9 t -151.66 177.91 9.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.473 0.709 . . . . 0.0 111.998 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.0 p -144.48 178.65 7.8 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.376 1.47 . . . . 0.0 111.563 175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -125.25 20.15 8.15 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.771 1.228 . . . . 0.0 112.008 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.3 m -133.86 172.21 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 126.721 2.008 . . . . 0.0 113.244 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.0 mt -143.38 135.59 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.027 1.731 . . . . 0.0 109.812 -171.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.73 149.68 60.77 Favored Pre-proline 0 CA--C 1.553 1.094 0 CA-C-N 119.547 1.067 . . . . 0.0 112.1 177.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.21 155.51 56.29 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 124.249 3.299 . . . . 0.0 111.579 174.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -93.27 -23.64 18.44 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 120.977 -1.077 . . . . 0.0 113.424 175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -119.95 141.13 49.93 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.931 -1.106 . . . . 0.0 110.648 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -142.0 102.77 5.73 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.643 1.177 . . . . 0.0 109.234 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -65.3 164.67 24.79 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 121.903 1.735 . . . . 0.0 111.637 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 40' ' ' GLY . 13.1 t-20 -62.78 163.67 9.02 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.957 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 66.27 -0.91 1.33 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 126.542 1.937 . . . . 0.0 114.151 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.96 -174.38 2.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.188 2.995 . . . . 0.0 110.81 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.31 172.85 17.23 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.651 2.38 . . . . 0.0 111.049 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.99 178.47 4.55 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.713 0.805 . . . . 0.0 109.737 174.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 20' ' ' VAL . 1.2 tp -134.88 131.9 37.9 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.886 2.074 . . . . 0.0 109.118 174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -148.05 166.27 28.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.274 1.03 . . . . 0.0 110.486 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -149.44 174.85 12.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.152 0.981 . . . . 0.0 111.068 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -158.95 119.22 0.88 Allowed Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.39 1.471 . . . . 0.0 111.369 -174.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.04 150.06 42.64 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 118.909 1.355 . . . . 0.0 112.393 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' HE3' ' CD1' ' A' ' 106' ' ' PHE . 0.5 OUTLIER -69.7 107.6 3.54 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.419 ' CB ' HG23 ' A' ' 80' ' ' VAL . 7.3 m-20 40.06 -150.49 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 126.113 1.765 . . . . 0.0 113.122 174.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -77.83 -38.74 45.58 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.82 -1.8 . . . . 0.0 111.347 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.82 -56.23 0.51 Allowed Glycine 0 CA--C 1.541 1.673 0 CA-C-O 118.628 -1.096 . . . . 0.0 114.78 -169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.54 -6.27 18.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.529 3.486 . . . . 0.0 114.825 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG23 ' CB ' ' A' ' 76' ' ' ASP . 9.7 m -122.8 139.96 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.268 1.827 . . . . 0.0 109.126 175.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.03 78.08 1.52 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.016 1.326 . . . . 0.0 110.77 -174.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 80.6 m -102.73 -65.16 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.848 0.859 . . . . 0.0 111.318 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 162.18 172.07 29.13 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.752 1.644 . . . . 0.0 111.125 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.33 108.69 8.88 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.409 1.105 . . . . 0.0 110.541 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.2 t -137.81 131.32 42.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.44 36.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.179 0.592 . . . . 0.0 110.651 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.96 149.97 35.19 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.935 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.84 172.47 12.98 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.858 1.663 . . . . 0.0 110.651 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -138.95 150.44 45.9 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.877 0.871 . . . . 0.0 111.249 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.621 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -128.37 114.37 16.76 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.66 1.184 . . . . 0.0 111.352 -178.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -75.02 115.13 14.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.559 1.544 . . . . 0.0 110.801 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.99 157.9 34.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.195 0.998 . . . . 0.0 111.733 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 87.4 p -59.65 -20.22 54.66 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.4 m -81.56 -11.7 59.06 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.615 1.966 . . . . 0.0 113.44 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.26 3.58 60.07 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.089 1.328 . . . . 0.0 115.244 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.27 175.11 8.64 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.811 1.245 . . . . 0.0 110.863 175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.515 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 18.9 m -141.73 147.75 37.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.725 0.774 . . . . 0.0 110.288 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.11 118.94 34.25 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.19 0.996 . . . . 0.0 108.34 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.33 142.3 22.88 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.537 HG12 HG22 ' A' ' 117' ' ' VAL . 25.6 m -140.89 137.97 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 124.547 1.139 . . . . 0.0 110.762 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.41 152.52 44.38 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.155 0.582 . . . . 0.0 110.879 175.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -125.88 142.22 51.62 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.684 1.193 . . . . 0.0 109.768 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.0 m -125.87 97.95 5.33 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.947 1.699 . . . . 0.0 110.309 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.2 112.31 58.09 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.674 1.59 . . . . 0.0 109.616 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -76.83 -173.08 1.61 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 124.336 3.357 . . . . 0.0 111.996 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.461 ' CD1' ' HE3' ' A' ' 75' ' ' LYS . 16.8 t80 -106.5 -13.04 15.44 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.37 1.068 . . . . 0.0 112.895 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -110.73 131.13 55.32 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 119.741 -1.849 . . . . 0.0 111.138 -173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.54 -66.4 0.7 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.02 -1.05 . . . . 0.0 110.837 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -82.19 -3.98 56.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.748 1.219 . . . . 0.0 113.795 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.51 -1.48 9.58 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.093 1.757 . . . . 0.0 112.699 -164.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -150.24 179.93 7.71 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 129.536 3.134 . . . . 0.0 108.887 175.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.9 t -142.48 163.57 32.49 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.938 1.695 . . . . 0.0 109.037 174.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -92.37 136.98 32.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.351 0.66 . . . . 0.0 109.227 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -125.31 151.1 46.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.096 0.959 . . . . 0.0 110.357 -178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -157.1 157.48 34.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.612 1.565 . . . . 0.0 110.632 176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.13 155.23 43.19 Favored 'General case' 0 C--O 1.237 0.435 0 O-C-N 121.624 -0.673 . . . . 0.0 109.909 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.537 HG22 HG12 ' A' ' 100' ' ' VAL . 43.6 t -140.87 122.02 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 124.947 1.299 . . . . 0.0 109.751 176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -124.86 145.3 49.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.66 1.584 . . . . 0.0 109.737 175.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.4 mt -115.5 120.39 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.755 2.022 . . . . 0.0 108.659 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -132.42 144.72 50.69 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.126 1.371 . . . . 0.0 112.13 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 34.8 p -80.39 77.97 7.13 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.635 1.174 . . . . 0.0 112.59 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.37 175.67 36.88 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.413 1.006 . . . . 0.0 113.818 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.51 116.78 26.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.754 1.622 . . . . 0.0 111.858 174.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -142.43 155.26 45.08 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.105 1.362 . . . . 0.0 109.445 175.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -133.05 161.91 33.12 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.78 1.232 . . . . 0.0 111.141 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.8 78.98 0.45 Allowed 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.602 1.161 . . . . 0.0 111.337 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -101.86 -65.59 0.97 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.444 1.498 . . . . 0.0 110.244 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.55 -71.77 0.2 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.088 1.755 . . . . 0.0 109.233 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.4 -19.33 68.53 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.541 1.067 . . . . 0.0 114.603 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.0 tpt -88.34 -52.71 5.06 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 118.117 0.958 . . . . 0.0 111.574 175.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -55.44 -45.9 76.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.335 0.654 . . . . 0.0 111.775 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -35.37 72.98 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 176.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -22.85 66.98 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.283 -0.886 . . . . 0.0 113.244 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -93.71 -35.91 12.57 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.427 1.091 . . . . 0.0 110.89 175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -76.26 -45.14 34.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.309 -1.494 . . . . 0.0 113.197 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -92.06 -14.87 28.63 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.929 1.292 . . . . 0.0 113.143 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.08 63.14 3.59 Favored Glycine 0 CA--C 1.531 1.071 0 C-N-CA 123.992 0.806 . . . . 0.0 113.706 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 31.97 73.75 0.5 Allowed Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 127.598 2.359 . . . . 0.0 112.528 -170.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -67.06 133.09 29.83 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.355 1.37 . . . . 0.0 110.895 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.75 124.8 23.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 174.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.31 31.98 0.34 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.385 1.874 . . . . 0.0 114.046 -176.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 47.39 62.96 3.63 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.51 1.529 . . . . 0.0 114.073 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.59 24.97 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.32 0 C-N-CA 126.338 1.855 . . . . 0.0 114.703 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 11.9 p30 47.76 30.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 128.164 2.586 . . . . 0.0 116.852 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -147.93 139.19 7.57 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.997 1.76 . . . . 0.0 111.156 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -49.58 124.05 8.82 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.839 1.256 . . . . 0.0 113.129 -175.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -110.41 120.83 43.68 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.105 2.162 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.79 138.76 17.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.729 1.212 . . . . 0.0 111.168 174.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -154.78 134.79 13.02 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.626 1.17 . . . . 0.0 111.266 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -54.23 132.67 43.92 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 50.6 tp -156.32 -41.06 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.758 1.223 . . . . 0.0 112.51 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.93 31.66 2.79 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 114.082 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.47 11.99 1.36 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.355 2.262 . . . . 0.0 115.743 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 170.85 -43.21 0.19 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.349 1.452 . . . . 0.0 113.097 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -109.37 151.5 26.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.519 1.127 . . . . 0.0 110.657 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -142.88 170.19 16.16 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.539 1.136 . . . . 0.0 113.06 176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -82.51 126.5 32.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.671 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -121.24 102.78 8.52 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 124.438 1.095 . . . . 0.0 108.36 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.91 171.45 25.47 Favored Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 115.082 0.793 . . . . 0.0 115.082 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.92 143.89 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 124.074 0.95 . . . . 0.0 110.045 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.03 148.8 33.07 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.407 1.883 . . . . 0.0 108.216 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 21.3 p -107.74 162.37 14.04 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.463 1.905 . . . . 0.0 111.025 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.7 p -92.11 19.82 6.48 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.533 1.533 . . . . 0.0 113.542 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.73 175.06 5.62 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.28 2.232 . . . . 0.0 113.456 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.57 9.8 Favored Glycine 0 N--CA 1.475 1.249 0 C-N-CA 125.362 1.458 . . . . 0.0 112.401 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -80.39 73.51 7.27 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.037 1.335 . . . . 0.0 109.639 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.23 91.69 0.25 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.688 0.795 . . . . 0.0 111.298 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -56.76 149.89 17.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.606 -0.684 . . . . 0.0 110.072 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.4 tpp -151.08 96.26 2.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.871 0.843 . . . . 0.0 110.649 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.548 ' HB2' HD11 ' A' ' 17' ' ' LEU . 54.6 tt0 -124.96 134.93 52.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 120.602 -1.311 . . . . 0.0 109.636 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.66 101.1 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.571 1.548 . . . . 0.0 109.664 -174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 10.1 mtpp -99.32 99.89 10.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.288 1.835 . . . . 0.0 109.845 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -85.92 118.08 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.449 -0.782 . . . . 0.0 111.16 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.05 165.78 26.23 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.87 1.668 . . . . 0.0 113.038 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.3 mtt180 . . . . . 0 C--O 1.251 1.141 0 C-N-CA 127.039 2.136 . . . . 0.0 111.648 174.968 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 110.652 -0.129 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.53 -0.77 42.65 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.59 143.03 53.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.023 0.929 . . . . 0.0 111.085 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.85 38.1 65.61 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 175.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.4 p -149.15 -169.73 3.45 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 118.425 1.113 . . . . 0.0 111.774 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.1 pt -126.47 153.27 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.974 1.71 . . . . 0.0 111.059 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 pt -148.94 170.0 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.824 1.65 . . . . 0.0 111.792 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.35 129.26 39.91 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.099 0.959 . . . . 0.0 109.601 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.03 -22.34 42.05 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.947 1.26 . . . . 0.0 113.932 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.31 -36.66 81.94 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.224 1.41 . . . . 0.0 112.267 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -32.58 32.34 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.94 1.296 . . . . 0.0 112.605 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.551 HD22 ' CB ' ' A' ' 68' ' ' ALA . 5.9 tp -60.41 107.93 0.74 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.071 1.349 . . . . 0.0 111.896 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 m -149.37 168.17 24.12 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.755 1.222 . . . . 0.0 110.149 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -39.02 21.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.766 1.626 . . . . 0.0 114.222 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -59.38 -35.0 73.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 175.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.72 -44.02 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.013 1.325 . . . . 0.0 110.474 175.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.7 mt -54.52 -43.87 72.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.886 0.766 . . . . 0.0 112.226 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.16 -47.31 80.37 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.982 -0.449 . . . . 0.0 110.881 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.65 -39.15 76.37 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.578 1.551 . . . . 0.0 114.0 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.19 -56.34 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.152 1.781 . . . . 0.0 109.598 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 mp -66.41 -40.82 89.8 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.149 1.38 . . . . 0.0 112.646 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -56.52 -54.58 44.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.915 1.286 . . . . 0.0 112.933 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -66.11 -42.0 89.8 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.8 tp -53.21 -55.54 23.52 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.03 1.732 . . . . 0.0 112.722 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.99 49.24 0.17 Allowed Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.927 0.775 . . . . 0.0 114.12 -172.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.91 123.71 0.86 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.561 1.944 . . . . 0.0 114.342 174.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.73 -161.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 127.086 2.154 . . . . 0.0 111.442 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.8 m -51.91 -34.07 39.86 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.807 1.643 . . . . 0.0 114.214 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -144.21 139.66 28.84 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.827 2.051 . . . . 0.0 108.932 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -162.73 148.32 12.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.574 1.949 . . . . 0.0 110.988 -174.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.592 HG21 HG21 ' A' ' 104' ' ' VAL . 3.1 pt -138.35 151.79 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.14 0.976 . . . . 0.0 108.803 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -110.57 113.1 25.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.596 1.159 . . . . 0.0 109.866 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.75 130.4 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.693 0.797 . . . . 0.0 111.436 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -143.9 114.96 0.85 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 124.654 1.121 . . . . 0.0 112.759 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 25.1 mt -109.11 101.54 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.846 1.258 . . . . 0.0 108.745 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -85.44 104.25 15.07 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.599 1.56 . . . . 0.0 111.696 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -82.79 104.35 12.96 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.572 1.149 . . . . 0.0 112.052 177.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.66 29.44 8.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.096 1.358 . . . . 0.0 112.331 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.0 t -84.02 -3.74 58.24 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 126.075 1.75 . . . . 0.0 114.747 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.21 14.64 80.12 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 120.505 -1.372 . . . . 0.0 114.287 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.65 20.23 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.445 1.498 . . . . 0.0 113.611 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 62.4 p -81.79 131.7 35.27 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.241 1.417 . . . . 0.0 112.527 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -108.35 164.43 12.33 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.741 1.216 . . . . 0.0 111.955 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 26.0 m -129.33 107.72 9.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.211 1.405 . . . . 0.0 110.082 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.27 117.82 10.57 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.309 -0.869 . . . . 0.0 109.985 174.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.03 -69.87 0.29 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.363 1.465 . . . . 0.0 111.223 -174.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -170.95 164.41 7.62 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.531 1.932 . . . . 0.0 111.015 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -113.73 124.71 52.94 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.91 2.084 . . . . 0.0 110.068 174.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -108.21 109.75 21.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.546 1.138 . . . . 0.0 111.504 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -78.29 96.53 5.3 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.341 1.456 . . . . 0.0 112.053 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -66.07 -51.94 53.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.759 1.224 . . . . 0.0 112.003 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -138.63 141.48 39.11 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.822 2.049 . . . . 0.0 110.552 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.89 -171.46 42.91 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 123.32 0.486 . . . . 0.0 112.771 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.97 176.43 9.92 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.808 0.843 . . . . 0.0 111.984 175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -142.65 -179.17 6.15 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.214 1.406 . . . . 0.0 111.355 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -137.52 22.89 2.94 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.915 1.286 . . . . 0.0 112.021 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.73 171.65 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.324 1.849 . . . . 0.0 111.726 -175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.01 138.82 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.843 1.657 . . . . 0.0 108.733 -173.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -88.95 151.2 46.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.107 0.867 . . . . 0.0 111.426 177.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.67 165.73 26.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 123.741 2.96 . . . . 0.0 110.136 174.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.42 -29.89 9.44 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 120.91 -1.119 . . . . 0.0 111.474 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.04 132.8 55.25 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.168 1.387 . . . . 0.0 111.044 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.45 81.94 47.47 Favored Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 126.051 1.74 . . . . 0.0 108.207 -175.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -66.06 157.69 58.25 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 121.959 1.773 . . . . 0.0 111.669 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -56.09 151.1 12.71 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.414 -0.803 . . . . 0.0 111.563 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 66.24 3.99 2.97 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.21 2.204 . . . . 0.0 115.257 -171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -130.95 99.13 4.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.146 1.779 . . . . 0.0 113.163 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.551 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -76.59 161.77 28.31 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 124.744 1.218 . . . . 0.0 112.628 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.91 170.89 7.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.911 0.885 . . . . 0.0 110.642 174.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -132.27 130.29 40.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.099 2.159 . . . . 0.0 107.877 174.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -149.12 161.48 41.88 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.307 1.443 . . . . 0.0 110.334 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.1 m -140.12 157.9 44.9 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.325 0.65 . . . . 0.0 111.512 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.07 118.69 1.4 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.579 1.561 . . . . 0.0 111.937 -174.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.85 169.47 13.21 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.175 1.39 . . . . 0.0 112.011 -173.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 52.3 pttt -99.89 111.61 23.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 0.0 109.891 174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.3 t70 36.89 -145.72 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.388 0 C-N-CA 128.637 2.775 . . . . 0.0 114.061 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.8 m -58.06 -57.56 12.31 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 119.942 -1.724 . . . . 0.0 111.941 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.8 -75.27 0.06 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-O 119.041 -0.866 . . . . 0.0 112.621 175.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.21 73.02 1.62 Allowed 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 125.216 3.944 . . . . 0.0 113.042 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.1 m -135.6 159.64 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.091 1.756 . . . . 0.0 111.662 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.05 65.23 1.38 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.065 1.346 . . . . 0.0 111.766 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.4 m -127.1 -88.82 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.637 1.575 . . . . 0.0 110.389 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.6 172.99 32.74 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.526 1.536 . . . . 0.0 111.322 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -125.58 116.9 22.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.719 1.207 . . . . 0.0 109.385 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 91.1 t -142.5 128.29 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 124.599 1.16 . . . . 0.0 108.351 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -151.54 165.78 33.18 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.605 0.717 . . . . 0.0 110.67 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.62 139.56 20.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.298 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.472 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -134.42 175.85 9.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.95 1.3 . . . . 0.0 110.341 -171.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.17 37.51 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.607 -0.683 . . . . 0.0 112.261 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -129.93 119.45 23.26 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.688 1.195 . . . . 0.0 110.496 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -80.59 112.07 17.6 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.461 1.904 . . . . 0.0 110.126 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 79.6 mtp -67.43 162.49 22.97 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.944 0.898 . . . . 0.0 111.749 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.9 p -59.59 -21.7 60.73 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 m -84.8 -14.95 46.53 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.511 1.925 . . . . 0.0 113.453 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.42 55.54 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.038 1.304 . . . . 0.0 115.447 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -82.01 165.36 20.74 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.482 1.141 . . . . 0.0 109.662 175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 86.0 m -123.49 143.72 49.99 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 109.147 174.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -117.36 109.18 16.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.134 0.974 . . . . 0.0 109.354 174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.65 114.24 3.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.56 HG12 HG22 ' A' ' 117' ' ' VAL . 19.8 m -108.26 140.22 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.171 0.988 . . . . 0.0 110.991 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.458 ' HE1' ' HA ' ' A' ' 135' ' ' TYR . 0.0 OUTLIER -141.39 155.25 45.92 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.338 0.655 . . . . 0.0 111.312 174.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 11.5 p90 -132.84 153.68 51.07 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.216 1.006 . . . . 0.0 111.516 175.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.3 t -137.39 115.03 11.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.403 1.081 . . . . 0.0 110.604 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.592 HG21 HG21 ' A' ' 31' ' ' ILE . 53.2 t -124.05 92.48 48.29 Favored Pre-proline 0 N--CA 1.469 0.487 0 C-N-CA 126.154 1.782 . . . . 0.0 108.579 -178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -75.76 171.6 17.89 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.081 2.521 . . . . 0.0 112.729 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -73.25 -55.95 5.74 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.514 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.75 122.0 22.6 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.36 1.464 . . . . 0.0 113.325 -161.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -67.22 -58.47 4.78 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -100.51 15.24 28.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.967 1.307 . . . . 0.0 114.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -129.94 0.31 4.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.856 2.063 . . . . 0.0 112.192 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -153.44 -179.02 7.37 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 127.419 2.288 . . . . 0.0 110.679 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 84.0 p -154.07 173.03 16.59 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.172 1.389 . . . . 0.0 112.076 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -95.8 147.54 23.53 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -134.86 142.48 46.62 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.005 0.922 . . . . 0.0 110.545 -174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.442 ' CZ2' ' CD2' ' A' ' 147' ' ' HIS . 30.0 p-90 -145.51 152.82 40.36 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.39 1.476 . . . . 0.0 109.411 174.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -153.63 145.8 23.79 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.739 1.216 . . . . 0.0 110.22 175.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 100' ' ' VAL . 71.7 t -143.28 112.88 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 126.261 1.825 . . . . 0.0 110.5 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.55 129.29 56.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.129 0.971 . . . . 0.0 109.518 175.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 24.5 mt -95.52 112.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.223 1.809 . . . . 0.0 108.755 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -124.19 141.45 52.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.473 1.509 . . . . 0.0 112.354 175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 38.3 p -77.1 78.66 3.63 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.96 1.304 . . . . 0.0 112.858 -177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.13 165.18 20.91 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.44 1.019 . . . . 0.0 113.245 177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.71 140.16 57.87 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.761 1.624 . . . . 0.0 111.856 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -156.04 168.32 27.62 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.516 1.527 . . . . 0.0 110.444 175.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -142.08 -175.42 4.41 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.097 1.759 . . . . 0.0 109.714 174.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.2 111.36 16.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -120.34 -67.22 0.99 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.287 1.035 . . . . 0.0 109.238 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.33 -71.53 0.21 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.153 0.981 . . . . 0.0 110.594 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.34 -22.91 74.94 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 123.935 0.778 . . . . 0.0 114.61 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.2 tpp -74.22 -54.18 8.25 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.489 1.116 . . . . 0.0 111.475 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -40.72 85.33 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.565 1.146 . . . . 0.0 111.666 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -55.63 -36.24 66.77 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.352 1.461 . . . . 0.0 111.812 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -21.58 66.51 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.324 1.05 . . . . 0.0 113.113 176.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.67 -43.25 10.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 108.558 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.458 ' HA ' ' HE1' ' A' ' 101' ' ' MET . 8.3 t80 -66.67 -49.74 65.16 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 120.866 -1.147 . . . . 0.0 113.669 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -92.56 -12.74 31.02 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.22 -66.91 2.5 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 124.191 0.9 . . . . 0.0 112.869 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -176.49 77.96 0.27 Allowed Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 128.374 2.67 . . . . 0.0 108.928 175.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.4 143.44 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.509 1.473 . . . . 0.0 108.315 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -79.44 -11.78 59.9 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -176.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.7 129.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 130.054 3.342 . . . . 0.0 112.529 -173.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.36 62.09 0.6 Allowed Glycine 0 CA--C 1.538 1.471 0 C-N-CA 127.05 2.262 . . . . 0.0 114.377 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -78.51 29.31 0.19 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.067 1.747 . . . . 0.0 114.535 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.253 10.9 p30 50.13 30.46 4.25 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 174.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.27 152.17 20.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 126.027 1.775 . . . . 0.0 111.017 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -64.37 112.67 3.2 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.843 0.857 . . . . 0.0 112.017 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.442 ' CD2' ' CZ2' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -110.03 123.51 49.81 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.053 1.741 . . . . 0.0 111.062 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -149.1 154.17 38.85 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.703 2.001 . . . . 0.0 111.836 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.39 135.85 10.21 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.308 1.043 . . . . 0.0 111.15 174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -61.49 127.47 31.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.002 0.521 . . . . 0.0 111.447 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.1 tp -149.67 -27.99 0.26 Allowed 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -84.29 18.76 21.62 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.998 1.285 . . . . 0.0 114.553 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 59.47 10.04 1.72 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.477 2.311 . . . . 0.0 115.438 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.85 -61.26 0.05 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 126.118 1.818 . . . . 0.0 110.579 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.1 159.78 15.52 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.796 0.838 . . . . 0.0 112.476 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 169.3 25.01 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.847 1.659 . . . . 0.0 112.82 174.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.491 ' HA ' HD13 ' A' ' 173' ' ' ILE . 1.3 pmm? -88.54 133.79 34.05 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.004 0.922 . . . . 0.0 112.011 175.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -127.16 107.24 9.84 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 125.329 1.452 . . . . 0.0 107.68 174.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -136.24 175.31 21.0 Favored Glycine 0 C--N 1.325 -0.077 0 CA-C-O 121.941 0.745 . . . . 0.0 113.441 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 20.5 tt -146.65 141.49 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 125.82 1.648 . . . . 0.0 108.074 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.7 ttt -144.23 130.59 19.82 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 175.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.32 161.54 25.0 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.346 1.058 . . . . 0.0 110.095 175.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -97.55 24.91 6.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.403 1.481 . . . . 0.0 113.278 179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.76 171.7 7.31 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.235 1.814 . . . . 0.0 112.269 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.44 -54.54 36.34 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.621 -0.674 . . . . 0.0 113.192 -178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 6.7 pt-20 -88.91 47.55 1.51 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.04 1.736 . . . . 0.0 113.777 177.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.18 141.49 57.33 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.895 0.855 . . . . 0.0 113.103 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -96.0 136.93 35.8 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.322 1.449 . . . . 0.0 108.757 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 16.6 ttp -134.62 95.37 3.35 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.775 1.23 . . . . 0.0 111.733 -174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -108.72 145.38 35.17 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.915 -0.491 . . . . 0.0 110.465 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 61.9 mt -130.26 112.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 125.764 1.626 . . . . 0.0 108.138 175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -99.39 108.15 20.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.14 1.776 . . . . 0.0 108.765 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 157' ' ' MET . 33.3 mm -92.44 109.66 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.429 0.691 . . . . 0.0 110.266 176.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.4 m -139.39 171.32 14.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.128 1.771 . . . . 0.0 111.996 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 . . . . . 0 C--O 1.253 1.286 0 C-N-CA 127.637 2.375 . . . . 0.0 110.385 175.028 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 119.83 -0.128 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 -32.28 24.05 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 121.746 -0.596 . . . . 0.0 112.084 178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -52.28 145.18 11.36 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -175.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.02 40.66 9.15 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.933 1.254 . . . . 0.0 114.81 -174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -145.51 -166.29 2.4 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.309 1.555 . . . . 0.0 112.639 -177.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.11 140.14 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.319 2.248 . . . . 0.0 110.1 175.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.5 pt -145.1 170.97 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.177 1.391 . . . . 0.0 111.987 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.76 111.39 5.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.759 -1.213 . . . . 0.0 110.898 174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.91 -25.23 67.57 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 123.981 0.8 . . . . 0.0 113.302 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.42 -23.68 64.58 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.956 1.303 . . . . 0.0 114.08 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.02 1.16 28.35 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.111 1.364 . . . . 0.0 113.319 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.51 117.16 12.71 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.097 1.759 . . . . 0.0 111.416 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -145.84 169.0 19.42 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.577 1.551 . . . . 0.0 110.157 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.64 -41.33 42.27 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.128 1.371 . . . . 0.0 114.141 177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -58.39 -42.59 87.42 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.644 0.777 . . . . 0.0 112.109 174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.37 -46.75 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.447 1.099 . . . . 0.0 111.382 176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 170' ' ' GLN . 33.7 mt -54.92 -49.85 70.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.736 0.814 . . . . 0.0 111.474 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -64.3 -41.26 96.94 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.167 0.802 . . . . 0.0 113.167 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -53.45 -45.35 69.47 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.091 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 70' ' ' LEU . 85.3 t -56.84 -56.89 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.038 0.935 . . . . 0.0 109.858 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.543 HD13 ' HB2' ' A' ' 32' ' ' ALA . 2.0 mp -58.99 -33.87 71.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.258 1.423 . . . . 0.0 113.953 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -55.77 30.85 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.816 1.246 . . . . 0.0 110.277 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.23 -15.36 60.04 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.65 -30.6 56.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.448 1.099 . . . . 0.0 111.9 174.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 44.51 47.84 8.75 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 126.452 1.977 . . . . 0.0 113.959 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.73 175.84 1.03 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.356 1.462 . . . . 0.0 114.48 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -63.2 -172.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 126.146 1.778 . . . . 0.0 110.922 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 m -48.92 -27.92 3.45 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.133 1.373 . . . . 0.0 114.591 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.6 mtt85 -127.36 149.86 49.87 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.753 1.221 . . . . 0.0 111.277 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -167.27 154.38 8.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.319 2.248 . . . . 0.0 109.899 -175.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.654 HD12 ' SD ' ' A' ' 169' ' ' MET . 13.9 pt -144.6 147.41 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.993 1.717 . . . . 0.0 109.083 174.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -113.23 105.59 13.6 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.67 1.188 . . . . 0.0 110.008 176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -97.14 135.49 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 125.73 1.612 . . . . 0.0 111.569 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.06 115.4 0.69 Allowed Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.979 1.276 . . . . 0.0 112.62 174.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.4 mt -106.63 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.337 1.455 . . . . 0.0 109.16 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -76.38 122.49 24.56 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.729 1.612 . . . . 0.0 113.845 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -77.34 90.52 3.78 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.195 1.798 . . . . 0.0 111.458 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -117.46 17.8 14.47 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.401 1.48 . . . . 0.0 112.635 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 89.0 p -76.48 -38.64 55.0 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.75 9.79 13.63 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 124.931 1.253 . . . . 0.0 115.568 -174.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -149.06 166.19 29.39 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-N 119.466 1.633 . . . . 0.0 114.946 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -81.66 130.89 35.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.35 1.46 . . . . 0.0 112.11 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 36.2 m0 -106.58 161.35 14.7 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.683 1.193 . . . . 0.0 111.04 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 96.8 m -129.58 110.35 11.75 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.252 1.421 . . . . 0.0 109.051 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.41 130.19 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.053 -1.029 . . . . 0.0 109.792 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.5 mt -73.23 -70.3 0.37 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 109.942 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -174.06 175.86 2.67 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.045 2.138 . . . . 0.0 110.549 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -126.03 154.87 42.37 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.728 2.011 . . . . 0.0 110.277 174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -141.52 108.05 5.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.06 1.344 . . . . 0.0 111.022 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -74.33 105.91 5.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.101 1.361 . . . . 0.0 111.12 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -45.74 54.73 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.183 0.993 . . . . 0.0 111.503 175.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.0 m -140.19 156.76 46.38 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.892 2.077 . . . . 0.0 110.932 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.17 -168.32 45.13 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 121.68 0.6 . . . . 0.0 112.611 -173.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -138.42 169.32 18.01 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.534 1.134 . . . . 0.0 110.142 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -147.23 137.11 23.09 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.91 0.862 . . . . 0.0 109.791 175.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.13 5.75 50.97 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.197 1.799 . . . . 0.0 112.754 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 HG23 ' A' ' 55' ' ' THR . 11.5 m -116.1 169.58 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 110.738 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -139.19 141.77 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.486 1.114 . . . . 0.0 109.495 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.67 151.48 61.62 Favored Pre-proline 0 CA--C 1.546 0.812 0 CA-C-N 118.756 0.707 . . . . 0.0 111.619 177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 164.41 35.8 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 124.124 3.216 . . . . 0.0 110.524 175.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.88 -34.34 10.17 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.704 -0.622 . . . . 0.0 112.001 174.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -105.6 136.14 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.862 1.21 . . . . 0.0 110.82 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.03 89.24 7.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.78 1.232 . . . . 0.0 109.754 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -67.46 166.43 23.76 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.668 2.245 . . . . 0.0 113.49 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -58.81 153.5 16.86 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.326 -0.859 . . . . 0.0 110.397 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.6 p 69.89 -9.15 0.73 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 126.855 2.062 . . . . 0.0 114.861 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -115.69 123.87 49.42 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.251 1.82 . . . . 0.0 111.914 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.32 176.69 6.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.872 1.269 . . . . 0.0 110.128 175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.14 173.08 6.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.656 0.782 . . . . 0.0 109.247 174.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -126.51 131.79 51.53 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.385 1.474 . . . . 0.0 110.042 175.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -148.67 163.81 36.19 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 123.745 0.818 . . . . 0.0 111.334 175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.1 m -151.39 173.88 14.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.202 1.001 . . . . 0.0 110.903 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -156.27 132.57 3.36 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.885 1.707 . . . . 0.0 110.323 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.76 178.57 6.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.3 1.04 . . . . 0.0 110.17 176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -64.12 -174.95 0.13 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.027 0.931 . . . . 0.0 109.881 174.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.34 -167.88 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 O-C-N 121.137 -0.977 . . . . 0.0 109.989 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.5 m -34.28 -42.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.794 2.037 . . . . 0.0 114.85 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 152.91 -51.75 0.48 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 125.51 1.528 . . . . 0.0 113.781 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.02 6.07 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.245 0 C-N-CA 124.426 3.418 . . . . 0.0 115.073 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 109.44 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.447 2.299 . . . . 0.0 111.496 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.09 70.06 3.86 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.079 1.752 . . . . 0.0 112.895 -174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -97.51 -81.12 0.43 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.315 1.046 . . . . 0.0 111.996 -177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -169.06 176.3 43.21 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 126.115 1.817 . . . . 0.0 110.319 -172.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.544 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -149.13 86.55 1.5 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.542 1.163 . . . . 0.0 109.08 174.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.8 t -132.58 118.77 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.266 1.426 . . . . 0.0 107.639 -173.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -141.06 166.29 25.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.055 0.931 . . . . 0.0 110.971 175.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.73 155.98 40.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.1 177.09 10.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.226 1.41 . . . . 0.0 110.32 -179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.9 142.35 40.64 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.579 1.151 . . . . 0.0 111.009 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -123.66 118.72 27.91 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.713 1.205 . . . . 0.0 110.594 177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -76.89 107.72 9.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.042 1.737 . . . . 0.0 109.229 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 1.6 mtt -64.54 166.64 8.2 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.498 -0.751 . . . . 0.0 112.212 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.3 t -62.98 -19.13 64.02 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.5 t -82.35 -18.83 40.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.652 1.581 . . . . 0.0 113.203 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.19 -0.72 54.33 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.165 1.364 . . . . 0.0 114.906 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -79.93 166.23 21.83 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.597 1.198 . . . . 0.0 109.948 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.1 m -123.03 149.82 43.86 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.938 0.875 . . . . 0.0 110.318 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.37 112.43 18.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 108.257 175.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.18 127.8 8.2 Favored Glycine 0 C--N 1.333 0.372 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.436 HG12 HG22 ' A' ' 117' ' ' VAL . 10.2 m -134.57 131.99 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 118.106 0.953 . . . . 0.0 110.157 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.48 156.65 45.18 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.156 0.582 . . . . 0.0 112.192 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -126.72 158.81 35.5 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.739 1.215 . . . . 0.0 111.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.2 t -138.67 108.25 6.21 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.486 1.115 . . . . 0.0 111.166 175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 38.5 t -109.74 98.1 31.7 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.633 1.973 . . . . 0.0 108.612 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.97 169.37 22.34 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.342 2.695 . . . . 0.0 112.844 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -83.65 -17.48 41.36 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.13 110.72 21.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.149 0.98 . . . . 0.0 110.741 -168.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -66.4 -58.4 5.37 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.09 -1.006 . . . . 0.0 113.269 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.81 10.76 27.21 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.688 1.195 . . . . 0.0 114.129 -177.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.15 0.56 5.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.189 1.796 . . . . 0.0 112.609 -175.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -153.84 173.16 16.27 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.237 2.215 . . . . 0.0 110.01 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.2 m -138.57 170.02 16.75 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.587 1.155 . . . . 0.0 112.155 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -90.84 142.64 27.55 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.396 -0.815 . . . . 0.0 110.143 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -135.69 139.92 44.05 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.348 1.459 . . . . 0.0 108.755 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -158.14 150.77 22.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.788 1.635 . . . . 0.0 109.322 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -151.36 154.65 37.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.79 1.236 . . . . 0.0 109.912 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.436 HG22 HG12 ' A' ' 100' ' ' VAL . 61.8 t -145.05 121.21 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.514 1.525 . . . . 0.0 111.4 178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tptp -123.31 136.17 54.55 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.513 1.525 . . . . 0.0 110.627 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.71 116.38 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.919 2.088 . . . . 0.0 108.363 177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -129.77 136.41 49.59 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.235 1.814 . . . . 0.0 112.54 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 48.5 p -79.99 79.36 6.54 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.09 1.356 . . . . 0.0 112.465 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.53 176.12 43.52 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.446 1.498 . . . . 0.0 112.355 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.78 104.11 16.11 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.584 1.954 . . . . 0.0 111.135 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -134.41 158.85 42.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.631 1.172 . . . . 0.0 111.371 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -136.75 164.77 27.49 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.092 1.757 . . . . 0.0 110.57 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -83.3 87.89 6.95 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.631 0.772 . . . . 0.0 111.2 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -102.27 -66.9 0.9 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.547 0.689 . . . . 0.0 110.375 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 43.4 tp60 -147.67 -75.0 0.19 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.677 1.991 . . . . 0.0 108.554 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.54 -37.17 88.07 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.357 0.979 . . . . 0.0 113.943 -177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -70.44 -52.97 18.42 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.145 0.972 . . . . 0.0 111.821 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.09 91.61 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.302 0.641 . . . . 0.0 111.381 175.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -62.92 -34.33 77.21 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.815 -0.612 . . . . 0.0 112.247 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.61 -23.06 64.43 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.669 1.122 . . . . 0.0 112.177 175.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.54 -58.09 2.75 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.208 1.003 . . . . 0.0 108.898 174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -59.24 -56.96 15.42 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 120.899 -1.126 . . . . 0.0 111.803 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.33 -18.66 44.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.264 1.026 . . . . 0.0 112.049 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.7 -68.9 1.45 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.346 0.974 . . . . 0.0 113.077 -177.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.31 88.98 0.27 Allowed Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 127.732 2.413 . . . . 0.0 108.599 174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.17 142.06 33.49 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.609 1.539 . . . . 0.0 109.429 174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -77.5 -9.68 59.05 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 55.13 107.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 128.931 2.892 . . . . 0.0 112.221 -170.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.19 85.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 126.344 1.926 . . . . 0.0 114.214 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -89.25 22.99 2.63 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.504 2.321 . . . . 0.0 113.865 -172.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.286 11.9 p30 50.47 33.6 8.05 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.871 2.068 . . . . 0.0 114.927 -176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.91 156.84 23.08 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.24 1.876 . . . . 0.0 111.965 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -69.16 114.07 7.09 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 121.801 -0.823 . . . . 0.0 111.282 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.29 121.65 43.53 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.026 1.73 . . . . 0.0 111.114 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.27 144.53 38.43 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.826 2.05 . . . . 0.0 110.126 175.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.81 133.7 13.11 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.29 1.036 . . . . 0.0 111.477 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -58.56 115.24 2.9 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.172 0.989 . . . . 0.0 111.192 174.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.92 -29.87 1.27 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.71 1.204 . . . . 0.0 113.279 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.5 18.05 35.79 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 125.357 1.456 . . . . 0.0 114.427 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 59.09 13.31 2.85 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.923 2.089 . . . . 0.0 114.709 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -175.42 -69.16 0.05 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 126.658 2.075 . . . . 0.0 109.664 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -87.19 150.15 24.14 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.324 1.059 . . . . 0.0 111.95 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.16 172.33 13.96 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.46 1.904 . . . . 0.0 110.896 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 18.9 ptm -101.57 150.05 23.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.626 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.0 tttt -130.71 107.55 9.24 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 126.255 1.822 . . . . 0.0 107.473 175.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.48 176.98 19.13 Favored Glycine 0 C--O 1.228 -0.266 0 CA-C-O 121.748 0.638 . . . . 0.0 113.119 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.9 tt -146.79 144.17 20.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 107.501 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -145.4 140.87 27.95 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.445 1.498 . . . . 0.0 108.439 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.34 162.26 13.42 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.89 1.676 . . . . 0.0 110.623 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.56 16.54 23.0 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.215 1.006 . . . . 0.0 113.405 -176.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -107.6 172.74 6.66 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.861 2.064 . . . . 0.0 112.439 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.8 -46.54 94.31 Favored Glycine 0 CA--C 1.535 1.281 0 C-N-CA 124.431 1.015 . . . . 0.0 114.097 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -96.99 60.01 1.69 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.369 1.468 . . . . 0.0 113.026 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.12 144.86 40.4 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.4 mmtt -89.01 147.95 24.01 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.909 0.884 . . . . 0.0 109.254 174.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.654 ' SD ' HD12 ' A' ' 31' ' ' ILE . 8.2 mtt -135.5 105.68 6.32 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.869 1.667 . . . . 0.0 110.068 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.466 ' HB2' HD11 ' A' ' 17' ' ' LEU . 17.6 tt0 -124.86 143.17 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 120.871 -1.143 . . . . 0.0 109.515 173.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.24 106.04 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 124.88 1.272 . . . . 0.0 108.503 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -100.22 103.87 15.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.093 1.757 . . . . 0.0 108.713 177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 25.0 mm -82.0 136.94 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.132 0.573 . . . . 0.0 110.042 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.5 p -158.4 159.87 36.25 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 . . . . . 0 C--O 1.252 1.222 0 C-N-CA 128.695 2.798 . . . . 0.0 113.455 176.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.537 ' C ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.537 HD23 ' C ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -150.43 -46.77 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 O-C-N 120.54 -1.35 . . . . 0.0 111.847 -175.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.651 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 59.6 161.31 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.887 2.475 . . . . 0.0 113.364 -166.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.4 46.71 93.82 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.036 -1.04 . . . . 0.0 115.091 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 p -155.11 -170.99 3.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.977 0.911 . . . . 0.0 111.75 -170.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 pt -118.82 144.01 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 126.786 2.034 . . . . 0.0 110.336 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 pt -142.72 169.79 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.659 1.584 . . . . 0.0 112.065 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.77 125.35 25.05 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.728 1.211 . . . . 0.0 112.143 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.12 -28.75 73.92 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.389 0.995 . . . . 0.0 114.382 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.81 -35.62 74.98 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.669 -0.901 . . . . 0.0 112.567 175.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 t -82.62 -22.8 34.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.466 1.106 . . . . 0.0 113.018 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.48 120.23 10.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.984 1.714 . . . . 0.0 110.029 175.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -152.43 171.96 17.24 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.109 1.764 . . . . 0.0 110.009 176.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -50.94 -36.33 38.05 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.078 1.351 . . . . 0.0 113.997 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.73 -35.5 76.52 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.741 -1.224 . . . . 0.0 112.988 174.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.04 -42.59 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.734 0.814 . . . . 0.0 110.248 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -51.34 -49.59 61.12 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.109 0.963 . . . . 0.0 111.755 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.47 -48.6 77.02 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.43 0.692 . . . . 0.0 111.986 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -56.87 -35.02 68.43 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.47 -56.84 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.073 1.349 . . . . 0.0 110.059 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.35 -41.75 94.28 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.201 1.4 . . . . 0.0 112.369 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -54.75 -49.36 71.04 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.949 0.9 . . . . 0.0 112.318 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -85.86 -32.42 21.72 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -54.23 35.37 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.392 1.477 . . . . 0.0 111.239 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.82 58.36 0.1 OUTLIER Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.383 0.992 . . . . 0.0 112.462 -172.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.79 139.6 7.34 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.925 1.29 . . . . 0.0 111.913 174.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.546 HG22 ' H ' ' A' ' 28' ' ' SER . 3.4 p -137.05 -163.19 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.036 1.334 . . . . 0.0 110.709 -173.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.546 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.2 OUTLIER -38.83 -44.9 1.09 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.19 1.796 . . . . 0.0 114.138 175.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -148.98 138.88 22.04 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.132 1.373 . . . . 0.0 110.93 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.02 151.63 16.24 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.869 1.668 . . . . 0.0 111.165 -172.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' A' ' 102' ' ' PHE . 14.5 pt -134.95 152.3 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.108 1.363 . . . . 0.0 109.4 174.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.52 117.92 33.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.341 1.457 . . . . 0.0 109.38 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.85 126.97 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.556 1.142 . . . . 0.0 111.037 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -138.81 109.44 0.66 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.38 1.466 . . . . 0.0 112.455 175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 171' ' ' ILE . 10.8 mt -107.54 101.9 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.763 1.225 . . . . 0.0 108.246 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.63 120.77 26.75 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.568 1.547 . . . . 0.0 112.62 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -84.99 102.49 13.23 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.1 1.36 . . . . 0.0 112.054 175.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.67 25.68 7.42 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.468 1.907 . . . . 0.0 111.615 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.7 t -77.99 -19.94 53.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.784 1.634 . . . . 0.0 114.387 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.75 26.85 25.88 Favored Glycine 0 CA--C 1.54 1.596 0 O-C-N 121.105 -0.997 . . . . 0.0 114.743 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -165.08 150.38 18.2 Favored Glycine 0 N--CA 1.476 1.325 0 C-N-CA 124.77 1.176 . . . . 0.0 113.959 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.6 p -71.14 140.27 50.53 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.439 -1.036 . . . . 0.0 112.918 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -114.35 164.41 13.98 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.47 1.108 . . . . 0.0 112.237 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 m -132.91 108.75 9.13 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.038 1.335 . . . . 0.0 109.714 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.87 131.49 46.4 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.8 mt -75.22 -69.32 0.48 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.735 -0.603 . . . . 0.0 110.539 -178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.7 163.02 2.8 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.059 2.143 . . . . 0.0 111.076 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.502 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -110.86 122.88 48.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.225 1.81 . . . . 0.0 109.224 175.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -110.1 105.75 14.97 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.434 1.094 . . . . 0.0 111.629 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -73.92 115.02 12.9 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.817 1.247 . . . . 0.0 112.034 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 -46.62 11.72 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.604 1.561 . . . . 0.0 111.495 178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 57.8 m -139.15 157.0 46.72 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.932 2.093 . . . . 0.0 111.47 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.0 -158.5 53.16 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 123.48 0.562 . . . . 0.0 112.631 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 76' ' ' ASP . 3.4 t -148.52 -168.8 3.19 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.068 -0.666 . . . . 0.0 112.323 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.2 p -142.26 178.67 7.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.105 2.162 . . . . 0.0 111.155 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -127.21 10.61 6.88 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.348 1.459 . . . . 0.0 111.971 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.651 HG11 ' CB ' ' A' ' 3' ' ' ALA . 6.8 m -139.2 169.18 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 128.184 2.593 . . . . 0.0 113.88 -168.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.8 mt -138.43 132.57 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 126.788 2.035 . . . . 0.0 109.804 -172.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -83.61 153.97 65.09 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 119.672 1.123 . . . . 0.0 111.842 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.5 165.45 30.62 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.824 3.016 . . . . 0.0 109.947 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.13 -33.67 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.414 -0.804 . . . . 0.0 112.153 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -115.11 133.72 55.79 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.509 1.524 . . . . 0.0 109.917 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.96 106.36 5.77 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 124.373 1.069 . . . . 0.0 110.121 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.71 163.35 35.59 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 121.776 1.651 . . . . 0.0 112.051 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -59.87 150.94 27.01 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 121.636 -0.665 . . . . 0.0 111.075 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.252 0.5 OUTLIER 76.96 -3.19 2.55 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.838 2.855 . . . . 0.0 114.17 -176.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -112.54 149.53 32.57 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.499 1.52 . . . . 0.0 109.372 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.23 157.72 29.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 125.11 1.364 . . . . 0.0 109.916 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.7 pt? -94.38 176.81 6.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.883 0.849 . . . . 0.0 109.72 175.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.48 129.7 43.28 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.925 2.09 . . . . 0.0 109.16 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -149.12 168.94 21.85 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.624 0.77 . . . . 0.0 111.204 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.7 m -148.66 174.43 12.17 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.157 0.983 . . . . 0.0 111.255 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -157.3 118.7 0.85 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 125.1 1.333 . . . . 0.0 111.839 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ptt85 -118.7 150.15 40.24 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.002 1.401 . . . . 0.0 112.379 -176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -70.16 116.08 10.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 175.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.404 ' O ' HG22 ' A' ' 54' ' ' THR . 10.2 m-20 42.85 -151.2 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 125.745 1.618 . . . . 0.0 113.533 175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.4 m -75.05 -39.95 60.61 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.268 -1.52 . . . . 0.0 112.034 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.41 -62.08 0.37 Allowed Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.21 1.386 . . . . 0.0 113.646 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.68 3.86 2.95 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 125.279 3.986 . . . . 0.0 115.601 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.56 132.31 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 127.646 2.379 . . . . 0.0 109.404 -174.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 69.85 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.303 1.441 . . . . 0.0 111.274 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -108.42 -71.21 0.77 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.364 1.065 . . . . 0.0 110.859 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.84 174.95 35.86 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.988 0.804 . . . . 0.0 112.164 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -135.38 112.18 10.14 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.765 1.226 . . . . 0.0 108.466 174.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.1 t -143.49 135.31 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -162.63 167.16 23.64 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.437 0.695 . . . . 0.0 110.704 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.43 141.66 22.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.776 0.798 . . . . 0.0 110.968 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.449 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -131.96 172.65 12.08 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.381 1.472 . . . . 0.0 109.151 -176.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.54 148.31 44.09 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 178.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -127.8 120.2 27.35 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.755 1.222 . . . . 0.0 110.779 -179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -82.69 125.11 30.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.614 . . . . 0.0 110.687 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.447 ' CE ' HD23 ' A' ' 98' ' ' LEU . 1.4 mtm -88.2 164.36 15.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.934 0.894 . . . . 0.0 112.953 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.8 t -60.52 -22.7 63.87 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.688 1.195 . . . . 0.0 113.634 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -81.98 -8.19 59.66 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.672 1.589 . . . . 0.0 113.272 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.15 3.23 65.56 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.928 1.251 . . . . 0.0 115.252 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -89.06 171.93 9.48 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.127 0.971 . . . . 0.0 110.979 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.6 m -133.74 146.43 50.76 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.059 0.944 . . . . 0.0 111.611 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CE ' ' A' ' 92' ' ' MET . 1.3 pp -117.45 130.61 56.58 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.432 1.093 . . . . 0.0 108.31 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.6 145.34 17.9 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.6 t -136.93 115.21 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.729 1.212 . . . . 0.0 109.005 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.512 ' HG3' ' H ' ' A' ' 116' ' ' ASP . 1.9 ptm -113.49 160.89 18.0 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 122.958 0.503 . . . . 0.0 112.086 175.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.626 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -138.46 141.62 39.46 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.554 1.142 . . . . 0.0 109.678 175.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.7 m -128.5 106.62 9.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.411 1.884 . . . . 0.0 108.801 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.2 101.59 53.67 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 126.487 1.915 . . . . 0.0 108.813 175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.6 171.36 18.37 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.317 2.678 . . . . 0.0 111.977 175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -85.02 -24.31 28.26 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.5 0.72 . . . . 0.0 112.023 175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.49 116.32 32.15 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.267 1.427 . . . . 0.0 111.889 -169.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -71.12 -59.3 2.85 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.32 10.54 29.33 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.103 -0.998 . . . . 0.0 113.612 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.76 -4.86 5.18 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.01 2.124 . . . . 0.0 112.615 -174.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -156.24 160.49 39.85 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 127.837 2.455 . . . . 0.0 109.249 176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.6 m -125.02 164.7 19.61 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.07 -1.019 . . . . 0.0 110.834 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -85.12 140.9 30.61 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.516 0.727 . . . . 0.0 109.884 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.38 156.94 47.63 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -161.93 140.73 9.45 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.501 1.52 . . . . 0.0 111.156 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 101' ' ' MET . 10.8 t70 -125.57 142.42 51.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.384 1.474 . . . . 0.0 109.214 176.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -138.36 113.08 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.345 1.458 . . . . 0.0 109.834 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.65 143.1 50.45 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.795 1.638 . . . . 0.0 108.845 175.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -110.28 118.59 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.661 1.984 . . . . 0.0 108.514 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -129.89 136.0 49.01 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.454 1.501 . . . . 0.0 112.426 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 31.1 p -70.32 84.77 0.57 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.483 1.913 . . . . 0.0 112.242 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.51 -174.12 44.44 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.451 1.024 . . . . 0.0 113.655 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -115.82 114.37 24.66 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.598 1.959 . . . . 0.0 110.151 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.24 159.65 40.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.984 0.913 . . . . 0.0 111.877 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.97 163.15 33.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.254 1.422 . . . . 0.0 111.27 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.33 89.09 0.2 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.255 1.422 . . . . 0.0 110.923 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.52 -61.33 1.61 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.548 1.139 . . . . 0.0 109.88 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -71.89 0.19 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.245 1.418 . . . . 0.0 109.046 174.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.1 -32.54 72.96 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.981 0.8 . . . . 0.0 114.416 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 7.0 tpt -66.07 -53.2 41.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.082 0.941 . . . . 0.0 110.549 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -57.76 -39.83 78.33 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.455 0.702 . . . . 0.0 110.592 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.53 -48.38 79.43 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -27.52 67.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.915 0.886 . . . . 0.0 112.923 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -82.7 -50.15 9.02 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.21 1.004 . . . . 0.0 110.127 175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -68.15 -47.71 67.33 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.095 1.358 . . . . 0.0 113.7 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.3 m-30 -88.81 -13.82 38.48 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.84 -83.15 0.05 OUTLIER Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.824 1.202 . . . . 0.0 112.197 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -168.12 72.75 0.88 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.013 1.725 . . . . 0.0 110.139 175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.4 133.04 29.01 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 120.625 0.883 . . . . 0.0 110.336 174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -61.42 158.34 14.88 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.046 1.338 . . . . 0.0 110.188 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt85 -95.16 3.71 54.4 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -164.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 54.69 49.45 61.44 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.481 1.039 . . . . 0.0 112.946 -173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.91 20.88 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 127.41 2.284 . . . . 0.0 115.058 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.265 9.7 p30 48.79 38.45 11.88 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 127.362 2.265 . . . . 0.0 114.674 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.86 160.35 26.63 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.596 1.57 . . . . 0.0 112.731 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -68.75 127.12 31.94 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.137 0.975 . . . . 0.0 111.423 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -120.84 106.38 11.61 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.602 1.961 . . . . 0.0 109.464 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -140.74 150.12 43.01 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.893 1.277 . . . . 0.0 110.989 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 142.28 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.2 1.8 . . . . 0.0 110.241 177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -61.53 132.41 53.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.111 0.564 . . . . 0.0 110.657 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 39.1 tp -147.4 -37.24 0.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.52 25.66 4.37 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.04 1.305 . . . . 0.0 114.47 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.86 9.75 1.3 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 127.338 2.255 . . . . 0.0 115.492 -176.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.96 -49.38 0.08 OUTLIER Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.239 1.399 . . . . 0.0 112.18 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -107.88 156.63 18.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.854 0.835 . . . . 0.0 111.597 175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.22 169.09 22.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.974 1.709 . . . . 0.0 112.06 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -94.77 138.8 32.11 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.214 1.006 . . . . 0.0 111.473 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -126.69 106.42 9.37 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.039 1.736 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -139.29 169.13 24.64 Favored Glycine 0 C--O 1.229 -0.188 0 N-CA-C 114.779 0.671 . . . . 0.0 114.779 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 tt -145.92 143.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 125.951 1.7 . . . . 0.0 109.317 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -144.84 147.6 33.02 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.537 1.535 . . . . 0.0 108.06 174.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.4 p -96.08 171.58 8.53 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.503 0.721 . . . . 0.0 111.241 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.4 m -104.28 21.83 15.89 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.317 1.447 . . . . 0.0 112.458 175.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.2 -178.32 3.54 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.4 1.48 . . . . 0.0 112.591 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.57 -36.52 78.32 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.99 0.805 . . . . 0.0 114.424 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.89 75.21 4.84 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.666 1.587 . . . . 0.0 111.023 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.91 73.06 1.13 Allowed 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.88 -1.138 . . . . 0.0 112.251 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -43.99 141.14 1.77 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.585 1.954 . . . . 0.0 110.465 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 ttm -142.13 106.25 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.132 0.967 . . . . 0.0 110.566 -176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -124.2 139.67 53.7 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.322 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.432 HD13 HG12 ' A' ' 35' ' ' ILE . 3.8 mp -131.39 101.33 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.633 1.573 . . . . 0.0 108.964 177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.71 104.78 16.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.363 1.865 . . . . 0.0 109.432 175.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 33.3 mm -87.63 124.28 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 121.819 -0.551 . . . . 0.0 110.989 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.1 m -141.21 167.88 21.11 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.136 1.374 . . . . 0.0 112.959 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 128.153 2.581 . . . . 0.0 112.686 175.126 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.1 -51.77 0.07 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 120.579 -1.326 . . . . 0.0 110.783 -171.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.35 158.05 0.06 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 128.699 2.8 . . . . 0.0 113.335 -166.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.84 44.59 96.92 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.296 -0.878 . . . . 0.0 114.1 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.7 p -144.74 -176.59 5.12 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.574 1.15 . . . . 0.0 111.433 -173.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.69 135.5 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.288 1.835 . . . . 0.0 110.616 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 pt -141.06 167.0 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.382 1.473 . . . . 0.0 111.225 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.0 125.73 27.24 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.925 -1.109 . . . . 0.0 110.423 174.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.36 -21.14 59.53 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 123.897 0.761 . . . . 0.0 113.447 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.32 72.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.226 1.41 . . . . 0.0 112.049 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.63 -30.33 41.34 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.707 1.203 . . . . 0.0 112.762 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.2 tp -55.53 106.41 0.24 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.053 1.741 . . . . 0.0 111.151 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.3 m -149.88 166.98 27.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 125.543 1.537 . . . . 0.0 109.762 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -44.62 -39.28 4.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.968 1.707 . . . . 0.0 114.618 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -60.31 -36.02 76.95 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.12 -35.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.874 1.669 . . . . 0.0 110.618 175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.9 mt -56.44 -52.22 65.48 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.902 0.774 . . . . 0.0 111.127 175.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -53.53 -39.82 64.98 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.973 0.806 . . . . 0.0 112.148 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . 14.0 mmtm -59.84 -32.44 70.69 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.547 1.139 . . . . 0.0 113.274 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG21 HD11 ' A' ' 70' ' ' LEU . 32.0 t -63.97 -52.31 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 108.968 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.04 -41.16 74.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.021 0.528 . . . . 0.0 111.757 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -58.8 -56.7 18.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.485 1.114 . . . . 0.0 112.617 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -77.81 -38.6 46.07 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.133 1.161 . . . . 0.0 114.133 -171.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.02 -21.79 66.4 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.262 1.025 . . . . 0.0 111.07 175.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.46 73.09 0.96 Allowed Glycine 0 C--N 1.337 0.637 0 C-N-CA 125.037 1.303 . . . . 0.0 110.153 -176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.2 ptmm? -45.2 102.19 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.637 1.575 . . . . 0.0 112.449 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 28' ' ' SER . 2.5 p -76.07 -163.47 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.51 1.524 . . . . 0.0 110.22 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.492 ' H ' HG22 ' A' ' 27' ' ' VAL . 8.0 t -44.28 -33.95 1.77 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.606 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.05 134.36 13.36 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.179 1.791 . . . . 0.0 110.78 175.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.2 165.01 34.58 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 11.5 pt -138.75 155.0 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.013 0.824 . . . . 0.0 111.731 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -102.23 115.58 30.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.005 0.922 . . . . 0.0 110.58 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.16 144.03 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.006 1.322 . . . . 0.0 110.948 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.06 117.36 0.77 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.92 0.771 . . . . 0.0 112.789 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 mt -108.89 103.93 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.817 1.247 . . . . 0.0 110.438 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -78.32 124.31 27.96 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.699 1.6 . . . . 0.0 113.741 -178.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -79.43 103.81 9.61 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.328 1.851 . . . . 0.0 113.954 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -123.25 36.49 4.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.803 2.041 . . . . 0.0 112.323 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.7 t -108.57 2.72 22.3 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.549 1.54 . . . . 0.0 113.662 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.59 11.63 49.29 Favored Glycine 0 CA--C 1.541 1.687 0 O-C-N 120.983 -1.073 . . . . 0.0 115.182 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.97 162.31 28.33 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 126.001 1.762 . . . . 0.0 113.051 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -76.57 137.67 39.68 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.601 1.16 . . . . 0.0 112.517 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.414 ' CD1' ' HA ' ' A' ' 92' ' ' MET . 49.0 m0 -107.61 164.32 12.33 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.91 1.684 . . . . 0.0 111.574 175.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 29.2 m -131.01 111.75 12.31 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.767 1.227 . . . . 0.0 109.28 -176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.639 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.64 127.19 30.12 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 174.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -67.71 -68.14 0.41 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 176.99 172.47 0.47 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 127.903 2.481 . . . . 0.0 110.497 -174.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.26 47.83 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.638 2.375 . . . . 0.0 109.514 174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -123.96 109.93 14.16 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.282 1.033 . . . . 0.0 111.177 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -70.19 112.26 6.42 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.4 1.48 . . . . 0.0 111.347 174.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.2 ttm180 -94.15 -32.94 13.52 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.291 1.036 . . . . 0.0 112.714 178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.0 m -142.58 148.99 38.43 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 126.958 2.103 . . . . 0.0 109.646 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.96 -175.46 47.76 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.549 1.071 . . . . 0.0 115.141 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.95 144.73 35.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.964 1.306 . . . . 0.0 111.93 177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.4 p -102.26 167.25 10.11 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.944 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.72 -0.76 21.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.482 1.113 . . . . 0.0 112.587 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.91 -178.56 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.873 2.069 . . . . 0.0 112.568 -174.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.38 139.54 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.381 1.472 . . . . 0.0 110.696 -172.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.71 146.33 79.82 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 118.856 0.753 . . . . 0.0 112.957 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.12 150.99 54.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 125.014 3.809 . . . . 0.0 111.608 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 16.9 tt0 -92.45 -22.21 19.74 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -123.54 126.85 47.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.575 1.55 . . . . 0.0 110.646 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.14 96.22 12.89 Favored Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 124.945 1.298 . . . . 0.0 109.672 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.0 167.6 21.2 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.848 2.366 . . . . 0.0 113.444 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.87 158.0 8.92 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.194 -0.941 . . . . 0.0 109.925 175.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.271 7.3 t 59.45 6.32 0.77 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.154 2.181 . . . . 0.0 114.474 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -127.38 121.47 31.03 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 126.82 2.048 . . . . 0.0 110.102 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.4 171.63 8.92 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.248 1.019 . . . . 0.0 110.15 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.456 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -108.41 171.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.69 HD11 HG21 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -123.53 130.35 52.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.909 1.284 . . . . 0.0 109.872 174.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.55 171.16 17.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.885 0.85 . . . . 0.0 110.857 175.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.3 m -156.71 170.44 22.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.88 1.272 . . . . 0.0 110.124 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.27 121.85 2.17 Favored Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.52 156.97 38.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.573 1.687 . . . . 0.0 109.564 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.423 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 12.7 ptpt -61.44 179.5 0.22 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.95 0.5 . . . . 0.0 111.176 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.721 ' HB3' HG21 ' A' ' 80' ' ' VAL . 0.5 OUTLIER -67.7 -160.08 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 O-C-N 121.061 -1.024 . . . . 0.0 110.738 176.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.5 m -30.67 -51.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.429 1.892 . . . . 0.0 115.922 -173.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 157.54 -60.64 0.33 Allowed Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.769 1.176 . . . . 0.0 113.269 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -69.82 -7.7 21.74 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.398 3.399 . . . . 0.0 114.957 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 76' ' ' ASP . 15.0 m -74.34 123.55 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.441 1.896 . . . . 0.0 112.443 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.47 71.8 4.37 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 120.893 -1.13 . . . . 0.0 111.646 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 54.6 m -119.21 -85.32 0.65 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.419 1.088 . . . . 0.0 111.689 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.16 -178.59 33.47 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.874 1.226 . . . . 0.0 111.251 -172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.725 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -142.96 111.43 6.24 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 123.597 0.759 . . . . 0.0 112.728 177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 t -143.84 122.65 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 -174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -142.03 150.43 41.28 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.969 0.908 . . . . 0.0 111.111 175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.64 143.97 51.11 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 111.115 -177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' CD2' HG23 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -146.64 175.17 10.8 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.522 1.929 . . . . 0.0 111.721 -174.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -144.1 153.18 41.89 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.959 -1.019 . . . . 0.0 112.109 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.639 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 2.0 m-85 -133.8 117.37 16.79 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.604 1.562 . . . . 0.0 111.03 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -75.19 117.24 16.79 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.734 1.614 . . . . 0.0 110.3 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.414 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 17.3 mtm -74.25 161.96 29.4 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.241 0.543 . . . . 0.0 112.156 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.4 t -60.87 -23.62 65.31 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.532 1.133 . . . . 0.0 113.519 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.2 m -78.63 -20.49 50.22 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.415 1.486 . . . . 0.0 114.045 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 105.38 5.63 39.69 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.671 1.129 . . . . 0.0 115.777 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -87.42 171.34 10.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.564 1.145 . . . . 0.0 110.666 175.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.431 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 53.9 m -140.07 136.99 34.2 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.597 -0.689 . . . . 0.0 111.748 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.19 126.99 53.43 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.538 -0.755 . . . . 0.0 108.984 175.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.58 128.76 8.71 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.43 HG23 ' CD2' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -137.54 140.24 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.593 1.157 . . . . 0.0 110.345 178.307 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.6 ptm -144.54 170.11 16.69 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.8 p90 -126.94 156.46 41.47 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 124.436 1.095 . . . . 0.0 111.142 175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.7 t -140.07 123.72 17.25 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.406 1.482 . . . . 0.0 109.754 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.725 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 44.2 t -120.81 91.37 47.4 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 126.895 2.078 . . . . 0.0 107.686 -175.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -69.24 143.39 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.399 2.733 . . . . 0.0 110.705 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.45 -41.08 85.29 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.103 0.561 . . . . 0.0 111.633 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.43 138.26 36.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.795 0.838 . . . . 0.0 111.042 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.04 -72.01 0.37 Allowed 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.458 -0.776 . . . . 0.0 111.457 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.67 -1.91 23.88 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.774 1.23 . . . . 0.0 113.639 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.89 -5.84 6.22 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.811 2.044 . . . . 0.0 112.731 -164.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.38 149.47 28.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.822 2.449 . . . . 0.0 109.48 175.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 m -111.07 163.73 13.56 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.661 0.784 . . . . 0.0 110.14 174.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -91.96 137.86 32.02 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.419 1.088 . . . . 0.0 109.234 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -126.81 138.49 53.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.717 1.207 . . . . 0.0 111.571 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 19.6 p-90 -150.02 146.21 26.85 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.28 -1.512 . . . . 0.0 111.335 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -127.91 154.89 45.01 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.234 -0.916 . . . . 0.0 110.975 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -141.38 115.44 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 125.397 1.479 . . . . 0.0 111.384 177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -114.97 117.7 31.35 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.8 1.24 . . . . 0.0 108.738 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mt -103.24 111.79 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.872 1.669 . . . . 0.0 107.587 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.14 162.83 34.01 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.475 0.71 . . . . 0.0 112.58 175.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.5 p -80.05 79.94 6.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.662 1.185 . . . . 0.0 112.275 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.98 -149.45 8.55 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.25 0.929 . . . . 0.0 113.509 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -131.26 84.51 2.19 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 128.322 2.649 . . . . 0.0 111.665 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.85 77.7 7.7 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.066 1.347 . . . . 0.0 111.827 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -65.11 164.43 13.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.608 0.763 . . . . 0.0 112.399 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.415 ' HB2' ' CD1' ' A' ' 131' ' ' TYR . . . -132.84 112.71 12.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.857 2.063 . . . . 0.0 110.211 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -111.35 -75.17 0.62 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -152.06 -74.94 0.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.953 1.701 . . . . 0.0 108.087 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -68.66 -11.15 62.13 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.072 1.32 . . . . 0.0 115.027 -175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.32 -63.98 1.28 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.833 1.316 . . . . 0.0 107.612 174.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -63.55 -16.46 60.86 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -33.03 61.9 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.849 0.749 . . . . 0.0 110.731 174.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -71.24 -28.97 64.55 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.397 1.079 . . . . 0.0 112.908 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.79 -33.85 22.9 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.338 1.055 . . . . 0.0 110.003 174.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -75.83 -45.45 35.76 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.206 -0.934 . . . . 0.0 113.21 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -96.2 -16.9 21.17 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.877 0.871 . . . . 0.0 113.336 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -70.09 1.06 Allowed Glycine 0 N--CA 1.475 1.242 0 C-N-CA 124.104 0.859 . . . . 0.0 112.556 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 179.99 73.32 0.17 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 128.215 2.606 . . . . 0.0 111.072 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.47 158.19 51.62 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 121.769 1.646 . . . . 0.0 110.965 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -87.56 121.64 30.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.437 ' NE ' ' H ' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -72.45 158.43 35.76 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.328 -0.857 . . . . 0.0 112.163 175.806 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.21 70.79 1.02 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.514 1.531 . . . . 0.0 112.633 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.26 24.48 0.34 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.388 1.875 . . . . 0.0 113.853 -176.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.2 p30 48.19 35.3 5.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.923 2.089 . . . . 0.0 114.901 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.96 156.46 23.81 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.057 1.313 . . . . 0.0 113.049 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -65.19 126.75 29.11 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.203 1.001 . . . . 0.0 110.538 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -125.57 105.58 9.13 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.804 1.642 . . . . 0.0 108.919 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.09 140.5 36.09 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.609 1.563 . . . . 0.0 111.419 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.0 mmtt -160.7 137.82 9.1 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.214 1.006 . . . . 0.0 111.391 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -57.71 107.17 0.42 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.789 1.235 . . . . 0.0 112.309 174.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 63.3 tp -128.67 -30.23 2.32 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.912 1.285 . . . . 0.0 113.046 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.93 22.16 7.08 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.656 1.122 . . . . 0.0 114.092 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.37 13.19 3.87 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 127.297 2.239 . . . . 0.0 115.091 -177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 175.38 -57.59 0.11 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.126 1.822 . . . . 0.0 111.65 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.2 mp -91.3 148.49 22.3 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.726 0.774 . . . . 0.0 110.606 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 169.5 17.86 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.512 1.525 . . . . 0.0 111.731 175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.83 144.66 29.52 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.757 1.223 . . . . 0.0 110.37 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -127.88 102.06 6.61 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.742 2.017 . . . . 0.0 108.464 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.29 167.55 21.86 Favored Glycine 0 CA--C 1.52 0.366 0 CA-C-O 122.0 0.778 . . . . 0.0 112.93 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.1 tt -151.81 139.36 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 126.548 1.939 . . . . 0.0 108.527 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.7 ttm -142.29 139.63 31.93 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 78.2 p -88.14 169.68 11.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.553 0.741 . . . . 0.0 110.977 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -87.15 11.36 14.15 Favored 'General case' 0 N--CA 1.482 1.135 0 O-C-N 121.098 -1.001 . . . . 0.0 113.615 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -90.92 170.44 10.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.147 2.179 . . . . 0.0 113.226 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.6 -73.6 0.72 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.937 1.256 . . . . 0.0 111.525 174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -70.72 38.66 0.05 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.984 2.113 . . . . 0.0 114.808 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.51 176.13 4.97 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.23 1.812 . . . . 0.0 113.301 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.525 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 mptt -129.8 145.53 51.57 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.008 1.323 . . . . 0.0 110.403 175.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 7.3 ttm -136.95 88.89 2.4 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.424 1.89 . . . . 0.0 110.672 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -83.42 157.46 22.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 111.044 168.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.91 116.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.101 1.76 . . . . 0.0 107.572 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.39 109.52 20.85 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.922 1.689 . . . . 0.0 108.4 178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.24 147.16 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 O-C-N 121.567 -0.708 . . . . 0.0 109.98 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.6 m -127.93 170.99 12.22 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.214 1.805 . . . . 0.0 111.239 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.534 1.934 . . . . 0.0 113.381 -174.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.4 tp -92.85 -103.73 0.12 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.413 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 48.2 169.79 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 126.916 2.086 . . . . 0.0 113.847 -166.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 57.2 40.27 91.4 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 117.027 1.571 . . . . 0.0 117.027 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.8 p -141.0 -170.94 3.15 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.561 1.144 . . . . 0.0 111.869 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -127.9 141.1 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.661 1.984 . . . . 0.0 111.024 175.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.499 HG12 HD21 ' A' ' 70' ' ' LEU . 1.9 pt -142.09 167.05 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.289 1.436 . . . . 0.0 112.232 177.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.53 124.27 18.41 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.751 1.22 . . . . 0.0 112.033 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.67 -24.19 39.17 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.558 1.552 . . . . 0.0 114.055 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.95 70.31 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.474 1.11 . . . . 0.0 111.898 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.61 -19.9 44.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.714 1.605 . . . . 0.0 113.237 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.531 HD22 ' CB ' ' A' ' 68' ' ' ALA . 6.3 tp -66.97 105.99 1.8 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.241 1.416 . . . . 0.0 111.206 174.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.2 m -144.36 167.87 21.44 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.249 1.42 . . . . 0.0 109.676 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -46.81 -33.65 4.63 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.623 1.569 . . . . 0.0 113.251 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -58.91 -53.73 55.06 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.192 0.997 . . . . 0.0 111.128 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.22 -40.5 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.945 0.898 . . . . 0.0 111.894 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 mt -59.65 -54.01 51.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.176 0.991 . . . . 0.0 111.759 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.55 -38.73 92.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -57.91 -48.45 79.84 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.256 1.022 . . . . 0.0 112.156 177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.6 t -55.91 -47.58 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 124.367 1.067 . . . . 0.0 111.253 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.4 mp -60.3 -42.47 95.58 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.45 1.1 . . . . 0.0 113.608 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.25 -47.77 84.5 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.768 0.427 . . . . 0.0 111.529 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.17 -39.18 72.05 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.5 tp -52.81 -57.27 10.75 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.91 2.084 . . . . 0.0 111.387 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.56 51.25 0.07 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.661 1.124 . . . . 0.0 112.896 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -37.65 127.69 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.514 1.926 . . . . 0.0 113.639 174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.495 HG22 ' H ' ' A' ' 28' ' ' SER . 2.7 p -129.83 -169.22 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.102 1.761 . . . . 0.0 110.623 -175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.495 ' H ' HG22 ' A' ' 27' ' ' VAL . 28.1 m -43.63 -32.11 0.9 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.675 1.99 . . . . 0.0 115.06 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -141.69 145.91 35.46 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.422 1.889 . . . . 0.0 107.604 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -165.22 147.64 7.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.822 1.249 . . . . 0.0 110.432 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 2.1 pt -141.52 144.42 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 118.562 0.619 . . . . 0.0 111.16 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -112.2 116.27 30.17 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.243 1.017 . . . . 0.0 110.772 176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.9 t -107.45 138.68 32.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.137 1.375 . . . . 0.0 110.3 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.84 114.81 0.67 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.419 1.009 . . . . 0.0 112.196 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.3 mt -107.73 104.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.436 1.094 . . . . 0.0 109.622 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -82.77 107.49 15.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.916 1.286 . . . . 0.0 112.258 175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -84.12 71.38 10.58 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.984 1.314 . . . . 0.0 114.225 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -76.23 21.45 0.18 Allowed 'General case' 0 CA--C 1.558 1.286 0 O-C-N 119.778 -1.826 . . . . 0.0 115.118 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 28.1 p -57.85 -48.47 79.71 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -174.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.0 -17.36 6.0 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 126.565 2.031 . . . . 0.0 116.107 -174.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.2 -104.04 1.89 Allowed Glycine 0 N--CA 1.482 1.761 0 CA-C-N 119.931 1.866 . . . . 0.0 116.282 -171.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.0 t -162.58 135.95 6.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.875 1.67 . . . . 0.0 111.671 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -115.04 167.43 10.82 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.793 1.637 . . . . 0.0 111.276 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.9 m -141.36 111.35 6.67 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.158 0.983 . . . . 0.0 110.292 -175.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.33 133.8 55.6 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 120.895 -1.128 . . . . 0.0 108.429 174.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -70.88 -69.26 0.38 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -172.41 171.29 4.74 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.962 2.105 . . . . 0.0 110.453 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -123.59 142.46 51.02 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.816 2.046 . . . . 0.0 109.301 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.55 121.0 18.15 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.532 1.133 . . . . 0.0 111.43 178.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -74.5 128.25 35.07 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.829 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -45.12 6.24 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.929 1.692 . . . . 0.0 111.66 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -141.58 153.97 45.15 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.186 1.794 . . . . 0.0 110.324 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 79.88 -170.05 53.63 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 121.493 0.496 . . . . 0.0 113.054 -175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 t -140.86 164.04 31.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.621 1.168 . . . . 0.0 110.651 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.6 p -149.71 178.98 8.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.774 1.23 . . . . 0.0 111.18 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 25.99 4.12 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.456 1.102 . . . . 0.0 112.446 175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.413 HG11 ' CB ' ' A' ' 3' ' ' ALA . 0.0 OUTLIER -124.33 172.16 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 126.71 2.004 . . . . 0.0 113.535 -174.64 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.5 mt -137.02 151.59 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 127.246 2.219 . . . . 0.0 109.199 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -100.14 141.16 22.22 Favored Pre-proline 0 CA--C 1.551 0.995 0 CA-C-N 120.212 1.369 . . . . 0.0 110.935 176.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.05 160.45 47.24 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.94 3.094 . . . . 0.0 111.028 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -104.22 -46.23 4.48 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.328 -0.857 . . . . 0.0 112.073 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -100.59 132.38 46.01 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 120.082 1.31 . . . . 0.0 111.938 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.5 t -138.91 92.15 11.25 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.868 1.667 . . . . 0.0 110.2 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.31 160.66 37.83 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.118 1.879 . . . . 0.0 112.042 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -58.14 159.9 5.45 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 121.124 -0.985 . . . . 0.0 110.706 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p 68.67 8.7 6.9 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.583 1.953 . . . . 0.0 113.543 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -136.66 110.12 7.95 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.368 1.867 . . . . 0.0 111.99 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.531 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -84.1 164.75 19.01 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.606 0.762 . . . . 0.0 112.164 175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.453 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.53 173.54 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.214 0.606 . . . . 0.0 110.947 174.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.499 HD21 HG12 ' A' ' 7' ' ' ILE . 3.2 mm? -129.7 127.66 40.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.478 1.911 . . . . 0.0 107.82 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -147.49 154.98 41.45 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.882 0.873 . . . . 0.0 110.65 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.4 m -148.52 162.93 38.65 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 123.068 0.547 . . . . 0.0 111.151 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.76 138.71 6.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 124.308 0.956 . . . . 0.0 111.953 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 167.57 19.91 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.823 0.849 . . . . 0.0 110.293 174.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.6 ptmm? -65.29 -179.62 0.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.044 0.538 . . . . 0.0 110.467 175.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -61.85 -179.95 0.23 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 121.63 -0.669 . . . . 0.0 110.642 174.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.4 m -24.65 -54.08 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 128.053 2.541 . . . . 0.0 116.166 -172.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.79 -58.98 0.32 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.404 1.478 . . . . 0.0 112.797 -178.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.91 0.09 7.66 Favored 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.779 3.653 . . . . 0.0 115.736 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.06 104.5 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 127.242 2.217 . . . . 0.0 112.008 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.94 77.87 1.66 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.632 1.573 . . . . 0.0 112.927 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.8 m -110.74 -82.21 0.58 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.004 1.321 . . . . 0.0 111.304 177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 161.95 179.42 36.6 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.099 1.333 . . . . 0.0 111.886 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.82 114.88 10.84 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.793 1.237 . . . . 0.0 110.026 175.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.7 t -147.48 130.35 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -150.21 167.84 25.73 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.731 0.777 . . . . 0.0 110.743 174.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.46 154.72 36.09 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.017 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.39 169.39 21.53 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.038 1.735 . . . . 0.0 110.838 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.15 140.53 47.65 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.697 1.199 . . . . 0.0 110.964 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.8 OUTLIER -123.67 112.56 17.53 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.032 1.333 . . . . 0.0 111.763 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -76.66 115.68 16.64 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 110.738 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.5 mtm -78.98 162.68 25.79 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.95 0.9 . . . . 0.0 112.284 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.9 p -60.23 -19.84 56.27 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.1 t -79.71 -11.37 59.85 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.405 1.482 . . . . 0.0 113.007 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.27 2.49 65.9 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.887 1.232 . . . . 0.0 114.435 -176.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -88.71 169.99 11.19 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.778 1.231 . . . . 0.0 110.608 176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 97.5 m -135.98 154.69 51.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.441 1.096 . . . . 0.0 110.19 175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.36 127.95 48.34 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.267 1.027 . . . . 0.0 109.726 174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.22 114.47 4.13 Favored Glycine 0 N--CA 1.461 0.355 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.9 t -117.24 126.07 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.233 1.013 . . . . 0.0 108.716 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -140.8 164.32 30.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.73 0.776 . . . . 0.0 112.285 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.0 p90 -140.63 151.4 44.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.767 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -130.5 116.31 18.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.948 1.699 . . . . 0.0 110.066 175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.67 99.19 47.63 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.834 1.654 . . . . 0.0 108.77 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.76 169.08 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.31 2.674 . . . . 0.0 112.432 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -76.51 -18.61 58.63 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.452 0.701 . . . . 0.0 112.783 174.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.23 109.5 18.06 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.685 1.594 . . . . 0.0 110.81 -167.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -64.98 -65.41 0.68 Allowed 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.276 -0.89 . . . . 0.0 113.127 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -86.57 9.3 18.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.66 -6.15 6.92 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.715 2.006 . . . . 0.0 112.661 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.86 139.06 14.63 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.728 2.011 . . . . 0.0 110.141 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.5 t -95.94 164.51 12.69 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 120.625 -1.297 . . . . 0.0 112.375 177.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -80.63 159.02 25.48 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.604 0.762 . . . . 0.0 109.092 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -141.27 141.18 33.98 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.27 -0.894 . . . . 0.0 111.531 177.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.2 p-90 -156.14 148.62 23.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.247 1.419 . . . . 0.0 110.502 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -145.3 155.21 43.07 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.309 1.843 . . . . 0.0 109.39 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.14 116.35 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 126.38 1.872 . . . . 0.0 109.414 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.3 tptt -120.41 137.33 54.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.488 1.915 . . . . 0.0 109.298 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 25.7 mt -102.41 120.19 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.971 1.708 . . . . 0.0 108.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -133.93 147.9 51.13 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.493 1.517 . . . . 0.0 112.062 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.6 p -77.02 78.98 3.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.41 1.084 . . . . 0.0 112.574 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.28 158.48 8.47 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.076 0.846 . . . . 0.0 114.883 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.25 121.87 16.63 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.522 1.529 . . . . 0.0 112.793 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.3 mmp_? -136.63 85.54 2.15 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.143 1.777 . . . . 0.0 109.289 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -60.21 170.97 1.12 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.007 0.923 . . . . 0.0 111.407 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -107.26 92.79 4.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.627 0.771 . . . . 0.0 111.067 174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -98.39 -68.75 0.79 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.548 0.739 . . . . 0.0 110.404 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.28 -70.08 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.557 1.143 . . . . 0.0 110.408 174.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.12 -25.05 76.38 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.059 0.838 . . . . 0.0 114.661 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.75 -48.08 27.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.261 1.024 . . . . 0.0 110.48 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.83 -37.34 81.79 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.099 0.959 . . . . 0.0 110.927 175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -54.75 -33.35 61.12 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -61.15 -33.35 73.26 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 119.434 1.016 . . . . 0.0 112.706 175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.49 -41.19 61.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.024 0.829 . . . . 0.0 110.313 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -65.36 -59.31 4.17 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.756 -1.215 . . . . 0.0 111.741 178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -79.44 -19.55 49.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.189 1.396 . . . . 0.0 112.698 -173.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -76.66 0.22 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.365 0.983 . . . . 0.0 112.598 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.37 84.15 1.59 Allowed Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.67 1.188 . . . . 0.0 110.433 174.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.49 157.21 59.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 121.539 1.493 . . . . 0.0 111.262 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.71 4.98 49.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.684 1.194 . . . . 0.0 113.412 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 30.25 66.81 0.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 128.194 2.597 . . . . 0.0 113.438 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -33.48 90.77 0.01 OUTLIER Glycine 0 CA--C 1.531 1.05 0 C-N-CA 128.398 2.904 . . . . 0.0 114.869 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -110.07 43.89 1.3 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.957 1.703 . . . . 0.0 110.349 -174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 58.18 42.57 21.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.548 1.539 . . . . 0.0 112.84 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.84 146.99 18.99 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.485 1.517 . . . . 0.0 112.813 175.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -68.58 131.15 44.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.25 1.02 . . . . 0.0 111.091 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -127.68 108.08 10.45 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.885 1.674 . . . . 0.0 109.293 -177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -150.31 153.09 35.49 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.285 1.434 . . . . 0.0 111.947 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -167.86 146.02 4.52 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.318 1.447 . . . . 0.0 111.004 175.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -66.67 125.5 25.99 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 118.443 0.565 . . . . 0.0 109.806 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 58.2 tp -141.01 -36.19 0.46 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.35 1.06 . . . . 0.0 112.834 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.72 20.02 5.68 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.685 1.136 . . . . 0.0 114.486 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 58.5 12.35 2.05 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.311 2.245 . . . . 0.0 115.286 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.91 -67.24 0.06 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.379 1.942 . . . . 0.0 110.605 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.06 147.78 27.2 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.925 0.89 . . . . 0.0 110.604 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.83 168.1 24.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.376 1.47 . . . . 0.0 111.924 175.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -96.15 139.14 32.75 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 123.717 0.807 . . . . 0.0 111.655 175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -128.67 108.33 10.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 125.72 1.608 . . . . 0.0 108.427 174.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.46 167.67 25.74 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-O 121.951 0.75 . . . . 0.0 114.154 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.3 tt -149.09 142.94 18.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 126.847 2.059 . . . . 0.0 108.823 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 4.2 ttm -134.82 137.36 43.26 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.427 1.091 . . . . 0.0 108.801 175.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.53 156.19 33.34 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.6 1.16 . . . . 0.0 111.7 175.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.93 9.15 31.7 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -173.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.42 177.67 4.8 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.132 2.173 . . . . 0.0 112.293 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.0 -48.16 55.68 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 123.835 0.731 . . . . 0.0 113.053 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -86.5 51.45 2.23 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.476 1.51 . . . . 0.0 113.694 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.95 17.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.777 1.231 . . . . 0.0 113.828 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 136.69 53.77 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.291 1.036 . . . . 0.0 112.432 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.42 90.29 3.27 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 127.392 2.277 . . . . 0.0 110.954 -174.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -84.55 143.14 29.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.86 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.42 122.49 62.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 126.458 1.903 . . . . 0.0 107.506 175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.2 tttt -118.71 111.01 17.96 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.879 1.272 . . . . 0.0 109.759 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 12.3 mm -83.13 117.7 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.183 -178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.8 m -89.29 174.8 7.63 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 0.0 111.75 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.313 1.845 . . . . 0.0 113.196 -177.417 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 68.17 19.63 9.11 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 174.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.22 168.08 0.57 Allowed 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.36 36.11 63.28 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.563 -0.711 . . . . 0.0 113.825 -173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.6 p -150.82 -169.19 3.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.121 0.968 . . . . 0.0 111.152 -176.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 63' ' ' VAL . 1.6 pt -129.71 137.63 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.538 1.935 . . . . 0.0 111.861 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pp -145.5 165.06 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 126.223 1.809 . . . . 0.0 111.472 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.22 126.7 19.64 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.155 0.982 . . . . 0.0 112.803 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.15 -21.09 30.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.087 1.327 . . . . 0.0 114.047 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.9 -38.02 72.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.465 1.506 . . . . 0.0 112.324 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.08 -34.71 66.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.386 1.074 . . . . 0.0 112.113 175.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tp -57.63 100.02 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.784 1.634 . . . . 0.0 112.25 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.9 m -143.08 172.01 13.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.629 1.572 . . . . 0.0 110.463 -178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' H ' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER -49.41 -39.74 33.81 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.594 1.558 . . . . 0.0 113.697 178.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.66 -41.97 91.77 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.598 -0.689 . . . . 0.0 112.521 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.5 t -57.38 -46.81 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.626 0.77 . . . . 0.0 110.044 174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 48.6 mt -53.35 -60.18 3.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.596 0.759 . . . . 0.0 111.036 177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -53.45 -43.28 67.96 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.071 0.948 . . . . 0.0 112.371 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -59.43 -29.17 67.58 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.686 1.195 . . . . 0.0 113.533 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -66.3 -48.07 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.226 -1.546 . . . . 0.0 110.009 175.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 mp -56.3 -34.81 66.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 122.959 0.504 . . . . 0.0 111.526 176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -67.1 -57.69 6.31 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.86 -40.38 47.85 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.853 1.206 . . . . 0.0 114.06 -172.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tt -62.43 -23.38 66.83 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.346 1.058 . . . . 0.0 111.532 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.14 68.2 1.44 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.368 1.461 . . . . 0.0 111.214 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.35 127.83 4.67 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.519 1.528 . . . . 0.0 110.774 174.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 -161.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 127.118 2.167 . . . . 0.0 110.049 -178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.9 m -41.21 -49.3 3.59 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.12 1.368 . . . . 0.0 113.508 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -146.31 137.16 24.26 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.333 1.453 . . . . 0.0 111.377 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -157.6 171.15 20.86 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.511 1.524 . . . . 0.0 113.952 174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -138.83 163.21 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 124.456 1.102 . . . . 0.0 112.122 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -122.68 111.91 17.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.302 1.441 . . . . 0.0 110.471 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -97.11 145.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.649 1.58 . . . . 0.0 111.904 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.53 122.38 1.14 Allowed Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.022 1.296 . . . . 0.0 111.33 175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.78 112.74 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-N 119.185 1.492 . . . . 0.0 110.226 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -83.0 134.97 35.02 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -89.35 79.22 7.07 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.056 1.742 . . . . 0.0 113.243 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -95.86 2.6 53.79 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.3 t -65.55 -17.52 64.64 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.521 2.328 . . . . 0.0 114.72 176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.71 4.3 89.32 Favored Glycine 0 CA--C 1.54 1.625 0 O-C-N 121.059 -1.026 . . . . 0.0 114.74 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.58 161.31 23.3 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.551 1.548 . . . . 0.0 114.026 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.9 t -78.25 134.86 37.5 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.491 1.516 . . . . 0.0 112.037 175.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -112.12 168.08 9.89 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.864 2.066 . . . . 0.0 111.469 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.5 m -136.93 108.06 6.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.477 1.111 . . . . 0.0 110.737 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.54 117.76 6.65 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.873 -1.142 . . . . 0.0 108.539 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -62.49 -64.46 0.92 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.774 0.829 . . . . 0.0 109.88 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -177.98 171.05 1.8 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.517 2.327 . . . . 0.0 110.874 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -124.72 138.82 54.27 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 109.096 174.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -128.43 110.22 12.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.234 1.414 . . . . 0.0 111.133 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -72.5 121.32 19.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.724 1.209 . . . . 0.0 111.477 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.77 -33.6 14.93 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.446 1.498 . . . . 0.0 112.926 177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.7 t -145.04 162.32 37.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.598 1.559 . . . . 0.0 111.115 175.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.9 -160.68 29.68 Favored Glycine 0 CA--C 1.539 1.577 0 N-CA-C 114.727 0.651 . . . . 0.0 114.727 -177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.8 t -144.83 -178.73 6.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.444 1.498 . . . . 0.0 111.972 176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.7 p -147.25 166.19 27.79 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.846 1.658 . . . . 0.0 110.617 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.64 6.97 20.29 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.591 1.156 . . . . 0.0 111.608 175.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.72 153.41 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 128.305 2.642 . . . . 0.0 111.038 -172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.1 mt -122.04 140.17 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.502 1.521 . . . . 0.0 108.764 -171.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.31 140.1 75.9 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.369 -0.832 . . . . 0.0 109.618 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HG3' HG23 ' A' ' 6' ' ' ILE . 69.4 Cg_endo -65.5 176.64 3.26 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 124.459 3.439 . . . . 0.0 110.956 174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -119.19 -21.89 7.39 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 120.656 -1.278 . . . . 0.0 113.036 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -128.83 137.28 51.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.414 1.886 . . . . 0.0 109.792 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 6' ' ' ILE . 27.1 t -139.86 96.91 8.18 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.843 1.257 . . . . 0.0 109.715 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.88 168.57 18.36 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.142 1.895 . . . . 0.0 112.557 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -58.27 159.83 5.69 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.578 -0.701 . . . . 0.0 110.148 174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.273 5.6 t 57.66 15.62 2.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.638 1.975 . . . . 0.0 113.792 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -133.09 120.12 20.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 127.927 2.491 . . . . 0.0 110.371 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.87 163.54 13.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.674 1.19 . . . . 0.0 110.45 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.567 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -100.96 169.0 9.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 174.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -130.19 132.93 46.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.871 2.068 . . . . 0.0 108.893 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -153.13 164.04 38.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.799 1.24 . . . . 0.0 110.44 175.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 m -145.31 175.29 10.4 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 124.462 1.105 . . . . 0.0 111.207 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.58 103.66 0.24 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 125.176 1.37 . . . . 0.0 110.742 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 176.98 4.85 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.428 1.114 . . . . 0.0 111.572 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -66.59 -176.98 0.52 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.44 -177.02 0.27 Allowed 'General case' 0 CA--C 1.559 1.298 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 t -10.33 -67.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 127.944 2.497 . . . . 0.0 116.521 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -168.43 -72.07 0.03 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.212 0.91 . . . . 0.0 113.038 174.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.99 84.07 1.72 Allowed 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.757 3.638 . . . . 0.0 112.368 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.08 140.8 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.151 1.381 . . . . 0.0 112.256 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.53 64.59 0.84 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.015 1.326 . . . . 0.0 111.635 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.514 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.8 t -122.53 -97.22 0.45 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.087 1.755 . . . . 0.0 110.855 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.514 ' H ' HG23 ' A' ' 82' ' ' THR . . . -174.74 -177.46 43.87 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 127.967 2.698 . . . . 0.0 110.883 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.478 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -141.29 99.46 3.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.111 1.364 . . . . 0.0 108.742 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 103' ' ' SER . 88.6 t -135.69 131.12 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.107 . . . . 0.0 108.584 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -154.1 166.9 31.6 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.57 0.748 . . . . 0.0 111.22 175.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.05 158.14 43.87 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.711 0.767 . . . . 0.0 112.42 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.46 171.18 16.49 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.648 1.979 . . . . 0.0 110.478 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.51 142.37 43.48 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.155 0.982 . . . . 0.0 111.174 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.567 ' CZ ' HD22 ' A' ' 69' ' ' LEU . 1.1 m-85 -125.84 111.73 15.18 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.047 1.339 . . . . 0.0 111.33 -176.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -73.61 114.35 11.76 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.004 1.321 . . . . 0.0 110.805 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 30.1 mtt -76.6 160.7 29.19 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.435 0.636 . . . . 0.0 111.364 174.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 t -61.66 -17.76 56.76 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.0 m -79.51 -13.33 59.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.014 1.726 . . . . 0.0 113.548 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.46 -7.21 55.97 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.605 1.098 . . . . 0.0 114.835 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.88 173.43 11.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.242 1.017 . . . . 0.0 111.687 174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.1 m -133.77 142.94 48.13 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.94 0.896 . . . . 0.0 108.587 174.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.92 125.72 54.36 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 108.932 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.62 148.46 24.95 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.2 t -142.8 130.55 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.312 1.045 . . . . 0.0 109.255 175.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.39 155.65 45.88 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 174.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 22.8 p90 -127.01 153.27 46.13 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.147 1.379 . . . . 0.0 110.696 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.454 ' HA ' HG22 ' A' ' 85' ' ' VAL . 19.9 t -136.9 111.45 8.63 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.497 1.119 . . . . 0.0 111.49 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 32.1 t -115.02 102.18 54.75 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.51 1.924 . . . . 0.0 109.344 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.01 171.25 18.69 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.841 2.361 . . . . 0.0 112.542 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -72.39 -53.83 11.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.326 . . . . 0.0 110.632 174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.01 107.48 7.1 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 130.227 3.411 . . . . 0.0 112.398 -171.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -63.19 -60.16 3.79 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.274 1.03 . . . . 0.0 113.539 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -93.59 9.45 36.74 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.14 -4.15 6.85 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.566 1.947 . . . . 0.0 112.456 -175.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -150.2 146.04 26.61 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.395 2.278 . . . . 0.0 109.496 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -102.92 165.31 11.11 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.365 1.066 . . . . 0.0 111.869 176.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -88.44 156.93 18.84 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.666 -0.646 . . . . 0.0 110.112 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -140.5 146.14 37.79 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.35 0.66 . . . . 0.0 109.92 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.0 p-90 -147.97 155.6 41.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.991 1.316 . . . . 0.0 110.021 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -149.56 138.23 20.93 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.846 -0.534 . . . . 0.0 111.62 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.7 t -147.74 103.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.334 1.854 . . . . 0.0 110.102 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -120.6 143.37 48.69 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.036 1.335 . . . . 0.0 110.065 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 33.6 mt -108.51 111.6 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.249 1.819 . . . . 0.0 108.756 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -116.33 141.47 48.11 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.711 1.604 . . . . 0.0 111.853 177.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 61.7 p -72.48 80.55 1.06 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.288 1.435 . . . . 0.0 113.104 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.06 159.56 8.64 Favored Glycine 0 N--CA 1.473 1.148 0 C-N-CA 125.221 1.391 . . . . 0.0 113.321 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -73.79 133.94 43.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.466 0.707 . . . . 0.0 112.383 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -141.9 143.15 33.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.515 1.926 . . . . 0.0 111.215 175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -99.32 -179.35 4.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.662 1.585 . . . . 0.0 110.942 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -123.9 95.9 4.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.206 1.803 . . . . 0.0 110.177 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -108.79 -71.08 0.78 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.903 1.281 . . . . 0.0 110.559 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -147.48 -69.79 0.24 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.323 1.849 . . . . 0.0 109.637 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.54 73.27 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.638 1.113 . . . . 0.0 115.241 -174.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -84.2 -45.82 12.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.182 0.991 . . . . 0.0 110.872 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -63.15 -44.01 96.72 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.995 0.918 . . . . 0.0 112.393 176.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.77 -29.23 69.29 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.025 -1.047 . . . . 0.0 112.441 176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.85 -16.06 60.42 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.192 -0.943 . . . . 0.0 112.499 175.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.66 -55.58 2.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.431 1.492 . . . . 0.0 108.44 174.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -69.03 -48.14 63.65 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -87.62 -15.21 37.94 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.746 0.819 . . . . 0.0 112.743 178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -78.78 60.18 4.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.575 1.083 . . . . 0.0 114.208 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 42.75 76.97 0.47 Allowed Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 127.046 2.138 . . . . 0.0 111.754 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.64 149.04 73.37 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.783 1.655 . . . . 0.0 110.827 178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -74.89 156.7 36.12 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.951 0.881 . . . . 0.0 110.489 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 115.42 30.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 109.207 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.61 67.01 0.78 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.323 1.439 . . . . 0.0 113.511 177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.75 25.36 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.786 2.034 . . . . 0.0 114.386 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 54.72 41.71 31.73 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.994 1.717 . . . . 0.0 113.063 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.4 167.51 24.15 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.656 2.074 . . . . 0.0 112.232 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -75.34 128.56 35.68 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 121.593 -0.945 . . . . 0.0 111.592 176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -120.1 112.86 19.65 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.363 1.865 . . . . 0.0 109.635 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.481 ' HG2' HH21 ' A' ' 156' ' ' ARG . 1.3 pm0 -153.88 148.59 26.41 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.775 1.23 . . . . 0.0 111.507 175.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.8 pttt -161.88 147.08 13.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.038 1.335 . . . . 0.0 111.4 174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -62.97 123.05 17.54 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.926 -0.484 . . . . 0.0 110.972 174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.8 tp -142.84 -31.6 0.5 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.263 1.025 . . . . 0.0 113.296 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.85 17.26 16.82 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.963 1.268 . . . . 0.0 114.541 177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.2 t80 59.87 10.31 2.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.416 2.287 . . . . 0.0 114.697 -175.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.9 -67.32 0.05 OUTLIER Glycine 0 CA--C 1.522 0.47 0 C-N-CA 125.647 1.594 . . . . 0.0 110.606 -173.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.5 mp -94.35 156.54 16.45 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.577 0.703 . . . . 0.0 111.626 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.481 HH21 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -143.94 165.88 26.51 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.067 1.747 . . . . 0.0 112.719 177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -92.44 133.59 35.76 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.85 1.26 . . . . 0.0 110.143 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.9 ttpt -123.11 106.79 11.09 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.718 1.207 . . . . 0.0 109.339 174.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 CA--C 1.518 0.247 0 CA-C-O 122.38 0.989 . . . . 0.0 114.65 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 14.4 tt -144.64 145.29 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 126.974 2.11 . . . . 0.0 108.186 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 5.6 ttt -136.8 131.3 33.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.234 1.814 . . . . 0.0 106.687 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.32 166.83 19.37 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.108 0.963 . . . . 0.0 112.079 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 m -95.13 11.6 31.66 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.661 1.584 . . . . 0.0 113.793 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.13 167.95 10.24 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.193 1.797 . . . . 0.0 112.368 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.78 -56.05 26.4 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 121.348 -0.845 . . . . 0.0 112.992 -177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.16 47.51 0.46 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.503 1.521 . . . . 0.0 113.715 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.46 161.39 27.82 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.716 -1.24 . . . . 0.0 113.44 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -119.08 133.99 55.47 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.401 1.48 . . . . 0.0 108.913 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.1 ttp -128.53 110.46 12.3 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.494 1.518 . . . . 0.0 111.081 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -122.65 140.98 52.23 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 121.626 -0.671 . . . . 0.0 109.654 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.7 111.9 32.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 125.754 1.622 . . . . 0.0 109.729 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -100.44 105.37 16.84 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 125.409 1.484 . . . . 0.0 108.368 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.6 mm -74.06 136.23 25.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 17.0 t -151.09 167.18 28.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.091 0.956 . . . . 0.0 112.108 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.263 2.225 . . . . 0.0 110.344 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 110.484 -0.191 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.66 2.92 18.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.654 1.182 . . . . 0.0 113.424 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.625 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -62.21 150.33 39.22 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.111 -0.993 . . . . 0.0 111.381 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 65.94 34.18 87.77 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 115.125 0.81 . . . . 0.0 115.125 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.0 p -142.52 -165.08 1.96 Allowed 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 118.596 1.198 . . . . 0.0 111.539 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pp -129.36 144.1 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 125.891 1.676 . . . . 0.0 110.991 175.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 pt -143.0 168.88 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.079 1.352 . . . . 0.0 112.18 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.09 120.67 7.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.105 1.362 . . . . 0.0 111.555 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.14 -25.36 64.37 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.156 0.884 . . . . 0.0 113.11 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.71 -30.05 68.62 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.174 1.389 . . . . 0.0 113.078 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -96.29 -16.41 21.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.147 1.379 . . . . 0.0 113.357 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.5 tp -68.64 107.22 2.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.15 1.38 . . . . 0.0 110.233 174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -145.5 169.92 17.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.275 1.03 . . . . 0.0 109.883 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -50.85 -31.53 17.56 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.878 1.271 . . . . 0.0 113.703 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -61.74 -36.24 80.43 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.358 0.663 . . . . 0.0 112.567 174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -39.97 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.782 1.233 . . . . 0.0 111.104 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.1 mt -56.28 -47.84 77.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.031 0.932 . . . . 0.0 112.03 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.02 -49.32 76.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.061 0.544 . . . . 0.0 111.69 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -58.53 -36.79 74.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.093 0.957 . . . . 0.0 113.013 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 34.2 t -63.79 -59.42 4.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.211 1.404 . . . . 0.0 111.237 175.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.43 -38.09 73.85 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.815 1.246 . . . . 0.0 112.141 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.06 -41.33 67.52 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.008 0.822 . . . . 0.0 111.953 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -73.68 -37.07 65.35 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 57' ' ' VAL . 11.2 tp -48.39 -52.77 20.3 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.496 1.518 . . . . 0.0 111.638 177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.15 58.67 0.15 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 124.699 1.143 . . . . 0.0 111.002 -172.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 142.33 6.06 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.253 1.421 . . . . 0.0 112.444 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.78 -169.81 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.673 1.589 . . . . 0.0 109.711 -177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.3 m -45.0 -31.23 1.22 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.311 1.844 . . . . 0.0 115.525 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HG2' HH11 ' A' ' 29' ' ' ARG . 0.0 OUTLIER -149.93 134.89 17.83 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.487 1.515 . . . . 0.0 109.222 174.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.43 161.04 30.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.371 2.268 . . . . 0.0 110.628 -176.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -139.21 166.22 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.732 1.613 . . . . 0.0 110.326 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.54 110.55 14.6 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.751 1.22 . . . . 0.0 110.866 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.91 138.6 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.255 1.022 . . . . 0.0 111.8 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.84 112.18 0.54 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.535 1.064 . . . . 0.0 112.911 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.8 mt -101.2 109.87 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.456 1.128 . . . . 0.0 109.214 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -87.81 110.76 20.73 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 112.41 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -71.45 98.1 1.76 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.271 1.428 . . . . 0.0 111.31 175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -115.93 12.75 15.82 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.942 1.697 . . . . 0.0 113.34 174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.4 t -62.68 -54.51 38.29 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.559 1.144 . . . . 0.0 114.001 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.34 5.3 2.36 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.949 1.261 . . . . 0.0 116.166 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -151.48 163.36 29.9 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.625 1.712 . . . . 0.0 114.03 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.4 p -74.09 138.85 44.22 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.108 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -112.76 167.73 10.25 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.304 1.442 . . . . 0.0 112.236 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 16.7 m -140.14 106.25 5.22 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.633 1.173 . . . . 0.0 110.016 -174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 125.55 25.21 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 120.88 -1.138 . . . . 0.0 108.667 175.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.5 mt -65.56 -62.93 1.24 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.636 1.174 . . . . 0.0 110.384 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -176.87 174.9 1.7 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.825 2.45 . . . . 0.0 110.644 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -127.8 146.6 50.55 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.223 2.209 . . . . 0.0 109.492 174.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.15 113.33 13.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.146 1.378 . . . . 0.0 111.406 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -73.49 122.92 22.93 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.78 1.232 . . . . 0.0 110.188 174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.95 -38.6 7.72 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.825 1.65 . . . . 0.0 112.633 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.2 m -136.92 152.14 49.86 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.653 1.581 . . . . 0.0 109.929 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.13 50.05 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 123.925 0.774 . . . . 0.0 114.88 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 t -135.81 145.65 46.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 111.54 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.3 m -133.26 125.52 29.49 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.348 1.059 . . . . 0.0 108.747 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.4 -1.04 31.54 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.327 1.051 . . . . 0.0 112.943 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 3' ' ' ALA . 23.4 m -110.89 174.82 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 125.812 1.645 . . . . 0.0 113.045 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mt -141.11 139.88 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.917 1.687 . . . . 0.0 108.801 -172.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.13 146.01 86.63 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-N 119.578 1.081 . . . . 0.0 110.86 176.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.35 167.17 25.99 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 124.575 3.516 . . . . 0.0 111.277 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -107.64 -24.27 11.81 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.416 -1.427 . . . . 0.0 113.487 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -125.81 133.3 52.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.433 1.493 . . . . 0.0 111.061 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.8 t -133.84 94.63 18.43 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 125.589 1.556 . . . . 0.0 109.891 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.26 161.36 34.52 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.595 1.53 . . . . 0.0 111.868 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -63.31 160.12 16.58 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.726 -0.609 . . . . 0.0 110.724 174.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p 68.0 -0.85 1.92 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.045 2.138 . . . . 0.0 114.418 -174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -118.13 160.52 21.41 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.284 1.833 . . . . 0.0 111.738 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -128.5 160.79 31.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.971 1.308 . . . . 0.0 111.68 178.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.85 174.94 6.54 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.37 0.605 . . . . 0.0 110.999 174.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -133.4 133.0 41.84 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 126.464 1.906 . . . . 0.0 108.394 174.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -153.99 164.19 38.84 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.112 0.965 . . . . 0.0 112.589 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -150.48 164.25 36.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.914 1.286 . . . . 0.0 111.014 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.97 118.1 1.08 Allowed Glycine 0 N--CA 1.466 0.661 0 C-N-CA 125.275 1.417 . . . . 0.0 111.067 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' C ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -129.33 161.56 29.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.714 1.257 . . . . 0.0 110.696 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.22 -174.25 0.11 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.859 0.464 . . . . 0.0 110.102 174.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.96 -143.02 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.285 0 O-C-N 121.277 -0.89 . . . . 0.0 113.015 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.4 t -40.89 -38.33 0.94 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 119.044 -2.285 . . . . 0.0 114.796 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 146.26 -60.94 0.47 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.566 1.555 . . . . 0.0 112.774 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -68.22 -3.68 11.26 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 124.99 3.794 . . . . 0.0 116.156 -177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.8 160.55 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.438 1.095 . . . . 0.0 111.717 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.87 66.43 1.03 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.244 1.017 . . . . 0.0 111.24 178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.6 m -126.72 -85.32 0.61 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.83 1.252 . . . . 0.0 112.049 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 154.59 -177.21 32.05 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.116 1.341 . . . . 0.0 112.33 -173.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.525 ' HB2' ' C ' ' A' ' 74' ' ' ARG . . . -135.05 125.58 26.77 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.76 121.24 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -137.44 152.59 49.75 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.441 0.696 . . . . 0.0 110.737 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.7 47.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.82 0.848 . . . . 0.0 111.469 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 171.06 15.3 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 125.508 1.523 . . . . 0.0 110.307 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.52 138.09 50.05 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.159 0.983 . . . . 0.0 110.203 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.3 m-85 -119.31 118.61 31.69 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.709 1.204 . . . . 0.0 111.081 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -83.12 113.36 20.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.162 1.385 . . . . 0.0 110.787 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 2.5 mtt -70.15 162.47 28.26 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.057 0.943 . . . . 0.0 111.315 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.9 p -61.27 -22.63 65.02 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.269 1.428 . . . . 0.0 114.102 176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.4 t -82.98 -14.57 53.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.46 1.904 . . . . 0.0 113.007 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.14 56.75 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.284 1.421 . . . . 0.0 115.069 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -80.18 164.34 23.36 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.618 1.167 . . . . 0.0 109.518 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.0 m -122.95 143.24 50.04 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.817 0.847 . . . . 0.0 110.193 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.55 115.7 23.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.33 128.34 8.43 Favored Glycine 0 CA--C 1.518 0.239 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.475 HG12 HG22 ' A' ' 117' ' ' VAL . 5.1 m -130.63 128.93 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.679 0.792 . . . . 0.0 109.539 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.11 154.8 49.19 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 122.079 -0.388 . . . . 0.0 111.185 175.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 4.3 p90 -134.05 153.9 51.5 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.701 1.201 . . . . 0.0 110.639 174.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 41.2 t -137.31 114.55 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.078 2.151 . . . . 0.0 108.931 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 21.8 t -111.76 95.2 27.16 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 128.683 2.793 . . . . 0.0 106.95 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -71.97 -168.66 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 122.509 2.14 . . . . 0.0 111.454 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -108.69 -43.46 4.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.995 0.918 . . . . 0.0 112.154 174.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.68 127.19 32.53 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 126.105 1.762 . . . . 0.0 112.36 -172.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -58.22 3.44 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -174.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -100.25 11.55 39.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.255 1.422 . . . . 0.0 113.917 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.23 0.87 7.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 127.108 2.163 . . . . 0.0 111.917 -175.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.43 178.36 10.24 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.753 2.421 . . . . 0.0 110.977 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 t -154.8 164.78 38.32 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.223 1.409 . . . . 0.0 110.932 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 112.72 24.77 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.01 -1.056 . . . . 0.0 111.181 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -98.58 136.32 38.85 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 -173.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 32.3 p-90 -142.92 145.23 32.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.658 1.183 . . . . 0.0 111.214 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -137.0 139.37 41.37 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.391 1.077 . . . . 0.0 109.677 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.475 HG22 HG12 ' A' ' 100' ' ' VAL . 84.8 t -136.06 110.88 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 126.121 1.768 . . . . 0.0 109.981 175.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -126.84 133.51 50.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.763 1.625 . . . . 0.0 110.189 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.6 mt -97.83 129.79 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.756 1.622 . . . . 0.0 108.592 175.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -133.63 144.18 49.07 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.822 . . . . 0.0 112.902 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 p -75.02 92.21 2.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.167 1.787 . . . . 0.0 113.102 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 143.7 -179.15 21.32 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.314 1.435 . . . . 0.0 112.483 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 145.21 25.98 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.626 1.17 . . . . 0.0 111.713 174.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -163.48 164.57 24.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.778 1.631 . . . . 0.0 111.002 174.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -140.55 156.16 46.39 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.243 1.417 . . . . 0.0 110.862 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.81 92.26 1.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.655 0.782 . . . . 0.0 111.019 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.67 -72.05 0.71 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.145 1.378 . . . . 0.0 110.583 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.81 -71.55 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.686 1.594 . . . . 0.0 108.091 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -52.43 -42.93 57.79 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.379 0.99 . . . . 0.0 113.999 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.4 tpt -74.22 -50.08 20.67 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.498 1.149 . . . . 0.0 112.628 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.96 -48.22 80.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.906 0.483 . . . . 0.0 110.061 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.16 -33.6 76.13 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -62.77 -28.68 70.15 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.508 1.504 . . . . 0.0 112.051 175.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.79 -40.21 12.62 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.562 0.745 . . . . 0.0 111.453 175.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -78.49 -42.32 29.99 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 120.427 -1.421 . . . . 0.0 114.104 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -96.29 -12.97 23.71 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.043 -1.036 . . . . 0.0 112.798 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.51 -77.22 0.16 Allowed Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.577 1.084 . . . . 0.0 112.083 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -175.06 69.05 0.27 Allowed Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 127.531 2.333 . . . . 0.0 110.608 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.76 130.38 18.02 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 120.789 0.993 . . . . 0.0 111.106 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.22 124.36 22.89 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 175.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 15.51 0.13 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.013 2.125 . . . . 0.0 114.425 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 52.97 59.1 9.84 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.3 1.429 . . . . 0.0 112.319 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.16 16.91 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 67.57 29.75 6.98 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.748 2.019 . . . . 0.0 112.97 -176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.1 158.16 23.79 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.809 1.671 . . . . 0.0 113.832 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -72.74 131.1 41.92 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.783 1.233 . . . . 0.0 112.034 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -122.88 108.48 13.02 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.747 2.019 . . . . 0.0 111.016 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -140.75 153.59 45.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.184 1.793 . . . . 0.0 110.782 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.99 138.99 1.35 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.63 1.172 . . . . 0.0 110.268 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -60.54 134.77 57.4 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 118.276 0.489 . . . . 0.0 111.403 176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 14.3 tp -158.54 -30.53 0.07 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.79 24.41 5.18 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.001 1.286 . . . . 0.0 114.623 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.4 t80 58.67 15.15 3.52 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 127.44 2.296 . . . . 0.0 114.708 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 176.42 -77.63 0.07 OUTLIER Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.833 1.683 . . . . 0.0 110.976 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.537 HD12 ' HA ' ' A' ' 174' ' ' SER . 3.2 mm? -77.35 145.8 37.09 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.401 1.081 . . . . 0.0 110.459 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.99 168.41 20.05 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.5 1.52 . . . . 0.0 112.162 175.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.41 ' HA ' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -81.48 142.54 32.82 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.912 1.285 . . . . 0.0 111.239 174.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -140.08 107.06 5.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 126.589 1.956 . . . . 0.0 108.523 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -142.6 168.02 26.02 Favored Glycine 0 N--CA 1.461 0.347 0 CA-C-O 121.503 0.502 . . . . 0.0 114.206 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 15.0 tt -143.49 142.82 24.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 126.322 1.849 . . . . 0.0 109.011 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.0 ttt -145.59 151.09 37.55 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.945 1.698 . . . . 0.0 108.479 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.8 p -88.26 165.07 15.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.425 0.69 . . . . 0.0 111.548 176.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.8 m -80.71 9.56 6.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.113 1.365 . . . . 0.0 112.819 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.08 157.22 17.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.843 2.057 . . . . 0.0 111.382 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -56.27 -66.01 3.16 Favored Glycine 0 N--CA 1.474 1.179 0 CA-C-N 119.311 0.959 . . . . 0.0 111.868 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.58 87.97 0.68 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.894 0.878 . . . . 0.0 109.507 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -127.92 146.86 50.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.0 1.32 . . . . 0.0 112.31 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -91.67 129.89 37.56 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.3 ttm -127.06 83.46 2.17 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.672 1.989 . . . . 0.0 109.503 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -89.07 144.48 26.11 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.677 -0.639 . . . . 0.0 109.816 173.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 59.1 mt -127.23 124.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 125.954 1.702 . . . . 0.0 108.219 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.1 tttm -114.09 107.23 15.36 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.173 1.789 . . . . 0.0 109.182 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 157' ' ' MET . 35.8 mm -88.95 103.94 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.633 0.73 . . . . 0.0 110.794 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.537 ' HA ' HD12 ' A' ' 155' ' ' LEU . 1.7 p -153.27 173.78 15.14 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.639 1.575 . . . . 0.0 112.571 -175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.252 1.203 0 C-N-CA 126.347 1.859 . . . . 0.0 111.429 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.877 -0.106 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 -36.19 11.52 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.81 0.844 . . . . 0.0 113.119 -176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.531 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . -41.73 146.11 0.27 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.051 1.74 . . . . 0.0 115.286 175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.07 38.75 34.28 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.583 1.087 . . . . 0.0 113.985 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.0 p -145.25 -170.6 3.47 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 118.732 1.266 . . . . 0.0 111.895 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.4 pt -118.51 142.51 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.776 2.03 . . . . 0.0 110.479 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.8 pt -145.63 162.48 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.26 1.424 . . . . 0.0 111.813 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.36 126.5 27.72 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.725 0.81 . . . . 0.0 110.863 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.93 -23.08 60.98 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.299 0.952 . . . . 0.0 113.059 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.57 91.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.98 1.312 . . . . 0.0 112.085 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.6 m -79.92 -24.02 41.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.763 1.225 . . . . 0.0 113.541 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.1 tp -63.32 97.55 0.13 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.062 1.345 . . . . 0.0 112.2 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -145.52 172.46 13.19 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.926 1.69 . . . . 0.0 110.17 -174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -46.56 -39.83 11.67 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.155 1.382 . . . . 0.0 114.6 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -56.62 -43.68 80.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 118.756 -0.64 . . . . 0.0 112.563 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.15 -45.2 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.274 1.03 . . . . 0.0 111.072 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 35.5 mt -56.05 -50.01 72.15 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.547 0.612 . . . . 0.0 111.492 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.33 -42.47 92.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.141 0.976 . . . . 0.0 112.218 175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -54.45 -52.83 60.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.598 1.159 . . . . 0.0 111.809 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.761 HG21 HD21 ' A' ' 70' ' ' LEU . 82.7 t -56.71 -49.21 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.728 1.211 . . . . 0.0 110.404 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -43.11 62.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.727 0.811 . . . . 0.0 112.399 177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -71.4 -53.25 14.69 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.892 1.277 . . . . 0.0 112.068 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -72.41 -29.26 63.57 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.536 1.534 . . . . 0.0 114.254 -171.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD22 ' HZ1' ' A' ' 30' ' ' LYS . 7.0 tt -63.61 -53.93 43.82 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.591 1.557 . . . . 0.0 110.589 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 127.45 75.24 0.2 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.268 1.413 . . . . 0.0 111.926 -169.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 139.95 2.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.496 1.518 . . . . 0.0 111.887 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.05 -177.85 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 126.754 2.021 . . . . 0.0 109.725 -174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -45.78 -42.86 12.62 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.287 1.835 . . . . 0.0 115.151 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 82.6 mmt-85 -148.79 141.37 24.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.31 1.444 . . . . 0.0 111.371 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.492 ' HZ1' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -170.5 168.94 7.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.584 1.953 . . . . 0.0 112.32 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.13 161.15 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.613 1.165 . . . . 0.0 110.637 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.18 106.95 13.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.406 1.482 . . . . 0.0 109.882 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.4 t -99.48 140.35 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.333 1.453 . . . . 0.0 110.99 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.58 120.56 1.0 Allowed Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.706 1.146 . . . . 0.0 111.992 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.4 mm -112.28 97.31 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.819 1.248 . . . . 0.0 109.373 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 7.1 t70 -75.89 114.12 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.205 1.402 . . . . 0.0 113.513 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -84.09 96.75 9.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.267 1.427 . . . . 0.0 111.227 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -124.17 34.33 5.07 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.239 1.816 . . . . 0.0 110.186 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 t -80.34 -51.0 9.39 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.964 1.306 . . . . 0.0 112.948 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.14 15.02 1.93 Allowed Glycine 0 CA--C 1.539 1.531 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 -174.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.83 160.6 32.57 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 119.53 1.665 . . . . 0.0 114.085 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 30.5 p -73.41 138.32 45.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.983 -0.716 . . . . 0.0 111.919 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.9 m0 -110.38 165.72 11.55 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.495 1.118 . . . . 0.0 111.457 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 62.7 m -133.78 115.58 14.7 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.084 1.354 . . . . 0.0 108.739 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.89 136.87 57.35 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.545 -0.722 . . . . 0.0 109.199 174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.18 -70.08 0.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -179.19 175.19 0.97 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.403 2.281 . . . . 0.0 110.285 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -130.1 147.16 51.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.377 2.271 . . . . 0.0 109.44 175.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.17 109.79 9.7 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.912 1.285 . . . . 0.0 110.638 176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -71.43 116.57 11.92 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.726 1.21 . . . . 0.0 110.779 174.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.65 -45.86 9.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.655 1.182 . . . . 0.0 112.123 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.1 m -137.37 146.94 45.1 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.087 1.755 . . . . 0.0 110.457 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' HA2' ' H ' ' A' ' 76' ' ' ASP . . . 83.2 -163.98 41.78 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 123.682 0.658 . . . . 0.0 113.191 -176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.45 174.64 14.12 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.265 1.026 . . . . 0.0 111.6 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -143.94 173.23 11.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.195 0.998 . . . . 0.0 112.009 175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.84 11.65 11.91 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.618 1.567 . . . . 0.0 112.061 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 18.7 m -129.57 166.87 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 127.226 2.21 . . . . 0.0 111.351 -171.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.97 133.36 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.971 1.308 . . . . 0.0 109.943 -175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.94 152.67 90.96 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 119.533 1.06 . . . . 0.0 112.326 176.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.53 171.61 13.91 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 124.414 3.41 . . . . 0.0 110.313 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 14.0 tt0 -111.05 -18.87 12.93 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -124.62 131.18 53.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.85 1.66 . . . . 0.0 110.26 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.98 98.14 6.91 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.675 1.19 . . . . 0.0 109.639 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -65.67 164.82 25.15 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 121.728 1.619 . . . . 0.0 112.573 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -62.28 157.72 18.92 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.493 -0.754 . . . . 0.0 110.393 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 p 68.67 -0.02 2.47 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 126.568 1.947 . . . . 0.0 114.248 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -125.45 145.81 49.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.471 2.308 . . . . 0.0 110.723 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 36' ' ' ASP . . . -120.46 169.16 10.58 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.922 1.689 . . . . 0.0 110.826 176.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.445 HD22 ' CZ ' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -104.22 177.52 4.82 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.876 0.846 . . . . 0.0 110.187 174.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.761 HD21 HG21 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -131.23 128.78 40.61 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.371 1.868 . . . . 0.0 108.747 176.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -149.22 163.8 36.6 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 123.512 0.725 . . . . 0.0 111.951 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.2 m -149.8 172.51 15.01 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.559 1.144 . . . . 0.0 111.199 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -157.67 106.19 0.29 Allowed Glycine 0 N--CA 1.47 0.922 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.735 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.88 162.97 14.73 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.07 1.348 . . . . 0.0 112.75 -174.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.66 105.28 17.25 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.333 -0.855 . . . . 0.0 110.944 174.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 23.4 t0 33.26 -134.58 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.918 2.487 . . . . 0.0 112.928 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -39.58 80.94 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 120.164 -1.585 . . . . 0.0 112.138 174.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 141.39 -62.28 0.53 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.566 1.555 . . . . 0.0 112.993 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -64.94 -3.71 7.52 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 125.001 3.801 . . . . 0.0 116.494 -176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.96 168.11 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.778 1.231 . . . . 0.0 112.267 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.22 68.61 1.41 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.652 1.181 . . . . 0.0 111.644 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.2 m -120.7 -89.35 0.61 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.258 1.423 . . . . 0.0 110.839 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 165.51 174.55 35.21 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.285 1.422 . . . . 0.0 111.315 -175.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -133.19 111.77 11.16 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.956 0.902 . . . . 0.0 110.122 175.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.4 t -139.34 120.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.83 168.21 20.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.841 0.857 . . . . 0.0 110.851 175.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.21 155.95 42.53 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.638 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.83 173.72 12.13 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.964 2.106 . . . . 0.0 110.716 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.96 149.7 45.03 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.275 1.03 . . . . 0.0 111.398 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -131.39 117.13 18.46 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.016 1.327 . . . . 0.0 111.624 -176.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -79.39 108.85 13.22 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.502 1.521 . . . . 0.0 110.213 177.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 10.9 mtt -71.06 162.7 28.99 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.575 0.703 . . . . 0.0 111.612 174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -59.69 -21.32 60.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.924 1.69 . . . . 0.0 113.956 175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.5 m -79.93 -12.4 59.73 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.631 1.972 . . . . 0.0 113.208 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 6.2 65.73 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 124.94 1.257 . . . . 0.0 115.072 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -90.74 170.45 10.11 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.517 1.127 . . . . 0.0 110.496 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 18.6 m -131.68 149.38 52.5 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 122.136 0.969 . . . . 0.0 110.94 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 122.74 42.13 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.195 1.398 . . . . 0.0 109.037 174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.79 139.4 24.4 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 108.854 -1.699 . . . . 0.0 108.854 175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.15 122.16 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.781 1.291 . . . . 0.0 109.03 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 3.4 ptm -127.81 158.76 36.84 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.606 0.762 . . . . 0.0 112.109 175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.523 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.7 p90 -131.78 150.74 52.06 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.213 1.405 . . . . 0.0 110.244 175.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.73 100.7 4.26 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.895 1.278 . . . . 0.0 110.524 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 42.2 t -94.69 104.27 13.85 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 127.332 2.253 . . . . 0.0 109.854 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.08 169.69 17.36 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.147 2.565 . . . . 0.0 112.718 175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -89.87 -37.0 14.74 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 110.23 175.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.68 111.65 23.96 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.895 1.678 . . . . 0.0 111.273 -163.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -66.8 -56.86 8.54 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.754 -1.216 . . . . 0.0 113.8 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -94.31 12.83 25.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.478 1.111 . . . . 0.0 113.644 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.91 -14.76 3.08 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.328 1.851 . . . . 0.0 113.068 -173.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -142.95 -179.32 6.28 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.832 3.253 . . . . 0.0 109.446 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.56 167.73 23.78 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.931 1.292 . . . . 0.0 111.016 174.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.57 149.1 26.12 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.586 -0.697 . . . . 0.0 111.188 176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -139.67 147.73 41.39 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.741 1.216 . . . . 0.0 111.205 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -158.41 148.82 20.14 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.798 1.639 . . . . 0.0 110.696 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -141.86 149.01 39.7 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 120.085 1.312 . . . . 0.0 111.603 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.9 t -143.97 86.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.559 1.543 . . . . 0.0 113.584 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt -88.4 138.91 31.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.225 1.01 . . . . 0.0 108.504 175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.9 mt -108.23 114.65 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.547 1.539 . . . . 0.0 108.68 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -127.53 136.44 51.73 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.326 1.451 . . . . 0.0 112.464 -176.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 33.4 p -78.08 84.28 4.33 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.284 1.434 . . . . 0.0 112.294 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.24 -175.45 37.86 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.3 0.952 . . . . 0.0 113.418 -175.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -112.91 107.02 15.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.427 1.891 . . . . 0.0 110.339 -172.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -140.55 167.97 20.9 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 126.518 1.927 . . . . 0.0 111.344 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -148.92 166.97 26.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.973 1.709 . . . . 0.0 112.486 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.32 84.96 4.48 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.294 1.438 . . . . 0.0 111.232 175.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -97.28 -64.61 1.03 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.786 0.834 . . . . 0.0 110.843 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 62.4 tp60 -152.2 -77.0 0.13 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.144 2.178 . . . . 0.0 108.501 176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.6 -24.87 71.33 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.338 0.97 . . . . 0.0 115.022 -174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.43 -56.49 4.66 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 118.667 1.234 . . . . 0.0 110.506 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -58.33 -38.89 78.04 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 118.965 -0.541 . . . . 0.0 111.485 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -58.42 -38.72 77.98 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.341 0.973 . . . . 0.0 112.668 175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.01 -38.67 89.52 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.646 0.657 . . . . 0.0 111.904 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.86 -34.34 64.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.456 0.702 . . . . 0.0 111.166 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -73.49 -47.87 37.78 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 120.52 -1.363 . . . . 0.0 112.823 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -94.6 -15.99 23.59 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.946 0.898 . . . . 0.0 113.285 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.79 -70.64 0.9 Allowed Glycine 0 N--CA 1.472 1.058 0 C-N-CA 124.309 0.957 . . . . 0.0 112.664 -176.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -178.17 77.47 0.23 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.807 2.443 . . . . 0.0 109.658 174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.04 128.18 18.2 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 N-CA-C 108.56 -1.361 . . . . 0.0 108.56 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.48 150.55 26.48 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 122.574 1.178 . . . . 0.0 110.311 177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.51 120.61 28.02 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.462 1.105 . . . . 0.0 108.687 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.8 55.95 1.34 Allowed Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.197 1.379 . . . . 0.0 113.976 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -71.4 25.71 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.229 1.812 . . . . 0.0 115.462 -175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.267 12.0 p30 52.84 31.72 11.16 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.154 2.182 . . . . 0.0 114.57 -178.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -127.77 175.9 18.18 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 126.721 2.105 . . . . 0.0 113.092 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -79.63 122.88 27.08 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.04 0.936 . . . . 0.0 111.759 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -114.34 116.2 28.58 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.431 1.892 . . . . 0.0 109.452 176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -142.93 146.12 33.69 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.6 1.16 . . . . 0.0 110.777 175.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -147.19 121.53 9.62 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.874 1.27 . . . . 0.0 111.747 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -72.12 93.92 1.47 Allowed 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.153 1.381 . . . . 0.0 112.269 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 tp -147.24 8.82 0.94 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -94.68 21.6 42.35 Favored Glycine 0 N--CA 1.476 1.334 0 O-C-N 120.623 -1.298 . . . . 0.0 115.341 -177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 65.35 9.32 5.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.388 1.875 . . . . 0.0 115.022 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.65 -40.84 0.21 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.546 1.546 . . . . 0.0 113.997 178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.42 150.53 47.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.528 1.531 . . . . 0.0 110.388 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.7 167.16 21.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.815 0.846 . . . . 0.0 112.904 175.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.36 139.77 30.34 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.361 1.064 . . . . 0.0 109.898 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -130.37 115.26 16.64 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.02 172.14 25.29 Favored Glycine 0 C--O 1.23 -0.12 0 CA-C-O 121.901 0.723 . . . . 0.0 113.494 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 tt -138.54 131.88 40.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 125.452 1.501 . . . . 0.0 109.318 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 8.7 ttt -129.1 143.07 50.74 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.183 1.793 . . . . 0.0 107.021 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.29 154.16 19.02 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.071 1.749 . . . . 0.0 110.598 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.6 m -92.59 27.26 2.36 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.108 1.363 . . . . 0.0 112.715 -178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -114.39 170.71 8.1 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.518 1.927 . . . . 0.0 111.58 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -65.41 -62.09 5.14 Favored Glycine 0 CA--C 1.528 0.88 0 O-C-N 121.289 -0.882 . . . . 0.0 112.823 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.52 51.11 1.4 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.406 1.882 . . . . 0.0 111.73 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.63 175.85 3.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.69 1.596 . . . . 0.0 112.443 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 3.6 mptt -134.67 154.11 51.68 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.285 1.434 . . . . 0.0 109.161 175.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 8.6 ttp -142.69 85.31 1.89 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.164 0.986 . . . . 0.0 111.969 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -91.36 142.04 28.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.263 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 58.7 mt -125.18 123.52 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 126.605 1.962 . . . . 0.0 107.697 175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.37 117.28 33.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.69 175.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 28.1 mm -89.31 130.22 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 122.953 0.501 . . . . 0.0 110.452 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.3 m -144.5 167.82 21.6 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.865 1.266 . . . . 0.0 112.89 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ppt_? . . . . . 0 C--O 1.252 1.234 0 C-N-CA 127.645 2.378 . . . . 0.0 113.594 -175.55 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 110.63 -0.137 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -99.06 -4.01 33.41 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.831 1.049 . . . . 0.0 113.831 177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.41 141.88 58.12 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.963 0.905 . . . . 0.0 112.576 -178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.68 40.29 85.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.304 0.954 . . . . 0.0 114.825 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 36.7 p -144.92 -171.48 3.64 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 118.163 0.982 . . . . 0.0 112.573 -178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.501 HG23 ' HG3' ' A' ' 60' ' ' PRO . 8.1 pt -127.0 138.9 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.214 2.205 . . . . 0.0 111.662 174.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.8 pt -148.1 170.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.109 1.764 . . . . 0.0 111.904 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.97 116.91 2.21 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.611 1.564 . . . . 0.0 112.335 175.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.78 -23.86 67.67 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 123.553 0.597 . . . . 0.0 113.266 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.62 -35.49 81.19 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.521 1.128 . . . . 0.0 113.076 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 m -86.49 -13.16 46.86 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.798 1.239 . . . . 0.0 114.091 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.439 HD22 ' CB ' ' A' ' 68' ' ' ALA . 17.5 tp -68.95 113.65 6.54 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.23 1.012 . . . . 0.0 111.102 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m -144.35 166.63 24.55 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 125.007 1.323 . . . . 0.0 110.578 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -49.21 -37.29 22.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.554 1.542 . . . . 0.0 114.64 179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -60.75 -45.02 95.92 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.225 0.61 . . . . 0.0 111.79 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' VAL . 21.4 t -57.07 -46.3 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.906 1.283 . . . . 0.0 110.492 175.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.9 mt -51.8 -48.45 63.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.205 1.002 . . . . 0.0 112.594 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -68.35 -43.81 76.65 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.425 -0.797 . . . . 0.0 111.864 175.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -56.12 -40.76 74.25 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.201 1.4 . . . . 0.0 113.081 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 70' ' ' LEU . 53.1 t -52.9 -59.19 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 126.506 1.922 . . . . 0.0 109.984 175.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 mp -61.39 -43.47 98.81 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.558 1.943 . . . . 0.0 112.757 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -51.15 -53.58 33.17 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.28 1.032 . . . . 0.0 112.086 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -78.4 -35.02 47.7 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.98 -42.09 62.66 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.12 1.368 . . . . 0.0 111.074 174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.09 58.69 0.87 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 110.558 -1.017 . . . . 0.0 110.558 -173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttt -59.32 171.65 0.75 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.737 1.215 . . . . 0.0 111.775 175.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.63 -162.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.808 1.243 . . . . 0.0 110.324 -176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -46.65 -41.28 14.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.614 1.566 . . . . 0.0 112.96 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -130.99 137.16 49.1 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.637 1.575 . . . . 0.0 111.136 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 162.24 36.63 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 112.44 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG22 ' HB3' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -141.48 151.95 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.885 1.674 . . . . 0.0 109.592 174.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -120.87 126.69 50.67 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.917 1.687 . . . . 0.0 107.452 174.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 45.9 t -118.43 132.61 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 125.354 1.462 . . . . 0.0 110.217 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.62 119.98 1.34 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.071 1.319 . . . . 0.0 111.249 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.479 HD12 HD21 ' A' ' 69' ' ' LEU . 12.2 mt -111.8 100.76 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.602 1.161 . . . . 0.0 108.47 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -74.96 102.85 4.94 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.909 1.283 . . . . 0.0 111.502 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -70.98 96.47 1.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.916 0.887 . . . . 0.0 112.039 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -123.77 16.47 9.45 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.131 1.772 . . . . 0.0 112.592 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 96.1 p -67.84 -41.21 83.34 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 120.858 -1.151 . . . . 0.0 113.808 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 12.82 3.94 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 -177.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.27 162.63 30.7 Favored Glycine 0 CA--C 1.535 1.3 0 CA-C-N 119.765 1.783 . . . . 0.0 114.347 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.2 t -71.29 132.69 45.28 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.262 1.025 . . . . 0.0 112.87 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -106.61 163.6 12.76 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.285 1.434 . . . . 0.0 111.6 177.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.7 m -129.72 114.05 15.49 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.683 1.193 . . . . 0.0 109.699 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.46 129.07 38.98 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.507 -0.746 . . . . 0.0 109.315 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.75 -68.32 0.44 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.943 0.497 . . . . 0.0 109.868 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 179.41 173.56 0.83 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.63 2.372 . . . . 0.0 110.483 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -129.13 146.83 50.98 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.764 2.026 . . . . 0.0 109.308 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -132.89 115.92 15.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.292 1.437 . . . . 0.0 110.626 175.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -78.52 115.78 18.46 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.054 1.342 . . . . 0.0 111.037 175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.0 ttt-85 -92.93 -39.28 11.23 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.107 0.963 . . . . 0.0 112.795 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.3 m -141.63 151.79 43.4 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.84 2.056 . . . . 0.0 110.372 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.04 -171.57 54.43 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 123.749 0.69 . . . . 0.0 113.87 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -136.39 173.77 11.34 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.933 1.293 . . . . 0.0 112.275 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -143.34 171.01 14.7 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.527 1.531 . . . . 0.0 111.752 175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -124.67 10.2 8.39 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.697 1.199 . . . . 0.0 112.396 175.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.8 m -143.06 170.35 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.488 2.315 . . . . 0.0 113.362 -171.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.75 140.4 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 127.196 2.199 . . . . 0.0 109.731 -172.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.414 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -78.99 156.22 77.1 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 119.119 0.872 . . . . 0.0 111.858 176.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' HG3' HG23 ' A' ' 6' ' ' ILE . 39.1 Cg_endo -69.52 176.01 7.15 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 124.332 3.355 . . . . 0.0 110.457 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 13.8 tt0 -118.04 -22.84 7.65 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.198 -0.939 . . . . 0.0 113.077 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -120.9 123.18 41.88 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.7 1.6 . . . . 0.0 110.416 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.4 t -132.1 93.32 26.83 Favored Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 124.859 1.264 . . . . 0.0 110.298 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -64.9 165.32 21.65 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.328 2.019 . . . . 0.0 112.51 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.87 160.18 10.05 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.212 0.605 . . . . 0.0 110.19 174.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 t 56.41 13.74 1.4 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 128.365 2.666 . . . . 0.0 113.857 -174.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.61 136.65 46.66 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 127.006 2.123 . . . . 0.0 109.653 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.439 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -117.84 161.07 20.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.381 1.072 . . . . 0.0 111.407 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.479 HD21 HD12 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -101.34 169.11 9.1 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.608 0.718 . . . . 0.0 109.709 174.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 20' ' ' VAL . 4.1 mm? -126.2 130.72 51.51 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 126.45 1.9 . . . . 0.0 107.951 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -147.51 162.44 39.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 124.523 1.129 . . . . 0.0 110.506 174.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.3 m -150.75 163.47 38.52 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.452 0.701 . . . . 0.0 110.798 -176.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.95 115.69 0.7 Allowed Glycine 0 N--CA 1.463 0.443 0 C-N-CA 124.536 1.065 . . . . 0.0 110.896 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 174.18 5.98 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.709 1.254 . . . . 0.0 111.134 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -64.07 -172.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.685 0.794 . . . . 0.0 109.561 174.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -62.97 -174.13 0.07 Allowed 'General case' 0 CA--C 1.555 1.15 0 O-C-N 120.084 -1.635 . . . . 0.0 111.216 175.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.3 m -37.22 -41.6 0.4 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.421 1.888 . . . . 0.0 115.698 -172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.5 -57.52 0.42 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.235 1.398 . . . . 0.0 112.955 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.45 1.77 5.2 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 124.763 3.642 . . . . 0.0 115.154 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 m -123.31 109.47 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.345 2.258 . . . . 0.0 111.141 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.01 78.76 5.91 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.489 1.516 . . . . 0.0 112.372 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 50.0 m -100.96 -70.99 0.72 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.516 1.126 . . . . 0.0 111.321 176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 168.22 -178.45 41.86 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.073 1.32 . . . . 0.0 112.043 -178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -140.22 106.97 5.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.927 0.891 . . . . 0.0 109.797 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.35 123.45 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 120.805 -1.185 . . . . 0.0 108.668 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -147.38 169.94 18.4 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.642 0.734 . . . . 0.0 110.989 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.61 158.21 43.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.902 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.0 170.54 16.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.432 1.893 . . . . 0.0 110.311 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.87 155.79 49.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.911 0.885 . . . . 0.0 111.382 174.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.646 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 1.1 m-85 -136.13 121.95 19.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.019 1.328 . . . . 0.0 110.969 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -79.18 115.94 19.15 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.665 1.586 . . . . 0.0 110.483 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.83 161.98 30.14 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.647 0.779 . . . . 0.0 112.362 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -62.28 -23.39 66.68 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 113.403 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.9 m -78.33 -13.85 59.67 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.899 1.68 . . . . 0.0 113.581 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.96 4.15 60.27 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.796 1.188 . . . . 0.0 115.086 -176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -84.9 172.54 11.3 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.286 1.043 . . . . 0.0 109.896 174.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.1 m -131.92 152.71 50.9 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.816 0.847 . . . . 0.0 109.735 175.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.82 135.37 53.74 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.441 1.097 . . . . 0.0 109.697 174.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.49 142.38 17.94 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.19 112.94 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 118.642 1.221 . . . . 0.0 109.518 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.87 150.44 46.47 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.144 0.578 . . . . 0.0 110.659 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.548 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 19.7 p90 -126.9 146.61 50.24 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.473 1.109 . . . . 0.0 109.672 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 t -131.16 110.89 11.48 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.54 1.136 . . . . 0.0 110.893 176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 31' ' ' ILE . 2.8 t -115.0 102.1 54.74 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.399 1.479 . . . . 0.0 109.363 -177.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.78 163.86 34.8 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.897 2.398 . . . . 0.0 112.492 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -75.01 -26.77 59.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.34 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.48 112.96 24.82 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 120.351 -1.468 . . . . 0.0 111.255 -173.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -66.25 -71.4 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 O-C-N 120.931 -1.105 . . . . 0.0 112.172 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.91 10.67 3.95 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.31 -3.42 4.95 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.441 1.896 . . . . 0.0 112.927 -175.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.82 133.09 11.79 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.348 1.459 . . . . 0.0 110.926 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.7 m -84.62 171.93 12.01 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 121.285 -0.884 . . . . 0.0 111.805 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -100.78 151.34 21.8 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.123 1.369 . . . . 0.0 111.097 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -137.63 139.48 40.33 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.548 -0.72 . . . . 0.0 110.632 -172.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.5 p-90 -151.71 150.78 30.6 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.965 1.706 . . . . 0.0 110.043 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -148.54 147.49 29.11 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.644 1.578 . . . . 0.0 109.189 175.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 56.7 t -143.98 109.97 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 126.146 1.778 . . . . 0.0 109.77 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -113.6 144.76 42.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.773 1.629 . . . . 0.0 109.288 174.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 26.6 mt -109.75 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.537 1.935 . . . . 0.0 108.466 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -126.69 143.4 51.25 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.658 1.583 . . . . 0.0 112.239 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 73.2 m -79.06 85.69 4.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.009 1.324 . . . . 0.0 111.817 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 149.64 176.38 22.76 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.422 1.487 . . . . 0.0 112.328 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 149.14 37.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.176 0.991 . . . . 0.0 111.979 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -154.37 135.69 14.09 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.997 1.319 . . . . 0.0 111.134 175.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -98.4 -176.66 3.46 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.369 1.468 . . . . 0.0 111.534 174.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -139.21 100.83 4.11 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.946 1.698 . . . . 0.0 109.114 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -120.55 -72.24 0.7 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.692 1.197 . . . . 0.0 110.161 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -145.57 -64.22 0.33 Allowed 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.907 1.283 . . . . 0.0 110.215 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.97 -24.25 70.02 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.408 1.004 . . . . 0.0 114.557 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.4 tpp -90.67 -37.58 13.65 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.623 1.169 . . . . 0.0 112.988 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -41.09 93.24 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.495 0.718 . . . . 0.0 111.135 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -59.74 -25.18 64.64 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -18.4 65.29 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.498 1.119 . . . . 0.0 112.786 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.81 -37.72 9.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.997 1.319 . . . . 0.0 108.662 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -68.23 -47.45 67.78 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 120.786 -1.196 . . . . 0.0 113.628 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.7 m-30 -99.22 -13.55 19.67 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.6 1.16 . . . . 0.0 113.447 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -51.69 -63.65 4.55 Favored Glycine 0 N--CA 1.475 1.246 0 C-N-CA 124.074 0.845 . . . . 0.0 112.639 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -177.64 80.29 0.24 Allowed Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 128.089 2.556 . . . . 0.0 109.104 174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.8 135.49 32.96 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 108.706 -1.305 . . . . 0.0 108.706 175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -71.28 -12.59 61.53 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.21 118.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.337 3.055 . . . . 0.0 112.688 -170.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.77 58.96 2.14 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 126.046 1.784 . . . . 0.0 113.925 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.09 22.35 0.3 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 127.435 2.294 . . . . 0.0 113.628 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.18 27.89 12.23 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 125.879 1.672 . . . . 0.0 113.328 -177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.27 135.96 9.31 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.787 1.661 . . . . 0.0 112.207 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -59.71 139.14 57.48 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.09 0.956 . . . . 0.0 111.883 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -130.01 121.25 26.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.735 1.614 . . . . 0.0 110.528 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.74 154.82 40.13 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.97 1.708 . . . . 0.0 110.614 175.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -165.37 131.53 2.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.862 1.265 . . . . 0.0 110.874 176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -62.85 112.15 2.43 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.308 1.043 . . . . 0.0 111.235 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tt -135.2 -24.94 1.39 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.397 1.079 . . . . 0.0 113.732 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.15 17.84 9.06 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.122 1.344 . . . . 0.0 114.96 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.14 16.81 4.1 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 126.97 2.108 . . . . 0.0 114.15 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.69 -65.18 0.06 OUTLIER Glycine 0 CA--C 1.525 0.677 0 C-N-CA 124.93 1.252 . . . . 0.0 111.293 -177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 155' ' ' LEU . 0.0 OUTLIER -93.36 164.37 13.24 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.153 1.381 . . . . 0.0 112.454 176.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.63 166.47 30.58 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.544 1.938 . . . . 0.0 112.627 176.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.71 143.41 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.843 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -128.46 103.71 7.28 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 126.295 1.838 . . . . 0.0 107.874 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.41 169.48 21.26 Favored Glycine 0 N--CA 1.455 -0.067 0 CA-C-O 121.796 0.664 . . . . 0.0 113.218 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.43 146.63 18.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 123.893 0.877 . . . . 0.0 109.872 176.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.83 132.19 41.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.657 1.583 . . . . 0.0 107.861 174.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.6 p -85.95 164.09 17.64 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.612 0.765 . . . . 0.0 109.905 175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.36 19.69 19.95 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.922 0.889 . . . . 0.0 112.967 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -106.05 -175.52 2.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.756 1.622 . . . . 0.0 112.999 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.75 -35.54 74.98 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.444 1.497 . . . . 0.0 114.413 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.46 92.45 5.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.446 1.498 . . . . 0.0 107.627 175.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB3' HG22 ' A' ' 31' ' ' ILE . . . -73.73 69.02 1.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.232 1.013 . . . . 0.0 111.733 -177.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -53.11 129.95 32.65 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.728 -1.232 . . . . 0.0 110.954 176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.7 ttm -134.61 123.83 24.44 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.131 1.772 . . . . 0.0 110.015 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -139.34 141.26 37.66 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.941 -1.099 . . . . 0.0 109.599 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.9 mp -129.67 93.83 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.936 1.694 . . . . 0.0 109.167 -174.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -86.0 109.26 18.67 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.043 0.937 . . . . 0.0 110.419 175.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 30.4 mm -91.57 116.42 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.751 0.82 . . . . 0.0 111.215 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.4 p -148.11 161.36 41.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 46.3 mtm180 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.859 2.063 . . . . 0.0 110.581 174.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 119.887 -0.102 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.617 ' HB3' HG22 ' A' ' 20' ' ' VAL . 23.6 tp -97.15 -6.33 35.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.495 1.118 . . . . 0.0 113.271 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.586 ' CB ' HD12 ' A' ' 24' ' ' LEU . . . -62.22 146.31 51.16 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.19 -1.569 . . . . 0.0 111.379 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.68 39.6 40.02 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 123.666 0.65 . . . . 0.0 114.488 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.0 p -143.26 -169.35 3.03 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 118.555 1.177 . . . . 0.0 111.822 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.02 141.75 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.765 2.026 . . . . 0.0 109.844 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 pt -142.28 173.93 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.569 1.548 . . . . 0.0 111.409 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.29 115.4 6.21 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.42 -30.78 65.35 Favored Glycine 0 CA--C 1.537 1.429 0 O-C-N 121.448 -0.783 . . . . 0.0 112.808 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.32 -28.29 69.91 Favored 'General case' 0 CA--C 1.549 0.905 0 O-C-N 121.246 -1.15 . . . . 0.0 113.345 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.7 t -90.48 -13.62 34.37 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.113 1.365 . . . . 0.0 113.39 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.6 tp -68.14 113.01 5.43 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.968 0.907 . . . . 0.0 111.733 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -145.12 165.84 27.11 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.595 1.558 . . . . 0.0 109.737 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -45.91 -41.69 11.78 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.618 1.567 . . . . 0.0 114.487 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.54 -36.77 76.78 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 t -65.74 -44.48 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.818 0.847 . . . . 0.0 110.247 174.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.15 -42.64 86.36 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.782 0.833 . . . . 0.0 111.145 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.01 -40.13 71.98 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.133 -0.979 . . . . 0.0 113.21 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.36 -43.19 88.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.911 0.884 . . . . 0.0 111.924 175.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 2' ' ' LEU . 87.6 t -63.04 -51.62 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 121.716 -0.615 . . . . 0.0 111.215 175.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -53.2 -43.83 67.5 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.689 0.796 . . . . 0.0 112.628 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -68.48 -46.19 70.38 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 117.986 0.357 . . . . 0.0 111.857 -177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.4 -38.96 59.6 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.554 1.542 . . . . 0.0 113.863 -174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.586 HD12 ' CB ' ' A' ' 3' ' ' ALA . 8.4 tt -54.02 -40.14 66.77 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.421 1.089 . . . . 0.0 111.381 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 108.37 62.82 0.55 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 124.977 1.275 . . . . 0.0 111.737 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.26 133.53 3.13 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.034 1.333 . . . . 0.0 113.298 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG22 ' H ' ' A' ' 28' ' ' SER . 3.1 p -121.95 -163.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.388 1.875 . . . . 0.0 109.603 -175.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.441 ' H ' HG22 ' A' ' 27' ' ' VAL . 7.4 m -39.39 -46.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.491 1.516 . . . . 0.0 114.938 176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -147.97 126.31 12.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.95 2.1 . . . . 0.0 110.319 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' NZ ' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -153.35 158.39 41.45 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.676 1.591 . . . . 0.0 111.832 176.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.18 173.72 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.725 1.21 . . . . 0.0 112.441 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.51 115.14 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.503 1.121 . . . . 0.0 110.525 175.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.26 143.74 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 111.213 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -153.39 125.61 1.8 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.407 1.004 . . . . 0.0 111.687 175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.3 mt -130.39 112.28 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 119.532 1.666 . . . . 0.0 111.362 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -91.93 109.0 20.33 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.118 1.767 . . . . 0.0 111.796 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -87.14 109.27 19.34 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.789 1.28 . . . . 0.0 112.179 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -122.61 27.55 7.76 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.482 1.913 . . . . 0.0 111.176 -176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -81.71 -1.79 48.21 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.734 2.014 . . . . 0.0 114.553 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.15 12.62 83.97 Favored Glycine 0 CA--C 1.539 1.57 0 O-C-N 120.934 -1.103 . . . . 0.0 114.492 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.54 145.36 12.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 125.422 1.487 . . . . 0.0 113.501 -174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -69.83 141.48 53.27 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.59 1.156 . . . . 0.0 112.811 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -112.07 162.59 15.24 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.54 1.936 . . . . 0.0 111.431 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 55.5 m -128.97 114.92 17.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.754 1.222 . . . . 0.0 109.328 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.32 122.72 18.52 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.704 -0.622 . . . . 0.0 110.146 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.4 HD21 ' CZ ' ' A' ' 91' ' ' TYR . 0.3 OUTLIER -65.67 -66.17 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.785 1.234 . . . . 0.0 109.855 -178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 176.43 173.76 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.884 2.874 . . . . 0.0 109.657 -177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -134.29 143.87 48.0 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.456 2.302 . . . . 0.0 109.217 174.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -136.25 112.32 9.68 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.04 0.936 . . . . 0.0 111.444 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -72.92 115.48 12.28 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.514 1.526 . . . . 0.0 111.487 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -89.87 -37.69 14.26 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.629 1.572 . . . . 0.0 112.756 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 m -146.46 159.46 43.37 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.382 2.273 . . . . 0.0 110.606 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.05 -172.47 49.63 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 121.612 0.562 . . . . 0.0 113.386 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 t -140.42 148.03 40.59 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.526 1.13 . . . . 0.0 109.726 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 57' ' ' VAL . 18.0 m -138.58 138.79 38.26 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.418 1.087 . . . . 0.0 110.205 -177.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.06 11.15 40.09 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.906 1.682 . . . . 0.0 112.854 -172.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 55' ' ' THR . 32.8 m -126.48 169.63 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 126.74 2.016 . . . . 0.0 112.364 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -141.11 135.78 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.577 1.551 . . . . 0.0 109.758 -169.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -77.27 152.95 81.96 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 119.291 0.951 . . . . 0.0 112.379 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.41 174.17 8.65 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 124.555 3.504 . . . . 0.0 110.759 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -116.3 -17.56 10.72 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.13 -0.981 . . . . 0.0 113.173 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -124.59 130.38 52.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.285 1.834 . . . . 0.0 110.343 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.59 82.67 44.6 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.324 -177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.6 153.66 77.2 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.162 1.908 . . . . 0.0 111.427 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -53.31 148.42 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.545 0.738 . . . . 0.0 111.176 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p 72.86 -0.95 3.18 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 127.953 2.501 . . . . 0.0 114.805 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -124.47 106.24 10.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.065 1.746 . . . . 0.0 112.391 -172.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.59 160.0 25.24 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.55 170.05 8.28 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.129 0.572 . . . . 0.0 109.769 174.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.52 HD11 HG21 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -126.39 134.77 50.94 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 109.636 174.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -150.21 169.86 20.33 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.601 0.76 . . . . 0.0 111.642 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.4 m -151.21 171.58 17.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.509 1.524 . . . . 0.0 110.474 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -152.97 115.99 0.71 Allowed Glycine 0 CA--C 1.523 0.551 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.71 163.14 15.4 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.161 1.481 . . . . 0.0 111.18 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -65.41 -177.23 0.39 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.592 0.357 . . . . 0.0 110.404 174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.79 178.11 0.49 Allowed 'General case' 0 CA--C 1.552 1.047 0 O-C-N 121.353 -0.842 . . . . 0.0 110.322 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.0 m -24.59 -53.34 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 128.175 2.59 . . . . 0.0 116.308 -171.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.36 -62.75 0.26 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.604 1.573 . . . . 0.0 112.325 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.15 -1.27 8.52 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 124.711 3.607 . . . . 0.0 115.439 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.72 123.66 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 127.484 2.314 . . . . 0.0 110.453 -178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.51 81.5 2.97 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.351 1.46 . . . . 0.0 111.241 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.7 m -114.1 -80.89 0.6 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.985 1.314 . . . . 0.0 110.523 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.43 -177.34 41.95 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.238 1.399 . . . . 0.0 111.051 -178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -139.14 110.61 7.03 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.054 1.342 . . . . 0.0 109.159 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.22 130.65 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.649 -0.657 . . . . 0.0 109.755 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -150.86 158.32 44.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.793 1.237 . . . . 0.0 110.293 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.97 155.43 45.45 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.936 0.874 . . . . 0.0 111.636 175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.71 168.03 25.59 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.416 1.886 . . . . 0.0 109.689 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.48 157.23 45.16 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.584 0.753 . . . . 0.0 110.868 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -138.95 118.5 12.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.702 0.801 . . . . 0.0 112.125 -175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.4 ' CZ ' HD21 ' A' ' 46' ' ' LEU . 17.3 m-85 -75.59 121.83 23.01 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.649 0.78 . . . . 0.0 111.226 174.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -87.44 159.3 18.73 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.47 1.108 . . . . 0.0 110.123 175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.7 p -63.83 -13.89 48.46 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.062 1.505 . . . . 0.0 115.062 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 m -88.38 0.49 56.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.852 1.661 . . . . 0.0 113.05 175.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.12 82.96 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.695 1.141 . . . . 0.0 114.126 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.46 167.22 16.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.837 2.055 . . . . 0.0 110.644 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.0 m -130.99 153.62 49.03 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.027 1.331 . . . . 0.0 109.629 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.21 138.66 53.66 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.396 1.079 . . . . 0.0 109.587 175.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.25 139.08 15.41 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 176.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.94 125.76 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 118.229 1.015 . . . . 0.0 109.476 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.01 155.94 46.12 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.405 0.682 . . . . 0.0 112.016 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.97 144.22 49.0 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.691 1.197 . . . . 0.0 110.086 175.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.03 110.64 11.8 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.951 1.3 . . . . 0.0 110.11 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.78 100.6 46.32 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 125.705 1.602 . . . . 0.0 109.655 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.03 163.93 34.3 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.277 1.985 . . . . 0.0 110.844 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.61 -47.25 76.32 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.726 0.811 . . . . 0.0 111.08 174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.08 117.41 22.24 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.478 2.311 . . . . 0.0 111.958 -172.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -69.2 -70.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.113 -0.992 . . . . 0.0 112.646 174.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -82.5 11.19 5.93 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.53 -3.48 5.42 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.134 2.174 . . . . 0.0 112.433 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -160.13 129.07 4.97 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.175 1.79 . . . . 0.0 110.718 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.9 m -90.94 168.13 11.91 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.567 -1.333 . . . . 0.0 113.214 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -89.67 155.74 19.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.797 1.239 . . . . 0.0 110.149 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.405 ' CE3' ' HD2' ' A' ' 141' ' ' ARG . 0.9 OUTLIER -142.14 140.53 32.48 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.582 1.153 . . . . 0.0 109.284 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -156.63 146.69 21.12 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.318 1.447 . . . . 0.0 110.399 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -140.98 147.49 38.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.675 1.19 . . . . 0.0 110.072 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 43.3 t -146.01 90.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.032 1.333 . . . . 0.0 112.051 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -106.09 144.81 32.28 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.237 1.415 . . . . 0.0 110.526 174.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.2 mt -108.33 123.34 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.293 2.237 . . . . 0.0 108.587 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -127.71 148.3 50.4 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.288 1.435 . . . . 0.0 112.955 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 27.2 p -74.08 87.82 1.9 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.578 1.951 . . . . 0.0 112.679 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 144.78 179.35 21.1 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.878 1.704 . . . . 0.0 112.387 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.7 140.83 29.94 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.441 1.497 . . . . 0.0 112.266 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.35 152.28 30.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.145 2.178 . . . . 0.0 110.411 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -131.53 153.37 49.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.457 1.903 . . . . 0.0 110.75 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.71 93.15 0.7 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.328 1.051 . . . . 0.0 111.762 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -113.3 -76.81 0.58 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 110.279 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -142.85 -67.08 0.37 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.393 2.277 . . . . 0.0 107.758 177.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.19 -30.97 75.25 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.618 1.104 . . . . 0.0 115.257 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 6.5 tmm? -75.45 -57.89 3.61 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.437 1.619 . . . . 0.0 110.864 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -49.98 -49.6 49.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.58 1.152 . . . . 0.0 111.504 177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.53 -37.61 80.14 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -60.79 -27.34 67.93 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 119.649 1.113 . . . . 0.0 112.627 175.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.1 -46.83 8.97 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.743 0.817 . . . . 0.0 110.563 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -72.41 -49.02 36.81 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.835 -1.166 . . . . 0.0 113.773 -175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.0 m-30 -91.83 -17.09 25.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.377 1.071 . . . . 0.0 113.046 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.99 -70.18 0.99 Allowed Glycine 0 N--CA 1.472 1.053 0 C-N-CA 124.224 0.916 . . . . 0.0 112.8 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -179.66 75.48 0.19 Allowed Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 127.962 2.505 . . . . 0.0 110.618 175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.52 131.71 19.27 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 121.812 1.674 . . . . 0.0 110.981 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.0 118.49 13.83 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.405 ' HD2' ' CE3' ' A' ' 114' ' ' TRP . 0.1 OUTLIER -63.58 123.48 18.92 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.376 -0.827 . . . . 0.0 110.898 178.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -69.75 69.84 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.733 1.635 . . . . 0.0 113.114 177.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -80.82 38.81 0.46 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.29 1.836 . . . . 0.0 111.841 176.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 54.44 41.79 31.76 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.83 1.652 . . . . 0.0 113.168 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -146.36 156.2 26.88 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.061 1.315 . . . . 0.0 113.418 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.15 134.38 51.65 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.156 0.983 . . . . 0.0 111.523 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -131.53 111.7 11.99 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.965 2.106 . . . . 0.0 108.902 -178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -147.91 146.78 29.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.017 1.727 . . . . 0.0 111.184 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.99 144.6 9.97 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.422 1.089 . . . . 0.0 111.208 175.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.17 137.09 58.24 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.841 0.457 . . . . 0.0 112.008 176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.44 -30.37 0.06 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 113.646 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -88.9 16.3 55.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.078 1.323 . . . . 0.0 114.169 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 60.38 14.06 4.47 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.091 2.157 . . . . 0.0 114.965 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.25 -65.45 0.06 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.254 1.883 . . . . 0.0 110.816 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.8 mp -96.28 156.34 16.38 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.905 0.882 . . . . 0.0 110.845 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -149.55 170.33 18.88 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.433 1.493 . . . . 0.0 112.397 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.4 ppp? -89.23 145.49 25.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.964 174.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -137.95 106.13 5.74 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.528 1.931 . . . . 0.0 108.684 175.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -143.85 170.65 25.72 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-O 121.765 0.647 . . . . 0.0 113.972 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.14 148.29 22.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.847 2.059 . . . . 0.0 108.531 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.5 ttt -142.11 131.99 24.37 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.379 1.072 . . . . 0.0 108.607 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.06 160.81 31.46 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.052 1.341 . . . . 0.0 111.608 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 7.6 t -93.4 5.0 53.06 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.993 1.317 . . . . 0.0 113.362 -177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.74 174.52 5.84 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.712 2.005 . . . . 0.0 112.235 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.17 -56.77 21.93 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.011 0.815 . . . . 0.0 113.552 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -76.04 36.52 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.545 1.938 . . . . 0.0 113.685 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.38 32.59 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.599 1.159 . . . . 0.0 114.045 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -106.49 131.2 53.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.905 1.682 . . . . 0.0 109.504 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 34.2 ttp -128.01 95.27 4.14 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.843 1.257 . . . . 0.0 111.361 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -109.34 143.57 38.7 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.73 -0.606 . . . . 0.0 110.695 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.2 mp -129.45 107.07 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.759 2.023 . . . . 0.0 109.668 -176.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.94 101.12 10.71 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.232 1.413 . . . . 0.0 109.795 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 16.6 mm -77.66 129.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.872 -0.517 . . . . 0.0 110.654 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.99 171.97 18.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.002 0.921 . . . . 0.0 113.16 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 128.973 2.909 . . . . 0.0 112.837 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 110.754 -0.091 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.531 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -104.68 6.17 34.07 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.836 1.254 . . . . 0.0 113.175 -179.339 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.24 147.05 38.59 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 120.553 -1.342 . . . . 0.0 111.88 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.94 34.33 81.81 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.605 0.622 . . . . 0.0 113.777 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -148.49 178.3 8.73 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 117.987 0.893 . . . . 0.0 111.501 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 69' ' ' LEU . 4.9 pt -128.35 139.62 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.489 1.516 . . . . 0.0 111.949 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 pt -144.84 167.39 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.804 1.642 . . . . 0.0 111.708 177.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.57 124.34 16.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.633 1.173 . . . . 0.0 112.173 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.95 -19.67 30.91 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.938 1.732 . . . . 0.0 114.1 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.57 -40.3 95.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.02 1.328 . . . . 0.0 111.692 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.42 -35.28 25.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.294 1.038 . . . . 0.0 112.321 176.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.535 HD22 ' CB ' ' A' ' 68' ' ' ALA . 3.5 tp -52.44 100.57 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.081 1.752 . . . . 0.0 112.602 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -145.72 170.3 16.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.019 1.328 . . . . 0.0 109.793 -177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.88 -36.9 28.95 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.115 1.366 . . . . 0.0 113.702 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -61.07 -35.21 76.35 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.026 0.93 . . . . 0.0 113.305 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' O ' HG23 ' A' ' 20' ' ' VAL . 62.1 t -67.74 -46.71 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 124.644 1.178 . . . . 0.0 109.519 175.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 38.2 mt -54.74 -44.84 73.93 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.636 0.653 . . . . 0.0 112.412 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.5 -42.08 95.63 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.838 -0.539 . . . . 0.0 111.361 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.9 -42.04 97.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.318 1.047 . . . . 0.0 111.407 174.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' A' ' 2' ' ' LEU . 44.5 t -61.2 -54.47 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.599 1.159 . . . . 0.0 111.247 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.27 -49.48 61.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 0.0 111.569 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.99 -42.83 72.55 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -175.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -78.2 -38.06 44.14 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -173.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.479 HD13 ' HZ2' ' A' ' 30' ' ' LYS . 3.4 tt -54.71 -45.14 73.97 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.453 0.701 . . . . 0.0 109.487 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.33 66.48 0.48 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 125.229 1.395 . . . . 0.0 111.564 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.87 124.21 1.11 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.542 1.537 . . . . 0.0 112.946 174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -104.09 -159.01 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.688 1.595 . . . . 0.0 109.556 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.51 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -49.06 -30.59 6.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.892 1.277 . . . . 0.0 114.117 176.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.27 135.11 11.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.143 1.777 . . . . 0.0 111.439 176.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' HZ2' HD13 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -157.77 165.25 35.83 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.755 1.222 . . . . 0.0 113.343 174.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.9 pt -139.39 161.27 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 125.181 1.392 . . . . 0.0 109.099 174.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.49 125.73 51.39 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.068 1.347 . . . . 0.0 108.07 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.55 142.21 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.171 1.788 . . . . 0.0 110.388 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.46 122.51 1.32 Allowed Glycine 0 CA--C 1.529 0.916 0 C-N-CA 123.948 0.785 . . . . 0.0 112.164 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.8 mt -113.53 111.69 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 118.336 1.068 . . . . 0.0 110.208 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -88.61 120.58 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.972 1.709 . . . . 0.0 113.798 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -72.39 90.39 1.29 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.089 1.756 . . . . 0.0 110.171 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -107.53 12.39 27.81 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.808 0.843 . . . . 0.0 112.595 174.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.6 t -82.33 -34.63 28.47 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -171.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.63 17.35 10.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.241 0.928 . . . . 0.0 114.997 -177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.3 160.93 31.3 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 118.988 1.394 . . . . 0.0 114.844 177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 13.3 t -74.08 134.42 42.94 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.805 1.242 . . . . 0.0 111.874 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.46 166.47 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.96 1.704 . . . . 0.0 111.26 177.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.2 m -133.93 113.24 11.97 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.986 1.315 . . . . 0.0 110.064 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.79 113.02 4.01 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.8 mt -61.72 -64.46 0.93 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.674 1.19 . . . . 0.0 110.142 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -175.22 169.11 3.31 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.892 2.077 . . . . 0.0 111.459 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB2' HD13 ' A' ' 59' ' ' LEU . . . -122.12 139.03 54.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.977 2.111 . . . . 0.0 109.103 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.9 110.93 11.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -73.55 101.49 3.58 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.174 1.39 . . . . 0.0 111.175 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -68.03 -42.33 80.79 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.46 1.504 . . . . 0.0 111.942 176.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.11 157.79 43.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.692 2.397 . . . . 0.0 111.144 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 68.35 -169.69 39.86 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 123.729 0.681 . . . . 0.0 114.574 -177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.7 t -136.77 173.3 11.86 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.056 1.342 . . . . 0.0 112.363 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.7 p -143.04 176.57 8.99 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 110.66 174.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -123.35 17.59 9.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.434 1.094 . . . . 0.0 112.193 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.4 m -136.07 175.51 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 126.985 2.114 . . . . 0.0 111.904 -168.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.1 mt -139.04 133.72 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.014 1.326 . . . . 0.0 109.76 -173.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -75.0 142.24 75.91 Favored Pre-proline 0 CA--C 1.551 1.015 0 O-C-N 121.318 -0.864 . . . . 0.0 110.151 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -64.93 172.01 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.607 3.538 . . . . 0.0 110.811 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -115.39 -20.26 10.35 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.204 -1.56 . . . . 0.0 112.556 175.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -129.88 141.35 50.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.353 1.461 . . . . 0.0 110.297 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.03 95.5 5.64 Favored Pre-proline 0 N--CA 1.473 0.72 0 C-N-CA 125.105 1.362 . . . . 0.0 109.982 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.92 161.53 32.62 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 121.556 1.504 . . . . 0.0 111.303 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -55.7 153.53 7.98 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.568 -0.707 . . . . 0.0 111.517 175.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 71.95 -25.79 0.18 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 126.038 1.735 . . . . 0.0 113.384 -178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -89.03 121.15 31.09 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 120.133 1.333 . . . . 0.0 110.659 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.535 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -91.11 160.5 15.55 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 111.402 174.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.492 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -101.68 164.46 11.73 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 175.026 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -128.65 134.74 48.62 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.96 2.104 . . . . 0.0 109.01 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -147.42 171.18 15.9 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.962 1.305 . . . . 0.0 111.786 175.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -148.08 168.82 21.4 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.834 1.253 . . . . 0.0 110.831 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 102' ' ' PHE . . . -146.43 116.38 0.87 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-O 118.036 -1.425 . . . . 0.0 110.602 175.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.09 163.81 15.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.704 1.252 . . . . 0.0 110.737 177.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.89 -177.81 0.66 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 174.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.1 -175.25 0.2 Allowed 'General case' 0 CA--C 1.552 1.022 0 O-C-N 121.143 -0.973 . . . . 0.0 111.036 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.4 m -19.7 -56.58 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 129.187 2.995 . . . . 0.0 115.589 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.94 -63.08 0.3 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.424 1.488 . . . . 0.0 112.226 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.66 0.14 6.78 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 124.925 3.75 . . . . 0.0 115.972 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.5 m -112.38 122.87 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.888 1.675 . . . . 0.0 111.783 -176.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.91 80.17 4.64 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.367 1.467 . . . . 0.0 111.713 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.49 HG23 ' H ' ' A' ' 83' ' ' GLY . 1.0 OUTLIER -104.91 -86.51 0.46 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.494 1.518 . . . . 0.0 110.789 177.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.49 ' H ' HG23 ' A' ' 82' ' ' THR . . . 174.24 179.94 45.18 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 127.41 2.433 . . . . 0.0 110.581 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.761 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -138.35 101.18 4.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.176 1.391 . . . . 0.0 109.966 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.3 t -140.77 126.8 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -173.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.641 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -149.95 164.94 34.11 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.351 -0.843 . . . . 0.0 110.8 174.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.6 155.93 40.38 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.961 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.23 168.02 27.39 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.968 1.307 . . . . 0.0 109.881 -175.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 148.91 43.05 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.727 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -134.62 115.77 14.21 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.279 1.032 . . . . 0.0 111.165 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -69.62 118.5 12.56 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.404 1.482 . . . . 0.0 109.36 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 89.7 mtp -82.47 151.68 26.42 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.604 1.562 . . . . 0.0 110.404 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.8 p -58.33 -19.18 33.01 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 63.2 m -82.3 -12.28 58.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.484 1.914 . . . . 0.0 113.848 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.51 -10.6 42.39 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.298 1.428 . . . . 0.0 115.127 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.55 173.32 12.71 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.514 1.525 . . . . 0.0 110.737 174.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.2 m -137.63 142.76 41.2 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.698 1.199 . . . . 0.0 108.39 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.23 140.75 38.7 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.25 145.57 16.27 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 175.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -148.87 130.15 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.11 0.964 . . . . 0.0 109.725 175.172 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.9 148.53 50.1 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.299 1.04 . . . . 0.0 110.296 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 10.4 p90 -123.21 152.99 40.71 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.037 1.335 . . . . 0.0 109.453 174.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.3 p -140.37 122.5 15.75 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.024 0.929 . . . . 0.0 110.626 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 23.7 t -119.75 108.15 39.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 126.407 1.883 . . . . 0.0 108.33 -175.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.16 155.56 37.67 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.297 1.998 . . . . 0.0 111.493 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -64.68 -36.09 83.15 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.646 0.778 . . . . 0.0 110.76 175.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.99 114.68 27.31 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.785 2.434 . . . . 0.0 111.612 -171.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -72.0 -63.77 1.07 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.047 -1.033 . . . . 0.0 113.445 178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -88.86 10.86 19.66 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.55 -6.0 6.41 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.83 2.052 . . . . 0.0 112.743 -174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.35 179.35 8.62 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 127.835 2.454 . . . . 0.0 110.284 178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.8 m -136.75 159.96 40.27 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.161 1.385 . . . . 0.0 110.955 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -79.63 155.33 28.14 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -136.83 151.61 49.33 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.857 0.753 . . . . 0.0 109.75 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.2 p-90 -161.6 157.73 25.15 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.675 1.19 . . . . 0.0 110.16 174.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' HA ' ' CE2' ' A' ' 140' ' ' TYR . 12.5 t70 -154.47 161.32 41.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.602 1.161 . . . . 0.0 110.245 174.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.422 HG22 ' HB ' ' A' ' 100' ' ' VAL . 67.5 t -146.23 138.0 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 126.346 1.858 . . . . 0.0 109.921 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.24 150.87 46.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.055 1.742 . . . . 0.0 110.007 175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.8 119.24 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.097 1.759 . . . . 0.0 108.71 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -127.92 139.4 52.62 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.465 1.906 . . . . 0.0 112.385 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.6 p -77.34 79.4 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.919 1.688 . . . . 0.0 112.525 -176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 161.75 174.78 32.05 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.355 0.979 . . . . 0.0 112.606 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.3 99.65 10.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.855 2.062 . . . . 0.0 110.593 -173.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.82 161.43 34.75 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.781 2.032 . . . . 0.0 111.464 -176.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.77 164.44 30.49 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.527 1.531 . . . . 0.0 111.301 -177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.41 87.96 0.64 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.128 0.971 . . . . 0.0 111.293 175.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.63 -64.16 1.12 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.999 1.32 . . . . 0.0 109.292 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.0 -75.02 0.17 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.989 1.716 . . . . 0.0 108.543 174.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.27 -37.41 93.98 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.804 1.192 . . . . 0.0 113.93 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 5.9 tpt -66.31 -46.42 76.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.299 1.049 . . . . 0.0 111.398 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -64.35 -43.66 93.86 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.728 1.211 . . . . 0.0 110.575 174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -62.35 -42.66 99.57 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.514 1.126 . . . . 0.0 112.338 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.16 -16.71 35.11 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.232 1.013 . . . . 0.0 113.153 175.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.43 -52.4 4.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.961 1.304 . . . . 0.0 109.202 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -60.55 -43.09 97.63 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 112.794 -176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.3 m-30 -98.46 -14.65 19.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.786 1.234 . . . . 0.0 113.591 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.48 4.16 Favored Glycine 0 N--CA 1.475 1.286 0 O-C-N 121.541 -0.724 . . . . 0.0 114.655 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 44.3 77.21 0.46 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.222 1.809 . . . . 0.0 111.78 -165.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.67 157.58 50.85 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.04 1.826 . . . . 0.0 111.01 174.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 116' ' ' ASP . 23.8 m-85 -90.28 2.9 54.99 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.294 0.0 OUTLIER 46.61 16.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 129.426 3.09 . . . . 0.0 116.848 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 45.69 62.98 3.01 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.176 0.893 . . . . 0.0 112.611 -170.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.74 16.65 0.08 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.281 10.7 p30 49.17 33.69 5.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.409 2.283 . . . . 0.0 115.15 -178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.24 147.89 19.36 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.965 1.745 . . . . 0.0 111.06 174.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -64.98 116.06 6.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.362 0.665 . . . . 0.0 110.382 175.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 138.09 49.26 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -160.42 128.57 4.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.91 1.284 . . . . 0.0 111.333 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -137.86 119.57 15.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.299 1.04 . . . . 0.0 113.372 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -46.77 123.94 5.63 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.411 1.484 . . . . 0.0 113.936 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.4 tp -158.3 -24.48 0.08 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.77 22.34 14.5 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.958 1.266 . . . . 0.0 114.085 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 7.0 t80 58.43 14.8 3.14 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.566 2.346 . . . . 0.0 115.024 -175.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.98 -64.03 0.05 OUTLIER Glycine 0 CA--C 1.522 0.52 0 C-N-CA 125.456 1.503 . . . . 0.0 110.913 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 20.0 mt -107.13 161.07 15.08 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.183 0.993 . . . . 0.0 111.149 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.02 174.44 10.51 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 126.886 2.074 . . . . 0.0 111.407 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -78.2 131.13 37.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.91 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -122.23 104.67 9.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 C-N-CA 124.717 1.207 . . . . 0.0 108.696 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -144.38 165.41 27.48 Favored Glycine 0 C--N 1.329 0.178 0 CA-C-O 122.401 1.0 . . . . 0.0 114.643 -175.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.3 tt -146.9 141.54 20.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 127.573 2.349 . . . . 0.0 108.469 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 13.1 ttt -141.7 140.6 33.21 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.07 1.748 . . . . 0.0 106.371 174.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.99 163.14 19.07 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.436 0.694 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.93 9.77 13.54 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.03 1.332 . . . . 0.0 113.776 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -96.28 170.58 9.15 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.234 2.214 . . . . 0.0 112.663 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.34 -71.79 0.88 Allowed Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 174.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.46 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.665 2.386 . . . . 0.0 115.995 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 158.49 8.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.168 2.187 . . . . 0.0 113.627 178.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -102.22 140.44 36.49 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.271 1.428 . . . . 0.0 110.685 174.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.2 ttm -133.48 135.4 44.47 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.999 1.719 . . . . 0.0 110.087 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -144.46 152.6 40.86 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.927 0.891 . . . . 0.0 109.225 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.1 mt -133.18 117.4 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.494 1.518 . . . . 0.0 108.453 178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -106.59 113.78 27.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.795 1.638 . . . . 0.0 109.561 174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.9 mm -86.35 101.07 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 60.3 p -161.73 -179.56 7.34 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.426 1.891 . . . . 0.0 114.914 -174.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 . . . . . 0 C--O 1.249 1.067 0 C-N-CA 127.997 2.519 . . . . 0.0 115.408 -164.715 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.149 0.5 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.33 -55.42 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.69 1.596 . . . . 0.0 110.1 -176.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.57 ' CB ' HG11 ' A' ' 57' ' ' VAL . . . 61.84 145.96 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.169 2.588 . . . . 0.0 113.082 -167.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.36 47.46 90.77 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.233 -0.917 . . . . 0.0 114.817 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.9 p -147.51 -174.65 4.59 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.33 1.052 . . . . 0.0 112.574 -175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.9 pt -124.47 136.82 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.673 1.989 . . . . 0.0 111.041 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 pp -145.53 174.21 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 125.476 1.51 . . . . 0.0 111.905 176.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.14 1.69 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.984 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 67' ' ' LYS . . . -64.14 -25.26 69.46 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 121.241 -0.912 . . . . 0.0 113.096 -175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.0 71.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.418 1.087 . . . . 0.0 112.549 175.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.3 m -83.63 -19.41 35.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.79 1.236 . . . . 0.0 113.374 175.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.508 HD22 ' CB ' ' A' ' 68' ' ' ALA . 16.2 tp -66.7 97.7 0.47 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.927 1.291 . . . . 0.0 111.688 -178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 14' ' ' PHE . 7.4 m -144.44 174.44 10.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.562 1.545 . . . . 0.0 109.508 -174.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.524 ' HA ' HD12 ' A' ' 17' ' ' LEU . 1.4 t80 -49.05 -33.63 11.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.95 1.3 . . . . 0.0 114.149 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -64.23 -32.9 74.66 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -77.5 -30.23 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.224 1.41 . . . . 0.0 111.422 178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 14' ' ' PHE . 52.6 mt -59.03 -52.84 64.02 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -56.92 -38.41 72.83 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.547 1.139 . . . . 0.0 111.666 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -58.88 -36.94 75.47 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.12 -46.49 90.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.332 0.969 . . . . 0.0 110.78 174.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.23 -40.17 85.03 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.213 1.405 . . . . 0.0 110.418 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.35 -53.36 37.15 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.385 0.674 . . . . 0.0 112.813 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.19 -48.72 41.06 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.496 -0.753 . . . . 0.0 112.766 -174.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.701 HD12 ' HE3' ' A' ' 30' ' ' LYS . 3.1 tm? -63.32 -39.45 94.58 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.77 0.828 . . . . 0.0 111.7 -178.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 103.74 69.53 0.8 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.137 1.351 . . . . 0.0 112.758 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.94 99.53 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.277 1.831 . . . . 0.0 112.376 175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 28' ' ' SER . 4.0 p -84.03 -160.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.123 1.769 . . . . 0.0 110.421 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 27' ' ' VAL . 67.5 m -44.02 -35.01 1.91 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.987 1.715 . . . . 0.0 114.754 178.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -149.71 137.48 20.2 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.616 1.966 . . . . 0.0 110.221 175.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.701 ' HE3' HD12 ' A' ' 24' ' ' LEU . 5.7 tptp -165.85 143.17 5.51 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.556 1.542 . . . . 0.0 112.017 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.22 143.46 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 119.371 0.987 . . . . 0.0 111.443 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -98.99 118.57 36.08 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.275 1.03 . . . . 0.0 108.867 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.6 t -108.64 139.67 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.984 0.913 . . . . 0.0 111.227 178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.77 133.73 4.42 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.925 1.25 . . . . 0.0 111.596 174.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -121.26 99.3 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.028 0.931 . . . . 0.0 108.699 -178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -81.02 105.61 12.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.814 0.846 . . . . 0.0 111.142 -174.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -73.61 96.15 2.42 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.978 0.911 . . . . 0.0 111.283 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -115.74 10.81 15.51 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.08 1.752 . . . . 0.0 113.442 175.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 36.3 t -64.06 -55.06 24.86 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.911 1.284 . . . . 0.0 114.006 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.02 0.9 3.03 Favored Glycine 0 CA--C 1.539 1.57 0 N-CA-C 116.048 1.179 . . . . 0.0 116.048 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.38 157.21 27.12 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 119.489 1.645 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.0 t -69.63 138.06 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.554 1.142 . . . . 0.0 113.129 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -115.26 166.05 12.28 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.551 1.54 . . . . 0.0 112.112 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 88.0 m -134.62 114.02 12.33 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.995 1.318 . . . . 0.0 110.295 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.49 124.29 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 120.959 -1.088 . . . . 0.0 108.994 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.6 mt -64.41 -66.78 0.5 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.185 0.994 . . . . 0.0 110.622 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -170.23 159.78 7.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.125 2.17 . . . . 0.0 110.558 175.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.08 122.92 47.64 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.478 1.911 . . . . 0.0 109.7 174.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -120.59 116.81 26.09 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.177 0.991 . . . . 0.0 111.829 -176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -71.49 114.2 9.32 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.177 1.391 . . . . 0.0 112.727 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.16 -44.83 44.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.044 1.738 . . . . 0.0 110.591 174.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 26.8 m -147.38 162.22 39.44 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 127.496 2.318 . . . . 0.0 111.574 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.67 -166.18 54.02 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.358 0.98 . . . . 0.0 113.934 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 t -147.32 173.32 12.7 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.889 -0.771 . . . . 0.0 111.954 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.57 HG22 ' HA2' ' A' ' 73' ' ' GLY . 5.1 p -143.82 -174.69 4.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.182 1.393 . . . . 0.0 111.479 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -129.07 13.46 6.22 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.286 1.034 . . . . 0.0 112.918 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.57 HG11 ' CB ' ' A' ' 3' ' ' ALA . 7.9 m -136.45 170.16 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 126.898 2.079 . . . . 0.0 114.043 -169.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mt -142.33 133.35 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 125.915 1.686 . . . . 0.0 110.785 -171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.33 143.48 52.06 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 119.196 0.907 . . . . 0.0 111.713 -176.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.79 146.36 59.74 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 124.655 3.57 . . . . 0.0 112.051 177.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -85.6 -26.74 25.91 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -113.63 128.03 56.28 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 120.216 1.371 . . . . 0.0 111.897 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.9 t -135.52 86.63 28.68 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.609 1.564 . . . . 0.0 110.137 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.73 162.12 36.01 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.303 2.002 . . . . 0.0 112.124 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -63.64 159.48 18.89 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.758 -0.589 . . . . 0.0 111.063 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p 68.45 -5.42 0.94 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.68 2.392 . . . . 0.0 114.444 -172.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.486 ' HA ' ' H ' ' A' ' 9' ' ' GLY . 73.9 mttt -116.31 165.44 13.19 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.581 1.952 . . . . 0.0 112.026 174.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.508 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -135.89 162.66 32.2 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.321 1.448 . . . . 0.0 111.272 174.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.55 167.02 10.19 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.292 0.567 . . . . 0.0 109.857 174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.51 136.08 52.96 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.506 1.922 . . . . 0.0 108.764 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -150.17 166.29 30.3 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 124.185 0.994 . . . . 0.0 110.662 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -155.29 170.12 22.6 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.591 0.757 . . . . 0.0 112.447 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.57 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -160.15 145.0 10.6 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.748 1.166 . . . . 0.0 112.582 175.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -127.17 148.92 50.17 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.652 1.981 . . . . 0.0 110.981 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.629 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 9.4 pttp -67.36 121.11 15.02 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 38.24 -149.77 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 126.034 1.733 . . . . 0.0 114.381 174.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.7 m -88.17 -42.65 12.18 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 120.634 -1.291 . . . . 0.0 111.598 175.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.9 -61.16 0.37 Allowed Glycine 0 CA--C 1.54 1.608 0 CA-C-O 118.696 -1.058 . . . . 0.0 114.252 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.16 0.81 5.4 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 124.929 3.753 . . . . 0.0 115.27 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -128.76 135.72 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 127.677 2.391 . . . . 0.0 108.995 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 106' ' ' PHE . . . -119.14 80.95 1.63 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.627 1.571 . . . . 0.0 110.226 -176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.8 m -110.42 -66.7 1.05 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.726 1.211 . . . . 0.0 110.75 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.02 -179.64 33.58 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 123.731 0.681 . . . . 0.0 112.793 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.629 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -140.1 115.46 9.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.03 0.932 . . . . 0.0 110.427 175.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 53.8 t -138.63 139.51 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.426 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . . . -154.71 158.82 40.15 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 123.31 0.644 . . . . 0.0 109.863 174.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.67 139.81 22.12 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.649 0.738 . . . . 0.0 111.919 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -134.73 176.43 8.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 126.573 1.949 . . . . 0.0 109.682 -172.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.73 37.07 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.336 0.655 . . . . 0.0 112.125 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -128.44 113.02 15.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.686 1.194 . . . . 0.0 111.112 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -73.04 111.77 8.46 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.215 1.806 . . . . 0.0 110.747 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 25.9 mtt -71.68 161.42 31.02 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.724 0.81 . . . . 0.0 112.106 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.3 t -60.98 -26.08 67.31 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.118 0.967 . . . . 0.0 113.245 175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -74.96 -12.1 60.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.622 1.569 . . . . 0.0 112.957 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.34 -2.86 59.48 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.665 1.602 . . . . 0.0 114.489 178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.79 176.38 9.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.533 1.533 . . . . 0.0 109.664 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 52.9 m -136.56 148.71 47.7 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.092 0.957 . . . . 0.0 110.241 175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.33 134.89 54.29 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.904 0.882 . . . . 0.0 108.637 175.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.23 144.04 19.03 Favored Glycine 0 N--CA 1.464 0.55 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.26 121.35 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 118.445 1.122 . . . . 0.0 109.481 174.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -128.64 162.22 27.83 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.359 0.664 . . . . 0.0 112.668 175.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 86' ' ' ALA . 3.8 p90 -131.4 150.89 51.97 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.875 1.27 . . . . 0.0 109.603 174.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 t -139.08 110.37 6.93 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 123.52 0.728 . . . . 0.0 110.383 176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 61.8 t -99.59 100.01 9.91 Favored Pre-proline 0 C--O 1.238 0.467 0 C-N-CA 127.897 2.479 . . . . 0.0 109.112 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.4 145.72 43.48 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.34 2.027 . . . . 0.0 111.372 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' A' ' 81' ' ' ALA . 23.6 t80 -72.89 -31.55 64.76 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.41 0.624 . . . . 0.0 110.167 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.73 114.85 28.11 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.522 2.329 . . . . 0.0 111.714 -165.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.01 -54.74 8.97 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -95.01 14.43 21.85 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.06 -16.92 2.79 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 126.373 1.869 . . . . 0.0 113.06 -175.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -143.07 175.1 10.11 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 129.062 2.945 . . . . 0.0 109.497 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 56.8 m -136.01 171.0 15.1 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.438 1.495 . . . . 0.0 110.768 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -87.24 151.97 22.71 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.069 0.947 . . . . 0.0 109.964 175.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -138.78 142.02 38.78 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.52 1.128 . . . . 0.0 110.231 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 21.1 p-90 -159.6 163.2 35.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.482 1.113 . . . . 0.0 111.154 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -163.71 147.19 10.11 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.395 1.478 . . . . 0.0 110.421 174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.9 t -141.21 108.25 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 126.009 1.723 . . . . 0.0 109.529 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -111.76 149.11 32.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.041 1.736 . . . . 0.0 109.734 175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.3 mp -106.1 117.76 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.687 1.595 . . . . 0.0 108.898 174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -125.21 135.88 53.01 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.145 1.778 . . . . 0.0 112.092 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.2 p -75.66 80.63 2.63 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.379 1.472 . . . . 0.0 112.792 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 150.14 167.63 14.5 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 115.207 0.843 . . . . 0.0 115.207 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -72.86 102.66 3.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.432 1.493 . . . . 0.0 111.665 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.51 132.45 31.22 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.318 1.847 . . . . 0.0 109.436 178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 167.13 17.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.048 1.339 . . . . 0.0 111.837 176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -68.64 88.54 0.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.598 1.559 . . . . 0.0 111.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -111.53 -64.38 1.29 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.776 1.23 . . . . 0.0 109.712 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -68.52 0.23 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.597 1.159 . . . . 0.0 109.139 175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.41 -35.77 90.62 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.038 -0.868 . . . . 0.0 114.682 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -52.77 33.27 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 119.086 1.443 . . . . 0.0 111.02 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -55.89 -44.43 78.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.253 1.021 . . . . 0.0 110.801 175.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -63.85 -39.38 94.08 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -22.32 61.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.453 1.101 . . . . 0.0 112.216 175.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.19 -58.86 2.47 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.431 1.492 . . . . 0.0 109.557 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -63.36 -57.63 9.73 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.295 -0.878 . . . . 0.0 111.248 -175.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -82.26 -17.95 44.14 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.347 1.059 . . . . 0.0 112.247 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.21 56.51 4.86 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 123.935 0.778 . . . . 0.0 114.676 -172.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.49 83.28 0.23 Allowed Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 126.444 1.898 . . . . 0.0 111.818 -166.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.48 151.27 83.41 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.132 1.888 . . . . 0.0 109.256 175.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -84.42 -2.9 57.93 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.1 95.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 129.179 2.992 . . . . 0.0 112.819 -173.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -38.67 75.32 0.0 OUTLIER Glycine 0 CA--C 1.542 1.781 0 C-N-CA 128.319 2.866 . . . . 0.0 117.239 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -81.97 25.55 0.56 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.629 1.972 . . . . 0.0 114.668 -170.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.275 11.6 p30 52.44 24.79 3.15 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 127.178 2.191 . . . . 0.0 114.842 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -126.35 172.25 18.07 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 126.888 2.185 . . . . 0.0 113.189 174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -79.69 117.89 21.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.727 1.211 . . . . 0.0 111.919 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -104.84 117.33 33.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.053 1.741 . . . . 0.0 109.526 175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -149.9 134.55 17.59 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.295 1.038 . . . . 0.0 111.293 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -148.09 127.77 13.34 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.608 1.163 . . . . 0.0 112.146 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -53.84 113.54 1.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.136 1.374 . . . . 0.0 113.016 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.8 tt -137.1 -28.36 0.94 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.944 1.298 . . . . 0.0 113.385 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -86.11 18.24 33.0 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.883 1.23 . . . . 0.0 114.498 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.66 11.25 2.32 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.385 2.274 . . . . 0.0 114.785 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.69 -72.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.648 0 C-N-CA 126.101 1.81 . . . . 0.0 110.319 -177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.43 156.75 22.77 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.813 0.816 . . . . 0.0 111.632 176.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.62 170.87 18.64 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.599 1.56 . . . . 0.0 112.43 174.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.9 130.87 35.2 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.303 1.041 . . . . 0.0 109.401 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.5 ttpt -125.71 101.32 6.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -134.45 168.76 23.35 Favored Glycine 0 CA--C 1.518 0.245 0 CA-C-O 121.963 0.757 . . . . 0.0 113.843 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 11.7 tt -143.74 141.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 126.343 1.857 . . . . 0.0 109.049 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.5 ttt -146.28 143.07 28.93 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.78 1.632 . . . . 0.0 107.501 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.7 p -97.53 173.22 7.27 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.22 1.008 . . . . 0.0 111.539 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.0 m -109.43 33.72 4.17 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.555 1.542 . . . . 0.0 112.392 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.8 175.08 5.58 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.248 1.419 . . . . 0.0 112.376 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -60.65 -47.47 91.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.177 0.894 . . . . 0.0 113.745 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -108.87 72.01 0.8 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.784 1.278 . . . . 0.0 111.633 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -73.5 175.01 7.42 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.918 1.287 . . . . 0.0 111.211 175.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -137.81 151.16 47.83 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 109.312 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 1.9 tpp -140.68 87.77 2.14 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.147 0.979 . . . . 0.0 111.736 -174.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.38 148.78 23.34 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.984 0.514 . . . . 0.0 111.05 174.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.5 mp -136.87 99.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.25 1.42 . . . . 0.0 111.19 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -83.76 108.16 16.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.798 1.639 . . . . 0.0 109.844 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.86 110.07 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.132 0.573 . . . . 0.0 110.86 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 55.4 m -147.29 161.33 41.18 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.921 1.289 . . . . 0.0 113.83 -176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 128.211 2.604 . . . . 0.0 111.686 177.834 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -110.79 11.07 22.56 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.504 1.122 . . . . 0.0 112.59 178.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.01 139.58 50.54 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 120.46 -1.4 . . . . 0.0 111.084 176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.02 31.83 61.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.716 0.646 . . . . 0.0 114.716 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.8 p -142.76 177.22 8.48 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 118.639 1.22 . . . . 0.0 112.398 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.53 HG23 ' HG3' ' A' ' 60' ' ' PRO . 6.5 pt -125.51 144.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.448 1.499 . . . . 0.0 112.734 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' CG2' HD21 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -146.38 174.09 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.748 1.619 . . . . 0.0 112.236 177.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.52 121.01 8.68 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.023 1.329 . . . . 0.0 111.587 175.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.7 -21.74 44.31 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.111 1.339 . . . . 0.0 113.863 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.39 -33.81 76.82 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.059 1.344 . . . . 0.0 111.931 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.9 m -88.51 -32.8 18.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.42 1.488 . . . . 0.0 112.361 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 68' ' ' ALA . 2.6 tp -55.42 106.54 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.761 1.224 . . . . 0.0 111.623 175.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.4 m -146.29 168.98 19.73 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.825 1.25 . . . . 0.0 109.747 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -47.85 -37.87 14.86 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.086 1.354 . . . . 0.0 114.05 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -58.85 -34.27 71.38 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 20' ' ' VAL . 46.9 t -72.51 -48.07 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.191 1.397 . . . . 0.0 110.198 174.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 170' ' ' GLN . 86.5 mt -54.31 -44.84 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.083 0.953 . . . . 0.0 112.629 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -66.87 -45.5 77.89 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 122.963 0.505 . . . . 0.0 111.624 177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -56.34 -41.54 76.26 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.821 1.649 . . . . 0.0 113.044 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 16' ' ' VAL . 67.0 t -50.07 -55.71 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.197 1.399 . . . . 0.0 111.193 176.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.6 mp -66.17 -38.65 88.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.283 1.833 . . . . 0.0 112.479 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.39 -49.63 75.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.12 1.368 . . . . 0.0 110.741 174.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -75.01 -36.07 61.96 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.08 -50.94 69.6 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.66 1.584 . . . . 0.0 112.23 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.79 62.83 0.36 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.893 1.235 . . . . 0.0 112.328 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -45.94 99.02 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.617 2.367 . . . . 0.0 114.04 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.5 -166.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.591 1.956 . . . . 0.0 111.211 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.4 t -43.78 -41.34 4.89 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 126.819 2.047 . . . . 0.0 113.99 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -144.38 138.91 28.12 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.551 1.94 . . . . 0.0 108.84 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HE3' ' CB ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -167.34 146.39 5.04 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 127.234 2.214 . . . . 0.0 109.591 -172.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.484 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -137.92 160.63 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.608 1.163 . . . . 0.0 110.916 175.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.49 118.04 31.57 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.995 1.318 . . . . 0.0 109.034 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.0 t -108.4 139.55 30.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 124.442 1.097 . . . . 0.0 109.87 175.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.65 118.14 0.88 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.921 0.772 . . . . 0.0 111.711 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 8.1 mt -109.79 97.33 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.128 0.971 . . . . 0.0 108.461 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -76.96 117.51 18.63 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.996 1.319 . . . . 0.0 111.403 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -92.77 101.7 14.09 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.976 0.894 . . . . 0.0 112.215 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -111.38 12.46 21.56 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.451 1.1 . . . . 0.0 113.489 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.0 t -56.42 -51.97 66.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.1 1.76 . . . . 0.0 114.36 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.42 4.83 0.74 Allowed Glycine 0 CA--C 1.538 1.526 0 N-CA-C 116.505 1.362 . . . . 0.0 116.505 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -154.41 166.85 32.33 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 119.642 1.721 . . . . 0.0 114.348 178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.8 t -69.94 126.93 31.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.125 1.37 . . . . 0.0 112.401 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -98.99 165.33 11.8 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.63 1.572 . . . . 0.0 111.872 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.5 m -135.41 106.97 6.9 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.104 1.362 . . . . 0.0 109.574 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -62.23 132.33 52.38 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.143 -0.973 . . . . 0.0 110.149 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -75.66 -72.63 0.3 Allowed 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.587 0.755 . . . . 0.0 110.291 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -170.51 165.33 8.49 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.499 1.92 . . . . 0.0 111.048 176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -114.21 124.18 51.41 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.885 1.674 . . . . 0.0 109.772 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.21 108.77 19.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.549 1.14 . . . . 0.0 111.37 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -73.31 118.54 16.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.481 1.112 . . . . 0.0 110.896 175.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 -39.62 12.99 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.769 1.228 . . . . 0.0 111.942 177.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -143.42 150.98 39.83 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.78 2.032 . . . . 0.0 111.397 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.31 -165.29 51.7 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.183 0.897 . . . . 0.0 113.648 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 t -149.13 163.23 38.17 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.875 -0.779 . . . . 0.0 111.094 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.9 m -142.43 130.17 21.58 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.892 1.277 . . . . 0.0 110.095 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.01 2.9 54.63 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.546 1.538 . . . . 0.0 113.521 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.71 169.76 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.697 1.199 . . . . 0.0 111.134 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -135.07 131.53 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.203 1.001 . . . . 0.0 110.037 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.58 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -76.44 154.27 83.91 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 118.289 0.495 . . . . 0.0 111.169 179.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HG3' HG23 ' A' ' 6' ' ' ILE . 45.9 Cg_endo -70.93 167.76 25.02 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.365 3.377 . . . . 0.0 109.957 175.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -112.14 -16.75 12.96 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.061 -1.025 . . . . 0.0 112.952 176.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -128.99 144.0 51.05 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.483 1.513 . . . . 0.0 109.958 174.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 6' ' ' ILE . 26.5 t -143.52 99.48 5.28 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 124.674 1.19 . . . . 0.0 109.634 178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.61 155.02 71.82 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 121.884 1.723 . . . . 0.0 110.545 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -55.86 150.2 13.58 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 121.953 -0.467 . . . . 0.0 111.597 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 0.9 OUTLIER 68.83 -7.3 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 127.185 2.194 . . . . 0.0 115.417 -173.695 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 47.0 mttt -101.58 141.71 34.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 120.402 1.455 . . . . 0.0 108.07 175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.567 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -112.73 154.48 26.1 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.213 -0.929 . . . . 0.0 111.784 175.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -90.94 171.01 9.59 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.44 175.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -135.45 134.11 39.26 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.577 2.351 . . . . 0.0 107.364 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -150.19 162.35 40.63 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 125.766 1.626 . . . . 0.0 111.206 174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.6 m -154.21 155.32 35.04 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.807 0.843 . . . . 0.0 110.367 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.484 ' H ' HD13 ' A' ' 31' ' ' ILE . . . -150.42 143.65 10.93 Favored Glycine 0 N--CA 1.474 1.182 0 O-C-N 121.2 -0.937 . . . . 0.0 113.411 -178.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -134.06 163.63 29.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.779 1.232 . . . . 0.0 113.48 -172.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.34 99.32 7.86 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 122.699 1.237 . . . . 0.0 110.411 174.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 36.28 -131.0 0.1 Allowed 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 127.87 2.468 . . . . 0.0 113.191 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.1 m -57.54 -53.67 55.57 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.806 -1.184 . . . . 0.0 112.73 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 150.22 -61.93 0.41 Allowed Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.251 0.929 . . . . 0.0 114.066 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.47 -8.72 23.91 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 124.433 3.422 . . . . 0.0 115.554 -178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.91 163.6 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.347 1.459 . . . . 0.0 112.836 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.64 74.51 1.01 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.056 1.342 . . . . 0.0 112.599 -177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 83' ' ' GLY . 2.8 t -106.99 -107.91 0.32 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.723 1.609 . . . . 0.0 109.76 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 82' ' ' THR . . . -171.57 174.88 45.14 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.628 2.537 . . . . 0.0 111.163 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' VAL . . . -136.82 93.13 2.81 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.067 1.347 . . . . 0.0 109.584 175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -129.84 124.52 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -151.55 157.82 42.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.012 0.434 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.33 130.53 17.49 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.95 0.9 . . . . 0.0 110.916 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CE1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -131.58 176.44 8.32 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.734 1.613 . . . . 0.0 110.241 -172.396 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -139.67 150.35 44.79 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.466 0.651 . . . . 0.0 112.686 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -132.88 114.11 13.67 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.874 1.67 . . . . 0.0 111.02 -175.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -79.54 123.54 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.219 1.408 . . . . 0.0 111.239 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 26.6 mtp -81.63 157.28 24.75 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.179 1.391 . . . . 0.0 112.257 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 p -62.2 -19.52 63.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.233 1.413 . . . . 0.0 114.757 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -84.06 -11.39 56.79 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.005 1.722 . . . . 0.0 113.755 175.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.85 -5.06 46.46 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.936 1.255 . . . . 0.0 115.11 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -76.12 171.82 13.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.654 1.182 . . . . 0.0 110.213 174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 71.0 m -136.69 140.7 42.87 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.979 0.912 . . . . 0.0 110.158 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.69 123.51 50.47 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.878 0.871 . . . . 0.0 109.835 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.51 139.08 18.51 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 175.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -137.14 122.18 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.711 1.205 . . . . 0.0 110.242 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -135.0 159.61 40.95 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 175.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -134.03 153.7 51.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.47 1.508 . . . . 0.0 110.913 174.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 t -137.1 104.79 5.54 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.574 1.55 . . . . 0.0 110.009 176.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 41.5 t -105.65 97.05 13.48 Favored Pre-proline 0 N--CA 1.468 0.45 0 C-N-CA 127.032 2.133 . . . . 0.0 108.475 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.57 167.05 28.23 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.773 2.316 . . . . 0.0 111.617 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -69.69 -45.27 68.66 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.614 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.66 114.59 26.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.573 1.549 . . . . 0.0 111.569 -165.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -65.76 -62.07 1.72 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -92.07 12.35 22.28 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.83 -7.72 5.0 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.606 1.963 . . . . 0.0 112.568 -174.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -152.68 139.92 19.42 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.458 2.303 . . . . 0.0 109.116 177.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 t -98.55 159.23 15.09 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.112 -0.992 . . . . 0.0 109.939 175.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -84.22 157.78 21.5 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.792 -0.567 . . . . 0.0 109.805 174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 10.4 m95 -138.98 145.67 40.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.986 0.915 . . . . 0.0 110.819 -174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -155.32 148.21 24.46 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.864 1.265 . . . . 0.0 110.792 175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -146.59 151.36 37.16 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 121.492 -0.755 . . . . 0.0 110.234 174.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.1 t -143.46 107.45 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.825 1.65 . . . . 0.0 109.77 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -115.86 148.03 40.4 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.221 1.408 . . . . 0.0 109.724 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 9.5 mt -120.51 111.77 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.863 2.065 . . . . 0.0 109.241 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -118.33 145.13 45.34 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.391 1.476 . . . . 0.0 112.349 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.6 t -73.35 90.11 1.64 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.385 1.074 . . . . 0.0 110.79 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.63 -174.23 42.04 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.476 0.56 . . . . 0.0 113.768 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 111.68 23.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.047 2.139 . . . . 0.0 110.908 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -147.84 156.56 42.84 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.312 -0.868 . . . . 0.0 111.655 175.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -140.38 167.4 22.24 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.522 1.529 . . . . 0.0 111.299 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -71.73 86.79 0.94 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.537 1.135 . . . . 0.0 111.555 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -111.18 -67.0 1.03 Allowed 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.047 1.339 . . . . 0.0 108.911 -173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.18 -67.64 0.28 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.849 1.26 . . . . 0.0 109.779 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -67.23 -36.62 90.12 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.961 0.791 . . . . 0.0 114.325 -177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 2.5 ttp -65.71 -48.26 72.58 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.791 1.295 . . . . 0.0 111.642 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -62.19 -49.42 75.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.674 0.79 . . . . 0.0 111.068 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 64.2 mt-10 -64.82 -37.33 87.26 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -60.37 -20.86 61.08 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.163 -1.585 . . . . 0.0 113.286 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.71 -50.41 5.39 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.484 1.513 . . . . 0.0 112.132 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -75.32 -57.16 4.06 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 119.587 1.085 . . . . 0.0 112.76 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -79.73 -19.35 49.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.337 1.455 . . . . 0.0 111.858 -176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.51 -90.14 0.05 OUTLIER Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.003 1.287 . . . . 0.0 112.467 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -162.02 79.17 1.99 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.073 1.349 . . . . 0.0 110.598 174.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.23 150.1 52.68 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 121.689 1.593 . . . . 0.0 111.546 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.4 164.51 26.57 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.864 0.866 . . . . 0.0 109.171 174.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.76 118.61 36.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.143 1.377 . . . . 0.0 108.856 -173.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.32 65.5 1.63 Allowed Glycine 0 CA--C 1.533 1.211 0 CA-C-N 118.878 0.763 . . . . 0.0 112.627 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -82.52 18.69 1.43 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.437 1.895 . . . . 0.0 113.647 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 64.52 43.35 4.5 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.526 1.93 . . . . 0.0 112.63 -173.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.64 153.57 21.72 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.604 1.573 . . . . 0.0 113.652 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -70.15 133.57 47.24 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.613 1.165 . . . . 0.0 111.893 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -130.91 113.73 14.38 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 126.294 1.837 . . . . 0.0 110.158 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.58 153.7 41.36 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.684 1.594 . . . . 0.0 110.578 175.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -166.48 150.65 7.49 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.237 1.815 . . . . 0.0 110.23 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.09 127.48 32.28 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 119.164 0.893 . . . . 0.0 110.143 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 tt -135.48 -39.74 0.73 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.522 1.129 . . . . 0.0 112.09 177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.85 20.98 10.25 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.008 1.29 . . . . 0.0 114.475 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 59.73 14.46 4.1 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.991 2.116 . . . . 0.0 114.668 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 177.3 -56.85 0.1 OUTLIER Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.065 1.793 . . . . 0.0 110.955 -177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.43 153.69 21.71 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.904 0.859 . . . . 0.0 110.128 175.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.6 169.51 24.51 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.043 1.337 . . . . 0.0 112.331 176.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -100.89 140.85 34.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.661 1.184 . . . . 0.0 111.606 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.4 ttmm -126.38 113.91 17.51 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -146.36 172.19 27.01 Favored Glycine 0 CA--C 1.519 0.307 0 CA-C-O 121.661 0.589 . . . . 0.0 113.103 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 10.8 tt -153.63 145.91 14.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 126.466 1.907 . . . . 0.0 108.316 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.3 ttm -140.96 137.91 33.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.223 1.009 . . . . 0.0 109.24 174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.89 161.02 30.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.428 1.891 . . . . 0.0 112.187 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.65 -33.95 23.15 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.335 -0.853 . . . . 0.0 113.269 -174.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -69.13 172.62 6.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 112.536 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -62.22 -42.07 99.72 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 121.352 -0.843 . . . . 0.0 113.27 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.443 ' CB ' ' HE3' ' A' ' 30' ' ' LYS . 10.9 pt-20 -81.52 57.91 3.49 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.858 1.663 . . . . 0.0 113.908 178.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.74 170.61 9.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.64 124.02 15.73 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.025 -1.047 . . . . 0.0 112.559 174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.02 91.17 3.69 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.699 2.0 . . . . 0.0 111.899 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.454 ' HB2' HD11 ' A' ' 17' ' ' LEU . 4.1 tt0 -87.45 139.02 30.97 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.874 -0.516 . . . . 0.0 110.373 165.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.4 mp -128.5 114.27 33.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 126.618 1.967 . . . . 0.0 108.37 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -110.01 108.52 18.78 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.477 1.511 . . . . 0.0 110.177 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 22.8 mm -89.13 120.22 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.658 1.183 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 49.9 m -117.32 170.02 9.03 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.597 1.559 . . . . 0.0 112.789 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.895 2.078 . . . . 0.0 113.667 -179.4 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.33 -14.34 21.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.58 54.56 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.205 -0.935 . . . . 0.0 111.578 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.23 41.34 11.99 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.301 0.953 . . . . 0.0 114.732 -175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 46.8 p -142.88 -169.67 3.06 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 119.194 1.497 . . . . 0.0 112.902 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.8 pt -122.99 127.25 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 127.615 2.366 . . . . 0.0 110.757 175.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -142.59 166.27 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.767 1.227 . . . . 0.0 111.787 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 110.91 1.96 Allowed 'General case' 0 CA--C 1.546 0.803 0 O-C-N 120.658 -1.277 . . . . 0.0 113.044 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.92 -29.08 61.51 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.164 0.888 . . . . 0.0 113.752 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.19 -32.97 74.49 Favored 'General case' 0 CA--C 1.548 0.893 0 O-C-N 121.267 -1.137 . . . . 0.0 112.834 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -89.59 -18.39 26.67 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.945 1.298 . . . . 0.0 113.291 177.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' A' ' 34' ' ' GLY . 15.8 tp -65.41 115.34 5.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.126 1.371 . . . . 0.0 110.481 174.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -142.94 166.3 25.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.553 1.141 . . . . 0.0 110.043 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -40.26 26.88 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.706 1.602 . . . . 0.0 113.927 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -60.35 -34.95 74.58 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.314 1.446 . . . . 0.0 113.267 175.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -77.01 -45.68 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.943 1.697 . . . . 0.0 109.82 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.63 -45.9 66.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.029 0.931 . . . . 0.0 112.435 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.31 -47.8 78.07 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 121.93 -0.481 . . . . 0.0 112.253 175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -53.54 -42.17 67.2 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.783 1.233 . . . . 0.0 112.683 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 56.6 t -54.22 -57.08 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.829 0.852 . . . . 0.0 111.216 175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.732 HD23 ' HD2' ' A' ' 30' ' ' LYS . 2.8 mp -61.49 -40.9 96.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.028 1.331 . . . . 0.0 112.671 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -56.98 -45.89 82.6 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.528 0.731 . . . . 0.0 112.164 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -84.98 -21.02 29.69 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.6 tp -58.26 -45.65 87.45 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.713 2.005 . . . . 0.0 113.605 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.36 32.78 7.17 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 114.747 0.659 . . . . 0.0 114.747 -173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 174.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.831 2.052 . . . . 0.0 114.293 174.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.33 -162.61 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 126.177 1.791 . . . . 0.0 111.478 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 m -54.5 -24.63 21.37 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -123.75 141.69 51.78 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.191 1.796 . . . . 0.0 110.293 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.732 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -161.1 149.32 15.84 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.342 1.857 . . . . 0.0 111.555 -170.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.406 HD11 ' CZ ' ' A' ' 102' ' ' PHE . 3.7 pt -143.41 145.93 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.795 1.638 . . . . 0.0 109.917 175.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.23 121.64 41.76 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.403 1.481 . . . . 0.0 108.029 175.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 t -113.96 136.46 50.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.108 1.763 . . . . 0.0 110.589 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' A' ' 12' ' ' LEU . . . -148.5 120.74 1.23 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.014 1.292 . . . . 0.0 111.829 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.7 mt -108.56 101.29 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.262 1.425 . . . . 0.0 108.451 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.38 104.94 8.2 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.071 0.948 . . . . 0.0 112.095 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -73.61 96.89 2.53 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.484 0.714 . . . . 0.0 110.684 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -122.25 21.62 10.34 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 126.106 1.762 . . . . 0.0 112.08 177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.6 t -71.53 -43.23 66.82 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.294 1.438 . . . . 0.0 113.687 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.03 16.83 3.17 Favored Glycine 0 CA--C 1.541 1.699 0 C-N-CA 125.925 1.726 . . . . 0.0 115.667 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.83 155.44 26.81 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 119.597 1.698 . . . . 0.0 115.057 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.1 t -68.45 132.02 46.28 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.547 1.139 . . . . 0.0 113.194 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -105.12 165.25 11.22 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.504 1.522 . . . . 0.0 111.849 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.9 m -134.45 113.76 12.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.105 1.362 . . . . 0.0 108.921 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -64.5 136.6 57.22 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.155 -0.966 . . . . 0.0 109.557 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.29 -70.76 0.4 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -177.48 175.78 1.38 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.617 2.367 . . . . 0.0 110.082 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.26 150.02 50.81 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.171 2.188 . . . . 0.0 109.306 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 112.3 8.92 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.779 1.232 . . . . 0.0 110.256 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -71.69 121.39 18.76 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.487 1.115 . . . . 0.0 110.846 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.8 tpt180 -95.5 -43.54 7.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.106 0.963 . . . . 0.0 112.032 177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.4 m -141.22 156.89 45.85 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.935 2.094 . . . . 0.0 110.299 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.1 -176.74 53.86 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.468 0.556 . . . . 0.0 113.508 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 t -137.67 164.44 28.83 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.602 1.161 . . . . 0.0 111.027 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -144.38 175.47 10.08 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.451 1.1 . . . . 0.0 111.76 178.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -134.23 17.05 3.75 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.367 1.067 . . . . 0.0 112.279 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.6 m -131.95 166.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 126.818 2.047 . . . . 0.0 112.565 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -141.96 134.14 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.833 1.653 . . . . 0.0 109.632 -171.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 154.47 86.42 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 118.993 0.815 . . . . 0.0 112.339 175.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.42 172.47 13.23 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.452 3.435 . . . . 0.0 110.525 174.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -113.38 -21.41 10.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -125.62 125.81 43.72 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.467 1.507 . . . . 0.0 110.675 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.97 95.0 19.45 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 125.034 1.333 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.04 160.33 34.53 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.876 1.717 . . . . 0.0 111.23 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.61 156.86 10.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.801 -0.562 . . . . 0.0 111.586 175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m 75.13 -22.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 127.182 2.193 . . . . 0.0 112.892 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -100.68 141.66 33.24 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.547 1.939 . . . . 0.0 109.576 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.05 178.0 4.59 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 126.775 2.03 . . . . 0.0 109.558 175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.28 175.92 5.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.582 0.706 . . . . 0.0 109.796 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.4 ' HA ' HD13 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -129.28 124.37 34.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.633 1.573 . . . . 0.0 107.363 174.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -146.0 150.17 35.52 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.592 0.357 . . . . 0.0 110.723 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.4 m -147.35 158.93 44.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.35 0.595 . . . . 0.0 111.129 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.57 142.01 10.89 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 125.515 1.531 . . . . 0.0 111.183 -177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -131.72 168.91 16.96 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.524 1.53 . . . . 0.0 110.467 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -63.52 179.34 0.47 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.029 0.932 . . . . 0.0 110.098 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.94 -179.98 0.24 Allowed 'General case' 0 CA--C 1.551 1.001 0 O-C-N 121.114 -0.991 . . . . 0.0 111.264 174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 m -28.58 -49.64 0.07 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 128.375 2.67 . . . . 0.0 115.939 -172.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.58 -59.61 0.33 Allowed Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.016 1.293 . . . . 0.0 112.677 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.77 -2.66 11.77 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 124.25 3.3 . . . . 0.0 115.067 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.9 m -119.71 124.2 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.462 1.505 . . . . 0.0 111.297 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.24 75.71 1.66 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.19 1.796 . . . . 0.0 111.786 -174.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.8 m -100.58 -75.44 0.58 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.623 1.169 . . . . 0.0 111.244 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 172.57 -176.52 45.46 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.74 1.162 . . . . 0.0 112.253 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.54 105.29 5.36 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.695 1.198 . . . . 0.0 110.671 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 20.4 t -140.18 120.41 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.311 1.044 . . . . 0.0 108.585 -171.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.94 168.59 19.89 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.89 0.852 . . . . 0.0 111.526 176.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.57 156.25 43.1 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.077 0.951 . . . . 0.0 111.727 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.73 175.52 11.9 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.777 2.031 . . . . 0.0 110.66 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.95 148.35 43.42 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.897 0.879 . . . . 0.0 111.504 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.587 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -125.73 118.66 26.07 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.595 1.158 . . . . 0.0 110.957 179.303 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -78.52 117.43 19.7 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.992 1.717 . . . . 0.0 110.309 176.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.9 mtm -75.58 162.6 28.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.487 0.66 . . . . 0.0 112.492 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 95.5 p -60.41 -21.55 62.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.928 1.291 . . . . 0.0 114.078 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.7 m -83.23 -12.19 57.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.05 2.14 . . . . 0.0 113.56 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.03 -1.56 57.78 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.475 1.512 . . . . 0.0 115.252 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -79.35 171.22 15.47 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.066 1.347 . . . . 0.0 110.143 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.0 m -131.59 148.34 52.6 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.746 0.818 . . . . 0.0 110.473 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -122.42 112.81 18.52 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.761 1.224 . . . . 0.0 108.237 176.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.44 141.9 29.43 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.25 127.69 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.609 1.164 . . . . 0.0 109.191 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 2.1 ppp? -140.72 162.97 34.15 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 17.9 p90 -140.43 159.93 41.1 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.84 1.256 . . . . 0.0 111.46 174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.4 t -140.71 112.8 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.939 1.696 . . . . 0.0 109.351 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.4 t -115.33 101.06 54.3 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 126.265 1.826 . . . . 0.0 108.48 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 163.88 34.49 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.554 2.169 . . . . 0.0 111.756 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.59 -26.72 60.11 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.06 114.48 27.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.04 1.336 . . . . 0.0 111.506 -172.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -76.33 -57.17 4.02 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.325 1.05 . . . . 0.0 113.66 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -89.13 13.65 12.65 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 120.908 -1.12 . . . . 0.0 113.807 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -132.72 -19.26 2.36 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 126.241 1.816 . . . . 0.0 113.438 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -141.83 169.6 17.28 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.934 2.893 . . . . 0.0 108.753 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 t -132.95 161.21 34.89 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.017 -1.052 . . . . 0.0 109.867 175.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -88.53 161.32 17.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.793 0.806 . . . . 0.0 111.415 175.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -141.58 151.46 43.2 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.116 0.966 . . . . 0.0 110.688 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 26.5 p-90 -154.17 157.83 39.43 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.124 1.37 . . . . 0.0 110.492 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -150.83 146.92 26.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.922 2.089 . . . . 0.0 109.509 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.02 117.88 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 125.534 1.534 . . . . 0.0 108.797 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -122.42 140.13 53.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.818 1.247 . . . . 0.0 110.471 175.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 34.1 mt -109.38 117.33 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.777 2.031 . . . . 0.0 108.525 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.79 145.43 50.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.164 1.386 . . . . 0.0 112.836 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 16.2 p -75.61 79.51 2.6 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.139 1.775 . . . . 0.0 112.661 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 155.03 173.54 23.92 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.147 1.356 . . . . 0.0 112.82 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 148.99 48.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.876 1.27 . . . . 0.0 111.683 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.8 112.69 2.68 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.433 1.093 . . . . 0.0 111.622 174.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.38 175.93 9.81 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.127 0.971 . . . . 0.0 110.564 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -131.56 99.08 4.69 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.825 1.65 . . . . 0.0 108.452 174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -112.05 -70.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.108 0.963 . . . . 0.0 110.226 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 -67.47 0.24 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.56 1.144 . . . . 0.0 110.84 175.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.66 -9.08 84.83 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.429 1.014 . . . . 0.0 115.252 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -43.65 9.96 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.518 1.127 . . . . 0.0 111.083 175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -66.95 -36.91 83.28 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.65 1.18 . . . . 0.0 111.299 175.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -58.74 -29.72 66.94 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.067 -1.02 . . . . 0.0 113.092 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -20.09 63.31 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.717 1.207 . . . . 0.0 112.816 175.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.08 -50.89 5.3 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.108 1.363 . . . . 0.0 109.196 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -62.06 -47.4 84.86 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 15.7 m-30 -94.44 -13.87 25.78 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.045 0.938 . . . . 0.0 113.103 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -52.53 -62.85 5.43 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.547 1.07 . . . . 0.0 113.049 -177.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -177.17 78.41 0.25 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 128.392 2.677 . . . . 0.0 108.694 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -69.3 157.62 60.6 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.493 1.462 . . . . 0.0 110.833 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -101.97 6.35 41.2 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 31.11 65.09 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 128.732 2.813 . . . . 0.0 113.617 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -44.02 101.56 0.03 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.399 1.952 . . . . 0.0 115.177 -169.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -90.58 28.29 1.53 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.16 2.184 . . . . 0.0 113.314 -175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 66.55 52.75 1.0 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.251 1.821 . . . . 0.0 112.849 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -151.59 154.38 25.52 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.276 1.417 . . . . 0.0 113.178 175.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -62.95 117.05 5.87 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.642 1.177 . . . . 0.0 113.31 175.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -108.09 119.18 38.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.152 2.181 . . . . 0.0 110.966 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -150.94 133.01 15.25 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.151 0.98 . . . . 0.0 111.236 175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -146.3 130.12 17.16 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.688 1.195 . . . . 0.0 111.981 175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.85 107.98 0.79 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.048 1.339 . . . . 0.0 112.277 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 33.9 tp -124.65 -32.34 3.11 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.009 1.324 . . . . 0.0 112.872 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -82.28 22.16 6.46 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.049 1.309 . . . . 0.0 114.821 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 56.84 8.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 127.264 2.226 . . . . 0.0 115.631 -175.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -174.64 -57.63 0.05 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 125.328 1.442 . . . . 0.0 111.413 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -101.64 156.53 17.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.832 0.825 . . . . 0.0 112.18 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.82 168.35 27.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.871 1.668 . . . . 0.0 112.21 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.5 141.46 28.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.878 0.871 . . . . 0.0 110.871 175.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.4 ttpm? -130.16 104.13 7.13 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 174.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -138.33 169.66 24.18 Favored Glycine 0 N--CA 1.454 -0.13 0 CA-C-O 121.888 0.716 . . . . 0.0 114.526 -176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.78 144.43 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 124.691 1.196 . . . . 0.0 109.312 177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 ttt -141.94 130.16 22.21 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.777 1.231 . . . . 0.0 108.556 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 60.1 p -88.31 163.05 16.25 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 110.952 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.3 m -96.12 -22.47 17.3 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -67.45 172.95 4.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.492 1.517 . . . . 0.0 113.165 175.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -50.59 -41.8 42.92 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 125.344 1.45 . . . . 0.0 114.158 -177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.87 78.34 8.6 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 111.105 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.41 79.85 1.03 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.804 0.841 . . . . 0.0 112.228 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -58.23 149.16 24.85 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 120.868 -1.145 . . . . 0.0 110.549 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 6.1 ttm -144.58 124.53 13.51 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.766 1.227 . . . . 0.0 109.975 -174.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -141.14 139.02 33.85 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 4.4 mp -130.96 92.37 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.259 1.424 . . . . 0.0 108.776 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.24 107.02 17.74 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.319 1.448 . . . . 0.0 108.553 174.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.79 131.37 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.007 0.523 . . . . 0.0 110.73 176.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.1 p -154.51 165.4 36.55 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 128.468 2.707 . . . . 0.0 111.903 175.867 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 7' ' ' ILE . 0.4 OUTLIER -94.98 8.81 41.67 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.99 1.316 . . . . 0.0 112.87 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.474 ' HB1' HG11 ' A' ' 57' ' ' VAL . . . -68.27 148.52 50.68 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 120.806 -1.184 . . . . 0.0 112.287 175.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.81 36.85 91.32 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.84 0.733 . . . . 0.0 114.2 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.3 p -142.28 175.79 9.49 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.908 0.854 . . . . 0.0 112.34 -175.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 pt -118.17 138.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.789 1.636 . . . . 0.0 111.38 175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 2' ' ' LEU . 7.5 pt -146.76 174.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 126.12 1.768 . . . . 0.0 111.587 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 103.53 0.11 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 112.364 175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.42 -25.66 67.15 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.252 0.93 . . . . 0.0 113.9 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.88 -18.88 14.79 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -117.43 7.31 12.74 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.804 1.641 . . . . 0.0 113.218 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 48.7 tp -72.95 114.48 11.15 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.513 1.125 . . . . 0.0 112.199 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 14' ' ' PHE . 5.6 m -146.25 172.55 13.3 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.261 1.425 . . . . 0.0 110.601 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.426 ' H ' HG22 ' A' ' 13' ' ' THR . 22.2 m-85 -48.41 -37.64 17.55 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.935 1.694 . . . . 0.0 114.188 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -56.41 -35.9 68.33 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.652 1.181 . . . . 0.0 113.302 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.8 t -77.79 -47.48 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.082 1.753 . . . . 0.0 109.643 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 mt -56.59 -46.18 80.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.393 1.077 . . . . 0.0 113.237 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.16 -42.75 99.49 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.654 -0.654 . . . . 0.0 111.103 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -39.23 72.14 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.758 1.223 . . . . 0.0 113.516 175.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.5 t -52.5 -59.55 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.294 1.038 . . . . 0.0 110.601 174.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.8 mp -63.72 -42.24 97.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.49 1.516 . . . . 0.0 112.406 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -54.17 -53.34 54.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.176 0.99 . . . . 0.0 112.167 177.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -73.35 -42.59 62.06 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 tp -48.52 -52.38 22.84 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.379 1.872 . . . . 0.0 112.349 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.01 59.79 0.23 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.607 1.098 . . . . 0.0 112.552 -172.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.66 141.74 6.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.588 1.155 . . . . 0.0 112.516 175.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.44 -160.16 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.771 1.628 . . . . 0.0 110.825 -174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -50.69 -31.91 17.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.238 1.415 . . . . 0.0 113.058 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -146.39 143.78 29.29 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 127.591 2.357 . . . . 0.0 110.237 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -164.69 153.54 12.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 128.078 2.551 . . . . 0.0 110.185 -173.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.518 ' CG2' HG21 ' A' ' 104' ' ' VAL . 0.9 OUTLIER -146.08 150.3 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.822 1.649 . . . . 0.0 109.953 175.45 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.51 123.85 51.0 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.614 1.166 . . . . 0.0 110.777 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -116.48 123.85 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.602 1.561 . . . . 0.0 110.778 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -135.67 112.05 0.95 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.854 1.216 . . . . 0.0 112.3 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 29.5 mt -109.18 111.09 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.635 1.174 . . . . 0.0 109.427 -177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.93 131.15 34.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.947 0.899 . . . . 0.0 113.228 -173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -82.51 93.16 7.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.552 0.741 . . . . 0.0 110.572 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.94 20.37 11.58 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.411 1.485 . . . . 0.0 112.278 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.1 t -85.56 -40.94 15.73 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.815 1.646 . . . . 0.0 114.748 -178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.25 12.48 10.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.665 1.026 . . . . 0.0 115.665 -173.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.99 161.14 29.46 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.336 1.568 . . . . 0.0 115.05 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t -76.99 127.4 32.62 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.211 1.404 . . . . 0.0 112.122 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -102.86 162.12 13.19 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.322 1.449 . . . . 0.0 111.62 176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 30.8 m -133.46 115.89 15.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.844 1.257 . . . . 0.0 109.439 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . . . -65.18 137.16 57.44 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.005 -1.059 . . . . 0.0 110.355 175.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.27 -71.02 0.47 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -174.72 176.54 2.24 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.992 2.117 . . . . 0.0 110.563 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.409 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -124.95 154.69 40.77 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.953 2.101 . . . . 0.0 109.841 175.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.73 106.04 6.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.035 1.334 . . . . 0.0 110.564 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -74.85 105.02 5.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.791 1.237 . . . . 0.0 111.18 175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -78.37 -51.94 9.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.937 1.295 . . . . 0.0 111.692 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 68.7 m -137.27 155.88 48.94 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.901 2.081 . . . . 0.0 110.361 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 -173.64 52.06 Favored Glycine 0 CA--C 1.535 1.33 0 O-C-N 121.722 -0.611 . . . . 0.0 113.329 -174.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 t -134.88 176.32 8.76 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.641 1.176 . . . . 0.0 110.316 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.5 p -150.5 178.12 9.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.525 1.53 . . . . 0.0 110.479 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -139.3 18.15 2.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.179 1.391 . . . . 0.0 112.025 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' HB1' ' A' ' 3' ' ' ALA . 9.0 m -134.6 171.76 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 126.892 2.077 . . . . 0.0 110.809 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.1 mt -143.87 132.3 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.377 1.071 . . . . 0.0 109.463 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -75.55 150.17 84.33 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 118.587 0.63 . . . . 0.0 111.572 178.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.68 166.3 26.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.73 2.954 . . . . 0.0 109.928 175.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 58.3 tt0 -105.81 -30.01 9.67 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.312 -0.868 . . . . 0.0 111.572 174.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -117.26 127.81 54.45 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.547 1.139 . . . . 0.0 111.029 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.06 91.31 24.17 Favored Pre-proline 0 N--CA 1.467 0.417 0 C-N-CA 124.89 1.276 . . . . 0.0 108.911 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -63.19 162.79 25.24 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.34 2.027 . . . . 0.0 111.483 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -57.61 158.72 5.73 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.637 -0.664 . . . . 0.0 111.061 174.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p 72.5 -35.42 0.33 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.941 2.097 . . . . 0.0 114.211 -175.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -86.91 124.71 33.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.488 1.515 . . . . 0.0 111.326 175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.08 171.63 8.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.431 1.092 . . . . 0.0 109.493 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.84 163.26 13.97 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -128.53 133.27 48.38 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 126.248 1.819 . . . . 0.0 107.824 175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.8 167.22 24.42 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 110.438 174.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 90.2 p -156.52 160.41 39.49 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.57 0.7 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.13 127.41 3.24 Favored Glycine 0 N--CA 1.462 0.415 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.32 167.16 15.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 118.223 1.012 . . . . 0.0 110.082 178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.4 179.98 1.49 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.217 0.532 . . . . 0.0 109.886 175.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.88 -172.67 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 125.824 1.649 . . . . 0.0 111.357 175.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 87.1 m -25.94 -56.53 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 127.312 2.245 . . . . 0.0 115.238 -177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 154.43 -57.07 0.41 Allowed Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.596 1.093 . . . . 0.0 113.831 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.79 -2.34 11.76 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 124.621 3.548 . . . . 0.0 115.574 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.66 130.84 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 125.96 1.704 . . . . 0.0 110.792 -176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.68 88.6 5.44 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 120.567 -1.333 . . . . 0.0 111.959 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.4 m -122.83 -86.51 0.65 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.684 1.594 . . . . 0.0 111.522 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.41 -177.97 42.74 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 119.781 1.173 . . . . 0.0 112.938 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -138.52 108.65 6.4 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.063 0.945 . . . . 0.0 111.012 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -143.93 119.63 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.987 -172.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 102' ' ' PHE . . . -144.42 171.45 14.32 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.995 0.902 . . . . 0.0 111.587 175.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.39 161.09 40.15 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.312 1.045 . . . . 0.0 111.716 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.38 175.76 11.54 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.711 1.605 . . . . 0.0 110.415 177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -133.95 140.87 47.04 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.833 1.253 . . . . 0.0 110.602 176.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -123.89 113.53 18.62 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.58 1.152 . . . . 0.0 111.356 -179.144 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -72.39 118.71 15.62 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.765 1.626 . . . . 0.0 110.691 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 7.7 mtt -73.06 163.53 28.02 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.849 1.26 . . . . 0.0 112.181 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 p -62.52 -21.03 65.22 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.76 1.224 . . . . 0.0 113.884 175.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.71 -16.22 39.71 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.76 1.624 . . . . 0.0 113.515 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.38 2.12 47.51 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.192 1.377 . . . . 0.0 115.647 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -86.23 173.53 9.71 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.738 1.215 . . . . 0.0 110.421 174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.443 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 26.1 m -136.04 143.22 44.58 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 110.144 175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.15 115.76 30.71 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.56 135.12 15.13 Favored Glycine 0 N--CA 1.463 0.495 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 117' ' ' VAL . 6.0 m -137.2 126.85 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 118.049 0.925 . . . . 0.0 109.704 177.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.3 153.65 51.1 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.717 0.807 . . . . 0.0 110.673 175.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 86' ' ' ALA . 13.4 p90 -135.01 154.55 51.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.672 0.749 . . . . 0.0 111.991 175.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.3 m -137.08 109.55 7.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 110.773 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.518 HG21 ' CG2' ' A' ' 31' ' ' ILE . 58.4 t -110.7 106.17 57.58 Favored Pre-proline 0 C--O 1.238 0.486 0 C-N-CA 124.527 1.131 . . . . 0.0 110.257 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -74.18 161.81 39.99 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.944 2.429 . . . . 0.0 112.007 174.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.0 -28.23 64.27 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.783 0.833 . . . . 0.0 112.807 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.36 120.86 41.21 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.471 1.508 . . . . 0.0 110.955 -170.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -73.93 -63.91 1.12 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -86.81 9.23 19.71 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.884 -1.135 . . . . 0.0 114.031 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.08 -5.62 6.73 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.259 2.224 . . . . 0.0 112.225 -174.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -160.39 138.75 10.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.678 1.991 . . . . 0.0 109.583 -177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -103.27 159.56 15.45 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.07 -1.019 . . . . 0.0 110.031 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -80.23 161.69 25.03 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.866 -0.521 . . . . 0.0 109.738 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 5.3 m95 -139.51 143.53 37.5 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.708 0.803 . . . . 0.0 110.804 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -155.06 149.77 26.53 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.658 1.583 . . . . 0.0 110.239 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -149.01 154.72 39.75 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.993 1.717 . . . . 0.0 107.675 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 100' ' ' VAL . 66.7 t -147.37 116.96 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 126.87 2.068 . . . . 0.0 109.416 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -123.39 148.15 46.38 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.542 1.537 . . . . 0.0 110.096 176.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 6.8 mt -110.97 112.57 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.79 2.036 . . . . 0.0 108.821 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -127.39 136.39 51.8 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 112.2 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.1 p -76.67 81.68 3.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.324 1.45 . . . . 0.0 112.58 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.35 178.6 45.31 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.27 0.938 . . . . 0.0 113.645 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -111.78 104.99 13.36 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.497 1.919 . . . . 0.0 110.885 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -145.81 158.14 43.88 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.918 1.287 . . . . 0.0 111.228 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.25 163.97 29.17 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.125 1.37 . . . . 0.0 112.527 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -72.57 79.07 1.07 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.633 1.173 . . . . 0.0 112.31 -175.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -104.21 -67.37 0.9 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.057 1.343 . . . . 0.0 109.576 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -149.3 -72.56 0.18 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.368 1.867 . . . . 0.0 108.801 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -63.21 -21.9 64.59 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.94 1.257 . . . . 0.0 114.732 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.3 ttp -83.85 -57.83 3.05 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.288 1.044 . . . . 0.0 110.409 174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -48.85 -49.83 37.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.083 1.353 . . . . 0.0 111.638 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -62.36 -32.25 73.01 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -68.01 -13.55 62.28 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.155 -0.965 . . . . 0.0 113.12 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -99.01 -47.96 5.05 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.445 1.498 . . . . 0.0 109.456 174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -66.06 -61.51 2.0 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 120.637 -1.29 . . . . 0.0 112.35 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -79.58 -19.89 48.3 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.681 1.192 . . . . 0.0 111.658 -174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.39 -80.91 0.07 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.334 1.445 . . . . 0.0 112.828 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.36 86.29 0.89 Allowed Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 125.318 1.447 . . . . 0.0 110.529 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.62 160.2 50.23 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.696 1.597 . . . . 0.0 111.709 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.94 1.01 39.37 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.52 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 33.87 60.03 0.54 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 127.796 2.438 . . . . 0.0 114.25 176.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -20.23 82.4 0.0 OUTLIER Glycine 0 N--CA 1.472 1.083 0 C-N-CA 129.409 3.385 . . . . 0.0 116.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.0 35.41 0.98 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.424 1.49 . . . . 0.0 112.052 -172.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 68.25 26.36 6.96 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.59 1.556 . . . . 0.0 112.245 -175.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.89 146.01 18.0 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.552 1.549 . . . . 0.0 113.3 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -65.97 138.15 57.62 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.543 1.537 . . . . 0.0 111.858 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.67 118.04 18.63 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.041 1.736 . . . . 0.0 110.641 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.97 145.64 32.38 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.296 1.438 . . . . 0.0 110.903 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -146.31 121.83 10.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.248 1.419 . . . . 0.0 110.549 175.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.09 91.22 0.35 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.682 1.593 . . . . 0.0 113.358 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.96 4.5 1.88 Allowed 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.32 22.57 31.83 Favored Glycine 0 CA--C 1.534 1.265 0 O-C-N 120.578 -1.326 . . . . 0.0 115.881 -173.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.52 7.69 2.53 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.597 1.959 . . . . 0.0 115.39 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 169.38 -36.71 0.19 Allowed Glycine 0 CA--C 1.532 1.097 0 O-C-N 120.764 -1.21 . . . . 0.0 114.365 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.0 mp -129.48 147.64 51.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.02 1.328 . . . . 0.0 110.681 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -128.4 173.94 9.76 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.122 1.369 . . . . 0.0 111.956 175.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.17 139.96 38.48 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.69 1.596 . . . . 0.0 109.56 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -131.76 107.75 8.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.567 1.547 . . . . 0.0 108.086 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -127.9 171.57 19.17 Favored Glycine 0 CA--C 1.517 0.217 0 CA-C-O 121.382 0.434 . . . . 0.0 113.477 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.7 143.83 23.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 124.506 1.122 . . . . 0.0 109.215 176.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.9 ttm -144.17 140.16 29.2 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.882 1.673 . . . . 0.0 109.014 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.19 157.72 27.8 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.505 2.322 . . . . 0.0 111.562 175.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.83 5.91 26.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.309 -1.494 . . . . 0.0 114.801 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -104.43 177.53 4.82 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.703 2.001 . . . . 0.0 112.77 -173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -57.67 -67.87 1.99 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.368 0.985 . . . . 0.0 112.269 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 2.9 pt-20 -74.85 39.52 0.13 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.536 1.934 . . . . 0.0 115.223 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.03 138.94 58.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.378 1.071 . . . . 0.0 112.861 177.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -91.28 124.35 35.42 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.302 1.441 . . . . 0.0 109.2 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 17.7 mtp -117.87 107.15 13.76 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.863 1.665 . . . . 0.0 109.971 -177.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -114.96 151.4 34.17 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.521 -0.737 . . . . 0.0 111.358 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.8 96.62 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.733 1.613 . . . . 0.0 110.912 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.2 mmtp -84.81 107.86 17.19 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.864 1.666 . . . . 0.0 109.919 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 38.3 mm -84.51 117.43 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.401 -0.812 . . . . 0.0 110.089 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 m -141.9 169.95 16.63 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.471 1.509 . . . . 0.0 113.195 -176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.355 1.862 . . . . 0.0 111.526 -178.047 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.402 HD11 HG21 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -107.36 -2.98 20.08 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.589 1.556 . . . . 0.0 112.704 177.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 20' ' ' VAL . . . -71.45 156.38 39.52 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.696 -1.252 . . . . 0.0 111.484 174.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.06 36.87 90.41 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 115.655 1.022 . . . . 0.0 115.655 177.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.2 p -146.33 -168.52 3.03 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.494 1.147 . . . . 0.0 111.923 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 pt -127.39 149.14 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.671 1.588 . . . . 0.0 111.29 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 2' ' ' LEU . 1.6 pt -151.25 169.6 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.343 1.857 . . . . 0.0 112.577 174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.44 124.81 17.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.892 1.677 . . . . 0.0 111.755 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.2 -21.9 48.38 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.284 0.945 . . . . 0.0 113.976 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.99 82.72 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.916 1.286 . . . . 0.0 112.49 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.94 -30.92 35.19 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.832 0.853 . . . . 0.0 112.385 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.61 HD22 ' CB ' ' A' ' 68' ' ' ALA . 7.8 tp -59.66 90.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.625 1.97 . . . . 0.0 113.635 -176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -146.73 169.29 19.35 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.799 1.64 . . . . 0.0 109.368 -175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 17' ' ' LEU . 2.6 m-85 -43.98 -37.46 2.96 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.018 1.727 . . . . 0.0 114.735 177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -58.2 -39.24 78.48 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.1 t -72.38 -42.05 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.861 1.665 . . . . 0.0 110.74 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.465 HD13 ' HB3' ' A' ' 168' ' ' LYS . 67.1 mt -53.79 -47.73 70.5 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.304 1.041 . . . . 0.0 111.386 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.16 -42.55 96.71 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.979 0.912 . . . . 0.0 111.437 174.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -58.79 -39.28 80.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.177 1.391 . . . . 0.0 113.668 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 3' ' ' ALA . 54.2 t -62.8 -55.37 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.548 1.539 . . . . 0.0 109.867 175.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' A' ' 32' ' ' ALA . 3.3 mp -55.68 -45.9 77.7 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.295 1.038 . . . . 0.0 112.49 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.15 -38.04 81.69 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -76.05 -43.9 41.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.509 1.124 . . . . 0.0 113.058 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 tt -52.71 -53.87 41.58 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.502 1.521 . . . . 0.0 111.173 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.13 63.02 0.11 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.356 0.979 . . . . 0.0 112.516 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -42.89 127.95 4.16 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 110.653 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.79 -165.46 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.353 1.861 . . . . 0.0 110.212 -178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -48.99 -45.46 42.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.647 1.579 . . . . 0.0 114.358 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -139.3 129.7 25.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.469 1.907 . . . . 0.0 109.569 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.43 155.54 15.36 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.112 2.165 . . . . 0.0 110.049 -177.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 102' ' ' PHE . 6.2 pt -137.17 162.49 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.173 0.989 . . . . 0.0 111.46 175.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.561 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -110.93 116.22 30.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.835 1.254 . . . . 0.0 109.529 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.6 t -106.63 142.95 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.709 1.203 . . . . 0.0 110.86 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.28 122.55 1.13 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.314 0.959 . . . . 0.0 111.953 175.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.0 mt -113.04 102.7 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.151 1.38 . . . . 0.0 108.654 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -83.61 111.81 19.45 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.72 0.808 . . . . 0.0 112.231 -178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -71.69 99.76 2.19 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.793 1.237 . . . . 0.0 111.117 174.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -116.68 14.31 15.34 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 126.26 1.824 . . . . 0.0 113.281 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.4 t -70.09 -45.59 66.67 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.93 8.08 5.29 Favored Glycine 0 CA--C 1.54 1.628 0 C-N-CA 125.234 1.397 . . . . 0.0 116.058 -176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.67 160.47 29.02 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 119.578 1.689 . . . . 0.0 113.634 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.9 p -73.96 138.87 44.47 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 121.722 -0.869 . . . . 0.0 112.185 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -112.84 167.05 10.81 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.777 1.231 . . . . 0.0 112.006 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.5 m -131.92 105.78 7.65 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.269 1.428 . . . . 0.0 110.128 -177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.5 122.68 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.21 -66.17 0.58 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.236 1.014 . . . . 0.0 110.262 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -179.34 163.21 1.23 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.211 2.604 . . . . 0.0 110.155 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB1' ' CD1' ' A' ' 88' ' ' PHE . . . -108.77 123.91 49.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.349 1.86 . . . . 0.0 110.4 175.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.95 111.71 19.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.301 1.041 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.26 124.34 26.91 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.993 1.317 . . . . 0.0 111.993 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -91.73 -47.63 7.26 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.093 1.357 . . . . 0.0 112.241 176.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -135.37 149.17 49.62 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.537 1.935 . . . . 0.0 109.951 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.06 -157.5 50.18 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.891 -0.506 . . . . 0.0 113.09 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -152.86 -176.71 5.87 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.521 0.676 . . . . 0.0 112.2 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -141.97 173.95 11.04 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.183 1.793 . . . . 0.0 111.367 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -121.51 12.79 10.85 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.927 1.291 . . . . 0.0 112.229 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.31 176.09 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 127.047 2.139 . . . . 0.0 113.628 -171.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.95 135.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.53 1.932 . . . . 0.0 109.776 -172.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.01 142.48 41.66 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 118.765 0.711 . . . . 0.0 110.606 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.81 164.86 22.85 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.95 3.1 . . . . 0.0 111.117 175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -107.55 -17.61 14.06 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.502 -0.749 . . . . 0.0 112.716 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.64 133.97 53.84 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.956 1.702 . . . . 0.0 111.097 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.7 t -135.88 88.04 23.69 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 125.896 1.678 . . . . 0.0 108.868 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.42 161.13 32.38 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.919 1.746 . . . . 0.0 112.06 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.44 153.66 34.63 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.407 -0.808 . . . . 0.0 111.448 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 p 66.23 5.04 3.41 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.692 1.997 . . . . 0.0 114.267 -173.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -123.39 147.81 46.72 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.621 2.368 . . . . 0.0 110.108 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.61 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -126.57 160.44 30.63 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.647 1.179 . . . . 0.0 111.354 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.16 170.75 8.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.408 0.623 . . . . 0.0 110.335 175.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 20' ' ' VAL . 3.3 mm? -126.44 133.89 51.11 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.334 1.854 . . . . 0.0 108.877 175.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -152.82 162.44 41.28 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.191 1.397 . . . . 0.0 111.536 174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 m -142.37 166.6 24.24 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.769 1.228 . . . . 0.0 110.972 176.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.75 115.24 0.77 Allowed Glycine 0 N--CA 1.472 1.092 0 CA-C-O 118.291 -1.283 . . . . 0.0 112.769 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 156.22 20.92 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.18 1.49 . . . . 0.0 114.378 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.568 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 0.3 OUTLIER -72.88 110.64 7.34 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 40.78 -151.19 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.69 1.596 . . . . 0.0 113.664 174.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.6 m -74.14 -49.57 23.17 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 119.958 -1.714 . . . . 0.0 111.286 174.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.91 -59.27 0.37 Allowed Glycine 0 CA--C 1.541 1.717 0 C-N-CA 124.665 1.126 . . . . 0.0 114.394 -170.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.33 0.15 7.22 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.699 3.599 . . . . 0.0 114.984 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.1 m -124.32 132.48 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 127.599 2.36 . . . . 0.0 109.364 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.82 71.84 0.81 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.034 1.333 . . . . 0.0 110.516 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.9 m -97.27 -65.03 0.99 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.01 0.924 . . . . 0.0 110.895 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.61 176.41 35.52 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.988 1.28 . . . . 0.0 111.712 -178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -138.69 108.34 6.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.065 0.946 . . . . 0.0 110.479 175.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.36 138.9 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 123.96 0.904 . . . . 0.0 109.585 -177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -158.11 161.98 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 123.967 0.907 . . . . 0.0 110.779 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.28 138.43 20.29 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.786 0.803 . . . . 0.0 112.976 176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' CD1' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -132.57 169.0 17.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.795 1.638 . . . . 0.0 109.446 -172.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.98 148.96 47.23 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -134.42 104.57 6.18 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.868 1.267 . . . . 0.0 111.796 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -73.54 111.82 9.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.084 1.354 . . . . 0.0 111.639 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.87 160.41 30.72 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.326 1.051 . . . . 0.0 112.317 174.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.0 p -60.99 -20.08 62.0 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 m -84.78 -16.09 42.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.524 1.93 . . . . 0.0 113.84 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.52 4.95 46.13 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.39 0.995 . . . . 0.0 115.565 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -92.51 165.31 13.08 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.449 1.5 . . . . 0.0 108.757 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.3 t -136.32 151.11 49.25 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.18 -0.95 . . . . 0.0 109.566 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.38 130.55 56.57 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.278 0.631 . . . . 0.0 110.354 174.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.21 138.74 18.29 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 89.5 t -136.02 118.0 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 124.354 1.062 . . . . 0.0 108.816 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.7 ptm -121.46 156.89 31.8 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 174.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.423 ' CD2' HD13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -124.39 141.03 52.4 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.104 1.362 . . . . 0.0 108.852 174.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -130.63 104.37 7.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.907 0.883 . . . . 0.0 110.75 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.2 t -115.61 101.57 54.21 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.007 2.123 . . . . 0.0 109.119 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.39 168.07 24.53 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.273 1.982 . . . . 0.0 110.454 174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -75.37 -41.33 56.69 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.707 -0.621 . . . . 0.0 110.32 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -88.35 121.86 31.22 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.637 1.175 . . . . 0.0 111.954 -166.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -72.83 -59.83 2.52 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -91.29 9.44 31.4 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -4.37 5.95 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.023 2.129 . . . . 0.0 112.538 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.71 158.34 36.76 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.791 2.436 . . . . 0.0 109.111 178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.24 169.36 10.64 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 120.826 -1.171 . . . . 0.0 111.602 175.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.26 148.36 25.14 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.752 -0.592 . . . . 0.0 110.445 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.51 157.63 44.14 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.035 0.534 . . . . 0.0 112.351 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -161.67 136.83 7.4 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.411 1.484 . . . . 0.0 110.396 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -124.76 147.51 48.62 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.217 -0.927 . . . . 0.0 110.117 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.28 118.3 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.099 1.36 . . . . 0.0 110.623 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.23 138.23 53.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.1 1.76 . . . . 0.0 109.452 174.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.4 mt -109.37 119.66 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.178 1.791 . . . . 0.0 108.543 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.44 147.61 52.57 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 0.0 112.555 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 12.6 p -74.0 80.97 1.7 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.652 1.981 . . . . 0.0 112.27 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.29 -166.8 37.92 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.705 -0.622 . . . . 0.0 114.393 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -113.18 115.87 28.93 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.384 1.874 . . . . 0.0 111.361 175.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -134.09 83.76 2.06 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.043 2.537 . . . . 0.0 108.46 -177.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.49 168.36 5.94 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.657 1.183 . . . . 0.0 110.95 177.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -108.19 99.04 8.5 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.136 0.974 . . . . 0.0 111.15 176.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -106.67 -70.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.112 0.965 . . . . 0.0 110.706 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -150.0 -68.81 0.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.167 1.787 . . . . 0.0 109.811 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.39 -24.26 77.11 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.386 0.993 . . . . 0.0 114.893 -173.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -76.33 -56.63 4.46 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.266 1.033 . . . . 0.0 109.82 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -54.73 -35.51 63.79 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.859 0.864 . . . . 0.0 111.429 175.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.06 -34.0 54.52 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -61.43 -41.26 96.9 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.903 0.881 . . . . 0.0 111.093 175.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 mp -70.79 -38.0 73.33 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 120.858 -1.152 . . . . 0.0 111.715 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -74.06 -51.73 14.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 9.9 m-30 -88.0 -17.89 30.22 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 113.079 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.87 -80.24 0.08 OUTLIER Glycine 0 N--CA 1.471 0.999 0 C-N-CA 124.711 1.148 . . . . 0.0 112.066 -177.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -170.15 74.78 0.63 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.74 1.616 . . . . 0.0 110.968 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.19 135.37 31.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 119.918 1.006 . . . . 0.0 109.788 175.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -60.19 156.86 14.41 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.743 1.217 . . . . 0.0 110.439 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -93.36 5.01 53.01 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -165.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 53.95 55.61 24.98 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.559 1.076 . . . . 0.0 112.654 -172.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.33 24.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.571 1.548 . . . . 0.0 114.901 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.252 10.1 p30 48.31 34.45 4.6 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.665 2.386 . . . . 0.0 115.021 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -141.38 159.62 26.75 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.912 1.72 . . . . 0.0 112.058 174.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -61.78 127.37 31.12 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 110.934 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -122.91 105.67 10.2 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.144 1.778 . . . . 0.0 109.637 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -138.38 137.12 36.99 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.579 1.952 . . . . 0.0 110.89 177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 33.1 mmtt -147.8 133.44 18.83 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.264 1.426 . . . . 0.0 110.964 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -58.9 123.96 18.24 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.995 0.518 . . . . 0.0 111.347 175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.6 tt -147.6 -34.29 0.25 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.182 0.993 . . . . 0.0 112.342 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.71 19.7 5.94 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.182 1.372 . . . . 0.0 114.748 177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 3.3 t80 60.06 9.27 1.75 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.799 2.44 . . . . 0.0 114.966 -175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -173.74 -71.38 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.403 1.478 . . . . 0.0 110.74 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.9 mp -89.53 151.43 21.96 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.949 0.88 . . . . 0.0 111.419 174.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.55 171.32 14.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.72 1.608 . . . . 0.0 111.527 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.5 ppp? -87.15 147.09 25.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.512 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -137.07 103.39 5.12 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.894 2.078 . . . . 0.0 108.506 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -133.02 169.43 22.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-O 121.593 0.552 . . . . 0.0 112.884 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.61 141.06 25.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 125.905 1.682 . . . . 0.0 108.769 175.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 11.4 ttt -144.35 140.48 29.11 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.4 171.94 14.35 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.098 0.959 . . . . 0.0 111.553 175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 96.0 p -93.67 7.71 43.71 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.52 1.528 . . . . 0.0 113.923 176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -111.22 165.22 12.1 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.635 1.974 . . . . 0.0 112.063 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.87 -55.29 29.22 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.209 0.909 . . . . 0.0 113.784 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.09 59.39 2.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.471 1.508 . . . . 0.0 113.251 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -100.06 171.81 7.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.905 1.282 . . . . 0.0 112.859 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.465 ' HB3' HD13 ' A' ' 17' ' ' LEU . 10.0 mptt -120.71 141.61 50.28 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.358 1.463 . . . . 0.0 108.421 174.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 27.8 ttp -133.88 83.7 2.06 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.076 1.35 . . . . 0.0 111.014 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -85.39 158.17 20.31 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.452 0.644 . . . . 0.0 111.524 170.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.94 122.02 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 126.866 2.067 . . . . 0.0 108.419 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -113.39 103.81 11.67 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 127.571 2.348 . . . . 0.0 108.941 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 32.3 mm -85.36 119.88 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 O-C-N 121.437 -0.79 . . . . 0.0 110.802 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 p -152.13 169.27 22.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.376 1.07 . . . . 0.0 112.956 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.729 2.411 . . . . 0.0 112.934 176.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 119.979 -0.058 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.92 -23.23 7.56 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.11 1.364 . . . . 0.0 113.058 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.497 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -58.0 150.93 19.57 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 120.82 -1.175 . . . . 0.0 111.683 176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 70.28 49.13 34.32 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 123.425 0.535 . . . . 0.0 113.687 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.5 p -146.78 -166.38 2.48 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 118.193 0.997 . . . . 0.0 112.115 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 pp -128.02 132.26 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 127.68 2.392 . . . . 0.0 110.74 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.0 pt -142.46 170.19 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.461 1.504 . . . . 0.0 111.777 177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 111.19 1.02 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.484 1.114 . . . . 0.0 112.185 175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.25 -24.33 67.23 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.424 1.011 . . . . 0.0 113.363 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.9 -34.61 78.52 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.786 1.234 . . . . 0.0 111.983 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.5 -24.83 22.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.82 1.248 . . . . 0.0 113.196 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.6 tp -59.23 110.36 1.05 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.266 1.426 . . . . 0.0 111.534 174.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.6 m -146.78 168.16 22.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.654 1.582 . . . . 0.0 109.669 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -45.27 -43.7 10.75 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.23 1.812 . . . . 0.0 113.814 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -58.01 -35.8 71.77 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.3 t -73.63 -46.05 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.494 1.518 . . . . 0.0 109.859 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.5 mt -54.48 -44.88 73.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.84 0.856 . . . . 0.0 113.008 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.17 -39.09 88.81 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 122.714 0.406 . . . . 0.0 111.927 175.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.85 -50.21 74.66 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.013 1.325 . . . . 0.0 111.622 174.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG11 HD12 ' A' ' 70' ' ' LEU . 74.8 t -53.51 -50.04 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.766 1.226 . . . . 0.0 111.994 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 32' ' ' ALA . 5.7 mp -60.11 -41.87 93.53 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.212 1.005 . . . . 0.0 112.359 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.84 -43.68 90.78 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.538 0.735 . . . . 0.0 110.781 174.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.38 -31.01 62.21 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.163 1.785 . . . . 0.0 114.271 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.3 tp -66.81 -51.48 55.23 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.697 1.199 . . . . 0.0 110.014 174.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 122.25 54.62 0.21 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.103 1.335 . . . . 0.0 111.991 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -43.54 129.1 5.26 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.713 1.605 . . . . 0.0 112.817 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.66 -164.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.183 1.393 . . . . 0.0 112.144 -177.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.0 t -42.43 -33.02 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.993 2.517 . . . . 0.0 113.958 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -153.31 137.89 16.86 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.599 1.96 . . . . 0.0 109.804 174.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.45 155.69 20.2 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.688 2.395 . . . . 0.0 110.416 -177.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -135.49 152.95 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.531 1.132 . . . . 0.0 109.509 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 21' ' ' LEU . . . -111.06 122.75 48.7 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.171 0.988 . . . . 0.0 108.365 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 t -116.0 135.47 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 124.593 1.157 . . . . 0.0 110.803 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.33 129.55 3.39 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.177 0.894 . . . . 0.0 111.82 174.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.9 mm -117.87 103.33 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.046 0.938 . . . . 0.0 109.742 -176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.96 122.45 27.8 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.899 1.28 . . . . 0.0 113.304 -176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -75.88 96.21 3.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.437 1.895 . . . . 0.0 112.02 175.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -123.83 30.81 6.05 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.94 1.296 . . . . 0.0 112.137 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.7 t -91.96 -48.12 6.93 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.916 1.687 . . . . 0.0 114.142 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.07 17.73 4.02 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.288 0.947 . . . . 0.0 115.453 -174.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.22 159.92 31.62 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-N 119.039 1.42 . . . . 0.0 114.125 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 t -70.51 135.83 48.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.079 0.952 . . . . 0.0 111.858 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -109.95 168.43 9.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.449 1.5 . . . . 0.0 111.382 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.3 m -134.61 107.14 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.137 1.375 . . . . 0.0 109.108 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.64 124.96 24.3 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.911 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.89 -64.87 0.78 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.307 0.643 . . . . 0.0 109.966 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.63 172.24 0.59 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.825 2.45 . . . . 0.0 110.736 -178.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -129.95 135.84 48.78 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.446 2.298 . . . . 0.0 110.105 175.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -124.3 114.83 20.08 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.348 1.059 . . . . 0.0 111.361 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -72.0 106.95 4.47 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.485 1.514 . . . . 0.0 112.357 174.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -50.02 44.89 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.131 1.773 . . . . 0.0 110.71 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -136.0 155.95 49.48 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.518 1.527 . . . . 0.0 111.988 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.75 -156.51 39.85 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 123.042 0.353 . . . . 0.0 113.395 -172.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.1 t -154.21 -176.17 5.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 110.534 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' HA2' ' A' ' 73' ' ' GLY . 17.2 p -139.37 -179.31 5.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.49 1.516 . . . . 0.0 111.384 174.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.63 12.87 13.24 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.639 1.176 . . . . 0.0 111.586 174.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.497 HG11 ' HB3' ' A' ' 3' ' ' ALA . 3.0 m -132.13 175.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 126.154 1.781 . . . . 0.0 113.151 -170.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.73 134.86 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.392 1.477 . . . . 0.0 110.091 -173.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.44 141.12 56.51 Favored Pre-proline 0 CA--C 1.552 1.054 0 O-C-N 121.256 -0.902 . . . . 0.0 110.601 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.84 163.68 32.51 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 124.045 3.163 . . . . 0.0 111.091 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -104.83 -21.22 13.37 Favored 'General case' 0 N--CA 1.481 1.078 0 O-C-N 120.816 -1.178 . . . . 0.0 112.945 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -126.51 137.14 53.34 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.127 1.371 . . . . 0.0 110.155 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.54 97.99 7.31 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 125.125 1.37 . . . . 0.0 110.257 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -64.57 162.12 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.054 1.836 . . . . 0.0 111.682 177.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -56.88 154.3 9.59 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.615 -0.678 . . . . 0.0 111.584 175.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m 72.03 -23.55 0.19 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.978 1.711 . . . . 0.0 113.83 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -95.89 126.87 41.44 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.707 1.603 . . . . 0.0 110.714 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.41 171.94 8.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.417 1.087 . . . . 0.0 110.009 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -110.24 169.07 8.97 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.473 HD12 HG11 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -125.47 133.47 52.41 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.516 1.527 . . . . 0.0 110.505 175.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.96 166.73 27.74 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.129 0.971 . . . . 0.0 111.09 175.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 p -160.46 170.22 21.4 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.53 1.132 . . . . 0.0 110.635 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.496 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -151.71 137.27 5.89 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.981 -1.455 . . . . 0.0 111.664 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.55 161.42 30.53 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 119.123 1.462 . . . . 0.0 112.529 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -70.7 113.03 7.39 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t0 32.31 -136.8 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.565 2.346 . . . . 0.0 114.138 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -61.64 -46.18 90.89 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 120.5 -1.375 . . . . 0.0 111.053 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.57 -58.58 0.45 Allowed Glycine 0 CA--C 1.537 1.465 0 CA-C-O 119.025 -0.875 . . . . 0.0 115.079 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -71.77 8.08 1.41 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 C-N-CA 125.207 3.938 . . . . 0.0 115.44 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.84 132.92 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.001 2.52 . . . . 0.0 110.561 -170.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.63 88.45 3.07 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.544 -173.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 83' ' ' GLY . 0.7 OUTLIER -114.77 -84.69 0.61 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.164 1.786 . . . . 0.0 110.866 178.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 82' ' ' THR . . . 172.61 173.68 39.33 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 127.262 2.363 . . . . 0.0 110.802 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -137.63 109.41 7.1 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.584 1.154 . . . . 0.0 109.442 174.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.2 t -140.49 126.71 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 O-C-N 120.789 -1.194 . . . . 0.0 108.259 -175.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -154.35 169.01 24.71 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.78 157.78 43.9 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.17 0.988 . . . . 0.0 111.603 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.17 169.9 20.21 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.895 1.678 . . . . 0.0 110.657 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.98 146.67 41.21 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.048 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -127.78 115.82 19.24 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.906 1.283 . . . . 0.0 111.525 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -81.08 112.61 18.62 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.194 1.398 . . . . 0.0 111.0 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.8 mtp -74.01 158.06 35.02 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.963 0.905 . . . . 0.0 111.414 176.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.0 t -62.35 -18.85 62.53 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.7 m -80.23 -15.34 57.21 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 113.739 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.83 -0.26 55.2 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 124.668 1.128 . . . . 0.0 115.194 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -85.62 166.7 16.0 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.194 0.998 . . . . 0.0 110.384 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.4 m -137.08 153.53 50.54 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.059 0.944 . . . . 0.0 110.73 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.62 134.14 53.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.307 1.043 . . . . 0.0 108.991 174.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.82 125.63 8.48 Favored Glycine 0 CA--C 1.519 0.297 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.593 HG12 HG13 ' A' ' 117' ' ' VAL . 2.6 m -126.76 137.29 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 117.537 0.668 . . . . 0.0 110.488 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.31 161.31 35.77 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.437 0.695 . . . . 0.0 111.648 175.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.04 142.54 47.63 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.983 1.313 . . . . 0.0 109.516 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.6 m -127.16 114.25 17.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.757 1.623 . . . . 0.0 109.086 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.0 t -120.85 92.61 48.35 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.478 1.511 . . . . 0.0 108.931 -177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -76.29 167.97 24.79 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 123.165 2.576 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.42 -23.69 37.38 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.626 -0.671 . . . . 0.0 112.437 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.54 111.93 24.81 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 120.327 -1.483 . . . . 0.0 112.392 -165.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -71.21 -51.81 22.62 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -95.39 12.34 29.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.51 1.124 . . . . 0.0 113.575 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.14 -11.0 3.72 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.491 1.917 . . . . 0.0 112.716 -174.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -151.32 175.92 11.75 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 128.722 2.809 . . . . 0.0 109.112 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m -145.86 164.86 30.63 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.492 -1.38 . . . . 0.0 111.167 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.04 138.16 34.91 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.525 0.73 . . . . 0.0 110.276 179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -130.61 152.61 49.79 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.315 0.507 . . . . 0.0 112.063 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -159.32 146.76 17.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.423 1.889 . . . . 0.0 110.634 177.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -135.32 149.47 49.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.148 1.379 . . . . 0.0 110.154 175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG13 HG12 ' A' ' 100' ' ' VAL . 22.5 t -145.77 105.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.315 1.046 . . . . 0.0 111.481 177.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -117.42 134.03 55.3 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.111 1.364 . . . . 0.0 110.365 174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.4 mt -97.75 112.39 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.296 1.438 . . . . 0.0 109.355 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -115.17 147.83 39.79 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.873 1.669 . . . . 0.0 112.826 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.4 p -75.74 82.59 2.7 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.739 1.615 . . . . 0.0 112.881 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 159.81 -173.91 36.57 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.529 1.061 . . . . 0.0 113.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -112.4 130.82 55.84 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.471 1.509 . . . . 0.0 111.59 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -153.24 163.97 38.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.594 1.157 . . . . 0.0 112.2 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 -139.36 148.87 43.47 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.603 1.561 . . . . 0.0 111.621 -171.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.99 90.69 0.64 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.245 1.018 . . . . 0.0 111.957 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -112.15 -68.57 0.92 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.517 1.527 . . . . 0.0 110.812 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -144.37 -76.19 0.23 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.533 1.933 . . . . 0.0 108.959 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.8 -28.54 73.51 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.381 0.991 . . . . 0.0 114.701 -174.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -57.46 5.13 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.086 0.943 . . . . 0.0 109.576 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -52.25 -40.87 62.27 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.921 1.289 . . . . 0.0 111.107 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -55.48 -43.28 75.42 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.641 -0.662 . . . . 0.0 112.734 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.08 -19.43 64.41 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.977 -1.077 . . . . 0.0 112.346 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.4 mt -91.37 -55.57 3.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.557 1.543 . . . . 0.0 111.435 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -74.82 -46.32 37.47 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.341 -0.85 . . . . 0.0 113.029 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.17 -17.47 30.84 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.232 -0.917 . . . . 0.0 111.121 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -83.76 52.5 4.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.357 0.979 . . . . 0.0 114.132 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 36.05 72.44 0.77 Allowed Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 127.623 2.369 . . . . 0.0 114.133 -172.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.24 140.14 57.76 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.936 1.757 . . . . 0.0 109.027 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.75 143.77 55.73 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.81 0.844 . . . . 0.0 109.528 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.53 12.88 21.5 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.831 1.252 . . . . 0.0 113.818 -166.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 58.32 57.68 18.54 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.204 0.907 . . . . 0.0 112.145 -172.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -72.57 33.96 0.07 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.802 1.241 . . . . 0.0 114.217 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 10.0 p30 45.97 34.24 1.91 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.833 2.853 . . . . 0.0 115.791 174.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -145.66 167.41 27.61 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.031 1.776 . . . . 0.0 112.262 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -69.96 123.48 21.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.417 0.687 . . . . 0.0 110.53 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 19.7 m-70 -119.71 116.75 26.59 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 126.082 1.753 . . . . 0.0 108.684 178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -149.09 131.69 15.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.989 1.316 . . . . 0.0 110.735 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -141.84 122.58 14.33 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.717 1.207 . . . . 0.0 110.72 -178.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -61.19 115.57 3.9 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.445 0.698 . . . . 0.0 111.486 175.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.48 -36.42 0.98 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.765 1.226 . . . . 0.0 112.309 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -77.73 22.49 2.78 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.118 1.342 . . . . 0.0 114.672 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 4.9 t80 58.01 10.74 1.25 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 128.245 2.618 . . . . 0.0 115.177 -176.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -178.86 -60.58 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.929 1.728 . . . . 0.0 110.178 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 mp -90.83 150.29 21.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 122.062 0.935 . . . . 0.0 112.479 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.65 163.1 35.18 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.413 1.885 . . . . 0.0 111.402 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.12 151.39 29.84 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.436 174.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -143.44 110.98 5.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.502 1.921 . . . . 0.0 108.262 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -154.04 168.7 32.47 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-O 121.642 0.579 . . . . 0.0 114.071 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.79 141.04 27.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 126.081 1.752 . . . . 0.0 109.311 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.7 ttt -144.84 142.41 29.91 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.25 1.82 . . . . 0.0 107.887 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.22 165.71 22.96 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.955 0.902 . . . . 0.0 111.042 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.93 14.97 12.35 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.609 1.164 . . . . 0.0 112.875 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.26 167.52 11.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.37 2.268 . . . . 0.0 111.661 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -61.92 -59.94 8.83 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 123.943 0.783 . . . . 0.0 114.492 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -76.4 40.85 0.23 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.443 1.497 . . . . 0.0 114.254 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.04 157.3 35.06 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.847 1.259 . . . . 0.0 112.702 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -103.11 140.49 37.26 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.449 1.5 . . . . 0.0 108.43 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 10.9 ttp -132.04 116.53 17.2 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.582 1.553 . . . . 0.0 109.461 -178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.34 138.8 43.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.233 -0.917 . . . . 0.0 109.622 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.7 106.76 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 125.208 1.403 . . . . 0.0 108.556 -174.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -94.81 105.34 17.26 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 126.966 2.106 . . . . 0.0 109.204 174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.27 124.97 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.4 m -128.28 177.1 7.18 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.571 1.148 . . . . 0.0 111.771 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.174 0 C-N-CA 128.261 2.625 . . . . 0.0 113.342 -176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 119.946 -0.073 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.97 -17.18 16.89 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.389 1.076 . . . . 0.0 113.284 -177.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB3' HG11 ' A' ' 57' ' ' VAL . . . -55.31 139.62 42.13 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.907 1.283 . . . . 0.0 111.985 178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.79 40.85 8.54 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.099 0.857 . . . . 0.0 114.278 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.0 p -146.38 -165.69 2.28 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 118.571 1.185 . . . . 0.0 111.945 -179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pt -124.98 143.86 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 126.365 1.866 . . . . 0.0 110.487 174.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -143.19 165.51 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.941 1.297 . . . . 0.0 112.248 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.15 119.37 6.72 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.799 1.24 . . . . 0.0 111.066 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.07 -18.73 42.36 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.195 0.902 . . . . 0.0 113.897 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.92 -38.05 76.13 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.953 1.301 . . . . 0.0 111.735 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.08 -31.33 27.38 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.843 1.257 . . . . 0.0 112.444 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.562 HD22 ' CB ' ' A' ' 68' ' ' ALA . 10.5 tp -50.02 100.48 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.61 1.964 . . . . 0.0 112.422 175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 m -145.79 164.78 30.81 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.216 1.406 . . . . 0.0 109.843 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -46.95 -40.24 13.93 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.443 1.497 . . . . 0.0 114.125 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -59.54 -47.31 86.02 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.166 0.586 . . . . 0.0 112.197 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 78.1 t -57.0 -48.66 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.804 0.841 . . . . 0.0 109.547 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mt -55.32 -47.04 76.23 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.629 0.771 . . . . 0.0 112.669 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.05 -42.97 88.8 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.686 -0.633 . . . . 0.0 112.366 175.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.15 -42.46 77.03 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.299 1.44 . . . . 0.0 112.917 175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' VAL . 89.1 t -51.77 -57.04 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.57 1.548 . . . . 0.0 109.721 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.501 HD23 ' HD2' ' A' ' 30' ' ' LYS . 5.0 mp -62.11 -38.22 88.07 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.618 1.567 . . . . 0.0 113.108 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -49.5 76.63 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.634 -0.666 . . . . 0.0 111.599 174.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -79.47 -15.83 57.1 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD11 HH12 ' A' ' 74' ' ' ARG . 27.7 tp -65.39 -53.72 39.17 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.816 2.046 . . . . 0.0 112.841 175.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.55 29.57 7.74 Favored Glycine 0 CA--C 1.54 1.64 0 N-CA-C 115.379 0.911 . . . . 0.0 115.379 -173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 174.82 0.14 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.928 2.091 . . . . 0.0 114.671 175.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG22 ' H ' ' A' ' 28' ' ' SER . 1.4 p -103.38 -168.51 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.487 1.915 . . . . 0.0 111.049 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 27' ' ' VAL . 66.1 m -49.59 -28.01 5.19 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.71 136.94 53.02 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.762 1.625 . . . . 0.0 109.601 175.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.501 ' HD2' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -171.43 146.19 2.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.867 2.067 . . . . 0.0 112.154 -167.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER -141.66 152.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.097 1.359 . . . . 0.0 110.167 175.001 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.61 114.4 24.04 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.278 1.031 . . . . 0.0 109.661 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.3 t -102.08 137.73 28.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 124.845 1.258 . . . . 0.0 110.38 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.66 114.59 0.71 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.048 0.832 . . . . 0.0 113.384 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 mm -107.72 106.26 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.47 1.108 . . . . 0.0 110.573 -175.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -89.3 104.65 17.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.846 1.658 . . . . 0.0 112.306 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -72.98 105.46 4.46 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.125 1.77 . . . . 0.0 111.333 175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.5 22.51 8.37 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.611 1.964 . . . . 0.0 112.606 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.6 t -84.8 -29.22 25.57 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.549 1.54 . . . . 0.0 114.679 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.64 20.4 8.14 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.047 1.784 . . . . 0.0 115.391 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -162.84 149.49 17.38 Favored Glycine 0 N--CA 1.476 1.331 0 CA-C-N 118.984 1.392 . . . . 0.0 114.408 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.1 t -66.36 141.12 58.08 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.169 0.988 . . . . 0.0 112.812 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -115.07 170.71 8.15 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.919 1.688 . . . . 0.0 111.499 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 46.5 m -135.39 110.2 8.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.194 1.398 . . . . 0.0 108.912 -177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.66 133.37 50.97 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.52 -1.362 . . . . 0.0 109.969 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.7 mt -71.11 -68.83 0.41 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.525 0.73 . . . . 0.0 109.791 -178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 179.92 174.79 0.84 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.677 2.391 . . . . 0.0 110.58 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' HB2' HD22 ' A' ' 59' ' ' LEU . . . -127.6 144.18 51.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.541 2.337 . . . . 0.0 108.797 175.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -130.19 110.97 11.98 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.546 1.139 . . . . 0.0 110.269 176.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.61 121.63 18.25 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.262 1.025 . . . . 0.0 111.165 175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.27 -41.42 8.67 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.964 1.306 . . . . 0.0 112.372 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.3 m -138.29 149.35 45.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.578 1.151 . . . . 0.0 110.685 177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.07 54.2 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 123.158 0.408 . . . . 0.0 113.163 -175.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 t -151.99 175.0 12.97 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.933 0.893 . . . . 0.0 111.196 175.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.556 HG22 ' HA2' ' A' ' 73' ' ' GLY . 23.7 p -140.45 177.11 8.24 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.236 1.414 . . . . 0.0 111.336 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -127.22 16.09 7.22 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.652 1.181 . . . . 0.0 112.684 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 3' ' ' ALA . 15.5 m -134.55 176.85 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 126.711 2.004 . . . . 0.0 112.745 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -145.25 137.07 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.484 1.914 . . . . 0.0 109.467 -173.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -77.3 154.76 82.11 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 119.902 1.228 . . . . 0.0 112.333 176.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.97 165.32 31.59 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 124.026 3.15 . . . . 0.0 109.58 174.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -106.87 -18.02 14.04 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -124.1 144.13 50.06 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.492 1.517 . . . . 0.0 110.161 174.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.51 92.66 5.49 Favored Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 124.88 1.272 . . . . 0.0 110.287 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -64.16 155.26 66.1 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.769 1.646 . . . . 0.0 111.362 177.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -58.3 155.16 12.09 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.094 -0.379 . . . . 0.0 111.095 175.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 m 74.4 -22.42 0.25 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.236 1.814 . . . . 0.0 113.027 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -99.47 146.38 26.42 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.925 1.69 . . . . 0.0 109.016 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.562 ' CB ' HD22 ' A' ' 12' ' ' LEU . . . -115.53 162.3 17.38 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.769 1.228 . . . . 0.0 111.934 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.7 167.78 10.56 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.071 0.462 . . . . 0.0 110.446 174.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.75 126.74 43.96 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.899 2.48 . . . . 0.0 108.652 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -144.37 151.22 38.99 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 123.823 0.849 . . . . 0.0 110.97 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.0 m -155.76 157.51 36.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.733 0.813 . . . . 0.0 110.883 -174.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.556 ' HA2' HG22 ' A' ' 55' ' ' THR . . . -150.4 166.66 30.15 Favored Glycine 0 N--CA 1.472 1.058 0 CA-C-O 118.46 -1.189 . . . . 0.0 113.199 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.458 HH12 HD11 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -139.85 158.01 44.79 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.86 1.33 . . . . 0.0 113.064 -174.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.498 ' HA ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 ptmm? -74.96 113.75 12.63 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 39.62 -147.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 125.646 1.578 . . . . 0.0 113.887 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.7 m -77.72 -47.73 18.38 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 120.496 -1.378 . . . . 0.0 111.334 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.85 -60.53 0.36 Allowed Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.819 -0.989 . . . . 0.0 114.455 -171.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.29 -2.51 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.612 3.541 . . . . 0.0 114.974 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.5 m -120.42 142.7 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 126.007 1.723 . . . . 0.0 108.705 176.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.94 69.15 1.19 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.667 1.187 . . . . 0.0 110.982 -172.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.4 m -96.65 -61.62 1.39 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.144 0.978 . . . . 0.0 111.335 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.88 172.15 31.0 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.737 1.16 . . . . 0.0 112.548 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.498 ' HB2' ' HA ' ' A' ' 75' ' ' LYS . . . -134.96 111.45 9.83 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.744 1.218 . . . . 0.0 110.364 175.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 t -146.57 135.82 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 123.655 0.782 . . . . 0.0 109.969 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -155.76 162.33 40.53 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.107 1.363 . . . . 0.0 110.594 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.67 150.51 40.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.406 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.12 171.66 13.97 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.247 1.819 . . . . 0.0 110.365 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB1' ' CG2' ' A' ' 97' ' ' THR . . . -139.72 152.0 46.31 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.971 177.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -128.18 117.14 21.03 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.67 1.188 . . . . 0.0 110.715 -176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -79.56 110.56 15.0 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.444 1.498 . . . . 0.0 110.872 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 73.8 mtm -78.77 160.07 27.59 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.263 0.625 . . . . 0.0 111.663 176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.8 p -60.75 -17.76 50.67 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 m -73.75 -14.53 61.14 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.591 1.956 . . . . 0.0 112.491 175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.52 7.46 72.09 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.689 1.138 . . . . 0.0 113.982 -175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -92.85 163.61 13.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.019 1.328 . . . . 0.0 109.736 174.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.428 ' CG2' ' HB1' ' A' ' 89' ' ' ALA . 54.1 m -125.19 152.74 44.1 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.121 0.968 . . . . 0.0 109.802 175.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.94 131.95 53.95 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.765 0.826 . . . . 0.0 109.904 175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.52 140.77 19.95 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.64 126.33 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.666 1.186 . . . . 0.0 109.283 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.86 157.21 45.61 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.142 0.577 . . . . 0.0 112.058 174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.79 139.42 53.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.143 1.377 . . . . 0.0 110.554 175.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 m -127.27 114.12 17.2 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.708 1.203 . . . . 0.0 109.76 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 84' ' ' ALA . 98.7 t -119.05 99.77 50.8 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.322 176.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.81 172.23 16.69 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.235 1.957 . . . . 0.0 110.102 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.99 -59.51 2.69 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.297 -0.877 . . . . 0.0 111.418 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.32 122.22 17.02 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.757 2.023 . . . . 0.0 112.489 -167.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -76.54 -52.25 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 121.184 -0.948 . . . . 0.0 113.209 -175.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -87.89 -4.51 58.84 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.95 1.3 . . . . 0.0 113.465 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.8 -4.13 7.06 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.883 2.073 . . . . 0.0 112.074 -164.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.43 167.58 29.55 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.741 2.816 . . . . 0.0 108.414 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.6 m -141.19 166.83 23.7 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.31 1.044 . . . . 0.0 111.038 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -81.78 157.17 24.59 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.377 -0.827 . . . . 0.0 110.514 175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -142.3 153.34 43.81 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.179 0.991 . . . . 0.0 110.587 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -152.16 159.8 43.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 125.564 1.546 . . . . 0.0 110.945 174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -156.31 150.46 25.33 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.275 1.83 . . . . 0.0 110.232 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 97.8 t -147.34 143.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 125.632 1.573 . . . . 0.0 110.354 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 40.1 tttt -149.04 146.55 27.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.168 1.787 . . . . 0.0 108.959 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 57.6 mt -111.17 118.41 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.999 1.72 . . . . 0.0 108.89 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -120.81 148.3 44.19 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.768 1.627 . . . . 0.0 112.827 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 6.4 p -77.7 80.96 4.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.568 1.547 . . . . 0.0 112.912 -178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.84 179.98 27.94 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 125.081 1.324 . . . . 0.0 112.958 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 126.23 36.64 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.835 1.654 . . . . 0.0 111.367 175.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -135.29 147.38 49.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.116 2.166 . . . . 0.0 108.538 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -115.24 179.93 3.82 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.435 1.494 . . . . 0.0 110.063 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -122.47 94.02 4.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.163 0.985 . . . . 0.0 110.093 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.84 -69.95 0.79 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.931 0.893 . . . . 0.0 109.429 -176.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -147.55 -69.4 0.24 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.984 1.314 . . . . 0.0 109.771 175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.97 -28.8 73.94 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.457 1.027 . . . . 0.0 115.319 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -53.72 10.61 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.327 1.063 . . . . 0.0 110.249 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -57.48 -38.77 75.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.529 1.132 . . . . 0.0 111.148 174.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -54.98 -44.29 74.31 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.42 -0.8 . . . . 0.0 111.288 175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -24.0 67.63 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.168 0.987 . . . . 0.0 113.128 177.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.09 -55.69 4.93 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -61.66 -48.25 81.67 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.998 1.319 . . . . 0.0 113.377 -176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -86.74 -11.72 50.27 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.7 0.8 . . . . 0.0 113.054 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.18 -71.69 0.69 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 124.104 0.859 . . . . 0.0 112.039 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.32 82.14 1.15 Allowed Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.604 1.561 . . . . 0.0 109.949 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.35 143.71 59.21 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.555 1.504 . . . . 0.0 110.885 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.442 ' HB3' ' CD2' ' A' ' 147' ' ' HIS . 38.8 m-85 -81.37 4.46 20.72 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.01 1.324 . . . . 0.0 113.563 178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 57.72 10.95 1.18 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.74 2.816 . . . . 0.0 116.067 174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 48.5 47.78 28.78 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.943 1.258 . . . . 0.0 112.611 -171.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -69.92 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -174.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . 0.25 12.2 p30 48.71 27.55 1.57 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 128.736 2.815 . . . . 0.0 115.711 178.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -136.16 151.44 20.76 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.718 1.628 . . . . 0.0 112.236 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -57.89 131.08 49.33 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 111.938 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.442 ' CD2' ' HB3' ' A' ' 140' ' ' TYR . 32.5 m-70 -124.22 114.19 19.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.335 1.854 . . . . 0.0 110.132 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.57 131.05 12.17 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.984 1.314 . . . . 0.0 111.986 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 32.5 mmtt -144.57 126.0 14.89 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.34 1.856 . . . . 0.0 110.645 -175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.95 101.28 0.2 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.261 1.025 . . . . 0.0 113.051 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -124.92 -26.39 3.74 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.829 1.251 . . . . 0.0 113.467 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -83.45 13.97 43.35 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.926 1.251 . . . . 0.0 114.679 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 2.8 t80 61.0 7.77 1.65 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.619 2.367 . . . . 0.0 114.964 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -170.1 -57.46 0.04 OUTLIER Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.075 1.321 . . . . 0.0 112.066 -175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 5.0 mp -106.05 155.74 19.1 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.247 1.019 . . . . 0.0 111.667 175.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -146.9 166.37 26.94 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.485 1.914 . . . . 0.0 112.169 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -89.07 135.29 33.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.079 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -125.72 101.7 6.99 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -132.03 169.42 22.11 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-O 121.565 0.536 . . . . 0.0 112.955 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.94 147.15 16.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.318 1.447 . . . . 0.0 109.264 176.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 31.0 ttp -152.8 144.7 23.66 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.483 1.513 . . . . 0.0 107.259 174.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.2 p -86.65 163.01 17.63 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.865 0.84 . . . . 0.0 111.381 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.2 p -81.47 13.67 2.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.417 1.887 . . . . 0.0 113.121 -176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -116.38 151.69 35.44 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.028 2.531 . . . . 0.0 111.612 -170.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -53.46 -57.21 16.3 Favored Glycine 0 N--CA 1.471 1.005 0 C-N-CA 124.145 0.879 . . . . 0.0 114.146 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -78.67 59.59 2.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.781 1.232 . . . . 0.0 113.832 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -93.2 176.89 6.24 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.236 1.414 . . . . 0.0 113.989 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.6 136.05 48.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.339 1.856 . . . . 0.0 109.052 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 2.4 ttp -124.96 88.49 2.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.069 1.348 . . . . 0.0 110.801 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -83.67 153.8 24.03 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.553 -0.717 . . . . 0.0 111.746 165.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 57.9 mt -136.08 115.86 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 127.184 2.194 . . . . 0.0 106.893 175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -113.12 97.14 6.32 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.434 1.894 . . . . 0.0 108.872 -176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 36.0 mm -83.21 106.91 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.206 0.527 . . . . 0.0 110.748 -176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 19.8 m -139.82 -179.62 6.05 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.852 1.661 . . . . 0.0 112.041 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--O 1.249 1.068 0 C-N-CA 126.147 1.779 . . . . 0.0 111.992 178.859 . . . . . . . . 0 0 . 1 stop_ save_